0001445305-14-003299.txt : 20140731 0001445305-14-003299.hdr.sgml : 20140731 20140731161718 ACCESSION NUMBER: 0001445305-14-003299 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140630 FILED AS OF DATE: 20140731 DATE AS OF CHANGE: 20140731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MCKESSON CORP CENTRAL INDEX KEY: 0000927653 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 943207296 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-13252 FILM NUMBER: 141006504 BUSINESS ADDRESS: STREET 1: ONE POST ST STREET 2: MCKESSON PLAZA CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 4159838300 MAIL ADDRESS: STREET 1: ONE POST ST CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: MCKESSON HBOC INC DATE OF NAME CHANGE: 19990115 FORMER COMPANY: FORMER CONFORMED NAME: MCKESSON CORP DATE OF NAME CHANGE: 19950209 FORMER COMPANY: FORMER CONFORMED NAME: SP VENTURES INC DATE OF NAME CHANGE: 19940728 10-Q 1 mck_10qx06302014.htm 10-Q MCK_10Q_06.30.2014
Table of Contents                                        


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2014
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from             to            
Commission File Number: 1-13252
 
McKESSON CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
 
94-3207296
(State or other jurisdiction
of incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
 
One Post Street, San Francisco, California
 
94104
(Address of principal executive offices)
 
(Zip Code)
(415) 983-8300
(Registrant’s telephone number, including area code)
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
x
  
Accelerated filer
 
o
 
 
 
 
 
 
 
Non-accelerated filer
 
o (Do not check if a smaller reporting company)
  
Smaller reporting company
 
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class
 
Outstanding as of
June 30, 2014
Common stock, $0.01 par value
 
231,599,218 shares



McKESSON CORPORATION

TABLE OF CONTENTS
 
 
Item
Page
 
 
 
 
 
 
 
 
1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.
 
 
 
3.
 
 
 
4.
 
 
 
 
 
 
 
 
1.
 
 
 
1A.
 
 
 
2.
 
 
 
3.
 
 
 
4.
 
 
 
5.
 
 
 
6.
 
 
 
 



2

McKESSON CORPORATION

PART I—FINANCIAL INFORMATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
 
 
Quarter Ended June 30,
 
2014

2013
Revenues
$
44,058

 
$
32,239

Cost of Sales
(41,261
)
 
(30,309
)
Gross Profit
2,797

 
1,930

 
 
 
 
Operating Expenses
(2,109
)
 
(1,260
)
Litigation Charges

 
(15
)
Total Operating Expenses
(2,109
)
 
(1,275
)
Operating Income
688

 
655

Other Income, Net
20

 
6

Interest Expense
(101
)
 
(59
)
Income from Continuing Operations Before Income Taxes
607

 
602

Income Tax Expense
(182
)
 
(174
)
Income from Continuing Operations
425


428

Loss from Discontinued Operations, Net of Tax
(14
)

(4
)
Net Income
411


424

Net Income Attributable to Noncontrolling Interests
(8
)
 

Net Income Attributable to McKesson Corporation
$
403

 
$
424

 
 
 
 
Earnings (Loss) Per Common Share Attributable
to McKesson Corporation



Diluted
 

 
Continuing operations
$
1.78


$
1.84

Discontinued operations
(0.06
)

(0.01
)
Total
$
1.72


$
1.83

Basic
 
 
 
Continuing operations
$
1.81


$
1.88

Discontinued operations
(0.06
)

(0.02
)
Total
$
1.75


$
1.86

 
 
 
 
Dividends Declared Per Common Share
$
0.24

 
$
0.20

 
 
 
 
Weighted Average Common Shares
 
 
 
Diluted
235

 
232

Basic
231

 
227




See Financial Notes

3

McKESSON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
(Unaudited)
 
 
Quarter Ended June 30,
 
2014

2013
Net Income
$
411

 
$
424

 
 
 
 
Other Comprehensive Income (Loss), Net of Tax
 
 
 
Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2
98

 
(61
)
 
 
 
 
Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil
(2
)
 
1

 
 
 
 
Retirement-related benefit plans, net of income tax expense of $1 and $4
2

 
7

Other Comprehensive Income (Loss), Net of Tax
98

 
(53
)
 
 
 
 
Comprehensive Income
509

 
371

Comprehensive Loss Attributable to Noncontrolling Interests
4

 

Comprehensive Income Attributable to McKesson Corporation
$
513

 
$
371








See Financial Notes

4

McKESSON CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except per share amounts)
(Unaudited)
 
June 30,
2014
 
March 31,
2014
ASSETS
 
 
 
Current Assets
 
 
 
Cash and cash equivalents
$
4,105

 
$
4,193

Receivables, net
14,920

 
14,193

Inventories, net
14,124

 
13,308

Prepaid expenses and other
824

 
879

Total Current Assets
33,973

 
32,573

Property, Plant and Equipment, Net
2,209

 
2,222

Goodwill
10,431

 
9,927

Intangible Assets, Net
4,390

 
5,022

Other Assets
2,003

 
2,015

Total Assets
$
53,006

 
$
51,759

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current Liabilities
 
 
 
Drafts and accounts payable
$
22,812

 
$
21,429

Short-term borrowings
507

 
346

Deferred revenue
1,124

 
1,236

Deferred tax liabilities
1,656

 
1,588

Current portion of long-term debt
25

 
1,424

Other accrued liabilities
3,121

 
3,478

Total Current Liabilities
29,245

 
29,501

Long-Term Debt
10,141

 
8,949

Other Noncurrent Liabilities
2,855

 
2,991

Commitments and Contingent Liabilities (Note 12)

 

McKesson Corporation Stockholders’ Equity
 
 
 
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding

 

Common stock, $0.01 par value, 800 shares authorized at June 30, 2014 and March 31, 2014, 383 and 381 shares issued at June 30, 2014 and March 31, 2014
4

 
4

Additional Paid-in Capital
6,686

 
6,552

Retained Earnings
11,800

 
11,453

Accumulated Other Comprehensive Income (Loss)
107

 
(3
)
Other
(7
)
 
23

Treasury Shares, at Cost, 151 and 150 at June 30, 2014 and March 31, 2014
(9,611
)
 
(9,507
)
Total McKesson Corporation Stockholders’ Equity
8,979

 
8,522

Noncontrolling Interests
1,786

 
1,796

Total Equity
10,765

 
10,318

Total Liabilities and Equity
$
53,006

 
$
51,759



See Financial Notes

5

McKESSON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)
 
Quarter Ended June 30,
 
2014
 
2013
Operating Activities
 
 
 
Net income
$
411

 
$
424

Adjustments to reconcile to net cash provided by operating activities:
 
 
 
Depreciation and amortization
284

 
162

Deferred taxes
135

 
98

Charges associated with last-in-first-out inventory method
98

 

Other non-cash items
14

 
32

Changes in operating assets and liabilities, net of acquisitions:
 
 
 
Receivables
(699
)
 
(139
)
Inventories
(901
)
 
(60
)
Drafts and accounts payable
1,368

 
589

Deferred revenue
(134
)
 
(116
)
Taxes
(134
)
 
31

Other
(260
)
 
(305
)
Net cash provided by operating activities
182

 
716

 
 
 
 
Investing Activities
 
 
 
Property acquisitions
(86
)
 
(69
)
Capitalized software expenditures
(33
)
 
(32
)
Acquisitions, net of cash and cash equivalents acquired
(14
)
 
(74
)
Other
21

 
(9
)
Net cash used in investing activities
(112
)
 
(184
)
 
 
 
 
Financing Activities
 
 
 
Proceeds from short-term borrowings
917

 
100

Repayments of short-term borrowings
(759
)
 
(100
)
Proceeds from issuances of long-term debt
6

 

Repayments of long-term debt
(230
)
 

Common stock transactions:
 
 
 
Issuances
34

 
50

Share repurchases, including shares surrendered for tax withholding
(102
)
 
(127
)
Dividends paid
(59
)
 
(53
)
Other
26

 
57

Net cash used in financing activities
(167
)
 
(73
)
Effect of exchange rate changes on cash and cash equivalents
9

 
(10
)
Net (decrease) increase in cash and cash equivalents
(88
)
 
449

Cash and cash equivalents at beginning of period
4,193

 
2,456

Cash and cash equivalents at end of period
$
4,105

 
$
2,905


See Financial Notes

6

McKESSON CORPORATION
FINANCIAL NOTES
(UNAUDITED)


1.
Significant Accounting Policies
Basis of Presentation: The condensed consolidated financial statements of McKesson Corporation (“McKesson,” the “Company,” or “we” and other similar pronouns) include the financial statements of all wholly-owned subsidiaries and majority‑owned or controlled companies. We also evaluate our ownership, contractual and other interests in entities to determine if they are variable interest entities (“VIEs”), if we have a variable interest in those entities and the nature and extent of those interests. These evaluations are highly complex and involve judgment and the use of estimates and assumptions based on available historical information and management’s judgment, among other factors. Based on our evaluations, if we determine we are the primary beneficiary of such VIEs, we consolidate such entities into our financial statements. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method and our proportionate share of income or loss is recorded in other income, net. Intercompany transactions and balances have been eliminated. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnote disclosures normally included in the annual consolidated financial statements.
To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. In our opinion, the accompanying unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods presented.
The results of operations for the quarter ended June 30, 2014 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies and financial notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2014 previously filed with the SEC on May 14, 2014 (“2014 Annual Report”).
Certain prior period amounts have been reclassified to conform to the current period presentation.
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year.
Recently Adopted Accounting Pronouncements
Cumulative Translation Adjustments: In the first quarter of 2015, we adopted amended guidance for parent’s accounting for the cumulative translation adjustment upon derecognition of certain subsidiaries or group of assets within a foreign entity or of an investment in a foreign entity.  The amended guidance requires the release of any cumulative translation adjustment into net income only upon complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.  Also, it requires the release of all or a pro rata portion of the cumulative translation adjustment to net income in case of sale of an equity method investment that is a foreign entity.  The adoption of this amended guidance did not have a material effect on our condensed financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
Discontinued Operations: In April 2014, amended guidance was issued for reporting of discontinued operations and disclosures of disposals of components.  The amended guidance raises the threshold for disposals to qualify as discontinued operations and permits significant continuing involvement and continuing cash flows with the discontinued operation.  In addition, the amended guidance requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation.  The amended guidance is effective for us prospectively commencing in the first quarter of 2016.  Early adoption is permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.


7

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

Revenue Recognition: In May 2014, amended guidance was issued for recognizing revenue from contracts with customers.  The amended guidance eliminated industry specific guidance and applies to all companies.  Revenues will be recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service. Revenue from a contract that contains multiple performance obligations is allocated to each performance obligation generally on a relative standalone selling price basis. The amended guidance also requires additional quantitative and qualitative disclosures. The amended guidance is effective for us commencing in the first quarter of 2018.  The amended guidance allows for either full retrospective adoption or modified retrospective adoption. Early adoption is not permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.
2.
Business Combinations
On February 6, 2014, we completed the acquisition of 77.6% of the then outstanding common shares of Celesio AG (“Celesio”) and certain convertible bonds of Celesio for cash consideration of $4.5 billion, net of cash acquired (the “Acquisition”). Upon the acquisition, as required, we consolidated Celesio’s debt with a fair value of $2.3 billion as a liability on our consolidated balance sheet and our ownership of Celesio’s fully diluted common shares was 75.6%. The Acquisition was initially funded by utilizing a senior bridge loan, our existing accounts receivable sales facility and cash on hand. Celesio is an international wholesale and retail company and a provider of logistics and services to the pharmaceutical and healthcare sectors. Celesio’s headquarters is in Stuttgart, Germany and it operates in 14 countries around the world. The acquisition of Celesio expands our global geographic area; the combined company is one of the largest pharmaceutical wholesalers and providers of logistics and services in the healthcare sector worldwide.
From February 7 to March 31, 2014, substantially all of the convertible bonds issued by Celesio (held by both third parties and us) were converted to 20.9 million common shares of Celesio. During the first quarter of 2015, we completed tender offers and we acquired approximately 1 million common shares of Celesio at €23.50 per share for a total of $32 million in cash, and the remaining convertible bonds were fully converted into 42,238 common shares of Celesio. At June 30, 2014 and March 31, 2014, we owned approximately 75.9% and 75.4% of Celesio’s outstanding and fully diluted common shares.
On May 22, 2014, Celesio and McKesson, through its wholly-owned subsidiary Dragonfly GmbH & Co. KGaA, entered into a domination and profit and loss transfer agreement (the “Agreement”). Under the Agreement, Celesio will subordinate its management to McKesson and undertake to transfer all of its annual profits to McKesson, and McKesson will undertake to compensate any annual losses incurred by Celesio and to grant, subject to a potential court review, the noncontrolling shareholders of Celesio (i) an annual recurring compensation of €0.83 per Celesio share and (ii) a put right for their Celesio shares at €22.99 per Celesio share. On July 15, 2014, the Agreement was approved at the general shareholders’ meeting of Celesio. The Agreement becomes effective upon its registration in the commercial register of Celesio at the local court of Stuttgart, Germany. Celesio’s obligation to transfer its annual profits under the Agreement will apply for the first time for the entire profit generated in Celesio’s fiscal period beginning on January 1, 2015 or the subsequent fiscal year in which the Agreement becomes effective. McKesson’s obligation to compensate the annual losses of Celesio under the Agreement will apply for the first time for the full fiscal period of Celesio during which the Agreement becomes effective. We currently anticipate the Agreement to be effective by the end of the calendar year, at which time, we will obtain operational control of Celesio.
Financial results for Celesio are included within our International pharmaceutical distribution and services business, which is part of our Distribution Solutions segment, since the date of acquisition.



8

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

The following table summarizes the preliminary recording of the fair values of the assets acquired and liabilities assumed as of the acquisition date.
(In millions)
Amounts
Previously Recognized as of
Acquisition Date
(Provisional)
(1)
 
Measurement Period Adjustments
 
Amounts Recognized as of Acquisition Date (Provisional as Adjusted)
Receivables
$
3,425

 
$
(3
)
 
$
3,422

Other current assets, net of cash and cash equivalents
acquired
2,413

 
(3
)
 
2,410

Goodwill
3,570

 
436

 
4,006

Intangible assets
3,018

 
(536
)
 
2,482

Other long-term assets
1,272

 
(44
)
 
1,228

Current liabilities
(4,096
)
 
(6
)
 
(4,102
)
Short-term borrowings and current portion of long-term debt
(1,990
)
 

 
(1,990
)
Long-term debt
(322
)
 

 
(322
)
Other long-term liabilities
(1,293
)
 
156

 
(1,137
)
Fair value of net assets, less cash and cash equivalents
5,997

 

 
5,997

Less: Noncontrolling Interests
(1,500
)
 

 
(1,500
)
Net assets acquired, less cash and cash equivalents
$
4,497

 
$

 
$
4,497

(1)
As previously reported in our Form 10-K for the year ended March 31, 2014.
During the first quarter of 2015, the fair value measurements of assets acquired and liabilities assumed of Celesio as of the acquisition date were refined. Among the adjustments recorded, the fair value of acquired intangible assets was decreased by $536 million. The fair value was primarily determined by applying the income approach using unobservable inputs for projected cash flows and a discount rate, which were refined during the current period, and are considered Level 3 inputs under the fair value measurements and disclosure guidance. These refinements did not have a significant impact on our condensed consolidated statements of operations, balance sheets or cash flows in any period and, therefore, we have not retrospectively adjusted our financial statements. These amounts are subject to change within the measurement period as our fair value assessments are finalized.
During the last two years, we also completed a number of smaller acquisitions within both of our operating segments. Financial results for our business acquisitions have been included in our consolidated financial statements since their respective acquisition dates. Purchase prices for our business acquisitions have been allocated based on estimated fair values at the date of acquisition.
Goodwill recognized for our business acquisitions is generally not expected to be deductible for tax purposes. However, if we acquire the assets of a company, the goodwill may be deductible for tax purposes.
3.
Noncontrolling Interests
At June 30, 2014, we owned approximately 75.9% of Celesio’s outstanding and fully diluted common shares, which was primarily obtained through our February 2014 acquisition of the then outstanding common shares and certain convertible bonds of Celesio. In April 2014, we completed tender offers and paid $32 million in cash to acquire approximately 1 million additional common shares of Celesio, which increased our ownership share by 0.5% and decreased noncontrolling interests by $35 million since March 31, 2014. The effect of changes in our ownership interest in Celesio on our equity of $3 million was recorded as an increase to McKesson’s stockholders’ paid-in capital. Net income attributable to McKesson and transfers from noncontrolling interests to McKesson equity amounted to $406 million for the first quarter of 2015.


9

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

4.
Discontinued Operations
In 2014, we committed to a plan to sell our International Technology and our Hospital Automation businesses from our Technology Solutions segment and certain businesses from our Distribution Solutions segment. As required, we classified the results of operations and cash flows of these businesses as discontinued operations for all periods presented in our consolidated financial statements in 2014 and depreciation and amortization expense was not recognized.
During the third quarter of 2014, our Hospital Automation business was sold for net cash proceeds of $55 million and we recorded a pre-tax and after-tax loss of $5 million and $7 million.
During the third quarter of 2014, we recorded an $80 million pre-tax ($80 million after-tax) non-cash impairment charge to reduce the carrying value of our International Technology business to its estimated net realizable value (fair value less costs to sell). The charge was primarily the result of the terms of the preliminary purchase offers received for this business during the third quarter of 2014. The impairment charge was primarily attributed to goodwill and other long-lived assets and as a result, there was no tax benefit associated with this charge. During the first quarter of 2015, we entered into an agreement to sell the software business within our International Technology business. We completed the sale of the software business on July 1, 2014 and no material gain or loss is anticipated. 
During the first quarter of 2015, we also decided to retain the workforce business within our International Technology business. This business consists of workforce management solutions for the National Health Service in the United Kingdom, which we now intend to wind down in 2016. As a result, we reclassified the workforce business, which had been designated as a discontinued operation since the first quarter of 2014, as a continuing operation for all periods presented. During the first quarter of 2015, we also recorded a non-cash pre-tax charge of $34 million ($27 million after-tax) primarily relating to depreciation and amortization expense for 2014 when the business was classified as held for sale. The non-cash charge was recorded in our condensed consolidated statement of operations as follows: $32 million in cost of sales and $2 million in operating expenses.
A summary of results of discontinued operations is as follows:
 
Quarter Ended June 30,
(In millions)
2014
 
2013
Revenues
$
36

 
$
85

 
 
 
 
Loss from discontinued operations
$
(15
)
 
$
(3
)
Income tax (expense) benefit
1

 
(1
)
Loss from discontinued operations, net of tax
$
(14
)
 
$
(4
)
The assets and liabilities of our discontinued operations are classified as held-for-sale effective in 2014. All applicable assets of the businesses to be sold are included under the caption “Prepaid expenses and other” and all applicable liabilities under the caption “Other accrued liabilities” within our condensed consolidated balance sheet at June 30, 2014 and March 31, 2014. The carrying values of the assets and liabilities classified as held-for-sale were $138 million and $144 million at June 30, 2014 and $267 million and $248 million at March 31, 2014.
5.
Income Taxes
As of June 30, 2014, we had $582 million of unrecognized tax benefits, of which $427 million would reduce income tax expense and the effective tax rate, if recognized. During the next twelve months, it is reasonably possible that audit resolutions and the expiration of statutes of limitations could potentially reduce our unrecognized tax benefits by up to $158 million. However, this amount may change as we continue to have ongoing negotiations with various taxing authorities throughout the year.


10

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

We have received reassessments from the Canada Revenue Agency (“CRA”) for a total of $261 million related to a transfer pricing matter impacting years 2003 through 2010. On December 13, 2013, the Tax Court of Canada dismissed our appeal of the 2003 reassessment and we have filed a Notice of Appeal to the Federal Court of Appeal regarding this tax year. During the first quarter of 2015, we filed a Notice of Appeal with the Tax Court of Canada relating to the 2004 through 2008 reassessments.  The ultimate resolution of these issues could result in an increase or decrease to income tax expense.
Through the appeals process, we reached an agreement with the Internal Revenue Service (“IRS”) to settle all outstanding issues relating to years 2003 through 2006. As a result of this agreement we will pay additional taxes of $21 million, which have already been accrued in our financial statements. We are also recognizing a $17 million discrete tax benefit during the quarter to record a previously unrecognized tax benefit.
The IRS is currently examining our U.S. corporation income tax returns for 2007 through 2009. The CRA is currently examining our Canadian Income tax returns for 2011 through 2013. In nearly all jurisdictions, the tax years prior to 2003 are no longer subject to examination.
We report interest and penalties on tax deficiencies as income tax expense. During the quarter, we recognized income tax expense of $4 million, before any tax benefit, related to interest and penalties in our condensed consolidated statements of operations. At June 30, 2014, before any tax benefits, our accrued interest and penalties on unrecognized tax benefits amounted to $161 million.


11

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

6.
Earnings Per Common Share
Basic earnings per common share are computed by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share are computed similar to basic earnings per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.
The computations for basic and diluted earnings per common share are as follows:
  
Quarter Ended June 30,
(In millions, except per share amounts)
2014
 
2013
Income from continuing operations
$
425

 
$
428

Net income attributable to noncontrolling interests
(8
)
 

Income from continuing operations attributable to McKesson
417

 
428

Loss from discontinued operations, net of tax
(14
)
 
(4
)
Net income attributable to McKesson
$
403

 
$
424

 
 
 
 
Weighted average common shares outstanding:
 
 
 
Basic
231

 
227

Effect of dilutive securities:
 
 
 
Options to purchase common stock
2

 
2

Restricted stock units
2

 
3

Diluted
235

 
232

 
 
 
 
Earnings (loss) per common share attributable to McKesson: (1)
 
 
 
Diluted
 
 
 
Continuing operations
$
1.78

 
$
1.84

Discontinued operations
(0.06
)
 
(0.01
)
Total
$
1.72

 
$
1.83

Basic
 
 
 
Continuing operations
$
1.81

 
$
1.88

Discontinued operations
(0.06
)
 
(0.02
)
Total
$
1.75

 
$
1.86

(1)
Certain computations may reflect rounding adjustments.
Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2 million and 3 million potentially dilutive securities were excluded from the computations of diluted net earnings per common share for the quarters ended June 30, 2014 and 2013, as they were anti-dilutive.


12

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

7.
Goodwill and Intangible Assets, Net
Changes in the carrying amount of goodwill were as follows:
(In millions)
Distribution
Solutions
 
Technology
Solutions
 
Total
Balance, March 31, 2014
$
8,078

 
$
1,849

 
$
9,927

Goodwill acquired
14

 

 
14

Acquisition accounting and other
445

 

 
445

Foreign currency translation adjustments and other
41

 
4

 
45

Balance, June 30, 2014
$
8,578

 
$
1,853

 
$
10,431

As of June 30, 2014 and March 31, 2014, the accumulated goodwill impairment losses were $36 million in our Technology Solutions segment.
Information regarding intangible assets is as follows:
 
June 30, 2014
 
March 31, 2014
(Dollars in millions)
Weighted
Average
Remaining
Amortization
Period
(years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer lists
9
 
$
3,022

 
$
(937
)
 
$
2,085

 
$
3,384

 
$
(863
)
 
$
2,521

Service agreements
16
 
1,014

 
(189
)
 
825

 
995

 
(173
)
 
822

Pharmacy licenses
27
 
1,051

 
(28
)
 
1,023

 
1,219

 
(11
)
 
1,208

Trademarks and trade names
15
 
377

 
(68
)
 
309

 
371

 
(59
)
 
312

Technology
3
 
218

 
(177
)
 
41

 
219

 
(173
)
 
46

Other
4
 
173

 
(66
)
 
107

 
165

 
(52
)
 
113

Total
 
 
$
5,855


$
(1,465
)
 
$
4,390

 
$
6,353

 
$
(1,331
)
 
$
5,022

Amortization expense of intangible assets was $130 million and $71 million for the quarters ended June 30, 2014 and 2013. Estimated annual amortization expense of these assets is as follows: $383 million, $468 million, $429 million, $410 million and $382 million for the remainder of 2015 and each of the succeeding years through 2019 and $2,318 million thereafter. All intangible assets were subject to amortization as of June 30, 2014 and March 31, 2014.
8.
Debt and Financing Activities
Celesio Debt
Upon the acquisition of Celesio, as required, we consolidated Celesio’s debt including corporate bonds consisting of 4.00% bonds due October 18, 2016 and 4.50% bonds due April 26, 2017. At June 30, 2014 and March 31, 2014, $500 million and $507 million of the 4.00% bonds and $726 million and $737 million of the 4.50% bonds, for a total of $1,226 million and $1,244 million, were outstanding. As of March 31, 2014, these bonds were classified within current liabilities as bondholders had the option to redeem the bonds at par value plus accrued interest. This redemption option expired during the first quarter of 2015 and the remaining bonds outstanding will mature according to their respective maturity dates. Accordingly, as of June 30, 2014, these bonds have been classified as long-term debt.


13

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

We also consolidated Celesio’s accounts receivable factoring facilities (the “Factoring Facilities”) with a total committed and uncommitted balance of $315 million. The Factoring Facilities will expire through September 2015. During the first quarter of 2015, Celesio borrowed and repaid $758 million and $746 million of short-term borrowings under the Factoring Facilities. At June 30, 2014 and March 31, 2014, there were $258 million and $246 million in secured borrowings and related securitized accounts receivable outstanding under the Factoring Facilities.
Celesio also maintains a syndicated €500 million five-year senior unsecured revolving credit facility, which expires in February 2018. Borrowings under this facility bear interest based upon the Euro Interbank Offered Rate plus an agreed margin. There were no borrowings under this facility during the first quarter of 2015 and there were no amounts outstanding under this facility as of June 30, 2014 and March 31, 2014.
Celesio also maintains bilateral credit lines with a total committed and uncommitted balance of $2.0 billion. During the first quarter of 2015, Celesio borrowed and repaid $159 million and $30 million under these credit lines primarily relating to short‑term borrowings. As of June 30, 2014 and March 31, 2014, there were $321 million and $188 million outstanding under these credit lines.
Accounts Receivable Sales Facility
We have an accounts receivable sales facility (the “Facility”) with a committed balance of $1.35 billion, although from time to time, the available amount of the Facility may be less than $1.35 billion based on accounts receivable concentration limits and other eligibility requirements. The Facility will expire in November 2014 and we anticipate renewing the Facility before its expiration.
During the first quarter of 2015, there were no borrowings under the Facility. During the first quarter of 2014, we borrowed and repaid $100 million of short-term borrowings under the Facility. At June 30, 2014 and March 31, 2014, there were no short‑term borrowings and related securitized accounts receivable outstanding under the Facility.
The Facility contains requirements relating to the performance of the accounts receivable and covenants relating to the Company. If we do not comply with these covenants, our ability to use the Facility may be suspended and repayment of any outstanding balances under the Facility may be required. At June 30, 2014 and March 31, 2014, we were in compliance with all covenants.
Revolving Credit Facility
We have a syndicated $1.3 billion five-year senior unsecured revolving credit facility, which expires in September 2016. Borrowings under this facility bear interest based upon either the London Interbank Offered Rate or a prime rate. There were no borrowings under this facility during the first quarters of 2015 and 2014. As of June 30, 2014 and March 31, 2014, there were no amounts outstanding under this facility.
9.
Pension Benefits
Net periodic expense for the defined pension benefit plans of the Company and Celesio was $11 million for the first quarters of 2015 and 2014. Cash contributions to these plans were $15 million and $5 million for the first quarters of 2015 and 2014. The increase in contributions in 2015 compared to 2014 is primarily related to defined benefit pension plans of Celesio, which we acquired in the fourth quarter of 2014.


14

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

The net periodic expense for our pension plans, which includes net pension expense for Celesio in the first quarter of 2015, is as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
Quarter Ended June 30,
 
Quarter Ended June 30,
(In millions)
2014
 
2013
 
2014
 
2013
Service cost - benefits earned during the year
$

 
$
1

 
$
4

 
$
1

Interest cost on projected benefit obligation
5

 
5

 
9

 
1

Expected return on assets
(5
)
 
(5
)
 
(7
)
 
(2
)
Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation
4

 
9

 
1

 
1

Net periodic pension expense
$
4

 
$
10

 
$
7

 
$
1

The projected unit credit method is utilized in measuring net periodic pension expense over the employees’ service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.
10.
Hedging Activities
In the normal course of business, we are exposed to interest rate changes and foreign currency fluctuations. At times, we limit these risks through the use of derivatives such as interest rate swaps and forward foreign exchange contracts. In accordance with our policy, derivatives are only used for hedging purposes. We do not use derivatives for trading or speculative purposes.
Foreign currency rate risk
Prior to the acquisition of Celesio, the majority of our operations were conducted in U. S. dollars; however, certain assets and liabilities, revenues and expense and purchasing activities were incurred in and exposed to other currencies. We have established certain foreign currency rate risk programs that manage the impact of foreign currency fluctuation. These programs are utilized on a transactional basis when we consider there to be a risk in fair value or volatility in cash flows. These programs reduce but do not entirely eliminate foreign currency rate risk.
Historically, we have entered into forward contracts and a foreign currency option to hedge against cash flows denominated primarily in Canadian dollars, Euros and British pounds. At June 30, 2014 and March 31, 2014, forward contracts having a total notional value of $463 million were designated for hedge accounting. These contracts will mature between March 2015 and March 2020. Changes in the fair values for contracts designated for hedge accounting are recorded to accumulated other comprehensive income and reclassified into earnings in the same period in which the hedged transaction affects earnings; amounts recorded to earnings for these contracts were not material during the first quarters of 2015 and 2014. Changes in the fair values for contracts not designated for hedge accounting are recorded directly to earnings; amounts recorded to earnings for these contracts were not material during the first quarter of 2014. All forward contracts were designated for hedge accounting during the first quarter of 2015.
Celesio has a number of forward contracts to hedge against cash flows denominated primarily in British pounds and other European currencies. These contracts will mature from July 2014 to June 2015. None of these contracts were designated for hedge accounting and accordingly, changes in the fair value of these contracts are recorded directly in earnings. At June 30, 2014 and March 31, 2014, the total notional values of these contracts were $1,449 million and $1,091 million. Amounts recorded to earnings were not material during the first quarter of 2015.


15

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

Interest rate risk
Celesio also has interest rate swaps to hedge the interest rate risk associated with Celesio’s variable rate debt. Interest rate swaps are used to modify the market risk exposures in connection with the variable rate debt to achieve primarily Euro dollar fixed rate interest expense. The interest rate swap transactions generally involve the exchange of floating or fixed interest payments. The interest rate swaps will mature through September 2014. These contracts are not designated for hedge accounting and, accordingly, changes in the fair value of the swaps are recorded directly in earnings. At June 30, 2014 and March 31, 2014, the total gross notional values of these contracts were $68 million and $96 million. Amounts recorded to earnings were not material during the first quarter of 2015.
Information regarding the fair value of derivatives on a gross basis is as follows:
 
Balance Sheet
Caption
June 30, 2014
 
March 31, 2014
 
Fair Value of
Derivative
U.S. Dollar Notional
 
Fair Value of
Derivative
U.S Dollar Notional
(In millions)
Asset
Liability
 
Asset
Liability
Derivatives designated for hedge accounting
 
 
 
 
 
 
 
 
Foreign exchange
 contracts (current)
Prepaid expenses and other
$
2

$

$
64

 
$
4

$

$
64

Foreign exchange
 contracts (non-current)
Other assets
15


399

 
27


399

Total
 
$
17

$

 
 
$
31

$

 
Derivatives not designated for hedge accounting
 
 
 
 
 
 
 
 
Foreign exchange
 contracts (current)
Prepaid expenses and other
$
2

$

$
174

 
$
2

$

$
255

Foreign exchange
 contracts (current)
Other accrued liabilities

26

1,275

 

13

836

Interest rate swap contracts (current)
Other accrued liabilities


68

 

1

96

Total
 
$
2

$
26

 
 
$
2

$
14

 
Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.


16

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

11.
Fair Value Measurements
At June 30, 2014 and March 31, 2014, the carrying amounts of cash, cash equivalents, restricted cash, marketable securities receivables, drafts and accounts payable and other current liabilities generally approximated their estimated fair values because of the short maturity of these financial instruments.
Our long-term debt and other financing are carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $10.2 billion and $10.7 billion at June 30, 2014 and $10.4 billion and $10.8 billion at March 31, 2014. The estimated fair values of our long-term debt and other financing were determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.
Included in cash and cash equivalents at June 30, 2014 and March 31, 2014 were investments in money market funds, time deposits and repurchase agreements of $3.4 billion and $2.9 billion, which are reported at fair value. The fair value of these investments was determined by using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.
Fair values of our forward foreign currency derivatives were determined using quoted market prices of similar instruments in an active market and other observable inputs from available market information.  These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, "Hedging Activities," for more information on our forward foreign currency derivatives.
There were no transfers between Level 1, Level 2 or Level 3 of the fair value hierarchy during the quarters ended June 30, 2014 and 2013.
12.
Commitments and Contingent Liabilities
In addition to commitments and obligations in the ordinary course of business, we are subject to various claims, other pending and potential legal actions for damages, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of our business. As described below, many of these proceedings are at preliminary stages and many seek an indeterminate amount of damages.
When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate a range of possible loss. When a loss is probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.
Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. We review all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties. Such factors bear directly on whether it is possible to reasonably estimate a range of potential loss and boundaries of high and low estimates.


17

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

Significant developments in previously reported proceedings and in other litigation and claims, since the filing of our 2014 Annual Report are set out below. Unless otherwise stated, we are currently unable to estimate a range of reasonably possible losses for the unresolved proceedings described below. Should any one or a combination of more than one of these proceedings be successful, or should we determine to settle any or a combination of these matters, we may be required to pay substantial sums, become subject to the entry of an injunction or be forced to change the manner in which we operate our business, which could have a material adverse impact on our financial position or results of operations.
Litigation, Government Subpoenas and Investigations
On May 21, 2014, four hedge funds managed by Magnetar Capital filed a complaint against Dragonfly GmbH & Co KGaA (“Dragonfly”), a wholly-owned subsidiary of the Company, in a German court in Frankfurt, Germany, alleging that Dragonfly violated German takeover law in connection with the Company’s acquisition of Celesio by paying more to some holders of Celesio’s convertible bonds than it paid to the shareholders of Celesio’s stock, and seeking approximately $356,000 (or €261,000) in damages plus an unspecified amount of interest, Magnetar Capital Master Fund Ltd. et al. v. Dragonfly GmbH & Co KGaA, (No. 3-05 O 44/14).  Other minority shareholders may seek to file similar lawsuits alleging the same claim, seeking damages based on their shares of Celesio stock. Dragonfly has not yet responded to the complaint.
On June 17, 2014, U.S. Oncology Specialty, LP (“USOS”), an indirect wholly-owned subsidiary of the Company, was served with a fifth amended qui tam complaint filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States and twelve states, against USOS and fifteen oncology practices, alleging that USOS facilitated the payment of illegal “kickbacks” from Amgen to the oncology practices in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys’ fees and costs of suit, all in unspecified amounts, United States ex rel. Hanks v. U.S. Oncology Specialty, LP, et al., (CV 04-3983 (SJ)).  Previously, the United States and the twelve states named in the operative complaint declined to intervene in the case.  The Court set August 1, 2014 as the deadline for USOS and the other defendants to respond to the complaint.
From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests also can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the healthcare industry, as well as to settlements. Examples of such subpoenas and investigations are included in the Company’s 2014 Annual Report on Form 10-K, and include subpoenas from the U.S. Drug Enforcement Administration to certain of the Company’s pharmaceutical distribution facilities seeking information and records about the Company’s distribution of certain controlled substances. The Company is currently responding to these requests. In addition, as previously reported, the Company was informed in the third quarter of 2014 of an investigation by the United States Department of Justice through the United States Attorney’s Office for the Northern District of West Virginia of potential claims under the Comprehensive Drug Abuse Prevention and Control Act.  The Company believes that the investigation is focused on the Company’s pharmaceutical distribution of certain controlled substances by its Landover, Maryland distribution center, which closed in 2012.
13.
Stockholders’ Equity
Each share of the Company’s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company’s Board of Directors (the “Board”).
In July 2013, the Company’s quarterly dividend was raised from $0.20 to $0.24 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.  However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements and other factors.


18

McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)

The total authorization outstanding for repurchases of the Company’s common stock was $340 million at June 30, 2014.
Other Comprehensive Income (Loss)
Information regarding other comprehensive income (loss) including noncontrolling interests, net of tax, by component are as follows:
 
Quarter Ended June 30,
 (In millions)
2014
 
2013
Foreign currency translation adjustments
 
 
 
Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 (1)
$
98

 
$
(61
)
 
 
 
 
Unrealized gains on cash flow hedges
 
 
 
Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil
(2
)
 
1

 
 
 
 
Changes in retirement-related benefit plans
 
 
 
Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1 and $4 (2)
3

 
7

Foreign currency translation adjustments, net of income tax expense of nil and nil
(1
)
 

 
2

 
7

 
 
 
 
Other comprehensive income (loss), net of tax
$
98

 
$
(53
)
(1)
The first quarter of 2015 includes net foreign currency translation loss of $12 million attributable to noncontrolling interests.
(2)
Pre-tax amount reclassified into cost of sales and operating expenses in the condensed consolidated statements of operations. The related tax expense was reclassified into income tax expense in the consolidated statements of operations.
Accumulated Other Comprehensive Income (Loss)
Information regarding changes in McKesson’s accumulated other comprehensive loss, net of tax, by component are as follows:
(In millions)
Foreign Currency Translation Adjustments, Net of Tax
 
Unrealized Losses on Cash Flow Hedges,
Net of Tax
 
Unrealized Net Loss and Other Components of Benefit Plans, Net of Tax
 
Total Accumulated Other Comprehensive Income (Loss)
Balance at March 31, 2014
$
168

 
$
(11
)
 
$
(160
)
 
$
(3
)
 
 
 
 
 
 
 
 
Other comprehensive income (loss) before reclassifications
110

 
(2
)
 

 
108

Amounts reclassified to earnings and other

 

 
2

 
2

Other comprehensive income (loss)
110

 
(2
)
 
2

 
110

Balance at June 30, 2014
$
278

 
$
(13
)
 
$
(158
)
 
$
107




19

McKESSON CORPORATION
FINANCIAL NOTES (CONCLUDED)
(UNAUDITED)

14.
Segment Information
We report our operations in two operating segments: McKesson Distribution Solutions and McKesson Technology Solutions. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. We evaluate the performance of our operating segments on a number of measures, including operating profit before interest expense, income taxes and results from discontinued operations.
Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
 
Quarter Ended June 30,
(In millions)
2014
 
2013
Revenues
 
 
 
Distribution Solutions (1)
 
 
 
North America pharmaceutical distribution and services
$
34,304

 
$
30,046

International pharmaceutical distribution and services
7,607

 

Medical-Surgical distribution & services
1,379

 
1,357

Total Distribution Solutions
43,290

 
31,403

 
 
 
 
Technology Solutions - products and services
768

 
836

Total Revenues
$
44,058

 
$
32,239

 
 
 
 
Operating profit
 
 
 
Distribution Solutions
$
748

 
$
619

Technology Solutions (2)
68

 
127

Total
816

 
746

Corporate Expenses, Net
(108
)
 
(85
)
Interest Expense
(101
)
 
(59
)
Income from Continuing Operations Before Income Taxes
$
607

 
$
602

(1)
Revenues derived from services represent less than 2% of this segment’s total revenues.
(2)
Technology Solutions operating profit for the quarter ended June 30, 2014 includes a charge of $34 million related to the retained workforce business within our International Technology business.


20

McKESSON CORPORATION
FINANCIAL REVIEW
(UNAUDITED)


Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.

GENERAL
Management’s discussion and analysis of financial condition and results of operations, referred to as the Financial Review, is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of the Company together with its subsidiaries. This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying financial notes in Item 1 of Part I of this Quarterly Report on Form 10-Q and in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2014 previously filed with the SEC on May 14, 2014 (“2014 Annual Report”).
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year.
Certain statements in this report constitute forward-looking statements. See “Factors Affecting Forward-Looking Statements” included in this Quarterly Report on Form 10-Q.
Results of Operations
Overview:
(Dollars in millions, except per share data)
Quarter Ended June 30,
 
 
2014
 
2013
Change
Revenues
$
44,058

 
$
32,239

37

%
 
 
 
 
 
 
Gross Profit
$
2,797

 
$
1,930

45

%
 
 
 
 
 
 
Operating Expenses
$
(2,109
)
 
$
(1,275
)
65

 
 
 
 
 
 
 
Income from Continuing Operations Before Income Taxes
$
607

 
$
602

1

 
Income Tax Expense
(182
)
 
(174
)
5

 
Income from Continuing Operations
425

 
428

(1
)
 
Loss from Discontinued Operations, Net of Tax
(14
)
 
(4
)
NM

 
Net Income
411

 
424

(3
)
 
Net Income Attributable to Noncontrolling Interests
(8
)
 

NM

 
Net Income Attributable to McKesson Corporation
$
403

 
$
424

(5
)
 
 
 
 
 
 
 
Diluted Earnings (Loss) Per Common Share Attributable to
McKesson Corporation
 
 
 
 
 
Continuing Operations
$
1.78

 
$
1.84

(3
)
%
Discontinued Operations
(0.06
)
 
(0.01
)
NM

 
Total
$
1.72

 
$
1.83

(6
)
 
 
 
 
 
 
 
Weighted Average Diluted Common Shares
235

 
232

1

%
NM – not meaningful 


21

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


Revenues for the first quarter of 2015 increased compared to the same period a year ago primarily reflecting our February 2014 acquisition of Celesio AG (“Celesio”), our mix of business and market growth. Market growth includes growing drug utilization and price increases, partially offset by price deflation associated with brand to generic drug conversion.
Gross profit and gross profit margin increased in the first quarter of 2015 primarily due to our acquisition of Celesio and growth in our North American distribution and services business, partially offset by a decline in our Technology Solutions segment. Gross profit in the first quarter of 2015 includes a LIFO-related inventory charge of $98 million; no charge was incurred in the first quarter of 2014.
Operating expenses increased in the first quarter of 2015 primarily due to our acquisition of Celesio, including higher intangible asset amortization and increases in acquisition-related expenses, and higher compensation and benefit costs.
Income from continuing operations before income taxes for the first quarter of 2015 increased slightly as higher gross profit was almost fully offset by higher operating and interest expense. Interest expense increased primarily due to our Celesio acquisition.
Net income attributable to McKesson Corporation for the first quarters of 2015 and 2014 was $403 million and $424 million. Diluted earnings per common share attributable to McKesson for the first quarters of 2015 and 2014 were $1.72 and $1.83.
On February 6, 2014, we completed the acquisition of 77.6% of the then outstanding common shares of Celesio and certain convertible bonds of Celesio for cash consideration of $4.5 billion, net of cash acquired (the “Acquisition”). Upon the acquisition, as required, we consolidated Celesio’s debt with a fair value of $2.3 billion as a liability on our consolidated balance sheet and our ownership of Celesio’s fully diluted common shares was 75.6%. The Acquisition was initially funded by utilizing a senior bridge loan, our existing accounts receivable sales facility and cash on hand. Celesio is an international wholesale and retail company and a provider of logistics and services to the pharmaceutical and healthcare sectors. Celesio’s headquarters is in Stuttgart, Germany and it operates in 14 countries around the world. The acquisition of Celesio expands our global geographic area; the combined company is one of the largest pharmaceutical wholesalers and providers of logistics and services in the healthcare sector worldwide.
Financial results for Celesio are included within our International pharmaceutical distribution and services business, which is part of our Distribution Solutions segment, since the date of acquisition.
Revenues:
 
Quarter Ended June 30,
 
 
(Dollars in millions)
2014
 
2013
Change
Distribution Solutions
 
 
 
 
 
North America pharmaceutical distribution & services
$
34,304

 
$
30,046

14

%
International pharmaceutical distribution & services
7,607

 

NM

 
Medical-Surgical distribution & services
1,379

 
1,357

2

 
Total Distribution Solutions
43,290

 
31,403

38

 
 
 
 
 
 
 
Technology Solutions - products and services
768

 
836

(8
)
 
Total Revenues
$
44,058

 
$
32,239

37

 
Revenues for the first quarter of 2015 increased 37% to $44.1 billion compared to the same period a year ago primarily due to our Distribution Solutions segment, which accounted for approximately 98% of our consolidated revenues.
Distribution Solutions: North America pharmaceutical distribution and services revenues increased in the first quarter of 2015 primarily due to our mix of business and market growth, reflecting growing drug utilization and price increases. These increases were partially offset by price deflation associated with brand to generics drug conversion. International pharmaceutical distribution and services revenues of $7.6 billion in the first quarter of 2015 represent revenues from Celesio, acquired in the fourth quarter of 2014. Medical-Surgical distribution and services revenues increased primarily due to market growth.


22

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


Technology Solutions: Technology Solutions revenues decreased primarily due to a decline in software product revenues and the planned elimination of a product line, partially offset by a higher volume of claims processing.
Gross Profit:
 
Quarter Ended June 30,
 
 
 
(Dollars in millions)
2014
 
2013
 
Change
Gross Profit
 
 
 
 
 
 
Distribution Solutions
$
2,458

 
$
1,520

 
62

%
Technology Solutions
339

 
410

 
(17
)
 
Total
$
2,797

 
$
1,930

 
45

  
Gross Profit Margin
 
 
 
 
 
 
Distribution Solutions
5.68

%
4.84

%
84

bp 
Technology Solutions
44.14

 
49.04

 
(490
)
 
Total
6.35

 
5.99

 
36

 
bp - basis points
Gross profit increased 45% to $2.8 billion and as a percentage of revenue, gross profit margin increased 36 bp in the first quarter compared to the same period a year ago. These increases primarily reflect an increase in our Distribution Solutions operating segment, including our acquisition of Celesio.
Distribution Solutions
Distribution Solutions segment’s gross profit margin increased primarily due to our acquisition of Celesio and growth in our North American distribution and services business which reflects sales of higher margin generic drugs and an increase in buy margin, partially offset by a decrease in sell margin. Buy margin includes volume and timing of compensation from pharmaceutical manufacturers.
Our last-in, first-out (“LIFO”) net inventory expense was $98 million in the first quarter of 2015 compared to nil in the first quarter of 2014. Our North American distribution and services business uses the LIFO method of accounting for the majority of its inventories which results in cost of sales that more closely reflects replacement cost than under other accounting methods. The practice in the businesses is to pass on to customers published price changes from suppliers. Manufacturers generally provide us with price protection, which limits price-related inventory losses.  A LIFO expense is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory.
As a result of historical cumulative net price deflation from 2005 to 2013, we had a lower-of-cost or market (“LCM”) reserve of $60 million at March 31, 2013 which reduced pharmaceutical inventories at LIFO to market.   In the first quarter of 2014, $37 million of the LCM reserve was released, resulting in an increase in gross profit. As of March 31, 2014, inventories at LIFO did not exceed market.
Technology Solutions
Technology Solutions segment’s gross profit and gross profit margin decreased primarily reflecting a pre-tax non-cash charge of $32 million for depreciation and amortization as described further below. Additionally, gross profit decreased as a result of a decline in revenue.


23

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


In 2014, we committed to a plan to sell our International Technology and Hospital Automation businesses from our Technology Solutions segment and certain businesses from our Distributions Solutions segment.  As required, we classified the results of operations and cash flows of these businesses as discontinued operations for all periods presented in our consolidated financial statements in 2014 and depreciation and amortization expense was not recognized.
During the first quarter of 2015, we entered into an agreement to sell the software business within our International Technology business. We completed the sale of the software business on July 1, 2014 and no material gain or loss is anticipated. During the first quarter of 2015, we also decided to retain the workforce business within our International Technology business. This business consists of workforce management solutions for the National Health Service in the United Kingdom, which we now intend to wind down in 2016. As a result, we reclassified the workforce business, which had been designated as a discontinued operation since the first quarter of 2014, as a continuing operation for all periods presented. During the first quarter of 2015, we also recorded a non-cash pre-tax charge of $34 million ($27 million after-tax) primarily relating to depreciation and amortization expense for 2014 when the business was classified as held for sale. The non-cash charge was recorded in our condensed consolidated statement of operations as follows: $32 million in cost of sales and $2 million in operating expenses.
Operating Expenses and Other Income, Net: 
 
Quarter Ended June 30,
 
 
 
(Dollars in millions)
2014
 
2013
 
Change
Operating Expenses
 
 
 
 
 
 
Distribution Solutions
$
1,728

 
$
905

 
91

%
Technology Solutions 
271

 
283

 
(4
)
  
 Corporate
110

 
87

 
26

  
Total
$
2,109

 
$
1,275

 
65

 
 
 
 
 
 
 
 
Operating Expenses as a Percentage of Revenues
 
 
 
 
 
 
Distribution Solutions
3.99

%
2.88

%
111

bp 
Technology Solutions
35.29

 
33.85

 
144

  
Total
4.79

 
3.95

 
84

 
 
 
 
 
 
 
 
Other Income, Net
 
 
 
 
 
 
Distribution Solutions
$
18

 
$
4

 
NM

 
Technology Solutions

 

 
NM

  
Corporate
2

 
2

 
NM

 
Total
$
20

 
$
6

 
NM

 
Operating expenses and operating expenses as a percentage of revenues increased in the first quarter of 2015 primarily due to our acquisition of Celesio, including higher intangible asset amortization and increases in acquisition-related expenses, and higher compensation and benefit costs.
Distribution Solutions segment’s operating expenses and operating expenses as a percentage of revenue increased in the first quarter of 2015 primarily due to our Celesio acquisition.
Technology Solutions segment’s operating expenses in the first quarter of 2015 decreased slightly primarily due to lower compensation and benefit costs.
Corporate expenses for the first quarter of 2015 increased primarily due to higher compensation and benefit costs and increases in acquisition-related expenses.


24

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


Acquisition Expenses and Related Adjustments
Acquisition expenses and related adjustments, which include transaction and integration expenses that are directly related to acquisitions by the Company were $49 million and $13 million in the first quarters of 2015 and 2014. Expenses for the first quarter of 2015 were primarily related to our acquisition of Celesio and expenses for the first quarter of 2014 primarily pertained to our 2013 acquisition of PSS World Medical.
Acquisition expenses and related adjustments were as follows:
 
Quarter Ended June 30,
(Dollars in millions)
2014
 
2013
Operating Expenses
 
 
 
Integration related expenses
$
29

 
$
8

Severance and relocation
17

 
5

Transaction closing expenses
3

 

Total Acquisition Expenses and Related Adjustments
$
49

 
$
13

During the first quarter of 2015, amortization expense of acquired intangible assets purchased in connection with acquisitions by the Company increased by $59 million compared to a year ago primarily reflecting our Celesio acquisition. Amortization expense by segment was as follows:
 
Quarter Ended June 30,
(Dollars in millions)
2014
 
2013
Distribution Solutions
$
118

 
$
54

Technology Solutions
12

 
17

Total
$
130

 
$
71

Other Income, Net: Other income, net increased in the first quarter of 2015 compared to the same period a year ago primarily due to our acquisition of Celesio.  
Segment Operating Profit, Corporate Expenses, Net and Interest Expense:
 
Quarter Ended June 30,
 
 
 
(Dollars in millions)
2014
 
2013
 
Change
Segment Operating Profit (1)
 
 
 
 
 
 
Distribution Solutions
$
748

 
$
619

 
21

%
Technology Solutions
68

 
127

 
(46
)
 
Subtotal
816

 
746

 
9

 
Corporate Expenses, Net
(108
)
 
(85
)
 
27

 
Interest Expense
(101
)
 
(59
)
 
71

  
Income from Continuing Operations Before Income Taxes
$
607

 
$
602

 
1

  
 
 
 
 
 
 
 
Segment Operating Profit Margin
 
 
 
 
 
 
Distribution Solutions
1.73

%
1.97

%
(24
)
bp 
Technology Solutions
8.85

 
15.19

 
(634
)
 
(1)
Segment operating profit includes gross profit, net of operating expenses, plus other income for our two operating segments.


25

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


Segment Operating Profit Margin: Operating profit margin for our Distribution Solutions segment decreased in the first quarter of 2015 primarily due to higher operating expenses as a percentage of revenues, partially offset by an increase in gross profit margin. Operating profit margin for Technology Solutions segment decreased in the first quarter of 2015 primarily due to a non-cash pre‑tax charge of $34 million recorded in connection with the reclassification of the workforce business within our International Technology business from discontinued operations to continuing operations.
Corporate: Corporate expenses, net of other income for the first quarter of 2015 increased primarily due to increases in acquisition-related expenses and higher compensation and benefit costs.
Interest Expense: Interest expense for the first quarter of 2015 increased primarily due to the March 2014 issuance of $4.1 billion of new debt issued to fund the acquisition of Celesio and due to interest on Celesio’s debt. These increases were partially offset by the repayment of $350 million of the current portion of our long-term debt in February 2014.
Income Taxes: Our reported income tax rates for the first quarters of 2015 and 2014 were 30.0% and 28.9%. Fluctuations in our reported income tax rates are primarily due to varying proportions of income attributable to foreign countries that have lower income tax rates and discrete tax items. Income tax expense for the first quarters of 2015 and 2014 included net discrete tax benefits of $12 million and $5 million.
Loss from Discontinued Operations, Net of Tax: Loss from discontinued operations, net of tax, was $14 million and $4 million for the first quarters of 2015 and 2014. Diluted loss per common share from discontinued operations for the first quarter of 2015 was $0.06 compared to $0.01 for the same period a year ago. 
Net income attributable to McKesson Corporation: Net income attributable to McKesson Corporation was $403 million and  $424 million, and diluted earnings per common share attributable to McKesson Corporation were $1.72 and $1.83.
Weighted Average Diluted Common Shares Outstanding: Diluted earnings per common share were calculated based on a weighted average number of shares outstanding of 235 million and 232 million for the first quarters of 2015 and 2014. The weighted average diluted number of shares outstanding increased primarily due to the issuance of share-based awards.
Business Combinations
As previously discussed, on February 6, 2014, we completed the acquisition of 77.6% of the then outstanding common shares of Celesio and certain convertible bonds of Celesio for cash consideration of $4.5 billion, net of cash acquired. Upon the acquisition, we consolidated Celesio’s debt with a fair value of $2.3 billion as a liability on our consolidated balance sheet and our ownership of Celesio’s fully diluted common shares was 75.6%. From February 7 to March 31, 2014, substantially all of the convertible bonds issued by Celesio (held by both third parties and us) were converted to 20.9 million common shares of Celesio. During the first quarter of 2015, we completed tender offers and we acquired approximately 1 million common shares of Celesio at €23.50 per share for a total of $32 million in cash, and the remaining convertible bonds were fully converted to 42,238 common shares of Celesio. At June 30, 2014 and March 31, 2014, we owned approximately 75.9% and 75.4% of Celesio’s outstanding and fully diluted common shares.
On May 22, 2014, Celesio and McKesson, through its wholly-owned subsidiary Dragonfly GmbH & Co. KGaA, entered into a domination and profit and loss transfer agreement (the “Agreement”). Under the Agreement, Celesio will subordinate its management to McKesson and undertake to transfer all of its annual profits to McKesson, and McKesson will undertake to compensate any annual losses incurred by Celesio and to grant, subject to a potential court review, the noncontrolling shareholders of Celesio (i) an annual recurring compensation of €0.83 per Celesio share and (ii) a put right for their Celesio shares at €22.99 per Celesio share. On July 15, 2014, the Agreement was approved at the general shareholders’ meeting of Celesio. The Agreement becomes effective upon its registration in the commercial register of Celesio at the local court of Stuttgart, Germany. Celesio’s obligation to transfer its annual profits under the Agreement will apply for the first time for the entire profit generated in Celesio’s fiscal period beginning on January 1, 2015 or the subsequent fiscal year in which the Agreement becomes effective. McKesson’s obligation to compensate the annual losses of Celesio under the Agreement will apply for the first time for the full fiscal period of Celesio during which the Agreement becomes effective. We currently anticipate the Agreement to be effective by the end of the calendar year, at which time, we will obtain operational control of Celesio.
Refer to Financial Note 2, “Business Combinations,” to the accompanying condensed consolidated financial statements appearing in this Quarterly Report on Form 10-Q for further information.


26

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


New Accounting Pronouncements
New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, “Significant Accounting Policies,” to the accompanying condensed consolidated financial statements appearing in this Quarterly Report on Form 10-Q.
Financial Condition, Liquidity and Capital Resources
We expect our available cash generated from operations, together with our existing sources of liquidity from our accounts receivable sales facility, the revolving credit facility and commercial paper issuance, will be sufficient to fund our long-term and short-term capital expenditures, working capital and other cash requirements. In addition, from time to time, we may access the long-term debt capital markets to discharge our other liabilities.
Operating activities generated cash of $182 million and $716 million during the first quarters of 2015 and 2014. Cash flows from operations can be significantly impacted by factors such as timing of receipts from customers, inventory receipts and payments to vendors. Additionally, working capital is a function of sales activity and inventory requirements.
Investing activities utilized cash of $112 million and $184 million during the first quarters of 2015 and 2014. Investing activities primarily reflect cash paid for business and property acquisitions and capitalized software.
Financing activities utilized cash of $167 million and $73 million during the first quarters of 2015 and 2014. Financing activities for the first quarter of 2015 include cash receipts of $917 million and payments of $759 million for short-term borrowings incurred by Celesio. Long-term debt repayments for the first quarter of 2015 were primarily cash paid on Celesio’s promissory notes. Financing activities for the first quarter of 2014 include $100 million of cash received and repayment of short-term borrowings. Additionally, financing activities for the first quarters of 2015 and 2014 included $102 million and $127 million of cash paid for stock repurchases, including shares surrendered for tax withholding.
The total authorization outstanding for repurchases of the Company’s common stock was $340 million at June 30, 2014. Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase programs, or by any combination of such methods.  The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations and other market and economic conditions.
We believe that our operating cash flow, financial assets and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that future volatility and disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.
Selected Measures of Liquidity and Capital Resources
(Dollars in millions)
June 30, 2014
 
March 31, 2014
 
Cash and cash equivalents
$
4,105

 
$
4,193

 
Working capital
4,728

 
3,072

 
Debt, net of cash and cash equivalents
6,568

 
6,526

 
Debt to capital ratio (1)
54.3

%
55.7

%
Net debt to net capital employed (2)
42.2

 
43.4

 
Return on stockholders’ equity (3)
15.2

 
16.2

 
(1)
Ratio is computed as total debt divided by the sum of total debt and McKesson stockholders’ equity excluding noncontrolling interests.
(2)
Ratio is computed as total debt, net of cash and cash equivalents (“net debt”), divided by the sum of net debt and McKesson stockholders’ equity excluding noncontrolling interests (“net capital employed”).
(3)
Ratio is computed as net income attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders’ equity excluding noncontrolling interests.


27

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


Cash equivalents, which are available-for-sale, are carried at fair value. Cash equivalents are primarily invested in AAA rated prime and U.S. government money market funds denominated in U.S. dollars, AAA rated prime money market funds denominated in Euros, overnight repurchase agreements collateralized by U.S. Treasury bonds, Canadian government securities and/or securities that are guaranteed or sponsored by the U.S. government and an AAA rated prime money market fund denominated in British pound sterling.
The remaining cash and cash equivalents are deposited with several financial institutions. We mitigate the risk of our short‑term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. Within the Celesio operations, the majority of deposits are placed in Germany with only banks that are part of deposit protection programs.
Our cash and cash equivalents balance as of June 30, 2014 included approximately $1.9 billion of cash held by our subsidiaries outside of the United States. Our primary intent is to utilize this cash for foreign operations as well as to fund certain research and development activities for an indefinite period of time. Although the vast majority of cash held outside the United States is available for repatriation, doing so could subject us to U.S. federal, state and local income tax.
Working capital primarily includes cash and cash equivalents, receivables and inventories net of drafts and accounts payable, deferred revenue and other current liabilities. Our Distribution Solutions segment requires a substantial investment in working capital that is susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements.
Our ratio of net debt to net capital employed decreased slightly in 2015.
Effective 2014, the Company’s quarterly dividend is $0.24 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.  However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements and other factors.
Credit Resources
We fund our working capital requirements primarily with cash and cash equivalents, as well as, short-term borrowings under the accounts receivable sales facility, revolving credit facility and from commercial paper issuances.
Celesio Debt
Upon the acquisition of Celesio, as required, we consolidated Celesio’s debt including their accounts receivable factoring facilities (the “Factoring Facilities”) with a total committed and uncommitted balance of $315 million. The Factoring Facilities will expire through September 2015. During the first quarter of 2015, we borrowed and repaid $758 million and $746 million of short-term borrowings under the Factoring Facilities. At June 30, 2014 and March 31, 2014, there were $258 million and $246 million in secured borrowings and related securitized accounts receivable outstanding under the Factoring Facilities.
Celesio also maintains a syndicated €500 million five-year senior unsecured revolving credit facility, which expires in February 2018. Borrowings under this facility bear interest based upon the Euro Interbank Offered Rate plus an agreed margin. There were no borrowings under this facility during the first quarter of 2015 and there were no amounts outstanding under this facility as of June 30, 2014 and March 31, 2014.


28

McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)


Celesio also maintains bilateral credit lines with a total committed and uncommitted balance of $2.0 billion. During the first quarter of 2015, Celesio borrowed and repaid $159 million and $30 million under these credit lines primarily relating to short‑term borrowings. As of June 30, 2014 and March 31, 2014, there were $321 million and $188 million outstanding under these credit lines.
Accounts Receivable Sales Facility
We have an accounts receivable sales facility (the “Facility”) with a committed balance of $1.35 billion, although from time to time, the available amount of the Facility may be less than $1.35 billion based on accounts receivable concentration limits and other eligibility requirements. The Facility will expire in November 2014 and we anticipate renewing the Facility before its expiration.
During the first quarter of 2015, there were no borrowings under the Facility. During the first quarter of 2014, we borrowed and repaid $100 million of short-term borrowings under the Facility. At June 30, 2014 and March 31, 2014, there were no short‑term borrowings and related securitized accounts receivable outstanding under the Facility.
Revolving Credit Facility
We have a syndicated $1.3 billion five-year senior unsecured revolving credit facility, which expires in September 2016. Borrowings under this facility bear interest based upon either the London Interbank Offered Rate or a prime rate. There were no borrowings under this facility during the first quarters of 2015 and 2014. As of June 30, 2014 and March 31, 2014, there were no amounts outstanding under this facility.
Debt Covenants
Our various borrowing facilities and long-term debt are subject to certain covenants. Our principal financial covenant is our U.S. dollar denominated debt to capital ratio under our $1.3 billion unsecured revolving credit facility, which cannot exceed 65%. For the purpose of calculating this ratio, borrowings under the $1.35 billion accounts receivable sales facility are excluded. If we exceed this ratio, repayment of debt outstanding under the revolving credit facility could be accelerated. As of June 30, 2014 and March 31, 2014, we were in compliance with our financial covenants.
Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources and other capital market transactions.


29

McKESSON CORPORATION
FINANCIAL REVIEW (CONCLUDED)
(UNAUDITED)


FACTORS AFFECTING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of Part I of this report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of these statements can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” or the negative of these words and other comparable terminology. The discussion of financial trends, strategy, plans or intentions may also include forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. Although it is not possible to predict or identify all such risks and uncertainties, they may include, but are not limited to, the following factors. The reader should not consider this list to be a complete statement of all potential risks and uncertainties:
changes in the U.S. healthcare industry and regulatory environment;
changes in the Canadian healthcare industry and regulatory environment;
changes in the European regulatory environment;
foreign operations subject us to a number of operating, economic, political and regulatory risks;
the Company’s ability to successfully identify, consummate and integrate strategic acquisitions;
material adverse resolution of pending legal proceedings;
European economic conditions together with austerity measures taken by certain European governments;
competition;
substantial defaults in payments or a material reduction in purchases by, or the loss of, a large customer or group purchasing organization;
the loss of government contracts as a result of compliance or funding challenges;
public health issues in the United States or abroad;
implementation delay, malfunction, failure or breach of internal information systems;
the adequacy of insurance to cover property loss or liability claims;
the Company’s failure to attract and retain customers for its software products and solutions due to integration and implementation challenges, or due to an inability to keep pace with technological advances;
the Company’s proprietary products and services may not be adequately protected, and its products and solutions may be found to infringe on the rights of others;
system errors or failure of our technology products and solutions to conform to specifications;
disaster or other event causing interruption of customer access to the data residing in our service centers;
the delay or extension of our sales or implementation cycles for external software products;
changes in circumstances that could impair our goodwill or intangible assets;
new or revised tax legislation or challenges to our tax positions;
general economic conditions, including changes in the financial markets that may affect the availability and cost of credit to the Company, its customers or suppliers;
changes in accounting principles generally accepted in the United States of America; and
significant liability if we withdraw from participation in one or more multiemployer pension plans.

These and other risks and uncertainties are described herein and in other information contained in our publicly available Securities and Exchange Commission filings and press releases. Readers are cautioned not to place undue reliance on forward‑looking statements, which speak only as of the date such statements were first made. Except to the extent required by law, we undertake no obligation to publicly release the result of any revisions to our forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.




30

McKESSON CORPORATION

Item 3.
Quantitative and Qualitative Disclosures about Market Risk.
We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates as disclosed in our 2014 Annual Report on Form 10-K.
Item 4.
Controls and Procedures.
Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company’s management, have evaluated the effectiveness of the Company’s “disclosure controls and procedures” (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.
There were no changes in our “internal control over financial reporting” (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during our first quarter of 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  The Company acquired Celesio on February 6, 2014 and is in the process of reviewing the internal control structure of Celesio. If necessary, the Company will make appropriate changes as it integrates Celesio into the Company’s overall internal control over financial reporting processes.
PART II—OTHER INFORMATION
Item 1.
Legal Proceedings.
The information set forth in Financial Note 12, “Commitments and Contingent Liabilities,” to the accompanying condensed consolidated financial statements appearing in this Quarterly Report on Form 10-Q is incorporated herein by reference.
Item 1A.
Risk Factors.
There have been no material changes during the period covered by this Quarterly Report on Form 10-Q to the risk factors disclosed in Part I, Item 1A, of our 2014 Annual Report on Form 10-K.

Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase programs, or by any combination of such methods.  The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations and other market and economic conditions.
The total authorization outstanding for repurchases of the Company’s common stock was $340 million at June 30, 2014.


31

McKESSON CORPORATION

The following table provides information on the Company’s share repurchases during the first quarter of 2015.
 
Share Repurchases (1)
(In millions, except price per share)
Total Number
of Shares
Purchased
 
Average Price
Paid Per Share
 
Total Number of
Shares Purchased
As Part of Publicly
Announced
Program
 
Approximate
Dollar Value of
Shares that May
Yet Be Purchased Under the Programs
April 1, 2014 – April 30, 2014
$
 
$
340
May 1, 2014 – May 31, 2014
 
 
 
340
June 1, 2014 – June 30, 2014
 
 
 
340
Total
 

 
 
340
(1)
This table does not include shares tendered to satisfy the exercise price in connection with cashless exercises of employee stock options or shares tendered to satisfy tax withholding obligations in connection with employee equity awards.
Item 3.
Defaults Upon Senior Securities.
None
Item 4.
Mine Safety Disclosures.
Not Applicable
Item 5.
Other Information.
None


32

McKESSON CORPORATION

Item 6.
Exhibits.
Exhibit
Number
Description
10.1*
Form of Statement and Terms and Conditions applicable to Awards Pursuant to the McKesson Corporation 2013 Stock Plan.
 
 
31.1
Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
31.2
Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
32†
Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
101
The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, formatted in Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows, and (v) related Financial Notes.

*
Management contract or compensation plan or arrangement in which directors and/or executive officers are eligible to participate.
Furnished herewith.



33

McKESSON CORPORATION

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
MCKESSON CORPORATION
 
 
 
 
Date:
July 31, 2014
 
/s/ James A. Beer
 
 
 
James A. Beer
 
 
 
Executive Vice President and Chief Financial Officer
 

 
 
 
MCKESSON CORPORATION
 
 
 
 
Date:
July 31, 2014
 
/s/ Nigel A. Rees
 
 
 
Nigel A. Rees
 
 
 
Vice President and Controller



34
EX-10.1 2 mck_exhbit101x06302014.htm FORM OF ST&CS APPLICABLE TO AWARDS PURSUANT TO THE MCKESSON 2013 STOCK PLAN MCK_Exhbit 10.1_06.30.2014

Exhibit 10.1
OUTSIDE DIRECTOR
McKESSON CORPORATION
STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO
RESTRICTED STOCK UNITS GRANTED TO
OUTSIDE DIRECTORS PURSUANT TO THE 2013 STOCK PLAN

I.
INTRODUCTION
The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.
II.
RESTRICTED STOCK UNITS
1.    Award Agreement. A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.
2.    Terms and Conditions. The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards. With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions.
(A)    Grant Date. Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders. An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.
(B)    Number of Units. Unless otherwise determined by the Board or the Committee, the number of Units granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $150,000 (with any fractional Unit rounded up to the nearest whole Unit). In addition, unless otherwise determined by the Board or the Committee, the Lead Independent Director shall be granted an annual meeting grant determined

2013 Stock Plan STC (Outside Director)


by dividing the Fair Market Value of a Share on the date of grant into $25,000 (with any fractional Unit rounded up to the nearest whole Unit). Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to a director pursuant to such annual meeting grant or grants exceed 5,000. A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director’s election to the Board.
(C)    No Restrictions. Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.
3.    Dividend Equivalents. Dividend equivalents in respect of Restricted Stock Units may be credited on behalf of an Outside Director to a deferred cash account or converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award. Currently, dividend equivalents in respect of Restricted Stock Units granted to Outside Directors are credited to a deferred cash account and accrue interest at a rate determined by the Committee until such time as the underlying Shares are issued.
4.    Assignability. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.
5.    No Stockholder Rights. Neither an Outside Director nor any person entitled to exercise an Outside Director’s rights in the event of the Outside Director’s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below.
6.    Time of Payment of Restricted Stock Units. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director’s separation of service with the Corporation (“Automatic Deferral Requirement”). “Separation of service” shall have the meaning provided under the McKesson Corporation Deferred Compensation Administration Plan III (“DCAP III”). Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation’s transfer agent recording the Outside Director’s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award.
7.    Satisfaction of Director Stock Ownership Guidelines. For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.
8.    Deferrals of Restricted Stock Units. Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.

2



III.
MISCELLANEOUS
1.    No Effect on Terms of Service with the Corporation. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation’s right to terminate the service of any Outside Director.
2.    Grants to Outside Directors in Foreign Countries. If an Outside Director is not a United States citizen, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director’s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.
3.    Information Notification. Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director’s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.
4.    Administrator Decisions Conclusive. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.
5.    No Effect on Other Benefit Plans. Nothing herein contained shall affect an Outside Director’s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.
6.    Withholding. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state or local income tax withholding requirements or payroll tax requirements, if any is required.
7.    Successors. This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. “Outside Director” as used herein shall include the Outside Director’s Beneficiary.
8.    Delaware Law. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of Delaware.

3




CHIEF EXECUTIVE OFFICER

McKESSON CORPORATION
STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO
OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS AND
PERFORMANCE SHARES GRANTED TO CHIEF EXECUTIVE
OFFICER PURSUANT TO THE 2013 STOCK PLAN

I.
INTRODUCTION
The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.
II.
OPTIONS
1.    Option Agreement. An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Stock Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.
2.    Exercise Price. The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.
3.    Option Period. An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section II.4 as modified by the rules set forth in Sections II.5 and V. The Option Period shall be not more than seven years from the Grant Date.
4.    Vesting of Right to Exercise Options.
(A)    Except as provided in Sections II.5 and V, an Option shall be exercisable during the Option Period in accordance with the following vesting schedule:  (i) 25% of the Shares subject to the Option shall vest on the first anniversary of the Grant Date; (ii) an additional 25% of the Shares shall vest on the second anniversary of the Grant Date; (iii) an additional 25% of the Shares shall vest on the third anniversary of the Grant Date; and (iv) the remaining 25% of the Shares subject to the Option shall vest on the fourth anniversary of the Grant Date. Notwithstanding

2013 Stock Plan STC (CEO)




the foregoing, the Administrator may specify a different vesting schedule at the time the Option is granted, which will be specified in the Option Grant Notice.
(B)    Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections II.5 and V. No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option. In no event shall the Corporation be required to issue fractional Shares.
5.    Limits on Option Period and Acceleration of Vesting. The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section V), as follows:
(A)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long‑Term Disability, Normal Retirement, Early Retirement or death, the Option Period shall end on the earlier of (x) 90 days after the date of the Participant’s termination of employment and (y) the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    If the Participant’s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.
(C)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates due to Long‑Term Disability during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (x) three years after the date of the Participant’s termination of employment and (y) the Expiration Date.
(D)    If the Participant’s employment is terminated:
(i)    By reason of Normal Retirement, the vesting schedule of the Participant’s Option shall be accelerated and the Option shall become fully exercisable as of the date of Normal Retirement; or
(ii)    By reason of Early Retirement, the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such Early Retirement.

2



(iii)    With respect to an Option held by a Participant at Normal Retirement or Early Retirement, the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (x) three years after the date of such retirement and (y) the Expiration Date.
(E)    If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (x) three years after the date of death and (y) the Expiration Date, and the Participant’s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount) remaining on the date of death.
(F)    If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (x) such time as the Participant subsequently terminates employment and (y) the Expiration Date. Upon the Participant’s subsequent termination of employment, the post‑termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant’s initial termination of employment and the Participant's re‑hire date; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (E) and shall not be adjusted as described in this Section II.5(F).
6.    Method of Exercise. A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows:
(A)    By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following:  cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant’s personal check. Payment may also be made by delivery (including by FAX transmission) to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount

3



sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VII.6) and to transfer the proceeds of such sale to the Corporation.
(B)    If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof; provided that such assurance shall be deemed inapplicable to (1) any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be) filed and become effective under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and with respect to which no stop order suspending the effectiveness thereof has been issued, and (2) any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.
(C)    As soon as practicable after receipt of the notice and the assurance described in Sections II.6(A) and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section VII.6) and without other incidental expense to the Participant, credit the purchased Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the purchased Shares; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.
7.    Limitations on Transfer. An Option shall, during a Participant’s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing: (i) a Participant may designate a beneficiary to succeed, after the Participant’s death, to all of the Participant’s Options outstanding on the date of death; (ii) a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act; and (iii) any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.

4



8.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to such Shares upon the exercise of an Option.
III.
RESTRICTED STOCK
1.    Restricted Stock Agreement. A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.
2.    Rights with Respect to Shares of Restricted Stock. Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.
3.    Special Restrictions. Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.
(A)    Restrictions. Until the restrictions imposed on any Restricted Stock grant shall lapse (the “Restriction Period”), Shares of Restricted Stock granted to a Participant (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii) shall, if the Participant’s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan or in Section III.3(B)) be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.

5



(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan or the Restricted Stock Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of death, Long‑Term Disability or Normal Retirement, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination.
(C)    Restriction on Sale. The Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.
4.    Dividends. Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award. Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restricted Period.
5.    Election to Recognize Gross Income in the Year of Grant. If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section VII.6 and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.
6.    Restrictive Legend. Each book entry in the records of the Corporation’s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and/or the Restricted Stock Agreement.
7.    Expiration of Restricted Period. If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant’s interest in the unrestricted Shares shall be entered on the records of the Corporation’s transfer agent.

6



IV.
RESTRICTED STOCK UNITS AND PERFORMANCE SHARES
1.    Award Agreement.
(A)    Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.
(B)    Performance Shares granted under the Plan shall be evidenced by a Performance Share Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Shares. Each Performance Share Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions and together both documents shall constitute the Performance Share Agreement. Performance Shares are also subject to the terms and conditions of the Plan.
2.    Special Restrictions. Restricted Stock Units and Performance Shares granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.
(A)    Restrictions. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section IV.2(B)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units or Performance Shares shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan, the Restricted Stock Unit Agreement or Performance Share Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date shall, while in such employment, be terminated as a result of Death, Long‑Term Disability or Normal Retirement, then the restrictions imposed on any Award of Restricted Stock Units or Performance Shares shall lapse on the date of such termination.
(C)    Restriction on Sale. The Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units or Performance Shares, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.

7



3.    Dividend Equivalents. Subject to discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units and Performance Shares. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units or Performance Shares (as applicable), and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit or Performance Share Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units or Performance Shares, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units or Performance Shares, including the same vesting restrictions as the underlying Award.
4.    Assignability. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units or Performance Shares, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.
5.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units or Performance Shares except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units or Performance Shares.
6.    Time of Payment of Restricted Stock Units and Performance Shares. Upon the lapse of the restriction imposed on Restricted Stock Units or Performance Shares, all Restricted Stock Units and Performance Shares that were not forfeited pursuant to Section IV.2(A) or V shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the number of Shares subject to the Restricted Stock Units or Performance Shares.
Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement prior to the date of the lapse of restriction imposed on the Restricted Stock Units is scheduled to occur and the vesting provisions of Section IV(2)(B) apply, then such Restricted Stock Units shall be paid to the Participant in full at the earlier of (x) the date on which the Participant has a Separation from Service, subject to the delay of payment (if applicable) provided in Section VII.15, and (y) the fixed date on which the lapse of restrictions was originally scheduled to occur. The procedures set forth in Section VII.6 will be applied for any taxes due upon the lapse of restriction imposed on the Restricted Stock Units due to a Participant’s Normal Retirement eligibility.

8



V.
SPECIAL FORFEITURE AND REPAYMENT RULES
Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result:
1.    Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock, Restricted Stock Units or Performance Shares as to which the restrictions have not lapsed shall immediately and automatically be forfeited and such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.
2.    If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock, Restricted Stock Units or Performance Shares (including any unpaid dividends or Dividend Equivalents) lapsed within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.
3.    The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates:
(A)    Discloses to others, or takes or uses for the Participant’s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know‑how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment, whether or not they are the Participant’s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained;
(B)    Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant’s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise;

9



(C)    Fails to provide the Corporation with at least 30 days’ written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, “business in competition” means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant’s employment with the Corporation or its Affiliates;
(D)    Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant’s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment with the Corporation or any of its Affiliates;
(E)    Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party;
(F)    Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates; or
(G)    Fails to meet the Participant’s continuing obligations with respect to non-disclosure, non-competition and/or non-solicitation under the Participant’s agreement with the Corporation or any Affiliate.
The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.
Any provision of this Section V which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section V.
VI.
CHANGE IN CONTROL
If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an “Exchange”), any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation’s assets either directly or through one or more subsidiaries) (the “Surviving

10



Company”) which are traded on an Exchange (a “Replacement Award”), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option; (ii) in the case of a Performance Share Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of the effective date of the Change in Control) equal to the value of the Performance Share Award (determined using the Corporation’s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the Replacement Award; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation’s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award; provided, however, that in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.15), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Share Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.
If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Share Award shall be replaced with a Restricted Stock Award or Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Award or Restricted Stock Unit Award shall be equal to the number of Performance Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Award or Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the replacement Award; provided however, that, in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.15).

11



VII.
MISCELLANEOUS
1.    No Effect on Terms of Employment. Participation in the Plan shall not create a right to further employment with the Participant’s employer (the “Employer”) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.
2.    Grants to Participants in Foreign Countries. In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant’s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.
3.    Information Notification. Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.
4.    Administrator Decisions Conclusive. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.
5.    No Effect on Other Benefit Plans. Nothing herein contained shall affect a Participant’s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.
6.    Withholding. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and/or dividend equivalents; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or

12



eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (1) withholding from the Participant’s wages or other cash compensation paid to the Participant by the Corporation and/or the Employer; (2) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant’s behalf pursuant to this authorization and any other authorization the Corporation and/or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares); or (3) withholding Shares to be issued upon grant, vesting/settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in (3) of this paragraph.
To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan.
Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.
The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.
7.    Successors. The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. “Participant” as used herein shall include the Participant’s Beneficiary.

13



8.    Delaware Law. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.
9.    Nature of Grant. In accepting the grant, the Participant acknowledges that:
(A)    the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time;
(B)    the grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past;
(C)    all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation;
(D)    the Participant is voluntarily participating in the Plan;
(E)    the Award is not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;
(F)    the Award will not be interpreted to form an employment contract or relationship with the Corporation; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation;
(G)    the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;
(H)    if the underlying Shares do not increase in value, the Options will have no value;
(I)    in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant’s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim;
(J)    for purposes of an Award, the Participant’s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant’s right to receive Awards and vest in Awards under the Plan, if any, will

14



terminate effective as of such date and will not be extended by any notice period mandated under local law; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates and will not be extended by any notice period mandated under local law; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee;
(K)    the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant’s acquisition or sale of Shares; and
(L)    Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan.
10.    Data Privacy. By accepting the Award, the Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this document by and among, as applicable, the Employer and the Corporation and its Affiliates for the exclusive purpose of implementing, administering and managing participation in the Plan.
The Participant understands that the Corporation and the Employer hold certain personal information about the Participant, including, but not limited, the Participant's name, home address and telephone number, date of birth, social insurance or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor, for the purpose of implementing, administering and managing the Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that recipients of Data may be located in the United States or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that if the Participant resides outside of the United States, the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the local human resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Shares acquired under the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan. The Participant understands that if the Participant resides outside of the United States, the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, without cost, by contacting in writing the local human resources representative. Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the

15



Participant later seeks to revoke the Participant's consent, the Participant’s employment status or service and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing the Participant's consent is that the Corporation would not be able to grant the Participant Awards or administer or maintain such Awards. Therefore, the Participant understands that refusing or withdrawing consent may affect the Participant's ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the local human resources representative.
11.    Severability. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.
12.    Language. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
13.    Electronic Delivery. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.
14.    Employment Agreement. Notwithstanding any provision contained in these Statement of Terms and Conditions, the Plan or the Grant Notice to the contrary, if there is a conflict between Statement of Terms and Conditions, the Plan or the Grant Notice and the employment agreement by and between the Participant and the Corporation, as amended from time to time (the “Employment Agreement”), then the Employment Agreement shall govern.
15.    Section 409A. If (i) the Participant is a Specified Employee at the time of the Participant’s Separation from Service, and (ii) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the “Deferred Compensation Benefits”) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.

16



VIII.
DEFINITIONS
When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below:
1.    Award Agreement” means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.
2.    Cause” means termination of the Participant’s employment with the Corporation or an Affiliate upon the Participant’s negligent or willful engagement in misconduct which, in the sole determination of the Board (or its designee), is injurious to the Corporation, its employees, or its customers.
3.    Early Retirement” means a termination of employment which occurs prior to Normal Retirement but on or after the date on which the Participant’s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term “service” shall include years and completed whole months of service.
4.    Family Member” means any person identified as an “immediate family” member in Rule 16(a)‑1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a “family member.”
5.    “Good Reason” means any of the following actions, if taken without the express written consent of the Participant, which shall not be affected by the Participant’s incapacity due to physical or mental illness:
(A)    Any material change by the Corporation in the Participant’s functions, duties or responsibilities as President and Chief Executive Officer, which change would cause the Participant’s position with the Corporation to become of less dignity, responsibility, importance, or scope as compared to the position and attributes that applied to the Participant immediately prior to the Change in Control, or an adverse change in the Participant’s title, position or the Participant’s obligation and right to report directly to the Board, provided, however that Good Reason shall not be deemed to exist if the Participant ceases to serve as Chairman;
(B)    Any reduction in the Participant’s base annual salary, MIP target or Long Term Incentive compensation (LTI) targets, which LTI targets include cash awards with performance periods greater than one year and equity based grants, except for reductions that are equivalent to reductions applicable to executive officers of the Corporation;
(C)    Any material failure by the Corporation to comply with any of the provisions of an award (or of any employment agreement between the parties) subsequent to a Change in Control;

17



(D)    The Corporation’s requiring the Participant to be based at any office or location more than 25 miles from the office at which the Participant is based on the date immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant’s responsibilities;
(E)    Cancellation of the automatic renewal mechanism set forth in the Participant’s employment agreement;
(F)    If the Board removes the Participant as Chairman at or after a Change in Control (or prior to a Change in Control if at the request of any third party participating in or causing the Change in Control), unless such removal is required by then‑applicable law; or
(G)    A change in the majority of the members of the Board as it was construed immediately prior to the Change in Control;
Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant’s notice to remedy the Good Reason condition; provided further that the Participant’s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.
6.    “Expiration Date” means the date that an Option expires as set forth in the Option Grant Notice as the “Expiration Date.”
7.    “Grant Date” means the date the Administrator grants the Award.
8.    “Grant Notice” means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.
9.    “Long‑Term Disability” means a physical or mental condition in respect of which the administrator of the Corporation’s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits; or, if the Participant is not then a participant in the Corporation’s long-term disability plan, a physical or mental condition that the administrator of the Corporation’s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.
10.    “Normal Retirement” means retirement at age 65 (62, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, “service” shall mean completed whole years of service (12 consecutive months).
11.    “Option Period” means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section II.5, ending on the Expiration Date.

18



12.    “Separation from Service” means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant’s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).
13.    “Short‑Term Disability” means short‑term disability as defined in the Corporation’s short‑term disability plan.
14.    “Specified Employee” means those employees identified by the Corporation as "Specified Employees" for purposes of Section 409A of the Code.
15.    “Stock Ownership Policy” means the Corporation’s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or a Participant’s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, CA 94104.    

19



EXECUTIVE OFFICERS OTHER THAN THE CEO

McKESSON CORPORATION
STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO
OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS AND
PERFORMANCE SHARES GRANTED TO OFFICERS PURSUANT
TO THE 2013 STOCK PLAN

I.
INTRODUCTION
The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.
II.
OPTIONS
1.    Option Agreement. An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Stock Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.
2.    Exercise Price. The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.
3.    Option Period. An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section II.4 as modified by the rules set forth in Sections II.5 and V. The Option Period shall be not more than seven years from the Grant Date.
4.    Vesting of Right to Exercise Options.
(A)    Except as provided in Sections II.5 and V, an Option shall be exercisable during the Option Period in accordance with the following vesting schedule:  (i) 25% of the Shares subject to the Option shall vest on the first anniversary of the Grant Date; (ii) an additional 25% of the Shares shall vest on the second anniversary of the Grant Date; (iii) an additional 25% of the Shares shall vest on the third anniversary of the Grant Date; and (iv) the remaining 25% of the

2013 Stock Plan STC (EO)




Shares subject to the Option shall vest on the fourth anniversary of the Grant Date. Notwithstanding the foregoing, the Administrator may specify a different vesting schedule at the time the Option is granted, which will be specified in the Option Grant Notice.
(B)    Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections II.5 and V. No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option. In no event shall the Corporation be required to issue fractional Shares.
5.    Limits on Option Period and Acceleration of Vesting. The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section V), as follows:
(A)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long‑Term Disability, Normal Retirement, Early Retirement or death, the Option Period shall end on the earlier of (x) 90 days after the date of the Participant’s termination of employment and (y) the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    If the Participant’s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.
(C)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates due to Long‑Term Disability during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (x) three years after the date of the Participant’s termination of employment and (y) the Expiration Date.
(D)    If the Participant’s employment is terminated:
(i)    By reason of Normal Retirement or Early Retirement, the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such retirement.
(ii)    With respect to an Option held by a Participant at Normal Retirement or Early Retirement, the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (x) three years after the date of such retirement and (y) the Expiration Date.

2



(E)    If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (x) three years after the date of death and (y) the Expiration Date, and the Participant’s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount) remaining on the date of death.
(F)    If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (x) such time as the Participant subsequently terminates employment and (y) the Expiration Date. Upon the Participant’s subsequent termination of employment, the post‑termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant’s initial termination of employment and the Participant's re‑hire date; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (E) and shall not be adjusted as described in this Section II.5(F).
6.    Method of Exercise. A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows:
(A)    By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following:  cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant’s personal check. Payment may also be made by delivery (including by FAX transmission) to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VII.6) and to transfer the proceeds of such sale to the Corporation.

3



(B)    If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof; provided that such assurance shall be deemed inapplicable to (1) any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be) filed and become effective under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and with respect to which no stop order suspending the effectiveness thereof has been issued, and (2) any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.
(C)    As soon as practicable after receipt of the notice and the assurance described in Sections II.6(A) and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section VII.6) and without other incidental expense to the Participant, credit the purchased Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the purchased Shares; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.
7.    Limitations on Transfer. An Option shall, during a Participant’s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing: (i) a Participant may designate a beneficiary to succeed, after the Participant’s death, to all of the Participant’s Options outstanding on the date of death; (ii) a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act; and (iii) any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.
8.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to such Shares upon the exercise of an Option.

4



III.
RESTRICTED STOCK
1.    Restricted Stock Agreement. A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.
2.    Rights with Respect to Shares of Restricted Stock. Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.
3.    Special Restrictions. Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.
(A)    Restrictions. Until the restrictions imposed on any Restricted Stock grant shall lapse (the “Restriction Period”), Shares of Restricted Stock granted to a Participant (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii) shall, if the Participant’s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan or in Section III.3(B)) be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan or the Restricted Stock Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of:

5



(i)    Death or Long‑Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination; or
(ii)    Normal Retirement, then, unless otherwise determined by the Administrator, with respect to any time-based Restricted Stock Award then held by such Participant as to which restrictions have not lapsed, the restrictions applicable to such Restricted Stock Award shall lapse on the effective date of such Normal Retirement as to that whole number of Shares, rounded down to the nearest whole Share, equal to (a) the total number of Shares subject to such Restricted Stock Award, multiplied by (b) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation during the entire vesting period applicable to such Award, and the denominator of which is the number of calendar months in such entire vesting period, minus (c) the number of Shares originally subject to such Restricted Stock Award with respect to which restrictions shall have lapsed as of the effective date of such Normal Retirement; provided, that for purposes of clause (b) above, “whole calendar months” shall be calculated commencing on the applicable Grant Date; and provided further, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.
(C)    Restriction on Sale. The Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.
4.    Dividends. Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award. Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restricted Period.
5.    Election to Recognize Gross Income in the Year of Grant. If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section VII.6 and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.

6



6.    Restrictive Legend. Each book entry in the records of the Corporation’s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and/or the Restricted Stock Agreement.
7.    Expiration of Restricted Period. If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant’s interest in the unrestricted Shares shall be entered on the records of the Corporation’s transfer agent.
IV.
RESTRICTED STOCK UNITS AND PERFORMANCE SHARES
1.    Award Agreement.
(A)    Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.
(B)    Performance Shares granted under the Plan shall be evidenced by a Performance Share Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Shares. Each Performance Share Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Share Agreement. Performance Shares are also subject to the terms and conditions of the Plan.
2.    Special Restrictions. Restricted Stock Units and Performance Shares granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.
(A)    Restrictions. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section IV.2(B)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units or Performance Shares shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by

7



virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan, the Restricted Stock Unit Agreement or Performance Share Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of:
(i)    Death or Long‑Term Disability, then the restrictions imposed on any Award of Restricted Stock Units or Performance Shares shall lapse on the date of such termination; or
(ii)    Normal Retirement, then, unless otherwise determined by the Administrator, with respect to any time-based Restricted Stock Units then held by such Participant as to which restrictions have not lapsed, the restrictions applicable to such Award of Restricted Stock Units shall lapse on the effective date of such Normal Retirement as to that whole number of Shares, rounded down to the nearest whole Share, equal to (a) the total number of Restricted Stock Units subject to such Award, multiplied by (b) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation during the entire vesting period applicable to such Award, and the denominator of which is the number of calendar months in such entire vesting period, minus (c) the number of Restricted Stock Units originally subject to such Award with respect to which restrictions shall have lapsed as of the effective date of such Normal Retirement; provided, that for purposes of clause (b) above, “whole calendar months” shall be calculated commencing on the applicable Grant Date; and provided further, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section IV.2(B)(ii) shall not apply to any Performance Shares or to any Restricted Stock Units the vesting of which is based, in whole or in part, on attainment of performance objectives.
(C)    Restriction on Sale. The Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units or Performance Shares, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.
3.    Dividend Equivalents. Subject to discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units and Performance Shares. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units or Performance Shares (as applicable), and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit or Performance Share Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units or Performance Shares, which will be subject to all of the terms and conditions of the underlying

8



Restricted Stock Units or Performance Shares, including the same vesting restrictions as the underlying Award.
4.    Assignability. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units or Performance Shares, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.
5.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units or Performance Shares except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units or Performance Shares.
6.    Time of Payment of Restricted Stock Units and Performance Shares. Upon the lapse of the restriction imposed on Restricted Stock Units or Performance Shares, all Restricted Stock Units and Performance Shares that were not forfeited pursuant to Section IV.2(A) or V shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the number of Shares subject to the Restricted Stock Units or Performance Shares.
Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement prior to the date of the lapse of restriction imposed on the Restricted Stock Units is scheduled to occur and the vesting provisions of Section IV(2)(B)(ii) apply, then such Restricted Stock Units shall be paid to the Participant in full at the earlier of (x) the date in which the Participant has a Separation from Service, subject to the delay of payment (if applicable) provided in Section VII.14, and (y) the fixed date on which the lapse of restrictions was originally scheduled to occur. The procedures set forth in Section VII.6 will be applied for any taxes due upon the lapse of restriction imposed on the Restricted Stock Units due to a Participant’s Normal Retirement eligibility.
V.
SPECIAL FORFEITURE AND REPAYMENT RULES
Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result:
1.    Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock, Restricted Stock Units or Performance Shares as to which the restrictions have not lapsed shall immediately and automatically be forfeited and such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.

9



2.    If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock, Restricted Stock Units or Performance Shares (including any unpaid dividends or Dividend Equivalents) lapsed within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.
3.    The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates:
(A)    Discloses to others, or takes or uses for the Participant’s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know‑how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment, whether or not they are the Participant’s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained;
(B)    Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant’s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise;
(C)    Fails to provide the Corporation with at least 30 days’ written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, “business in competition” means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant’s employment with the Corporation or its Affiliates;
(D)    Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant’s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment with the Corporation or any of its Affiliates;

10



(E)    Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party;
(F)    Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates; or
(G)    Fails to meet the Participant’s continuing obligations with respect to non-disclosure, non-competition and/or non-solicitation under the Participant’s agreement with the Corporation or any Affiliate.
The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.
Any provision of this Section V which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section V.
VI.
CHANGE IN CONTROL
If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an “Exchange”), any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation’s assets either directly or through one or more subsidiaries) (the “Surviving Company”) which are traded on an Exchange (a “Replacement Award”), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option; (ii) in the case of a Performance Share Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of the effective date of the Change in Control) equal to the value of the Performance Share Award (determined using the Corporation’s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the Replacement Award; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of

11



the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation’s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award; provided, however, that in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Share Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.
If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Share Award shall be replaced with a Restricted Stock Award or Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Award or Restricted Stock Unit Award shall be equal to the number of Performance Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Award or Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the replacement Award; provided however, that, in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.14).
VII.
MISCELLANEOUS
1.    No Effect on Terms of Employment. Participation in the Plan shall not create a right to further employment with the Participant’s employer (the “Employer”) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.
2.    Grants to Participants in Foreign Countries. In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant’s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the

12



Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.
3.    Information Notification. Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.
4.    Administrator Decisions Conclusive. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.
5.    No Effect on Other Benefit Plans. Nothing herein contained shall affect a Participant’s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.
6.    Withholding. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and/or dividend equivalents; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (1) withholding from the Participant’s wages or other cash compensation paid to the Participant by the Corporation and/or the Employer; (2) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant’s behalf pursuant to this authorization and any other authorization the Corporation and/or the broker designated by the

13



Corporation may require the Participant to sign in connection with the sale of Shares); or (3) withholding Shares to be issued upon grant, vesting/settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in (3) of this paragraph.
To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan.
Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.
The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.
7.    Successors. The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. “Participant” as used herein shall include the Participant’s Beneficiary.
8.    Delaware Law. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.
9.    Nature of Grant. In accepting the grant, the Participant acknowledges that:
(A)    the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time;
(B)    the grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past;
(C)    all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation;

14



(D)    the Participant is voluntarily participating in the Plan;
(E)    the Award is not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;
(F)    the Award will not be interpreted to form an employment contract or relationship with the Corporation; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation;
(G)    the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;
(H)    if the underlying Shares do not increase in value, the Options will have no value;
(I)    in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant’s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim;
(J)    for purposes of an Award, the Participant’s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant’s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates and will not be extended by any notice period mandated under local law; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee;
(K)    the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant’s acquisition or sale of Shares; and
(L)    Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan.

15



10.    Data Privacy. By accepting the Award, the Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this document by and among, as applicable, the Employer and the Corporation and its Affiliates for the exclusive purpose of implementing, administering and managing participation in the Plan.
The Participant understands that the Corporation and the Employer hold certain personal information about the Participant, including, but not limited, the Participant's name, home address and telephone number, date of birth, social insurance or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor, for the purpose of implementing, administering and managing the Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that recipients of Data may be located in the United States or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that if the Participant resides outside of the United States, the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the local human resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Shares acquired under the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan. The Participant understands that if the Participant resides outside of the United States, the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, without cost, by contacting in writing the local human resources representative. Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant's consent, the Participant’s employment status or service and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing the Participant's consent is that the Corporation would not be able to grant the Participant Awards or administer or maintain such Awards. Therefore, the Participant understands that refusing or withdrawing consent may affect the Participant's ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the local human resources representative.
11.    Severability. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

16



12.    Language. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
13.    Electronic Delivery. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.
14.    Section 409A. If (i) the Participant is a Specified Employee at the time of the Participant’s Separation from Service, and (ii) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the “Deferred Compensation Benefits”) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.
VIII.
DEFINITIONS
When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below:
1.    Award Agreement” means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.
2.    Cause” means termination of the Participant’s employment with the Corporation or an Affiliate upon the Participant’s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer’s designee), is injurious to the Corporation, its employees, or its customers.
3.    Early Retirement” means a termination of employment which occurs prior to Normal Retirement but on or after the date on which the Participant’s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term “service” shall include years and completed whole months of service.

17



4.    Family Member” means any person identified as an “immediate family” member in Rule 16(a)‑1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a “family member.”
5.    “Good Reason” means any of the following actions, if taken without the express written consent of the Participant:
(A)    Any material change by the Corporation in the Participant’s functions, duties, or responsibilities, which change would cause the Participant’s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control;
(B)    Any significant reduction in the Participant’s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control;
(C)    Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control;
(D)    The Corporation’s requiring the Participant to be based at any location which would increase the Participant’s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant’s responsibilities; or
(E)    Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control;
Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant’s notice to remedy the Good Reason condition; provided further that the Participant’s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.
6.    “Expiration Date” means the date that an Option expires as set forth in the Option Grant Notice as the “Expiration Date.”
7.    “Grant Date” means the date the Administrator grants the Award.
8.    “Grant Notice” means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.
9.    “Long‑Term Disability” means a physical or mental condition in respect of which the administrator of the Corporation’s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits; or, if the Participant is not then a participant in the Corporation’s long-term disability plan, a physical or mental condition that the administrator

18



of the Corporation’s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.
10.    “Normal Retirement” means retirement at age 65 (62, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, “service” shall mean completed whole years of service (12 consecutive months).
11.    “Option Period” means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section II.5, ending on the Expiration Date.
12.    “Separation from Service” means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant’s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).
13.    “Short‑Term Disability” means short‑term disability as defined in the Corporation’s short‑term disability plan.
14.    “Specified Employee” means those employees identified by the Corporation as "Specified Employees" for purposes of Section 409A of the Code.
15.    “Stock Ownership Policy” means the Corporation’s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or a Participant’s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, CA 94104.    

19



EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY

McKESSON CORPORATION
STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO
OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS AND
PERFORMANCE SHARES GRANTED TO EMPLOYEES
SUBJECT TO STOCK OWNERSHIP POLICY PURSUANT

TO THE 2013 STOCK PLAN

I.
INTRODUCTION
The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.
II.
OPTIONS
1.    Option Agreement. An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Stock Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.
2.    Exercise Price. The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.
3.    Option Period. An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section II.4 as modified by the rules set forth in Sections II.5 and V. The Option Period shall be not more than seven years from the Grant Date.
4.    Vesting of Right to Exercise Options.
(A)    Except as provided in Sections II.5 and V, an Option shall be exercisable during the Option Period in accordance with the following vesting schedule:  (i) 25% of the Shares subject to the Option shall vest on the first anniversary of the Grant Date; (ii) an additional 25% of the Shares shall vest on the second anniversary of the Grant Date; (iii) an additional 25% of the

2013 Stock Plan STC (ECOT)




Shares shall vest on the third anniversary of the Grant Date; and (iv) the remaining 25% of the Shares subject to the Option shall vest on the fourth anniversary of the Grant Date. Notwithstanding the foregoing, the Administrator may specify a different vesting schedule at the time the Option is granted, which will be specified in the Option Grant Notice.
(B)    Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections II.5 and V. No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option. In no event shall the Corporation be required to issue fractional Shares.
5.    Limits on Option Period and Acceleration of Vesting. The Option Period may end before the Expiration Date, and in certain circumstances, the vesting schedule of an Option may be accelerated (subject to the provisions of Section V), as follows:
(A)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long‑Term Disability, Normal Retirement, Early Retirement or death, the Option Period shall end on the earlier of (x) 90 days after the date of the Participant’s termination of employment and (y) the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    If the Participant’s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.
(C)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates due to Long‑Term Disability during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (x) three years after the date of the Participant’s termination of employment and (y) the Expiration Date.
(D)    If the Participant’s employment is terminated:
(i)    By reason of Normal Retirement or Early Retirement, the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such retirement.

2



(ii)    With respect to an Option held by a Participant at Normal Retirement or Early Retirement, the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (x) three years after the date of such retirement and (y) the Expiration Date.
(E)    If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (x) three years after the date of death and (y) the Expiration Date, and the Participant’s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount) remaining on the date of death.
(F)    If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (x) such time as the Participant subsequently terminates employment and (y) the Expiration Date. Upon the Participant’s subsequent termination of employment, the post‑termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant’s initial termination of employment and the Participant's re‑hire date; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (E) and shall not be adjusted as described in this Section II.5(F).
6.    Method of Exercise. A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows:
(A)    By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following:  cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant’s personal check. Payment may also be made by delivery (including by FAX transmission) to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount

3



sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VII.6) and to transfer the proceeds of such sale to the Corporation.
(B)    If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof; provided that such assurance shall be deemed inapplicable to (1) any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be) filed and become effective under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and with respect to which no stop order suspending the effectiveness thereof has been issued, and (2) any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.
(C)    As soon as practicable after receipt of the notice and the assurance described in Sections II.6(A) and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section VII.6) and without other incidental expense to the Participant, credit the purchased Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the purchased Shares; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.
7.    Limitations on Transfer. An Option shall, during a Participant’s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing: (i) a Participant may designate a beneficiary to succeed, after the Participant’s death, to all of the Participant’s Options outstanding on the date of death; (ii) a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act; and (iii) any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.

4



8.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to such Shares upon the exercise of an Option.
III.
RESTRICTED STOCK
1.    Restricted Stock Agreement. A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.
2.    Rights with Respect to Shares of Restricted Stock. Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.
3.    Special Restrictions. Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.
(A)    Restrictions. Until the restrictions imposed on any Restricted Stock grant shall lapse (the “Restriction Period”), Shares of Restricted Stock granted to a Participant (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii) shall, if the Participant’s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan or in Section III.3(B)) be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.

5



(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan or the Restricted Stock Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of:
(i)    Death or Long‑Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination; or
(ii)    Normal Retirement, then, unless otherwise determined by the Administrator, with respect to any time-based Restricted Stock Award then held by such Participant as to which restrictions have not lapsed, the restrictions applicable to such Restricted Stock Award shall lapse on the effective date of such Normal Retirement as to that whole number of Shares, rounded down to the nearest whole Share, equal to (a) the total number of Shares subject to such Restricted Stock Award, multiplied by (b) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation during the entire vesting period applicable to such Award, and the denominator of which is the number of calendar months in such entire vesting period, minus (c) the number of Shares originally subject to such Restricted Stock Award with respect to which restrictions shall have lapsed as of the effective date of such Normal Retirement; provided, that for purposes of clause (b) above, “whole calendar months” shall be calculated commencing on the applicable Grant Date; and provided further, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.
(C)    Restriction on Sale. The Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.
4.    Dividends. Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award. Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restricted Period.
5.    Election to Recognize Gross Income in the Year of Grant. If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make

6



arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section VII.6 and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.
6.    Restrictive Legend. Each book entry in the records of the Corporation’s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and/or the Restricted Stock Agreement.
7.    Expiration of Restricted Period. If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant’s interest in the unrestricted Shares shall be entered on the records of the Corporation’s transfer agent.
IV.
RESTRICTED STOCK UNITS AND PERFORMANCE SHARES
1.    Award Agreement.
(A)    Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.
(B)    Performance Shares granted under the Plan shall be evidenced by a Performance Share Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Shares. Each Performance Share Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Share Agreement. Performance Shares are also subject to the terms and conditions of the Plan.
2.    Special Restrictions. Restricted Stock Units and Performance Shares granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.
(A)    Restrictions. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section IV.2(B)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units or

7



Performance Shares shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan, the Restricted Stock Unit Agreement or Performance Share Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of:
(i)    Death or Long‑Term Disability, then the restrictions imposed on any Award of Restricted Stock Units or Performance Shares shall lapse on the date of such termination; or
(ii)    Normal Retirement, then, unless otherwise determined by the Administrator, with respect to any time-based Restricted Stock Units then held by such Participant as to which restrictions have not lapsed, the restrictions applicable to such Award of Restricted Stock Units shall lapse on the effective date of such Normal Retirement as to that whole number of Shares, rounded down to the nearest whole Share, equal to (a) the total number of Restricted Stock Units subject to such Award, multiplied by (b) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation during the entire vesting period applicable to such Award, and the denominator of which is the number of calendar months in such entire vesting period, minus (c) the number of Restricted Stock Units originally subject to such Award with respect to which restrictions shall have lapsed as of the effective date of such Normal Retirement; provided, that for purposes of clause (b) above, “whole calendar months” shall be calculated commencing on the applicable Grant Date; and provided further, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section IV.2(B)(ii) shall not apply to any Performance Shares or to any Restricted Stock Units the vesting of which is based, in whole or in part, on attainment of performance objectives.
(C)    Restriction on Sale. The Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units or Performance Shares, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.
3.    Dividend Equivalents. Subject to discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units and Performance Shares. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units or Performance Shares (as applicable), and cash dividends, along with accrued interest (if any) on

8



such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit or Performance Share Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units or Performance Shares, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units or Performance Shares, including the same vesting restrictions as the underlying Award.
4.    Assignability. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units or Performance Shares, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.
5.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units or Performance Shares except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units or Performance Shares.
6.    Time of Payment of Restricted Stock Units and Performance Shares. Upon the lapse of the restriction imposed on Restricted Stock Units or Performance Shares, all Restricted Stock Units and Performance Shares that were not forfeited pursuant to Section IV.2(A) or V shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the number of Shares subject to the Restricted Stock Units or Performance Shares.
Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement prior to the date of the lapse of restriction imposed on the Restricted Stock Units is scheduled to occur and the vesting provisions of Section IV(2)(B)(ii) apply, then such Restricted Stock Units shall be paid to the Participant in full at the earlier of (x) the date on which the Participant has a Separation from Service, subject to the delay of payment (if applicable) provided in Section VII.14, and (y) the fixed date on which the lapse of restrictions was originally scheduled to occur. The procedures set forth in Section VII.6 will be applied for any taxes due upon the lapse of restriction imposed on the Restricted Stock Units due to a Participant’s Normal Retirement eligibility.
V.
SPECIAL FORFEITURE AND REPAYMENT RULES
Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result:
1.    Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock, Restricted Stock Units or Performance Shares as to which the restrictions have not lapsed shall immediately and automatically be forfeited and such Shares of Restricted Stock shall be returned

9



to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.
2.    If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock, Restricted Stock Units or Performance Shares (including any unpaid dividends or Dividend Equivalents) lapsed within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.
3.    The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates:
(A)    Discloses to others, or takes or uses for the Participant’s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know‑how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment, whether or not they are the Participant’s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained;
(B)    Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant’s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise;
(C)    Fails to provide the Corporation with at least 30 days’ written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, “business in competition” means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant’s employment with the Corporation or its Affiliates;
(D)    Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant’s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment with the Corporation or any of its Affiliates;

10



(E)    Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party;
(F)    Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates; or
(G)    Fails to meet the Participant’s continuing obligations with respect to non-disclosure, non-competition and/or non-solicitation under the Participant’s agreement with the Corporation or any Affiliate.
The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.
Any provision of this Section V which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section V.
VI.
CHANGE IN CONTROL
If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an “Exchange”), any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation’s assets either directly or through one or more subsidiaries) (the “Surviving Company”) which are traded on an Exchange (a “Replacement Award”), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option; (ii) in the case of a Performance Share Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of the effective date of the Change in Control) equal to the value of the Performance Share Award (determined using the Corporation’s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the Replacement Award; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of

11



the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation’s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award; provided, however, that in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Share Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.
If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Share Award shall be replaced with a Restricted Stock Award or Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Award or Restricted Stock Unit Award shall be equal to the number of Performance Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Award or Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the replacement Award; provided however, that, in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.14).
VII.
MISCELLANEOUS
1.    No Effect on Terms of Employment. Participation in the Plan shall not create a right to further employment with the Participant’s employer (the “Employer”) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.
2.    Grants to Participants in Foreign Countries. In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant’s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the

12



Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.
3.    Information Notification. Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.
4.    Administrator Decisions Conclusive. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.
5.    No Effect on Other Benefit Plans. Nothing herein contained shall affect a Participant’s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.
6.    Withholding. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and/or dividend equivalents; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (1) withholding from the Participant’s wages or other cash compensation paid to the Participant by the Corporation and/or the Employer; (2) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant’s behalf pursuant to this authorization and any other authorization the Corporation and/or the broker designated by the

13



Corporation may require the Participant to sign in connection with the sale of Shares); or (3) withholding Shares to be issued upon grant, vesting/settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in (3) of this paragraph.
To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan.
Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.
The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.
7.    Successors. The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. “Participant” as used herein shall include the Participant’s Beneficiary.
8.    Delaware Law. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.
9.    Nature of Grant. In accepting the grant, the Participant acknowledges that:
(A)    the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time;
(B)    the grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past;
(C)    all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation;

14



(D)    the Participant is voluntarily participating in the Plan;
(E)    the Award is not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;
(F)    the Award will not be interpreted to form an employment contract or relationship with the Corporation; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation;
(G)    the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;
(H)    if the underlying Shares do not increase in value, the Options will have no value;
(I)    in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant’s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim;
(J)    for purposes of an Award, the Participant’s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant’s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates and will not be extended by any notice period mandated under local law; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee;
(K)    the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant’s acquisition or sale of Shares; and
(L)    Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan.

15



10.    Data Privacy. By accepting the Award, the Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this document by and among, as applicable, the Employer and the Corporation and its Affiliates for the exclusive purpose of implementing, administering and managing participation in the Plan.
The Participant understands that the Corporation and the Employer hold certain personal information about the Participant, including, but not limited, the Participant's name, home address and telephone number, date of birth, social insurance or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor, for the purpose of implementing, administering and managing the Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that recipients of Data may be located in the United States or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that if the Participant resides outside of the United States, the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the local human resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Shares acquired under the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan. The Participant understands that if the Participant resides outside of the United States, the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, without cost, by contacting in writing the local human resources representative. Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant's consent, the Participant’s employment status or service and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing the Participant's consent is that the Corporation would not be able to grant the Participant Awards or administer or maintain such Awards. Therefore, the Participant understands that refusing or withdrawing consent may affect the Participant's ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the local human resources representative.
11.    Severability. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

16



12.    Language. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
13.    Electronic Delivery. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.
14.    Section 409A. If (i) the Participant is a Specified Employee at the time of the Participant’s Separation from Service, and (ii) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the “Deferred Compensation Benefits”) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.
VIII.
DEFINITIONS
When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below:
1.    Award Agreement” means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.
2.    Cause” means termination of the Participant’s employment with the Corporation or an Affiliate upon the Participant’s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer’s designee), is injurious to the Corporation, its employees, or its customers.
3.    Early Retirement” means a termination of employment which occurs prior to Normal Retirement but on or after the date on which the Participant’s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term “service” shall include years and completed whole months of service.

17



4.    Family Member” means any person identified as an “immediate family” member in Rule 16(a)‑1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a “family member.”
5.    “Good Reason” means any of the following actions, if taken without the express written consent of the Participant:
(A)    Any material change by the Corporation in the Participant’s functions, duties, or responsibilities, which change would cause the Participant’s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control; provided, however, that, any such change attributable to the Corporation’s no longer being a company with publicly traded common stock shall not constitute Good Reason; and provided, further, that a reduction in the Participant’s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant’s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation’s business) shall not constitute Good Reason;
(B)    Any significant reduction in the Participant’s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control;
(C)    Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control; or
(D)    The Corporation’s requiring the Participant to be based at any location which would increase the Participant’s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant’s responsibilities;
Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant’s notice to remedy the Good Reason condition; provided further that the Participant’s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.
6.    “Expiration Date” means the date that an Option expires as set forth in the Option Grant Notice as the “Expiration Date.”
7.    “Grant Date” means the date the Administrator grants the Award.
8.    “Grant Notice” means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.

18



9.    “Long‑Term Disability” means a physical or mental condition in respect of which the administrator of the Corporation’s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits; or, if the Participant is not then a participant in the Corporation’s long-term disability plan, a physical or mental condition that the administrator of the Corporation’s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.
10.    “Normal Retirement” means retirement at age 65 (62, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, “service” shall mean completed whole years of service (12 consecutive months).
11.    “Option Period” means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section II.5, ending on the Expiration Date.
12.    “Separation from Service” means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant’s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).
13.    “Short‑Term Disability” means short‑term disability as defined in the Corporation’s short‑term disability plan.
14.    “Specified Employee” means those employees identified by the Corporation as "Specified Employees" for purposes of Section 409A of the Code.
15.    “Stock Ownership Policy” means the Corporation’s Stock Ownership Policy, as amended from time to time, which can be found on McKNet. A Participant or a Participant’s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, CA 94104.    

19



EMPLOYEE

McKESSON CORPORATION
STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO
OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS AND
PERFORMANCE SHARES GRANTED TO EMPLOYEES PURSUANT
TO THE 2013 STOCK PLAN

I.
INTRODUCTION
The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any rules promulgated thereunder. In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern. Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.
II.
OPTIONS
1.    Option Agreement. An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option. Each Stock Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement. The Option is also subject to the terms and conditions of the Plan.
2.    Exercise Price. The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.
3.    Option Period. An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section II.4 as modified by the rules set forth in Sections II.5 and V. The Option Period shall be not more than seven years from the Grant Date.
4.    Vesting of Right to Exercise Options.
(A)    Except as provided in Sections II.5 and V, an Option shall be exercisable during the Option Period in accordance with the following vesting schedule:  (i) 25% of the Shares subject to the Option shall vest on the first anniversary of the Grant Date; (ii) an additional 25% of the Shares shall vest on the second anniversary of the Grant Date; (iii) an additional 25% of the Shares shall vest on the third anniversary of the Grant Date; and (iv) the remaining 25% of the

2013 Stock Plan STC (Employee)




Shares subject to the Option shall vest on the fourth anniversary of the Grant Date. Notwithstanding the foregoing, the Administrator may specify a different vesting schedule at the time the Option is granted, which will be specified in the Option Grant Notice.
(B)    Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections II.5 and V. No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option. In no event shall the Corporation be required to issue fractional Shares.
5.    Limits on Option Period and Acceleration of Vesting. The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section V), as follows:
(A)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long‑Term Disability, Normal Retirement, Early Retirement or death, the Option Period shall end on the earlier of (x) 90 days after the date of the Participant’s termination of employment and (y) the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such termination of employment. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    If the Participant’s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.
(C)    If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates due to Long‑Term Disability during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (x) three years after the date of the Participant’s termination of employment and (y) the Expiration Date.
(D)    If the Participant’s employment is terminated:
(i)    By reason of Normal Retirement or Early Retirement, the Option shall be exercisable only to the extent that it was exercisable under the provisions of the foregoing Section II.4 at the time of such retirement.
(ii)    With respect to an Option held by a Participant at Normal Retirement or Early Retirement, the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (x) three years after the date of such retirement and (y) the Expiration Date.

2



(E)    If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant’s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (x) three years after the date of death and (y) the Expiration Date, and the Participant’s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount) remaining on the date of death.
(F)    If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (x) such time as the Participant subsequently terminates employment and (y) the Expiration Date. Upon the Participant’s subsequent termination of employment, the post‑termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant’s initial termination of employment and the Participant's re‑hire date; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (E) and shall not be adjusted as described in this Section II.5(F).
6.    Method of Exercise. A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows:
(A)    By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised. Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following:  cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States. Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise. The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant’s personal check. Payment may also be made by delivery (including by FAX transmission) to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VII.6) and to transfer the proceeds of such sale to the Corporation.

3



(B)    If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof; provided that such assurance shall be deemed inapplicable to (1) any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be) filed and become effective under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and with respect to which no stop order suspending the effectiveness thereof has been issued, and (2) any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.
(C)    As soon as practicable after receipt of the notice and the assurance described in Sections II.6(A) and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section VII.6) and without other incidental expense to the Participant, credit the purchased Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the purchased Shares; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.
7.    Limitations on Transfer. An Option shall, during a Participant’s lifetime, be exercisable only by the Participant. No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution. Notwithstanding the foregoing: (i) a Participant may designate a beneficiary to succeed, after the Participant’s death, to all of the Participant’s Options outstanding on the date of death; (ii) a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act; and (iii) any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.
8.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to such Shares upon the exercise of an Option.

4



III.
RESTRICTED STOCK
1.    Restricted Stock Agreement. A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award. Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement. The Restricted Stock Award is also subject to the terms and conditions of the Plan.
2.    Rights with Respect to Shares of Restricted Stock. Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation’s transfer agent recording the Participant’s interest in the Restricted Stock. From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.
3.    Special Restrictions. Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.
(A)    Restrictions. Until the restrictions imposed on any Restricted Stock grant shall lapse (the “Restriction Period”), Shares of Restricted Stock granted to a Participant (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii) shall, if the Participant’s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan or in Section III.3(B)) be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.
(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan or the Restricted Stock Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of:

5



(i)    Death or Long‑Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination; or
(ii)    Normal Retirement, then, unless otherwise determined by the Administrator, with respect to any time-based Restricted Stock Award then held by such Participant as to which restrictions have not lapsed, the restrictions applicable to such Restricted Stock Award shall lapse on the effective date of such Normal Retirement as to that whole number of Shares, rounded down to the nearest whole Share, equal to (a) the total number of Shares subject to such Restricted Stock Award, multiplied by (b) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation during the entire vesting period applicable to such Award, and the denominator of which is the number of calendar months in such entire vesting period, minus (c) the number of Shares originally subject to such Restricted Stock Award with respect to which restrictions shall have lapsed as of the effective date of such Normal Retirement; provided, that for purposes of clause (b) above, “whole calendar months” shall be calculated commencing on the applicable Grant Date; and provided further, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.
4.    Dividends. Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award. Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restricted Period.
5.    Election to Recognize Gross Income in the Year of Grant. If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section VII.6 and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.
6.    Restrictive Legend. Each book entry in the records of the Corporation’s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and/or the Restricted Stock Agreement.

6



7.    Expiration of Restricted Period. If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant’s interest in the unrestricted Shares shall be entered on the records of the Corporation’s transfer agent.
IV.
RESTRICTED STOCK UNITS AND PERFORMANCE SHARES
1.    Award Agreement.
(A)    Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement. The Restricted Stock Units are also subject to the terms and conditions of the Plan.
(B)    Performance Shares granted under the Plan shall be evidenced by a Performance Share Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Shares. Each Performance Share Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant’s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Share Agreement. Performance Shares are also subject to the terms and conditions of the Plan.
2.    Special Restrictions. Restricted Stock Units and Performance Shares granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.
(A)    Restrictions. If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section IV.2(B)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units or Performance Shares shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate. If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short‑Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.

7



(B)    Termination of Employment by Reason of Death, Long‑Term Disability or Normal Retirement. Notwithstanding any provision contained herein or in the Plan, the Restricted Stock Unit Agreement or Performance Share Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of:
(i)    Death or Long‑Term Disability, then the restrictions imposed on any Award of Restricted Stock Units or Performance Shares shall lapse on the date of such termination; or
(ii)    Normal Retirement, then, unless otherwise determined by the Administrator, with respect to any time-based Restricted Stock Units then held by such Participant as to which restrictions have not lapsed, the restrictions applicable to such Award of Restricted Stock Units shall lapse on the effective date of such Normal Retirement as to that whole number of Shares, rounded down to the nearest whole Share, equal to (a) the total number of Restricted Stock Units subject to such Award, multiplied by (b) a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation during the entire vesting period applicable to such Award, and the denominator of which is the number of calendar months in such entire vesting period, minus (c) the number of Restricted Stock Units originally subject to such Award with respect to which restrictions shall have lapsed as of the effective date of such Normal Retirement; provided, that for purposes of clause (b) above, “whole calendar months” shall be calculated commencing on the applicable Grant Date; and provided further, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section IV.2(B)(ii) shall not apply to any Performance Shares or to any Restricted Stock Units the vesting of which is based, in whole or in part, on attainment of performance objectives.
3.    Dividend Equivalents. Subject to discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units and Performance Shares. Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units or Performance Shares (as applicable), and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit or Performance Share Award, and to which the cash dividends relate, are distributed. Stock dividends shall be converted into additional Restricted Stock Units or Performance Shares, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units or Performance Shares, including the same vesting restrictions as the underlying Award.
4.    Assignability. A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units or Performance Shares, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.

8



5.    No Stockholder Rights. Neither a Participant nor any person entitled to exercise a Participant’s rights in the event of the Participant’s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units or Performance Shares except to the extent that a book entry has been entered in the records of the Corporation’s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units or Performance Shares.
6.    Time of Payment of Restricted Stock Units and Performance Shares. Upon the lapse of the restriction imposed on Restricted Stock Units or Performance Shares, all Restricted Stock Units and Performance Shares that were not forfeited pursuant to Section IV.2(A) or V shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse. Payment shall be made in Shares to the Participant’s brokerage account of record. If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation’s transfer agent recording the Participant’s unrestricted interest in the number of Shares subject to the Restricted Stock Units or Performance Shares.
Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement prior to the date of the lapse of restriction imposed on the Restricted Stock Units is scheduled to occur and the vesting provisions of Section IV(2)(B)(ii) apply, then such Restricted Stock Units shall be paid to the Participant in full at the earlier of (x) the date on which the Participant has a Separation from Service, subject to the delay of payment (if applicable) provided in Section VII.14, and (y) the fixed date on which the lapse of restrictions was originally scheduled to occur. The procedures set forth in Section VII.6 will be applied for any taxes due upon the lapse of restriction imposed on the Restricted Stock Units due to a Participant’s Normal Retirement eligibility.
V.
SPECIAL FORFEITURE AND REPAYMENT RULES
Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result:
1.    Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation. In addition, any Award of Restricted Stock, Restricted Stock Units or Performance Shares as to which the restrictions have not lapsed shall immediately and automatically be forfeited and such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.
2.    If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise. In addition, if the restrictions imposed on any Award of Restricted Stock, Restricted Stock Units or Performance Shares (including any unpaid dividends or Dividend Equivalents) lapsed within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately

9



pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested.
3.    The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates:
(A)    Discloses to others, or takes or uses for the Participant’s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know‑how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment, whether or not they are the Participant’s work product. Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained;
(B)    Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant’s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise;
(C)    Fails to provide the Corporation with at least 30 days’ written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates. As used herein, “business in competition” means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant’s employment with the Corporation or its Affiliates;
(D)    Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant’s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant’s employment with the Corporation or any of its Affiliates;
(E)    Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party;
(F)    Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates; or

10



(G)    Fails to meet the Participant’s continuing obligations with respect to non-disclosure, non-competition and/or non-solicitation under the Participant’s agreement with the Corporation or any Affiliate.
The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.
Any provision of this Section V which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section V.
VI.
CHANGE IN CONTROL
If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an “Exchange”), any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation’s assets either directly or through one or more subsidiaries) (the “Surviving Company”) which are traded on an Exchange (a “Replacement Award”), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option; (ii) in the case of a Performance Share Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of the effective date of the Change in Control) equal to the value of the Performance Share Award (determined using the Corporation’s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the Replacement Award; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company’s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation’s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award; provided, however, that in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the

11



excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award, or Performance Share Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Share Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.
If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Share Award shall be replaced with a Restricted Stock Award or Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Award or Restricted Stock Unit Award shall be equal to the number of Performance Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Award or Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Share Award was to be measured prior to the granting of the replacement Award; provided however, that, in the event of the Participant’s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VII.14).
VII.
MISCELLANEOUS
1.    No Effect on Terms of Employment. Participation in the Plan shall not create a right to further employment with the Participant’s employer (the “Employer”) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.
2.    Grants to Participants in Foreign Countries. In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Participant’s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.
3.    Information Notification. Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed

12



envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.
4.    Administrator Decisions Conclusive. All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.
5.    No Effect on Other Benefit Plans. Nothing herein contained shall affect a Participant’s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.
6.    Withholding. Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer. The Participant further acknowledges that the Corporation and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and/or dividend equivalents; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (1) withholding from the Participant’s wages or other cash compensation paid to the Participant by the Corporation and/or the Employer; (2) withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant’s behalf pursuant to this authorization and any other authorization the Corporation and/or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares); or (3) withholding Shares to be issued upon grant, vesting/settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined. In no event, however, shall the Corporation be required to issue fractional Shares. With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and/or

13



the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in (3) of this paragraph.
To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan.
Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.
The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.
7.    Successors. The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. “Participant” as used herein shall include the Participant’s Beneficiary.
8.    Delaware Law. The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.
9.    Nature of Grant. In accepting the grant, the Participant acknowledges that:
(A)    the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time;
(B)    the grant of the Award is voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past;
(C)    all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation;
(D)    the Participant is voluntarily participating in the Plan;
(E)    the Award is not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments;

14



(F)    the Award will not be interpreted to form an employment contract or relationship with the Corporation; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation;
(G)    the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty;
(H)    if the underlying Shares do not increase in value, the Options will have no value;
(I)    in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant’s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim;
(J)    for purposes of an Award, the Participant’s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant’s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates and will not be extended by any notice period mandated under local law; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee;
(K)    the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant’s acquisition or sale of Shares; and
(L)    Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan.
10.    Data Privacy. By accepting the Award, the Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this document by and among, as applicable, the Employer and the Corporation and its Affiliates for the exclusive purpose of implementing, administering and managing participation in the Plan.

15



The Participant understands that the Corporation and the Employer hold certain personal information about the Participant, including, but not limited, the Participant's name, home address and telephone number, date of birth, social insurance or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor, for the purpose of implementing, administering and managing the Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that recipients of Data may be located in the United States or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that if the Participant resides outside of the United States, the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the local human resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Shares acquired under the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan. The Participant understands that if the Participant resides outside of the United States, the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, without cost, by contacting in writing the local human resources representative. Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke the Participant's consent, the Participant’s employment status or service and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing the Participant's consent is that the Corporation would not be able to grant the Participant Awards or administer or maintain such Awards. Therefore, the Participant understands that refusing or withdrawing consent may affect the Participant's ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the local human resources representative.
11.    Severability. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.
12.    Language. If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

16



13.    Electronic Delivery. The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.
14.    Section 409A. If (i) the Participant is a Specified Employee at the time of the Participant’s Separation from Service, and (ii) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the “Deferred Compensation Benefits”) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.
VIII.
DEFINITIONS
When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below:
1.    Award Agreement” means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.
2.    Cause” means termination of the Participant’s employment with the Corporation or an Affiliate upon the Participant’s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer’s designee), is injurious to the Corporation, its employees, or its customers.
3.    Early Retirement” means a termination of employment which occurs prior to Normal Retirement but on or after the date on which the Participant’s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term “service” shall include years and completed whole months of service.
4.    Family Member” means any person identified as an “immediate family” member in Rule 16(a)‑1(e) of the Exchange Act, as such Rule may be amended from time to time. Notwithstanding the foregoing, the Administrator may designate any other person(s) or entity(ies) as a “family member.”

17



5.    “Good Reason” means any of the following actions, if taken without the express written consent of the Participant:
(A)    Any material change by the Corporation in the Participant’s functions, duties, or responsibilities, which change would cause the Participant’s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control; provided, however, that, any such change attributable to the Corporation’s no longer being a company with publicly traded common stock shall not constitute Good Reason; and provided, further, that a reduction in the Participant’s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant’s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation’s business) shall not constitute Good Reason;
(B)    Any significant reduction in the Participant’s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control;
(C)    Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control; or
(D)    The Corporation’s requiring the Participant to be based at any location which would increase the Participant’s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant’s responsibilities;
Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant’s notice to remedy the Good Reason condition; provided further that the Participant’s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.
6.    “Expiration Date” means the date that an Option expires as set forth in the Option Grant Notice as the “Expiration Date.”
7.    “Grant Date” means the date the Administrator grants the Award.
8.    “Grant Notice” means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.
9.    “Long‑Term Disability” means a physical or mental condition in respect of which the administrator of the Corporation’s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits; or, if the Participant is not then a participant in the Corporation’s long-term disability plan, a physical or mental condition that the administrator of the Corporation’s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.

18



10.    “Normal Retirement” means retirement at age 65 (62, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, “service” shall mean completed whole years of service (12 consecutive months).
11.    “Option Period” means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section II.5, ending on the Expiration Date.
12.    “Separation from Service” means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant’s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).
13.    “Short‑Term Disability” means short‑term disability as defined in the Corporation’s short‑term disability plan.
14.    “Specified Employee” means those employees identified by the Corporation as "Specified Employees" for purposes of Section 409A of the Code.    

19



CEO Other EOs ECOT


FORM OF
MCKESSON CORPORATION 2013 STOCK PLAN
STOCK OPTION GRANT NOTICE
Optionee Name:
 
Optionee Address:
 
Type of Option:
Nonstatutory Stock Option
Grant Date:
 
Shares Granted:
 
Price per Share:
 
Vesting Schedule:
 
Expiration Date:
 

McKesson Corporation (the “Company”) is pleased to grant you a nonstatutory stock option under the Company’s 2013 Stock Plan (the “Plan”) to purchase shares of common stock of the Company (“Shares”). This Grant Notice (“Notice”), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the “ST&Cs”), constitute your Stock Option Agreement, which along with the Plan (note that the Plan incorporates by reference the Company’s Compensation Recoupment Policy (the “Recoupment Policy”) and the Company’s Stock Ownership Policy (the “Company Stock Ownership Policy”) as both are amended from time to time) set forth the terms of your grant.

Below is a list of documents that are made available to you in connection with this Notice. PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF AN OPTION. This grant, along with any other grants you may have received in the past can be viewed on the Merrill Lynch web site at www.benefits.ml.com.

This Option is subject to earlier termination than the expiration date set above in certain circumstances, as set forth in the Plan and ST&Cs. For more information about stock options, including information on how to exercise your Option, visit the Corporate Secretary’s Website on McKNET under About McKesson/Legal/Office of the General Counsel/Corporate Secretary/Stock Administration.

By signing below, I acknowledge that:
1.
I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company’s website and stockholder information, including copies of any annual report, proxy and Form
10-K, from the Investor Resources section of the McKesson website at www.mckesson.com; and
2.
I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360); and
3.
I have access to the Company’s web site; and
4.
I consent to receiving electronically a copy of the document set forth above and attachments to this Notice; and
5.
The Plan, (including the Recoupment Policy and Stock Ownership Policy) and ST&Cs are incorporated by reference to this Notice; and
6.
The Company recommends that the Optionee consult with a tax advisor prior to accepting or exercising this Option; and
7.
I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this Option.
IN WITNESS WHEREOF, the Optionee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.
   
 
 
Name      Date         Optionee Signature         Date
Title        
McKesson Corporation
ATTACHMENTS:
* 2013 Stock Plan
* ST&Cs Applicable to _____________
* Compensation Recoupment Policy
* Stock Ownership Policy
* 2013 Stock Plan Prospectus
July 2013    





EMPLOYEE


FORM OF
MCKESSON CORPORATION 2013 STOCK PLAN
STOCK OPTION GRANT NOTICE
Optionee Name:
 
Optionee Address:
 
Type of Option:
Nonstatutory Stock Option
Grant Date:
 
Shares Granted:
 
Price per Share:
 
Vesting Schedule:
 
Expiration Date:
 

McKesson Corporation (the “Company”) is pleased to grant you a nonstatutory stock option under the Company’s 2013 Stock Plan (the “Plan”) to purchase shares of common stock of the Company (“Shares”). This Grant Notice (“Notice”), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the “ST&Cs”), constitute your Stock Option Agreement, which along with the Plan (note that the Plan incorporates by reference the Company’s Compensation Recoupment Policy, as amended from time to time (the “Recoupment Policy”)) set forth the terms of your grant.

Below is a list of documents that are made available to you in connection with this Notice. PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF AN OPTION. This grant, along with any other grants you may have received in the past can be viewed on the Merrill Lynch web site at www.benefits.ml.com.

This Option is subject to earlier termination than the expiration date set above in certain circumstances, as set forth in the Plan and ST&Cs. For more information about stock options, including information on how to exercise your Option, visit the Corporate Secretary’s Website on McKNET under About McKesson/Legal/Office of the General Counsel/Corporate Secretary/Stock Administration.

By signing below, I acknowledge that:
1.
I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company’s website and stockholder information, including copies of any annual report, proxy and Form
10-K, from the Investor Resources section of the McKesson website at www.mckesson.com; and
2.
I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360); and
3.
I have access to the Company’s web site; and
4.
I consent to receiving electronically a copy of the document set forth above and attachments to this Notice; and
5.
The Plan (including the Recoupment Policy) and ST&Cs are incorporated by reference to this Notice; and
6.
The Company recommends that the Optionee consult with a tax advisor prior to accepting or exercising this Option; and
7.
I accept ALL the terms and conditions as set forth in the Plan and the ST&Cs applicable to this Option.

IN WITNESS WHEREOF, the Optionee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.
 
 
 
Name Date             Optionee Signature Date
Title    
McKesson Corporation

ATTACHMENTS:
* 2013 Stock Plan
* ST&Cs Applicable to Employee
* Compensation Recoupment Policy
* 2013 Stock Plan Prospectus
* Appendix – (country specific)

July 2013





OUTSIDE DIRECTOR

FORM OF
MCKESSON CORPORATION 2013 STOCK PLAN
RESTRICTED STOCK UNIT GRANT NOTICE

    

Grantee Name:
 

Grantee Address:

 

Number of RSUs Granted:
 

Date of Grant:
 

Vesting Dates:
 

Vesting Schedule: 100% vested on grant date.

McKesson Corporation (the “Company”) is pleased to grant you restricted stock units (“RSUs”) under the Company’s 2013 Stock Plan, as may be amended from time to time (the “Plan”) to receive ownership of shares of common stock of the Company (“Shares”). This Grant Notice (“Notice”), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the “ST&Cs”), constitute your Restricted Stock Unit Agreement, which along with the Plan set forth the terms of your grant.

Below is a list of documents that are made available to you in connection with this Notice. PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs. This grant, along with any other grants you may have received in the past can be viewed on the Merrill Lynch web site at www.benefits.ml.com.

By signing below, I acknowledge that:
1.
I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at www.mckesson.com; and
2.
I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360); and
3.
I have access to the Company’s web site; and
4.
I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and
5.
The Plan and ST&Cs are incorporated by reference to this Notice; and
6.
The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs; and
7.
I accept ALL the terms and conditions as set forth in the Plan and the ST&Cs applicable to this grant of RSUs.

IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.

                     
By: _______________________________________     ______________________________________
John H. Hammergren Date Grantee Signature Date
Chairman, President and Chief Executive Officer
McKesson Corporation         

PLEASE RETURN ONE SIGNED COPY OF THIS AGREEMENT TO:
      McKesson Corporation
      Stock Administration
      One Post Street, 35th Floor, San Francisco, CA 94104
      Attention: Evelyn Shaffer
        ATTACHMENTS:
    2013 Stock Plan
    ST&Cs Applicable to Outside Director
    2013 Stock Plan Prospectus for Non-Employee Directors
    Designation of Beneficiary Form

July 2013






CEO Other EOs ECOT

FORM OF
MCKESSON CORPORATION 2013 STOCK PLAN
RESTRICTED STOCK UNIT GRANT NOTICE
Grantee Name:
 
Grantee Address:


Number of RSUs Granted:
 
Date of Grant:
 
Vesting Dates:
 

Vesting Schedule: Provided you continue to provide service to the company or any Affiliate of the Company through the vesting date, the RSUs will become vested _________ on ___________________.

McKesson Corporation (the “Company”) is pleased to grant you restricted stock units (“RSUs”) under the Company’s 2013 Stock Plan (the “Plan”) to receive ownership of shares of common stock of the Company (“Shares”). This Grant Notice (“Notice”), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the “ST&Cs”), constitute your Restricted Stock Unit Agreement, which along with the Plan (note that the Plan incorporates by reference the Company’s Compensation Recoupment Policy (the “Recoupment Policy”) and the Company’s Stock Ownership Policy (the “Company Stock Ownership Policy”), as both are amended from time to time) set forth the terms of your grant.

Below is a list of documents that are made available to you in connection with this Notice. PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs. This grant, along with any other grants you may have received in the past can be viewed on the Merrill Lynch web site at www.benefits.ml.com.

By signing below, I acknowledge that:
1.
I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company’s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at www.mckesson.com; and
2.
I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360); and
3.
I have access to the Company’s web site; and
4.
I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and
5.
The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&Cs are incorporated by reference to this Notice; and
6.
The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs; and
7.
I accept ALL the terms and conditions as set forth in the Plan and ST&Cs applicable to this grant of RSUs.

IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.
    
 
 
John H. Hammergren                        Grantee Signature     Date
Chairman of the Board, President and Chief Executive Officer            
McKesson Corporation

ATTACHMENTS:
* 2013 Stock Plan
* ST&Cs Applicable to __________
* Compensation Recoupment Policy
* Stock Ownership Policy
* 2013 Stock Plan Prospectus
* Designation of Beneficiary Form
July 2013





EMPLOYEE


FORM OF
MCKESSON CORPORATION 2013 STOCK PLAN
RESTRICTED STOCK UNIT GRANT NOTICE

Grantee Name:
 
Grantee Address:
 
Number of RSUs Granted:
 
Date of Grant:
 
Vesting Dates:
 


Vesting Schedule: Provided you continue to provide service to the company or any Affiliate of the Company through the vesting date, the RSUs will become vested ____ on __________________.

McKesson Corporation (the “Company”) is pleased to grant you restricted stock units (“RSUs”) under the Company’s 2013 Stock Plan (the “Plan”) to receive ownership of shares of common stock of the Company (“Shares”). This Grant Notice (“Notice”), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the “ST&Cs”), constitute your Restricted Stock Unit Agreement, which along with the Plan (note that the Plan incorporates by reference the Company’s Compensation Recoupment Policy, as amended from time to time (the “Recoupment Policy”)) set forth the terms of your grant.

Below is a list of documents that are made available to you in connection with this Notice. PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs. This grant, along with any other grants you may have received in the past can be viewed on the Merrill Lynch web site at www.benefits.ml.com.

By signing below, I acknowledge that:
1.
I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company’s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at www.mckesson.com; and
2.
I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360); and
3.
I have access to the Company’s web site; and
4.
I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice; and
5.
The Plan (including the Recoupment Policy) and ST&Cs are incorporated by reference to this Notice; and
6.
The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs; and
7.
I accept ALL the terms and conditions as set forth in the Plan and the ST&Cs applicable to this grant of RSUs.

IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.
   
 
 
John H. Hammergren                        Grantee Signature         Date
Chairman of the Board, President and Chief Executive Officer            
McKesson Corporation

ATTACHMENTS:
* 2013 Stock Plan
* ST&Cs Applicable to Employees
* Compensation Recoupment Policy
* 2013 Stock Plan Prospectus
* Appendix – (country specific)

July 2013





McKESSON CORPORATION
Total Shareholder Return Unit (“TSRU”)
TARGET AWARD NOTIFICATION
Fiscal Years 20__ - 20__

The Compensation Committee (the “Committee”) of the Board of Directors of McKesson Corporation has approved your target number of Total Shareholder Return Units (TSRUs) under the TSRU Program for the three-year performance period beginning ______, 20__ and ending on ______, 20__ (the “Performance Period”). The final number of shares of McKesson Corporation common stock that may be issued to you under the TSRU Program will be based on achievement against the performance criteria described below. Your participation in the TSRU Program will be subject to the terms of the McKesson Corporation 2013 Stock Plan (the “2013 Stock Plan”), which includes the Statement of Terms and Conditions that is delivered with this notice. In the event of any conflict between the 2013 Stock Plan and this document, the 2013 Stock Plan will control. This notice of your participation in the TSRU Program sets forth your TSRU Target and the TSRU Performance Criteria.

Participant Name
 
Target Number of Units
 
Date Target Approved
 
Performance Period
 
Vesting Date
 

Award and Vesting
Provided that:
You continue to be employed by McKesson Corporation or one of its affiliates through the date on which the Committee meets to determine achievement against the performance criteria, and
The Committee determines that, based on achievement of the performance criteria, a grant of shares of McKesson common stock will be made to you under the TSRU Program for _____-_____, then
You will receive a grant of shares following the date the Committee meets in _____ 20__. No additional vesting period will apply.

TSR Calculation - Performance Criteria and Measurement
The performance criteria for the TSRU Program will be a comparison over the Performance Period of McKesson’s total shareholder return (TSR) and the TSR of each of the companies comprising the S&P 500 Health Care Index (the “Index”).
There will be a 30 calendar-day measurement period to set the beginning and ending values for the TSR calculation for McKesson and each of the Index companies.
At the end of the Performance Period, McKesson’s TSR will be ranked against the TSR of each of the companies comprising the S&P Health Care Index.
If the performance criteria are met at no less than the threshold level, you will receive a grant of shares.
You may earn from 0% to 200% of the Target Number of Units set forth above; however, if the absolute value of McKesson’s TSR over the performance period is negative, the number of shares you receive will not exceed the Target Number of Units.

The Committee has the authority to adjust the performance criteria and the amount of your final award. The Committee may adjust the final award to take into account, for example, a significant change in the Index companies. The Committee will make the final determination of the TSR calculation for the Performance Period in its discretion.

I acknowledge that I have received, read and understand this Total Shareholder Return Restricted Stock Unit (TSRU) Target Award Notification.
________________________________________    __________________
Employee Signature                         Date

Encl – 2013 Stock Plan and Statement of Terms and Conditions
July 2014


EX-31.1 3 mck_exhibit311x06302014.htm CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 MCK_Exhibit 31.1_06.30.2014


Exhibit 31.1
CERTIFICATION PURSUANT TO
RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John H. Hammergren, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of McKesson Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:
July 31, 2014
 
/s/    John H. Hammergren
 
 
 
John H. Hammergren
 
 
 
Chairman of the Board, President and Chief Executive Officer




EX-31.2 4 mck_exhibit312x06302014.htm CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 MCK_Exhibit 31.2_06.30.2014


Exhibit 31.2
CERTIFICATION PURSUANT TO
RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James A. Beer, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of McKesson Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:
July 31, 2014
 
/s/ James A. Beer
 
 
 
James A. Beer
 
 
 
Executive Vice President and Chief Financial Officer



EX-32 5 mck_exhibit32x06302014.htm CERTIFICATION PURSUANT TO 18 U.S.C.SECTION 1350 MCK_Exhibit 32_06.30.2014


Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly report of McKesson Corporation (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/    John H. Hammergren
 
 
John H. Hammergren
 
 
Chairman of the Board, President and Chief Executive Officer
 
 
July 31, 2014
 
 
 
 
 
/s/ James A. Beer
 
 
James A. Beer
 
 
Executive Vice President and Chief Financial Officer
 
 
July 31, 2014
 
 
 
 
 

This certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



EX-101.INS 6 mck-20140630.xml XBRL INSTANCE DOCUMENT 0000927653 mck:CelesioMember 2014-02-06 2014-02-06 0000927653 2013-04-01 2013-06-30 0000927653 mck:OldRatePerShareMember 2013-04-01 2013-06-30 0000927653 mck:AccountsReceivableSalesFacilityMember 2013-04-01 2013-06-30 0000927653 us-gaap:RevolvingCreditFacilityMember 2013-04-01 2013-06-30 0000927653 us-gaap:ForeignPensionPlansDefinedBenefitMember 2013-04-01 2013-06-30 0000927653 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2013-04-01 2013-06-30 0000927653 mck:DistributionSolutionsMedicalSurgicalDistributionAndServicesMember 2013-04-01 2013-06-30 0000927653 mck:DistributionSolutionsMember 2013-04-01 2013-06-30 0000927653 mck:InternationalDistributionandServicesMember 2013-04-01 2013-06-30 0000927653 mck:NorthAmericaDistributionAndServicesMember 2013-04-01 2013-06-30 0000927653 mck:TechnologySolutionsMember 2013-04-01 2013-06-30 0000927653 us-gaap:CorporateMember 2013-04-01 2013-06-30 0000927653 us-gaap:OperatingSegmentsMember 2013-04-01 2013-06-30 0000927653 2013-10-01 2013-12-31 0000927653 mck:CelesioMember mck:The2014and2018BondsMember 2014-01-01 2014-03-31 0000927653 mck:AccountsReceivableSalesFacilityMember 2013-04-01 2014-03-31 0000927653 2014-04-01 2014-06-30 0000927653 us-gaap:ParentCompanyMember 2014-04-01 2014-06-30 0000927653 mck:NewRatePerShareMember 2014-04-01 2014-06-30 0000927653 mck:CelesioMember 2014-04-01 2014-06-30 0000927653 mck:CelesioMember mck:AccountsReceivableFactoringFacilityMember 2014-04-01 2014-06-30 0000927653 mck:CelesioMember us-gaap:RevolvingCreditFacilityMember 2014-04-01 2014-06-30 0000927653 mck:CelesioMember us-gaap:RevolvingCreditFacilityMember mck:RevolvingCreditFacilityDueFebruaryTwoThousandEighteenMember 2014-04-01 2014-06-30 0000927653 mck:CelesioMember us-gaap:FairValueInputsLevel3Member 2014-04-01 2014-06-30 0000927653 mck:CelesioMember mck:The2014and2018BondsMember 2014-04-01 2014-06-30 0000927653 mck:AccountsReceivableSalesFacilityMember 2014-04-01 2014-06-30 0000927653 us-gaap:RevolvingCreditFacilityMember 2014-04-01 2014-06-30 0000927653 us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-04-01 2014-06-30 0000927653 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-04-01 2014-06-30 0000927653 us-gaap:ForeignExchangeContractMember 2014-04-01 2014-06-30 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:MaximumMember 2014-04-01 2014-06-30 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:MinimumMember 2014-04-01 2014-06-30 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:MaximumMember 2014-04-01 2014-06-30 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:MinimumMember 2014-04-01 2014-06-30 0000927653 us-gaap:InterestRateSwapMember 2014-04-01 2014-06-30 0000927653 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2014-04-01 2014-06-30 0000927653 mck:PharmacyLicensesMember 2014-04-01 2014-06-30 0000927653 us-gaap:CustomerListsMember 2014-04-01 2014-06-30 0000927653 us-gaap:OtherIntangibleAssetsMember 2014-04-01 2014-06-30 0000927653 us-gaap:ServiceAgreementsMember 2014-04-01 2014-06-30 0000927653 us-gaap:TechnologyBasedIntangibleAssetsMember 2014-04-01 2014-06-30 0000927653 us-gaap:TrademarksAndTradeNamesMember 2014-04-01 2014-06-30 0000927653 us-gaap:CostOfSalesMember 2014-04-01 2014-06-30 0000927653 us-gaap:OperatingExpenseMember 2014-04-01 2014-06-30 0000927653 mck:CanadaRevenueAgencyAssessmentsMember 2014-04-01 2014-06-30 0000927653 us-gaap:InternalRevenueServiceIRSMember 2014-04-01 2014-06-30 0000927653 us-gaap:MaximumMember mck:DistributionSolutionsMember 2014-04-01 2014-06-30 0000927653 mck:DistributionSolutionsMedicalSurgicalDistributionAndServicesMember 2014-04-01 2014-06-30 0000927653 mck:DistributionSolutionsMember 2014-04-01 2014-06-30 0000927653 mck:InternationalDistributionandServicesMember 2014-04-01 2014-06-30 0000927653 mck:NorthAmericaDistributionAndServicesMember 2014-04-01 2014-06-30 0000927653 mck:TechnologySolutionsMember 2014-04-01 2014-06-30 0000927653 us-gaap:CorporateMember 2014-04-01 2014-06-30 0000927653 us-gaap:OperatingSegmentsMember 2014-04-01 2014-06-30 0000927653 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-04-01 2014-06-30 0000927653 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-04-01 2014-06-30 0000927653 us-gaap:AccumulatedTranslationAdjustmentMember 2014-04-01 2014-06-30 0000927653 2013-03-31 0000927653 2013-06-30 0000927653 2014-03-31 0000927653 us-gaap:ParentCompanyMember 2014-03-31 0000927653 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-03-31 0000927653 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2014-03-31 0000927653 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2014-03-31 0000927653 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-03-31 0000927653 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2014-03-31 0000927653 mck:CelesioMember 2014-03-31 0000927653 mck:CelesioMember mck:AccountsReceivableFactoringFacilityMember 2014-03-31 0000927653 mck:CelesioMember us-gaap:RevolvingCreditFacilityMember 2014-03-31 0000927653 mck:CelesioMember us-gaap:RevolvingCreditFacilityMember mck:RevolvingCreditFacilityDueFebruaryTwoThousandEighteenMember 2014-03-31 0000927653 mck:CelesioMember us-gaap:CorporateBondSecuritiesMember 2014-03-31 0000927653 mck:CelesioMember mck:FourPercentBondsDueOctoberEighteenTwoThousandSixteenMember 2014-03-31 0000927653 mck:CelesioMember mck:FourPointFivePercentBondsDueAprilTwentySixTwoThousandSeventeenMember 2014-03-31 0000927653 mck:AccountsReceivableSalesFacilityMember 2014-03-31 0000927653 us-gaap:RevolvingCreditFacilityMember 2014-03-31 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-03-31 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2014-03-31 0000927653 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2014-03-31 0000927653 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-03-31 0000927653 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-03-31 0000927653 mck:PharmacyLicensesMember 2014-03-31 0000927653 us-gaap:CustomerListsMember 2014-03-31 0000927653 us-gaap:OtherIntangibleAssetsMember 2014-03-31 0000927653 us-gaap:ServiceAgreementsMember 2014-03-31 0000927653 us-gaap:TechnologyBasedIntangibleAssetsMember 2014-03-31 0000927653 us-gaap:TrademarksAndTradeNamesMember 2014-03-31 0000927653 us-gaap:NondesignatedMember 2014-03-31 0000927653 mck:DistributionSolutionsMember 2014-03-31 0000927653 mck:TechnologySolutionsMember 2014-03-31 0000927653 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-03-31 0000927653 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-03-31 0000927653 us-gaap:AccumulatedTranslationAdjustmentMember 2014-03-31 0000927653 2014-06-30 0000927653 us-gaap:ParentCompanyMember 2014-06-30 0000927653 mck:AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember mck:CelesioMember 2014-06-30 0000927653 us-gaap:PurchasePriceAllocationAdjustmentsMember mck:CelesioMember 2014-06-30 0000927653 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-06-30 0000927653 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2014-06-30 0000927653 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2014-06-30 0000927653 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-06-30 0000927653 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2014-06-30 0000927653 mck:CelesioMember 2014-06-30 0000927653 mck:CelesioMember mck:AccountsReceivableFactoringFacilityMember 2014-06-30 0000927653 mck:CelesioMember us-gaap:RevolvingCreditFacilityMember 2014-06-30 0000927653 mck:CelesioMember us-gaap:RevolvingCreditFacilityMember mck:RevolvingCreditFacilityDueFebruaryTwoThousandEighteenMember 2014-06-30 0000927653 mck:CelesioMember us-gaap:CorporateBondSecuritiesMember 2014-06-30 0000927653 mck:CelesioMember mck:FourPercentBondsDueOctoberEighteenTwoThousandSixteenMember 2014-06-30 0000927653 mck:CelesioMember mck:FourPointFivePercentBondsDueAprilTwentySixTwoThousandSeventeenMember 2014-06-30 0000927653 mck:AccountsReceivableSalesFacilityMember 2014-06-30 0000927653 us-gaap:RevolvingCreditFacilityMember 2014-06-30 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-06-30 0000927653 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2014-06-30 0000927653 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2014-06-30 0000927653 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-06-30 0000927653 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-06-30 0000927653 mck:PharmacyLicensesMember 2014-06-30 0000927653 us-gaap:CustomerListsMember 2014-06-30 0000927653 us-gaap:OtherIntangibleAssetsMember 2014-06-30 0000927653 us-gaap:ServiceAgreementsMember 2014-06-30 0000927653 us-gaap:TechnologyBasedIntangibleAssetsMember 2014-06-30 0000927653 us-gaap:TrademarksAndTradeNamesMember 2014-06-30 0000927653 us-gaap:NondesignatedMember 2014-06-30 0000927653 us-gaap:InternalRevenueServiceIRSMember 2014-06-30 0000927653 mck:DistributionSolutionsMember 2014-06-30 0000927653 mck:TechnologySolutionsMember 2014-06-30 0000927653 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-06-30 0000927653 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-06-30 0000927653 us-gaap:AccumulatedTranslationAdjustmentMember 2014-06-30 0000927653 mck:AmountsPreviouslyRecognizedAsOfAcquisitionDateMember mck:CelesioMember 2014-02-06 0000927653 mck:CelesioMember 2014-02-06 0000927653 mck:CelesioMember mck:FourPercentBondsDueOctoberEighteenTwoThousandSixteenMember 2014-02-06 0000927653 mck:CelesioMember mck:FourPointFivePercentBondsDueAprilTwentySixTwoThousandSeventeenMember 2014-02-06 mck:Defendants mck:States mck:country iso4217:EUR iso4217:EUR xbrli:shares xbrli:pure xbrli:shares iso4217:USD iso4217:USD xbrli:shares 22812000000 21429000000 3121000000 3478000000 107000000 -3000000 107000000 -3000000 -158000000 -13000000 -11000000 -160000000 278000000 168000000 6686000000 6552000000 130000000 71000000 2000000 3000000 51759000000 53006000000 33973000000 32573000000 32000000 2000000 34000000 267000000 138000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation: </font><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements of McKesson Corporation (&#8220;McKesson,&#8221; the &#8220;Company,&#8221; or &#8220;we&#8221; and other similar pronouns) include the financial statements of all wholly-owned subsidiaries and majority&#8209;owned or controlled companies. We also evaluate our ownership, contractual and other interests in entities to determine if they are variable interest entities (&#8220;VIEs&#8221;), if we have a variable interest in those entities and the nature and extent of those interests. These evaluations are highly complex and involve judgment and the use of estimates and assumptions based on available historical information and management&#8217;s judgment, among other factors. Based on our evaluations, if we determine we are the primary beneficiary of such VIEs, we consolidate such entities into our financial statements. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method and our proportionate share of income or loss is recorded in other income, net. Intercompany transactions and balances have been eliminated. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, do not include all information and footnote disclosures normally included in the annual consolidated financial statements. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. In our opinion, the accompanying unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods presented. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of operations for the quarter ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies and financial notes included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;"> previously filed with the SEC on May 14, 2014 (&#8220;2014 Annual Report&#8221;). </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cumulative Translation Adjustments: </font><font style="font-family:inherit;font-size:10pt;">In the first quarter of 2015, we adopted amended guidance for parent&#8217;s accounting for the cumulative translation adjustment upon derecognition of certain subsidiaries or group of assets within a foreign entity or of an investment in a foreign entity.&#160; The amended guidance requires the release of any cumulative translation adjustment into net income only upon complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160; Also, it requires the release of all or a pro rata portion of the cumulative translation adjustment to net income in case of sale of an equity method investment that is a foreign entity.&#160; The adoption of this amended guidance did not have a material effect on our condensed financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Discontinued Operations:</font><font style="font-family:inherit;font-size:10pt;"> In April 2014, amended guidance was issued for reporting of discontinued operations and disclosures of disposals of components.&#160; The amended guidance raises the threshold for disposals to qualify as discontinued operations and permits&#160;significant continuing involvement and continuing cash flows with the discontinued operation.&#160; In addition, the amended guidance requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation.&#160; The amended guidance is effective for us prospectively commencing in the first quarter of 2016.&#160; Early adoption is permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition: </font><font style="font-family:inherit;font-size:10pt;">In May 2014, amended guidance was issued for recognizing revenue from contracts with customers.&#160; The amended guidance eliminated industry specific guidance and applies to all companies.&#160; Revenues will be recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service. Revenue from a contract that contains multiple performance obligations is allocated to each performance obligation generally on a relative standalone selling price basis. The amended guidance also requires additional quantitative and qualitative disclosures. The amended guidance is effective for us commencing in the first quarter of 2018.&#160; The amended guidance allows for either full retrospective adoption or modified retrospective adoption. Early adoption is not permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.</font></div></div> Celesio is an international wholesale and retail company and a provider of logistics and services to the pharmaceutical and healthcare sectors. Celesio’s headquarters is in Stuttgart, Germany and it operates in 14 countries around the world 2014-02-06 Celesio AG 0.776 0 1500000000 1500000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Combinations</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">February&#160;6, 2014</font><font style="font-family:inherit;font-size:10pt;">, we completed the acquisition of </font><font style="font-family:inherit;font-size:10pt;">77.6%</font><font style="font-family:inherit;font-size:10pt;"> of the then outstanding common shares of </font><font style="font-family:inherit;font-size:10pt;">Celesio AG</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;Celesio&#8221;) and certain convertible bonds of Celesio for cash consideration of </font><font style="font-family:inherit;font-size:10pt;">$4.5 billion</font><font style="font-family:inherit;font-size:10pt;">, net of cash acquired (the &#8220;Acquisition&#8221;). Upon the acquisition, as required, we consolidated Celesio&#8217;s debt with a fair value of </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;"> as a liability on our consolidated balance sheet and our ownership of Celesio&#8217;s fully diluted common shares was </font><font style="font-family:inherit;font-size:10pt;">75.6%</font><font style="font-family:inherit;font-size:10pt;">. The Acquisition was initially funded by utilizing a senior bridge loan, our existing accounts receivable sales facility and cash on hand. </font><font style="font-family:inherit;font-size:10pt;">Celesio is an international wholesale and retail company and a provider of logistics and services to the pharmaceutical and healthcare sectors. Celesio&#8217;s headquarters is in Stuttgart, Germany and it operates in 14 countries around the world</font><font style="font-family:inherit;font-size:10pt;">. The acquisition of Celesio expands our global geographic area; the combined company is one of the largest pharmaceutical wholesalers and providers of logistics and services in the healthcare sector worldwide.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From February 7 to March 31, 2014, substantially all of the convertible bonds issued by Celesio (held by both third parties and us) were converted to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">20.9 million</font><font style="font-family:inherit;font-size:10pt;"> common shares of Celesio. During the first quarter of 2015, we completed tender offers and we acquired approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">1 million</font><font style="font-family:inherit;font-size:10pt;"> common shares of Celesio at </font><font style="font-family:inherit;font-size:10pt;">&#8364;23.50</font><font style="font-family:inherit;font-size:10pt;"> per share for a total of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$32 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, and the remaining convertible bonds were fully converted into </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">42,238</font><font style="font-family:inherit;font-size:10pt;"> common shares of Celesio. At June 30, 2014 and March 31, 2014, we owned approximately </font><font style="font-family:inherit;font-size:10pt;">75.9%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">75.4%</font><font style="font-family:inherit;font-size:10pt;"> of Celesio&#8217;s outstanding and fully diluted common shares. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 22, 2014, Celesio and McKesson, through its wholly-owned subsidiary Dragonfly GmbH &amp; Co. KGaA, entered into a domination and profit and loss transfer agreement (the &#8220;Agreement&#8221;). Under the Agreement, Celesio will subordinate its management to McKesson and undertake to transfer all of its annual profits to McKesson, and McKesson will undertake to compensate any annual losses incurred by Celesio and to grant, subject to a potential court review, the noncontrolling shareholders of Celesio (i) an annual recurring compensation of </font><font style="font-family:inherit;font-size:10pt;">&#8364;0.83</font><font style="font-family:inherit;font-size:10pt;"> per Celesio share and (ii) a put right for their Celesio shares at </font><font style="font-family:inherit;font-size:10pt;">&#8364;22.99</font><font style="font-family:inherit;font-size:10pt;"> per Celesio share. On July 15, 2014, the Agreement was approved at the general shareholders&#8217; meeting of Celesio. The Agreement becomes effective upon its registration in the commercial register of Celesio at the local court of Stuttgart, Germany. Celesio&#8217;s obligation to transfer its annual profits under the Agreement will apply for the first time for the entire profit generated in Celesio&#8217;s fiscal period beginning on January 1, 2015 or the subsequent fiscal year in which the Agreement becomes effective. McKesson&#8217;s obligation to compensate the annual losses of Celesio under the Agreement will apply for the first time for the full fiscal period of Celesio during which the Agreement becomes effective. We currently anticipate the Agreement to be effective by the end of the calendar year, at which time, we will obtain operational control of Celesio.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial results for Celesio are included within our International pharmaceutical distribution and services business, which is part of our Distribution Solutions segment, since the date of acquisition.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary recording of the fair values of the assets acquired and liabilities assumed as of the acquisition date. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Amounts</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Previously Recognized&#160;as&#160;of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Acquisition&#160;Date<br clear="none"/>(Provisional)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized as of Acquisition Date (Provisional as Adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Receivables</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,422</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets, net of cash and cash equivalents </font></div><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,413</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,410</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,570</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,006</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(536</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,482</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,272</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,096</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,102</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term borrowings and current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(322</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(322</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,293</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,137</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of net assets, less cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,997</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,997</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Noncontrolling Interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired, less cash and cash equivalents</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,497</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,497</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As previously reported in our Form 10-K for the year ended March 31, 2014.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2015, the fair value measurements of assets acquired and liabilities assumed of Celesio as of the acquisition date were refined. Among the adjustments recorded, the fair value of acquired intangible assets was decreased by </font><font style="font-family:inherit;font-size:10pt;">$536&#160;million</font><font style="font-family:inherit;font-size:10pt;">. The fair value was primarily determined by applying the income approach using unobservable inputs for projected cash flows and a discount rate, which were refined during the current period, and are considered Level 3 inputs under the fair value measurements and disclosure guidance. These refinements did not have a significant impact on our condensed consolidated statements of operations, balance sheets or cash flows in any period and, therefore, we have not retrospectively adjusted our financial statements. These amounts are subject to change within the measurement period as our fair value assessments are finalized. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the last two years, we also completed a number of smaller acquisitions within both of our operating segments. Financial results for our business acquisitions have been included in our consolidated financial statements since their respective acquisition dates. Purchase prices for our business acquisitions have been allocated based on estimated fair values at the date of acquisition.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill recognized for our business acquisitions is generally not expected to be deductible for tax purposes. However, if we acquire the assets of a company, the goodwill may be deductible for tax purposes.</font></div></div> 536000000 3425000000 -3000000 3422000000 4102000000 4096000000 6000000 -536000000 3018000000 2482000000 322000000 0 322000000 -156000000 1293000000 1137000000 1272000000 -44000000 1228000000 0 4497000000 4497000000 5997000000 5997000000 0 4105000000 4193000000 2456000000 2905000000 3400000000 2900000000 449000000 -88000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingent Liabilities</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to commitments and obligations in the ordinary course of business, we are subject to various claims, other pending and potential legal actions for damages, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of our business. As described below, many of these proceedings are at preliminary stages and many seek an indeterminate amount of damages. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate a range of possible loss. When a loss is probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. We review all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties. Such factors bear directly on whether it is possible to reasonably estimate a range of potential loss and boundaries of high and low estimates.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant developments in previously reported proceedings and in other litigation and claims, since the filing of our 2014 Annual Report are set out below. Unless otherwise stated, we are currently unable to estimate a range of reasonably possible losses for the unresolved proceedings described below. Should any one or a combination of more than one of these proceedings be successful, or should we determine to settle any or a combination of these matters, we may be required to pay substantial sums, become subject to the entry of an injunction or be forced to change the manner in which we operate our business, which could have a material adverse impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Litigation, Government Subpoenas and Investigations</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 21, 2014, four hedge funds managed by Magnetar Capital filed a complaint against Dragonfly GmbH &amp; Co KGaA (&#8220;Dragonfly&#8221;), a wholly-owned subsidiary of the Company, in a German court in Frankfurt, Germany, alleging that Dragonfly violated German takeover law in connection with the Company&#8217;s acquisition of Celesio by paying more to some holders of Celesio&#8217;s convertible bonds than it paid to the shareholders of Celesio&#8217;s stock, and seeking approximately </font><font style="font-family:inherit;font-size:10pt;">$356,000</font><font style="font-family:inherit;font-size:10pt;"> (or </font><font style="font-family:inherit;font-size:10pt;">&#8364;261,000</font><font style="font-family:inherit;font-size:10pt;">) in damages plus an unspecified amount of interest, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Magnetar Capital Master Fund Ltd. et al. v. Dragonfly GmbH &amp; Co KGaA</font><font style="font-family:inherit;font-size:10pt;">, (No.&#160;3-05&#160;O&#160;44/14).&#160; Other minority shareholders may seek to file similar lawsuits alleging the same claim, seeking damages based on their shares of Celesio stock. Dragonfly has not yet responded to the complaint.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 17, 2014, U.S. Oncology Specialty, LP (&#8220;USOS&#8221;), an indirect wholly-owned subsidiary of the Company, was served with a fifth amended </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:inherit;font-size:10pt;"> complaint filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">twelve</font><font style="font-family:inherit;font-size:10pt;"> states, against USOS and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">fifteen</font><font style="font-family:inherit;font-size:10pt;"> oncology practices, alleging that USOS facilitated the payment of illegal &#8220;kickbacks&#8221; from Amgen to the oncology practices in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">United States ex rel. Hanks v. U.S. Oncology Specialty, LP, et al.</font><font style="font-family:inherit;font-size:10pt;">, (CV 04-3983 (SJ)).&#160; Previously, the United States and the twelve states named in the operative complaint declined to intervene in the case.&#160; The Court set August 1, 2014 as the deadline for USOS and the other defendants to respond to the complaint.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests also can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the healthcare industry, as well as to settlements. Examples of such subpoenas and investigations are included in the Company&#8217;s 2014 Annual Report on Form 10-K, and include subpoenas from the U.S. Drug Enforcement Administration to certain of the Company&#8217;s pharmaceutical distribution facilities seeking information and records about the Company&#8217;s distribution of certain controlled substances. The Company is currently responding to these requests. In addition, as previously reported, the Company was informed in the third quarter of 2014 of an investigation by the United States Department of Justice through the United States Attorney&#8217;s Office for the Northern District of West Virginia of potential claims under the Comprehensive Drug Abuse Prevention and Control Act.&#160; The Company believes that the investigation is focused on the Company&#8217;s pharmaceutical distribution of certain controlled substances by its Landover, Maryland distribution center, which closed in 2012.</font></div></div> 0.24 0.20 0.20 0.24 0.01 0.01 800000000 800000000 381000000 383000000 4000000 4000000 371000000 513000000 -4000000 0 371000000 509000000 32000000 32000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation: </font><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements of McKesson Corporation (&#8220;McKesson,&#8221; the &#8220;Company,&#8221; or &#8220;we&#8221; and other similar pronouns) include the financial statements of all wholly-owned subsidiaries and majority&#8209;owned or controlled companies. We also evaluate our ownership, contractual and other interests in entities to determine if they are variable interest entities (&#8220;VIEs&#8221;), if we have a variable interest in those entities and the nature and extent of those interests. These evaluations are highly complex and involve judgment and the use of estimates and assumptions based on available historical information and management&#8217;s judgment, among other factors. Based on our evaluations, if we determine we are the primary beneficiary of such VIEs, we consolidate such entities into our financial statements. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method and our proportionate share of income or loss is recorded in other income, net. Intercompany transactions and balances have been eliminated. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, do not include all information and footnote disclosures normally included in the annual consolidated financial statements. </font></div></div> 41261000000 30309000000 42238 20900000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt and Financing Activities</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Celesio Debt</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon the acquisition of Celesio, as required, we consolidated Celesio&#8217;s debt including corporate bonds consisting of </font><font style="font-family:inherit;font-size:10pt;">4.00%</font><font style="font-family:inherit;font-size:10pt;"> bonds due October 18, 2016 and </font><font style="font-family:inherit;font-size:10pt;">4.50%</font><font style="font-family:inherit;font-size:10pt;"> bonds due April 26, 2017. At June 30, 2014 and March 31, 2014, </font><font style="font-family:inherit;font-size:10pt;">$500 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$507&#160;million</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;">4.00%</font><font style="font-family:inherit;font-size:10pt;"> bonds and </font><font style="font-family:inherit;font-size:10pt;">$726 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$737 million</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;">4.50%</font><font style="font-family:inherit;font-size:10pt;"> bonds, for a total of </font><font style="font-family:inherit;font-size:10pt;">$1,226 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1,244&#160;million</font><font style="font-family:inherit;font-size:10pt;">, were outstanding. As of March 31, 2014, these bonds were classified within current liabilities as bondholders had the option to redeem the bonds at par value plus accrued interest. This redemption option expired during the first quarter of 2015 and the remaining bonds outstanding will mature according to their respective maturity dates. Accordingly, as of June 30, 2014, these bonds have been classified as long-term debt.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We also consolidated Celesio&#8217;s accounts receivable factoring facilities (the &#8220;Factoring Facilities&#8221;) with a total committed and uncommitted balance of </font><font style="font-family:inherit;font-size:10pt;">$315 million</font><font style="font-family:inherit;font-size:10pt;">. The Factoring Facilities will expire through </font><font style="font-family:inherit;font-size:10pt;">September 2015</font><font style="font-family:inherit;font-size:10pt;">. During the first quarter of 2015, Celesio borrowed and repaid </font><font style="font-family:inherit;font-size:10pt;">$758 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$746 million</font><font style="font-family:inherit;font-size:10pt;"> of short-term borrowings under the Factoring Facilities. At June&#160;30, 2014 and March&#160;31,&#160;2014, there were </font><font style="font-family:inherit;font-size:10pt;">$258 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$246 million</font><font style="font-family:inherit;font-size:10pt;"> in secured borrowings and related securitized accounts receivable outstanding under the Factoring Facilities.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Celesio also maintains a syndicated </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">&#8364;500 million</font><font style="font-family:inherit;font-size:10pt;"> five-year senior unsecured revolving credit facility, which expires in </font><font style="font-family:inherit;font-size:10pt;">February 2018</font><font style="font-family:inherit;font-size:10pt;">. Borrowings under this facility bear interest based upon the Euro Interbank Offered Rate plus an agreed margin. There were </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> borrowings under this facility during the first quarter of 2015 and there were </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> amounts outstanding under this facility as of June&#160;30, 2014 and March&#160;31, 2014.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Celesio also maintains bilateral credit lines with a total committed and uncommitted balance of </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;">. During the first quarter of 2015, Celesio borrowed and repaid </font><font style="font-family:inherit;font-size:10pt;">$159 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$30 million</font><font style="font-family:inherit;font-size:10pt;"> under these credit lines primarily relating to short&#8209;term borrowings. As of June&#160;30, 2014 and March&#160;31, 2014, there were </font><font style="font-family:inherit;font-size:10pt;">$321 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$188&#160;million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under these credit lines.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounts Receivable Sales Facility</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have an accounts receivable sales facility (the &#8220;Facility&#8221;) with a committed balance of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.35</font><font style="font-family:inherit;font-size:10pt;"> billion, although from time to time, the available amount of the Facility may be less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.35</font><font style="font-family:inherit;font-size:10pt;"> billion based on accounts receivable concentration limits and other eligibility requirements. The Facility will expire in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">November 2014</font><font style="font-family:inherit;font-size:10pt;"> and we anticipate renewing the Facility before its expiration.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">first quarter of 2015</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> borrowings under the Facility. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">first quarter of 2014</font><font style="font-family:inherit;font-size:10pt;">, we borrowed and repaid </font><font style="font-family:inherit;font-size:10pt;">$100 million</font><font style="font-family:inherit;font-size:10pt;"> of short-term borrowings under the Facility. At June&#160;30, 2014 and March 31, 2014, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> short&#8209;term borrowings and related securitized accounts receivable outstanding under the Facility. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Facility contains requirements relating to the performance of the accounts receivable and covenants relating to the Company. If we do not comply with these covenants, our ability to use the Facility may be suspended and repayment of any outstanding balances under the Facility may be required. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">we were in compliance with all covenants</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revolving Credit Facility</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have a syndicated </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.3</font><font style="font-family:inherit;font-size:10pt;"> billion five-year senior unsecured revolving credit facility, which expires in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 2016</font><font style="font-family:inherit;font-size:10pt;">. Borrowings under this facility </font><font style="font-family:inherit;font-size:10pt;">bear interest based upon either the London Interbank Offered Rate or a prime rate</font><font style="font-family:inherit;font-size:10pt;">. There were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> borrowings under this facility during the first </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">quarters of 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> amounts outstanding under this facility.</font></div></div> 10800000000 10700000000 0.04 0.045 0.04 0.045 0.045 0.04 1124000000 1236000000 1656000000 1588000000 5000000 15000000 5000000 5000000 2000000 7000000 5000000 1000000 5000000 9000000 7000000 10000000 1000000 4000000 11000000 11000000 1000000 4000000 1000000 0 284000000 162000000 255000000 399000000 174000000 399000000 64000000 64000000 2000000 15000000 0 2000000 2000000 17000000 2000000 0 4000000 27000000 0 0 31000000 2000000 13000000 0 0 0 0 26000000 0 0 0 0 0 1000000 26000000 14000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Hedging Activities</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are exposed to interest rate changes and foreign currency fluctuations. At times, we limit these risks through the use of derivatives such as interest rate swaps and forward foreign exchange contracts. In accordance with our policy, derivatives are only used for hedging purposes. We do not use derivatives for trading or speculative purposes. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign currency rate risk</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the acquisition of Celesio, the majority of our operations were conducted in U. S. dollars; however, certain assets and liabilities, revenues and expense and purchasing activities were incurred in and exposed to other currencies. We have established certain foreign currency rate risk programs that </font><font style="font-family:inherit;font-size:10pt;">manage the impact of foreign currency fluctuation</font><font style="font-family:inherit;font-size:10pt;">. These programs are utilized on a transactional basis when we consider there to be a risk in fair value or volatility in cash flows. These programs reduce but do not entirely eliminate foreign currency rate risk. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Historically, we have entered into forward contracts and a foreign currency option to hedge against cash flows denominated primarily in Canadian dollars, Euros and British pounds. At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, forward contracts having a total notional value of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$463 million</font><font style="font-family:inherit;font-size:10pt;"> were designated for hedge accounting. These contracts will mature between </font><font style="font-family:inherit;font-size:10pt;">March 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March 2020</font><font style="font-family:inherit;font-size:10pt;">. Changes in the fair values&#160;for contracts designated for hedge accounting are recorded to accumulated other comprehensive income and reclassified into earnings in the same period in which the hedged transaction affects earnings; amounts recorded to earnings for these contracts were not material during the first quarters of 2015 and 2014. Changes in the fair values for contracts not designated for hedge accounting are recorded directly to earnings; amounts recorded to earnings for these contracts were not material during the first quarter of 2014. All forward contracts were designated for hedge accounting during the first quarter of 2015.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Celesio has a number of forward contracts to hedge against cash flows denominated primarily in British pounds and other European currencies. These contracts will mature from </font><font style="font-family:inherit;font-size:10pt;">July 2014</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">June 2015</font><font style="font-family:inherit;font-size:10pt;">. None of these contracts were designated for hedge accounting and accordingly, changes in the fair value of these contracts are recorded directly in earnings. At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, the total notional values of these contracts were </font><font style="font-family:inherit;font-size:10pt;">$1,449 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1,091 million</font><font style="font-family:inherit;font-size:10pt;">. Amounts recorded to earnings were not material during the first quarter of 2015.</font></div><div style="line-height:120%;padding-bottom:17px;text-align:justify;text-indent:25px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest rate risk</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Celesio also has interest rate swaps to </font><font style="font-family:inherit;font-size:10pt;">hedge the interest rate risk associated with Celesio&#8217;s variable rate debt</font><font style="font-family:inherit;font-size:10pt;">. Interest rate swaps are used to modify the market risk exposures in connection with the variable rate debt to achieve primarily Euro dollar fixed rate interest expense. The interest rate swap transactions generally involve the exchange of floating or fixed interest payments. The interest rate swaps will mature through </font><font style="font-family:inherit;font-size:10pt;">September 2014</font><font style="font-family:inherit;font-size:10pt;">. These contracts are not designated for hedge accounting and, accordingly, changes in the fair value of the swaps are recorded directly in earnings. At June 30, 2014 and March 31, 2014, the total gross notional values of these contracts were </font><font style="font-family:inherit;font-size:10pt;">$68 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$96 million</font><font style="font-family:inherit;font-size:10pt;">. Amounts recorded to earnings were not material during the first quarter of 2015.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding the fair value of derivatives on a gross basis is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="25%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Caption</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value of </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S. Dollar Notional</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value of </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S Dollar Notional</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liability</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liability</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives designated for hedge accounting</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (non-current)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated for hedge accounting</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (current)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap contracts (current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</font></div></div> 836000000 68000000 96000000 1275000000 2014-09-30 manage the impact of foreign currency fluctuation hedge the interest rate risk associated with Celesio’s variable rate debt <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Discontinued Operations:</font><font style="font-family:inherit;font-size:10pt;"> In April 2014, amended guidance was issued for reporting of discontinued operations and disclosures of disposals of components.&#160; The amended guidance raises the threshold for disposals to qualify as discontinued operations and permits&#160;significant continuing involvement and continuing cash flows with the discontinued operation.&#160; In addition, the amended guidance requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation.&#160; The amended guidance is effective for us prospectively commencing in the first quarter of 2016.&#160; Early adoption is permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition: </font><font style="font-family:inherit;font-size:10pt;">In May 2014, amended guidance was issued for recognizing revenue from contracts with customers.&#160; The amended guidance eliminated industry specific guidance and applies to all companies.&#160; Revenues will be recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service. Revenue from a contract that contains multiple performance obligations is allocated to each performance obligation generally on a relative standalone selling price basis. The amended guidance also requires additional quantitative and qualitative disclosures. The amended guidance is effective for us commencing in the first quarter of 2018.&#160; The amended guidance allows for either full retrospective adoption or modified retrospective adoption. Early adoption is not permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.</font></div></div> -5000000 -7000000 -15000000 -3000000 1000000 -1000000 85000000 36000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discontinued Operations</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2014, we committed to a plan to sell our International Technology and our Hospital Automation businesses from our Technology Solutions segment and certain businesses from our Distribution Solutions segment. As required, we classified the results of operations and cash flows of these businesses as discontinued operations for all periods presented in our consolidated financial statements in 2014 and depreciation and amortization expense was not recognized.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the third quarter of 2014, our Hospital Automation business was sold for net cash proceeds of </font><font style="font-family:inherit;font-size:10pt;">$55 million</font><font style="font-family:inherit;font-size:10pt;"> and we recorded a pre-tax and after-tax loss of </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the third quarter of 2014, we recorded an </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$80 million</font><font style="font-family:inherit;font-size:10pt;"> pre-tax (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$80 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax) non-cash impairment charge to reduce the carrying value of our International Technology business to its estimated net realizable value (fair value less costs to sell). The charge was primarily the result of the terms of the preliminary purchase offers received for this business during the third quarter of 2014. The impairment charge was primarily attributed to goodwill and other long-lived assets and as a result, there was no tax benefit associated with this charge. During the first quarter of 2015, we entered into an agreement to sell the software business within our International Technology business. We completed the sale of the software business on July 1, 2014 and no material gain or loss is anticipated.&#160;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2015, we also decided to retain the workforce business within our International Technology business. This business consists of workforce management solutions for the National Health Service in the United Kingdom, which we now intend to wind down in 2016. As a result, we reclassified the workforce business, which had been designated as a discontinued operation since the first quarter of 2014, as a continuing operation for all periods presented. During the first quarter of 2015, we also recorded a non-cash pre-tax charge of </font><font style="font-family:inherit;font-size:10pt;">$34 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$27 million</font><font style="font-family:inherit;font-size:10pt;"> after-tax) primarily relating to depreciation and amortization expense for 2014 when the business was classified as held for sale. The non-cash charge was recorded in our condensed consolidated statement of operations as follows: </font><font style="font-family:inherit;font-size:10pt;">$32 million</font><font style="font-family:inherit;font-size:10pt;"> in cost of sales and </font><font style="font-family:inherit;font-size:10pt;">$2 million</font><font style="font-family:inherit;font-size:10pt;"> in operating expenses.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of results of discontinued operations is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (expense) benefit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations, net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The assets and liabilities of our discontinued operations are classified as held-for-sale effective in 2014. All applicable assets of the businesses to be sold are included under the caption &#8220;Prepaid expenses and other&#8221; and all applicable liabilities under the caption &#8220;Other accrued liabilities&#8221; within our condensed consolidated balance sheet at June 30, 2014 and March 31, 2014. The carrying values of the assets and liabilities classified as held-for-sale were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$138</font><font style="font-family:inherit;font-size:10pt;"> million and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$144</font><font style="font-family:inherit;font-size:10pt;"> million at June 30, 2014 and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$267&#160;million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$248 million</font><font style="font-family:inherit;font-size:10pt;"> at March 31, 2014.</font></div></div> 1.86 1.75 1.83 1.72 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings Per Common Share</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share are computed by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share are computed similar to basic earnings per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The computations for basic and diluted earnings per common share are as follows:</font></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations attributable to McKesson</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to McKesson</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options to purchase common stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share attributable to McKesson: </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.72</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.81</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.02</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.86</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Certain computations may reflect rounding adjustments.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3 million</font><font style="font-family:inherit;font-size:10pt;"> potentially dilutive securities were excluded from the computations of diluted net earnings per common share for the quarters ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, as they were anti-dilutive.</font></div></div> 9000000 -10000000 0 0 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding the fair value of derivatives on a gross basis is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="25%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Caption</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value of </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S. Dollar Notional</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value of </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S Dollar Notional</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liability</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liability</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives designated for hedge accounting</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (non-current)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated for hedge accounting</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;contracts (current)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap contracts (current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, the carrying amounts of cash, cash equivalents, restricted cash, marketable securities receivables, drafts and accounts payable and other current liabilities generally approximated their estimated fair values because of the short maturity of these financial instruments. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our long-term debt and other financing are carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were </font><font style="font-family:inherit;font-size:10pt;">$10.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$10.7 billion</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$10.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$10.8 billion</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">. The estimated fair values of our long-term debt and other financing were determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in cash and cash equivalents at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;"> were investments in money market funds, time deposits and repurchase agreements of </font><font style="font-family:inherit;font-size:10pt;">$3.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.9 billion</font><font style="font-family:inherit;font-size:10pt;">, which are reported at fair value. The fair value of these investments was determined by using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair values of our forward foreign currency derivatives were determined using quoted market prices of similar instruments in an active market and other observable inputs from available market information.&#160; These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, "Hedging Activities," for more information on our forward foreign currency derivatives.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> transfers between Level 1, Level 2 or Level 3 of the fair value hierarchy during the quarters ended June 30, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> 863000000 59000000 52000000 189000000 177000000 173000000 1331000000 66000000 937000000 1465000000 173000000 11000000 28000000 68000000 2318000000 383000000 382000000 410000000 429000000 468000000 173000000 3022000000 5855000000 3384000000 219000000 1051000000 377000000 995000000 1219000000 165000000 218000000 6353000000 1014000000 371000000 4390000000 5022000000 107000000 2085000000 825000000 2521000000 822000000 309000000 1023000000 312000000 113000000 46000000 1208000000 41000000 P4Y P9Y P15Y P27Y P16Y P3Y <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</font></div></div> 9927000000 10431000000 4006000000 3570000000 436000000 8078000000 1853000000 8578000000 1849000000 14000000 14000000 0 80000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill and Intangible Assets, Net</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in the carrying amount of goodwill were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Distribution</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Solutions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Technology</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Solutions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, March&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,078</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,849</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,927</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition accounting and other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, June 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,578</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,853</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,431</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, the accumulated goodwill impairment losses were </font><font style="font-family:inherit;font-size:10pt;">$36 million</font><font style="font-family:inherit;font-size:10pt;"> in our Technology Solutions segment.</font></div><div style="line-height:120%;padding-bottom:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding intangible assets is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td width="27%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Dollars in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(years)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer lists</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,014</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(189</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">825</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">995</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(173</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">822</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy licenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,051</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks and trade names</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">371</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">312</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,855</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,465</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,390</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,353</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,331</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,022</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense of intangible assets was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$130 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$71 million</font><font style="font-family:inherit;font-size:10pt;"> for the quarters ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">. Estimated annual amortization expense of these assets is as follows: </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$383</font><font style="font-family:inherit;font-size:10pt;"> million, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$468</font><font style="font-family:inherit;font-size:10pt;"> million, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$429</font><font style="font-family:inherit;font-size:10pt;">&#160;million, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$410</font><font style="font-family:inherit;font-size:10pt;"> million and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$382</font><font style="font-family:inherit;font-size:10pt;"> million for the remainder of 2015 and each of the succeeding years through 2019 and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,318</font><font style="font-family:inherit;font-size:10pt;"> million thereafter. All intangible assets were subject to amortization as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> 36000000 36000000 445000000 445000000 0 41000000 45000000 4000000 1930000000 2797000000 428000000 417000000 607000000 602000000 428000000 425000000 1.81 1.88 1.84 1.78 -4000000 -14000000 -0.06 -0.02 -0.06 -0.01 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$582</font><font style="font-family:inherit;font-size:10pt;"> million of unrecognized tax benefits, of which </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$427</font><font style="font-family:inherit;font-size:10pt;"> million would reduce income tax expense and the effective tax rate, if recognized. During the next twelve months, it is reasonably possible that audit resolutions and the expiration of statutes of limitations could potentially reduce our unrecognized tax benefits by up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$158</font><font style="font-family:inherit;font-size:10pt;"> million. However, this amount may change as we continue to have ongoing negotiations with various taxing authorities throughout the year. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have received reassessments from the Canada Revenue Agency (&#8220;CRA&#8221;) for a total of </font><font style="font-family:inherit;font-size:10pt;">$261 million</font><font style="font-family:inherit;font-size:10pt;"> related to a transfer pricing matter impacting years 2003 through 2010. On December&#160;13, 2013, the Tax Court of Canada dismissed our appeal of the 2003 reassessment and we have filed a Notice of Appeal to the Federal Court of Appeal regarding this tax year. During the first quarter of 2015, we filed a Notice of Appeal with the Tax Court of Canada relating to the 2004 through 2008 reassessments.&#160; The ultimate resolution of these issues could result in an increase or decrease to income tax expense. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Through the appeals process, we reached an agreement with the Internal Revenue Service (&#8220;IRS&#8221;) to settle all outstanding issues relating to years 2003 through 2006. As a result of this agreement we will pay additional taxes of </font><font style="font-family:inherit;font-size:10pt;">$21 million</font><font style="font-family:inherit;font-size:10pt;">, which have already been accrued in our financial statements. We are also recognizing a </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$17 million</font><font style="font-family:inherit;font-size:10pt;"> discrete tax benefit during the quarter to record a previously unrecognized tax benefit.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The IRS is currently examining our U.S. corporation income tax returns for 2007 through 2009. The CRA is currently examining our Canadian Income tax returns for 2011 through 2013. In nearly all jurisdictions, the tax years prior to 2003 are no longer subject to examination. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We report interest and penalties on tax deficiencies as income tax expense. During the quarter, we recognized income tax expense of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4</font><font style="font-family:inherit;font-size:10pt;">&#160;million, before any tax benefit, related to interest and penalties in our condensed consolidated statements of operations. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, before any tax benefits, our accrued interest and penalties on unrecognized tax benefits amounted to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$161</font><font style="font-family:inherit;font-size:10pt;"> million.</font></div></div> 261000000 21000000 4000000 174000000 182000000 1368000000 589000000 31000000 -134000000 -135000000 -98000000 -116000000 -134000000 60000000 901000000 305000000 260000000 139000000 699000000 2000000 2000000 3000000 2000000 101000000 59000000 98000000 0 14124000000 13308000000 53006000000 51759000000 29245000000 29501000000 144000000 248000000 0 246000000 0 258000000 0 188000000 321000000 0 0 0 we were in compliance with all covenants we were in compliance with all covenants 2018-02-28 2014-11-15 2015-09-30 2016-09-23 bear interest based upon either the London Interbank Offered Rate or a prime rate 1300000000 1350000000 500000000 315000000 2000000000 726000000 500000000 1226000000 10400000000 10200000000 1424000000 25000000 737000000 507000000 1244000000 10141000000 8949000000 261000 356000 0 15000000 15 2015-03-31 2015-06-30 2014-07-31 2020-03-31 1796000000 1786000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Noncontrolling Interests</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At June 30, 2014, we owned approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">75.9%</font><font style="font-family:inherit;font-size:10pt;"> of Celesio&#8217;s outstanding and fully diluted common shares, which was primarily obtained through our February 2014 acquisition of the then outstanding common shares and certain convertible bonds of Celesio. In April 2014, we completed tender offers and paid </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$32 million</font><font style="font-family:inherit;font-size:10pt;"> in cash to acquire approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1 million</font><font style="font-family:inherit;font-size:10pt;"> additional common shares of Celesio, which increased our ownership share by </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">0.5%</font><font style="font-family:inherit;font-size:10pt;"> and decreased noncontrolling interests by </font><font style="font-family:inherit;font-size:10pt;">$35 million</font><font style="font-family:inherit;font-size:10pt;"> since March 31, 2014. The effect of changes in our ownership interest in Celesio on our equity of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$3 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded as an increase to McKesson&#8217;s stockholders&#8217; paid-in capital. Net income attributable to McKesson and transfers from noncontrolling interests to McKesson equity amounted to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$406&#160;million</font><font style="font-family:inherit;font-size:10pt;"> for the first quarter of 2015.</font></div></div> 35000000 -73000000 -167000000 -184000000 -112000000 182000000 716000000 424000000 403000000 0 8000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cumulative Translation Adjustments: </font><font style="font-family:inherit;font-size:10pt;">In the first quarter of 2015, we adopted amended guidance for parent&#8217;s accounting for the cumulative translation adjustment upon derecognition of certain subsidiaries or group of assets within a foreign entity or of an investment in a foreign entity.&#160; The amended guidance requires the release of any cumulative translation adjustment into net income only upon complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160; Also, it requires the release of all or a pro rata portion of the cumulative translation adjustment to net income in case of sale of an equity method investment that is a foreign entity.&#160; The adoption of this amended guidance did not have a material effect on our condensed financial statements.</font></div></div> 20000000 6000000 14 2109000000 1275000000 688000000 655000000 68000000 127000000 746000000 816000000 619000000 748000000 23000000 -7000000 2003000000 2015000000 12000000 2000000 0 7000000 3000000 4000000 1000000 0 110000000 -2000000 108000000 1000000 -2000000 -61000000 98000000 98000000 -53000000 -2000000 110000000 110000000 2000000 -2000000 -7000000 0 0 2855000000 2991000000 -32000000 -14000000 9000000 -21000000 127000000 102000000 53000000 59000000 4500000000 74000000 14000000 86000000 69000000 32000000 33000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pension Benefits</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic expense for the defined pension benefit plans of the Company and Celesio was </font><font style="font-family:inherit;font-size:10pt;">$11 million</font><font style="font-family:inherit;font-size:10pt;"> for the first quarters of 2015 and 2014. Cash contributions to these plans were </font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> for the first quarters of 2015 and 2014. The increase in contributions in 2015 compared to 2014 is primarily related to defined benefit pension plans of Celesio, which we acquired in the fourth quarter of 2014.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net periodic expense for our pension plans, which includes net pension expense for Celesio in the first quarter of 2015, is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost - benefits earned during the year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost on projected benefit obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension expense</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.</font></div></div> 0 0 0.01 0.01 100000000 100000000 0 0 0 0 0 0 824000000 879000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation.</font></div></div> 55000000 6000000 0 50000000 34000000 0 0 758000000 159000000 100000000 0 0 26000000 57000000 917000000 100000000 424000000 411000000 2209000000 2222000000 14193000000 14920000000 0 0 -2000000 -2000000 746000000 30000000 0 100000000 230000000 0 100000000 759000000 11453000000 11800000000 44058000000 32239000000 43290000000 7607000000 836000000 1379000000 34304000000 768000000 31403000000 1357000000 30046000000 0 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding changes in McKesson&#8217;s accumulated other comprehensive loss, net of tax, by component are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Translation Adjustments, Net of Tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unrealized Losses on Cash Flow Hedges, </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net of Tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unrealized Net Loss and Other Components of Benefit Plans, Net of Tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Accumulated Other Comprehensive Income (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified to earnings and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at June 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary recording of the fair values of the assets acquired and liabilities assumed as of the acquisition date. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Amounts</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Previously Recognized&#160;as&#160;of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Acquisition&#160;Date<br clear="none"/>(Provisional)</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Measurement Period Adjustments</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts Recognized as of Acquisition Date (Provisional as Adjusted)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Receivables</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,422</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets, net of cash and cash equivalents </font></div><div style="text-align:left;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,413</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,410</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,570</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,006</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(536</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,482</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,272</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,096</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,102</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term borrowings and current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(322</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(322</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,293</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,137</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of net assets, less cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,997</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,997</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Noncontrolling Interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired, less cash and cash equivalents</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,497</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,497</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As previously reported in our Form 10-K for the year ended March 31, 2014.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding other comprehensive income (loss) including noncontrolling interests, net of tax, by component are as follows:</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">&#160;(In millions)</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gains on cash flow hedges</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in retirement-related benefit plans</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1 and $4 </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments, net of income tax expense of nil and nil</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The first quarter of 2015 includes net foreign currency translation loss of </font><font style="font-family:inherit;font-size:8pt;">$12 million</font><font style="font-family:inherit;font-size:8pt;"> attributable to noncontrolling interests.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pre-tax amount reclassified into cost of sales and operating expenses in the condensed consolidated statements of operations. The related tax expense was reclassified into income tax expense in the consolidated statements of operations.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of results of discontinued operations is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="76%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (expense) benefit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations, net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The computations for basic and diluted earnings per common share are as follows:</font></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from continuing operations attributable to McKesson</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from discontinued operations, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to McKesson</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options to purchase common stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">232</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share attributable to McKesson: </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.72</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.81</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.02</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.86</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Certain computations may reflect rounding adjustments.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding intangible assets is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td width="27%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Dollars in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(years)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="font-size:8pt;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer lists</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(863</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,014</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(189</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">825</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">995</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(173</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">822</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy licenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,051</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks and trade names</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">371</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">312</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,855</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,465</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,390</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,353</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,331</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,022</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in the carrying amount of goodwill were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Distribution</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Solutions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Technology</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Solutions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, March&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,078</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,849</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,927</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition accounting and other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, June 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,578</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,853</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,431</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net periodic expense for our pension plans, which includes net pension expense for Celesio in the first quarter of 2015, is as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost - benefits earned during the year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost on projected benefit obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension expense</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution Solutions </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">North America pharmaceutical distribution and services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,304</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,046</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International pharmaceutical distribution and services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,607</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical-Surgical distribution&#160;&amp; services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,379</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,357</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Distribution Solutions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,290</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,403</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology Solutions - products and services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">768</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">836</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:68px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,058</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,239</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating profit</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology Solutions </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">746</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate Expenses, Net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest Expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(101</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from Continuing Operations Before Income Taxes</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">607</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">602</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Revenues derived from services represent less than </font><font style="font-family:inherit;font-size:8pt;">2%</font><font style="font-family:inherit;font-size:8pt;"> of this segment&#8217;s total revenues.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Technology Solutions operating profit for the quarter ended June 30, 2014 includes a charge of </font><font style="font-family:inherit;font-size:8pt;">$34 million</font><font style="font-family:inherit;font-size:8pt;"> related to the retained workforce business within our International Technology business.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Information</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We report our operations in two operating segments: McKesson Distribution Solutions and McKesson Technology Solutions. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. We evaluate the performance of our operating segments on a number of measures, including operating profit before interest expense, income taxes and results from discontinued operations.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution Solutions </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">North America pharmaceutical distribution and services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,304</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,046</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International pharmaceutical distribution and services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,607</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical-Surgical distribution&#160;&amp; services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,379</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,357</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Distribution Solutions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,290</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,403</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology Solutions - products and services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">768</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">836</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:68px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,058</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,239</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating profit</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution Solutions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology Solutions </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">746</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate Expenses, Net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest Expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(101</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from Continuing Operations Before Income Taxes</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">607</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">602</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Revenues derived from services represent less than </font><font style="font-family:inherit;font-size:8pt;">2%</font><font style="font-family:inherit;font-size:8pt;"> of this segment&#8217;s total revenues.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Technology Solutions operating profit for the quarter ended June 30, 2014 includes a charge of </font><font style="font-family:inherit;font-size:8pt;">$34 million</font><font style="font-family:inherit;font-size:8pt;"> related to the retained workforce business within our International Technology business.</font></div></td></tr></table></div> 346000000 507000000 -158000000 340000000 8979000000 8522000000 10318000000 10765000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders&#8217; Equity</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the Company&#8217;s quarterly dividend was raised from&#160;</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$0.20</font><font style="font-family:inherit;font-size:10pt;">&#160;to&#160;</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$0.24</font><font style="font-family:inherit;font-size:10pt;">&#160;per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160; However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements and other factors.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total authorization outstanding for repurchases of the Company&#8217;s common stock was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$340</font><font style="font-family:inherit;font-size:10pt;">&#160;million at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding other comprehensive income (loss) including noncontrolling interests, net of tax, by component are as follows:</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="77%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarter Ended June 30,</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">&#160;(In millions)</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gains on cash flow hedges</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in retirement-related benefit plans</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1 and $4 </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments, net of income tax expense of nil and nil</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The first quarter of 2015 includes net foreign currency translation loss of </font><font style="font-family:inherit;font-size:8pt;">$12 million</font><font style="font-family:inherit;font-size:8pt;"> attributable to noncontrolling interests.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pre-tax amount reclassified into cost of sales and operating expenses in the condensed consolidated statements of operations. The related tax expense was reclassified into income tax expense in the consolidated statements of operations.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated Other Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information regarding changes in McKesson&#8217;s accumulated other comprehensive loss, net of tax, by component are as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Translation Adjustments, Net of Tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unrealized Losses on Cash Flow Hedges, </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net of Tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unrealized Net Loss and Other Components of Benefit Plans, Net of Tax</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Accumulated Other Comprehensive Income (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified to earnings and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at June 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> -17000000 151000000 150000000 9611000000 9507000000 582000000 161000000 427000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. In our opinion, the accompanying unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods presented. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of operations for the quarter ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies and financial notes included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;"> previously filed with the SEC on May 14, 2014 (&#8220;2014 Annual Report&#8221;). </font></div></div> 232000000 235000000 227000000 231000000 0.83 27000000 0.754 0.759 0.756 0.759 23.50 2413000000 2410000000 -3000000 2300000000 0 1990000000 1990000000 3000000 406000000 1000000 1000000 0.005 85000000 108000000 4000000 1000000 9000000 1000000 0.1 80000000 12 2109000000 1260000000 0 -1000000 0 0 22.99 0.02 false --03-31 Q1 2015 2014-06-30 10-Q 0000927653 231599218 Large Accelerated Filer MCKESSON CORP 96000000 463000000 68000000 1091000000 1449000000 463000000 The first quarter of 2015 includes net foreign currency translation loss of $12 million attributable to noncontrolling interests. perating profit for the quarter ended June 30, 2014 includes a charge of $34 million related to the retained workforce business within our International Technology business. Pre-tax amount reclassified into cost of sales and operating expenses in the condensed consolidated statements of operations. The related tax expense was reclassified into income tax expense in the consolidated statements of operations. (1)As previously reported in our Form 10-K for the year ended March 31, 2014. Revenues derived from services represent less than 2% of this segment’s total revenues. Certain computations may reflect rounding adjustments. EX-101.SCH 7 mck-20140630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Business Combinations (Fair Value Of Assets Acquired And Liabilities Assumed) (Details) link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Business Combinations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Commitments and Contingent Liabilities link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Commitments and Contingent Liabilities (Litigation Reserve and Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 2419401 - Disclosure - Commitments and Contingent Liabilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Debt and Financing Activities link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Debt and Financing Activities (Accounts Receivable Sales Facility and Revolving Credit Facility) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2414401 - Disclosure - Debt and Financing Activities Debt and Financing Activities (Celesio Debt) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Discontinued Operations Discontinued Operations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Discontinued Operations Discontinued Operations (Schedule of Results from Discontinued Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 0002000 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Earnings Per Common Share link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Earnings Per Common Share (Basic and Diluted Earnings per Common Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Earnings Per Common Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Earnings Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Goodwill And Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Goodwill And Intangible Assets, Net (Changes In The Carrying Amount Of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Goodwill And Intangible Assets, Net Goodwill And Intangible Assets, Net (Narrative - Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - Goodwill And Intangible Assets, Net (Information Regarding Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Goodwill And Intangible Assets, Net (Narrative - Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Goodwill And Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Hedging Activities Derivative Fair Value Table (Tables) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Hedging Activities Derivative Instruments Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Hedging Activities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2408401 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Noncontrolling Interests Noncontrolling Interests link:presentationLink link:calculationLink link:definitionLink 2406401 - Disclosure - Noncontrolling Interests Noncontrolling Interests (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Pension Benefits Pension Benefits link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Pension Benefits Pension Benefits (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Pension Benefits Pension Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Pension Benefits Pension Benefits Tables (Details) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Segment Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - Segment Information (Schedule of Segment Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2420405 - Disclosure - Stockholders' Equity (Changes in Accumulated Other Comprehensive Income (Loss) by Component) (Details) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Details) link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - Stockholders' Equity Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Parentheticals) (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 mck-20140630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 mck-20140630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 mck-20140630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Maximum [Member] Maximum [Member] Business Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] Distribution Solutions [Member] Distribution Solutions [Member] Distribution Solutions. Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Revenue Derived From Services, Percentage Revenue Derived From Services, Percentage Revenue Derived From Services, Percentage Assets, Fair Value Adjustment Assets, Fair Value Adjustment Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Minimum [Member] Minimum [Member] Derivative, by Nature [Axis] Derivative, by Nature [Axis] Derivative, Name [Domain] Derivative, Name [Domain] Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Interest Rate Swap [Member] Interest Rate Swap [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Derivative [Line Items] Description of Foreign Currency Derivative Activities Description of Foreign Currency Derivative Activities Derivative, Notional Amount Derivative, Notional Amount Maturity of Foreign Currency Derivatives Maturity of Foreign Currency Derivatives Description of Interest Rate Derivative Activities Description of Interest Rate Derivative Instruments Not Designated as Hedging Instruments Activities Derivative, Maturity Date Derivative, Maturity Date Earnings Per Share [Abstract] Basic And Diluted Earnings Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Equity [Abstract] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract] Net periodic pension expense Defined Benefit Plan, Net Periodic Benefit Cost Defined Benefit Plan, Contributions by Employer Defined Benefit Plan, Contributions by Employer Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets Defined Benefit Plan, Straight-line Amortization of Unrecognized Actuarial Losses, when Percentage Exceeds Greater Of Projected Benefit Obligation Or Market Value of Assets Defined Benefit Plan, Straight-line Amortization of Unrecognized Actuarial Losses, when Percentage Exceeds Greater Of Projected Benefit Obligation Or Market Value of Assets Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current Assets Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Receivables, net Receivables, Net, Current Inventories, net Inventory, Net Prepaid expenses and other Prepaid Expense and Other Assets, Current Total Current Assets Assets, Current Property, Plant and Equipment, Net Property, Plant and Equipment, Net Goodwill Goodwill Intangible Assets, Net Finite-Lived Intangible Assets, Net Other Assets Other Assets, Noncurrent Total Assets Assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Current Liabilities Liabilities, Current [Abstract] Drafts and accounts payable Accounts Payable, Current Short-term borrowings Short-term Debt Deferred revenue Deferred Revenue, Current Deferred tax liabilities Deferred Tax Liabilities, Net, Current Current portion of long-term debt Long-term Debt, Current Maturities Other accrued liabilities Accrued Liabilities, Current Total Current Liabilities Liabilities, Current Long-Term Debt Long-term Debt, Excluding Current Maturities Other Noncurrent Liabilities Other Liabilities, Noncurrent Commitments and Contingent Liabilities (Note 12) Commitments and Contingencies McKesson Corporation Stockholders' Equity Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding Preferred Stock, Value, Issued Common stock, $0.01 par value, 800 shares authorized at June 30, 2014 and March 31, 2014, 383 and 381 shares issued at June 30, 2014 and March 31, 2014 Common Stock, Value, Issued Additional Paid-in Capital Additional Paid in Capital Retained Earnings Retained Earnings (Accumulated Deficit) Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Other Other Additional Capital Treasury Shares, at Cost, 151 and 150 at June 30, 2014 and March 31, 2014 Treasury Stock, Value Total McKesson Corporation Stockholders’ Equity Stockholders' Equity Attributable to Parent Noncontrolling Interests Stockholders' Equity Attributable to Noncontrolling Interest Total Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total Liabilities and Equity Liabilities and Equity Noncontrolling Interest [Abstract] Business Acquisition, Percentage Of Voting Interests Acquired Fully Diluted Business Acquisition Percentage Of Voting Interests Acquired Fully Diluted Business Acquisition Percentage Of Voting Interests Acquired Fully Diluted Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase Of Interest By Parent, Common Shares Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent Common Shares Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent Common Shares Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase Of Interest By Parent, Percent Ownership Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent Percent Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent Percent Noncontrolling Interest, Period Increase (Decrease) Noncontrolling Interest, Period Increase (Decrease) Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Paid In Capital Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Increase In Paid In Capital Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Increase In Paid In Capital. Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net Income Attributable To Parent and Transfers from NCI Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net Income Attributable To Parent From Noncontrolling Interests Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net Income Attributable To Parent From Noncontrolling Interests Goodwill and Intangible Assets Disclosure [Abstract] Amortization expense of intangible assets Amortization of Intangible Assets Annual Amortization Expense, 2015 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Annual Amortization Expense, 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Two Annual Amortization Expense, 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Three Annual Amortization Expense, 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Four Annual Amortization Expense, 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Five Annual Amortization Expense, After 2019 Finite-Lived Intangible Assets, Amortization Expense, after Year Five Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Contingency [Table] Income Tax Contingency [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Canada Revenue Agency Assessments [Member] Canada Revenue Agency Assessments [Member] Canada Revenue Agency Assessments Member. Internal Revenue Service (IRS) [Member] Internal Revenue Service (IRS) [Member] Income Tax [Line Items] Income Tax Contingency [Line Items] Unrecognized tax benefits Unrecognized Tax Benefits Unrecognized tax benefits that would impact income tax expense and the effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit Tax assessments received Income Tax Examination, Estimate of Possible Loss Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Tax Adjustments, Settlements, and Unusual Provisions Tax Adjustments, Settlements, and Unusual Provisions Income Tax Examination, Penalties and Interest Expense Income Tax Examination, Penalties and Interest Expense Accrued interest and penalties on unrecognized tax benefits Unrecognized Tax Benefits, Interest on Income Taxes Accrued Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Long-term Debt Long-term Debt Debt Instrument, Fair Value Disclosure Debt Instrument, Fair Value Disclosure Cash and Cash Equivalents, Fair Value Disclosure Cash and Cash Equivalents, Fair Value Disclosure Fair Value, Assets, Level 1 to Level 2 Transfers, Amount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount Income Taxes Income Tax Disclosure [Text Block] Goodwill And Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Committments and Contingencies Disclosure [Abstract] Committments and Contingencies Disclosure [Abstract] Debt Disclosure [Abstract] Debt and Financing Activities Debt Disclosure [Text Block] Pension and Other Postretirement Benefits Disclosure [Text Block] Pension and Other Postretirement Benefits Disclosure [Text Block] Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 (1) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1 and $4 (2) Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service (Cost) Credit, Net of Tax Foreign currency translation adjustments, net of income tax expense of nil and nil Other Comprehensive Income Translation Impact On Pension Plans, Net Of Tax Other Comprehensive Income Translation Impact On Pension Plans, Net Of Tax Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Statement of Comprehensive Income [Abstract] Net Income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Net of Tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Retirement-related benefit plans, net of income tax expense of $1 and $4 Other Comprehensive Income (Loss), Net of Tax Comprehensive Income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Loss Attributable to Noncontrolling Interests Comprehensive (Income) Loss, Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income Attributable to McKesson Comprehensive Income (Loss), Net of Tax, Attributable to Parent Line of Credit Facility [Table] Line of Credit Facility [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member] Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member] Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member] Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member] Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member] Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member] Investment Type [Axis] Investment Type [Axis] Investment [Domain] Investments [Domain] Corporate Bond Securities [Member] Corporate Bond Securities [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Revolving Credit Facility Due February Two Thousand Eighteen [Member] Revolving Credit Facility Due February Two Thousand Eighteen [Member] Revolving Credit Facility Due February Two Thousand Eighteen [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Accounts Receivable Factoring Facility [Member] Accounts Receivable Factoring Facility [Member] Accounts Receivable Factoring Facility [Member] Revolving Credit Facility [Member] Revolving Credit Facility [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Celesio [Member] Celesio [Member] Celesio [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Credit Facility Capacity Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Expiration Date Line of Credit Facility, Expiration Date Proceeds from Lines of Credit Proceeds from Lines of Credit Repayments of Lines of Credit Repayments of Lines of Credit Borrowings Outstanding Line of Credit Facility, Amount Outstanding North America pharmaceutical distribution and services [Member] North America Distribution And Services [Member] North America Distribution And Services [Member] International pharmaceutical distribution and services [Member] International Distribution and Services [Member] International Distribution and Services [Member] Medical-Surgical distribution & services [Member] Distribution Solutions Medical Surgical Distribution And Services [Member] DistributionSolutionsMedicalSurgicalDistributionAndServicesMember Technology Solutions [Member] Technology Solutions [Member] Technology Solutions Member. Operating Segments [Member] Operating Segments [Member] Corporate [Member] Corporate Segment [Member] Segment Reporting Revenue From External Customers Revenue, Net Operating Income Operating Income (Loss) Corporate Expenses, Net Corporate Operating Expense and Other Income, Net Corporate Operating Expense and Other Income, Net Interest Expense Interest and Debt Expense Income from Continuing Operations Before Income Taxes Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Foreign currency translation adjustments arising during period, income tax expense of nil and $2 Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax Unrealized losses on cash flow hedges arising during period, income tax expense of nil and nil Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Amortization of actuarial loss, prior service cost and transition obligation, income tax expense of $1 and $4 Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service (Cost) Credit, Tax Foreign currency translation adjustments, income tax expense of nil and nil Other Comprehensive Income Translation Impact On Pension Plans, Tax Other Comprehensive Income Translation Impact On Pension Plans, Tax Fair Value By Balance Sheet Grouping [Abstract] Fair Value By Balance Sheet Grouping [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Prepaid Expenses and Other Current Assets [Member] Prepaid Expenses and Other Current Assets [Member] Other Assets [Member] Other Assets [Member] Other Current Liabilities [Member] Other Current Liabilities [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative Asset, Fair Value, Gross Asset Derivative Asset, Fair Value, Gross Asset Derivative Liability, Fair Value, Gross Liability Derivative Liability, Fair Value, Gross Liability Derivative Asset, Notional Amount Derivative Asset, Notional Amount Derivative Liability, Notional Amount Derivative Liability, Notional Amount Fair Value, by Balance Sheet Grouping [Table Text Block] Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customer lists Customer Lists [Member] Service agreements Service Agreements [Member] Pharmacy Licenses Pharmacy Licenses [Member] Pharmacy licenses [Member] Trademarks and trade names Trademarks and Trade Names [Member] Technology-Based Intangible Assets Technology-Based Intangible Assets [Member] Other Other Intangible Assets [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Intangible assets Finite-Lived Intangible Assets, Net [Abstract] Weighted Average Remaining Amortization Period (years) Finite-Lived Intangible Assets, Remaining Amortization Period Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Net Carrying Amount Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition, Period Distinction [Axis] Business Acquisition, Period Distinction [Axis] Business Acquisition, Period Distinction [Axis] Business Acquisition Period Distinction [Domain] Business Acquisition Period Distinction [Domain] Business Acquisition, Period Distinction [Domain] Amounts Previously Recognized As Of Acquisition Date Amounts Previously Recognized As Of Acquisition Date [Member] Amounts Previously Recognized As Of Acquisition Date Member Purchase Price Allocation Adjustments Purchase Price Allocation Adjustments [Member] Amounts Recognized As Of Acquisition Date As Adjusted Amounts Recognized As Of Acquisition Date As Adjusted [Member] Amounts recognized as of acquisition date as adjusted [Member]. Business Acquisition [Line Items] Business Acquisition [Line Items] Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Other current assets, net of cash and cash equivalents acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents, Net of Cash Acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents, Net of Cash Acquired Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Other long-term assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Short-term borrowings and current portion of long-term debt Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Short term Borrowings Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Short term Borrowings Long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Fair value of net assets, less cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Less: Noncontrolling Interests Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Net assets acquired, less cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Statement [Table] Statement [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Parent Company [Member] Parent Company [Member] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Foreign Currency Translation Adjustments, Net of Tax Accumulated Translation Adjustment [Member] Unrealized Losses on Cash Flow Hedges, Net of Tax Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Unrealized Net Loss and Other Components of Benefit Plans, Net of Tax Accumulated Defined Benefit Plans Adjustment [Member] Statement [Line Items] Statement [Line Items] Beginning balance Other comprehensive income (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified to earnings and other Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Ending balance Earnings Per Common Share Earnings Per Share [Text Block] Changes In The Carrying Amount Of Goodwill Schedule of Goodwill [Table Text Block] Information Regarding Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Accounts Receivable Sales Facility [Member] Accounts Receivable Sales Facility [Member] Accounts Receivable Sales Facility. Line of Credit Facility, Interest Rate Description Line of Credit Facility, Interest Rate Description Line of Credit Facility, Covenant Compliance Line of Credit Facility, Covenant Compliance Pledged Assets, Not Separately Reported, Finance Receivables Pledged Assets, Not Separately Reported, Finance Receivables Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill, Impaired, Accumulated Impairment Loss Goodwill, Impaired, Accumulated Impairment Loss Fair Value Of Assets Acquired And Liabilities Assumed Schedule of Business Acquisitions, by Acquisition [Table Text Block] Accounting Policies [Abstract] Basis of Presentation Consolidation, Policy [Policy Text Block] Use Of Estimates Use of Estimates, Policy [Policy Text Block] Reclassifications Reclassification, Policy [Policy Text Block] Fiscal Period Fiscal Period, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Recently Issued Accounting Pronouncements Not Yet Adopted Description of New Accounting Pronouncements Not yet Adopted [Text Block] Schedule of Net Benefit Costs [Table Text Block] Schedule of Net Benefit Costs [Table Text Block] Hedging Activities Disclosure [Text Block] Derivative Instruments and Hedging Activities Disclosure [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] United States Pension Plan of US Entity, Defined Benefit [Member] United States Pension Plan of US Entity, Defined Benefit [Member] Foreign Pension Plan, Defined Benefit [Member] Foreign Pension Plan, Defined Benefit [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Service cost - benefits earned during the year Defined Benefit Plan, Service Cost Interest cost on projected benefit obligation Defined Benefit Plan, Interest Cost Expected return on assets Defined Benefit Plan, Expected Return on Plan Assets Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets) Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets) Net periodic pension expense Schedule of Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Discontinued Operations and Disposal Groups [Abstract] Revenues Disposal Group, Including Discontinued Operation, Revenue Loss from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Income tax (expense) benefit Discontinued Operation, Tax Effect of Discontinued Operation Loss from discontinued operations, net of tax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Treasury stock, shares Treasury Stock, Shares Schedule of Earnings Per Share [Table] Schedule of Earnings Per Share [Table] Schedule of Earnings Per Share [Table] Schedule of Earnings Per Share [Axis] Schedule of Earnings Per Share [Axis] Schedule of Earnings Per Share [Axis] Schedule of Earnings Per Share [Domain] Schedule of Earnings Per Share [Domain] [Domain] for Schedule of Earnings Per Share [Axis] Schedule of Earnings Per Share [Line Items] Schedule of Earnings Per Share [Line Items] [Line Items] for Schedule of Earnings Per Share [Table] Income from continuing operations Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest Net income attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Income from continuing operations attributable to McKesson Income (Loss) from Continuing Operations Attributable to Parent Loss from discontinued operations, net of tax Net income attributable to McKesson Net Income (Loss) Attributable to Parent Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Weighted Average Number of Shares Outstanding, Basic Effect of dilutive securities: Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract] Options to purchase common stock Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Restricted stock units Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Diluted Weighted Average Number of Shares Outstanding, Diluted Earnings (Loss) Per Common Share Attributable To McKesson Earnings Per Share, Basic and Diluted [Abstract] Earnings (Loss) Per Common Share Attributable To McKesson (Diluted) Earnings Per Share, Diluted [Abstract] Continuing operations Income (Loss) from Continuing Operations, Per Diluted Share Discontinued operations Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Total Earnings Per Share, Diluted Earnings (Loss) Per Common Share Attributable To McKesson (Basic) Earnings Per Share, Basic [Abstract] Continuing operations Income (Loss) from Continuing Operations, Per Basic Share Discontinued operations Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Total Earnings Per Share, Basic Loss Contingency, Damages Sought, Value Loss Contingency, Damages Sought, Value Loss Contingency Number of States Filed On Behalf Of Loss Contingency Number of States Filed On Behalf Of Loss Contingency Number of States Filed On Behalf Of Loss Contingency, Number of Defendants Loss Contingency, Number of Defendants Income Statement [Abstract] Revenues Cost of Sales Cost of Revenue Gross Profit Gross Profit Operating Expenses Operating Expenses Excluding Certain Other Charges Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Excludes certain generally non-recurring costs charged against earnings in the period. Litigation Charges Loss Contingency, Loss in Period Total Operating Expenses Operating Expenses Other Income, Net Nonoperating Income (Expense) Income Tax Expense Income Tax Expense (Benefit) Income from Continuing Operations Net Income Net Income Attributable to Noncontrolling Interests Earnings (Loss) Per Common Share Attributable To McKesson Dividends Declared Per Common Share Common Stock, Dividends, Per Share, Declared Weighted Average Common Shares Diluted Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of Sales [Member] Cost of Sales [Member] Operating Expense [Member] Operating Expense [Member] Assets Fair Value Adjustment, Net of Tax Assets Fair Value Adjustment, Net of Tax Assets Fair Value Adjustment, Net of Tax Proceeds from Divestiture of Businesses Proceeds from Divestiture of Businesses Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Goodwill and Intangible Asset Impairment Goodwill and Intangible Asset Impairment Goodwill and Intangible Asset Impairment, After-tax Charge Goodwill and Intangible Asset Impairment, After-tax Charge Assets of Disposal Group, Including Discontinued Operation Assets of Disposal Group, Including Discontinued Operation Liabilities of Disposal Group, Including Discontinued Operation Liabilities of Disposal Group, Including Discontinued Operation Stockholders' Equity [Table] Stockholders' Equity [Table] Stockholders' Equity [Table] Dividends Rate Per Share [Axis] Dividends Rate Per Share [Axis] DividendsRatePerShareAxis Dividends Rate Per Share [Domain] Dividends Rate Per Share [Domain] DividendsRatePerShareDomain Old Rate Per Share [Member] Old Rate Per Share [Member] OldRatePerShareMember New Rate Per Share [Member] New Rate Per Share [Member] NewRatePerShareMember Stockholders' Equity [Line Items] Stockholders' Equity [Line Items] Stockholders' Equity [Line Items] Stock Repurchase Program, Remaining Authorized Repurchase Amount Other Comprehensive (Income) Loss, Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest Other Comprehensive (Income) Loss, Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest Document And Entity Information [Abstract] Document And Entity Information. Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Statement of Cash Flows [Abstract] Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Deferred taxes Increase (Decrease) in Deferred Income Taxes Charges associated with last-in-first-out inventory method Inventory, LIFO Reserve, Period Charge Other non-cash items Other Noncash Income (Expense) Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Receivables Increase (Decrease) in Receivables Inventories Increase (Decrease) in Inventories Drafts and accounts payable Increase (Decrease) in Accounts Payable Deferred revenue Increase (Decrease) in Deferred Revenue Taxes Increase (Decrease) in Accrued Taxes Payable Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Property acquisitions Payments to Acquire Property, Plant, and Equipment Capitalized software expenditures Payments to Acquire Software Acquisitions, net of cash and cash equivalents acquired Payments to Acquire Businesses, Net of Cash Acquired Other Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from short-term borrowings Proceeds from Short-term Debt Repayments of short-term borrowings Repayments of Short-term Debt Proceeds from issuances of long-term debt Proceeds from Issuance of Long-term Debt Repayments of long-term debt Repayments of Long-term Debt Common stock transactions: Proceeds from (Repurchase of) Equity [Abstract] Issuances Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Share repurchases, including shares surrendered for tax withholding Payments for Repurchase of Common Stock Dividends paid Payments of Ordinary Dividends, Common Stock Other Proceeds from (Payments for) Other Financing Activities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net (decrease) increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Business Combinations Business Combination Disclosure [Text Block] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] The 2014 and 2018 Bonds [Member] The 2014 and 2018 Bonds [Member] The 2014 and 2018 Bonds [Member] Effective Date of Acquisition Business Acquisition, Effective Date of Acquisition Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Name of Acquired Entity Business Acquisition, Name of Acquired Entity Cash Paid for Acquisition Payments to Acquire Businesses, Gross Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt Description of Acquired Entity Business Acquisition, Description of Acquired Entity Number of Countries in which Entity Operates Number of Countries in which Entity Operates Debt Conversion, Converted Instrument, Shares Issued Debt Conversion, Converted Instrument, Shares Issued Business Acquisition Tender Offer Price Business Acquisition Tender Offer Price Business Acquisition Tender Offer Price Annual Recurring Compensation to NCI Under Domination Agreement, Per Share Annual Recurring Compensation to NCI Under Domination Agreement, Per Share Annual Recurring Compensation to NCI Under Domination Agreement, Per Share Put Option for NCI Under Domination Agreement, Celesio Per Share Put Option for NCI Under Domination Agreement, Celesio Per Share Put Option for NCI Under Domination Agreement, Celesio Per Share Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles Beginning Balance Goodwill acquired Goodwill, Acquired During Period Acquisition accounting and other Goodwill, Purchase Accounting Adjustments Foreign currency translation adjustments and other Goodwill, Translation Adjustments Ending Balance Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Noncontrolling Interest Disclosure [Text Block] Noncontrolling Interest Disclosure [Text Block] Segment Reporting Disclosure [Text Block] Segment Reporting Disclosure [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Schedule of Results from Discontinued Operations Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block] EX-101.PRE 11 mck-20140630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Intangible Assets, Net (Narrative - Intangible Assets) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense of intangible assets $ 130 $ 71
Annual Amortization Expense, 2015 383  
Annual Amortization Expense, 2016 468  
Annual Amortization Expense, 2017 429  
Annual Amortization Expense, 2018 410  
Annual Amortization Expense, 2019 382  
Annual Amortization Expense, After 2019 $ 2,318  
XML 13 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Segment Reporting Information [Line Items]  
Assets, Fair Value Adjustment $ 34
Maximum [Member] | Distribution Solutions [Member]
 
Segment Reporting Information [Line Items]  
Revenue Derived From Services, Percentage 2.00%
XML 14 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Narrative) (Details) (USD $)
Jun. 30, 2014
Mar. 31, 2014
Jun. 30, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Long-term Debt $ 10,200,000,000 $ 10,400,000,000  
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount 0   0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Cash and Cash Equivalents, Fair Value Disclosure 3,400,000,000 2,900,000,000  
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt Instrument, Fair Value Disclosure $ 10,700,000,000 $ 10,800,000,000  
EXCEL 15 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!LLG4[(@(``&XA```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VEUKVS`4!N#[P?Z#T>V( M%7VX:TN<7NSC2/"[ M@4*65MM0LB;&X9KS4#74FY"[@6QZLG*^-S%]]6L^F&ICUL3E?'[!*VY7,#$/75B:FI/S!UJ^ZS!X[Y&GE M]$YHVB%\2#$8/]AA?/+W!H_KOJ>M\6U-V:WQ\9OI4PR^[?AOYS>_G-ODQXL< M2.E6J[:BVE7W?=J!/`R>3!T:HMAW^73->]/:I]Q'^D\O!SY=Q)F#C+]O*GQB M#@F20X'DT"`Y"I`<%R`Y/H+DN`3)<0620\Q1@J"(*E!(%2BF"A14!8JJ`H55 M@>*J0(%5H,@J4625*+)*%%DEBJP215:)(JM$D56BR"I19)4HLBH4616*K`I% M5H4BJT*15:'(JE!D52BR*A19%8JL&D56C2*K1I%5H\BJ4635*+)J%%DUBJP: M15:-(FN!(FN!(FN!(FN!(FN!(FOQOV2-:9I-?/K\][_I5.:-<6J(NX["F4<@ M^Z)O=6Z,I_I']&GN?_8`+VL?RY&FXK?>#2&=#_!T^BX\'0`85\^&5(A\;.GY M","A4?ISQW2VX/2&KV;Y-)Y>J*D^T)M/IR66?P```/__`P!02P,$%``&``@` M```A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G M:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-` MZ^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8`"````"$` MYZKC[EL"``#7(```&@`(`7AL+U]R96QS+W=OZ3HM-W+=ITA]B5YZL^F'?YC(< MUO6A7;RVZUCK=#JKA[_7.&YZ68JUZ.A_+J]Q?O5ZOM(C[UB^_[ MV.5_O*/^V0^O:1-C+HNVPSKFQHU3J3X]$9L4S:[^CYP2#ZZ<.R1'9V0Y.D-R M[)XLQ^Z1'!6R'!4DQSQ9CGDDQRM9CEIE!.8,L)2`Y[ MK^!6L?,8IK&PB2R0R,HFLD(B"YO(`HFL;"(K)+*Q,]E@*AO[E!L\YIY-9`^) M[-E$]I#(@5TG!U@GAZO6R6G3#G'Y-0_E6I**$;Z5[A?3R*[86P5W2MA(%HAD M-@(A`=FA@9$1=F@$QD;9[J#0'93M#@K=P=CN8-`=C(T<@\SQ;'?PT!W\5=UA M[."FOJ>-A%"5>MV7-I?L6SE-.P/GW"6I0=$AP1=IT>8&S8V0N35]@< M%LAA87-8((>5#3Z%X#-ZZL#<,?8I-WC,_57!-T+W#+]QZ@^'<;."[>$*/=RS M(>@A!`.['`VP'&4'!\:&G<(BY>.N_'Y\[M^0>IYMB-XZ`B!71B'L3"N+_Z. M,/\-``#__P,`4$L#!!0`!@`(````(0!P]-NOD`0```,1```/````>&PO=V]R M:V)O;VLN>&ULE)A?3^,Z$,7?K[3?H\DI>$D3B-X:IV0TYDSOQD[G'Y[R;/1LRB,U.K,\[].O)%0L4ZD M6I]Y_]U?_SWW1L9RE?!,*W'FO0KC?3O_\M?I5A=/CUH_C4A`F3,OM79S,AZ; M.!4Y-U_U1BBZL])%SBTMB_78;`K!$Y,*8?-L'$PFLW'.I?)V"B?%1S3T:B5C M<:GC,A?*[D0*D7%+X9M4;HQW?KJ2F7C8933BF\TMSRGNE\P;9=S8JT1:D9QY M4UKJK6A=*,K-HI09W3T.)Z$W/F^2O"M&B5CQ,K/WE-Y>G?P*HB"857]96?$@ MQ=:\/U0M1R^_I4KTMOI3LO:U6844P+:^]5LF-J7[D\FDN?9#R'5J]Q=)?@SZ MM8/T._7G2-7I[1UA5"EVI:RTK^Q&[=R7FDI8N7Y#F?G>J#B1]*6X2?PJ<%3Y MKE4BE!$)HV]&9S+A9!9;6OK(!:@$H!)\3H4":(()0:;V^P/!+'C&58S!3&<@ M$WTPFC<9C(;<;ZR9?E#FS1KRHTD*HZG1P*26:.ES90F=9]>,WRHJ" M.L&P^@;*'(/,<5?F4II*1JJ2&/FU$843QHR0;\+P)UV!&PHC%^R>O]!0`0-; MC#J07O%"4=B&W8FBRC_7BBU37J![,P34=PC]1^MD*[.,75"W4/I5C)MB% M,<*V0D%"?0?12_%HZXZ[IAJHN#+S(K;R65K9SBA"'QQ$[ZCG:'ZQA5!B):D. MK0OH#"+J.XS^$,GZ<`S(I>^`>/#D(:.)`> M[)=:">U!2@.'TN&F:=F#F`8.IBVZ'=Q;0LCL;I_%8>KRSBY%(9]I#CT+AIDA MNH&#;@]R/2XCMH&+K4M>CP;2&SCT]G-SRXMJLCY#/G,$.71`[M?9=SCJ(,>A MP_'P/H&%"A%E6G0ZZQ#*N^L04(@HT^)3.JV`D.7081EW'K8W6!`]ELL,>[0Z MIC4[&"TZ`1WNK4H4$T.20V?Z'M99<"-1!TD.'9*'>Y2*U,S">:MB#L[#0E2E M1BA$IFG1<6A8B*K4"$4(-2T^)41E>A="JB.'ZL%-&Z?&'&&,7*B'-G^&,,X1 MQLBA>G@>8M&BEI!#];`0%BU"K&G1\;IGL$*3H-6(=>1@W:,#`[IE42L@A^O] M[.J<3MY:%P/"*1TY6`\?4EH!M3)SL.[;,MXM@H"F2#4M.D[WZ?RRZ>YDNT$= MA'KJ0-VG\WX-=;#OIP[4[\\TIR_V/:7SL3"L>E5OFFR*S4&+;EX]VV&_/XCT MU$&ZYT#'EG$JDI*.Z_A>.T6`:$'QC.M@Z44YYEE,;_#51_4*7!=AO/__Q?G_ M````__\#`%!+`P04``8`"````"$`3+F?+=,%```)%@``&````'AL+W=OP,5S MIP+]&]3OXZK_YWQU+_^-C3[/YJNAFI# MGU0'GOO^FX)^V:LE>-BSGOX\=^#/P=G7A_+E//W5O_Y>-\?3!.V.U"-5?X9( M\-=I&S4#D'KY8_Y\;?;3:><&\7V4^(&0D>L\U^/TN5'/ND[U,DY]^Q^"A':% M3J1V`I_:B8!_W_EPH!^&S^7A]S+P,)NY"I_*J7QZ'/I7!T8+^(Z74@VJ>`#' M*OW`AS94ROA166<,+(^P^OTICAZ][U#/2D-RA"2NLT`D110V(HX7B`<\%C)0 MBQ69*PFU2DE$G`1"DKG6BGBQ6B`1(,6-"&H5\E[E$"<+P[D2.4+"%22DB.(M M!.$`3C8XJ-6="[R7.L8IC9`C))W[$`J?%:&@YBQ8GB;185@WHJM5%CU;GL<* M("2>HXLPDSZU%]0N;L6/-^.K51H_8?YSA%SC"\GK3^Q!X)OJD?QA4C?R5ZLL MOJ#YY0@)Y_Q3*SJQ)J9V)+9Z:9C-=IUOMU,0NXQ6 M=A(_VXRO5EE\YC]'",:7TC?I87AJEH8]B2Y`G#?2GY=9?-;;7&-T\_TP8,TI M""#+I-F^E`*5NVL'!$K4>O,E;'?E&H,4PB!CXUD0>^3?+()2)GL&U&N`-\&( M)&Y`C=%=\'W6I(+9A6RK(1P`K&Z83#2/M=Y)F0HS M]3.@T$YTNT0HC0?*85L1A2V)*9NY7&-0DR*?M:L@YB`TS:+QMQ51V)*8LEV7 M:PRF*&Q)IG89W&*PK8O"%L:4%3G7&,T@CDP$W82U,HHH-=-$:["MC,*6QI3M MNEQCL`?2[#D=?RV-,`-F5$E\N2V-\S*5QM1XP#G4&*P`'$99CPIJ#U?[B3+8 M5D9I*V/*@Y\$9H0V`@"2+/P MQF:42L!L<9R762/8;LLU1IR M.;./TA;.5:UUA1"#FY:I:J$=<"/E0$5SYI"L.-CBF7'IDHC!,%8UMHV4P[9L M2ELV5V=QG?]:%N.8;Z="^\!9CJ/(<*<,MF53VK*9L01SC=$;5J2^U06BG"*, MC/`2#O!K]:W],IOISLV8/N4:@YT0UFN4F.]NT=C6S\#6SXQKE\9@^#LF*P6Q MREO1J7+R+1K8"IJQ.+G&8$/NLE@8?4+%8(#U<8,VA$JHQ46964/,6QG',T`, M4%``!, M&0``&0```'AL+W=O76*383[]B,QFOV^*LHO3?%2EZ?>!&G+8]X#_^Y0 MG;LA6EU\)%R=M]]?SG=%4Y\AQ%-UK/H?.F@'CN/?U5[\`?;;0K M]_G+L?^S>?NUK)X//6RW5(\4S1$RP<^HKE0/P-+S=_W[K=KUATTL%C.Y3`3C M,HZ>RJ[_6JEGXZAXZ?JF_M>`&(8R03@&@=\8A,E9RN5R]7^B"(P"OXCKH^3R M8?X*E2T0L_4QC"*R`:$V!-)>FF]"'<2>DC%HL+A)"`10=( MJ%'8ZCBZ+)PMQ26`+L[68-(1)J6(;`I!2$"0``DUNHEA*1<2DMM5&!(&LS)[ MLY).I;+Q]$)(NP22'CHYD%Z-NNF7=(5;@UGH]'+YWX6X.!*E^VR.V!*00AH8X6 MJ\1!#6KT5B,:S!2)*00AL28DM!V(Y&(':I961/(UK?C68,9DI'"JEOD86S5" MAX&Q!XJBAUTBKC(09%I#C/=>*R>C\V)UC0)UR&%?F#$U*DY7'0A*C3S6PIG/ MZ/QJ<46>3+F9WQIZV*V"JP\$F2KP9.4*E,Y+?D6@3%E9@()QN'$5N.>3^EDX M5B9$,@FA'0%A0D34\"V=,`.:)#(%H42H:;I2@9>)VUI!T)B0'%DD]JF)-`9= M:]6PC;*0CWIJ&3LE2YA-@2S,O&GE]=JV$2U*V$F9;Z62.V+8(@C%PE:.L63. M_*C-*(6PCS)C@>-.E=P3R^"3ZDUGY;[I9!C#,%Q=.TP8]="+803,4]CSR)SF M^MD;4OFP>?*P>>KA6U)!4+CI3$=,0LB6<&JAKE3TM.MCSNYO$30F)(7U2Z1D M3'D,LGU,*84ME:MAEXHK%0092V6)M):)+$P0G.?,+H52"%LJ]RW5UPJ"4"MN M'V=TFEF"E`#4*6"E7`V[-7"5@J"A!MS;"1-DJ$%BGZ<4J(D.6E%?K1P*?&G+ M:+2"H/!FXTY\V#IYV#KU\$VM#-9X_240XX2YTHI0!_6T$G)2KS(&-,XFA14" MUL8'60BE%'94'G)43RMC1Q5+Q_,SC&'Z6"RO-6K847G`4;U3!4&HE(7M0ZS" MX*;*\>^DK22I`+P"AY2BAV\I!4&XQ,1F,`3H-+,'`B5`'730B0B\A`I[-.L, M6P2-N\%N-)+XL&^*L&_JX5LZ0=`D$6.=80BM"'5/5R3PNG@ M+`"RY:.4(%#`3X4:=KO$R;)%D.D2SMPV=:;M0BB!L)L*WTW]$P5!J!/F*=6= MMX9/*81]5!B+A-V]?$_VW[X09"BDU@NP1P>754I-;?UH>NJ>%YWXKKFV$5`F M4WZ(%*8@E$?8,H5Q0^C-2QD"UTJ#95J0;3@D,@6A1*AU>C()6:CM+JS,X)&6 MD/2^R@H?9%D32FG83/7P+9D@R+2(5[J,3H\NHRB!L)FF`3/UCA,$H4Q&=XIF M8^BTO.+F<+$=,@H][%;`<8(M@LR%'TO<`Y5.,U>EYC[<7`"?\^?R][Q]KDY= M="SWT)');`E6T9K;%R6_]Y@/]:E'`YG,P`O&^:?OB@KG&ULG-I;B&*E1L8`D,_]^NVU@Z$.'TYEYR"2'C]--?[[KZ>/*/Z1G((@ M54B&:])73VEZ>VPVD_TIN/A)([H%5[+D&,47/R5_QJ_-Y!8'_N&^TN7597B,97)$QV.X#ZQH_W8)KBE+$@=G/R7]3T[A+G0TBV@`Z[$@?'OOI=>]QIAMI\?KH/T+]A\)&4?E>2 M4_0QCL/#/+P&9+3)?J)[X"6*?E#J'&B(K-RLK&W?]\`Z5@[!T7\[IV[T,0G" MUU-*=K=)5]E'9](2^:E<0EH#9-/]G_?_/\)#>NJK[4[#[+;:FFZJRDN0I'9( MUU65_5N21I?_&-*R5"R)GB5IDVYFR\V&WC,UL_.%+$:6A;3[YUWIY-M#ARS; M(/W+&Z05P_)[D_Y@7,@>SD:WM$U&P]#-;N\KXZOE6Z63?N5;);V;FFR7WTO% M\E/_^2F./A0R_TBRY.;3V:P]DLRD*FCT.PWWU:ZJD/V>D.C[L]GN/37?2;GM M,S-@AOPLC,Z+855T.CRQJ@0D&54%3&)7"4@R%@B3[\FD2F`[3I6`=J95`9/, MJ@0DF:-B416PF665@&9650&3K*L$)-E4!4SB5HEAM/G!WU8-:,BK"MC0KDK* M#35)Q1=E3XY6Y;)7Z+'1,(ORIXMI^=-C)9T/`Q8@#12U;AB@AT,)8U6-V7[@ MQV(D86R!,5I\GK&$F4@81\),)<(5-+KI$A4W#7&&S0*FP8<#*`^7"!@4YDC!V;O)3RA@&)C#@Y(&:IJ<2 M9B8RH&;F$F8A898B`X9K)6'6$F8C8=S MHL)"Q0@5-BK&J)B@PD'%%!4S5,Q1L4#%$A4K5*Q1L4&%BXHM*CQ4[.H$5^GD MSKY%A8H1*FQ4C%$Q086#BBDJ M9JB8HV*!BB4J5JA8,Z&9[?NCGU:C!2X7-AAP,;#E`7D@]L#]ZXV^@9.%]^4U M=E]9@YL>]!&XX*D8#<-IT>4/\P-F>O>!TUKDD3?[QZLAKPRQLIBJF6(C5-BH M&*-B@@H'%5-4S%`Q1\4"%4LFLOVCZQW1[EFA:=;E-*9X]VW0+"XJMN5VNN+> M>FB679W@"O]!7/@TS!=^#SP%&3#2N=>]GHT(*/HRT0P]JWH>60S5U3PJ;%2, M43%!A8.**2IFJ)BC8H&*)2I63+"]I^F&<->LT32;0E"5R;/CDN72N!<.`P^AIWBB&4[F7%N?'&X7>)XE3E8X6>-D M@Q,7)UN<>#C9U1)^)M`W*(+K'OHJ%!S_30.\MAADJ*;,ASBQ,D)?Q;P_&[K> M!==7(SR'#7)TVN#698SGF.#$P8X&3)4Y6.%GC9(,3 M%R=;G'@XV=42OO+I2Q-1Y;.7*=R=L`F.<0.-H=K*1XF596'G@*[9$YT\1WA3 M=D'H#`)='=9%430R7FQ\--^+'"RQ,D* M)VN<;'#BXF2+$P\GNUK"5SQ]FR*J>/:6A:]X\)IVH#%46_$HL;(L6<4;PENQ M$=Z4C9,Q3B8X<3*27:9E5U?\_L[W,*VKHD/^^5N:CWA"6S&90+=G&<+29[BN3,X`2WJUE_BZZ]PLL;) M!BC-_\U6/CQ:WA-E'-P)*NV&EWR+BUFWY:R/]+H=O^J\"5*R:>B M]U]/Y!O@@'PUTFH0?(RB-/^#OCLMOBI^_A\``/__`P!02P,$%``&``@````A M`-YZK3?P!0``]R```!D```!X;"]W;W)K&ULE)K; MDJ(Z%(;O=]5^!XK[$5&P6ZMU:I23''?MVH=K&K&E1L0"NGOF[2UE*_[[C_'E412*,KR= MPFMVB[?BS[@0O^[^_./I/Q\3J)8RZ+7-+Z53"2/ MKV%)ZE]ZHZZ+\D?B\ZGX7BDKV;>7)RDUM,>IN,$QV!YRS[3M'CB89(9JF7VZA& MX*]<.,7G\/5:_IV]6W'RZ>\NQ=("8C-2_N(;6LO*'*=4_4S6G[A@Q11/%OE-^*#Z)` M6EV0Z-M.59=/TAOI[*AF]GU&YHE#0]`.I[(:"Y#WCJS"9]*;3!\,D#4:HI$U M&]DF8#6!3S6.#=%DL6'`@0$7!CP8\&$@Z`0D,A+M<"SXX6AZG89IKS>5VK,` M46G[:\'WUF&`4'E$ZR.K%8_H?0248PP0H!RSC\!RK#X"RCGV"2AB]Q$@XO0) M*.+V$44!!O?Z#"C([Q.PH*"/=`OB7+'D75$]I,MY^TS29,X=+-!UAZJ"03E, M8+0)C#[`*'/>1<8$QIS`6'U&4<`L<9S`V!,89P+C3F"\"8P_@0G&&0K>20.VAX*Y(5I1UY57GD)^$] M8QZK/9N\5.?LQ4,'!HU82$,)G2^H+@H8'3V MC!EQP`$E-)30^X2J/O!>-?H,6/!,E+!0XH@2-DHX*.&BA(<2/DH$8P3G$W)6 MT?5)LPVA8>@/,+7O&:-4,PA(.["T%5N$AF=LKG#LX2'Y\'(+LMIA/:^+@B(LC'H[X.!*,(KPSZ)E7QQGP($MF9V*\0\`& M=%]#71.H*MC%'@8@L(AH`TA/1Q^`@(Z!(R:.6#ARQ!$;1QP<<7'$PQ$?1X)1 MA'<./?X:ZL2NK"481W"AG!4:?0=+!A4>!/''+W2*$1,QQP1,,1'4<,'#%Q MQ,*1(X[8-2*K2[:[G\W!,^*@A(L2'B"4F;+F7H_Z%[!M\'\_"[U?IF/X_]K;K&!O&]O"%WH.0V#\1U M>4,N,4E<:A/(;?0]?(F],']);H5PC<^DJ/GL@1P9YNSBFGTILWMUF_N0> MNOIX(7\PB,EY_GQ&X'.6E&ULC%5= M;]L@%'V?M/^`>*\_XMAMHSA5DZK;I$V:IGT\$XQM5&,L($W[[WI+ M$KCGGGONN4#6=R^B0<],:2[;',=!A!%KJ2QX6^7XU\_'JQN,M"%M01K9LAR_ M,HWO-A\_K(]2/>F:,8.`H=4YKHWI5F&H:I.,5*X M)-&$BRC*0D%XBSW#2KV'0Y8EI^Q!TH-@K?$DBC7$@'Y=\TZ?V`1]#YT@ZNG0 M75$I.J#8\X:;5T>*D:"K+U4K%=DWT/=+O"3TQ.T6%_2"4R6U+$T`=*$7>MGS M;7@;`M-F77#HP-J.%"MS?!^O=AD.-VOGSV_.CGKT&^E:'C\I7GSE+0.S84QV M`'LIGRST2V&W(#F\R'YT`_BN4,%*)%BM&?:/'*;BQ$]:"/%'P^*>RI/LNA)$I#9QV'K M[>30"W$-/!!#-FLECP@.!932';%'+%X!8:^\+S_T`HY2B[ZW<)<$*C7L/F_2 M+%Z'SV`.[3%;C[G&:,#,$+L3PGH*.@8QT,9(S*FFW9W53&7QG!5,5VK&DT MHO+00DX,O,.N?VJV\-2X^QH.`7@!.E*Q;T15O-6H826D1L$U6*#\8^$71G;N MG.^E@;OO?M;PIC.X>%$`X%)*TE<"&T1,#6INDW:I&G:CV<3#%A-XL@VI?OO=_8E(78@ MVPL0W^>[S]^=+\?RPUM9!*],*BZJ54@F<1BP*A=;7NU7X<\?SS?W8:`TK;:T M$!5;A7^8"C^LW[];GH1\40?&=``>*K4*#UK7BRA2^8&55$U$S2JP[(0LJ89' MN8]4+1G=VDUE$=W&\3PJ*:]"]+"0_^-#['8\9T\B/Y:LTNA$LH)JX*\.O%:M MMS+_'W!^Y+G M4BBQTQ-P%R'1X9D?HH<(/*V76PXG,+('DNU6X2-99.0^C-9+*]`OSDZJ]SM0 M!W'Z*/GV"Z\8J`UY,AG8"/%BH)^W9@DV1X/=SS8#WV2P93MZ+/1WWC9,IT&SLL#2^.4(B]@!/5-/U4HI3`%4!H51-38V1!3ALF#?A MN[.`I+E!/QJXW00L%:R^KI/Y;!F]@CAY@TD1:%\'8W4I M)'.?`F(@5D?3UV$,X9"9CY(QUG\E!3%C9,80#ADH[1%EC-559AH_>,E!S,PF M)W9M6=]VSIM#P+PWO$O;*U%C]0@0+TB*&"3@E6]VV>80>'`(M&5I5OW`YQ/@ MW4`,!K[Q(U\Q.J$)=&?_\+.DNY_6[)/PXJ0-"%GX->D8SXES2;AMLQ6`8&,; MOY@-Z$IP](#&7M;X.\`@Y$MG@!X)X1N'\S0U?W!6/\%``#__P,` M4$L#!!0`!@`(````(0#%4WZ(=`,``)L+```9````>&PO=V]R:W-H965T@`DT%R6I6E7=K;0KK59[>7;`)%8! M(^PTW;_?\84X&*?-2PC#X8SGS!GCU=U;706OI..4->L03>(P($W."MKLUN'O M7T\W\S#@`C<%KEA#UN$_PL.[S>=/JR/K7OB>$!$`0\/7X5Z(=AE%/-^3&O,) M:TD#3TK6U5C`;;>+>-L17*B7ZBI*XO@VJC%M0LVP[*[A8&5)<_+(\D--&J%) M.E)A`>OG>]KRGJW.KZ&K_E482#,(?JZR1*TBEY!E-Q@'L88BX@@RRD5T)^E MZE/(J),BD9)O6G`(BG"!E=A[!. MFR*Q:]0I-&:N5%PLDIF?'_S@X9?1(7^2Q2<"S:\QJ>)'%U9_ZV6749?=%4AC M-'N:V@X-])\-Z)69IO')3/*IF\8526-,F@M9Y/9I+=O[2$:'[%DR=232F%LM M49Q.;9&#,A;>!#+J)K`RZQYHS!4V0K#9>(I0X8^\:D#79!E.=R\5TB/[OET- M2(LUCV?SDY8#K9`_OM*@?<;M7VBD:RN4?=.2;]%$_!J,^3Q<7Y/*/.AK/NL>]_;#+ MSZ+5UC'>=`U(?_C0/+/.UE+IXY4^E+1X1[[C;D<;'E2DA*]I/)G!>'3Z<*5O M!&O5@6'+!)R5U-\]'(()'%CB"8!+QD1_(X]OIV/UYC\```#__P,`4$L#!!0` M!@`(````(0"3BQ+1_0(``'H(```9````>&PO=V]R:W-H965T^)8[XA1UBFX#-F`8=GE6;#D6:EN&I#3MWX^2 M;,=6@J8O240>'AV2DIC-_6M5HA)8%I0H!0RUC7"C5K#U/I@6MB)SPAM;@R;FHB(*E M.'BR$91D)J@JO=#WYUY%6(TMPUI\A(/G.4OI(T^/%:V5)1&T)`KTRX(ULF.K MTH_0540\'YN[E%<-4.Q9R=2;(<6H2M??#C479%]"WJ_!E*0=MUE>2L/F+:;C$$&NNQ(T#S&#\%Z%_C8VVY,@?XR>I*#WT@6_/1% ML.P[JRE4&_JD.[#G_%E#OV7:!,'>1?23Z2O7$="Q&Z5$J7OVSH*"E MLB1A2Q*!S-8/IO>#/2O$)/!(%-EN!#\A.!6PE6R(/F/!&@A;Y>WV?2Y0TE2C M'S3L0NJ:@HQ<#:0S$='MJJ[/G M;$R87$+",6)W!7$F&8F`*@Q$F(I$?E\`[86N#9(+IVX!+&8ZP$P=->\A1F*` MY!TQVAMC2*VO]"QPMDHL9FEZ%42^(V3H79S;--(`)W.@H>N*MKI[GRMJ3DMB M,5.S=[1TRK3KO&?U9^TC`?.K`K35%3`?IY=8C!4PG2_'WEWGO2D`SO*5"FBK M*V`QWB*QF%9`N!I[=YWWI@`]*,ZWM&N!MKH"G!P3BVD%!&[[.^]-`:NK`K35 M%>#DF%A,=P;<:]EY;PJ`YWM8`O=:&K/0.&`@-.=`?1!Q8+5%) MWJ3#=IQ8X56.4Y["49<,5T(5>7X M]Z_5PR-&UE%5T$8KGN-W;O'3_/.GV5Z;C:TY=P@8E,UQ[5P[)<2RFDMJ>[KE M"DY*;21UL#45L:WAM`A.LB'])!D1287"D6%J[N'092D8?]%L*[ERD<3PACK0 M;VO1VB.;9/?026HVV_:!:=D"Q5HTPKT'4HPDF[Y62ANZ;B#OMW1(V9$[;*[H MI6!&6UVZ'M"1*/0ZYPF9$&":SPH!&?BR(\/+'#^GTV6&R7P6ZO-'\+T]^4>V MUOLO1A3?A.)0;&B3;\!:ZXV'OA;>!,[DRGL5&O##H(*7=-NXGWK_E8NJ=M#M M$(_I!B+!%TGA1P`RIV]AW8O"U3D>C'K9.!FD_0RC-;=N);PO1FQKG99_(RCU MT3N2_H$$U@-)"K]W.@\.SK!VSOP62!7MM2/Z?I%(A] M^N,,NL#\X;,_#1@P6[#NYEDRF9$=%)0=,(N(&6/48?KGB.4U8C3J(`2$=&J@ M&"=JCBJ\]4)%UOD'H8L(&8=B>^7+$\-9!,CQ@PC>FF/PZ7+(TN0B1,0,3S## M<\3R%N),!)!\(,);8:I.`F1I>AYB$3&W1-Q"G(F`J3T1$3H_2+K.^]/+BEST M=1$QCV$N!O\[&CH"=]837!U&"?$ZQD&4W%1\R9O&(J:W"CK0!\;.&E^!13J% M'L-5NK`OX74(=M(=P*5M:<6_4U,)95'#2Z!,>C#5R,3['3=.MV&HUMK!=0V_ M-3S#'*8GZ0&XU-H=-_X%Z1[V^3\```#__P,`4$L#!!0`!@`(````(0#"FFIZ ML0(``-4&```9````>&PO=V]R:W-H965TGAUCP"I@9#M-^_<[MA,"I%OU)8&9,V?. MS-A#=/O2U.B92<5%&^-@[F/$6BIRWI8Q_OWK87:#D=*DS4DM6A;C5Z;P;?+Y M4W04\DE5C&D$#*V*<:5UM_,\12O6$#47'6O!4PC9$`VOLO14)QG);5!3>PO? M7WL-X2UV##OY$0Y1%)RR>T$/#6NU(Y&L)AKTJXIWZLS6T(_0-40^';H9%4T' M%'M><_UJ23%JZ.ZQ;(4D^QKJ?@F6A)ZY[@YTGA-Z7?/6VWK` ME$0YAPI,VY%D18SO@EVVP5X2V?[\X>RH!L](5>+X1?+\&V\9-!O&9`:P%^+) M0!]S8X)@[RKZP0[@AT0Y*\BAUC_%\2OC9:5AVBL30D4-F>`7-=P<`:B-P/5]M_#!8K##:,Z4?N(G%B!Z4%LU?!PI.5(YD<2()0>;)#Z;W@STG MQ!9P3S1)(BF."`X%I%(=,4P-Q(1F) M@"X,1-B.A'[?`..%J0V*6_B37*G#+`>8Y5AO]AYB)`9(!F+.'3'6&$-)?8<7 MFW&&U$%N[(C"]=B9#9TW_VD#G,H&SD#?O0 M4=7K-W,;ZR1W,#E9J<.XW!-?-O3-+LY19CBU@ZJGPS?>L8)P6KR#N+[/@NG< M1]Z+TTEPZ\7=SH;)DF6LKA6BXM#:G9!$O=5MM12VFET-7N^`9=.1DGTGLN2M M0C4K(-2?;Z#KTNTE]Z)%9Z_47FA8,_:Q@L\'@SONSP%<"*'/+^:6]A^DY!\` M``#__P,`4$L#!!0`!@`(````(0`9>&BD^P(``!8)```9````>&PO=V]R:W-H M965TQ4%\OB#FN=)"%EM"QP'Q>!') M6!2'+?G]ZVFT))XVK(A9)@N^)>],!0Z"U)C2G7OJ^C ME.=,CV7)"X@D4N7,P*LZ^+I4G,5N4I[YDR"8^SD3!4&&M1K"(9-$1/Q11L>< M%P9)%,^8@?7K5)3ZS)9'0^ARIEZ.Y2B2>0D4>Y$)\^Y(B9='Z^=#(17;9^#[ MCKA]H2/S= MQB7HC^`GW?COZ52>OB@1?Q,%AVS#/MD=V$OY8J'/L1V"R7YO]I/;@1_*BWG" MCIGY*4]?N3BD!K;;Z44R`R7X]7)A:P"LLS?W/(G8I%LRG8_#13"EDY!X>Z[- MD[!SB1<=M9'Y7P11JUZ33"H2>%8D-!S/)N%B.8#%QQ4Y)X_,L-U&R9,'Y0&: MNF2VV.@:F*V%:0"IC&SPWD8=!H8UC+[N9JOIQG^%I$05YJ&/H37"!Y5:"N@; M4F<).]J6",-ZOEO%0Q\RJ1$MA>E5!3L*KHC7,#&K"5`",;,FID:T)`!RQ80= MW1)89T.BZP(Q2Y?%<'G#`91#@]YMQRRLM\-&NS+S>IWH!#$SW*S)HHZV7,P_ ME+'1KLR%"&40@S(C&BZOZRSZ.HWJLM&NSH4(=1!3V;DN8H_3VR5LHUV154V$ M(HA!$3J_4;ZK#V5LM"T3!D%'!C$#BHS"4=2P=&X5-_R_2JY`0U3:O5^K8$,W MBSD,+CG!C%$$8?>WAH7[B;MTAB5$G;_$#_7VY\.Z?\*-$0%,%U/ MC1:E-MSUU#LR$51E[Y+;5H_"3=(3:C2/"W>%NL=:!<)#9T0O38Q*>+/A?5"R M`__.U$$4VLMX`@=9,%[`$A3>:_AB9.G.ZKTT<$VYORE\?W"X*X(Q@!,IS?G% MWISU%\WN'P```/__`P!02P,$%``&``@````A`!%Y@/=9`@``6P4``!D```!X M;"]W;W)K&ULC%1=;^(P$'P_Z?Z#Y??B!$BYHB15 M2]6[2E?I=+J/9^,XB45L1[8I]-_?VH8O?5B.J[4!ROR"UAKO?'0I\J'()E<9#^&!?PPJ.(U MW7;NI]Y]XZ)I'6P[\RE,=U`)?I$4W@+0.=V'_YVH7%O@V?4D6R2S=)IAM.;6 M/0J?BQ';6J?EWPA*#U219'H@F8',PSV$WD\F44AHX($Z6N9&[Q"8`DK9GGJ+ MI4L@/"@_E!]Z@8DRC[[S\)`$*BU$7\HLR7+R`L-A!\Q]Q"PP&C#I.6)U1/B9 M@HY!#+1Q(N98TT='-<8W[B)F? M8$:(U7N(,Q%`#5OPMP6&EH8)9\GU2$S$S,..QL,XO9L->5%`-'GT MB.2FX2O>=18QO57!F64^1..[=0_O5C`H&2[`\CUM^#,UC5`6=;R&U&2R`(^; M^';$@]-]6.Q:.S![>&SA(\;!:\ZO,K%KJ@.:_>?OY\? M%J[3M%FURTZBXFOW)V_<;YM??UE=1/W:'#EO'?!0-6OWV+;GI>Z/LSK\R*RI4>EO57?(C]OLCY5N1O):]: MZ:3FIZP%_LVQ.#?:6YE_Q5V9U:]OYX=\T1W'YK2YV/XJ*0[:A3EB!%R%>$?I]AR(P]@;6SUT% M_JR='=]G;Z?V+W'YG1>'8POEGJ))+DZP$OQUR@)[`$+//KKGI=BUQ[4;S2;3 MN1\%X=1U7GC3/A=HZSKY6].*\C\)"I0KZ2143N"IG`2/HP:1,H"G,IA-%M-I M/%O,8=61E6)E",^OK03NNOC@^:65/)F?+J_;K,TVJUI<'&A6R$!SSK#U@R4X M4PE57$V*H=(YHI\0WAE!\AJ0OF^F_GSEO4/-MZM5=\U!*:D4]H2DS< MT7P@RZ9::1*I!=CFQ!/3.IK"V2A'U%*.I/\2B9$UUK#4`F3Y0-!,*RE)G-K7LTFW(TIMUUHP6G)P;KP:UNA%'08T>[$;7VW@XC0B21&.AVL[%(9E*- M,'G4@D]-F$;09`8P;'M\=38[L9W.*4VGPLABA]'@-$?/:[>74-L@)#W,C'K` M$8_]8<4#.0W@U#*)"B.2JD2!QK)I(":=1G+U3/PR`QF0Q4/_!EDY"ZSC,B+S M(@DD2&64]*=17FF.P%D?;C5H@,?\#8+R]+<)SFP.26>+-<4-2_HA-&4!!+SV+5`,)F3T9(J/6[F:URD$%OB9$$687>M]K^%N*C,B8]%BB,*-;IS?PU(\)+>GUI7V\,>,7]IO% M.;2GI/P]9&V=#F$/S,'641A=B@5ICE3IQTM!G9#;SK:,`=^*B7DBCLCM>[,"`,.TQ^Z@+$4'J1;>.PNAZS:Y2\/O"4GTZ- MDXNW"E;#L6>D\IXJ@7NJ+HE4'B[A]S_X)?)M"/=:-^1/802*Z(8&(M9789YQ M!C=4Y^S`_\CJ0U$USHGO@9X_P&ULC%A=KZ)($'W?9/\#X7W$ M1E$TZF1@O'=>-X6HMCZ;3'V/5[DX%-5IZ__S]\NGV/>:-JL.V454?.O_X(W_>??K M+YN;J%^;,^>M!Q&J9NN?V_:Z#H(F/_,R:R;BRBO8.8JZS%KX6I^"YEKS[*`N M*B]!.)TN@C(K*A\CK.MG8HCCLCJU^4`G_6WH$?L[=+^Y>X_HC@1#C(N%"$!+RMM'/ M:D="KIJ5,,Z9("96$SQ?&'5*?[9+DJ](J?G28,+0]MVX+1A:(*70>R!:F`8Y:X%Q[!!*1-J=A0BZH-O&&(+L67!6G1!*!,(,B)A. MQN2VV:Q+PSLT:$@H6AJWOM0"ZD6FE"SF.A@?>&@84S+Z(=&@(:4^FZ[1T^[* MJ+W>&Q<=\8%8+MO41%P06AF[M3)T1=J^QG$3#4)?,Q],4K*[ZEN?IK>;*K.X M:FS>>S5(WI3>=W.V8N:]3@/LBE$:%GM=#)[#+/X:]WZ@A]EEGUH6%X00"NT. MJY8?.:P&V8^-1)P02H0ZK#G,H<5I8T.'1(.T4.%T9312J@%VQI2.M,/>Y!2= M@5`ANB5IV]BXWR8:9,^FZX-Q[!!*2#IG3Z@;Y!`-U3W(&F3/HHE@'#N$$@', M@,A(*+EMN.Y8*`1U$Q5'1H^G(0+@\WYC[;6D="R..Q3*XKAQ'TH=/I$_SH"S M/9NNCPM""=D=-WS&<37(2>1IQPVIXXZ$LCCO6"@$::%FJW`D%`+LC&E=J`./ M)LKFQ.:C98@@>S8ME`M""5$OOD\4>N>#B7(9K";B@A`B\$/<-5%J^]%$:5!G M?2PV2B??C_R\QY$.OO_`UP;7[,2_9_6IJ!KOPH\PA=/)$F:@QK)FA_CW#6RH.KQ2F$P`?A6B[+_*EP/V]U^Y_````__\#`%!+`P04``8` M"````"$`K*[J5B4%``#[%0``&0```'AL+W=O69)DZ".N`(Z,[,WV_9 M92Y5$'=>.AW7H>JX?'P9"BJK7^NZ^LZ"*KT+/.DFJBK M+"!R5&6>U/"U/`75M93)P3R47X)P.IT'>9(5/F98EX_D4,=CELJO*GW+95%C MDE)>DAKX5^?L6C79\O21='E2OKY=/Z4JOT**E^R2U3]-4M_+T_6W4Z'*Y.4" M\_XAGI*TR6V^#-+G65JJ2AWK":0+D.APSJM@%4"FW>:0P0QTV[U2'K?^%[&. MHYD?[#:F0?]F\E;U_O>JL[K]5F:'/[)"0K=AG?0*O"CUJJ'?#GH('@X&3S^; M%?BS]`[RF+Q=ZK_4[7>9GIEZH+5(*_7IYI#<#4DQ_F\Y8=ZO/6C^:3 MV6(:B7#F>R^RJI\S_:SOI6]5K?+_$"1T]39):)/`ITTBX-\''X[LP_#9/OPH M@P!G8[KP-:F3W:94-P^D!7RK:Z*%*M:06$__:0;+D.K@%QTU&!BN8/1]-UO. M-\$[-#2UF#UB%K[78D**B(>(>9(P3F3@(ZR@BLIHP` M8IZ00"@]XNT%%&81$Q"HAQ+8@+0TDH"##S7B,X!Q-F)`;* ML"!DP603WPE2$B,&.>\,0Z"W$<=8=?,Q"MQ;D&M=G!!*2#O;4![Z'/E0'Q;D M)()YQB&4B+:YCLA@>=`%26<&&A&-5>JCA5L'"=[9N`*(NDCH\(<:0=`=C8P' M:2>HA38[%GY&#(NS2>XM"(O/NUFB=]V+TO(C!MIS+S'FH-R^+`@FVYY\`RZ- MD8Y!*"%JIVT_T`'=!YMPV:1MB@M"B5`K'4@4W?`#B3:6J24JV.^.6/2C8>=R ME(;;3,6(FPZ-K.^8`R,;#Q(2(7739E',,-\A7*06A"*-5LSIX[MA2L#MI.&8 MDS(-[BW()5,GA!+25M<96-L1=$"W3$,$.8FX()2(=L&.")=IB"8)Z=J].1LX MJ07A$K'UB^\$*0EM=`X2.LQUPG2X#Q$T[J1W@I3$N)/J-ZQ!<3;)O05A<;%@ MTHE).)QU&YD2&/'2WG$?CGEIEPJ/>PMR:N-A+PW'O=0,?_1ST(*<1![VTM#M MI2;,]#$4:=\MF7ABFX&+ARZ/VTG#1YS4@NQ.X6\+)"JZ8Y+0@#?&_EYIG,,, MLQZL6(&]!R[]KP MEBF7Y4G&\G*IO%2]%7"`A2#\=A3O^/9B#1FZP7`P``)@H``!D```!X M;"]W;W)K&ULE)9=;YLP%(;O)^T_(-\W0`+D0TFJ M)JA;I4V:IGU<.V""5<#(=IKVW^_8#@23E'2Y2(+/XY?W'!]LEO>O9>&\$"XH MJU;('WG((57"4EKM5^CWK\>[&7*$Q%6*"U:1%7HC`MVO/W]:'AE_%CDAT@&% M2JQ0+F6]<%V1Y*3$8L1J4D$D8[S$$B[YWA4U)SC5D\K"'7M>Y):85L@H+/A' M-%B6T83$+#F4I))&A),"2_`OJD+](>2H^C\=T3.CE\X3;_1BD"U89W4"NP8>U;H4ZJ&8+)[ M,?M1K\`/[J0DPX="_F3'KX3NI4?P&"*O^)!^N0J."#BFH&A@6, MOJS#^6SIOD!%DQ.SN63&-K&])*+(1N)+9!RVB`M>6\.0:M]P$+:&510R0$YK M.)A-6R&=U,8PD.R9L8GM32(>(BR[8*5CMZFK&ETA$&DMA$'?IF%FNNJ^!_N" M^?2LVE1PG8H-=3UERRX@';O]=E#1GNWYW#:T,4R@;7MV;-O$SFD'-A$WA&JU M\VS+(CQN?8N=!E!1VV+DG85,`Q@&;M56OV=C>Y.(APC+;C1H5T5O]:MAANS> M).(APK([O;3;V0]4M%]=WU["C6$BW0"3=QIRVX7&\W>ZUD#7$[=,J].XMXEU M6D)%^Z9[6]3&,-=OI9MF>Y.(APC+[GS0KHK>:@G##-F]2<1#A&47SM]N>9L] M3`_WZSKI-<,):G:QZ?65WO:PV75,O0FHVES/VW@V)[TYXFJ\)]\QW]-*.`7) MX&GW1E-X<+DYY\V%9+4^X79,PK&M_^;P/D;@^/-&`&>,R>9"O4FT;WCK?P`` M`/__`P!02P,$%``&``@````A`/MBI6V4!@``IQL``!,```!X;"]T:&5M92]T M:&5M93$N>&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3 MHD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%= MW_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\ MHYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)< MF+%#OEP:TKR0]`5-5-O[,,&0$0MZKYY__^KY4_3J^9/CA\^.'_YT_.C1\<,? M+2UGX2Z.@^+"E]]^]N?7'Z,_GG[S\O$7Y7A9Q/_ZPR>__/QY.1`R:"'1BR^? M_/;LR8NO/OW]N\*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T M0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0 M."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]> M)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H M'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U M9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#?7O,T MD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT M&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLU MUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^ MI+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!\*])`79T74LF M$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TS MY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@ MG^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL_CZG ML?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]6QEMNX\85_E^@[T`P:=$`M2GJ M8EL;R\5::[8+I-L@NT4+)$%!293-+"\J225VBO[I\_2I^B0]P^L9\3)#J7$U6QO*V_L[W'E?KG#\;% MC:J$D>GM3,?WK)7Z8H7J[^Y^^8O;,'IQK/=/EA4I8,(+5^I3%!U>:5JX?;)< M,[ST#Y8'[^S]P#4C>!H\:N$AL,Q=2`YR'6TZF5QIKFE[:F+AE;OE,>*:PV8TOWCYZ?F!N'(#ZK,_-;68[?E(R[]K;P`_]?70) MYC1_O[>W5AGE4EMJ8.GNUCNZAAN%RM8_>M%*G>6WWUB[[[_[3?F][[Y0M6P89!-BT&SS MW>Y]KZ!YI@//Y)6[V_!GY4?3`9WJY/-;W_$#)0*Y`='Q*Y[I6LDGUJ9C;P*; M?&QONK;SDKP\)2_$"DT_Y]J@EWCP9(1QQ]D0-)E/-P0&Y=.,O()]*S1.\+A9J88!Q4R?3`BM M.&`##;9<3V"\T0:[6HSFVAO[1DT]<0$H*O0'V[5"Y9WUD_*-[YH>`8FGUOC3&NX,*/DSS;_U MGJS`CGVGK%!:ZVPEIU.HA7P^*R=8:[:J$#;8KZ,+DWY-8M04TCHC&99RFW6B MB3H#.&C+OB@ZNX&Y$.)*!R.QED-(%=MQ\M70C"R'R"MWM[`PBZS`,^")DC[^ M\'*`)MV#-21A3DL^Q_CT8V"^Z-.X5>4[(/0=>T=0/*[CI4$JM?75@[%^B,=% MR'A1U!@UC/7U`$8?[I=K\4C7RUBPFD#WIP;\"4;Z>D'^!!LUX']K89RFT]5< M%,C*A1$3(DI?FBFPPR_L1!J/V$!*\R1!#C9!K=DXZ_/GU M?'(]7TRODD64H*%=:V(<+'XF0!KX_H"#X?T0&'V$U*E*KHS)G7^$,^BG M`3:,F\DDV1'E':?9(`)>H9AJ$.B8,I_,0RH891[3UE>H+Z7&=^ M61)ACY$V7=##;2W'>4^ZJK_N\T8.]BOO;I_WZ.HEN*2,G$$C%T>1AW!2('V8 M-&W)$_"G[J!I[4&*>3@X+^^.[L8*C/@ZLWB(^%5R\J%X=A]WF\7S^!RE:\4[ MKFIBYNO`CZQM%%\'%Y]0J\,SJ\&CIX9X\/09?UXS/O#$S4>?\6%'KS*(P(O4 M\4%,/-234F,Q+:L@!O:PKOS!^@Y<&57Y[T8SJ+0B] MH!F>-`#H-61=B9558E#8(=,*"N!)`P4&S+IBICR]KN9+(P057*#Z.:,;6*!BG*NZE,&O%>.;-HXF0FUS:US&0DE"'0 MG2M3\35=W:F"W.X_W8F+W`AP%/+-MV06ATM%M*8EA-S\'W)JZI!?=7#(&:.F M[+]/3U0-G?^B9RDLZD[EL@[0((1U0HA*II#$ZUHCJ<&%T=,5S1"S!Q93A]Q# M@:+1Z3`/-R4?/?4.F8IH]=VB4:C>`Z"[?]J'VE40IIAW4N0"7>:X/>I.S/-Z M00I-NJ)O07TGDL7D5)G1)C#W&3??Z+0QR47Y35@MS M1(R$1X#;97)#*AY%)ZW(A%2JKIYPE6U3Z#NIMN^>.4T?HPK0XI1>$QC]-(VV M$[O,FL`Z^]90".!ZYR8U"$/?2KOUB34\7+&%8!B\7)XQJ>A8Z04LUNH*Q MY@)AZ)G3?LU%`"RX/%IT M%J(.T"#S5A>$J"#!PTW\'1#RJP)E@-SE74C$RN/3XN9&TS>$Y"WQX9-!E*#@B9"5J1!U,P>FKC"&H\:4>&"D"K*E:+[GP62L!3 MWL77%[7A5Z4]ET3@1E$.=%%7'[4*-F*/0L-0(O?\6[SQ]L4`5L;H=WE_T)B#&XD,84_,PR=U`;#TXY[YS--N\AZGRQ"/>Z#: MQ`.T70]"`66M>#I-0$+7Q``WJUWC2`-W3ZS]7MPQT>A8K0?=W/6@N2M<2@;P MI&G[EVLB*,^E;=BCX`RH2B9=7+MSW1IB`3'ON82C6!XFZ'G97\2W5RVU=C7\ M-B,;;+G1DT\ZYQF$TN'OF%,YO=>MZ*6!EB]>XR&8QM^I9/6DNUDD'7:7^6>J M&C4#HGP5BKJM$[J'WZ=C.E)9BTD9R^"3AU5K:'B=GAJJI5(K9V;!U:_.X7>L M]2MR\B^]<&),+N*[#\#]!M#=6^E[M^9W)U`\T[56ZG3R*^5">;TE:X1<6.0W M-C='VXELCUP?0-976_@E9]^]3UY,?^J_R1;(-PGT%$HTM@4+G+:VP$)J"RX- MQ+8@U&UMY>NK&7B+;,&-;5O;RB_`GL$C;`M.";3%!81SG-/<+3NZO*N-(:Y7Z3LPYZP3VL8@CS?V"D_O3BDHKGEP;PN-=8J6('3Q"')&^@-]* M$35:Y3-.E2=8BGC1^IYSZCNQ4D0*["&/YO`&OT=YC&8TNW-.=N_-759U:<%, M.2E9F\[VZ)CDKN*9(;+81`Z1$TD\#JV?K.U'90UW7,\-T?E`IE$>0P_/!\?T MS,@/7A1R5Y[<'!WT!:>YW_M^SA%M80I/>0#]P3)WMO>H`"_I)$X11+Z5T\9, MG@LT/>0[N&W,P-$)&EI_Y&Z*;2^^L8Q28N?[HE)IR$O/.#]S"!ETB)F2->=HSOO,C*R.1 M+"11[I#U!`_P/QTC1",Y"ADA-Q/A,?+!CIP""&6"P.(RX<.=LG)?3BH*IXV_ MF(%'LH5*W1.-UGA4W'@,NO_=\S[O^V/>(W/C6.^C%\="KRL[:V\>G>A#_N9* M+1[_T=K91Q?$E'[J:_M'/XI-K-3B\5?VXU,$60RQA7+S51C%_RK'P%ZI_WBX MOUZ^>3"F%S>3^YN+^^>M;G*_4I MB@ZO-"WWMK:>$A@*(2/EE6Y#K:=#)9:DO- M-6V/W%I-G[\*'?A4D#J;@G]?O+92T9,$?KS[`?#AW@.9$UI(R'I/!KG[+P`` M`/__`P!02P,$%``&``@````A`'W*0%,;6@``1U,!`!0```!X;"]S:&%R9613 M=')I;F=S+GAM;.R=V6X<5YKG[P>8=P@(K#$-4#0W;54N-FA*LM5>I))871@4 MYB*8&2333F:R,C(EL:X*@WF!!N:F@1G`Z.MY"L^;^$GF]_^^5\WPRS,?32?'[>Y=%>>\?]O_S?_J\+.<9WT[*W]\[F\\O?OO99^7@ MK#C/R\WI13'AR?L]+/R8E;DP_*L*.;GX\]VMK8>?G:>CR;WLL%T M,9G__M[.HVWF64Q&?UD4A_[3P[V']_8_+T?[G\_WGTX'B_-B,L]81_9L,A_- M+[,7$Y^`=6?Q^>>?S?<__TS?^'>[V;?3R?RLY)MA,6P^_4?SXX+N>S?##_;\TO/VG^$!;\NC@=Z1.V\5U^7C3?^N3;PZ^? MO7GS\KOL\.7K5\VG88Q#@##+QVQ^6+S/OBXNF^]]LL7_/=EY]/#!;O/1X6(V MX_/L^:@<,,1_+?*9X)(]S>?MQ=R_O[5[?W>[.498QO/1N)AEAWQX.IVUU_!- M/CLMLH/!H.`U7AHR)W\U!ZM`?'1YT5[!]M;]/_1^\:J8C:9"A>[E5R.G>WT. M$I7-$3_A[!\T?VQ^'F;K'N`/+2`=@*I#0]?GX_RT.?@G)_FX;&TWGN_T_!Q\ M?C.?#G[8R-Z3+)O1^.Q7MG(BO>#XF*>L6E?0,:8^0;$.2[* M,IO.SXK9NU%99.5%,1B=C*ZFJQ86OH"YG!?L,*PPZR>DU\7;8K(H6F=V.(7U M3$^R-SDK:F[ER]F45;Z:34]&\^:S`(C):?;L/3RJ;'_]S6@^.C5898<`_[3] MQM%T#O%C MR0($B2O387]1P"&+,$=VE+]O[R8,PK-?/$US7=\(_K:J(8S&%P9^3BLDW,@F MA9W?/'_?_!@XA/7V/\D.YO/9Z'@QSX_'13:?9M]-@2)\<0H&`X$(N!9J:/"1 MHU_>&.+;P=<@]W32G/59/ILP)H2C;7UJ1'$8:%3$N;R6HVD6!\K6GX[&"UA? MB]:2LZIATISWS]LML?*T&YK-+PT_FS_>8AM?Y.5HT-K$T]';$8QG6&9/B\$8 M0`Q;H&FNX4_%Z/1,LN``;2-'/J1P;)U5@%YS$%M-\\?#8C;/1Q-TB?,+L,(Y MW7E^FJ#+(E>=>;;?(9BO]VMV$P5``IV$HN_$*_K5"^^G$Z'[SBEYFQ(SWQR.I)H=0AU M?NV,IAN$OM[N9W$7WXSRX]$89:NMDCR=Y2<Y?5USZ!7/*Y@33L8A/ M??IA<=Q2X!Q&[&&V8/8K1EX^X"M`\XWF.])VG_;.)V4H&'I7C`2S.!^Y(#1( MNU)R"K)DR5?9^G?3>9%M[[08]B<__?C3CTU(1N:"E)P!)1<<9LJ<3<=#7`R? M9,_`R?EE\T-H(9Q1Z8;/VM;FUC:G/LN@O@7Z\?;65E:Z-90OYAR[9`6,>1I_ M'96EH#R%<5UE+9EUU3?)XZY)8&$9CH*B1,\@D7<1[4YS"]&V!W--Q%=B$OV'16\Y@O8X(OSA0NU M:Y6#YL?V0?/'(R1UN9A=NFT([V.#,L@XHP`TUXV._BRE`S&C[GKJ7;E8#^PS$.&UR^Y\O7O-%6HNC=W< M6<^)56JWN4Q,#7B.SMFK8]3V_<%@CC74)X MF$UE2Z%T7F;K"[ER1A/T7C>79;-4P_^VN96GQ05CCH*&+H%Y+N'T5_NA_7+@ MLH_PMTB!PK=P-`R\@2$$M7,;(KFT]:YGE1GUG^NSTY.Y#H!^/B#C5PSN?(S_QNH!L.\ M"\.Z%K`^+`92'8I/M5O[2^3?BZ7-,0[[##/I&L>$5B9RU&F][H^XT?>`NO_+ M-UB\^+D'LJO0IQ2=TDRO\+8/.NR7CE=Z?=PS@EL*HOVVO,@'!-=@YV4Q>UO< MVY>CRU`705^B.AA+_VWFN^(S_?\K_JO\JU1D`G=;]S[;_WPP'0M9",,QV+9^ MF3W',^JOO)C@<1[-]>MG]FW/U/(%(*B"6L-?=5PA(`Z*:1G]][;(3JUM_>>_ M_:_X8./GO_UOK2OC-TCH(I]%7HL3)KRSBPK1_@/4/X1C1/`C;X4 MO!`V1-\B\O$X>P>!C"_O3]])*2X7Q^5H.,)=):<1HY_GWV,YS"]__ML_^QM, MS_[,<\S[`UL8+V]F?RHR]+1I5LC^$-I/%U@6C#HKST87&_X5Q+,`%/6Z*W>& M,)M#,Z5`PGY8R$A%4\]&)]K#92:6_I:5F0\[?E=_(]C]TXMG)7#Y%/9PDKTK MLK,\163(8B)R%13:DF"]B27O+`5%N_G/!:6^[MQ3C9[=`:*Q:V*E]GJ MSG#7CB\-*&-BC1H2T3\=LXCO%\-3\6;[4?,@,(Q3("P(^09HHTHLSB_<&WL, MX7.ZDRQ_FW.T\BZ<$0SE-!2*'"6A7#^G"0YBS?#SW_ZEK*;#UD!SA,:9 MX+X_J0`,]*:&$UW(N$D(0JJ`BR].YWB!OU3!L^1[4'7$7,PR1!F+0ZA5>!(X%'(44SLH` MG02,5GAJD)'/B_"Z*W>.W,`54@R.#UG!"[I4-(\!S/L'RY*2.Y,ZR[[] MH/P=TTL$&2C!"2TXF(/\M)F.W;U7.C".BP(R&L,,P.-B:(BJ,UF9,QG%V"@P MU@LV;:O2QF=#@R%_CT,GPAA"E@)@(4\5#_5J?QQPDZ[=`C MF,;]B/<*CS,1[9<'!Z]$M`94H['1>7($+$,:.E-%$ITM-)O^-2M.9:D;`1J9 M,M7FF\WL38%#QUF)7GL6Q3%\]!PMA_=MYC?/#FUBWMG00>)3P5N[$=$KKCQWU;9P0 M"RECU*2>VA#/8BB;LAQ,I(2E*(@U'+%6V)WBO'PD3AWV5BU99.42ZF(T`1_L M_(W`3=)J@L4D1\$4WMZ$@%*D<7P`7&"CQ7W2D-`$;WA9BHF*F>0PYY%X1JVZ M"'#BSS6H+J9NS&TP9+D8.^"#G64R"/B9=JC0#Z8#XPIFD:9M><<9(8!)$*/JS1^"JE:W9Z_/M[SY\K_6;+=+%$\SH:G4-0WQ7O MLM=3L%4:V$F.BG,9=+=$)=N7K_&G'Y>SDC3OW>E[)@TD@>(A:F$C`J8#F!'2 M/J!\/"6C'R'F,9A(@&\@I(J`DX!#MEP6BL``9[`U'EA]\@E18]@MQHJW@02Y M<1C0\_O%Q&PJ)W(=>NXL)Z)PUU`(M5HWCY+.**]^6SQ.3@>+:-EL0LD#'_RU ML6;I*,_A,7B<[W]=;>O$4Z:T+63X!\&)MC:^;TYESGXI<'7'9P_YO!U-%R5' M?H)G*GA]!'/DB8#Q+2>]O>>A-),S2I9;AIG$3J0^EELS^_T8F4>N0KY.LA6? MK:4S/`4_4VG)1%)R`I_7GUJ)&`Z(%;\/%&^2LA4W!.G)F)<+" M)]D!"QIG[J[F/.VWZ-+?1,`CDOF-N3W327B#4)7HM$B%5*U2J\L5H\"GB]R> M&=)+,^*M\R*73MZ[E-:RY;^:S#F$@^'4=(V#&IGQ:\@*&GA"UZI,[M#]_B+@ MHR2.G[@D/[0UN8\0TIX[X\BF3^=AP) MWNF>XJ!(3">@B&U4*O08JU(+U-X(VLY'IJY53\8DTRH?,$`B%UE525+&E5$D M?#,5=&S#^:K0T:X/,).QM$BRZ=LI],`B(949+G!2"3-3@?UXA"_7@V$9"(`? MO<"@6!*;#^>S;+8DIV7R"L.D>;35D0DI`XS``5YLGN&0,+WD8S#`9>%BN(^S M(KC(7/>J]:I:X-22+E#\,GNLJ%Z^0GAO+]&3XC8G81?_DU-0FPGL+Z6'O?3H M`6I4<$O>L12!\IVE2CC(3&]0P3LT9SED@Z906T'05D^6H(GNU![Q5]$:<4^-US!N&`C40MD;CTZP\]#-NW/L;"V` M%,NC_.G',K&\15(A\3(X1U@#YH5TU_I1HL::Q2FL[YY*6P&8>8@`!T6^M:]( M:O$]D#$%E9AF]_ANTTS01)OO2^$C#@4L8#$5BO.6`6K)U0TOPX0:NMOBG$0< M8VY#,J9JOIOW+*#WK"`\IR>Q>&U@(=U^JB1C::$LB@,'$!9J@`7T29J'FH%P M.!^8N!%E,[:?'F+07%V/Y:B%*:5&B\'PB?RQ#!P!I5AZ9P>`+ ME,Y*0B8TY^XU!D?FE22FB^=S[B`31A=:QO1X').[CX/S22%1[=`V-450(>N% M=CA6&/>4'"D3L/CD1PR@=8$WOF&3G$QKIKJ31,@W=8XC_""N&])@^-0=?L+; MH%NX]63;93_VHS1P(;]16&/ZS0@#/X<@SX6J]K:VD"MWDGR/N7Q8/7L7)Q9X MIYAWS,;"BAQ'9`^@:C<8:)^#"?)00:%2.+PD*"L+S[M&IP9&>'I'I;OJ6F+` M7.J5GI`P+UBPU"T?6IA@/#G\.^%4/>-V\8[5N,7C7JP5A(+;H4`WE`=F`>+- M"E2HR)1J#L.1G5,SI6J(GEJ-;\_V7&-/%\6R!8^BG'Q^Z$1D\ZZZ^>I@B"8:+`A\]VGSX&_TA6N$_XK=5 M!8R)`7#17-"F"!RB5>,%S0Z^-/LT_#/Z0BL+`/K`.3ZWS,9CG,A+WXKF3$HO M4RUK6-O;?)"1JZCBF$9L75%W^937M4Y\OTD8WDWB/\HDT<-D@VA'\03\&O#M`DK45@DF!5 M/$M#IA,+T^5XM`*&!L"ERCUZP`$Y+29[SDS+DPI@.L3)PFP\..UB3JJG"9(< M9H&#$:MG2@+'UREF1C^=G`ZQ7W@XAJ128/!\&?Z*Q7G27 M-_/%?'Z*YV`C^Q*M$E^%C801Y?Y/-LM;N%DLV.SA2ZMA,&1Z-YV-0S`DP:OD M#.668V4@.(`]'4\Y?<(9T]-9?D',2>Z^_'#7=+B]>,;@I2!]'!J MD*0#BUK>=`70F<,(<6G0,X+J`5]0V%JPRFPS[P!^PR72KRD]ER,\:&-2]34:`\,-R]CPYI>86F]E30E-! M;^[W^PB]Y*R`V\LP%)VA>#DX%9.-C!3];S9];R%D^,]*._M0(-W^NX"GVZ(:G$*\'3$)K8GE4IJ# M6AN4](8$-SIT:553HSG-5EKKAT*>O9V-G=W'*TUY6_#T4^+!*GGJ4)MGOBR3 M&@+]R6\,XBMMXD/!C6GW?K/2C+<%6\VR3+-*]4GAV14*3W=@XZ4'1G9VHLB) MTD.C54E/X"]B^_0,]RAV:V=JTF7VE&)(XMHPO"_/C[_*_DM^?O$[0AB;V==? MY@=48UN)E()59GT.,4U=M;'C@E^J3DVS6@*&^9'AK5E^.BLL8%!KI_&7H)L: M(Q:!'<0'&Y4,-!L;*4J>A.5>V`:2.+MD;JB8M;FEZE=R=)_4:7/!J\R&` MY\LU;2I^[X0>_^76_=)P$A[46RK@[HJ291]HMZ8FF1O'Y'5Z!"P#=4>E3^SB M>R4R&O0N".28GUR:U4P^Z[>CXIU[V1JE:69?R&$H056C3[8^^I1UQ`T1;0C1 M\&J9P94,&]_:I"I$7#RNS--F=%CK(PV34:Z:S506&XS^@JCYTLM`SB7"SN:3 M)^VQ-C,0\1\7X,[V@XB)2T=J.KG1^END+V/I:;#I7;B$+4(61*VH3T"8U[L- M.GY$$-PN;!.PUYXZ"T;HA,E>L>X6YDH/ZIZ8E=*5$%O^V$1_M<.P''DBI)'K M0)BZK1Q7^KW3;NW%29&M`\L,C6S'%8H[?LG/Y)D*`H?K+62NN=]1/PE)T/`" M=3F\I+ZPKW`\MI007.2(U8S"PHN>A,JAY*#IC'.Q8WD@+Y(&EF:*[;`O'O"O1^/*Z.&&YQBS0(K<3:KF?#Q:L^P?`G0)/E(=? M8298S)98I_,T\]JV-CVV"O$JO<00SJ)A*;:[**K;QSR'^>%P-O3U=!%I8I%` M9?%5N00A?BB+Z\62^=DPGG!F>?,"L0EQ@LK"C$F"+-HV@"VFX++6IU&?IA^^ MF6*:RT'#YY:)"9]C*0Z]F)N4&(<-XZK'!WTD8B!_UNHH23E7EF:Y."=/DE($ M=VI>X`"T?#Q0&]YG\L$8AD[%DG[,1V$<4S_%1*I*PY>@JHL[]'QQ+LY4?U'7 M,EB6592_]:FLOYA$9;UL%28>>.94\R1?B=-[FL-K][!3/_C3CSGAG.E)\^7$ MI_'3CT]!RN479)KNK[^2U:ODNWP<%I$8?\=D^,3,[$?*[KEA8O9^52//H$D^ MQ;=6>^=R_95SG22@O[S,^7Z`!6[CRE/N<$XV:-U_LG0W.@L?M*-YQ5ISCO7= MYB_-(^G.^'L)=N!R"YD=CB8-]QJH8EX>^N[.ZU5-N%W M%3BV-W:>M%"'M6WO/FHNY+ER"2O7I^KF(KI8FH[AB#AI$UF:XWQ#4L]O5VX6 MPUH>;+7@I%(:G[WR6FQD-UO&@>*:%3>JLD]1`<3FG[=RSY*DLV4_UVI,_7H' MS3+K5NY220*PXMC&E!O;-:Q+3E;@,!:>:`+]W-P]9\3)Y'8DW=7R^4U0)*62 M+EB4<=58&E-$@I<]M$SAINK&(B,S"-:@\9]^#*TH7)6M192]3LA*T@UEL"H2 ML"]-$XI^K9![8UJT(F6>*K^83%'E9M8!@L6@R7N.*CJC[`UDFN&C)Z\*/4-$ M?('JIT*J*.;-A1$`DN8&5X1M;-ZM)&D<,4#!!-_0T&"<[<;9:[TNV>72:6H9 M=32MBKT::$IY6G0L?O"-G)7@3(B;+07B.$#/1@8JHB+V$12W>AUQ MEQZPQ;`"F(EQ./`:MZ#'"?$2T%4+8KT:ON9(HHZR=)AI1,ULC6S:>DM"B:JJ MS>;OII8S6)J::K%1J?#N*,VSR>+\&!$)SI?*P^=/P_U0`6MQ(:!E3NJ@(@;M M%@LN:(7$89]7D(CYNU)AM8FH;RX/6R=E5JIMX$Q"O*K!7!>`:Q44?LUL(7,C M'=\T.E;U*I0^P@F)&3OAK+(FX!#"UE5!$0$*$*JO!^;(3" MDBLUZ6H8H9G787'A8I4&[>;*L!@N2%J1^JR!5+M)K2=Y-*HL^VKZ#K*=Q>*D MP,^,TP5.*RXGC_L%E.`L4(D`9L:$M.NK)FA*O;Z&""L+PIX!KHCZ]GV!"1.J M2[(_'U&/EGW!:?[0:'0F[;I;93QH.#B-;+J\F0Z"1!V/JGA:)/D!?9A/_MY] MF)6L03#7(L]M8CAF]%**`JO`FJ5Y)QQ'C$@DQ7^NBL>;(B9?(%PCN.0[(^Y6 MLI+F#,+;:^[7#A-9KZ2/>K"_4N##')5N+BL?ZO^/>%B2"@02=(8:(PXCEJQX MW`5]G<+@OE7\0Q\52;8V'WP,ENC`!Z1(-E/VO[3Z([I$@ MD1MF@R6JQ]QE\FA-\;&,`S&`&J)Q5/3+RN>%TTHOR217H!0IT:'WI),%Q.-PS58,??IQJ6!M;ZLVM#[*T9A>A33JS#D( MAO&RZTS*AV=D`Z`Z/]Y76SL7>UZSH^&9)T/38WAQ45ZA`;V8A"Q;EVKDC9?\#8FYIM>:M]F%2P.HA5S]<1AO5&&Q!7NN"KX M'X66@%NU):N`TQL`3<12?-EJSS#?[%H!@+S5'\`0Z"!N M*GKD5J(`H4J*6A)E2&##T'KH).,&:1$BOHZ7!7>(*`*,6O"5)2#3)L2+5("$ M%ABZE'P-=9(S%*TGV/:$1MI2[<$IMD3+7$0C2K^$*M+KH8GZ&M.]Q^#-J^*W?"@VCJ9+#S1T0MUO&UQ[#3D5N#Z^WL#[H;9::$I4+(\].[6!% M/`^U**%9#>[6R/-@#B9-`V.1/-W=B_(F6U_;J<1I+7H_37B/E\@H)U9]GQA- M[11CM!\5O6K06.D<.E%34ZR.28<7X6HDGM3&`P[+3M87HACG.-72$UY8*0LB M#->5KG33B_82W8N)/!.`B%GB"!&2#,+M&YI?E#:D&J$"CV;S(P(`DY!H>"1R3J9-]]@YHL>;*1AI-MC6@(D\ M@G]TX?Y2($J)0]>U>0X*QY+.4^D4/8=S%>0M].=8<@MG=4SL/8X28Z6);[W#>:-$J--#%+C[45=3X/J9$O&J*%;/'7#];/S`^,5*F[X* MVATT__'[1IF*+(WO+K:S]N!QR"_Z2)2/%%UP"TWT^J16%0%ZGGI6YIWL=6\G M)#U]I+V^LZ9;P8Y':LLI+:4FZ#0FC"7J:]5`3SUKA5ZD-926=.V)0KKS=X4Z MA!+"X=I%ZPN#F:.`#:;*,6D:.%!+"PA:S;HU].)Q;=V(&=G4[R]&H70>V"N+ M@\NTC'ADN?-/RWXE:1S=H\KJ9_RP*2E$O<>I*`G-?]!>[N0TMQ]\G%*@*K&I M2BDP:]^C`-C&=,SPG!9T9\RX8$69"\>R/'`S3&533;C$D9I=AZC4)FLQ2[*L M<$(OA!LWU.&>L[&*%C6"US%YH[<*C+6!W1W"_U-(X`&#W,DBS*@3:$P]U["' MM'0.GT_Z(Z/%GGX^D#U*V[^<82A)`ZI657P@0-CLSPY8*KFU/Q* M%3%*-=%NRQK:LMN(I"U4:SD\_;N^:[X'_U@(1 M$M3HA(J%L%H43=Z9S4W6FL;^">E+(79,0>X`-3G'#&"H"%PFVDU M\ZWZ9?!1*,K2ZOV4Y#K$]5Z6)M*89,!-8YJ^=GY5,`G.S7&%G-'O(NQ\\?J- M82?G1@/1N6PGB_+4W0O"5E,H=N+?UK(CQF$ESU;EC@-Y+">(/ODDO]';T[U! M(('SR;6=BB)J]PRL.1^SP:':-ZII2C">9+>#M%UI757#G,IC0GNU4,U?$;X$ M5U\[\JL4F1MIQMN5YV6E>3G?6]D$,JC),G31&!VLB0\XAGTX;/>V*+I79_;V MB9\NW;.;6QZ!H&"4JO)#-B@"KGA/YU"O,N+`K$$P/BS2O]W)E!`&:U_,*!%Q M]](6E?(!\2'9)V[+PDVO&MT8VP@Z".JO&,SRJ-O;R:C;NY;5,X&?*B$3S/\> MCWDY')$,AW_3.6=D4N:NAZJ!GC%'.1!PZ.9U>;J MA*7@&D>SP!]%LP;),3S*6HF:5M'$GR(??D-.)N`+RM"2BA../+")2E=L?R5Z M70E)KR*.#BU_+3B,[E91K.Q/LG7]#EDEY0I>@0S4L[>2L7(F=T`XL)0>YTN= MERM0U9Y'G$_S.X'`#0?LX")AJ54[(**CG3M!L^V&X MU?IN$2UZ`;IXXOZS>/?N*QC"H:>%O5$'"M]Q[0!>>M'>Z$_-Z.:T7"%`8Q3X MEA@KG(D),8JJ/#3WH9*1BPUB]0'6*D]ZE^*6@?HQ*J11O(O7W');@UUS6^=Q MIT/"@9*>1HE4J7LCL@K*2N$_H0_/BLN+EV>`&NK%==6VPDW?9HI9!T^[+E=* M/K6O5:FT]0%2`".T&9.2-N5>.71H=6]47$H-P>HN]7!UCV36#=<8DY"O.D!6 M@%7"E)>#Q#L-&-:2.@"<9WGP3829WFZR__F^)"1O<"[!?)&L\UV+W=OB.+&K M(=<;6I`*N9^$#YM*SN-?4MF7C%=;2_MI36-U`[O0L!3"!WIO5SL&N6QV4[#O MA)4U.VV2RA59:'V99LTAUH-U6]/?M:OHS7AKCEW=$1V))QY_:#Q3DTSKNJ5G MH1EK)TJVWGX9[B4!PZH$@#B74*VYL-=H$-B/0DO+](,WD\"P_);0I9N]5`S* MKC4F6-CB+SW7D5_1`O)#EI6N<]UFNQ)1=W`N[Y"R5WYLU/WU;_M59"%H@UU\ M`L:I>-$2)W3H>D=>!*7TBC;#B.:=\W1_AW)Q\4$SJCLT MM"H6ZJ`3S[C"-H+3WLI&T8Y7FNB&>N9NE,PK#7[;752RI@=1+%"&L/+H8N4E M6N+\:)&1W4LH][-\B0@)N*#+DX5$=/!NH/CQ=4ZS7,ZP*QSC$ZISVL<^J%:E6:7/#-@JM5WI?OO4ZW:.Z`<%.5F-M\]B8F M!34?U#E7S2=?>/7EA@?$FI=-=`$NM&YH#G20]&D(/1NE>@A&QH*;[S^_ZNIX M+]X,591](U1+7XK3+\_3+XP^4.3M)@ZK?ZOD?Y,]6FU)$XT^((L0^8!>U276 M%=TD:9:AQ8U1TMKNPRBZ,,S,T*Z)(:L()E;(=O*9%\EU=+6+'3='9#@AUT/N MV'["[3K]FKXZX58_7G]*'Q:%)=A#B/.TM?^H+2^3`.E5;GDV?WX=&^DU'QPD M26G-9Z_,"&W^NFX^ZV:GCWWJ(LJ&4CS?/PSY,LTQF)5:^-:O]5DW'W6P]\,% M^B(MIN@I0_)D\X/U)^UF$NN/'P8Y5@,[>O`KWWI[I.W'3UJC;S]JC?0*.X7V ML)>LA_M<"(*T/MII64_KVRTM^VB6#SFLV0\@&-R0$!9:\H1VVNWQ'K;'>]"U MU%97C?6';8W_04.U1]_?WMA[^*"UB^V-W=W&JJ_@O`EZ52%F1&";H)0H[7-= MPT%NJ+R0#_5Q*P9T:G>RD4=53&>EX>&>MS(O_D-7M@MU;XAN'UY7[G8KT%*^ M:GX0;TCKH340@P$B7"W MNTBB1BLQIQM2U=K>]M9*XWX@E+HS4WIM]R.GMD4N[IV42251R`TF]<"V:+=_ M\`-@(^S*7;>%991X5D(=,MY^E>5VZ@IP"Q90W_SL#3:2I\*%+>[[2`GNKF"2DQH7T0ACTWTW(_E&+G3H2U M^FPOKY`5BRD0;NK0%\U1NN[*$)##-^8LNL&U&>Y;ED6KX(`-JT3>Q MF;)2AK75<.T>(1B2-FE6;3_ZX!1C7-#2U%"&U;,A\M-KNPE]<10 MRZD2`,:WQ_1PJME%%B_VM628"IAUUZT$HGRUW,HQD&I->62YA+9A26NN0##6 ME4)KQLBV-A;Q,A6N49E/[=*&<*&*4E_B%3;/JX?\I=M6>&@9;9;_%N\@4*3, M6QH(([F:M/IWK*D!F]=V$3!5CNH1D.X:W$'LAP94O5WZ&]VW;MW/)*66,G`Z MS[)N7$['\AD-MI2\ITQ"*SA:>_2@*C=PPGNT5],4*^5>P-G\/K+@'#S5]QQR MR;8D*84A7>NNB+Z^J]G&KIGU3S^R>$H8&0'L<>?43G,E.\E*?!I.?&H"U:UM.KE;;(>]CHUQQY^P05JX*9RV$FI%9V, MZ30:;I"\F539V=R*-Y_=6C!L/ZBN47+!4+L):_:/D%Y:<]UE(DWB-AGR\]_^ MF4VF4B1J4AVF0BTI#)K+@F*W3M[VE6T_?EPI;$L)$_$$I9FEZVPI"])(3&"\ MMN(+J^Q]8S7[6&U5F8#:80J+$N3CH%[188-Z87C%R!+5PF9)U8E.Q6$E M?G$5>^K(REC;WMP-;NP/93EU^^0B;J+T<2N<7?[B^0JZ7D**HUU+(!Z>O^4B M.J^O]BM$@P403\,J>(ZY(T]WT9-Z]P&:[/P]`":(,M()NW`'XXS`"0$/98S# M)'3CLA&`I_70MN5T!"^1HAV,00L:FWB3GN:/K"XBZ)1H57>!4-]-WU8:ZD?) MR38H4/-1MS8!`ESD;`:)*ZF^^9!T;/UUJB*Z#E[=K_,]K?ONY\G^20R\[<2SLIH] M%T!%K4&?9$X\-Z!=U`NI4.F1]&%!MS34PKJJ2A!7?#NVMRP6]PRTI+Q[RI;4@XVA5AY):N<'? MT+#6G1&&T:+3T"SV"K#2`GY)P5J'"%W&H)5FN"4C,UQ;::(;,K"&3KK2%+?< MBU&U>4>0U(8]%)P-5-M((;)JR"K\B>G_'%U%%O-]:H2#!7[HED7$)E]\=);U MTT^ES7Y0ET8'GD@'_1@0C2HHU9P?Q&^QTIIOB&A+'KZ0B"*2O((J;XEGO]SA M$JY_%Z?B3IPA>FF/YX7$8E6`2M-'@?7F7%%PW`40?SUUXTK7REULM4K61@94 MD4LY(5::[-:HJO77=/=JE@2Q4 M,UM/;J-PO13T6M.QHC=3B8EKU+J'<%8UX)(M9",L,2=>JR-GJ4QVQ=J+>I#4PMNE2Z:S\8$N3AD5%H54. MBW^J_+_AT?2'$585C`+,?-6PX0";&.B0:R*4"FAV0?)$#5+.8J&-+`W-V'), M:N$JV>D\-E5*Q^.RJ>-\H7BL#)_Z@:8''L\N+F8T(XX2>S8$,4*#(C"^/X?; MVBL8NK?PC':A_4]C1K'URKP?J^8I-:+"&/`FT0B%E9ICFWJAJ(^WVIQP0/%. ML7@:=65M\^-GX+S5*7JC!C4Z\+2_YHOK[;3>=I)P*R&8K.TZ#08H+M6H$SQ> M<)T:7GZEY&\(L=")RM"85KMQ_J+3MKX\L6E)_W:6Z#DB0CCFYHZ$2#6H5*$9 M/>+G!;Y8^L9C)\XQ#A4_!2W\@B_9Q4OHUY@EPW[U.#"9!N/I9:&(^+]4NQJ/ M3L(U3YH])9)->O"J,8C:I3#A,G`(?JCZVG.MMK=^$^UPVKLH4!+_66^G??*J MEA:9$>'[`8!6+;A#EF>H&]9I,3L,/-=%TS26GI!Z$;<4ZVSK)(B3A64[Q$-S MHFRW0* M\0NHX9S@=.R^:Z:IP`B^<7F7\(-CPJE_]BP=ADH-0`G8VX! M6WAANCD?Y/N'*N"4YMC6X3$A'5+(\X^I#SI0^458QA`QY@#DFM\%%P_"J):G M+]_E7$,1)G]'*ZAJ$>"6]_XRV0/JD9+"=N7EF0UK^]JX*Y>Z#4A22:?3IJ<3 M_#@LQ3NATQ#)SKN^R`R[.?A\M-[T:\LWI&9!^"'ZAR$MY#NB2T#]>9-XGS?! M9P`60)D):F<6KXG^\4OK]'VZUIY%\4`3+>WL6TX MQ!\WLS>;;--J<7Z7G<6[VP;AAJM(:AQ_DO"DLF6\9@MH7&<3A9+^#L7F@@R' M$A+J?&($FC#'Y@V?1:3SX$=`+#)RK"63A>"0$H201MREB*LN+*J%B!4DQ1U/ M9SF-\*V5@[<7-QX2[W0\J3"H"XTWU7&?PZZ&$9Y4'%62QMFZMF:MR=6*`15' M5X:!]8"VI)6Z<2T^Y+".41J,``3LI-L_6(-7!Y2Q2`_/ZKLT6VL`9(N!6F;/ M(SX20$)5!7M#EW\(M1\FT:L4]>-^1]%79`V".@.<4I`+^_$3L!0-G1K[81HC MPXKJ#`'R]O1U[IL("RBH@[TD?GU;"BV+IW1Z@LV`-M4]I<"BZLH4\'+#TD$< MU[X`M<$&NG<0%P9/KG!PUT5[EC/86#=[,R3EE-1B;T)G.CO12LHX55[CL[G* M&+Y)$LG:WL./6Y%N6GG2Q)Z#I?.ZG91'O`%.Q,3ZL,,=C29`CPM:88+WYE*M M?1;QGSOT%VQ4"=?XSZWDFK`>^)J56'\:[T$&LH"'\/FJ8C(P#_3^60$AEF+# M\!J[B`J.Q&=U=W]#8BFI;,]REL0Q2PK/@G(N,O4^J'I@`&$^=5ATDJH-KN?(Z@:F( M,)E&,]P(K$-XRF`.5P&^<0-WNCV)+C.8K!\[JV^0Z"HXV@N[,/B#3I="-)W. MT#C2BVC;:P`6-V=@RTS*6*0CJ=+:+HJ\TJ%,U+G(2?!C1%`@Y.1::H7=#&*V M+*N1/\VHC1O7IM)T+:VZC6#7'CVDX=H2:"Q^[_I4110U8G5-(;E8(7R%.!!/ M1)R5.;/HK(L%1W=%>V=KE&SN-?*:MKE\OO)>,+_!@Y%"3K? M?Q'3%BO-PZ5%_4;$,$LK%9IU*;85<@D(RR](+Y1=NW3931C4,I_?R@[5Y06V MA"$%!U*`82BRJ^VWH#Q+@PFZ_3E.HQ/OXA5L*IO&M/\%'XK[@8<3V(`<;C'& M:>URE^=R'GPV0@U,9+=E;;K0)C;S'EYH"ZEV%A1%DRN-_6JQ*:--;R`>310! M\U!JI?>#]URZA@;E.KA/5\U$S]`D;Z;Z.8%+*LJB;;(4M.&:B"9E"NM78JNZ MUOM&Q)75A[4:655Y]L9=7.C6I1@U49VJ8KVAW5Q!6@\;B>1/JCSRCT%4L%_X MGE"O[DJ@K2SSHM02,Y7<]^BJ^)7NKF[+*K3=R-Z<%7@96H3L%WPT?NX>Z;DN MZ/ZG?$R9#>C9^`2W=#1WFT_,S^8-$:Q%LA31CG>R:UXY4)N8YG??P"7,RF@^ MJ)?##87U;492(IJ*8//3Y\&4C<38?/[3C[4T6W<[:][JI;#TDMWP8WZ%]HON M5G=+M#E3NHG)]0I/\_,VPTP4J-Z5OR[(1A<'#,5C:'#?T0DLV][>R.XE./`M MGFK8JC&BC7NFGN%<%*>O$1T$!L,1H`N!C**CBF^&,4E(WP"76+,L:$6O?R)63 M^F^4^NXL1W57-+975CQ6!9W(XUW?F%167H:J8CW3\<")EHK@\'KY83#)$N_'PRG^18"-[7Z.S@7*L4FGZ,?HE[;+D"+='5P_AR9$&S MZG`U0J&A<(]89O`YR^'ORDRC`5;PBW5NKU+84S"93KI&3_Z=*KE%<-4OC^I? MHG3ZL%C[*T7HM;>]>F]AMX_K7^YFMW=*H_N.#=UXS<'+'[L"P@7#=TZIA85S M%Z7DPE\6"!FK=U(T!(\9#?VEL>>>06_NUBI84E/E]%BA#B/5T81&L@0#=:%R MG9WO])]*I1B"-,0//DUW;!R3(H3./\YV>%^#H>=R4Q-(AP&5N/^ M<#;-PA90::#NI,>NN1>M2S\Q(0]:F;L$&C/MW$8+#]@G9)]Y\*;#IN\G\A?Q MTC89-^*&6G"3+8JN5V+75SG\.B3"KT1;=[&5.R6<;GTZQ@W>0E`>7.,,:5I- M1\6`M"?R`I,DHY0T[J*<$A-QW@L:+F:X-)`C== MI]I9?BV>G,#K?P`(;]1M`3?;?/4<;WG&9UB/C_D=%[B#H^?[S1"<(O!.( M+44!JQC.L+*M0L))`OTET`>\"2?`L+&;>*)$`$A`M'P"!C,'PB]@J.&2&,,2 M8\&-"2;CZ9KE\!/:'RS,2),PJG(V/9?? M/+-J?W`7W%?NWY7&96&WL2<,P5::Z(:2D`U\X.3P[LXN9+=14U>G8AR2FX;V M!)?-HBL$N\1WF+AK^[ZR>U-JN[G_WH7]WHE;0_R"-(YX_Y'8*9&MI1W6N465 M\QZG-];1C`O2H"LWI5HY'TGK'_F2=1T:@;+1.;+&^1RY/I;A('WI(G8Z1]<\ M15AY-$QY95Q;E9_GI\K[<`DX.C47GBS(L;MG6?.I$G(F.A4^'N?OHI`^M;P) M5,R$O^("1'+R"\YI\^X2^(91B^*J3!9+8="OXAMQ:[@HS94U(!<1N7U9,\27[_M:JZJJN[]][8GDDBC31F=W==5JW[ MK7Y1G@#JNERR."IQDEFZ`&ME60>U-:T,QW";H%L2N/DM'N^N88T0G7H250), M6I$!A,\J_]13`^R=^H8RS?^@RB[54[[.>X#P;D0.&;L*2S3_/\J\\NW,X:^> M-2@KG)D'&HVN2`1B+R-:35W0H/R$ZX:82*\#5]V,9,",T--Y#J6,*`![,CM+ MJ_03B-WL(%U0DB[[N24E"/;-$AAEHL9)G$W'I*HX0JH0K]JC:TY MY08-0'I0O<3W)S*`4*8"V04&D[>68?TB),N!BM@/`,W^8<@/((@EM!E*6M\R M7#(NAT*PVDHR:#[U@4HV-$^TK-%EXH%4T3:`9!Q?(O@ M92][MH]OKEY$Z]Y/1^1HQM:I3YRR)0LM^+Q)TC4YHH=[3J4=A',#9QX?#&DM M;4H7M''>7ED6T4^N.%C=W!..YZ;)FX=L1ZL@IL>(\8*)ILC"L*LMZP/O/I2" ML)MDS8G%XW+NS8G-[(K)X0$HSQ$F7';.U,,[;(E-OE&@)D>(Y+P\._[D1Z!M M4FG);]ANR(V8_8`9*7T..H(LVU>',D<_CUBM\Q@)8$FTC9`I2!2[?LUJ.4PB M3ZG$F]``RN#HPC:&*'6<8K+*@1LH)_($9CPO.9[5Q+2Q2BGA@T_D>":KEF@CG2;L,KI8R?429&Y)RH-^!'7/W1&6W*3_ZK=)=YM7*=19\ MB$")+3C-@._"R=B#D6WDV3),`I9,[6)N[X)H1`;OM`YZH*4V/=$M7#TCD!I[ M^-[=+#(*-'$6T0+P=QY_^]WJ0QHUK$!M-''CPF;]\Y[V&,R$NG79[$)*-;'-,71*``YG).B/75:N75"/?8X_L/O_WR>??+YR=/OEE[E36,<(J9PV9D*#H^PT54VQN0&P* M\8V.;U>OP>O$UJ(TWS:ZN$B/826O4*C_931^+ZXC+=OC^8'CX7GUH/3:[<8[)$!E*>RY)%)>J06O4V!LH:/=_"D,9BG.7JYLCFW%.;:Y=BT>EGIX>9H7=<]395F:^U*4ZQ8)B,.3Z6PAP8*#DFE/F$(]H8WCY9'L70S:X*6-M$4A`[0.\>;LITF.&(%0,4XP M])B)1-X<=LMUI2896XNZ$>>2Y-O\N7KXY/[C'W]X7*T,_G+/I-Y>;3GYX377 M;88WI^W4[38-P@BVK0(=8W)!L25VF+@@%JO*(DU(F9:!PTL12_N`6/AQ"%`% M5BA3:F/V5EZBH*BJ-$]8=G0\/+("2W'+FL[UQ$TYBJH1(!@+O"Y_CPG'B,GU M>CI$(^$^9258(%>2%(>6[W_3%5'&4CX2J(2N&M1PEJ#>1UAM;HOE_C_+<8@H MGKS/M3'^0,F]4V,6#]"P0T< MFPOJ\K%E.4Y05;5%.AYBX*N+"F6#\++=4HSS(%F6,P%'EW-H+FJ:E%]Z1`C)]1QZ5\/((U!O+ MIE`T%Z^7L"\:M.;6Y&:83]@XF/A:3,=!%;$('S;(8[ MN5I[>/\G5L)Y`&B[SC6!U+!,J_<,WO'L;;4M)W2`T\81H)&6X?8]6X@EC"PZ M@XHMX=*OUCJFW%#I`/@NZYX*<@))D,@_$[EQCNR.F2H_@M/BRYFV!F^,IN/C MG#$@A533,88@K(%=R68N"!W(0V@G*@V9JTZ#JC^H8J#*SNZR MYF5\Z)I2DZBEAOI&$O^:OI/3O=G'X(E.V?15*LU&G3SJJA!6X$665G0)]IO2WFIC=?08G8($U=\!=64/U\JJ;3IT/- MD?R,@62PJ#!<-(!0+!6E;0D_-HA6'5=[0$9..)!,A[?IQR#AG#BQ&>!R9ZG* M0NP7!ZX&;:"V7)]6VS"_Z94+UCIVMNZ_S@FUYH.P MS>YANI75[2$^5;/Q='0EN/+.>^)X0-2L/PL6*)N'R*3@?$SU+K$+'L/O<##! M3>7R5-H;S\6JLFTZ[Z!DD/.>BM+T7)X&Y>6B-0)E88&ND%8T@H0F>9B)L?%J MDZ7;D3X=J0Z>Q6^9QUJ^X=B!V![)P5,&-&1X4K0$.3`;Y_*X088V;"`XGL=E M5*).FBKH.,7HLHO=9?Y?I[G@OLD\65.O1\A&^3%.AO2#?WPC8T\7;]# M,NS#6]:YOGR>COX7MG'+F1OK7S[3M<)$LA#44$DL*QY[EY#T\OS3XVAH.'S()8$A2G5/P+>3%C(G_FY"R5,DT-+HNJ0J(F M;IQ&G#E:0&(BR?$5PK!I$._68:Z),!XH;!()T MOPM[](8?L3(1GVN=.NK80P3(?FVN_4V6>57MHX MG$D[//UK\/.3-XNDM>0*G1NR,>0JUMI0KILT&)%H_Q]FW'9G'+F?4B>61/V.UY^OO"!2U*I\VLGR%%*AF^,9AYT-@\8I MI_:*`DYR)$O_E.Y%N534W-P"0`"CEF`YJ]&/!-OP$V$:Y?^<7R*N%"E`WH`[ M)RA[HX^3/Y4R]\OG%>1#:/_57O*SLGD).NW%Y,SQ.;O=@Y8J^\7IO'#LOCD;I0EX]SMOJK8LF#>\ M5*4.+Q)+G@%166M@5%?_*@.<':[QQ2HEERT`^ITUA_F3VX;YHTZ8+XM`"U8= M487_-V$Z77>RGD./]="@7_GQRKR:!6YJG^?)<=#%0%N(T;T=$I9Q<3,=K M+:6#KH(<7FZZ$AS='.\P(?S+PY^X!6)T8:KHHN8>CKO7Y701>RWCK=;M&4T+[8OUX1ZV5!Q\DQ$KW1H.4=+V/3.DC,1 MO:1!#2V2P#'6;DK#T\`>]M1S<<[2U_>MWD_(H%TTAP+$+LJ5AX M7FYM9>V[H%349-`-NH6T!OL[4>ELHII#8VI1&:K'7X?ES;R;>T9?**U1_7/" M0H%L=25QD%'8JJZ)X-]D4AA(8YJCO"C6ZL<@K/0BZ4K\M(F>)!,< M=D\Z#@/6O2^\0"6^IT`K1KI2CV+6L=>)F'/.\N_B7%U390#-P"<^D7>A"04? MD''2^)(HP.-P@E46;T&)+3^"A+!OI#/"Y(,4<1#0##4.>.@1^[!)J9D)9 MPG2FOQ9LM%_3!.F3'S4AI%,+G^F_W)5QFXJA^0]I1D-QTB&-T^`45Q>-5 MTUD2\HZ.V%/$0+OKCO)2R=C#L_N#&9[+TL'\Y;-G#/4MP85&-RC+Y791=W5? MCC*U'716,'^>U_*-$M8I1]Y%^P=CH!RG@?+Y,NOK1Y3.=?L4MX8FW;KLYDAI M!'+,;'L_9Q?@Y?96UAZV9,;*#^TFMVL/6^9(A"B.17J0P-Z,%\13$,6Z\Y(@ M3KR+Z]'?.\_#OQQHUW0S]V>8]YH3*MG&>B<0$Q<(O`ON:P0?G?PX;EA30X9& MU@Z^*&-P_-98-5Z*:*.R:,Q/L7YG'IA,!#3$N\VAQD MV@X9["V4?UVKYD'?*0=X!C^'*^QQKJ.C\N%3E3[J1!%O,]+B';8^*E[ M#4NR9C(3(A(6GSPBOX`TL:RQ`\]G1)W+*:'!)%\"P:J:HF_2P2')CS.R"0#4 MZY"=:V;4>=R:-O9.CTCR^&HZAVCG.PY]3'F M;!0PP"0J5"RCT&'E6G??M)O!V-FY\,@S_20L>]'U52%!'+V<-=,'`=%;O/_" MO];TY6=[:H4(-()ET&Z;O]29R/"(ML6F];?^U="GFJ-`M@L_JRWQ'2B`K`0K MZ_W9FB3Y2'T02R^:*RMJV]ZFZ3GQO$O!8?%R\FA1##DMM7@K!WAO6IE2]SVK,U#'E8OT2[?30B# MP])+E'PSV*I6[K0X)?<&/Z@>^F7S+>,I9F'^^M+R!5IFSO:;U^1#_OM_MD8U M3CV^*M>PCZ)IT7ZI7/SQ`X$$A=SZQL^Q<">TO(AUPGW?U``T[AEREW]]`2^N M=BC[F+0W85U%11U;4@/@A=F7Y0ZZ1E^5!%`@%HM'G_],.UMG$NX8KOEX.=@K M9<;&^11QW%:4L@6UN_$8-IZ7(YB'8V]XBE*!6%]FW9DT6H6CU0WD=]#^IR1% MFXU7RA\=5X?\686U'$S+-2T$$>RV%T2D1"LH&Z1#.?26575*?C'\O:93\(4F#/SV,L2U7YUV9)5J%F[?!*!L65.#YLJ=-1_"KM` MGV"&E:!^)7/W" M&7#8NU8&,:C+(*`G`B8X8_1@/'EW>NF:(T$6YG=1SCNQQ0CH9(HECZNG5^%; M+33I(RW5K@M'D:KPS;'?=X[BB#E8XE_73JR6X79VP@G5.R%^Y%`HUU`77RDQ M2'Q&DA)UPU1<(>2KS1V2K;63+6_Q+45D@ZL?S!UCS,K/JQQY;P;(G;C$31:- M$[F2E#_3^LKQ:B`W>,Z>J$JXA.;<$),[I`8I.I+I^3L*P9%HIF3:Y!U>%92" M^M=_LMFD:,!)DDC;*_G;1C=_RV1MM2+YV1:?T>.)G1%K[C*FNC&QV:3&!T$D M$5/"J<9DPSGU8QZYP9'MN;7/./'"V527[[!K4V;PNGJ&&1%*R2 MGK"T+255H_+1A4EZ8&28'6*X\7!.`&0[ MPK;>]V$^&S)EF;ET8BRE8Y)H<9MZDQBZ\^9JAY#`Z5CQ@Q*"RWZ'Q*`F96QA M7Y0&G%CE2$$*.*0<:F;92K[$9(]N4)0CY;KQ+0R7A!6;,*9L0,IG>4D'!K"& M,,*%M/B@"@C[X1CC^@?W@\VS?GS\U=PSD"1MN<^PF+2^3$+-BWO*>2$T&%AT MO<]R"P2'2A-I3'HP'O&?NPB6\70M(?D3^<@/^34,(GU9S3N9QOU> M1)1B%DI+%>A]$9.`,/%'J]P.%=JGGM2DX4+0RE!+HM@[L\@.UE.YQ,OCS[VQ MKH=+L#>FA]"CR\HLFM>Q4PCJ+"%T>>S`Z;KJUK^UFSN"HZN<,P.6J@[('O24 M03QL7O$4^8?9VA%SRE'0*32$Z"Q. M@F)-9<:5D>ED8KD+O5@KV`R5FQ#>@TQ55=.RU\P&D'HIR#:NJA5:QF$IWLNHUJ7&X'A*`\,6(A'C!M MT4.PZQO?!SEH9>G?EMM9]$&X^#SEO2SZH'5!YZ(/6A'111_\^%5[,/U-;N+6 M9S6VS#M)EU`XI18&?98XUJ=JKZ&^:54(A90[V?:4\IZG*"Q=B1"1A,K!EMI? MYCQ!4O2&II;8'%JOXI3-J%BYIIS0@Q8AW5W[KOO!GN>`7.'*QEN/'"Z7?O?1 M]]U?WN4&95M$^47BB[M MYC]=B2XZO08>="FIY?J"]VW"F<0["+`-Y,#6\?"7:B&O>I405!9ZYNG5374@ MG-[DBRTJ7@A/C6=JC;-/\ML^O98F@L6VX0]E^GT$E+(Z%&#*]8.^+Y[)/Q7= M,1Z5TOR[[/P`J5[/V%C'X/23VA[T+L,''<'[.3[TE/;X&S1#/F-S&+HT&CG] MU-SGP`H5Y\U@<2W$2PO:AC2Y]QZD=>WY-4H_RAP*$Z@<%@M]ECCR8G3Q M]CZ?G'?&?\JEX"$":]I*9,_2N7#RT^6I@IUR,718(4T7BD:Q)%R?MEPJ(=EP M&Y7LSP4O/QV-QZ./("]NVU0F5`ZY@.:Z",CMWIIXA,*]A-)#IWU^R[5'U;RH M[Q*KZ:.(WO-IH`LHH$YK%C8H(77WX!CO+MCOV'5@'-**Q(Y)"H*J9':"3$>< MM`UZ0$<(C[^`?T)&*Z##HTSI8J=%VKO&38IF+RBHL^C(V:E*JUNK^TB\C)7) MAK4P@[WER:=4AO*;#]$2$WO4D:I+6'2=O*(=$;>7#64R$\[R+`#IILZR)=XB M*VV/M3A1I(MK]V'#UO&)Y6'%K!%EI%O,KM8^K+?J-D$5[AIO96%W?XZ\@04K M-..I]>9\CO%N["W\F6+XSZFZX:05\8!$?R/H"8SB0G:Y1SBT&=P=R]6O:S0\ M$06Z=$B6!X2)OR")QI.I4D;$UX#%G$54,\S`@/ENF+QO45R3`"N.\F80@O:* MA3=AWT=7!$'L*N]\J.6_[LCOZ93K?:"(LW-N%DF%0`BJ(.![A=A62A^:!Z>, M#P@P<9[-6.F1#9,4F/+([WK>N#&&X+%BK).R`"Z[_+P<(<[;O[_JW\2SZ)\) MMA+FGUAQB!`XB<0E8(%Y'6\M1AN>M?W42RV$,:Z_F"8?'N@2QSZ<*PZG^>5R M)T.J()JZ.';-T,7P*FH$>R_+3)D.Z@9CH1K[YJ@C;:2YIL9N.+$;`2IMEGP93X[KI,^3;KF'Q(W-(O?'OSY MF^EZ7E";)JM3OF@&E&:-']=NY7*`VZ482)#<"FL4&KQAGH(5"N="ZH(K$#7= MEDO*]A2`P7EX"LH-F/?25,\>?+D+EKD4Y%CY\B+C5J#WNRRK>7X1F93.UB_# M:HR.KX.8"P[R%J5*?8JNTDQK\IBWZ$0W50C9>HSHZW2VNC@@QH-7*T^#75/" ME__Y*.4]]`4UTF*0@QY`MM6LRD()(>0(?7:;O][,OEWK/21+2)5]:W^HF5!( M&LI92*9ZEY2:SWFC)3[J76++_9'FG+,PQ8`67VVSG(_-/-+NRH*ASUK-TF-[ MXA(XYIAIZ0+8'210J>U?^;ZON>L^GM:U.+V5K%;X+!L!#5F13BR5H5TY0X'I M#"_NJEMQY=3E9U5*0O5=8!RK'=.N:B2L<^ONR:(Q(/8ZD[5_T]T5!U]C1'>. M,$_6V@>R^V-**O;OV_'P7'15.[9#%QKVG+W8+7T";VQ40-`A!"?%\3VSP2&F M8!+5YI4E/6'&R6LF^K-_4Z2E?Z=0+2#$[D;9)(*+&:]0E9[GN53*(.U.M2O/ M9Y>&\.:DP5,8ZGXB]RA?M:Y3LA86O]H)_94ND(2`MZ<_Y3M;(N0!X%.8#G@` MN>#CP"4`4>)R(@4V%.GA"B)_15#%4L8G84"[1G..E5B"F&)ROSYJU2,LL=7H M.M"2_'62*^@,&QN7U&Z7T)&@&P'*0^J$?.>/7WT*W MQ)(E6!CD`SX/4Z.(JJ='S6D[SX53CAU'[CPJ]ZY$E*%?@RH$D$NYW33F>I-U MM#>Y7>SKWFO=$Z;9 M;894?*8."2'3"0;<'WV*BV[L.D^CZ7AA">R)7R58Q!7:RK:)]-$(X*S:G$VF M".)Q2]NZ7L.!WL,UR^6K.P_T#C>W!4&XLZ2N2>]#N)2A&:#5;ZVE"&S?8`&\ M:IAX_;KXY&%<4!Q_V6Q?4!<@_!\O@_]F,IFN_X\`````__\#`%!+`P04``8` M"````"$`[T5=4B0$``"<#0``&````'AL+W=OV6)GR0U:>-O:/_YY'"]L2 M35(>DIR7;&/_9L+^O/WTU_K*ZQ=Q9JRQ($(I-O:Y::J5XXCTS(I$C'G%2O`< M>5TD#;S6)T=4-4L.[:(B=R:N.W.*)"MM&6%5?R0&/QZSE.UX>BE8V<@@-5%!B'V69\WO-JAM%>GJRZGD=;+/(>\WST]2 M%;M]&80OLK3F@A^;,81S)-%ASDMGZ4"D[?J0008HNU6SX\9^\E:QY]O.=MT* M]#-C5]'[WQ)G?OV[S@Y?LY*!VE`GK,">\Q>$?CF@"18[@]7/;06^U]:!'9-+ MWOS+K_^P['1NH-P!+DEY#CO!7ZO(L`<@]>2M?5ZS0W/>V-/9.)B[4V\2V-:> MB>8YP[6VE5Y$PXM?$N1UH62021<$GN\$>;!PVBV$9[?0FX\70>#/%G/8_L%* MOUL)SS_;$L*V""OG5"8B4@@L)$;=44/<,SA`5+.% MVOP)6X03MH'))920/MN)B8@40K-5AEN"$Q(U5A#L[CY_:!'*?^IJ<=$+K=M3 M+IB99$()@7[1XA+Y(X70=)7A[I)8(2A;V*;'5K4`6C?VM$0OT7).6$H(A+\E8B(BA=!:*L/= M);%"4"UG0[9^H"N/7E/38&%R"27$;S5=$F`(]X5]VOMR:ND M?US-2$'##B.YDN,GTLX;4QE2PDGCQ'VX\=5X>"<\X"FO#(,G*5/8AMC8\EP- M/.*..G?O8#46O*.IW+-=8'+%&^'&5===7A20HM(B]`:F:&C:#4VQ83(WQP/_ MMKDZV.^/)/*"Z"OGD[,OA"D5/RC40Q^0LT&E-4BEM[NM4R8<>+M08)+$Y0`K MQZJ"U2<6L3P75LHO)>R&I[RVRL$YQ,$91:3VR0K&C:%]-UG!2#&T/WE3"#1] MQP,9J]G.\8AM9;3M7QI>-5.37O>P+#<_GN& M7T$,1C5W#.`CYXUZ01'T[ZKM_P```/__`P!02P,$%``&``@````A`/6OXP^\ M!@``V1H``!@```!X;"]W;W)K>'L\#WRFO1'*KK:>?__=>GA[7O=7U^/>27YEKN M_.]EYW]X^OFGQ]>F_=*=R[+WP,.UV_GGOK]MY_.N.)=UWLV:6WD%S;%IZ[R' MK^UIWMW:,C\HH_HR%T&PG-=Y=?71P[;]$1_-\5@5Y;XI7NKRVJ.3MKSD/?#O MSM6M,][JXD?7V4#3U#5P\5Y>J_ZZ<^EY=;#^?KDV;/U]@W]_"."^, M;_5EY+ZNBK;IFF,_`W=S)#K>\V:^F8.GI\=#!3N08??:\KCS/X;;+(K\^=.C M"M`_5?G:.?][W;EY_:6M#K]5UQ*B#7F2&7ANFB\2^OD@16`\'UE_4AGXH_4. MY3%_N?1_-J^_EM7IW$.Z%]*D:"ZP$OSUZDJ>`=AZ_DU]OE:'_KSSH^5LL0JB M4"Q\[[GL^D^5M/6]XJ7KF_I?!(7:%3H1V@E\:B?A9G#RCF&D#>%3&RYG8KT( M%TNY^CN&L3:$S_^W(KA5^X7/'UIQCO%2<=[G??[TV#:O'AQ>B$AWRV4IA%MP MI@.L.=N00^8+B?XHX78-(B&B#37('`,21SB8$PREE#%D#!*$+!7# MAS@42WX4$>!0)!91$`6TP=/'A)@I8 M#!T\X0=G?B*&4DKY<8<)0G0,1<@#DJ+>(4@,(.:`4K9I',91]?9QB M)68<6;]+-`8Y"IYEJ[5IMA)%D=6(58X(RDX^01`;O-L,([;I)$0,$GP(`W9( M4ZL?*!*+!>L+F6M`,RT;^4!2S6QG"H;8YPE9/E\T1F<\X#W'J@>N9GBH<`;L ME&>N`>4J6_K`U11UB)V><&0D$HTQ`5VS-5.K'TB:^8&UO6)G*',M*$O9U"=8 M8J\G+%EQ)'`;'6HGYC>#U*H'DM2`^F--V9D$HV!"K;W39;+ MU$)L1*WD3:/,0O@!$'06*<[A:@8_V$R(%8*.I9AQ2C1FH^X>X6S%3X'6RXDX M[(N-CCUSLF:+9'>6`5E M=[S0C4U,/9:O\>"+^5`1B+'Y8B63:OV=?5$G:W:6LSM.Z+;H@!R5#HXT6'`X M/NR,)<*,/0=#+SRIA0RE<]'*.2P@$SNF= M5#`G+#;9'2=T6Q,3EIVP\9"-664D`C'OE`X"[NR+>V$'-=/+O.6%;DP.P6&$ M3.4+QR34ZW#,1J6#&),O_L,D%:A_BQ$^Z=$@XV3-HI?=<4*W14>X;=L3HYO? MA`1BD$8PXY,NU7IG-'(+6F"9:T!)RIDYQ-Z2Q%'JUO6"70D28<:MDQ2Z;&HA M0UW?-0VH`__LI<`QI'.??&.8]P',*/3[-",A:E M8]%^+,J(B"XNA].P.!8[=$E\"CU^H@N/[T?7`79!231&_B*U_6'!IEXZ@,SV M]F.1?%N@NKJ004#B^/0?GTK797LJT_)RZ;RB>;G":O(^9J7XUB&!MPXJB%PN MMJGRR^1[L85'M+`>DW^,0`&1'&M@Q^;%QMP:P?N&6WXJ?\_;4W7MO$MY!'K! M;`7!;?'5!'[IFYMZ"OW<]/"F0?U[AE=()3SI#F8`/C9-;[[((-B74D__`0`` M__\#`%!+`P04``8`"````"$`($-7CYX&``"+&P``&0```'AL+W=OFR/:]4W5V/->-G"HK+S9% MV#;OB5$?#F5>/-7Y2U5<.@K2%.>L`_[MJ;RV,EJ5OR=5U=(<1S M>2Z['WU0VZKR[>?CI6ZRYS/T^[L(LES&[G],PE=EWM1M?>A6$,XAHM,^WSOW M#D1Z?-B7T`-,N]44AYW]46Q3W[>=QX<^0?^6Q6NK_6^UI_KUMZ;:%O/1=M]*M'7MO*7MJNK_P@DAE`4 MQ!N"P%,&$:M-&`;19@U19CS]P1.>@Z=P5]XF%&&$[Y_Q#`9/>/[D.R%NWV5X MON^=#N6LS_53UF6/#TW]:H&`(2OM-(W_]X'R#<TFA1]WPP8$R0@,6\X/]FJDBD-O?:YFE+9 MRA,9OR%]+7K\*:++$5D8S M8DDDR)!$EZT(B6Q5+*6A3Z++)EPJ6SE+K.QLK=)88JO),N+BB0D#$E**Y9-' M(A15:;CIDDH$IWL_2Q=;E^8Z8>;H2H2B*PVWZ4H$IRN@0L^DMV_F^66S)1Y` M43^9_,!W>7H'`#[&(6":?S*CN&[`U)8N1#'6!8&EY+9J^F;6KRJ`@TFYH) M/9:F>`#-II_B:,5OV2E5D$GZL?;,I)]*$Z1&2_^$M*Q?(XA!$MB"8^=UTM)R MTRG5GQ1>!R_8)Z4(4LUM8PL9N M*>%09=.[,]F."%G]L#:N`S9!$M4\3EG=(1*\Y.L.)D>L6R-'7O0%E36=:Q2P M[4<\@&9%KI7'8;,O+3-ZD9")R+%ZS9"FXK8@&R\8#/C&SZYJ7-V`":)8VO,=;&9:=402:DL8S= MUKI'54[/]!NR(1"5PG7$5Y,AAK:8*PLN/QN?[[Q4\X0LUC)&5JQ7<`*BE($( M4^:3Q<\CS/`=,6%+K8;&(X^)Z\F((;R)QA>"F"+'TC;V2G6%*IZ1^H!]Q<1X M^-.+X:9>$P491;[HE.I.)EFL8"-9OJ![5.#FU\8!!#E2NP2^`5"0D31%GG%* M=2>3]-N5TGM'I1PP)):-8%)-5//(4Z^4Z\E7A>Y@'>;"X9@>![D`%$1TQP1,)7C:%=6^-,CPW[_$QU!R.U_MLEKS?#*2,= M*.,A5CPU)5/3T]24&B;SY5A;V+CBMIK.EZY83^,!@U]T:KI'`9_P M(TJ-]=24&B:3.=8@QAQS?),YU2R#%%_E8[AYP.XQZJR#R8@:J2M':<);C"&6 MTB7=2M!)>54TQR(ISN?6RNN7"V0*=V'*2K'BZR>Q/WA8. MB:?VCSY>J[P9R0<7R/+4!Y(AKV(<]1JX(;EFQ^*/K#F6E]8Z%P<@[J[P,J.A MRQ3ZT=77_H3\N>[@;J3_]P277@7(V%T!^%#7G?R!Z5'7:(__`P``__\#`%!+ M`P04``8`"````"$`ZLD=A5H"``#G!0``&0```'AL+W=O&N;Z%0U658/Q)L9WDK0TDFC?4POY-+3IS M8I/L%CI)]7;7W3$E.Z!8BT;8-T^*D63SYTVK-%TWX/LU&5-VXO:3*WHIF%9& M538".A(V>NWYGMP38%KDI0`'KNQ(\ZK`C\E\.<5DD?OZ_!3\8,[^D:G5X9,6 MY1?1-2E[176._J<-G+C:UA=/.7`I3 M#2C!%TGA6@"9=/9#2PD[,@[>:*6+G*M#@BZ`S1-1UVO)7-@=A;2&"K)7/#1 M13T&E@VL[A>3-,W)'HK"CICE-2;I$014>BF@/Y,Z2;C52XDLZ_/]+I;7D%&/ MN%!(+Q2&9EP4W&%T9F;<$P6I@!F?8?X@+J0`\A8CR;#20"9N:K MF?Z#';KBC'UHQ$4O52;IL&8!T0W_2O5&M`8UO((CB:,IU$6'FQHF5G6^^];*PL7SOS4\ MJ!RZ/XX`7"EE3Q/W%O1/].(W````__\#`%!+`P04``8`"````"$`+^@;K)L$ M``"Y$@``&0```'AL+W=O9$"=!`S@",IG]][WVM9W89F!?9H+O\?7Q M_3A@;SZ]5Z7W1INV8/76)]/0]VB=LV-1G[?^?_^^3):^UW99?BFNKO%7Y MK[BKLN;U=IWDK+J"BT-1%MU/X=3WJGS]]5RS)CN4L.]W,LMRY5L\..ZK(F]8 MRT[=%-P%2-3=\RI8!>!IMSD6L`,>=J^AIZW_F:S3:.4'NXT(T/>"WMNGWUY[ M8?<_FN+X5U%3B#;DB6?@P-@KAWX]\B&8'#BS7T0&_FZ\(SUEM[+[A]W_I,7Y MTD&ZYWQ*SDI8"?YZ5<%K`+:>O8O_]^+87;9^G$SGBS`FT=SW#K3M7@H^U_?R M6]NQZ@>"B'2%3B+I)`::T@Y#PY,#)"(V\"7KLMVF872 MN5Q>[P5"FG/T9PX7DX!E"Z-ONR1:;((W"$XN,7O$+'Q/8XB)2!6"QQ1X:#*P MC2@AP4>W/GC1FTJBI;G&'C%+$99) M;!I3-,Z>',PTPE@?($_KBXS$H4X`MYH\YG;\$3(3-%86Q_39.)D_2!H4H!:? M**@\\%%SZ21:Z3V(^M@C!M/G8"1)!#.Q6 MY^NQE$"D0P@C&E#)/='@HR8)MR`0(Z.1V*E0UCZ*!@'^FK!Z]*DBN-4B$H=6 M6A`CB1#+FBKK*)'5(!%N-8G$*ZOS]XA!(C8-91NE04"@!P(BS"81IT%:YU`U%!*32C8M7DGB!(DK%?*MHZSL64 M5%O1X&-AO'W>Y1V\@^`B1,591VGTB^MI$];G>91 M\BDX$$O_4^FCOYS-6NV1U]E)*$8E<R\=B2HOV*U<9R*J;%V\T2NUKHO'@E"*G;% M:N,XE6&EC5RE=9I'8CY@@@[Z"\FHDJA?8L6PE1?G*TV"D,*$S.TWC[:/QX/K MXT-C5:U&?-AB$5M1WTM0_UZQ:08A9CA,@=5$7&%UFX:?O8"M#(>M)-HZ'HQA M98U<94W;B[$Z3_0!KA/N&9G^BUKSD7=>B4]P=1PNH`B M;O#J`1\Z=A6GY@/KX"9!_+S`%1&%8WPX!?")L4X]\(.XOG3:_0\``/__`P!0 M2P,$%``&``@````A`!21[=7<`@``LP<``!D```!X;"]W;W)K&ULC%5=;^(P$'P_Z?Z#Y?>2!$@HB%`5JMY5NI-.I_MX-HF36(WC MR#:E_?>WMDE(3`_U!'9V/5G6=Z^\1B]4*B::%$>3$"/:9")G39GBW[\> M;VXQ4IHT.:E%0U/\1A6^VWS^M#X*^:PJ2C4"AD:EN-*Z706!RBK*B9J(EC:0 M*83D1,.C+`/52DIR>XC7P30,DX`3UF#'L)(?X1!%P3+Z(+(#IXUV))+61(-^ M5;%6=6P\^P@=)_+YT-YD@K=`L6K9[*1DBRKZ'OUVA.LH[;/ES0 M+[:+5;XF"SMO/YP^A1#7XC M58GC%\GR;ZRA,&RX)G,!>R&>#?0I-R$X'%RZKT(S-G,"":;-92'!&8`DJIEAB+12L@/"D_E>][ M@8EF!GUOX/80J%00?=DDX7P=O,!PLA-FZS`+C'I,-$;L.H29*>CHQ4`;OIA9 MV-7F*F8\3N&F(D!J8Q$-,-P$2-"'.W9B+;+G#N=C[W:[Z'.2L? M59V_6]5$1U6[P+EJ$B9>IQW&GS(X[9W&3'14H@L,2RR\$AW&+Y&,2EA7#2[2 M9,'Y`X,DX>V8>>LPT$)O(L]FNVN(T4C!B8-^?3$FFV)P15\H"9>>&(>YM7Z? MQ?Z<73:*8YN?)F>WCV287>^]:8.9F*PG(PH]&0XSMV4BWV/_28XD+*]*,%E? MPKD7YW:'.4DX6]@F8<,:@HNDD^"6I]L]G,J2[FA=*Y2)0P.3CZ"I/NIV]A9V MMGW/@CX!J[0E)?U.9,D:A6I:P-%PL@`;2K=UW8,6K:%$>Z%AB=J?%?PY4GA? MPPF`"R%T]V"LV__=;OX!``#__P,`4$L#!!0`!@`(````(0"^T^S[(@,``)() M```9````>&PO=V]R:W-H965T$L;6"FXJ(F"5W$(9"LHRKMT"Q9Q53 MKX84HSI;?SLT7)!]!7&_1'.2]=SFY8*^9IG@DA=J`G2!%7H9\RI8!<"TW>0, M(M!I1X(6";Z/UFDTQ<%V8Q+TE]&3/'M&LN2G+X+EWUE#(=M0)UV!/>=/&OHM MUR;8'%SL?C05^"E03@MRK-0O?OI*V:%44.Z%WI+Q"CS!+ZJ9[@$(G;R8_Q/+ M59G@63Q9+,-9-%U@M*=2/3*]%Z/L*!6O_UE0U%%9DFE',@.9W3J8QC<'5H@) MX($HLMT(?D+0%>!*MD3W6+0&PDYYY][%`BG--/I>P\TF4"G!^KR-H^DF>(;D M9!UF9S%+C!PF\A%IC]`Y!1U.#(0Q%#,+G6^]ZON>SGWBW16(CTBO(!8.XHF! M;)R)Z1.@K5"UL^#B:.8(3))V%C,_PPQTIF,(3P207!&AK0F&4%R&YZN!!@M9 MF1*%DV&BTL&RV^PYAY8\M47$4>#.'<6[")F,,X25##XVW$]N+T-;W^M)BQD2,(3P1JZLBM-7/Q$5?6LB8!HMPG>L2 MZ?F/X(Z^D@5C]A7$T=)1V%ITH#$-HQ!?B'^!]N6([!4W?D]TH%$AENB M;[;+OH"Q]VY-.HQ+^>`4Z]&I.<9$V-%H)TM-Q8&FM*HDROBQ@<,=P5EU5CN2 M=WHDFZ'J%F!0MN1`?Q!Q8(U$%2U@:SB!DXZ$G:GV1?'6C($]5S`BS6,)WSX4 MYE,X`7#!N>I?](1Q7U/;_P```/__`P!02P,$%``&``@````A`)@$)YCX`P`` MF`P``!D```!X;"]W;W)K&ULE%==CYLX%'U?:?\# MXCWA*Y`/):D&PNQ6:J5JM6V?"7$2-(`C[$RF_W[OM; ?MO@S#O><>'Q]? M;&?]X:VIG5?2L8JV&S>8^JY#VI(>JO:T<;_^^SQ9N`[C17LH:MJ2C?N#,/?# M]L\_UC?:O;`S(=P!AI9MW#/GEY7GL?),FH)-Z86TD#G2KBDXO'8GCUTZ4AQ$ M45-[H>\G7E-4K2L95MWO<-#CL2K)CI;7AK1_NNKP MJ6H)N`WKA"NPI_0%H1\/&()B;U3]+%;@2^<ON;5*)8LYL#RHC/I*>/:5H3^=!_XR^D7AK"^$IQIRH/O!B*!' M3!B>?6$P?ZC5DXX)IW<%+[;KCMX<:%_PA%T*_!B"%;#U%O>SU:;#VI>(?D*X M*`([&41?MTFP6'NOL(IECTDE9NXZ&A.8B$PA<"61=F<'\D'``Z5:+BS._Y&+ M<%-N')M:4@D9J@U-1*806JT*W"<86JRY@F![#_5#BPST*U`A"Q$ARRM M9":3`>P'FF!F&;@;$DP2JX'RQPR&X]#4#Z:"66LJ2\MX"9F)J4SLWE!)[;D* MX*=AJU8YV^UD+#'QM=N8-24F@:U18J3&R-2?R9SA=A+Z)F@W))B;N?P7!(;; M\!T]( MGL16!^4#N+'8V%,#)]5N)L*PZ\KC%?G3<2@;AW;C4&Z$S,'QB+"6$2X'[Y]< M\D@9[EKVII."9'06[C3WGB+,[2"_Q.)0;(5,XG@V6<%C<]X4CWESNT?>; MHF1;>;2P^C:[H^[2=:$*X96NY])M*:]H\N+0D.Y$,E+7S"GIM84M/(&]2D?E MU3#%JR'VEQT/5W">CN.[<`5GYCC^%/A`)*Z)-E.`0_QTC`#(8!*H7A?!=?%2 MG,CGHCM5+7-J<@3A<$N#CNGDS5*^<'H1%X8]Y7!1%/^>X1<`@2[VIP`^4LK5 M"PZ@?U-L_P,``/__`P!02P,$%``&``@````A`*$'05^=`@``W@8``!D```!X M;"]W;W)K&ULC%7;;J,P$'U?:?_!\GL#Y$+:"*B: M5-VMM)56J[T\.\:`58R1[33MW^_83@B0*.H+8,^9XS,7#\G]NZC1&U.:RR;% MT23$B#54YKPI4_SG]]/-+4;:D"8GM6Q8BC^8QO?9UR_)7JI773%F$#`T.L65 M,>TJ"#2MF"!Z(EO6@*602A`#2U4&NE6,Y,Y)U,$T#.-`$-Y@S[!2G^&01<$I M>Y1T)UAC/(EB-3&@7U>\U4*,7G"JI):%F0!=X(6>QWP7W`7`E"4YAPALVI%B18H?HM5F MB8,L][Z1KN3^F^+Y#]XP2#:4R19@*^6KA3[G=@N<@S/O)U>`GPKE MK""[VOR2^^^,EY6!:B^L"Y4UG`1/)+AM`8BF2O$LGBR6X2R:+C#: M,FV>N/7%B.ZTD>*?!T4'*D\R/9#,0.;!#EO7G0,OQ`7P2`S)$B7W")H"CM(M ML2T6K8#PH/QP?!<+9)1:](.%.R=0J6'W+8NGTR1X@^30`V;M,4N,.DPT1&R. M")M3T-&)@3!Z8HYGVMWAF8O%D'!]#AF)VEQ`G$@&(B`+%T387:A6+ZA9/!^I M\)AY#S-";*XA!B*`I"?"E66^Z*I@K2F&D+H,Q]/92(S'W+H:A4/;IF\[)6H@ M`-KQB@!K'0L8Q;KVF/E%`9=M`P'Q50'6.A9PJJ?KU;7'>`'C#NS;3L('`J"! MKV3`6L<"XF&:UQYSN027;5Z`GS/^F@JF2K9A=:T1E;O%O#>',S M(N@,,'5:4K(7HDK>:%2S`ES#R1(RK_R`\@LC6W>WMM+`O'&?%?Q'&%SV<`+@ M0DIS7-CKVOV9LO\```#__P,`4$L#!!0`!@`(````(0!7=[!$&@,``)<(```8 M````>&PO=V]R:W-H965T&ULC)9;;YLP%,??)^T[(+\W8')K MHI"J7=6MTB9-NSX[8()5P,QVFO;;[]B'&$AIU9<$#G^?W[G9L+EZJLK@D2LM M9)T0.HE(P.M49J+>)^3WK[N+2Q)HP^J,E;+F"7GFFEQM/W[8'*5ZT`7G)@`/ MM4Y(84RS#D.=%KQB>B(;7L.37*J*&;A5^U`WBK/,+:K*,(ZB15@Q41/TL%;O M\2'S7*3\5J:'BM<&G2A>,@/QZT(T^N2M2M_CKF+JX=!!IN\D$9&#+ M'BB>)^2:KF_HE(3;C2O0'\&/NG<=Z$(>/RN1?14UAVI#GPS;_>0E3PW/H',D ML!W92?E@E]Z#*0*(=@(+T?].F.O84D*/Z5^?D'>N;=]5D/&<'4KS0QZ_<+$O M#)#F=GDJ2]#";U`).SA0+_:$88C,%`F9+B;S932E\9P$.Z[-G;!K29`>M)'5 M7Q31UA4ZB5LG\'_$YS%D4(4$\&6H]\`EBK!=C: M6>(-&OK^XG%_TX$_E\G4]A8#MT^AVKVPIMX-@E`QZREF7C$('"0C@5MK0B!: MG_?<+T<`*OJ`A5<,`#`*(P!K'0*6?CD"4-$'7'K%`+`8!5CK$+#RRQ&`BCZ` M=NT?$&!"1E*PUB&!=L.!")0,$*_TVYZXW>2>^FRM9XCS1J-D@'BETZM1A+6> M(AF_4B4*Q]-(#LY\1NA&!>O4:@99=/,PZ`6U6_)EI9SYC-+- M2TO!W3R@=$,QI(SO9XK[M[\O>M5H*:CI4^)N+H:4MWQ-WX]/24+-P MS8FG=+Y:Q;1+''%X[.-)67&UYY]X6>H@E8?:G<_;C;?Z]U+[PO`/X.!OV)Y_ M8VHO:AV4/(>ET60)VU3A.P)OC&S<.;R3!HY\=UG`!P"'TR^:@#B7TIQN[!O) M?U)L_P,``/__`P!02P,$%``&``@````A`&YS;'A.!```@1```!D```!X;"]W M;W)K&ULE)C;CJ,X$(;O1]IW0-QWP`DY*LEH`/7N M2#/2:+2':T*J^TX06K M=SZ9A+Y'ZYP=B_J\\__Z\_EIY7N\S>IC5K*:[OQ?E/N?][]]VMY9\\(OE+8> M>*CYSK^T[743!#R_T"KC$W:E-5A.K*FR%FZ;<\"O#:ORC[BKLN;E=GW*674%%X>B M+-I?PJGO5?GFZ[EF378H8=UO),IRY5O,`,' MQEY0^O6(CV!P,!K]+#+PH_&.])3=RO8GN_]!B_.EA73/<4C.2I@)_GI5@34` M2\_>Q/5>'-O+SI\M)O-E."/3N>\=*&^?"QSK>_F-MZSZ1XI(YTHZF79.X-HY M(?#S@X-GW6"XZL&3Z6I.YHO_@1!U7N#:>_G@.@(9$Q'+-&NS_;9A=P\*%%;- MKQF6.]F`XRZ(721T6"&[.:J_H%P,@H!Q>/JZCY:K;?`*>9SDL#7MF`Z*%:TVZ)57&AZ1K)RE:;5*KT&*I MB<1^(3/KI9HHZWL@,OU*@>N8+OKB,(J40)MU1%28;=#^E22U"DQ6;%A6*$=5JWL M)P^JUM5T1+$D\*6+:WZ,J4+W)404NB:24)T%Y>JEHQ6PVN*0./43^4)-"8;.&K@F4(;X%QXS<[T>]:8&C/H7#2C@!\8FQ5MW@!/J?!_M_`0``__\#`%!+ M`P04``8`"````"$`$)16>7'Z%KDR4;_F53ZM^VOOZP_BO*UNB1)K8&&O-KHE[J^K0RCBB]) M%E6SXI;DL'(JRBRJX6=Y-JI;F43'9E-V-2S37!A9E.8Z:EB57]%1G$YIG`1% M_)8E>8U*RN0:U>!_=4EOE=26Q5]1ET7EZ]OM*2ZR&ZAX2:]I_;-1JFM9O/I^ MSHLR>KE"W)_,B6*IN_DQ4)^E<5E4Q:F>@3H#'1W&[!F>`9JVZV,*$7#:M3(Y M;?1GM@K94C>VZX:@?]+DH^I]UZI+\1&6Z?%'FB?`-IP3/X&7HGCET.]'+H+- MQF#WH3F!/TKMF)RBMVO]9_'Q6Y*>+S4<]YQOB8LK6()/+4MY#D#HT6?S_$B/ M]66CVXO9W#5M9LUU[26IZD/*]^I:_%;51?8O@IA0A4HLH02>0@F#KU_<;(O- M\&PW_V\/'*$$GG?"&'$=@FSBAZ>T;L^88RYX^"/[%F(?/*7!^6PYGSN+I?MU MXERA!9Y2RY?9-_`DFPP(HCK:KLOB0X-K!6=5W2)^2=D*%(NC%\&TR0`Y&7/T M,X(;MB@?$1`\I:C*4B=D/$8J%"@B'$<6P5LY<8GJC< MNP,*X/.1Y7`,80`E+2^0DI07VVQIX*LJ#?.YZIR/$+=)?>[B\A7Q0 MM>PEI@T1!?T0G86G;@KO8%RSQ2AAPCVB8<+-?WC\',[CEN[X*.A%206!%/2B M=)S6F>;<]A(CU1Y0H$1)-X7C&"5*N.B]*&4N(MKXI>"AV7`,H<0.I]F+'2^X.X.")6G@@(T..=.&R!BE`3%@L\50 M&B81`2*63=&P'8OC=:[ZJ M(ZH! MJV-<21!N83Q#&@1EA*2[+T!CE$Q#`@%!4IXDS!(VR,@D)A!:9+99'JOE>`"9H MD88XMVQ.7`V)$69W]4!E!H*AS/0O$5\FI65)6S2&H%%:)B&!T(*TS#VO,Z'RPEL[PDL_5;#S4TGI2G=SB#Z3O>,(*9.00&C! MAA[^.0U2!55,<((@5$)8#1];4"GA/5Y'B?Q?PT3SV/NW.A3MAJ)@*-H/18>A M*%1$JHN\Z^I2ISH/*=Y MI5V3$X1CSOBTKL0!*?ZHBULS!WHI:IAW-E\O,,A.8.!CS@!\*HI:_@#31CL: MW_X'``#__P,`4$L#!!0`!@`(````(0#HPR6,`@X``*<\```9````>&PO=V]R M:W-H965TV M#\>[>71U/9_UQ]WPL#\^WG[N^\L,'H[GN_GSY?*:+1;GW7-_V)ZOAM?^",GC<#IL+_CGZ6EQ?CWU MVX?1Z/"RB*^O5XO#=G^<:P_9Z2,^AL?'_:XOA]VW0W^\:">G_F5[0?_/S_O7 M,WD[[#[B[K`]??WV^FDW'%[AXLO^97_Y:W0ZGQUV6?=T'$[;+R^(^V>4;G?D M>_R'<'_8[T[#>7B\7,'=0G=4QGRSN%G`T_WMPQX1J+3/3OWCW?QSE'7I9KZX MOQT3]-]]_^/L_/_L_#S\:$[[AW_LCSVRC7%2(_!E&+XJU>Y!03!>".MZ'(%_ MG68/_>/VV\OEW\./MM\_/5\PW$MELAM>T!+^.SOLU1Q`Z-N?X^^/_ MK^>S+_WY4N^5S7RV^W:^#(?_:6%D7&CCV!@GZ)Z6)ZNKY?HZB>+EAYVDQ@E^ MC9,(__M&JW`]=AF_QB"]BC?+:+E2K;YAN#*&^#6&\=)V]PU#9&1L$;_&\&-V M6$VC'7X_%MJ-,<#OAT);Z-$<9T&YO6SO;T_#CQF6%L;M_+I5"S7*X,P,OTG. M-"$P+W=*^[-2OYLC/`SY&>CW^SA.;A??,<-V1B>7.A'7*$A#S3+EMO2!R@=J M'VA\H/6!S@$6B'8*&9/Q=T)6ZBIDZFQ.@),#+S[2()/2!RH?J'V@\8'6!SH' M8/%AD?U.?$K];H[_.D.:\H!RK1,AHY.2IU),*E/0`JD$4@ND$4@KD,Y%6.BH M![\3NE+'Q$!&MO(@FI2DB M@50"J072"*052.W>0A$IE$>D$8PK=;802"F02B"U0!J!M`+I7(1U M']MAH/L*Y=TWR$C2QNVL$$@ID$H@M4`:@;0"Z5R$=3\"%W3Z;[;VJS66V^5Y MO_N:#UC_D=W9E3H/;/0`"`/LE(JU-]6,5HR.6*WK#=#T4;;#YH5:I-T!]^#278;9VX;_C` M%L:0:44K+SLE:=V,V4ECKP)7)+7CN1C6SPWBE@$ M)J`[&8M7O'5TN&UGU'AF.6>8"*6]@`IZ6M*0<+1$.).RQQ$ONC;K3, M0HJ\RE]&DYS241'DKF.CY4[OR5!5M-2OI2UYL46P(RBP:!7_"$2M:0F+6D.( MFOI;J+T-TW]C5U4IH8H@.PJU@=BB%;Y:,K3N.X("BU8Q$1O(.#_5'4MPM]:L MA45GB`S*T%2N$U&MM1*FF%6*_0VEC"8M2E1%D+O+!Q:RZ98=_H8,>8O>YMA: M+6JQ(^A7+?*IKVB0S=TT]17LD1H-L:F?BIEOE-Q#QS5>ZMKT9JM1+J&,0F=ZR(F!=@O%('89KGHX87DS+")2U&?RH'<>)-T<(8 M.F6LE%`EH=I`Z#2EK)%:K80Z!O$P%8&R84ZQ:5[EEKI80XRT+/TU3$IJY'%- M*=B*E5,$E8&/6'&90,2:XK"(#>NQU+90I`4#C/"HI5)"E8%8 M3-K0@1IIV$JH8[YX((J1!`(Q1,4NICS6T`9CXPR=?[%FM)*-KBH\QZ654N05 M07;#JR74$*3=>E6ZM5)RVQ$TNN41*SYA(Q;;H7?OH^YM/(ID(&2"FBL,E%HB M6TJH(LC.A=I`SIIM2,OZ:B74$33Z8@%B>K@!4J498;X'&HCO$]ZIM2`E,Z*) MMUA+*Z=L5`39/;XV$'Y(JR$MBU/\W9NV!G(H M26&@C4-3)51)J):^&JG52JAC$`^0TQM]O&,L3MVA^3%I2&V[3E'R&$=A#)WA M*"542:BF%NT(-5*KE5#'(!ZFHA:V_$RK4S,.=^=(-,08ZE*L3JWDU(_2V#E0 M):&:O-M-J)%:K80Z!O'0%/\(A*9I"0M-0XP&I#[#2;02JT[RD$E:FBM$5VOO M.K,R"L[@UQ)JR`V6S3211&,M:5%C&Z_/'?/,DZ,X32`YFNJPY&@(R:&Z5V`L M1\9@M^.2(#M^E8%8I-K0@1HRM+Y:@JROCOGB@2@28@-Y;_],-&=A`6IHXQZ] M4I](&#OLJ'9`XL0;W-)J4:XJ`VU0;^U(BBM5H^44P\;ZLH:Q?T/46BUJL7NO M19Z^,.$"81*US1`N+(,ID%24-JVT=',IYFUIO..AE&*^6"3>7EN1@BUTM8'8 MU/E(8RWYHL;\6^F.%,;&>')^CYLEDIL9B"T>K75CJ4=)6C;&+`/" M5TN&UE='D-S%4\[-Q.+Q=O%1G=,4`_%=P1O.PBBY^[J$*@G5Y-U6@D9JM1+J M&,3&%,<56J8YYYCM7<$HO;,K6"U*3$7>W]X5C):[*UA?M@K' MJ?>%KK5:U&+W7HL\?6%6F$I6:"!.G?Q=P2B]LRL8+;LK>$>[BA1L::L-Q*:. M[N3;C;7D:]H5O`V_(P6Y*Z2*"'Z<<8SJ7F715/+&3N7":*7.T<=`2WOPK@BR MRZ*64"-]M:1E?74$C;[XZ"N6]D:`_JZ@29U+J5(#V=VK8!!O+L#@XOC*7I>G MDK,9:)F.#.*35TX+([Y!89FXRM)>T_#F%8OPHGWGW1JFJ"@7AHN@JU.+<2KZ M-6G1NBR-+SP0(ZB24"VA1D*MA-1C=-55[5['K1^7ZV?%A_[TU!?]R\MYMAN^ M'='U"!_R[F\G7#]KS]<9WHVA@SZ>;NB]NR?!`LO4K),V6%FP"4GP>/[S.!L] M7SD>U8]+QA0E[#GHHF0I$B3K$1QEMX:2%0EEY(<*D!'P[4R142D"T,2XA"0@B>C`28F^(0?>0MY`D1T;S7V0T M0@Y"N2YAHSB)[!L(&'H0DH"'(0@8OK`Y*&DB:H"1'I/DO M(EVB;Z$H&\A"2Y1T+>0!!>-\!8:.5P;8GQ"$MS: MP2:T&G$'!YN0I$BPLG!!)>/!Y19L0I(\N4;>0N4.5]_(3DB"&VZT$Y+@HAO9 M"4EPWXU9%9+@6AM]"TGPT27+<=,OXRD@49\8I`1?5#+UI4%*\&$E4Q\A"J5?C2")N0)(]7B#2TYO`U$)&&)/CL MAW9"$GS]0Z0A"3X"(M*0!%_[T+>@)+J!)%03\0P"/0B-'!XUP"8DP9L"V(1F M/%X(P"8DR>,$V0GG&KM94(*O]6@G9(./]LA.2()O]\A.2%)$F&]@*G*T\8(I M4^^3I"1'WO)PWB`I@A(\&D(\H5SCN1#B"4GP:@CQA"0-)$U0@@=#B#1DDT>8 MB?JIB[[L`E)\(05\8367`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`/7J?. M.N58HR$:KI=P;ILI:*6@G8)."KHIZ*6@GX)!"H8I&*5@G())"J8IF*5@GH)% M"I8I6*5@G8)-"K8IV*5@GX*[HGI=CX\(*<($]^,OA8G3=V$B%5P7$,1-$A.B M(2;-%+12T$Y!)P7=%/12T$_!(`7#%(Q2,$[!)`73%,Q2,$_!(@7+%*Q2L$[! M)@7;%.Q2L$_!W5U`HIA`.TLQ42T5+8438XP7M135N,[KN8X;`13-22U6:10J M15P0:1%I$^D0Z1+I$>D3&1`9$AD1&1.9$)D2F1&9$UD061)9$5D3V1#9$MD1 MV1.YNPM1%"_H7"E>W,`H'T1S5^/TT2TA_(K@X+[&*YV*H$*EB"`B+2)M(ATB M72(](GTB`R)#(B,B8R(3(E,B,R)S(@LB2R(K(FLB&R);(CLB>R)X7,TK_OCD M%T40@B6,(!F3.'P,%*G@>DZN,;`*0B=M60HE,6L2:1%I$^D0Z1+I$>D3&1`9 M$AD1&1.9$)D2F1&9$UD061)9$5D3V1#9$MD1V1.YNPM1%!>H9RLN'([C(B>7 M\?#U,NEQ"J4B+HBTB+2)=(ATB?2(](D,B`R)C(B,B4R(3(G,B,R)+(@LB:R( MK(ELB&R)[(CLB=S=A2B*"]2S%1<.QW&1$SS#294WB#2)M(BTB72(=(GTB/2) M#(@,B8Q"$I4#'O^MD4 M.J'KF]AUMU`2LQZ1/KD>%#KJNG8=>QX6.N)Y%)*H2-W,7UBF?@+AG9O5>OOZ M]/![_8#2*1=/!4?]N+`]N@WN/H\J2#8HVR2;3=62?+88M3VJYA/);K:AHUHG MW'=52]SW&/79_8"UAHQ&$8K+U#V7!Y,R,LYQSTE)H'ITBR8P**C;N#X;7JN* MH7FA5;Y*XJDI6I?':9V;TG6BT!(%?:QO,^H(.IE85[3RQ,HWM23//5'0Q/J, M!H).)C84K3RQV]M*$DDC43@F%M>%>_JUZB)_*L;3B01'W3VIH'IN-<<-CZJJ MU114*PQ;@HZK-,?YL#:CCB#UU16DOGJ"U%>?T4"0^AH*4E\C04=?<:FXASRK M5!Q/[NX<78H>>ZPR]8]#6E=UMP"!XD"9BM^& M1T$)-1FU/(H*+?<5H`X;=AGUV%>?T8`-AXQ&D6%<*F[0;Y5*_C"`$)4BJ+NY M!)3*%89!12M7N4Q[;:]5O3E&6JV6C/Z;*A?'+4%Z3[49=02%XX$RAUJ>220O M[GMBJ.[[C`:"_B;?0Y6+XY$@X_YU0V:K5/.A=%2J.4*IBM]&.4?!-309M03I M9;49=01I>709]02IKSZC@2#U-60T$F24BAM`6Z62#ZRC4LE1TJHE"R$-MV27 M-UNN>:@EH=A4L11MRZ/@;FPSZJCAT6_WN.R@E4MZM,;1(6;? MPU[7&/'EOJI^Q(==#7$HM<2-WOQM07HK=@2=3*PK6C+BNTSRW!,%3:PO2!,; M"#J9V%"T?&*E6C6Y^4:B<4PM"EVWY!U6QC^%[E$_'O1X='NKC:9HE31LF@73 MZ&H53.^$ML$Z!5-_W8*IOU[!U%_?8(."J;]AP=3?J&!'?W'!)<\M5'#+PX_P M6;#"SS,>H?T+HSL9#C942UJB)J,6HS:C#J,NHQZC/J,!HR&C$:,QHPFC*:,9 MHSFC!:,EHQ6C-:,-HRVC':,](RPMYA&0=W=Q+/W-T8[1DA9L):BV/&/24:O:C;$93&3(["&5^O%:`FHQ:C-J,.HRZC'J,^ MHP&C(:,1HS&C":,IHQFC.:,%HR6C%:,UHPVC+:,=HSTC!$A8MW&`_,TCMMOW ME0:(1_HLT1`M14U&+49M1AU&748]1GU&`T9#1B-&8T831E-&,T9S1@M&2T8K M1FM&&T9;1CM&>T8(D+!NXP!)9AMH!)/,9J.QH,#QJ!1,SHA:"<^#P:`]72L( MU*2/:AFL;;".P;H&ZQFL;["!P88&&QEL;+")P:;"=,`_$Y245#)?.P_4I*06 M!EL:;&6PM<$V!ML:;&>PO<$0=A(9QB/'W\S'N*VA:W!IB64*L M!R&7S+(WO5I-JZ`EEAAB!997R7BJ':A)%70,UN44>H%:F$)R"?U`35(8&&S( M*8P"M3"%Y.K'@9JD,#'8U+-@H#@+U,(4DE*:!VJ2PL)@2\^">E@%:F$*22FM M`S5)86.P+:>P"]3"%))2V@=JD@*"V8=A/A"/&U$WZV4-P_+9L&CH[A&"65PW MW"YD%_-QY%XE*P9-4<,RFIBV"H;'"@WZJZ2=;0=J8MHQ6->SH-I[@5J80C+Q MUP_4)(6!P8:!2ZPN+033J^=F&J,S(=@W4]BT)74BCNEWYA6:`!HR'[ M&A5:)W,[#M2D^"<&FW(*LT`MK."D/.:!FJ2P,-B24U@5:L7%KQEM&&W9UZ[0 M.ED>^T!-(O"T9MJF+4+M:*\ M.HRZ'D6!1[[Z;#A@-&1?(]8:,YHPFK*O&6O-&2T8+=G7BK76C#:,MNQKQUI[ M1HB;L%BC5@R%;[9B1Q[/G0D*PZ9@<=@DT_5-40O#IF!%C+09=1AU/<*/W!@] MUNHS&C`:>H0?\35BK3&C":.I1_@17S/6FC-:,%IZA!_QM6*M-:,-HZU'^!%? M.];:,\+V?!<OC%^EK:"@DJ!0L?!H8?<;B%?E* MBWO6CYXKVL)-6+VR8/^#Q6X[L&KLV[QO&D,\]1N%7';0`X MMO:Z/:+I6547U5N"=(VX+4@-.X+4L,NH)TA]]07I4_Y`D&H-!:G[D2#5&@O2 M?$T$J>&4T&T:/5==)F]%5+W`\$X=8J6M9R>E,/.<61 M&.:;46\J26,X5KFD-6$O4T8S-3SV5[>)X[G*Q?&"O2P9K=10+[5RG;A?JY:X MWP@Z649;3G$GAE)&28NZ5[FDA0C.PRH/FSB"W=2X-33P4^9Z:]2Q6F*H0Z0^HX$@S?Z0?8U$2WV-&4W8 M<,IHQH9S1@LV7#):L>&:T4:07N.6?>U$2Z]QSP@1DE>1%2%_LT*"YI#:N!S% M^X"ODS:L(8;8>NQNQO25@*:7Y\WM<5-^2U!N42ZE>XO;JB`1UA&D/4R744]0 M/-Y-)KOZJB7N!X).WK]#T=),C`3)M522/F"L"I+81)"ZF3*:"?*>*^5D7#Y7 M!?&\$*2>EXQ6@N)22A=$5$O<;P2=+*6M:&DF=H+D6DI)8GM5D,00Q'G\X0>$2+$5]'1,HX0-QEL18CCR5`N1\E0+KG9&MBD?S24H5PR M)FAZ>=1/YB;^79SJ==(,M;U)\*I)A[UT&?74,!BEW"1/]7W5DO@="#IY_PXY MQ9$8YJ.4:BDIG;'*):T)>YDRFJFAZSRJZ?/Z7.7B>,%>EHQ6:AB64?*\N%8M M<;\1=+*,MISB3@Q]&95I)%>$@Z2%`,Z9U4^[66DK@/ULM=X_]6J.HI&FS89S00I-D?LJ^1:.DH9\QHPH931C,VG#-: ML.&2T8H-UXPV@O0:M^QK)UIZC7M&B)"PUJ(F#H-M,T*./&[B/(I''7:2@_%VJ2CGQV%:YA'Q'D#;V748]0;@]BD?.RDUR1_552]P/ M!)V\>X>BI9D8"?*OA24-Q5C%DM1$D#J9,IH)DB)*6LZYRL7Q0I`Z7C):"8J* MB!Y554O<;P2=+**M:&DF=H)\$24/`GL52U(X@29?)#&&<&A@[.CEQ9"C:CR$ M\ZB,4)7$FIY%\9D[0RLK6FW14M01I)?:9=03I(9]1@-!>N\/!:G[D2#U-68T M$:2&4T8S0>IKSF@A2'TM&:T$J:\UHXT@O<:M('6_$Z2^]HP0(;Z*CI9Q^X8` MM7K`FN-)^Y:C:`AWF\1G0^S\""Z9^&IZ<=#+M3Q"%H]S<>GT7EOE$EX=]M)E MU%/#L'E+&MR^:HG[@:"3]^Z04QR)H;^44C(6':MRRC=WCA7 MN3A>L)9@`/=/J\!'_22L\YGJ<&`G6N'`SK,HG=('+D)=::7TW0=K1;VEGU9&Q@I?O*@KAOD:W"7.J([?=>V(@DXB=P5I]]`3=#*QOFAA M$%QDJ9(NJ@Y$*_)%"Q2BI9D8"8H,TU7'L6CE5URKWB9/VA-1T"N>"M+$9H). M)C87K3RQJVKZ=N]"%#2QI2!-;"7H9&)KT8J+-^DX-Z(5^4J+=RM:FHF=H,@P M+=Z]:/F`HET"N%5\8!XO.;Y5W#QW<*O\8R.;SXN'^T]K'N$]9KDY&L+P6J6P MIK"2WGZM@NF-U2Z8VG8*IK9=@_4*IO[ZPO"ZGN1E("QX!WI8,-4;%4S]C0NF M^9L43&VG!IL53/W-"Z;^%@53?TN#K0JF_M;"@NO="`NN=ULP36-7,/6W+YCF M#Q'E*SVOS#BDD@628TCAXPBP2`]8S0_F2E[&QC:QE7_U(S\P_OGQYSA\,?WQ$1E:M;/&$4//_@ M2+UV57QQ)!&AR26SJ[LLFQYLC%50@,"VJ$!RW M9R06=T@<5\_YJA]S90DNX4*O5WF&A-.!)U>YIH4EJ"CRUS#PA)T M;IEK7EB"#BUSC0Q+T*]EKJEA"88*F6M@68(Q0N::699@J)"YQI8E&#%DKLEE M"48)F6MX68+A0>::7Y9@$):Y3HN`6((Q5^:Z(98,(7&= M$4LPW,INF M68)G4\2;%>UX1$5461(\@R*J+`F>.Q%5E@2/G[BI+0GN9W[!&+E@0/^(A%2X+G?$2<)<'C/"+.DF#"$%=DM2RXF)*[(DM6A[^Z MZ0\S.(@%*R5,WB`6+`GF<%#CE@13-:AQ2X(9&]PIE@03-[@?+`EF9G`_6!+, M`*/DK"O%1"]*SI)@OA M2X+))NY MM3268(TV%Z+`DV1B'B+`GV M1R'B+`EV02'B+`DV0R'B+$D=$K>CATL4V]`0!Y8$&]`0!Y8$^]`0!Y8$N\T0 M!Y8$F\X0!Y8$VTE1/]8(`KM*43^6!-M&43^6!%M%43^6!#M&<0=9$MP\;IAM MRK`]%S5D66&7+FK(DF`S+FK(DF!/+FK(DF!K+B+;DF`'+B+;DF!;/Z[(ZCMQ M,6[D8\KJ\."]%L2()<$++8@12X+W6A`CE@2OMV3N+0).!Z^T('HL"=YE0?18$KPQ MA%JP)'AQ*.N9$KPLA/JQ;/""$.K'DN"E(-Q!E@3O!F7N#0N^GCHD=5."=ZX0 MHY8-7K="C%J2%B3N#1-.!V]:(7HM"5ZQ0O1:$AQD@3BP1CT?WMUVHN-R;]*UXTU<)[)Z0KQM"5&^=)5:5=W$A)E#'/.!>\7*.T[[ MR-RQ'9QU'*8`B95SO,$.B95QO(X,B95OO'&*^^LXS9AD&V\,0F+E#<>?X(ZP M)#@%)7/'F7"N<<@$)%:N\68_)%:N\4(V)%:N\>%20&+ENH=%J['O7%NV.!ZW+O# M+,$ALR@=RP8'RV;N6%2VP8&RF3L*D["G?FSJ%F"0[QSMQQU"S!6=ZX4DN"SQC`YKC(GP0/OF8`&TN"KQ:@="P) M#MU'Z5CEUH#$'0O/><-Y^B@=2X)C]5$ZE@2GZZ-T+`F.ST?I6!*3:DN"[$\BU)<'G)Y!K2X+O2R#7E@1?1H&-=0?C MDRBPL23X,@JNU)+@`RF9^]H'7P\^BH+:MB3X&@IJVY+4(7&?.6%O^,1,YKYV MPA)\5@8E:DGP/1F4J"7!9V50HI8$7Y?)W)=0.)TZFC>KSZBC<)!=<%/E]_?C^Q_V7 MQ]']RY>G[Z]GWQX_8_$-7P_'TN[+TQ?WQ>;\/V_Y\=IGOQW>W@[/V).%SSD_ MWG]ZQ">/2FX=^//A\";_00%>_'5X^?WX1>B/_Q,```#__P,`4$L#!!0`!@`( M````(0!Y/3:!+P,``#@)```9````>&PO=V]R:W-H965T%A./Q. MTP2_48GO=Q\_;,]YRRECSP]5;16AD30DBCP+PO6R`M;E;Z' MKB+B^=36E*,JG3S]5AS00XEK/LUG)/TPMV^7-%7+!5<\EQY M0.<;H]=KCOW8!Z;=-F.P`IUV)&B>X'VX>0B7V-]MVP3]8?0L!_^1+/CYLV#9 M-U93R#;LD]Z!`^?/.O1KIB&8[%_-?FIWX(=`&NN_0"K2+N;!Q,#3QH0VP@=V*P%^)R0TJB5TKK3F@P&&?-$T MWVR23Z,)AJ>U$ZUC2V`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`VK\_V@QX%NB.?GYH@ME0\5 M3YEC[Z9SU_?ZM\K%'W1YKUOB^;E)>E@O>9_J'Y^;IB<+PC,KXLI@>K(,U#\^ M.6!9")Y9"5?&!:M:S]6$]-H!2TP]$]2/EU&KV#WYKAMO+INGAU/VLX%4!J^= MWS^E[+-1/ M^5[I*]^+UX8"3#`Z]5",1$.:C&TPL4%@@]`&4QM$-IC98&Z#A0V6-EC98&V# MV`9)!=0Y:O2Y72V40F1`(B(9$I MD8C(C,B M:J6/@E&JE,$@,B$2$`F)3(E$1&9$YD061)9$5D361&(B2974@@&_5X,A.5WA MW.?BJV%!!G@Q5:)@K_=229J-B4R(!$1"(E,B$9$9D3F1!9$ED161-9&82%(E M-1?#9547Y^_33O\&^K];\:I%W?L%Z==?LOWZ'AB52J7WB4R(!$1"(E,B$9$9 MD3F1!9$ED161-9&82%(E->_#957ORP)7N.[B@E@NOK5<7"J5+B8R(1(0"8E, MB41$9D3F1!9$ED161-9$8B))E=1&]$9$QD0B0@ M$A*9$HF(S(C,B2R(+(FLB*R)Q$22*JGY$W#/`JO+SMMM^&&3SLE8=P=;2V5KP@,^F11AV$OXQ/IVU->FRT M9-(31@&CD-&44<1HIE$M/L6$/A[J@FTM&:T8K1G%C)(:JL='798^$Y_B,`HT\CK=4BTT:JH0 M`=/616%J%,1TQ&BF4?^^M#PW6MJR->B%41#+2T8KC:J#7ALU]Z!CHR"FDQJJ MAU'=O"IAE/>Q*F79VZE`?23(I-+S+EY&UR"*1FIYFC.97];20AD5/5N"7(C4]K1BMK^HIEH;. M.24BS7NJ!UW=\%Q!US>_ZAX5U"L7]TC5*O.U8=BX9.:\-A&&)"\K,7"P4%C' MV)N6S-B+A%7LS1QL+JQB;U$R8V\IK&)OY6!K815[<]VD?;,-O/:]C;36D7HKL M!:A`")#8'7D:&7^/&4T$F4D%C$)!QM:4423(V)HQF@LRMA:,EH*,K16CM2!C M*V:4"')X6%T)71XNKHHU#Q<(K^KJ%K!R]DC]W("-TJN6\?#K77VCC(V61&NB M4BW/=:WF[K/5A9#4>?J?%3G\E03ZP(F M"-NODBNM;#C2+;M%FK"F,C92F,UH*<9F,C%;.)(,=.5I=G.WA>__=7,WW9-@ESZ`DR@QYIUC,' M]#&CB2#SW@TTZAI;H6@96U-&D2!C:\:VYJ)E;"T8+0496RNVM18M8RMFE`C* M;=7V3>'1KWZ.<*N46JM_W-<%UO.'301JGZ27\RM!DC5OMKL/`ED:5_M>98@6?MJZ[,$ M.=M7&8`ER-.^2@0L08[V53Y@R1"2H5,R@D1E0&XSAD0E0I;@!>>K?,@2O.=\ ME199@M>=K[(C2W#F\]4Q@R4X^OGJ:,$2G/%\=<)@"8YZOCIHL`0G/E\=+EB" MHQW6C$N".Y6O;DS4,3!3EP3U"L3')4'9 M`O%Q25"]@'=<$I0I$!^7!*5"6'/M1E0,?56HXOF@2HA^7!)4"-&/2X(B%.+C M&L$($E7;X'Y084)\7!(4FA`?EP3U)L3')4%A"?%Q25#)11O7J%'%11N7!,5< MQ-0E04W75P5#G@_JN(BV2X(:+J+MD@PA&3HEJ(O[JG#*_8PA4>53EJ#^#8^Z M)"B#PZ,N":KAOBJHLK4A-GU>N['R.'ZSA-?R@[HEP4^$6!\N"7Y'0QM7=IM# MHGXUXOY'7@>S<;UA\#L,K+DD^!T%GG9)\#,(^LDEK7+8^+[[??.:+C>GU]WQ MW-BG+S@6M/-[Z:GX%+SXXU(```9````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`6FH3WHWQ]:C;MWEW]C]GNT.AW6 M:80:7=$P,Z!QVXM!/P9I#`8Q&,8@B\$H!N,83&(PC<$L!O,8+&*PC$$>@U4, MBABL8U!ZX!*QK`.*&/Y10(V^":B$HB/`1;@914\TQ*07@WX,TA@,8C",01:# M40S&,9C$8!J#60SF,5C$8!F#/`:K&!0Q6,>@]$`0/4SC%+W653WZC!A[@F#T MW8?1Z50Z9C&IAV@[5.G6*G4$B?2)I$0&1(9$,B(C(F,B$R)3(C,B9:I0XS MD3Z1E,B`R)!(1F1$9$QD0F1*9$9D3F1!9$DD)[(B4A!9$RE]$H09$?7#+"NF MP<=H2A0Z%;G%5LC%-UY$N[62F/6(](FD1`9$AD0R(B,B8R(3(E,B,R)S(@LB M2R(YD161@LB:2.F3('@(AA8\@\/@5>0ZV`$UX_U-K50'CTB?2$ID0&1()",R M(C(F,B$R)3(C,B>R(+(DDA-9$2F(K(F4/@F"AV!HP3,X#)XE+70#-_2:\?[& M:=7A8]1GE#(:,!HRRAB-&(T931A-&7R!NOUHTC448[(I$([45+J/=6JD.-9$^D93(@,B02$9D1&1,9$)D M2F1&9$YD061))">R(E(061,I?1+$%<=JBFOK[L*E?7@W9$S"P%8D"FR\QZV5 MZL`2Z1-)B0R(#(ED1$9$QD0F1*9$9D3F1!9$ED1R(BLB!9$UD=(G06!-NHLB M>WK$'DW"R%H4A?8Z&K-.JXXMHSZCE-&`T9!1QFC$:,QHPFC*:,9HSFC!:,DH M9[1B5#!:,RH#%(;;I!^\O)%L=LVQ,QJM@J)%]R8.JK6$FHLJL[[G3O12A0T4 M-E18IK"1PL8*FRALJK"9PN8*6RALJ;!<82N%%0I;*ZP,61AHDZGP`OV&E=@< M7.,^4*%H7-_&7:#6DLCVK"\8"NHS2AD-&`T998Q&C,:,)HRFC&:,YHP6C):, M6,5HP*1FM&98#"`)K,A1=`^Y;MPKPE/WS;/O[5V6$*;=1I M?O.6-%Y!+7(+85>TL"?W)N#H=4!/M)KWQ[=U[<9=G$KN>RK2D5*%#10V5%BF ML)'"Q@J;*&PJS-5])JBNU6TSJOC<4Y%:+12V5%BNL)7""H6M%5:&+.P;)@GB M]8UZQ;7)$7]P5PCO@Z1"7?-6W/24H`^THG<%/=&"I==56E'6LN^IR0-2A0T4 M-E18IK"1Q_RB1&F9L: M\XL2I2K6GIH4I0Q9V&-,=L7K,;^=3:IL3+!,5,AKMJZY+8&>U*[[5L\2##&_ M\%&RM.^TI.PIHP&C(:.,T(>[U\-&ZB8=(U,XLQO#I> MC[.7-2IV@R6IMFRUHBQ-WUI"2QHQ931PR/<5)0>&3DM\98Q&%B&XHC5F-&$T MM>C:&']15X.M8K'?XVPA?""&A_@1EZ(`9^CH'<#D4+=:Q+V+B+MA09NQ^) MX4GW8]&J2GT3K=X3]CME-!,G)Q\U%ZWJ4=&3%NQV*08GW>:B=;*!5NR^$,.3 M[M>BI3=0&?@->RO\^I-1/0,9'LU`@OQNV&I%F_ZNN<)H+-%;91;M68:^*:@O MR(WUU**@]U7./,,A&V9L.!(M]\2Q(/?$"1M.&&O&&Q'J!6/I!*LCM40:"_!+19#)T6N(K$^1\C015!6K=1[UU[.3B92+( M>9DRF@FJ'#>CA7CNQ.)W(1US#&CB2#7ZE-&,XN\TL\9+02Y0BP%N=+GC%:"G&%AD5?Z-:-2D!+M M7V0WS9V`>!&PJ(6)N9X'VE'O[UI#;R;O673M[U]I']&W6FT[?T1^4Q&[I67P M)K]#,?3[(DTIF6@Y]R.+O)J,&4T831G-+#K=!'.K99L@SA`M1.S*N'R3WUP, M3S;!2K2<^\(BKPG6C,H`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`B=5"BXR0<51QK9F(F2+;`TIF8&9`E6!L3,Q&R!$MD8N9#EF!93,RTR!(L MB8F9'5F"G3`:6*LF-L2)V1JQ#3:^:!E-TL%S.NISNI"898F]8;>3]%0)=CA) M7Y6DD)BUBKUADY.8)8LEV-@D9N5B"8XXB=G"L@1'&<1'D^!$@_AH$AQL$`5- M@I,+HJ!)<(#!`-`D'4@ZJ@3'2K2H9M.#Q!P"N#XX*Z+=-`F.C&@=38(S(7JO M)D%Z!S75AA3R-ZBI)D$:!S75)$C7H"=J$F1MT!,U"9(SZ(F:!-G>Q*0#N0V0 MY\5XUR1=>.NJWI"S0XMJST%2#BVJ29";0XMJ$N3@T**:!*DX]$1-@H0;>J(F M0=X-/5&3($^?F"0LMP%R](G)Q;($J?K$I&19@O1\8C*S+$%*/C$)6I8@,Y^8 M/"U+\*(C,2EIEN!]1V(RTRS!.X[$)*A9@K<;BSB,^VNJ# M-_*(CR;!6WC$1Y/@93S&@B;!.U&46ML0X*4G(J=)\%834=`D>$>)_J9)\!(2 M9=,D>,N(LFD27*Q`";12XWX%2J!)<($"_4"3X!X%^H$FP=T)C!]-@FL3J(\F MP54JU$?;!>!&%68D38*+4ZBI)NG@.1WU.;@3@SZJE0!78]!'-0FNPZ"/:A+< MA$&T-0DNQ*"/:A)<@D$?U22X)8=QJM4'E^$0'TV".W&(CR;!U3A$09/@"ARB MH$EP$PYC09/@YBPDVG8/MV41.4V"2[.8Q30)+LHBIIH$=V014TV"NX^(G%:V M'B3F9AJ/>EQK1'PT"6XW(@J:!-<7,4HT"2XX(PI:V7#/&5'0)+CNC%&B27#% M&?'1)+C>C/AH$MQRQBRF27!?'NVF'1^ZL#&W@;EU<%<=/5Z3X'XZ6E23X&XZ M6E23X(HZ>KPFP;5TM+4FP55TM+4FP8UTK&::!+?0,4HT";XRPTE%F_U[C?O$ M?'/#;8#/;A+S!0U+\.%+8KYA80D^8TG,%RDLP5<>:!TM"OB,`S75)/A.`[U* MD^"K"_0#38+/*C#F-$FG@<-4]1HL.DWA^]?$?%3*I<8WI+#1)!VT:`/*('6;OAZ,3$?J?%S\!$CVEI[#KY@@^1H]I\03[AZOAY\6OU:^/5_QRJ2U%GGW8'_'@X4@[XO5_\ M*OP&']5=F=_6^K+;'>1_4*C+^G?F/_R_`````/__`P!02P,$%``&``@````A M`.UIG+J[`@``#P<``!D```!X;"]W;W)K&ULC)7; M;IPP$(;O*_4=+-\'`V&/6C;:-$I;J96JJH=KKS%@!6-D>[/)VW>,66?)4FEO M./R,OQG/C(?-W8MLT#/71J@VQTD48\1;I@K15CG^_>OQ9HF1L;0M:*-:GN-7 M;O#=]N.'S5'I)U-S;A$06I/CVMIN38AA-9?41*KC+7PIE9;4PJNNB.DTIT6_ M2#8DC>,YD52TV!/6^AJ&*DO!^(-B!\E;ZR&:-]1"_*86G3G1)+L&)ZE^.G0W M3,D.$'O1"/O:0S&2;/VU:I6F^P;V_9)DE)W8_UZ1 M%0'2=E,(V(%+.]*\S/$N6=\G,2;;39^@/X(?S=DS,K4Z?M:B^"9:#MF&.KD* M[)5Z]%\YYZ33O=I+G5,CK63AI ML@@`[\+;9&?1[#!V4$3^-I^.H2OHH#VWT=LP=ES/Y/B\.4N8P\749P MNL.1]'S_^T$JN*_Z)-XU!3!U:J)@[LT$-8V^7NG/U7L_6 M.S\.2?@"4ZJC%?].=25:@QI>`C-V%47:#S3_8E4'@<*H4A;&4_]8PX^'P\&- MH;U0J90]O8!G$GYEVW\```#__P,`4$L#!!0`!@`(````(0"E?$1?.`<``/$< M```9````>&PO=V]R:W-H965T3M]V_WP=U=#IGK MR^;Q\[?+V?E:U$U975>N]S!VG>*ZKP[E]67E_O,E_K1PG:;-KX?\7%V+E?N] M:-S/Z]]_>WROZM?F5!2M@PC79N6>VO86CD;-_E1<\N:ANA57C!RK^I*W^+-^ M&36WNL@/G=/E//+'XV!TRG M\M;(:)?]1\)=\OKU[?9I7UUN"/%Q?4=2[[,'NY5G7^?(;N;]XTW\O8 MW1\D_*7D+@]_E-<"V<8ZL15XKJI79IH=&(+SB'C'W0K\53N'XIB_ MG=N_J_>T*%].+99[QESVU1EWPK_.I61[`-+S;RO7QQW*0WM:N9/@838?3SQ_ MYCK/1=/&)?-UG?U;TU:7_[B1)T+Q(!,1!%<1Q!L_3/W9?-%%N>,Y%9ZX2L_E M@[^8>;.`W?^.)T:[B>,J/!*IZN:*J_3$ MW>_<:BD<> M63\Q\Y4+@5CR!O3KVA][CZ.OV&E[8;.A-I;%5EJPW<;"[FP0V2"V06*#U`:9 M!D90JR1C)_^*9&;.),O);B30'S-8W M&:L59*-XAHT5],WY;[B-AP2J99Z:)EMEHC02$A$2$Y(0DA*2Z<10BJ)@*T4- M^^'F9>;8Y\B;DD5WKS"ZIUV9*.V$1(3$A"2$I(1D.C&T0Z>F73Z?C'82Y=0V MG,Q13GXL>JN,I-N.D(B0F)"$D)203">&(DQ14]25H@E*-NQY(:35B'F8:CF9 MF05J8NU=9:34$A(1$A.2$)(2DNG$4(LIVFK]V<,=LIEI.++4S:VF5D5)+2$1(3$A"2$I( MIA-#+<[17U3+/$RUG%AJ`TNM,E)J"8D(B0E)"$D)R71BJ/70>VIR927JL*E) M($O4W!+56RE5%$44Q10E%*44908RM;$>HM^X2AMO+7"2R"ENV&&))42UDFA+ MT8ZBB**8HH2BE*+,0*80UBP,".$]A"%$H(4FA*`=.T39CNVM(HIBBA**4HHR M`YE"6#/0"Q$-:U=*VE.Y?]U4..8\U>UXHG?05TJ@OJ/;"BL?>UP[)!?FQMSU M5G*)(XIBBA**4HHR`YF:61/P"YI%SZ!KYFB&DJ4$>@%IR[E5$,C&WCI+=IXR MZ#-`4"RL9DNU@Y+>4;PR6$=RVAO(R)F!S'RP%J+/AWHJ&;8J#D>!KMLG!8<; M3;`OM.20U1=6RRXY$ZL41ZSOQ,TG_:Z**4HDNGNK5%KQ6RVL,RZ3P]VMS,2P M;J-/S$\?#MZSU[J8H$F@0J? MT%BI=.QC91)UL4R!K,.X(_!+=3.>?MZ0&`(%T@5R-._3L/,(BBB*!<)%YB^A M5BE%F8%,@:RIZ`6JKY.(I56^B2\P!*422LCEC8),YNL:1G()N]EC&QR M--X\-2JW0R007K\EBBE*>D<]_=9+>=I;R5B91$;* M?I0,'RG3DO&SXM"9F]54("1)SF`KT52A'4610)-^3\02]9E)J&-*4291UV@9 MJ^V;S5HGT`^Z%\BAUJ`SMP3R)B[0\SFQ=N!6^`7Z5J&/E+3"\:@]4M:Q%TDK M(Y:V@%UMC:55WULF$AF.]G.=2BMS$M:IGDDK(Y8V"3/)R(V]BV9(F_V*[G0I MM^HQ/FC;)[1`3.VU$44113E%"44L2^O;.I8EZX(\\`_Y;. MOYY>BOJEV!;G<^/LJ[&]"`)M[XY"]=0R,^+[\[F_Y MX`>!I^Z$LO@&/Q1TSY7-6:"A.TQ"?%"C=WZ:(OZ@PS3$5RCJL)F%^)8SP(,0 M7ST&^#S$!X(!O@CQ*DTYVJ"0=0=T!!T0-`^-;+UYR$YJZH.3&3Y#(QMO&6Y0 M5:C/%B.LG-$1%/:0534Z@OH>LN)&1U#F0U;0Z`CJ.-9J:`2OE9CUT/+BG04C M0PNY]:;(P="*H0V'S]#(!AEEO1^=VQ8CK`6D(SN,L$Z0CJ`9Q@R&1M`3AZPO MI#YHC4/6'F)DI'8R?H>ZY2_%GWG]4EX;YUP<\:"-NY>]FO]DQ?]H>=OG/%3E^*,DHZF':DC554?:X*QC6+``O*8O^_%)(S39)&- M98[//>>^\.+I*!NTY\8*K7*<)@.,N&*Z$*K*\>]?+P]3C*RCJJ"-5CS'[]SB MI^7G3XN#-EM;<^X0*"B;X]JY=DZ(9367U":ZY0J^E-I(ZN!H*F);PVG1!R>*D63SUTII0S<-U'U,1Y2=M;O#E;P4S&BK2Y>`'`F)7M<\(S," M2LM%(:`"WW9D>)GC53I?CS%9+KK^_!'\8'OOR-;Z\-6(XKM0')H-8_(#V&B] M]=37PD,03*ZB7[H!_#"HX"7=->ZG/GSCHJH=3/O1AS#=@!,\D11^!:!R>LQQ M!@ZB<'6.A^/D<3(8IMDC1AMNW8OPL1BQG75:_@VDM',/6ET.S]31Y<+H`X*Y M`MNVU&]).@?AD_E)(:8#36&>O?+T'$\P`B,+Z'Z9SB8+LH?ZV(FS#AQX?G`B M@X!M]`:_GO?9PJ/>PC?`>ZX#T-?+;NL-;^IY%%K53VS:)"\`BD.SQ@F#<\/-IYQ+ZI+=E+-I MFL#>G+ON&9?R)P1<8E'P8XA%!?VPU6&C)#<5_\*;QB*F=PJB,I"/:+Q,J\S/ M]G]\-%]UEXS$#[#[+:WX&S654!8UO`3)03*!C$RX)N'@=`N9PPW0#K:^>ZWA M;\9A=P8)D$NMW?D`QB3^'Y?_````__\#`%!+`P04``8`"````"$`_6G&W=@" M``"`"```&````'AL+W=O)"@:8130)N,Y:_8)^O/[X6:!`JE(DY.*-S1!;U2BV\W7+^LC M%\^RI%0%P-#(!)5*M:LPE%E):R)'O*4-9`HN:J+@4>Q#V0I*L^S0TT;94D$K8@"_[)DK3RQU=DU=#41SX?V)N-U"Q0[ M5C'U9DA14&>KQWW#!=E54/=K-"'9B=L\G-'7+!-<\D*-@"ZT1L]K7H;+$)@V MZYQ!!;KM@:!%@NZBU3;"*-RL38/^,GJ4'^X#6?+C-\'R'ZRAT&W8)[T#.\Z? M-?0QUR%8')ZM?C`[\%,$.2W(H5*_^/$[9?M2P79/]9*,5Z`$_X.:Z1F`TLFK MN1Y9KLH$Q;/1=([C:#Q%P8Y*]<#T6A1D!ZEX_<^"HH[*DHP[$KAV)!'<7KDX M[A;#M5]\K8/05F.Z<$\4V:P%/P8P6N!7MD0/:K0"8EU^C&$;,IV\TUF#@;"$ MZ,LFPN-U^`(-S3I,>H[Q$-MSQ&S6DX1@I'<#S;C@1F?!'@IZ-TO<\QC#J85, M/D`F+F)[">%X`9T/7DX=T=$$`4GO(<*Q*Y%:S-+T"X]PY*:WGZ8=>:AA0%Y' M?7FOPM1B9MUV8?OG>;B,<8S`=`\8T5'?R-0522UF8OO@YK;#.4=X-BBLH[[P M^S39*;"88>'AG",\'Q3645]X[E:56LRG._]IVI'71\O[*WD:/!WUY1>>O,78 MG5]T&^^](=O+&,?(ELP]77,P.@31A=U`G6MZXNR9NP98K^>+=G3)R+VK)%!10OX&.#1'&9: MV!/$/BC>FH_GCBLX$,QM"2<]A2\K'@&XX%R='O09U?]VV/P'``#__P,`4$L# M!!0`!@`(````(0"B456QTP4``.`6```8````>&PO=V]R:W-H965T&ULC%C;;MLX$'U?8/]!T+LCD_(UL%/4++);8`LL%GMY5F39%F))AJ0D M[=_OD$.)G)$L]*5-.(15N0_%PSP,LC*MCGEYWH?_ M_/T\VX1!TR;E,;E69;8/?V1-^.GIUU]V'U7]VERRK`W`0]GLPTO;WAZCJ$DO M69$T#]4M*\%RJNHB:>'7^APUMSI+CF93<8WD?+Z*BB0O0_3P6/^,C^ITRM/L M2Y6^%5G9HI,ZNR8M\&\N^:WIO!7IS[@KDOKU[39+J^(&+E[R:][^,$[#H$@? MOY[+JDY>KI#W=[%(TLZW^67@OLC3NFJJ4_L`[B(D.LQY&VTC\/2T.^:0@2Y[ M4&>G??A9/*IX$T9/.U.@?_/LH_%^#II+]?%;G1__R,L,J@U]TAUXJ:I7#?UZ MU$NP.1KL?C8=^+,.CMDI>;NV?U4?OV?Y^=)"NY=Z2UI=(1+\&Q2YG@%(/?EN M_O_(C^UE'\:KA^5Z'@NY#(.7K&F?<[TW#-*WIJV*_Q`DK"MT(JV3&&A:.RQ- M;XZ0B$G@2](F3[NZ^@A@*B!4A6WY2@L4X(&;A81:,Q12"D``G(R3TZCZ$5/K*+N8TP@$A&].: M!6^-(E;IV)'8,(E>;#,2BV4_`=K*"Q$S$HB!8(XG1:@I!"&S(F2ZD="KM!!" MN&S,J!X0LS"5D!MF5;Y5K%PG27"88:\277"]RH.[6<+@B,'@(F96Y5NWF[XT M)+:^&]C!C.=]%[25),J#BV#J11E0533W@Z=,8D0>I3OFEHJO@&+#S,KZ0";KN[V@$MGW`J4- M!JJ_?83D-Y3H],^!!A,Q!:$5&5=*,2*5WIUK*^'+X6S#>J:L#]N3U9US(:E< M=I4PRTR=I.LJ$K"@KNNL4(J97:=(!2251SX3QLR)L%0/%F2)\.M<4?/:=8L2 MT4(V5`BIERF!P?&P&(S/#Z\BUMF]/F@5&XF.XD;5@=^9TE?`F>`?EXK9O0\: M6H!QB90H?_10,!$^6!!`^Y/CRHP:,0FA1,:54O^=PSHAI"NGG4E?";>"E4I9 M']@I,;]S6\EQI33+=!1$[%Q8`D0JUTM&4%DGW:S>I3`ME7)$*CW=MU1\J61G M1ED/R,,E01LQ+I,2Y8T,I?S2G1Q:B7&5C($S;0"=KE8NE&AU*A MU[]-/_T/``#__P,`4$L#!!0`!@`(````(0`H+TLP(P,``/D(```8````>&PO M=V]R:W-H965T&ULC);;;J,P$(;O5]IWL'Q?3H&<%%*E6W6W MTE9:K?9P[8`)5@$CVVG:M]\Q=@#GL,I-$GZ&[Q_/,'96]^]UA=ZHD(PW*0Z] M`"/:9#QGS2[%OW\]W%"RC MCSS;U[11!B)H113D+TO6RB.MSF[!U42\[MN[C-I"CWTB6_/!5L/P[:RA4&_JD.[#E_%6'/N=:@H?]LZ>?N@[\ M$"BG!=E7ZB<_?*-L5RIH=^>7\0JN_)BK4]CTELA3XMI3)U$MFP>0&B&\RZE;R2!19KP0_ M('@]P%*V1+]LX3*"$F9:W&@UQ3.,("D)ZMLZC*.5_P;%R&S,@XF!SR&FC_"! MWEM`OA%-+O*TFF+X'-*))WU"QL+$Q*.8N(]P+"#D M0LI:A3I!HB./(4GC88)N\(#&7_#0:N?1U\4J[LH&5R?OJ<-$^H6,@X4W[1NK M`UR\5<8)A_&5LL`+,4JYPT=![,V2GJ\C7+Y58!6CHB67RZXWQN%E[/AA,AGS M=83+MXK+GU[F+\[YDT6?N[[KLJWBLF>7V2%L'Z?)3V-O*$T7X/*/DFLPOV*@ M!^ZD.M'4@PVDGUH[DM$P5*&5W/8NKCBXDVKZ.P\="SNE8PLK.19)<,5"C^#_ M%V&&%*:LGX#02JY#>,4!HLX=YN-&Z(B31EC)=;@R9+#%GSE,XE$;]/T3OI5< M_K`]F2$V!XW9GFLJ=O0+K2J),KYO8';T[MRK_0&WZ>ITJL?+C3F(_/X.G$0NYP*'$%!U'WLX2_&!2VZ`"*B`K.U?$" M.N3W?UK6_P```/__`P!02P,$%``&``@````A`!6?,I/^#P``S$D``!@```!X M;"]W;W)K?3G[GC:'U[OQ\'5S7BT>]T>'O:O7^_'__DC_6TY'IW.F]>'S?/A=7<__GMW M&O_^Z9__N/MQ.'X[/>UVYQ$LO)[NQT_G\UMX?7W:/NU>-J>KP]ON%9+'P_%E M<\:OQZ_7I[?C;O/0%GIYOI[7W>NY M,W+]D'F#B2_[Y_WY[];H>/2R#8NO MKX?CYLLS^OU7,-MLQ7;["YE_V6^/A]/A\7P%<]==0[G/J^O5-2Q]NGO8HP?* M[:/C[O%^_#D(F]E\?/WIKG70?_>['Z?!_T>GI\./[+A_J/>O.W@;STD]@2^' MPS>E6CPHA,+75#IMG\"_CJ.'W>/F^_/YWXF,Q]W6MST\HR;\.WK9 MJQA`US=_M3]_[!_.3_?C:7`U65_G5:@ MJN^M3+25*=JIK2RNYK< M?ZC<0I?#3VGU;-#W=VJ\U27Q4Y=<72WG\]EB^9.F8GRU3<5/73#X8)4K71(_ M=T]M&351!J.SJ^-=1U(\(#,RM4O^L M]._'>)P(]1/HGY^"^>SN^D\,L:W667MT;(U(--304&9C%R0N2%V0N2!W0>&" MT@65"VH7-`-P#9?U?L-#^R6_*7WE-^GQ6H!QY,1QDFA(D=@%B0M2%V0NR%U0 MN*!T0>6"V@7-`%A.0CS]DI.4/N95*[CFME?6G8X:<'T$.O$7]2J]YX@D1%(B M&9&<2$&D)%(1J8DT0V+Y$)/\+_E0Z6,PXY'T_N$1JI7>`)2^[;..S.TU86$/VZA7ZGU& M)"&2$LF(Y$0*(B61BDA-I!D2RV?H*OEL,K^"CR]Y396PO=81QVNWCM=ZI=YK M1!(B*9&,2$ZD(%(2J8C41)HAL;RFMDQNJK&87IE$D(--%;'=UA'';4O';;U2 M[S8B"9&42$8D)U(0*8E41&HBS9!8;D,>.W2;S%T*VZ[IR!39ZV#N6CFNZ95Z MUQ!)B*1$,B(YD8)(2:0B4A-IAL1RC4K9?;YIN>T<0=UV3.6<$:.84<(H990Q MRAD5C$I&%:.:46,AVRLJ9QT,-(D8E3,Y(:.1/9P6-T[,&*T^:!@EC%)&&:.< M4<&H9%0QJADU%K(=I?)6GZ.Z?!8YE/1WK?(I^`Z;=$$1HYA1PBAEE#'*&16, M2D85HYI18R';*RH5]7E%IZA#KVBT''B%4*RVE2KNC%;"*&64,47GG$.O=&B"],%,Q(O`'51:"_/^0,O9`\9!KR5QES!*-<+4 M+UJ9T1J:=[*RW&A)P8)1R>8KHS4T[Z0OM=$2\XV%;`^K%-7GX2YU1<"*D34. MZ-K1N.A1),AVY]1V>FRTQ%;"*-7(NT<1PS@4+1B7;JEBK9M18R':4RDM] MCNKR5+6 M"?M(:\'54GO,*-'(*#J)CU$01R:"S*A+&66"EJWEV=3-((U<#!>" MC.&2426H:_(,;[WM)M=&02PW@CSC'4/6-PNJH>RL5!H-9T%!9FJ)&26"3+]2 M1ID@,^7EC`I!QE;)J!)DVE4S:@1YO*)V#YZU08TZURL=F@W#++AU9K9(%]13 MW_0F<)=NHR`/+=%H,!131ID4M*8^-\YSHR7F"T%VPYWX+[G&2@K*U+=T)I_: M*$AEC67&'M$7=B_JM;[KZ@[!U6(WTEK6/*>US!23:"W+DYW6`&5B:SC/:5L& M%:)E&E&R^4JT3"-J1HU5T/:*V@WX`K#;)0R3$[5=5JFA_1R=S"\2K6[6"";N MBA$;!7%N(LB,M911)@@9ZF!!7&RTQ,.) M1HYY)TQ2K84MF13,C*UANR@I[-LE!8L/U5ARC96WQJ73U-IH28W-SVJTYX8+ M&Y<);UPTLN>&)>7E>B\#3Y@'Z,[JL=@RH9@(>G<$IZ)EHC,39-?H+)JYT1)' M%8*,K9)1)<@V3\M4WVTQWTC!2QVRG@/6#N\0:;F]/])HF#H),NZ,&26"S&!/ M!1D79(*,K9Q1(<@4+!E5@HRMFE$CJ&V7[16U@?!,'#BJ<==SC>S4:>FFZ*)E M31Q+9WV+C98\S$30I8?97J!*M18Z)`4S*6C7Z$:GT9*"!=LJ&56FX'"X.1VJ MC9:8;P1=ZI#]'*#E?0Z*.]'9H6%>I68,:&&VEMIC1HF@871V!2UWDJU<"AKS MA4:#@B6CB@O6C!I!GNB\L-U1!VNN5SJD;`UF12>OB73!J3W5.(M?;+3$G8D@ MR[R[_4Q%RXS93%"WL<0M6GO[EQNYU%4(,E9*1I4@NRO."ET;+3'?"+K4%3LN MG:W5S\Z6I[SET@A/1IH0:32;]BAFE`@R25$JMHQK,M$RMG)&A2#S8K-D6Y5H M&5LUHT90VR[;6VH#XIM-NXW),`V;ZKV*]1263KH3B=:B/9:8KU84JMJ,<4@B M94QNE6HT&*V9:-GA0[.F-F^6ET(*&O,EFZ]$ZU+#:Z,@4=$(XL/?Z87]5::BTK)E9._AD;+7ERB2#+/,^.VKR)U4P*6C4N M*0K[=DF-A10TMDI&E2#+O-NAVFB)^4;0I0[9SP'FA\_AIW.DTG>BMD/6'-DA M:XXDE*B53*W\PSE2VS*NR43+S&LYHT+0<(XD6Y5H&5LUHT:09XZ\L!^:\GY( M(SOC7#D;@TAKS:T+8>ZKIUAL=1/2;.;.I(DHF'DMU6@P)60?JBP76_#>(!EQ MPKH0+5-CR356'ZJQ%EN7NM>(`D^NF`1_*7Q;?3M\-9JM^O4\8A1KA%NW,LX2 M028W2!EE;"L7+1.%A2!CJV14L:U:M$R[&D&`2;E^#TG!JZ-"\.W+[S9G!H];F_7B.Q=V$ MY\J$I]T`)P=O9[?I4KUBO'@-&),6-:E#]A6\E;M[U`6A)2$2,TH8I8PR1CFC M@E')J&)4,VHL9#O1ET:_?Y4:4SKYL$..#YVM:*0+6C[L"XI;$]9*&66,GT^C[>'[*\9Y@(W?I[N>=]^= MKH.;4-VQ17=)@D]2<:G4(YE-\;%J._.Z968S2-HUGR1S^<"5)!#X:D&!-A-Q M]1D^\I?9Z%GQ$]7``I M=%@B" M\([/HSCQ@W=\$ISRP3L^"0[[X!V?!&=Z\(Y/@J,]>,NJ3X"4*ROBB M%^]24,8GP,,/?5)UNC/VMN?"!+U#E^&A>K/+$KSRQBSND^!=;*C>M'(9O#,-BG,+<,,@5._&68*+!FB;3X*;!*%Z+O) M#*WVK5FXJX-6^R2XD8-6^R2XF(-6^R2XGX-6^R2X@(-6^R2X=(.G[9/@[@V> M@D^"&S;HJ4^"JXHHXUOF<2$197R2-?RV]OH--^;@'9]'<2\.WO%)<#T.WO%) M<$L.WO%)7I4%W[90DN3(?J]B]+<&\Z5)>` M68*[TJ&Z"\P27))&'NB3K"%9>R41).H2-%O#+?10W85F":Z?A^I*-$MP"SU4 M-Z-9@LOHH;H@S1)\6H96>V?R`&.[NPGB)+P1).H[(+:&[V`@\8T??/@!B2]S MP!<-D/CF'7Q8A/[X)/B^",_4)\'70GBF/@D^&D)/6\EUWR'\B9VWS===LSE^ MW;^>1L^[1^S(\-=LL(D[=G^-I_OEW)T>C;X<-^K# MZ\?#X2R_P"W7_=]A^O1_````__\#`%!+`P04``8`"````"$`D?KO^:H615*0M2,U;FN%7*O'U[O.G[8F+ M)UE1JA`XM#+#E5+=QO=E7M&&2(]WM(5(R45#%#R*@R\[04EA)C6UOPB"I=\0 MUF+KL!$?\>!ER7)ZQ_-C0UME302MB8+URXIU\N+6Y!^Q:XAX.G97.6\ZL-BS MFJE78XI1DV\>#BT79%]#WB]A3/*+MWF8V3^VL?G';; M@D$&NNQ(T#+#-^'F-@RPO]N:`OUA]"0']TA6_/15L.([:RE4&_9)[\">\RZ9GHM1?I2*-W^M*#Q;69/%V02N9Y,P\>)%DJX^ MX.+;%9E,[H@BNZW@)P3M`4S9$=ULX0:<=0IQ`J7,=?!&1XT&AB6,/N_B--KZ MSU"4_*RYG6M"I_"!XE!@/T!=$'ITC$@2-]^LXG8N63C%B!#]EZ!'H>(8N23" M]K*,3\'*Z45:S,MCHC0HNWZ7HZ)32+]>F9S6QH?2Q40W3=R$Z M.H&D_698B-5<:IAXP_K!??CEJD]^A-9'[Z3=!]NGHU/TM!FMQN87]<$193VG M#%XJ'9U2IDUB-6>*:Z`1!$ZV62[IX-75X2DF=5:VCL8CP[8GXJ!?A279D\^> M%QTYT$9?W7,$Q9FXK^#Y1.$L"#\0EY^KR MH$]6]\7;_0,``/__`P!02P,$%``&``@````A`-(\EM6T`@``#@<``!D```!X M;"]W;W)K&ULC)5=;YLP%(;O)^T_6+XO!@))$X54 MZ:INE59IFO9Q[1@#5C%&MM.T_W['F%!HD-8;P*^/G_-A^["]>9$U>N;:"-5D M.`I"C'C#5"Z:,L._?]U?76-D+&UR6JN&9_B5&WRS^_QI>U+ZR52<6P2$QF2X MLK;=$&)8Q24U@6IY`S.%TI):&.J2F%9SFG>+9$WB,%P2246#/6&C/\)012$8 MOU/L*'EC/43SFEJ(WU2B-6>:9!_!2:J?CNT54[(%Q$'4PKYV4(PDVSR4C=+T M4$/>+U%"V9G=#2[P4C"MC"IL`#CB`[W,>4W6!$B[;2X@`U=VI'F1X7VTN8U" M3';;KD!_!#^9T34&/M?VI3M^X*"L+VYVZ)4S5X`F>2`IW!B!U^M*]3R*W588781`EX3).,3IP M8^^%6XH1.QJKY%]O$_4DSXA[!KS/C&60KL)%]'\(\?%T>=Q12W=;K4X(#@>X M-"UU1RW:Q%!`YL2]4S.\P@B",J`^[Q9)NB7/4`K6V]QZ&W@.-M%@08`^N(!X M9UPXU;EPM7(^;[TPYL7SO,4LSZE0U5$XBV0Y`+P+;Y.,;)+!8A(RF,R$[%2H M$P0ZI'Q9%F_T`1^P\3,^G-KY&.K2*]/,WC9C$O=RPD3=<0SC8)4..^LLIOQ> M`3>CK%;S=8$3,8K9\]=OQ\9-3^&],H5?S\-=4WP[BA=P-SV%]\H4OIZ'KV?@ MJW4`-^=\YIW%E-\K$WX:SO.ARUQ$GT;CRG<64P=G:>KA_37RW&ULE)S94AP[$H;O)V+>@>#^`-4+T!4V$^[:>^^)6:XQ;MO$`9J@V_:9 MMY\_JY2EY9_RC^N3T\.Q]NG3[_=B__'GXNML= M3V#AZ?#^].OQ^)R>GQ_NONX>;P]G^^?=$R2?]R^/MT?\]^7+^>'Y97?[J2WT M^'`^N+BX/'^\O7\Z[2RD+V^QL?_\^?YNE^_OOCWNGHZ=D9?=P^T1[3]\O7\^ MJ+7'N[>8>[Q]^?/;\Q]W^\=GF/AX_W!__%]K]/3D\2YMOCSM7VX_/J#??R6C MVSNUW?Z'S#_>W[WL#_O/QS.8.^\:RGV>G$_.8>GFW:=[]$#CT_.;=ZV#_G._^W%P?C\Y?-W_J%[N/RWNGW;P-L9)1N#C?O^GJ#:?!*'P M.94NVQ'8O)Q\VGV^_?9P_.?^1[V[__+UB.$>2Y&[_0-JPK\GC_<2`^CZ[5_M MSQ_WGXY?\=OD;'`]3L:7@_'IR2^'3D[MOA^/^\;]&R]CJK`R,E2': MV(66O%([I&T?\-,4'-O*7REW:Y!>M M]1=]U$C!5-`BR?#L>CP>75[_(L@2C1;YQ50WP("^YA>-E\0)F(O7!O"\FYWM MK,YOC[B+[]5K4P5V,`:!HU5#B^0A*$)0AJ`*01V" M)@2S$,Q#L`C!,@2K$*Q#L`G!U@&>H[$$_):C1?_]*?YU@GSD>W;:ZAC<<+0 M]G[F%<"Z&RV(N%NR[N"-C?VN]#%S<*_4N)E(0*8E41&HB#9$9D3F1!9$E MD161-9$-D:U+/!?#9:Z+VQQF@$Q=)U(0*8E4 M1&HB#9$9D3F1!9$ED161-9$-D:U+/._+R=[)('4-$>R[N".!BZ\#%_=*O8N) M%$1*(A61FDA#9$9D3F1!9$ED161-9$-DZQ+/Q3BEQ5PLV'>Q(4.$OK-.3P(? M6ZW>R8P*1B6CBE'-J&$T8S1GM&"T9+1BM&:T8;3UD.=R.>C&?-YRW^D&^8%] M=1$XW6KU3F=4,"H958QJ1@VC&:,YHP6C):,5HS6C#:.MAWRGRTDILI9(EAU$ MND&X!5)W9HQR1@6CDE'%J&;4>,COB1Q%8CWICBA(9[794TEMI7/7/F!N",[G5.'Z]O_MSNL=2D]@+`I/YNSTTR)Y_B\(IN M0E3MJKU,&5PDP2DREULHB8^A=5\18:5AXTD?1Y6C)CWP9NSH;6RUWVX/7YVQ;Q MTSE%0UCHY^\XS*&-EC_):>VV6MK)0M'/)E`WBU7+ADREZ+I="H)]I+92K:E1 MU-KP'>7F679>(L["Q4P1G*%V,\/0=44YHT*1C:A2D=NIKDK'5JU:UGRC*-(3 M29XXG`>"@V$UR,9;9K3QP_6F&6K2'QM'TX%F1%A7 M^QDZO`IO:XR:V3N#_3>W4NU=89`3#R6CRA:4+3FHM+92-=MX-GQW2,9BW=$/ M=9?(N+N*Y"#A_FB8LQGFC`J#O$YUQAQ4<<&:4>/9\GOBYD[.BL+IT4#3(W=Y M'5X%F4UFU+SU=9`$Z6-NM=3;A:)?K*]=*YQ)46E!-ZB2ZR!L:JNE-3:*(JN3 M)")V?']U=!J8),@-=8.\];=CHV$_+W-3TD&%HO9=$+.I=`6]3I.M6@M:\XVB M]K#MC[ND-K:'?01W&8\7P1UR@BZ3I]P(ZE&WH]'8]E+U=*$%[+I;&N28K52K M,TL3E,PV6J`UZW^F0TXY,#K?2/;M^YHP*@YR"):/*('GK1;U1 M1UBC#'QJ\1'-:)DHIB.:BIV8-0@]T;&LWE15K;80PG;?NPYN M&INHK9\=T89^`O7+J.#$JK6`0''B/#-L9+/&W*"Q758*17:]*QE5;*M6+6NK M\;3\L'`S*SGA=:^XV`NL?^V?T?P^T1IRHJ7(IJ29A_SZW!Q'ZQL.I3Y='H>< MTQB$5_'2V=B7F$%1%61E@5876$-1$VB[!YA"TB;!EAJPA;1]@FPK8^\\=`ML_8 M&'3;JC<&'?*?BUQ3!/1:=@@(%9('(E!A2[5*1A6CFE'#:,9HSFC!:,EHQ6C- M:,-HZR'?Z6X:X@8^YR%R:P%'.7E"QBAG5#`J&56,:D8-HQFC.:,%HR6C%:,U MHPVCK8<\#TLF$`OKEOM9D")GS624,RH8E8PJ1C6CAM&,T9S1@M&2T8K1FM&& MT=9#OH?=[,R)8:0-X9YAT`2[9)_F))=V4VA/,YG1DN2]UQJ&Y[7<:NG"43`J M#7(S,JOEFK=;;MN(VFJI^8;1C,W/K99K/KB[65@M-;]DM&+S:ZOEF@_.0ANK MI>:W'O('T,T4=?M/QC:/"AX$RI,-R2UL=C2*Y_L-R0N5._LTHTK1JW75JH4=K6_1(+PH:E3+ ML^6<=MIY.E,MVZZY(J]@^`!NH5IN(X;7P4EQJ5J>K;`1*]6RC5@K\@J&C=BH MEMN(Y#)HQ%:U/%M.(_P`"DXI?0#QT61D$*)19TQF&$Y=BG)%=E\L%-D+_Y)1 MI6,"D:EFK>V*M:J&36,9FQKSEH+1DM&*[:U9JT-HZV' M?`\')](^B/D<.E*$G_UJ,IP$=R>944,JWJYO22#/K5SCOE!D(Z=D5"GRLI7P M>6%MM=1\H\@]^2?.K#;K6]<]YVIWK@7=&ND^>V&UM,:E(MNA%:.U(N.I\-V= MC96KX:VBUK`_D#\YV8_X9-\CV[S,,(R:UI4S*A39@B6C2I&U53-J%-FU8:;( MFI\KLK86C):*;,$5H[4B:VO#:*NHM>6[6$[0D8,[[BUI->J09!_.5*'\VV@A M?^^U*+YR8QYII0Y-89"SLI6,*EOP%?.UU5+S#=N:,9K;@C+1@TN)A96JV27; M6#%:VX(1LQLK5;-;SX8_8'*2=P:,[BW#?%OT@WR[0][&W:$K^U@HQRVM%'10 M89"37)>*G$MK+E@S:K2@C8"9(FMKS@47C)9:T-I:*;*VUEQPPVBK!5M;GN?E MPM_UO&XK+?<];)#38#@)PBE3+9,UTZYBY1H7A2*[BY>*[#I1*<((VNII M5[%::KY1]+-+1B>"!?Q1@17'_G*&B'\2/03@=Z'S,\'!1U+"R*\H-/`Z%![L_`M+]N8#' MW#B=W]^9#J\2N7Q$4J3Y!J2-GL-)6/\R9)8 MB&()CKBIG*%8@I-N*NT#O\4DN->!WV(27._`;S$);GG@MY@$ESGP6TPRA60:E>!V#7Z+E<$E&OP6 MD^`N#7Z+27"E!K_%)+@S@]]B$ES!HZ>QE0\W\:G<^+*OQ:%M,@IM5C$],@GM2U!.3X!D)?!!K`9Z+H)Z8!,]"$#LQ"1Z) MI'*#SC[`8Q!$54R"1Q]H=4PRA60:E620R!,$KB>'1!XDL`1/EN#1F*2$1!XK MT(";!XV.T(":I()$'PEP/'E9" M$BN#I\48GY@$#XWAZY@$CX`1US$)G@0C=F(2O+N9RIN9D;9!(N]9LF0ZA'>Z M0W&0.620R&M_7":'1-[^8TD!B;P$R)(2$GD7D"5X4S*55P)9@KT+58&;[:C;3$)/IU! M/3&/XD,8E(E)L@%F,#X-X?[@LQ*4B4GPJ0=\$%OY,DCD

VAL\X4$],@J\Y MX(.8!!]UP`0-MBDND`>57W+C3%#O*JJ`1??Z%ML?6@A$0^D.+^X,,O MM"TFP1=>:%M,@H\Y4_G`D:WA`\Y4OG-D"3Y33.4C1);@HT.4B4FR9((RL>C% MQWPH$Y-,T0+YWI/KP3>Q:1:5Y)#(QY]8R^/X:96*2+$%^@"^18V60'W22\SZL\'O'1_@K/[S[%[D_GDX_Z(/ZB)(SI>=L:? M2MWA+^SAKP.>GGS>[X_Z'U1]WO_QU9O_"P```/__`P!02P,$%``&``@````A M``*O>>);$```S4L``!D```!X;"]W;W)K&ULE)S) M0OEP*06=A+G_[\Z_7E[.=F?]CNWNY+Y?/+TMGF[6'WN'W[=E]:+EI_W);. M#L?UV^/Z9?>VN2_]O3F4_OS\W_]\^K7;?S\\;S;',WAX.]R7GH_']_3BXO#P MO'E='\YW[YLW2)YV^]?U$?_=?[LXO.\WZ\?,Z/7EHG)Y>7WQNMZ^E7(/Z?XC M/G9/3]N'36/W\.-U\W;,G>PW+^LCRG]XWKX?Q-OKPT?WV' MBZ_;E^WQ[\QIZ>SU(>U^>]OMUU]?4.^_RM7U@_C._D/N7[[DM?RNFJ M_6KOMX^#[=L&K8TXF0A\W>V^&]7NHT$POB#K5A:!R?[L/Q^;Z47)]?W5PFYSK MYG!L;8UMZ>SAQ^&X>_U?KE2VKG(GB76"G]9)I?JOG52M$_P4)R#*Y0\^35JZ_-&F1N;8IWVTL<;'FJ`B#6Y^L:;5\]NKJ^KU[TL3ZN/W_: M[WZ=H=^#]N%];7K15_0:#T;]B]&_+Z$A\2(>0']^KB;)IXN? M>/\?K$Z-=2R M>/N,&*.B\_8EY3L_.K5D3Z1`9$A MD1&1,9$)D2F1&9$YD061)9&52[R@8FBCH)IA+.^FN8\U^NB/D2,:P:3JQ[!F ME4Z%N5`IPDRD2:1%I$VD0Z1+I$>D3V1`9$AD1&1,9$)D2F1&9$YD061)9.42 M+\R(J!MF&3$-SJ(I4:CEI.K&-ZG<^O&M%TIBUB#2)-(BTB;2(=(ETB/2)S(@ M,B0R(C(F,B$R)3(C,B>R(+(DLG*)%[SK>/`,]H.7$RQ()"YU(@TB32(M(FTB M'2)=(CTB?2(#(D,B(R)C(A,B4R(S(G,B"R)+(BN7>)'"W#/VFAGL1\J2;&6; MS3+K1!I$FD1:1-I$.D2Z1'I$^D0&1(9$1D3&1"9$ID1F1.9$%D261%8N\2*% MQ9,;*;NV.#>+FN/S]N%[;9>MYJ6C-.I^!"W1R6G=DCMG:$PJP0RH(8[N\O5) M^;9RZ7>N3=60M[C%J,VHPZC+J,>HSVC`:&B15GBD2ME:JWP3UG:L&E*7":,I MHQFC.:,%HR6CE8>\)$"HW"208!OL!SLGF.Q*->I6!S^*>5"2!*%L6"78N5K! M@K.I6N*]Q:C-J,.HRZBGR"U$L"[NJY848L!HF".G'4:JY'H/JCA6+?$^831E M-&,T9[10Y!8BF)4N54L*L?*0EQIF<\K-C=]U$)F^GS06.:U5MZA:Y%'#D@I* MXB12L*IMJI84O<6HS:C#J,NH9U$YR;\L-K=E.<\!8QM;LLE2(TM;(@3$2= MH(8+:E$SIP"%VDW0332LEKW'=%R M-W7*M\$THLON>V)XTGU?M/)27P=C]X#]#AF-Q,G)1XU%*W]4\*0)NYV*P4FW M,]$ZV4!S=K\0PY/NEZ(5;Z"5Y]?/5K,I%,M6NUGD9JL@-PV3)%C#U,UYF.F[ MD*W:!^4,N2FH:=6JVE.U+/*RCPP[;-AEPYYHZ1/[@O2)`S8<,AJ)H?H:"U)? M$S:H+Q`R5V0K7V5BY>!(/4R9#02E#NN!`/Q6,7B=R)(_4X%G:SI3+7$UUR0 M^EH(^H>:+E4N7E:",B]^`IE-+">!?KO`R3>]O,02Y%8NJ0:KX'K9JB&QI%P- MRZI)@9J,6H)T0[,M2`T[C+J"U+!G$?)6"M%G-!"DK3YD-++(*?V8T420%F(J M2$L_8S07I(8+BYS2+QFM!$6B;3;"G&@74Q;#@V6K18D['E6#[*^;F0H,G9Z\ M8=&5.W^E>433:E5M_Q'X;8E8AY;VA_QVQ-#-1>I2NJ*E[GL6.37I,QHP&C(: M672Z"<96RS9!$O2P$Q%K&:E.7--JW6I]6H+T76];Y!AV1$L-NX+4L&>1 MTS9]1@-&0T8CBYQ"C"UR2C\1I(68LN%,M+3T#=SS;)%[MW1%'7M'8[34-8*^?(7]-6@T5)7;1TYM.PZ%9W"YJ,6HS: MC#J,NHQZ%CG3E#ZC`:.A1=Z:-J^V4_JQU7+0A-&4T8S1G-'"(J?T2T8K#WF! M-A%R`RT#1,;]5[5`)@WDIA7/)T7-=!N%&JUIK=9OUK2BE2]^@O1I6:F3Y&TQ M<,2SQJ(5;:$)NYV* MP4FW,]$ZV4)S=K\0PY/NEZ)E2WT5K"96GF,_7U&B:+X:'N2K(#<1>56+]S>S M1+[*"-2PS%W5"M*^JF61EW^Y,\>PPX9=-NR)EO:A?4'ZQ`$;#AF-Q%!]C06I MKPD;3D5+#6>"U'#.A@O14L.E(#5<>89^5)$NT:@:'D15$&8$1?<2Z86LFK>J MO0W>Q(:Y76IF&JXOFCPV54L2I"5(UPMM07;9&.ZRJUB<=`6IDYZ@:K[*KMP$ M;T9?%<3-0)"Z&3(:"3I9U;%JB?N)('4_%63G\L%FX$S%XF0N2)TL!.5.;I.@ MP98J%R\K09D7/X'^86NV(ONPQ;M=*Y#;$I%NP5JZJU=KZJS&FHQ:@K2N;4$Z M0^LPZ@I2PYX@74+W&0T$J>&0T4B0%F+,:")(?4T%J>&,T5R0&BX$J>&2T4I0 M9NA'U>P1.K/08G*2[QVZ>Q(5BQ*$3;N%:I":=5'S)B?<+>3.L(.IOB+=0J$E M"=JR[KT1H=`ZX:MC#9T]TR[[ZJF6N7@1G@#T52P%&K"3(:.1&IXHXUBUQ/V$ M?4U5RY0Q6./.5"H^YNQCH5K&QQWU#$63BI.5Y\3/(;,QZ>30[]:H.*NC(<,5F*8?]#E?580;&46W8/L3Q;AJE4L2I`Z M1?=`FUM6RUE,-02YW0HM*)JBE=_NHG5*_G#GG+8M!B?==D3+N@W>@ZZ(=>+: M$Z2=<)_1@-&0T4C0R3*.12M:]8E(M8A302?=SD0K=UL.)FYS$:O?A2"M^I+1 MRD-^1X%EPK_J*(Q^,#>U"%FF'47.O)S*T;6SQV&V5N#L1E_1EB!]T]H6.88= MT5+#KB`U[%GD%*+/:,!HR&ADD5.(L45.Z2>"M!!3-IR)EI9^+D@-%Q8YI5\R M6GG(CRQF>BS$+/\@]'\:[37S?[;IKYY>3FQ^O*';*%^9!6O!\T]5 M:UB&4I-S+$'7DYK48PFZG=1D($LPVT`#Q\*%24=JAA^VP>0"+1:38%A):]'G MU"&I1R484=)&5()1)&U&)2U(3'_`9<-`DIIN@248/%+3.[`$T\C43!-8@NDB MXA.38-:(^,0DF#PB"C$)9H>(0DR"22)>@)BD!DDM*L'4'2T:LVE`8B9:7!_, MQ]%N,4D;$C/'8AO,NY&],0F6T*AI[!7!&ADUC4FP5$9-8Q(LB9&),0E6QLC$ MF`0+8&1B3((=-=C$7G?LI<$F)JG#6SWJ#?LB:-'8<[#Q@1:-2;#_@1:-2;#/ M@1:-2;#=@4R,2;"I@4R,2;"W@4R,2;`7BOC$:HI]4,0G)L%V*#KIF`1;H(A< M3()M3T0N)L'N9VKVPF)9=8DVB$FPIYR:W3^VP3XR6BI.1=B MR0@2<\K#$ASTH&PQ"4YR4+:8!(?7*$&LU#C#1@EB$AQ2I^8DDDN`L^K4'$BR M!.?3J3F79`F.IE&?F`3755"?;,H=3#-P:R4U=Q78&RZGH*8Q20W/J46?@WL' MJ3D79F^X?I`VHA)<.4C-*3';X+8!HAV3X-)!:LZ,V087#5)S=,P2W$1*S9T2 MEN#"$>(3D^#>$>(3D^#Z$:(0D^":$:(0D^"V$=Z%F`2W$R&)S=)P(Q&1BTEP M,3$U]]2X/KB,B)C&)+B'B)C&)+A?ALC%RM:`Q-S^X>?@ZACB$Y/@!AFB$)/@ MBAC>DI@$ET@1A5C9<)<448A)<*44;TE,@FNDB$],@BNDB$],@INDZ,5B$MQ) M1KO%IN-UV)@;E]PZN`^,C(])<`<8+1J3X/XO6C0FP35@9'Q,@JN_:.N8!-=] MT=8Q"6[]IN:&)I<:-WWQEL0D"]/QQ3K_1KF,0L$XL"+@IC^?$)+@*CZ2*27"Q'26(27!S'26(26I8W,52MW&;XI,\ M;LS1;8K/VYC7[M!_9HOIH#=N8!"+C2WX#@D5C%GTS.`6:ZWA'=Z9F,4(0UOL M&?@N"-7.+"Z*8N%O++VOOVV&Z_VW[=OA[&7SA/7U9?:)S3[_8[]UJ?=[BC_07M<%'^(Z_/_!0```/__`P!0 M2P,$%``&``@````A`%'*E*WQ$```0$T``!D```!X;"]W;W)K&ULE)S;4MM*%H;OIVK>P<7]!F39@%4)4['./GMJS\RU`R9Q!3!E M.\G>;S]_2[W4A[^!Y":0;QW4O?JTNJ7FP[_^>GKL_=@>CKO]\\>SZ/SRK+=] MOMO?[YZ_?#S[SY_%'S=GO>-I\WR_>=P_;S^>_;T]GOWK]I__^/!S?_AV_+K= MGGKP\'S\>/;U='I)+BZ.=U^W3YOC^?YE^PS)P_[PM#GAOX7PW9SWQ@] M/5[T+R^O+IXVN^>SUD-R^!4?^X>'W=TVV]]]?]H^GUHGA^WCYH3R'[_N7H[B M[>GN5]P];0[?OK_\<;=_>H&+S[O'W>GOQNE9[^DNJ;\\[P^;SX^H]U_18',G MOIO_D/NGW=UA?]P_G,[A[J(M*-=Y=#&Z@*?;#_<[U$"%O7?8/GP\^Q0EZ\'H M[.+V0Q.@_^ZV/X_6[[WCU_W/\K"[G^V>MX@VVDFUP.?]_IM2K>\5@O$%61=- M"ZP.O?OMP^;[X^G?^Y_5=O?EZPG-/50F=_M'/`G_]IYVJ@^@ZIN_/I[%>,+N M_O05OUV=#Z\OXZ@_/.M]WAY/Q4[9GO7NOA]/^Z?_M4J1=M4Z&6@G^*F=#,ZO MH\M1?`T?;]A!VCPB7BCC2 MAOBI#6],>-ZH6B2!5;_((ZW(OF7:U\^,\(LVM1OE+5,T8U//R+2G^O4M$VD$ M=`]Y6A3_6C-$5_(X_*)+VK_^I;A&TH3J%XG/Y9N/O6B[;M/EL\UI<_OAL/_9 MPSR""!]?-FI6BA+E3G=V7>NN^V,4WBGU3TK_XQD4T;&/H#]N!_'PP\4/C*<[ MK3-FGR(+(DLB*RMHG3&%BV[,:025[A)N82 MJW%+AO:\'U]?NJV0=DIBEA')B11$2B(5D9K(A,B4R(S(G,B"R)+(BLC:)DZ( ML;J'0JRP&^*6('.4Z*5$,B(YD8)(2:0B4MO$*3^:/%1^A=WR:W)CRD\D(Y(3 M*8B41"HBM4V<\JM=&2FEBEMVT)7VDM=V4 MU+^\<0=#UBE)<^9$"B(ED8I(;1.GJBC0[U15J;M5U21&9^AJ%E_[R9MH73?I M7_\R\M:]S"AT=6=4M&C8;.2:)+`T2BJOA./8C6EE%,1Q[2`G&A$V?G8X9')K MN%MOC:Y@8=7;SZ6T5FQZ0L8H9U1HU&\W?BK?+5FK8E0[R*VQ%.+KR>[QHJ<'TXW;DB7,M MCIO-=]/@!:-2G+SYJ$JT[`4_OO;Z82U:CB]KU7(C"BT[HEUW4=SK+AHA:A+) M5"4H4$.(!&6"3+/G&CDQ:`TM5(JA\54),KYJ08V66Q65?%F=HZN*3LJ,W[': MX*+85M=,-<(D8&K2:EDH9ZV"?96L53&J'>361&4NH9KHC,:N28NNW"[A;4W3 MJ-6RHITQRAD5&F&++%$I6:MB5#O(K9S*&:S*-7OO]\9PFV>@[:488W7VT(QA M3(7=&!Z.W*DSU5KN0*>9VVB)^UP0NFGG/;(&D1[);2&L'E**X4TS'7B+2&6D M\J1:4-/QW$BI[,2*5->AVZS%B89&L5E74G74@@A9PS5CE`LRH2T$F:%0"C)# MOV)4"PI4124JH:KH!,8\?:R.8U3#FBZ7:N1TWU;+0CEK%>RK9*V*4>T@MU%4 M'F+5I.V^P_-AETM%;:;B-$^+O)76V\ZEVM#J31FCG%&AD36=E:Q5,:H=Y%93 M91A4S7=66IV5V(TIB8J[TE[[P[15&[1KJ+<.9U$GE4&3:V0U?\&H-(9J:?8> M6AFIN*T='TX\^J^D50UWUTE!UL!+-4,%Y5D9HUPCNU:,2C:L&-6.H5L5E?U8 M32O3"KI/,_"LYA.$:<5,@_&UE^.D6LV99?N1ETAF1DMBD`MZ>Y85+6L^$F1W MJ^C&ZSB5T9(GUH)XBNJKC,0*BSX3?G7+U.A[+=\F-9$]"VNU06RU?*MFH5RT M!IU6H9$U&Y2B97Q5C&I!S9;:;?E7,J0^9T@:65TQU6C0KFS4NJT/2"76N1B8 MF;Q@MZ5HM6[]06JDXK86U+AUZ_=*WM3GO$DCIWZMEC-&">5L6#`JNR>:U4_W=-J0UN+=VQ:2W=DVK&)V.ZV.I4RF[CREQY5B2][GHIOO!/$ M.NC+2C;=J'FIU+OS%*=8?8VLKIYJUKYA;M].:30TTTTNR*P1!:.2?56B97S5 MCI9;194NO345_[E_P]-Q1J9Z2@5K0:YSU,)AO^\.%9#K5L.APTF?X?7JJ?:O'(7MNLURE.`3`-.060IS;ZT8G]#EQDM&0\YHT(C+(NB51HMV[VW9%1& M2PQK1A-V/S5:MGOO?&=FM,3]G-&"W2^-ENW>6Q171DO478B%:IA!+08ZA7XB5:-F%B*Z\0JQ%R_%E%<+M0&HK8FU@N@ZD MN+=_T,AZ99>JXSVH(4^4090),NMB+L@Z^2T> M>>TFO%B6B9 M0DP%V4^D`^^9T9(GS@497PM&2T$Z4OYG/2LC%\=K08UCMR&]37_7D-W>7IR, MU;<5S01EBI=JAE83M8Q1+L@8%HQ*0<97Q:@69.:&B2#C?BK(^)HQF@LRA@M& M2T'&UXK16E#CRPTQEH7@;*2X-QNU2/FRAHJ??ZM\`H:J43LMZE^9T9*FR36R M9K:"46D,WW!?&2UQ7[.O":.I,6P^H7+?+LZ,5-S.V<>"T=(8!MRNC%3&V6,5DW".*1?\:E#9$J MO+*J:"]F$Y2+B*T5I0 MX\N-O'=&T*WC?!8PT$@-PZX+QB/OA7RJU=YY/Z>UY$6SOTG,16XZ8:&1M0J5 MO_2L2GS9>54\\@Z&ZJ`O:S/6;DNY$-.@H;\CG(4+X1UUS(.^_$(LN!#+H*%? MB)4I1#.M77K'2VN1!T:H.I.P=I_OCE"E[R4I&F$:D/&8HOV;E,3,HYE&]AM) M0695+!B5[*L2+3,Z:M::B)9Q/V6MF6@97W/66HB6\;5DK95H&5]K08VA.T2Q M5K1W%\UW`?KE*.+8WO5M+SX^;0]?MNGV\?'8N]M_?\8@C>#V]D/'VUO&XV&R M;MK`XY_B?O()!O#J2?`R+E&OF$*2&)*F'IX->FFBPL$VZ*R)B@I+T$$3%1R6 MH&OB:G1(@CO3GX(EPUWJ)E/PRC5&58+ZJB*!)W\:))_:M,IW-$")`@:8;Q+5 M\[@2F&,2U0%9,H%$]4.68'I)5'=D"::41/5*EF`:253G9,D8DG%0@GD[4<.1 M;3)(U*AD"6;I)`]*,%DG:HRR#>;L1`U5EDP&0\2@67.]2".'04U#$B0KJ&E( M@IP%W2\D0>J"3A:2($-!DX8D8TC&04D*B4HKN#[("!&=D`2)(:(3DB`_1-\) M29``HN^$)-@L(6ZAGH@]$^(6DF!SA+B%)-@C(6XA";9*B%M(@CT1XA:2C"$9 M!R4I)&HC$XI;C+B%)-AU(FXA"3:?B%M(@MTEXA:2X`@&<0M-!3B)0=Q"$ARU M(&XA"4Y<$+>0!`0 M!*=J+-8EN`0'/-N2((#5=2G MV25Z\P&.1U&VD`2'G6B?D`1'EXAU2(+7%HDZO^:RX55%HHZQ68+7$XDZS68) MWE(DZE";)7@SD:BS;9;@;42BCKA9,H9D')2DD*A#?;;)(%%G^RS!RYY$'?&S M!.]\$G72SQ*\^DG4@3]+QC$60+R@#TFN4.HFB?1:#N^`48*0!&]T48*0!"]V MT0JAF0_O#R$)V>`%+MHG),%[7,0Z),%;6?3KD`0O9U'3D"3M8XYO/]WP:HHO M)Q/U760@.GU$!Q_&L22%1'VDQY(,DBPHR2%1G^RQ30&)^G*/)?BP,5$?\+$$ M'S,FZCL^EN`#1M0G)!GW8]0GU`_P.3%*'9+@NV&4.B3!Y\,H=4B"KXA1MI`$ MGPNC;"')N(]Y%!]+@I+<'\$-J'L";=!8!.2C*,18A":^5)(U!T%?@XN7R`& M(0GN8"`&(0FN8B`&(0GN7"`&(0FN>"5C7"GB$N!:5Z+N,K$$][80@Y"D@$3= M;&(;7-E*U&TFEN!N%N(6DN`J)FQ"+8?KE[`)27#%$&4+;2-P81`V(0EN[L$F MU'MQ#P\V(0FNMR)NX1)$B;JRR37-8*-N;K($%UA1@I`$]U@1T9`$UUD3=9V3 MO8TQ483BF:*#AOIGBJX66E]*=)H03R/D!>W']/Z<"XFZ68PR770B_%FKE\V7 M[7QS^+)[/O8>MP_8%U\V6^E#^Q>PVO^Y_W)_Q!*VR=L>O&7RK;XD[S M)3ZF[3WL]R?YCWI`][?/;O\O`````/__`P!02P,$%``&``@````A`,T_AO#> M"P``XC```!D```!X;"]W;W)K&ULE%O9;N,Z$GT? M8/[!\'O'VKP)22Y:NX`98#"X,_/L.$IB=&P%MGNY?S^G1)8HLMCISLOUS:F% M=;@4BQ3[]H\?Q]?9M^Y\.?2GNWEX$\QGW6G?/QY.SW?S__Q9?=K,9Y?K[O2X M>^U/W=W\K^XR_^/^[W^[_=Z?OUQ>NNXZ@X?3Y6[^7F_ZM M.T'RU)^/NRO^/#\O+F_G;O$T5Q[2\^_XZ)^>#ONNZ/=? MC]WIJIR/!S"@ M;I^=NZ>[^>_W$X=>AMC!.-P$/? M?R'5]I$@&"^$=36,P+_.L\?N:??U]?KO_GO3'9Y?KACN)9GL^U>TA/_.C@>: M`Z"^^W$WC]'"X?'Z@O];W2S701Q&R_GLH;M]+^3.IW<[#$T%V`?KM/XLWMXAMFS%[K9%(GM#5RUJ!9 M0VX+%RA=H'*!V@4:%V@GP`)L1\K1QRB3.E'F8#,&3!]$#C_68)/"!4H7J%R@ M=H'&!=H)8/'#BOO(D)+ZL$S'(8VW:YM0IG1"].BHE-@J^:@RDA9(*9!*(+5` M&H&T4\2BCCSQ$>JDCHF/CC2TXJU-+--*[W$?54;N`BD%4@FD%D@CD':*6-R1 M9USNT?)FS#YR+9/!P)ZCSA2RM)9W$-C]D8]*;%8(I!1()9!:((U`VBEBD46" MGI#E[$2HS4@AR,$<;"Z00B"E0"J!U`)I!-).$2M\]+`G?$+M\#6R,>$+I!!( M*9!*(+5`&H&T4\0*GXHYL6GX"4?.=I)KI=ALJH6$2@E5&HI4E4BE0RVU&@FU%F13HS+!3.:1FJH> ML#=P[V2T_='H8EF,U)+`'4NM%0]EM*YNE.$$*J569=QSB[74:B346I#-C4H$ M#S=5.5C<%+1!QIIP<^L:VBG1`S%^1JUPY:Y2UDJ&Z1PG<>#,YY(U5F/G5A*J M&7JWM8:U=&M!D*SL>=ZRQM":W3]42'CZ1]<7T[%7$/J'!R6+WL4J4KPD%?%`T:??60X MJ-+\!7F&<@VI([->KDIK`I5:R^*FM"90S;Y,=FHDU%J^;")4+WB(J#+"(J(@ M9[DZRRP/E5:LED88KYW2MC`*W!\E0]/YJMT8J&8M]KQTYD=C%-ASRY!G]E*A M87CK0^A/ZPE*P,XNJR%K>6JMQ(1=L.4$*S66F#E1:2@VEK7'LO%@K>7-'EPJ M,0S)<9]1E8U/%1JX**.X='6J=0+H\#)D=MY*0]9$MES' M8>(FB(;]F"YJ&1I]Z8MI/`V6ESK950[4_;AEL9&#F/4*FAR0A5$JJ-(3G>Q$[# MC9&SX];R8K.F*L:P_E6ZB531,YVF&D)O<',Y0V:[+B14:B@V.T3%D)FUM31L M)-2RX>#+)DB5B2'(J292!8M%1$,)%L5D7)ULGFO+>#KZLNYCK:5*2$FP=,:_ M9`VSNBN&3"*I&7JWM8:U5&MQ%+D7-RUKR(04V>72+V>`+*,&#UCKZ#@S!93: MRD`%JRW-Z)8:6T_G@+*7,G@14GYA)(#C^V;\A?@R5NMBE M:VIG4V7(C%:NH;6IJ0H)E1*JI*]::C42:BW()DAEB2$X$E'5BC7+%62=21/W M"K74:B346I#-S:Z(1FZR\HD4E$P/24G@%'JY3\NS M@+4OG;X3L7R5W,K5`JI_JZV&M51;J]")N-5RU9;=-U2<>,9=5TUF:F:1+F,, ME$NH8,@,7ZDABZCR-8%J-C3N&X:,K];R91.A2L1#1!1\-P[2SZBK5,U]7&ES%, MQ.VOT>(66_;ULQ;M?OI8#85+"-%_NEZ:3O_8/>5JNS5TQUY(Q`6YT6(R)4/( M>J.AI_MT6&:IU&PX;3':.,/:&"UNL67H9RW:W6>79[S#Q[(,T]`*.^U(Q#T` MY5J)1G!4DAL\:VW5#N'>ZI4L-[U1,62VB)JA=]MJ6(O;=NAVFRW)U@X,# MMS!HV+N0AIB7,SES+79XF:U7!:`>2:GG-,?N_-SEW>OK9;;OOYZP"''9(L!Y2FBM2@A==GX>YZ%AD>.DU9'T7CU(\#9%^LA@->/#/ M2?H9?#T&"9Z2^7!$.M0]3L-Y'*>TD4E/V))`VR?)XP0VOE:0AV'CDV3HJLS; M54B#*2UT&4$!"2UW*4'22VG12PER7TI+7TJ0`E-*`%*2Q2%B\W5_#@E5-=(& M]1HB\$E0MB$"GP35&WK')T&1AG'V27#F2NF$(B/`:0MSQB?!T0-\?+,#QPWP M\4EPK``?GP2G"_#Q27#(`!^?!&<)\/%),D1-9SS)!^?=E(YZ4E)`0B<^*2DA MH8.?E%205%X)SKHI'0.E#:ZGT->^V8MK*?2U3X+;%43@6UFX*X&-3X);"]CX M9B+N(&#CDV2((/M)!#'ZS1=;`1NZS9),<:F'"'P2W.VAWWP27/&AWWP27(_# MFV^T<=D-/CY)%F'-J2W7S4B0T#6L+VJL.:\$U\^(VF>#6VB,J4^"RV;$YI-D MX2;-\"E!1H#O-RE]QY`2?*1)Z6N&E.!;34K?-*2DAH0^8T@)OLM@G_!)LG"% MV(;ZR^TW2.ACF?2&[X.(S2>I(*$O9](&7PL1FT^";X*(S2?!=VK$YIWQD!1> M";Y`(S:?#3Y$(S:?!-^C$9M/@@_.B,TGR4/,'3RZ\#&E/=DGR<((?+P[("3T MED!Z*R"A)P52@@<4B,`GP3L*,/5)\)PBI7<&TAN>4*`/?!(\G0`?GR3#P/ER M2X[)YLN'.;8$WQRLD=Q].)X(@:%OM>/!#V(:)(MQVN+A^=ONN?OG[OQ\.%UF MK]T3"C"\W,9IZJS>J*L_KNK2>_;07_'D'"4A7CSCWQ)T>$@4T%/)I[Z_\A_H MJ,7XKQ/N_P\``/__`P!02P,$%``&``@````A`'C?JD=N!@``"2,``!D```!X M;"]W;W)K&ULG)IM;Z,X$,??GW3?`?%^0R"0M%73 M50G/NI-.IWMX30E)T(80`=WN?OL=8T/PP'FRUQ=-,OP8S/P]M@?\_/E;>=:^ MYG535)>M;BZ6NI9?LFI?7(Y;_>^_@D\/NM:TZ66?GJM+OM6_YXW^^>777YX_ MJOI+<\KS5@,/EV:KG]KV^F0837;*R[195-?\`D<.55VF+?RLCT9SK?-TWYU4 MG@UKN5P;95I<=.[AJ;['1W4X%%GN5=E[F5]:[J3.SVD+[6].Q;7IO979/>[* MM/[R?OV45>457+P5YZ+]WCG5M3)[BH^7JD[?SG#?WTP[S7K?W8^)^[+(ZJJI M#NT"W!F\H=-[?C0>#?#T\KPOX`Y8V+4Z/VSU5_,IL4S=>'GN`O1/D7\TH^]: M*NJ+PR-]\P$)QN3LX-.@3]J;9\?TO=S^V?U$>7% M\=2"W`X[):O.<"7XKY4%ZP-PZ^FW[O.CV+>GK;Y:+YS-F[8J_^50U_3!B268/V.-2[`AA`;(FX8-Q\YC7NB=YJ,#`8$;8@<=,=QY/H`,3,+ M4'^^RPW@98B&A:(Q)6Q[)3/>E$%>?)((IL1Z+5\FG"*3ID13!C4EGA+X0LD4 MN3F1P@R9,1=F9I;"S`WC,-OVS677/W9SC"U'P+N#\>]@@CN8\`XFFF,V([V`2-2,%$^:YN6`RLQ1,;A@%$QL\;/"Q(<"&$!LB;(BQ M(>D-XS#>\DBZM?7\K3$S3/2C`<^V'V7U7,Y`&(=!$'P:=U<;U#Z>*0'GR0"D@A) M(B*)F"02%2%%G!4M>(6T6@X+(G881QZM*5S.J")/$AY)^"01D$3("=-9=7U@ MN=ALULOQWVTDZ$;AB/08DT2B(B0E8+T\5J)?<3$S5@"UT^6,2H$9PL&+L!E& M'M=\D@A((B2)B"1BDDA4A!1U5A7,A;VSX[BC4=P5D"KP`GG@HX[3]S8YL![M MR*>1@$9"&HEH)*:11(G("K`2!`]!-ANFNR1\-7F)(H_^:+WD"DBI!/>S[I2P M5O^E!*<4CGSZ6@&-A#02T4A,(XD2D95@90M68C09F+RLD95`LZ@KH-$@ZSSV ML>X^T?2Q$RC MW.%UD:P8JJ]8@>9SS:22@D9!&(AJ):211(K(2$+V) M$N/480AMV@G$(50'NW%I[T$ M-!+22$0C,8TD2D26@=5_6(9Q,O#Z4)8!5Q6FJHCLAOP=C7@TX@O$=&RQ-EN@ MY5U`.PEI)**1F$82)2*KP&H_K,(X&7AM**N`JC+7Y!!/AA6\"F1_.!M41::8 MG&DWOKB4(JD"&@EI)**1F$82)2(+PMF;J;?R"RQ604@:RDO9H M+SZ-!#02TDA$(S&-L'T);`')'_= ML&JM^58&_J.MKMWK\;>JA9T)W=<3;#G)X477<@'PH:K:_@>\A#*&32PO/P`` M`/__`P!02P,$%``&``@````A`*DNC@CT`@``"@@``!D```!X;"]W;W)K&ULC%7;CILP$'VOU'^P_+[<',A%(:ML5]NNU$I5UF52<=&F./0"C%B;B9RW M98K__'ZZ6V"D-&US6HN6I?B=*7R_^?QI?1#R156,:00*K4IQI76W\GV55:RA MRA,=:^%-(61#-3S*TE>=9#3O#S6U'P5!XC>4M]@JK.1'-$11\(P]BFS?L%9; M$<_W>BV+49*OGLA62[FK(^RV< MT>RHW3]^DL?E#;KG$,&INQ(LB+%VW#U$!+L;]9] M@?YR=E"3_TA5XO!5\OP[;QE4&^[)W,!.B!=#?8P1Z M"M#7#8FCM?\*:60#Y\%RX'?DA"/#!_71`N*]8F%08V'R-)X/%ICJG1P=/>+H M(5,O$HRAF[<`3,(B,1D#LU:6,YMP9B/#L0+*E=`-"O6"@,?427Q2L!Z6]`$/ MN+N)1Y].E'API;BS5@+A)WJA6@V3)?O"ZEJA3.Q;:&^S]$9TW/C;/H]S?+;:VB^!/[Z!!=W1DOV@LN2M M0C4K0#,P[8^DW>7V08L.8H&PO=V]R:W-H M965T-'T`W``(P[W__L=OVOA>'XZ;#X_J]V*V.5^5'L8?EM3SL5B?\>7@;'#\.Q>JE*K3; M#D;#X?5@M]KL^[6"?;A$HWQ]W:R+1;G^W!7[4RUR*+:K$]I_?-]\'$EMM[Y$ M;KBM?5Y_;T MO_++*S9O[R>D>RJ*K,LM:L+/WFXCQ@"ZOOKQT!^AALW+Z?VA/[Z^FMX,Q]9H MVN\]%\>3LQ%E^[WUY_%4[OZJG2PI58N,I0B>4F2D-,Z4F\AR>%+E5S?6\&Y\ M@[K/E(.U:C2>5-]9_VOICZ?TM]#?,Q7;:"%$5'5)'ZYK$\6I5KTG2JYJ%<6Y5?\0B7/-X\R:ZG4_B3D M&)VR1RI+EXTBB[(E?CG7O$$]]JLYLUB=5H_WA_*KAX4(D3E^K,2R9ME"1,X6 M.4*:^8-IO!;N3\+_H0]'S(PCZ/?'R=BZ'WS'A%Q+GQGWT3SFY"$FI9!=Z&"I M`T<'K@X\'?@Z"'00ZB#20:R#1`>I#C(=Y"TP0-B;V&,P_J?8"W\1>XK:C(!* MQJB;BCEY4)&%#I8Z<'3@ZL#3@:^#0`>A#B(=Q#I(=)#J(--!W@*=0&/NLD!/ MILV8%F8L_JTQ/1YJ@9S5/F(A40-?BW7CT@2;D24C#B,N(QXC/B,!(R$C$2,Q M(PDC*2,9(WF;=$*/19"%7JQW]1N(KR_"'VL1,JGB/-:3(9W.):-Q:9+!R)(1 MAQ&7$8\1GY&`D9"1B)&8D821E)&,D;Q-.LE`W%DR1M.K,^D0):IT4!AG-9FV MWP#CX;4V%1HG*K9@9,F(PXC+B,>(STC`2,A(Q$C,2,)(RDC&2-XFG>CCY=Z. M/KU1!>Z&N";8A%+TYHPL&%DRXC#B,N(QXC,2,!(R$C$2,Y(PDC*2,9*W22>> M&(*F>`KC"P863+B,.(RXC'B,Q(P$C(2,1(SDC"2,I(QDK=))Y[B M`-S:"M+X%+@;3TG41F1>DQ$>S:H]'MYT%X5%XT3#>LF(PXC+B,>(STA0$VQH MJ:ZP\6DW\;;;Q*AQHF(Q(PDC*2,9(WF;=**.8T\[ZG(#?B4.3:?WS?K;K$1( MK6:O(MR[V9!$=75>DQ$>339&0ZVKB\:)NKIDQ&'$9<1CQ&B*?+1I&L\O.N& M;&[RLJ[U.26])IW4WVKA7Y*7FK$.1^Y%-7I4\+8:1MH@\\FJ:@HX"B^J*:*" M=4U:XF.RJIH2CM*+:LJHH+%/.5FKFKI)%\<_4]+K8R'.%#1R9N)\48V#28V`NL9&JPVN8TO.)M?0"`PN)M?2BABF]F%A++S&PE%A+ M+VN8TLN)U7K=B(MCGRGB\CC8CGB-QNV#W=@:ZM-,>M6IGW:M"W$'AZR-U49N M24BMD@Y'+B&CK*>LE$^?D)(-.`H)U;+:DA$I*\G&A)1LPE%*R#C^,V4EV9Q0 M)=M-D#@*FA(DCXCM!-4("2+=N;C![,9[P=&2D.J4PY%+2.7.X\@GI+0"CD)" M2BOB*":DM!*.4D)**^,H)V2(L#CNF2)<'P,Q>2B<,W'M@7#BK==ZTUC:FCV7 M7I/VY0;^(Z%/A5H+7B2_-,E;-]H,8ZBTVI'0 MWI.1\J(:XXMJ3'B-J=)JUZB]Q3+E137F/ZNQ.]W$6;4U&*K-_`A7^?]^WV75 MQ]O.."&$I]J26-IJ.)62E]+R./()*:V`:X7DI;0BCF)"2BOA M6BEY*:V,HYQ0I=4-O3@=MT)/5P]6?6KN3(X:3;K["/W^41;L;.H-VW6I99Q! M2ZDQ45M:1Z*QVOFY%]7DD985GU:[XR"&DW4V70NO5IH(=%4#V\FMH:QP"S M16<@JEDPSFS1)V[!V+)%U[@%X\H6/>06?%?R5'59JV6&[TVJ+NE\A.]0##JS ML9U7T=3\GR;VD['BV<3.JS.>5@"SWA;CAC<5$]X6PX=;,.]M,8JX!=/?%H.) M6S#E;3&FN`73W19#BUMFL,R,ECDL8C+Q,@M8Q)SB%JR5MIA:W((ETQ8SC%NP M)$?DP6W3E`S36MDV6&%LR,+9C#(H[)/`NXK$!^ M3!;<62`_)@NN+I`?DP5W%,B/R8)+090QM=J'1=PW\;;A7A`Y-5EP/8AUQV3! ME2"R;;+@.A#9-EEFL(C;-]X"7+%BW3%9%K"(FSA>!E>IB*C)@AM51-1DP<4J MUAV3989)7VVVM55GCL6ZNA[0>(@WD8G/[VS\#X2W-KRS8K2R#1@Z?/7ZLWHIX=7C;[(^];?&*E_BP.MH\,&CV`KTWO$E:X%/M(;B%/M:EB?Z`QT<--_&/OX#``#__P,` M4$L#!!0`!@`(````(0"Z[ODF,0T``$4Y```9````>&PO=V]R:W-H965TCTWFUOU\]'_:;V_%?F]/XC[N__^WFU^'X_?2TV9Q' MD+`_W8Z?SN>7;#(YK9\VN]7IXO"RV8/R<#CN5F?\>GR'K;K37E8_]AM]F]P?CJMOS]#[=S);K4EV_XL0O]NN MCX?3X>%\`7$3NU"I\_7D>@))=S?W6VA@S#XZ;AYNQU^3K)O-QY.[F]Y`_]UN M?IV"_X].3X=?S7%[_X_M?@-KPT_&`]\.A^^&M;LW$`9/Q.BZ]\"_CJ/[SNW7;BQ^?G;M$^N'WG_EZKRZNSD>?HVP*6#IT\O* M;+$D@USG.&?]P96(J+7A_FK8;\=0'$XZ`?UY-TNO;B8_$1MKQY-+GH1S%,1A MG&K$EC%0Q4`=`TT,M#'0!<`$V@XJPUF?4=FP&Y5IL3D!W@9II!]QT)`R!JH8 MJ&.@B8$V!KH`8/IA;WU&/\/>;\C!I6DZXPKEEB>!10>FB*486`:E!5()I!9( M(Y!6(%V(,-61$3ZCNF%'X,.07JUT$>GNF-[2?6`9=!=()9!:((U`6H%T(<)T M1T8+=*<-:]!>15I:;I%YN(?3>`\7`Q,-*P52":062".05B!=B#"-KE2-#,HU ML@@*""VV$$@ID$H@M4`:@;0"Z4*$+1\65AQB4+Y\ARS]\@52"J022"V01B"M M0+H08.O\M%U_SP_8,\E0&`PW5\LAD#]LKC3>7(5E2E%Y/-/E MDN_`164KBNG;]Q9Q+J8CN2W(MH8:@<$5BKI:X:*YH+1W1^[FX M;4Q[X??'8!O;=:"FD'ES4S81'DL/%1(J"9H.`RN"9@-4.VAZ-4`-<7GQ+4%> M5D=0+XLK8OH(11';7C!%+#0+ZV4ZO>3N*4PYA;JSL&"FTZ@%+#T7V:DB*!2? M+"+QM>.:]@>2OGML:&`X8[*,X]YST8P=D\6-8EH,;Q37%[^:_1+7D7@?Y`Z" ML6BZPD$+[\]20A5!OIS5#F(ZVQD#62T-].([&MB?G[B"IH_P"@[AZ]H+O^H\ ML=`T=$LZC5M>XG(;*8FZJ-+3R1P50>$^=G.%X>V@5W9H2U)\!NP(4C:MZ344 MK6T+@G"@Q>4XO9HHAM8$%0Y:^EU52J@BR'NA)EFA5E9\(*NE@5Y\1Y"R:4W7 MX17IXS,UI58IS8GM4)AVKFD)D^-49&O+A!`+BUS3$?3:C#ST3$ONN$O,?SQ$(L]&Z;7>4/!/P\O85>; MV-:(*>@@[ZC"<2U\Y)02JB14DW@OJY%CX-NMM4*_859 M^W8D+%_S>`\3DSG/H&D6W8JG4\JI'!34Y%I"C1_8"X[//ZVGD^".2>%*F\Y* M4=K`D4,M%#8?J8.\$TH)50YB6MF!`=3(@:V$.B:+*V*:%T41V],P[UG(!$(0 MF5%"*U++Q2)30)7DJAT$DY/Y&\G52JAC$-?-]"N*;K:-8;I9:(E6(-`M.NT4 MJ>5".]U'$&^V2T\E!2H'!?ZJ)=3X@8K8UE-);,=D<(U-+Z-H;%LGQK M6YAK?WM:H)E*"54.8CK9@0'4R(&MA#HFBRMB.A)%$=>H^/2>IQ9:XD?@NN@B MO'!T(ZL5RC4T_X35^K]Z;#C/. M-!:")6BZPG'-?"-;2J@BR,="[:!@&S?$Y66U$NH(ZF5Q!4V_X!4PD#YG$ M97N%Y&(176=6CB%P?BVAAL3`#4,@B"KIA:*,A-)4'>?Y6#F*9V8``U--#GN98@+ZMCLK@BI@GQBKR7::>V9V$* M6F@9-KBSN)%PXU!1O4/2:>3V]&;C[3`GGS477&!A;[WT)\DXC49IGFH2U%W)9.^LS6<&R2J-96Q.`3 M7>T@%CH?F:PE6319?"O=$4,_&3?.YWJSJ>S-',0VC^6Z#K._Z^"\NA4-#*JX M@Y@%A*R6!GI9'4%*%3<]C_>^V#QQ%;AITKJX)E>J\J.*XA44==;>7F"GQ; M2ZAQT-N3M<0U3!9EJ8Y)9L:9\:Z.C-/#O'MS4!C8#@JK`D$^DU<."C654$,# M@ZI`D)?5L8%<$:5[2^:O?CPR7\JB=L=!;U<%Q_1.5?!VV]>^U`N'-F%_ZZ M',]F1=A9:#[K[W6^1.FT<".NP_9Y[J]I[/3V*:U]BKG;'!\WQ>;Y^31:'W[L MD>\3?/F[NQEP^X@789,96V)7113$"][W:A0\_/W:VS@:D>-!4H)0J!5DA,_M"CD%RR,SVD!3DB,SL$DE!MYB9 M%DI2T";"_AH%[4UFFAA#X:I9C.,W/ZD9KB'`-I&B6'1?-7+'J5%2H%1P?, MHWD!9P9X0:/@Z)#5*J4!I5$I.33-7]%TBK5I-B@QQIR#I0UPZ,?:-`K._EB; M1L$5`-:F47!-!FF:YW#I!?]H%-PY88RV&W&#A#$:I9AB9^%Z1>K3@&(N7B0E M3Y=9CEM#2<'%;6:N*R4%][.9N;64%%S39N;R4E(:4,R%I:3@4A;Y4Z/@DP'6 MID4(/A-@;1H%WP.P-HV"SP)8FT;!UP&L3:/@,P#6IE/@!7RMD_K@RQI6H.4J M?"?#&(V2IS-HJNTY?,N"IAH%'ZTPCT;!MRMHJE'P"0N::A1\J\+:5$JR0-W3 M'S?Q@HT2IXFL(YN:U0SE8)OS9A'&X-/ MSK".1L&79UA'HQ0)X@T/9C1-$3LJ!2]ALOP5NRVR0J7@R0OFT6R-QRZPM4;! MFY?,//O0UK;(&I6"YRY8M38&3]>P:BT."E#,XRTY#UZE86T:I0;%/.628QI0 MS/,M2<%3-,2.1L'+4XS1,A_>G&*,1LF3%/IH>PZ/+J&/1L&K2NBC4?"2$OIH M%#RHQ-HT"EY,8FT:)4=RT6*J0$+4?%-@NVE[JL%FT_`<5C$O::6-\:H8$:A1 M\)(85M$H>$,,JV@4/"6&530*7A0C`GO*9&A1\;=M+ZO'S3]7Q\?M_C1ZWCR@ M>[_LC_I'^V=P]I>S?5&PO M=V]R:W-H965T7P=N%HQ_VOA#ONSI^_O'W8#\#U<_QJ#SF?'?=8]GX;S[M,K='^/ MTMV>8X__$.&/A_UYN`Q/UQN$6ZB&2LW;Q7:!2`]WCP+YXN!L[Z+^'_MO%^O_9Y67XUIP/C_\XG'KT-L:)1N#3,'PFU^Z1$`HO1.EZ M'(%_G6>/_=/NR^OUW\.WMC\\OUPQW"LJLA]>41/^.SL>:`Y`^N[[_3Q!#8?' MZPO^;WVSVBR3*%[-9Y_ZR[4^4-GY;/_E/5 MYG:,\DY)U#%6CU^N_MV:UMH?OUS3YM=JVNB2^.6:;C;1?@VP_)`GU_>=K38H@PQ]!#JMDZ# MBKFU)^^/Y'X_ASP,UP7TZT.R7=\MOF*6[+5/+GTBUZ-@#YHI%+;T0>6#V@>- M#UH?=!980.TD.?X]R>1.DKFQ.0/3![&GCSVX2.F#R@>U#QH?M#[H+.#HPRK[ MG2$E]W%I6D.Z<07ERB="CTY.J>M23"Z3:$$J06I!&D%:03J;.-*Q-_R.='+' MQ$='3K*2[:TK+-=.[VF?7";M@E2"U((T@K2"=#9QM&.'L;3S@B4Z2N2FY8IL ML+E9HKTU7$Q.7*P4I!*D%J01I!6DLXFC"$VT%(U[TPK#H/91N3>1NRM5D96[ M76W=\2TFITFJ()4@M2"-(*T@G4THHFITF1()4@ MM2"-(*T@G4T<193DF8.%%1%U%2F"/(`;6PA2"E()4@O2"-(*TMG$:3[.PD#S MB;K-U^36-%^04I!*D%J01I!6D,XF3O,C)'-6^_6Y?D-IR/7EL/^<#UC\D3G6 MR=T5-D8`6B9&FF8QJIWVCGCI;9BE\>(AK22J)6HD:B7J'.2*IA/?S+F?BB9W M3[1"&TR+26"T%NF+\EJOQP0H7D;>65C208G(<#`](%"MO5;;R:LQ!2FU0N3$ M7=JM<>#(G8/<_J`,P?0'KT$Z[WS="FUQL$ZZ8R\)*'2YQ*1"I4251+5&L%KI%<@5QJE``%I.C,8'WK&U#*/-,)&-4E+EV)(E5R MO&H3G@>DD5ZM1)V#7&UTQ`>TZ9/?UJ;0+8X52YN?C4;**['3G&@M5JWV2E56 MGR9+;U97',?,ZEJBAM&[M;7LI6M;+E,O`^G88ZS-[1]*&`+]H_((S!D>B1P/ MHS33T3^,"HW0&8Q*1NF$*D:F8"U1P\C$:AF96!VC@!!*!P)"5);@"%'HEK9O M?O!*E][F4$3**UV.0[A9+[T57!H'%E]IY$QI%<9"#1?$)C;5']UZ];?&B\-W M3GAW%"ES"(A7"84C7B&(Y[!%I!"4,BHEJC2RA-02-5S0[$ZM1)U3T!5".41` MB$HM'"$*>S%D5?>_&B-`T?N M&`5F+R4?1O=/3UN=JYC%DD<*.Z6FV:5VBRQ6:9::.5%KE)B23:!D&V"= M$\T9W-C-H_@(';&;.C!*,36G-9(N5^X!7F@W:*$3/DWBK9>]E\:#!Z%B9$[> M6B-K;C?LI4(GD=@@6N/!H3M&8VA7.F4L9GPGZ2J1L>BC'">A1J8^C1R'$XB85L4+6Y"HE MJB2J-;)B-=*KE:ASD"N$$I.`$)WH6`LL5FB#'VM*>B=MH;U2>ASX^K`1F8&Q M4G1O7/MIM8I3/.L"J$WN#J"NVU M,<=U*5&E46+F0\W(S-I&%FPEZKC@&,L5&$YKZ(;/$.]TZ]@AL2)27_,8, M4&F,,P,T0L>9*:#8VJ`RUFXK,[J59AM[#B@W:T]HM)<5K`T$ZYQ@[B2@Q.8= MC7\.;SAV,%3J.CY6>9"C42,S6H7VVIB=H92HDJCF\"96([U:B3H'N0(I+3$" M)R$J6W&$*.0\DZ;^94,1BS2GE*B2J-;(V9A%K%86[!SD:J/D):!-YS2F^W.Z M0<&BQLLY>P%[2Z$(>046L(ZEM^]4+%]E=_9J@9I?JJME+U77.O):W&F[JLOI M&Z!0WXS83:0T4B\NQVE>2%0R,NNQT@@_O+AKB1HN:$:C961B=4Y!5T@X+<+A MX&_3&F%_L`8Y\M*]@KUNQ_U7'+[&S*(J1F;SK25J&*FXD7^;TQH[!^X8C8%= MT93^F)G]L\.7KAJ\,TLC:[,L-$K->5Q*5#&R,GT9JV$O$ZN5J&,TQG(%4J9D M!/*V1&>G+T0C>A-A#E__[-4%D9J.J4_DI3ZEL7/O5XS,9EMKA,G(7@U[J<`; M_]JD-78NTC&2)RJ>,8.J9>XT>F*=0C7'+31#WLBHE*C2R-)02]3(@JU$G5/0 M';]P\I3(Y$FC-?8C,WR1?Q^HO1*<"):7=[-6&B_N@4HC>JR:"D8;;]'7[&6Z MKC&Q3,%4W/\:+ZZQXU@_JM'M)\I9S#S_Z4+6F9#9+'/:SK`DUO;T3_RG7.V$ MO-H6X]UTE,:+Q52,<$"]UWVZ66:I-%S0KC&^]8:U-5Y<8\?H1S6ZW>>F9],V M(=,PW)*/W82?28C_`%1H)UJ@DY,\X-EKJTX(_U:O8KOIC9J1.2(:1N_6U;(7 MU^7-^([M@;V$DJ??F%DJU[(3/EILM-FNS&PKF"W-%E@RPQ,RCV+%;&E8'6#- MQ$R\EID5KV.FXKES@)*G=X1Z*7JB&.4U07QS?T`*6> M`48'-X72:*4N^CYXJZ#0YJV3?49F#;OUA_,=[/K^R[K,T:L:H#YG4Q]!'?OS1_'.>K%RO&MWG@:^#S.\*&/ MC),GJ"#`/Z;91Y4Z^X%2?`P8*)"O,GR!$:A@G>%S!1)!3VB:X?$$>D(6/(9`3\B"IQ'H"5GP4(*VA2QX]D#;0A8\ M*Z-MH5;C^1CS(&0I8:$GQ,`HP$(/BM)2PT+/B]*"9V/,@Y`%UUD97?#(,KC& MPKH-67`;D]%=BRR#NQ64"5EPRX$RH9G8P$(W$C):CA;D/VC!*BN"EA)EZ/9+ M1L,E(%H0LN`N,*N#E@86NA&3T7"=CFBAT<;E./2$+'F,-8?;TU`TK+F@!??4 MJ"=4!M?5:'7(@EMKC&G(@LMIM"UDR>,EVA;:OO&^!VT+6?!2!VT+6?!N!VT+ M6?"*!VT+6?`>!VT+6?+H-J,W;8%^@X5>KDD+WB=F](I-6FI8Z$V;M.#M8D8O MUZ0%[Q!QMH4L>;1&VX(S'A9ZI2NCX8TUVA:RU+#0"UY9!N^OT;:0!2^HT;:0 MI8@P=_"11B@:YD'0DDD*6'`,7VEN*"+--O6+SSI@BPJF`+Y)D_?BV"65" M%GQ8A#*A-8_/A%!FM"RFBO"'!6^[Y_Z?N_/SX729O?9/2-N6XZ=M9_4W".H? M5W55/OLT7/$G!4B0\74[_E:DQ^='2Z3/LZ=AN/(_T-S%]-&PO=V]R:W-H965TV'+L7(PD1;JBVX`-&(9=GE5'283: MEB$I3??WHZ18MNP4R$L0T]0ASZ%(>G7_5I7HE4G%1;W&9!)CQ.I"['A]6./? MOY[N%A@I3>L=+47-UO@?4_A^\_'#ZBSDBSHRIA$@U&J-CUHW>12IXL@JJB:B M836\V0M940V/\A"I1C*ZLX>J,DKB>!95E-?8(>3R%@RQW_."/8KB5+%:.Q#) M2JHA?W7DC6K1JN(6N(K*EU-S5XBJ`8AG7G+]SX)B5!7YUT,M)'TN@?<;26G1 M8MN'$7S%"RF4V.L)P$4NT3'G9;2,`&FSVG%@8&1'DNW7>$OR!S+'T69E!?K# MV5GU_B-U%.?/DN^^\9J!VE`G4X%G(5Z,Z]>=,<'A:'3ZR5;@AT0[MJ>G4O\4 MYR^,'XX:RIV9(X4H(1+\HHJ;.P#4Z=L:)Q"![_1QC:>S23:/IR3),'IF2C]Q M`I ML+YN4C)?1:]`H[CX/#@?^/4^Q'M$@.Y#0+Y70ABK"6%XFI@/SM#'2Z[C3:_B M&2LHTD\GG7H`%\+YI#V?U'L$*8/+E92-%72"1#WEE"P\@HOAG&Z(`37KQ4"F M[&F\G,Q\$8R##>?4C_).#+@@0PI)G$[F MF>=@/$(.%PM0\2*2-/,9!&4P(ZZ[G%8BDDW[^,8CQ+]80OS9=?QE@-]J9*Q# MC9+8([@R.Z<;-"(P$(8DIDLOD'T=,FA-(86N_0*)B&G#3J.6@S6/2'0-ZDA< MO&YA$3:Q+<4LG72%-ETQJ$1K"GET_1+R"+OZ4NMVE/FYV.GF>CEH1I(.;S*Y MN>,)B-#3T<9/%F0"H]5K:EP&I;J8^@J2K+LK(440HA?"PQKSH%0D&Y7*>?4# MO=.4).Q\QV2VZ-?*3P$_6>PA2**/3[)W!C!LPSX1&V&:]H0:=[T],L+OYK,3 MRNU(MY\J)@_L$RM+A0IQJF%8S*$2WMKNYBS?NN4\>I-O$[-EV MOGO0H@&98)T+#2O<_CW"MQF##1E#"=%>"-T^`+O(?^UM_@,``/__`P!02P,$ M%``&``@````A`!;8_H5I&@``27P``!D```!X;"]W;W)K&ULE)U7UK%\8\I/!X1I8)`&Y_V___/T[>3/AY?7Q^?O'TXK[\Y/3QZ^WS]_ M>OS^YM7YU_7IR>O;W?=/=]^>OS]\./WOP^OIOS_^__^]_^OYY??7KP\/ M;R?P\/WUP^G7M[[UW?//QZ^0_+Y^>7I[@W_^_+E[/7'R\/= MI]SHZ=M9]?S\\NSI[O'[:>$A>_D5'\^?/S_>/[2>[_]X>OC^5CAY>?AV]X;\ MOWY]_/$JWI[N?\7=T]W+[W_\^-?]\],/N/CM\=OCVW]SIZ[ MW[ZAW/^IU._NQ7?^/^3^Z?'^Y?GU^?/;.[@[*S+*9;XYNSF#IX_O/SVB!*[: M3UX>/G\XO:UDM[?UB].SC^_S&MH\/OSU&OS[Y/7K\U_=E\=/H\?O#ZAN/"CW M"'Y[?O[=J?8_.03C,[+NY(]@]G+RZ>'SW1_?WA;/?_4>'K]\?K%ZWIR M_\?KV_/3ME"JN-1+)S7O!'^]DTKE7:5^?OD/?-2]#_SU/BXT'T?21B[S`N"O MMT-1CNA?>GW\_4?I7'D[_)5TWE6O+RH7>2&/)(@VE6<0?[UA4,%'[&Z\'?Z6 M"=:K%U?7^9,Y8EA!M.0ING^42?Z:J81#!?^05(]69P6U722F$?1KY:M(U+A_ M_%I:$B.5?QHD%7EZ[A^_EI8\MHH^MU\+R*K4H?N'I/5KH5*5RG3_\*;(\)%G M795*=/_P%I5W5Y7SF]H56L0Q2VDXKHU*-H];2-.I_F+;.2OZFKR/:MV]W7U\ M__+\UPEZ?E3,ZX\[]QZI9%44T/=./KME?X5^\]ZIWSK]#Z=01$_T"OKGQWKU M^OW9G^@`[[U.@W4JL493-%S/Y=RV4M!.02<%W13T4M!/P2`%PQ2,4C!.P20% MTQ3,4C!/P2(%RQ2L4K!.P28%VQ3L4K!/P2$%M^7C=2\T1$@9)F@$_RA,G+X+ M$WG`#0$:-]4D)D1#3%HI:*>@DX)N"GHIZ*=@D()A"D8I&*=@DH)I"F8IF*=@ MD8)E"E8I6*=@DX)M"G8IV*?@D(+;VX!$,8%NCF*B=E[V%$Z,(4S04U3KM?B9 M-PH=]X;3[B16:98J95P0:1/I$.D2Z1'I$QD0&1(9$1D3F1"9$ID1F1-9$%D2 M61%9$]D0V1+9$=D3.1"YO0U1%"\8*5"\8"#\TU>-T\=K">&GP5&]B<.CX96. M15"I4D80D3:1#I$ND1Z1/I$!D2&1$9$QD0F1*9$9D3F1!9$ED161-9$-D2V1 M'9$]D0,1S,:*!Y]/;*((0K"$$21C$H?S0)$'W"C(13A,J=8OXM!IEDIBUB+2 M)M(ATB72(](G,B`R)#(B,B8R(3(E,B,R)[(@LB2R(K(FLB&R);(CLB=R(')[ M&Z(H+C`(MN+"X3@N"H)AMCSR)I$6D3:1#I$ND1Z1/I$!D2&1$9%Q2*)Z0+Q; M]>!P7`^>7&L]$&D1:1/I$.D2Z1'I$QD0&1(9$1F')*H'S!.M>G`XKH>"W*## M*5\QE(ZUZI)*[[1`;D>D@Z M(R+CD$2UZ):!PFJ4-UC.X_KRZ`:-/:B>9/C3]%HU#+I*K)0EL4=,+68=05=#2QGF@5B56NZTF>^Z*@B0T8#04=36PD6D5B-S?5)'[& MHI`G%C\+-_L-EC[*9U',BC'NE+AHN`D*POE&<]STJ*9:+4'UTK`MZ+)$'49= M0>JK)TA]]06IKP&CH2#U-1*DOL:"BQNJ5AJN^U1T$]V&'75,(C\ZV2"V5,M<=]G7P-&0S6T MLCU2L?@=1T[B.D4-F77J>-+J"W15*P.FZ=9DBPJ4I%J,VAY%E588!JC+ACU& M??8U8#1DPQ&C<608UXH;YEN1YH?_&L$-M\B,*KC$"[_LY:H7Z7O::]6N\TBK MI^/]ELJE(MN"M$UU&'4%X>58)E_A4"LRB>3%?5\,U?V`T5#03_(]4KDX'@LR MVJ\;)%NU6@R>$:3BI.'FWD6M"FIZ%)2AQ:@M2(O58=05I/718]07I+X&C(:" MU->(T5B042MNR&S52C&4CFJE0&B!^K"K%^EB9:70\KU:/0G%EHJE:ML>!:VQ MPZBKAOG2>MQ9]E0J;OOL8\!HJ(:YVV0F/%*Q^!U'3N)VZX;=05W^W5#0[?.D MO5R!HE[.(WU)M;SAE:*V1\%0KR,H&%6S88]17PQUV#@0I+Z&;#AB-!9#7K)P M>U9A;96CC&*D'45>@6[";J9ZD;S1FKE#K*N&\6F,^`I?-3_BPU9E'$IM<:-# MFHX@;8I=04<3ZXF6C/C2//=%01,;"-+$AH*.)C82+9_8>;V6-+ZQ:!A#/C

A6PSDHX=4H)N;LA]M5KS6N89-JV0:7>V2:1_<,5BW9.JO5S+UUR^9^AL8 M;%@R]3OX13O]R_7QDHYUHO98,#1NB=6SQ5G6D M:VHQ:C/J,.HRZC'J,QHP&C(:,1HSFC":,IHQFC-:,%HR6C%:,]HPVC+:,=HS M.C#"+I(+(80$=Y'5GTS$HSZC`:,AHQ&C,:,)HRFC&:,YHP6C):,5HS6C#:,MHQVC/:,#HP0,^%3BSND MGTQ3W6F-9+#A4;CHRZC%J,VHPZC+J,>HSVC`:,AHQ&C,:,)HRFC&:,YHP6C) M:,5HS6C#:,MHQVC/Z,`(`5(\[N+9Q@&"443XJI=QESN;!:4S+,9\K%@NI%NET0J,D[JFVPCL&Z!NL9 MK&^P@<&&!AL9;&RPB<&F!IL)TQG`7-!Y7%/)`NXB4).:6AIL9;"UP38&VQIL M9["]P0X&0]CY8$'9D.DX[I(%FCSNJM5WP,4103YSA^Z-^BR/SN/)8C++:XKE M.?(31&.R(M_R:G5].FVQQ-PGL+Q,AEJ=0$V>3M=@/4ZA'ZB%*21%&`1JDL+0 M8"-.81RHA2DDI9\$:I+"U&`SSX(QY#Q0"U-(:FD1J$D*2X.M/`N>PSI0"U-( M:FD3J$D*6X/M.(5]H!:FD-32(5"3%!#G/@R+&7(*VB):12ZWM3MSVE_?9F\$SNEJ:[>=`W6\RP*74FA;"^#TK)$0T8C M]C4NM8[F=A*H2?5/#3;C%.:!VI'Z6`1JDL+28"M.85VJE87?,-HRVK&O?:EU MM#X.@9KD%N$HS\58'W%KN58X%FN\43AZ%(6CL#@1U'@D:\!&PX9C=C7F+4FC*:,9NQKSEH+1DM&*_:U9JT-HRVC'?O: ML]:!$>(FK-;X!9PL=I>]&"]JNS,XU(L)B\,FV8YHB6D4-MY4>Z=.J1:$#6GU MO%84-J0U8%]#1B/V-6:M":,IHQG[FK/6@M&2T8I]K5EKPVC+:,>^]JQU8(2P M":LU"AM4?M3;_-V\.->/5VD%G0>;)"7#B#%XLZ7'0;Q:L,'7%DN<))#NLF.P MKL%Z[*YOJ`T,-C38B-V-#;6)P:8&F[&[N:&V,-C28"MVMS;4-@;;&FS'[O:& MVL%@^`9`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`[[%T-=1A49R93A(6@C@@EGO:;&"%"PJ<6=W%N`=J* M$+\PK3KB#U MTF/4%X3"EU/.ZG72H@:J)>Z'@HZVWI%H:2;&@OPG9$E',5&Q)#45I$YFC.:" MI(J2GG.A011>)^*X9'JV@G6IJ)O2!?1A?$I2$O?8=05I$7M,>H+4E\# M1D-!VOA&@M3]6)#ZFC":"E+#&:.Y(/6U8+04I+Y6C-:"U->&T5:0EG$G2-WO M!:FO`R/<5%/L*[[*7'J*^&8?>6=+@#U1+W0T%'V^Z(4QR+H2_*>3(6G:A< MTIJREQFCN1KF=90>;URH7!POV62%L+7[S?D:V%Q^"+]\/7\=[O`=:>?='P%"@=VHA4.[#R+(M=;ZORI MX[6";T&[8JA#D)X@7=OKL^&`T5"0WDXR8E]CT=)\31A-Q5#S-1.D^9JSX8+1 M4@S5UTJ0^EJSX8;15I"6<<>^]J*E93PP0N04CP@;5HBF.'+<\JXQL*O[W03M M=QN"W`>;Y4`IO:2F*5KX@$PBM^59]+;TR\KX4_KB35TQ+/;@+J[3;\>ZHJ"+ MR#U!^GKH"SJ:V$"T,(PHLX1[BN,O<8>B%?FB#0K1TDR,!46&Z:[C1+2*$M=K M-\E,>RH*6N*9($UL+NAH8@O1*A*[K*5?`B]%01-;"=+$UH*.)K81K;AZDQ?G M5K0B7VGU[D1+,[$7%!FFU7L0+1]0=$H`304.T#5BLDQ-Q:US!TWE;SM9O\,1 M-B&/\.VN-(YF7=2TUV@).U?;=LFT875*IK;=DJEMSV#]DJF_@3!\J"7Y&PH+ MOI<>E4SUQB53?Y.2:?ZF)5/;F<'F)5-_BY*IOV7)U-_*8.N2J;^-L*"\6V%! M>7GCY\M!\^/;M M]>3^^8_OZ*VJ.'7S\7W)B[OR$>V9RQ*L$XD+/OBG##?MY,1.;AKMY/R]7 M*JA"8%JX-/*=]<3BMI[=%DT@$30@N+4RU;B`('\5)A;X4#FSRX&>*G.!P*5' MAY6Y<&`).JG,!05+T#%E+C18@LXHOO,-1>6H(?/7*-A";KVS#4=EN`%FKD.@R5XCV:NVV`)WIV9ZSQ8 M@O=EYKH0EHP@<1T)2_"JS%QWPA*,0;*&*<&X(W-=*=M@])&Y#I4E;4A(*HL">8/B"I+@CD#HLJ28.J`5FU)T'3R M7\>P9)BGH;8M":9KB$5+@ED98M&28'*&6+0DF*,AXBP)IF*(.$N"Q1Z4*.]& MT]:-11W7(UBR!OPU3'^8?2,6K)0P\48L6!+,O_'$+0FFV7CBE@2S;;042X)) M-]J#)<&L&NW!DF#U#C5GE12+=*@Y2X*U.L2<)<&2'6+.DF!-#C%G2;`.AYBS M)%@C17DL"19!41Y+@H5/1)PEP?HG(LZ28)T3$6=)L-R)B+,D6'!&'%@2+#(C M#BP)UI<1!Y8$R\R(`TN"U63$@27!HC+BP))@LRAS:_O<6V#/*'/K^2S!IE#F MEO59@HV@S*WNLP3[09E;T6>)V_9Q;V%+ALVWS.V(L!7VX#*W"\(2;+5E;C.$ M)=AQR]R>"$NP\9:Y?1"68'\M<]LA+,$N/DJ4C^^Y3W"#`5.&_=6L8?K#GFK6 M-"783CR7!:3^T M($N"QI./S"T9CE;B"5D2G+#$$[(D.$B))V1)<)X23\B2X%@E(MN2X/0D(MN2 MX$@V2F2].U$B-_(Q90WX:YC^<&06L6"EA,.RB`5+@C.SB`5+@I.QB`5+@@.R MB`5+TH?$G4'DR,)!6+0A2X)C]8@?JQ9PNCYSAYS9&T[4([(L"4[1([(L"4[. M([(L"0[09^X`-*>#;Q(0(Y8$'R,@1BP)ODE`C%@2?)J0N1/@G`X^1T#T6!)\ MAX#HL23XV@-/P9+@HX_,G8#G=/"A!YZ/)<'''7@^E@0?=*`%61)\UY&YT_&< M3@.2ABG!]S*(4GI)!8^<;7@I!8V<;77FAY M5MYP=05:A"7!#1:9NXJ"L^P;+!'3&9N^R%O>$*#DBL\K11'G=5@65S#8E5GC;*TS7+ M@V]#T<=8><-EHIF[^)+3P06BF;O^DB6X.#1SEV"RI%'-5R2MSJQ9K2-$K-YP)V\R)]5=PWDO&'F'-?%9NZ"4O;6@L1= M4\H2W`V;NFN8]=:$Q%TSS.G@NF;4@27!KDHW8L"6Y+1TDM20/E:9CEP0\. M(-=62?'#`LBU)<'O"R#7E@0_,X!<6Q+\C@!R;4GP"QBPL5HP?OH"-I8$OX"! MDEH2_!`&>C)+@A^_P-.V)/C5"SQM2]*`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`Y5SWLPV,UCZ>'=_ MP`R4VR>G_<.'Z:W@;ZZ16 MX//Q^%6IUO<*H?%,M"Z&%?C7:7*_?]A^>[K\^_B]VA^^/%ZPW"O59'=\0D_X M=_)\4#&`J6__^C!=H(?#_>41O]U7VC3/R@&:1#W_AIFD57M]'U9G'[XW8WIAU^4CLX MZ`<=W9H&^&D:;-[5$7;#,$#\I(Z65_/U*EK];&H;TQ(_3ILX3L2SS'8B)3.%!U_1'!--5G9^BVZN7>^EHQ(URP3)!2D$*06I M!*D%:01I!>D$Z6WBN`8/\)!K%'9=HPG*"9IU*D@F2"Y((4@I2"5(+4@C2"M( M)TAO$\H0$,^5=CUJ2;P*=E,#8%IRX%> M.L]&)6J6"U)H8CM0Z%2"U((TPDXK=#I!>ILXKE$U=L@W`W>=8Y#M'4*N>[QZ M(&.MT3\2%0;9'I):E42U1(VTU4JM3J+>0:ZC5"5J;4Q3J5^IT\7E\;#[FAP1 M(1$7ZKIR12%`DTY4T82`FW,5FA+"^ECQY=5<&6N1K5RBPJ"%/I>JLKZ46I5$ MM42-M-5*K4ZBWD&N`U65:CF0,ILJE;QM:-`"11E[)=JX"2`-:MVL7:V,M%;# M86FQG'O.S4F!5Z60J"3D#,GOK"(M=SF]@=>DY=BZ]:J$ M^,E?$V*MAA";;PFQ5D>(Q]43&AJZ7E%UK16YP]:?WURA%AN#V)2^W$42:32' M4SB(;_T'M-%:7@_A.5]&_K.%%7CO:\M6IBR,EH5*:F@?,J(;+Q8KUB+S-2'[ M"!/)\!2#:*GA.!V&?&BVXFAIF$N4&69XL)"JI(>?:2J*:$`^UD;9:TN)Q=1+U3D/74:JF#CE* MU]J.HS3"#F5'W7J/ZS0R2DN=,?$BU$^IHP(Y,JA40E(4YYE40U(;;52-02XG%U$O6$`EY1Y77(*[KL=L),HZ4=9M&ME]G2 MR&CI=+&XCL2C>U2@1L1>9K0N[`O?AOY"!::DBI M;^TEGXX5J+/>,>/N:%6NAURMRWC'U1K!U60WC0SB?)))E!MDN:V0J*2&=IXS MYAG5I,6#:*2MEK1X7)U$O=/0\1$N(YC+W-E/'"M193TCN M];DZJ00"<.">J_6AQLZ`1FO!F2:3*"?$DR@D*@E9&5"BFI`5@(38?$N(Q]5) MU!,*>`6K$O2*XIY7-/**/^\51CK76DLW3WDKE[$6K5QND&?>RU.%T4)*IX8E MV[(#TR\*68L:UN_JL9$]MFS+ZG'M#;5C+>JQ_UF/;FY01X]0P.HCB9TQE=/T M*<4>D%^7DY:S@_VLGK$6#3LGA*6UMKXWWX*T.#I+0FZ/WD.S8BWJL2;$MAJ) M6D*N>2_C=:Q%YGM";TW(70=U*@BM@SXM..M@#A"\9].Y0;S9,XER0MRP(,0N M*`FQK4JBFA`W;"1J";&M3J*>T#`NURMO'&74W0`_<6CDEDYKOT0W#=W$L?:> M;QEKT6+FA-Y:S.'5;F&TK-J@I(9.JEJ+Z#2CMVH#::N1J`V;]R;4L19-J"?T MUH3<=5`'EU!TZ@.-$YT:V765>M6.U8+3J?=,HIR0'9VZH>-.8:NBAFR^-LAJ MV$C4RH:=1#VA0'2^<=S!>TH1G>-QQTIN:Z^N24W#A9MJO(=?QEKDSIS06XMI MHM,,@O=L20WUP1)74]SC7\5RZJLFQ%8:B5I"[E2\)W3'6F2^)_365-RXA'D[ M+G_V;GFN]+V"0R.G#--HN;#B5:#:LXJS"VBMWTKG1NAE>2ZPV&Q&JHP*M M;TYMN+8J#+)V:TE:<#L7`S)K&O/\>*FI(9MOI/F6M-X:>,<*-/">D'SYBX$' M_3IP-]H,LK,C(3[=91+E!N$'#:B0J*2&G`HKB6K9L)&HI8;<8R=1[S1TH@V? M4\)>T><>.]H&U>']M[7:&Z_T2TG+B8F-5W]FK$6.R@DYP>R_G"M(B_-:2FI"[#M"R=_W/FMZ/2D$DJMW,/II^,H#$]ZG#/7G9G14*E%FT(IS M9T[(*DDE*J6MBK0X"FM";*N1J)6V.M+B#^7) MIT'?"VMSMN*':DI:`W*3BRK'K9)BZ&\^O^(/?-CH(IUHM-*OW'[S,GAJ6JPP M#MXQ&SXQZ0'HV^OZ2O#S_O1EG^Z?GLZ3W?';"UI%.%-^O!NYOC>?+&/B3$ARL M8W70DQ*R3$IRF,=.0!"\LT284O7AOB38A"5Y,PCLA20*_ M)4&_I9"HES9R;'@S!N^$)'@;!N^$)'@I!N^$)#4DZNV-[`P/B$)OGM@/J%\@.\3&%M(@N\(Z"R#3YPQ^H#KI3@.W>L/MI*";YF8Z8A":X% MH4VH,,'E'[0)21+X3=VMD/W@=@J\$Y+@#@J\$Y+@*@J\$Y+@1@J\$Y+@X@F\ M$Y+@_@F\$Y+@&@IF&I*DF*FZ;"3GDT.B[AQ)">YT8=0A":YV8=0A">YN8=0A M20.)NGPD^\&E15@+E56XJ`AK(0DN)\):2(([BK&Z<"?[P;U$>"R']SXA*]#$ESUA*]#$MSXA*]#$ES\C-5E1-E/@JT=S.-J M8X>208K=&WKXI:A:0ALGC9"D<"%9=HUKPY"$^BA4'@@)2K790X)&[?60H%4; M>A#,QMR%OYI]W7[9]]O3E\/+>?*T?\`AY7JX`WW2?V"K_W/1Q[/)Y^,%?R^K M3FJ31_PA]!YWDJ]QJ)H\'(\7^@^F-QO_M/KC_P$``/__`P!02P,$%``&``@` M```A`)'M:P/U!0``CA8``!D```!X;"]W;W)K&UL ME)AM;Z,X$,??GW3?`?%^PT,2TJ`DJQ(>I3OI=-J[>TT)25`#CH"VN]_^QM@& MVT.K]LUF^_-XF/]X;`_LOO^L;\9KV785:?:FL[!-HVP*_%5VYO?#[[_MWDC[W%W+LC?`0]/MS6O?WWW+ZHIK6>?=@MS+ M!D;.I*WS'OYL+U9W;\O\-$RJ;Y9KVYY5YU5C,@]^^QD?Y'RNBC(DQ4M=-CUS MTI:WO(?XNVMU[X2WNOB,NSIOGU_NWPI2W\'%4W6K^E^#4].H"S^[-*3-GVZ@ M^Z>SR@OA>_@#N:^KHB4=.?<+<&>Q0+'FK;6UP--A=ZI``4V[T9;GO?GH^)GC MF=9A-R3HWZI\ZZ3_&]V5O"5M=?JC:DK(-JP378$G0IZI:7:B""9;:'8\K,!? MK7$JS_G+K?^;O*5E=;GVL-QK.J4@-W@2_&O4%:T!D)[_W)LN/*$Z]=>]N?06 MZXV]=-RU:3R571]7=*YI%"]=3^K_F)'#73$G2^X$?KD3KL5ML+8<:"/,^/^Q: M\F;`QH+5ZNXYW::.#W[YXO,5',L!JK*@UH_4?&^"<%CH#NCK8>6N=M8KU%?! M;0)LXZ@61V%!:XRZ#740Z2#60:*#5`>9!"Q0.TJ&@ON*9&I.)8M@`P&F'+B: M/F$AIH0ZB'00ZR#10:J#3`**/MA:NKZE/:X@'86=*ZV@:VOQ!\S&@01.RZQ) M'$U&C8A$B,2()(BDB&0R493"0:`KA9/KW>*EYE#GD+=)EKM6A073-*J)45<0(W#DBV",B(2(1(C$B"2(I(IE,E/`APS,+0JD:/B%6&;>;:S^HE1>.1F(Q(T1B1!)$4D0RF2A*(:`O**76JE)&UN!_U.5X^A7' MC#QON"-=V]$NR7`<'W4C$O,';<=*248;>O."UZ6:S70<%UXSF2A9<*!1E-(@ M%G;`JEZ./%FPJY\@W&@)9[64%7VUA=5V2,O24\./Q/!41#%&B4`?/BH55NQ1 M#]HQGXGAX5%J8FC?\/F=0&])K4`X\B891X&FM0PYV@S=^=`&10*QEIEV1C%' MR^$%8+!*L*]43)Q\90(-OE2!M''X0.`/E_J`CF2!3*T<<=B#?E$ M"448Q<+]Y"O!5BE&F8)4@;1AF`2.I6P.NRO93'\G;KC(*\-"#0W<"6&/'X]>=QV&(:#^A7(5HO.G=]>#&PB-PUT*L,X11NC&P2-PA,!SYD;@)/'I-L)SX$`!/7,C<&)`;',C@>?# M^P'V=7SPH1V=X5L_&CH";1&3K0^-&[8/()/!.YFT?=IDX#DAS*&]!AZ!=@NR M,C<"71=D96X$FB^?-B#@S1J#AH^$]_Q2_IFWEZKIC%MYAF*VAT.Q9=\3V1\] M:RR,)]+#YT':8QA7^.Y;0I]C+^"`.1/2BS_H`\8OR8?_`0``__\#`%!+`P04 M``8`"````"$`U_^.%(T#``"0#0``$``(`61O8U!R;W!S+V%P<"YX;6P@H@0! M**```0`````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````"<5U%/VS`0?I^T M_U#E?:0P.DTHS50H#*0-*K6P1\LXU];"M3/;R6"_?N>$M@F]9L!3$ON^\W=W MW]E.\NUQI7HE6">-'D:'!_VH!UJ83.K%,+J=77SZ&O6NA"NV&T]#X_B6,GEK#B[@"G-<[,C5UQCY]V$9OY7`H8&U&L M0/OXJ-__$L.C!YU!]BG?.(QJCR>E?Z_3S(C`S]W-GG(DG":C/%=2<(]1IC^E ML,:9N>^=/PI02=R<3)#=%$1AI7]*^TG<_$RF@BLX0\?IG"L'2;P=2"Z!AZ1- MN+0N34I_4H+PQO:<_(MI.XIZ]]Q!H#.,2FXEUQYI!;/ZHWI7N?,V_67L@UL" M>)?$:%`/5J]-V^:[/$X'@\H"W]J6P4/-!"?:'&?2*W`W\PFWGJ`\�Y5RQJ MQC6A=149:H.=:X_Y8E>ZKK8T3>:;&,X,%EH[R!B^.:-DQCU^3#T^5IC-C6'( M2[U*-^3P+9A3KK@6;UKF&?*F99ZC.2*I3>5"2^P!K#X;"6$*S)M>L`GF0DB: MVFGAI`;G,&>K>ZDK";>$LN% MO%?`1LZ]4/XFP#'<^TIN%Y@'+4*0(^%E*<,N1,8W0;EAR[-3T#"7F(K6``FY MA&SQ"L\7V.?LCJL"V$_@KK"H8-WNV`WOD`OIJ_F*/HHZE!WMV0_)2193;\3# MTJ@,=V9V_KO`[J+M8!'\-CI/TW:=PJ,%3BH/ZX]5HK.]1TU=D+V:J4!D*-W" MH4-IE7U'!S1F5PAL#%:6V"(E,)(:4;6NX*>[Q>LRI^MQS6WHVI(D1$/6VB4A MW;L(G:I]A:_'R66Z(?0RS1V(K>,&K(KG4M&2W*^O@">9[8><L]S5/UCIX?%!_W,??RL:8TF\_95*_P$``/__`P!0 M2P,$%``&``@````A`(XG%W@R`0``0`(``!$`"`%D;V-08W&W!)@VYT6[_WK3KZD2?A+R$<^Z7 MOAP;<.?-"`2219+*6KR38$5U**<@M&8!8=-HKKUAL1XM5OJ!/R76R`SAB[ MI`:"4"((V@-3-Q')B%1R0KH/WPP`)2DT8,`&I'F6TV]O`&_PSX%!.7$:'?8N M[C3&/64K>1`G]P[U9.RZ+NN*(4;,G].7Y?WCL&JJ;=^5!,+[?AJ!81FK7&M0 M-WN^>_--@KBMZ&^M4G)(5TH/(H!*XGOE(=U1>2YN[U8+PF3T`S!O@W\0C@0^Z??\Z_````__\#`%!+`0(M`!0`!@`(```` M(0!LLG4[(@(``&XA```3``````````````````````!;0V]N=&5N=%]4>7!E M&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L````````````` M````6P0``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`.>JX^Y;`@``UR`` M`!H`````````````````@0<``'AL+U]R96QS+W=O4%``!,&0``&0````````````````#B%0``>&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-YZK3?P!0``]R```!D````````````````` M=2,``'AL+W=OE%9L"``!J!@``&0````````````````"<*0``>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`,53?HAT`P``FPL``!D`````````````````5S```'AL+W=O&PO=V]R:W-H965T8#W60(``%L%```9``````````````````I```!X;"]W;W)K&UL4$L!`BT`%``&``@````A`&QO?CN"!0``"Q4``!D````` M````````````FD(``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`"T>FZP7`P``)@H``!D`````````````````?U(` M`'AL+W=O&PO=&AE;64O=&AE;64Q+GAM M;%!+`0(M`!0`!@`(````(0#)7@,NZ@\``$BI```-`````````````````))< M``!X;"]S='EL97,N>&UL4$L!`BT`%``&``@````A`'W*0%,;6@``1U,!`!0` M````````````````IVP``'AL+W-H87)E9%-T&UL4$L!`BT`%``& M``@````A`.]%75(D!```G`T``!@`````````````````],8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`)@$)YCX`P``F`P``!D`````````````````Y.8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*+DT.^X"@``23`` M`!D`````````````````ZR@!`'AL+W=O:7[@,3``"L7@``&0````````````````#:,P$` M>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*5\1%\X!P``\1P``!D````````````` M````!DH!`'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`/UIQMW8`@``@`@``!@````` M````````````#U0!`'AL+W=O&PO=V]R:W-H965T&UL4$L! M`BT`%``&``@````A`!6?,I/^#P``S$D``!@`````````````````?V`!`'AL M+W=O&UL4$L!`BT`%``&``@````A`-(\EM6T`@``#@<``!D````````````````` MJ',!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`%'*E*WQ$```0$T``!D`````````````````OID!`'AL+W=O&UL4$L!`BT`%``&``@````A`*DNC@CT M`@``"@@``!D`````````````````H+T!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(8%-+@X#```PC(``!D````` M````````````7]@!`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`*#UWK,8#@``GST``!D`````````````````&P," M`'AL+W=OUK M`_4%``".%@``&0````````````````!J$0(`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(XG%W@R M`0``0`(``!$`````````````````61P"`&1O8U!R;W!S+V-O&UL4$L% 3!@````!``$```@`````` ` end XML 16 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Schedule of Segment Information) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Segment Reporting Information [Line Items]    
Segment Reporting Revenue From External Customers $ 44,058 $ 32,239
Operating Income 688 655
Interest Expense (101) (59)
Income from Continuing Operations Before Income Taxes 607 602
North America pharmaceutical distribution and services [Member]
   
Segment Reporting Information [Line Items]    
Segment Reporting Revenue From External Customers 34,304 [1] 30,046 [1]
International pharmaceutical distribution and services [Member]
   
Segment Reporting Information [Line Items]    
Segment Reporting Revenue From External Customers 7,607 [1] 0 [1]
Distribution Solutions [Member]
   
Segment Reporting Information [Line Items]    
Segment Reporting Revenue From External Customers 43,290 [1] 31,403 [1]
Operating Income 748 619
Medical-Surgical distribution & services [Member]
   
Segment Reporting Information [Line Items]    
Segment Reporting Revenue From External Customers 1,379 [1] 1,357 [1]
Technology Solutions [Member]
   
Segment Reporting Information [Line Items]    
Segment Reporting Revenue From External Customers 768 836
Operating Income 68 [2] 127 [2]
Operating Segments [Member]
   
Segment Reporting Information [Line Items]    
Operating Income 816 746
Corporate [Member]
   
Segment Reporting Information [Line Items]    
Corporate Expenses, Net $ (108) $ (85)
[1] Revenues derived from services represent less than 2% of this segment’s total revenues.
[2] perating profit for the quarter ended June 30, 2014 includes a charge of $34 million related to the retained workforce business within our International Technology business.

XML 17 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hedging Activities (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Mar. 31, 2014
Foreign Exchange Contract [Member]
   
Derivative [Line Items]    
Description of Foreign Currency Derivative Activities manage the impact of foreign currency fluctuation  
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
   
Derivative [Line Items]    
Derivative, Notional Amount $ 463 $ 463
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
   
Derivative [Line Items]    
Derivative, Notional Amount 1,449 1,091
Interest Rate Swap [Member]
   
Derivative [Line Items]    
Description of Interest Rate Derivative Activities hedge the interest rate risk associated with Celesio’s variable rate debt  
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member]
   
Derivative [Line Items]    
Derivative, Notional Amount $ 68 $ 96
Derivative, Maturity Date Sep. 30, 2014  
Minimum [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
   
Derivative [Line Items]    
Maturity of Foreign Currency Derivatives Mar. 31, 2015  
Minimum [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
   
Derivative [Line Items]    
Maturity of Foreign Currency Derivatives Jul. 31, 2014  
Maximum [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
   
Derivative [Line Items]    
Maturity of Foreign Currency Derivatives Mar. 31, 2020  
Maximum [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
   
Derivative [Line Items]    
Maturity of Foreign Currency Derivatives Jun. 30, 2015  
XML 18 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Discontinued Operations Discontinued Operations (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Mar. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]      
Proceeds from Divestiture of Businesses   $ 55  
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax   (5)  
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax   (7)  
Goodwill and Intangible Asset Impairment   80  
Goodwill and Intangible Asset Impairment, After-tax Charge   80  
Assets of Disposal Group, Including Discontinued Operation 138   267
Liabilities of Disposal Group, Including Discontinued Operation 144   248
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Assets, Fair Value Adjustment 34    
Assets Fair Value Adjustment, Net of Tax 27    
Cost of Sales [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Assets, Fair Value Adjustment 32    
Operating Expense [Member]
     
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Assets, Fair Value Adjustment $ 2    
XML 19 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 20 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Intangible Assets, Net (Tables)
3 Months Ended
Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes In The Carrying Amount Of Goodwill
Changes in the carrying amount of goodwill were as follows:
(In millions)
Distribution
Solutions
 
Technology
Solutions
 
Total
Balance, March 31, 2014
$
8,078

 
$
1,849

 
$
9,927

Goodwill acquired
14

 

 
14

Acquisition accounting and other
445

 

 
445

Foreign currency translation adjustments and other
41

 
4

 
45

Balance, June 30, 2014
$
8,578

 
$
1,853

 
$
10,431

Information Regarding Intangible Assets
Information regarding intangible assets is as follows:
 
June 30, 2014
 
March 31, 2014
(Dollars in millions)
Weighted
Average
Remaining
Amortization
Period
(years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer lists
9
 
$
3,022

 
$
(937
)
 
$
2,085

 
$
3,384

 
$
(863
)
 
$
2,521

Service agreements
16
 
1,014

 
(189
)
 
825

 
995

 
(173
)
 
822

Pharmacy licenses
27
 
1,051

 
(28
)
 
1,023

 
1,219

 
(11
)
 
1,208

Trademarks and trade names
15
 
377

 
(68
)
 
309

 
371

 
(59
)
 
312

Technology
3
 
218

 
(177
)
 
41

 
219

 
(173
)
 
46

Other
4
 
173

 
(66
)
 
107

 
165

 
(52
)
 
113

Total
 
 
$
5,855


$
(1,465
)
 
$
4,390

 
$
6,353

 
$
(1,331
)
 
$
5,022

ZIP 21 0001445305-14-003299-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001445305-14-003299-xbrl.zip M4$L#!!0````(`#."_T1"^Q$_`L``00E#@``!#D!``#L75ESXSB2?M^(_0]<3VS' M3H1=YDW15=43/*1N[]3ALEW3LT\=,`E9Z*)(-4':5O_Z3?`2)4HJ29;+I(1^ MZ)))''E\F4B`0.+=/Y[&@?"`8TJB\/V)]$8\$7#H13X)[]^??+TYLVZ(WF4M%R^6D,\Z]Q>D5-"BG^3@X;+PH3_)0( MQ']_XK*Z7]0!OA/UWPO9_6ZGE(0@?LO[,R64)&`HUA.AOT-?OSLXP&`Y'_'X M#L57#8"$DF1;/JJ?$9\^'!,="Q@*>X[]$G7/YSY.?1?C/E`U=4]Z=+U9> M;);B>V:2U>/BA0]D/$T"XI$DIU'P"93+C;U@\&(%@R<_`X<7B?";J5=O5NX5*./175"G?S)-3 MZ[I\5&!A%3P&.3ZD+[?N*^CZF6($^P>Q2-N($:KH9XKX@F+,C,@E#XQ9GUY# MZU#:B932'4/0X9-D@#R()Y)I M!1/+\Z(T3.@U]C#$'G8V8AICJ%-,%2^NL8/4?`` MD>I\F4#D?EGE'Y-20PC[])@#I:%_[GX=>;?B8N#M(* MI+L)BV.V@=E,A(S9<@)ZD_-.JZ`.U)+$Y"YE4]*;*,C^I1]AF/)0<)/&]^S? M>ADK]&]P_$`\3+L-T;6BR6._9\N&(W)_B#Q.K'$4[8BB2V@@#A$3X[R1HB-R M8)L+@6-L!XQ]BN)D9(VA-P\=ZQBYL0PXPG9`V"WV1F$41/?3XQD)5_+,$;0E M@JJUN"B>1#&4/&CL5"MQ\]QRU.R(FL_0&80.X7WY]BC0LX)KCB*&(J6CGV4E M<6LQ2O*9(KV0&-6Z,6Z\]Z&J\2$*[R&N'[OX+KF=3F;?<6]'F+4/P3W\T[.C MT.^XS>YOV\0VO2Z3;Q&:K!+P:^W:D+;$-5117A#7_\<_(A_^1^27Q)#6T9T_ MZDYB?+&1.A?C[SXFOW_`]RC(OYG,17=7*`9>G6@\06%'K0[8NUA@;Q;'+>'O MM9QT"Y'Q_3UAG_#C4>P)6\HG1TJ%%+Y%MS5;=`\!'=N'AU`DB6*8D!]&B/@Z M4YK-`],5XN:8?QG,'_2>R/9@O;T[,3G&%QI@JRZ7(4WB[`!UK]_!5@CV)O-/V`'W`POQ6[+',93M*$9@44;I3;][J9W&N[O%<+GMO!'NR` M?X+AGV#:CVO^":8+GV`ZAZ&#GK/RV>/^L,//\1WG.;Y#1B4_QW>8Y_C:CMD8 M@I:$/,`$\!-*TN)#[8*K[#]Y(Q3>8P=:BY'7>>PMX[GA`9YM#+534C M9`-=[9.<2MTS"N;TS2VVBQ9+0FZQQV2Q=7USBWT5B_T4A7X%!#ZFMLI"E^B& MCZ'<(OF8>4P6R_H1_1'%3H#H+%/(U0C%8^1-/Q`/%-+U MQ#-;<)]_WE_./L?5LW!5[0%(:1*-@";_'%E[0=;G9(3C MQ=)'B+`U-I(( M1]]^T!@%L-;R M6X`.%)''B36.HAU1Q&\!:O\M0%W'&+\%J.VW`'4=8?P6(#X.[HZ@V1H^OP6( MHX;?`M2U6X`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`G\/*S59&FPK2)\*2?$AY]X@\7]FXJQV/^_@QSW MN0^@[2E"VH/ZRN&EL3="%%_%[#M#$)1YAJI1<3&)$T?[O$/=4'X85# MGC2[M7G)>-+L5A\0:9%]\J391YNCMS5VVIJ/70=DE_SD3/<,DA_B:9DEMC3% M[E&'MCSE+H]Y#\ZBCVJ\Y1;,Q^##7\WD:X6[:)DGS6Y-YM4.),WN#G;+5P>9 MA*H]F"W?M3#UU8%AE2?-/G0SV"ZX/I"DV2VU4IXTFR?-[@I6>=+L=B<2[E#2 M[$XBG"?-;@_6.YDT^X>@GB?-[D32[-?"PD&O5_"5@R8&^'?KXT@O?-S?A_FW MW,-$]7%],^5;__A^NR[BEB?-?C&H\Z39W#IXTNR7M`Z>-/MUK8,GS>YJTNS6 MX:-:]^))L]N1-+NU".%)LVM'I-J4Q+:UB.%)LUN6-+NU2.%)LSN4-+N]*.)) MLTOTM"]I]@]!S?&LY_+5U+K>+T,/@O=;]&2ER2B*%[_<9XO;(0JNV9:6%!=C M\N7U3;1/W0 MDJBW$V<\B7H;DZB_!%:*?/L#?*?OG%;Z*L8/)$II,%V;&'GAZ_G!IJ;8.:WT M5G+'T9B$ZSLL0,[X6*K`Q1Z;C99O:WQ_5WIANL0= MSI,T@9\[:2;G96W;J]G];NLI];^#J*\W[JXMOR2B5I#564355BORF2.:LG/5 M18Y/H?"9UWA8NR5-\+%'QBB@[T_.])-\H0AYR9EAFX:C.'K/$C5;'[BN[0R4 M@3U0=)(O9?^_.UQ.R&[$0QZPD5I;=@:S"_V79TB3+ M4:6>4A+K*+K3(%9297-'8N,4^[6$Y3L)5QN83E^4^U)/5"U7[&F*T\OIU M)1F+]"J2+"TA=SDI.U.\3L*:K&I&WY`MT5;LOJK8MN*4$K8TPVY0K!J]W2DN MU]KR%+71>!+C$0N%'G#^)9HMXW["R>?A+7K:3O+`I:+V[$'?TJR^K6J.I)LY M'[(M#_KB(A^2:"QA8QOZ]LS<.B6)?=-U34?KVXYK#L`2!I:<,V?V#*6G+S)W MIK2+MUVN*5PE"ZOGJHZL]G75&;C&0.D;CIC+0K)=6^YW0=%[$X;JF+8,DG`' MFN2XLN3T],)Z%XK37DN"R2Z*L_GF+;#QDC),?I:SU8TW;$D MV2Y-NR<:9E-RNM@NT;W8M]R5(E,-U^PIMFEKNN*:NJ&9B@"4E0 ML&7,#',41;*D`1!NVWVQU[.+Z*'7DPQ#7F1"UWMZ@XOEA.Q([;H@V%8-T51L M0W8-PS!MRQ(5JPR"8:+5F*GHH)C=J!U'<4+^R@#Q>;BX97Z>:#<7\9=;=R7= M?5T$Y5MB3S1AK@VS$T/2<[I%6Y0,MP$5I>F.UE+T/.K5]=3#[*EOF:[E]!W7 M=C5#EU6UG!]"W-U;I-YH#D/;$`_AL$_87L('/$L+VW_R@M3'/AM:F96D2=%8 M'\4A#*RT7$O*/ZQOK2%7TT`EIB4Z$!5*HMIS="WC47-=RY7JR"H7W)K(V@?E M/T08WU%X7W/MGB8/;-6T#$N!@51QE)/=513LG31@?&LQ*X)+F,1NYH$`U^#EV4P74',VG4W2]$U0Q$'HN8HFNE* MKE+,6W53!IMO$`-2;7K;E<3LM%QE]51%EH`"RS(DR11[_5Z_'`!$B#<;BS^* M:3257>]_*]+6>GO'ZBN&)>JFX^H#QW14R2Z]O3[H-P981=9V(*U*`S$;^%=Y MCX63(E64L?1B+">B,&IG>2^_$TC8S+X&FJ':LNJZHF2KDBJYLC-P%571E,8* MI]+T/*LX^9$,?YZPE70PXN(>JN]PW>O;LFY)?57131V"S+[4[^5<:S*,,XUU MBQ_&]$J*P3KT`2!04Q3-U?5^W^S;.<5R#T;TAODJZK-(_CQT"9U$%`6_Q%$Z M`16`ZV2GM0AEE),PA:@QEWD4;KFFKEOVH&=!^*&;@YXM.7W5[!F2"H&KT5>E M9K"O-Q?0MJ?Q!9AD^>;M0/8`9^=D(LSTV%Y(L_O=;1M\9 M"H"?"P9E,IRN;(8]7T8&"6'B0Y+%>MF?CWE7=U'@YPW5)"?,1">4LF/]G+.: M9:?G0/PF?$R0SS1Z=ALDMC=OZ9)-.R5]%\FY<$LI@-QE`Y$Q$C'"J]$83?,+1+(P$_ M@!^'WH0HC056*:8C,CG-JX&%ID#.C`%2I$>D\$O(MM0P$I((/!C;^`.@%,B0 M,3,5(`06'H!$]K6RJC>K4Q?ZOR[[M":POY^R1AZQ,$(/0.625J#S9!11/&N. MDELC(R&1=F*]C<"((=5SEEG)[XR:D=@3<$TDU*`G[(V2,A2 M/V/AC]3/-A55_:10'UJ&YL!Q)P4!B-)T/,D;O&/I"@1`%WI`H'-&_HA0=D^: M!Q(EX3"*QSG\<@6&Z#[3>"D'R7A+JVY/!32.P$OD2AAF]ZT!&W;9!]-=C9M2 M?C.EP!^,0T;Y)`:*XZEPERU+`MS@-W!"4V\D,$620>2NV(=6KP]8)M`BHR\2PBC)U5S`]!2J%$\8L?FWV"E#&'["L4=` M[+3F04&.`4N,!LIX`,E$90"7"75&X:3PKJ>9%%#N=IF;`/M@%-YGG>%LJ4T8 M8\"+GX,^S6QUPN;^49@)@TWMF+Q(%D\R`PLBX`^\7(R]*(:9(6.QM!96YE0( M<0(6EQU#SDT0&&++=<@KP`==W>5WI-*<]SN,P;X"DFVSP#[4WM;9S9J9L+M5 MXYPNQGKLLXZ$1Y*,2E$P"0`NH!%`/A7N`1HQ>)TI>X\G25Z7B>@K2\+@"_GV M,28&:XP9HN?,^1?+NJJ;$PH7?3F-WUGCA"H<\H:BS&0!(HI`%@Z8>9H%RUS M&$4)E`&P0JP$J@;O0J$2%&'R*6I6\D%AF.9+@NO5\V;)$-B1D3X?>J,25JM' M+I)%NTR:S*HRN#%DG-:<*EK!OMCCJ0(((M%DF;I/*9!HD4A`@@%`R;J__I[3"]#< M)1FT"0H/+HLDT.BS?&?KTPT>B&JV^M90!PIFU:W$WM21HNT4:I12:YBD$WJX MMH"=X`[%,&)C3"BP)L+[4K\+#@A&>R!QP1Q=27:X"TG'RUF^RA(`2Y"NIRK`'M8_5O`_X2FVDN2U-B6_K'?\`8685M0,!W>+G/@)Y*R9 M[)%K[IA^L<8XV3MWW1H,25'%*<9;*2@`,W:U7VC",;#&>%`5;OE(,*[E/A+_ M1!Y.>)V9WR\;Y.M.LP>-)<^@U8JA M@:+\:Y%A5D'#['M,"A"D$-NAUX/@#@(\&DL#3V,%HI0JG:PP[Z8/@1`>KIJ3 MF(5L1^;46:;OJ&&$#UF?`CHGJ5=":2K8 M95MUJ9L%-_\%!+%S0@JV*UL$=!-NI-9*2##F%.O"4B2--AWS17P@OL^%)?`/ M>"E>M,#*"$_TE1W773?.AV:N6Y3B@>8IIE(L2LA(S`HJF!L?IXT6(2"KKK/P M!2@T)9@5;RJ:F".-N%\KI:E:_4N6_H6S$!R)ZPH9\E*&Y+T:&B6 MEL=%B$I;3PMOV)1IDB9-/2=6,.$I,(`B+'?C=:HFF=F9&%^8U:G-[0UDM(>L MK?(S<.Y_08K<+E\8'^25)J5>:BK?M!.2WHB``2/,P;9FWL=8H:,"0`/:I/&@ MRXD\LXUD5J[YL$OI(AK],*E;\HX;NS@M.?"K&8PURS,VD69`@/!?K,<6BQ:' MYK3$DFY5-L^4ZZ'\+F;):.FZKEI+/TDY>AV[[WZD3-H-VIR$%P"J@T8]KCO4 MUEC(2=Y+V@(2WLWK,:>\2Y,5M>&U21&,6Z^C4E/&:WIS0EBY*,$NW+2Q]L<) MW2E#,'C,CJ$=9G5CM-CEDGW%'`S<-&&\WQL!V/*31G&!159A6>$93+JL-O(? M5K3G&0%<*$K\O!J50N`ZJ?;;X\;@'BE&7IBMX>=\*K\UH4^+H1UFMX\U,^Q` M')17P>=$BX)B;8W#;\+?N7#P?F$LX!+:#5%G."CW,_(@H8-+.PK0>O*6UH;016E)7*J8F,0-(M'QGQ1 M`Y(O6FOD414#'2!EGJ+/G^8Y794LV2&L+$,3#*!!UX+GS`S-D,QE9%(QXXF: MG":BE0)N92M)HH8$\V2U)4KVF'^9U94F&&[C\0"RWV3!Q+5HV.7X*<:,%"*P M"M=&]A!/UW^`S]A4Q+)Z$L/$]G"J65[!,`YC01;=8;":Q!DX%9@?"T?!J<&] M8UQ%YVM`6SI!5W%W65ZP.T@_&QMU@CH8_EDRL_L&WF7Q'F?CW*.*C+SB%6*2 MLD7-%4W=J\:D2A%GH>$]6$LZG/.EFHZ>KQ0C53;\+`USO9#4S7LT`J= MR/-&P=!PAU=_YW=2S"Q8QL6.[HY9GP.A:0M;!@3X">OUP`P;VA+<94Z5+#;9A,4/'-6EJ*4MV1N/R*JBB^YXR8S$636;H!Z4A"^C*WQ"_R/R;;@HX1I- MD0VJ_L]J5553^&J@?$<0TFPVD->Q$(*M;&NFP@Z_H)82DD6^L'F?%UDB"?Q) M8CHJXI%`*1ZTMG;RFG8:$3N>JD5>.(Q\TS$M-8JRB)'6R/ZT,^*D5D1#EKBEAR-L<@U]U0VL,+)`T*%C M`[8!V6O;T<1)(>JUXQR6_B,HV\V=83X?I_RT_V:X7VY_A-\^S.*%IJI\[)_S MA53=$L/SJIC,XI*\1X_MLU!@;2]6^>RC)/?N?/*=R`4# MZWNZH7M69'FZY3I#(S(\PXXT:[,]5-V61FN<_)R"ZL+QG_MD9IBF/C*<0/-' MNA8%NN8Y5&:J$=F&%?E;+;V6NK61JM/">Q[*),D=E)?/=]B*=WVT*+G(&WE& M$'B^ZD?Z4`6A0:#K#%W=4WW+V-[Z[QF9!QQ?ML67O='76'K?%-OS9:Y1M2&-<-E`\["QZ\3QET'POLHDFZWC@@ MJT-C1^4%85 M,(O6>&.E)`OL_1D7:3(E2I;'H#6T-_\CC6>F8B6?-HN3](YN"\!J1XE-_8SI M=1,E/!-"@9U-DI]B7Z##1[6\BGX&B`71GE`&KP^ MN\5ZQI)[N+VSZSXL5L&"O0A8%`>U3S2(#?@"S7H#"&VTN!4+"1O>CB_;`)Z% M1%_-2$:_`")QC2$M$M9*QAM$5^4WX`2*>C!6]S]-BZ^TT,5ZNM"N4^YXT+CM>@JI_I+WS(,'3 M,)=2I'T>_BAQU8XUYU;3L,VWNG%MJ2VU]I*"[W!B>P*J'`^X>4J\\G3.?V7H M[?*>]3_-!LVV(C*'$)>O26[@GB*8!2<-CFE[V0E)-O6!;K@G1Z)?*;@#0!&- M_Y0AFS82T,:VBCX3:D?B,:^E3`RG?I:V%6@TV\LV=\5$HK=!B<4K[+?S2?'+9C9) M/1Q>7%_1D$9[+V#B>9'0S@Y*E;1##L,:L6F=AATX6(4[YC#T'81-H]G% M5D^SS2*$Y%#5:]=HSY\*:IA?18Z]2I$P9;D"KB``15-WNG%Q>9)H0;_VO!-1 M![H.$/['"E"'<1[#\)K>TRR:>IH[=#FL0X_WPZSI@60!:2L?;]9LG-N'M6'' M!%N?Y885V@V>TDP;TR->LN))$6UC*?@N9/R9A:=2D$:3L7Q2JR_\NIV(7N^V MUTVGCPS1'=A<;1L&ADKLWGJ0]I%A&%V!4]O<,L>-%&,@WZ:]L_K"]K/P/45T MEPV-AV"*_X@7-(%B`8&E\`>@*25_K7!&\@:=>O=^=9C]("!A9P[P1K(WTGX] M;F\D>3R?3[2K:)UZ:5R^L_>Q%/U'[AW"M'*2+L7%C`/6&TY6-:F*T[5/E)D[RE3@#AV?[^M+FYM,F?;0!% M@=3P*DBSG9)OH<"ZR+W2(,R8&G(W811LSR.*H\KN^E?H5 MSPI_2Q!XK13+F?(><:G$T^T2"=XW+I1)!GKV[@ICUJMO:SJZ2A0:_ML<^P=I MF8&54%?S>5S`=24_XH0WRH)=8Z=R"]CX72T&*DC-Q6;U0Q#)<#?I:?S1,;<4^5+W'@C\W`C+,3DF7\ MFG=7ZA7]7"[CB?C\].SK/DVJV1O/NS8U2U=-&_NH=,OY^BV&P*1X#=E9%B]+ M\D;\(7,#29.F6-1_82*$$UN\N]+T*Z7([_F'^N)OJZ3YL]@Y!)W:NRO3_7IM M!&GH7:,U-VK/O<_\S`_4>P([2>`^Q>4HI+4M<)8<+,RB"%P)^[+\J-#5/$44 M0-;,A@XF0+8)\F<^@OP5S5_H-T?)D`S5)J!;<@]2)4?>#O+J9B$*C.4W!\WT MNH1J&HRKLV/P8:9.:&GC9$TTVT^B0_/^K,;8?;-=_,T@2"N79SA%I)>M/84G_A3^S=B;0:P-I9 MY5,F>C7MU?0LU)3[:\GY\017[GI"SZ'(+@*O$3W6CXZFGA>WQI,_I[23YS5? ML9M,"+F]O9R`M3XA@G6"M68:GL.@O=P^%SY]U9KA/*97![CT3&90K6N5&\;` MU*V3<^1<9/^L0F:;*O&"G6AO:5ZVI7FUO19^*G8TB#D=@UK7EJ>4E'HCU!NA MW@@],]S1^W#GE.G69655]&6D]6&Z;(%W8UN8V&>#6[KNL"6CVK$-Z7B9ETY] MC7F:WO*2MUB8?D[I0S]2^GB.V)]0R&C?%.@#4VLM)#D7=3UU@M.'$!>,B/8B M]#X0[\%RX6!!][&]6^J%NX^^/K^?M]_E>8(-N:=`3ZLL_**P,@:6TQJL+CY! MZQ"TNNN:+@=T]66Y'BX7#A=]8+JM+?">B^KW9;E3+_!F M.J^FMU9[ MN'BOUI?PW@YY5Z!TQ$N?@U$/-E"]OFC1%RWZHL4C`=.#I0=+#Y9'>Q=-;:WZ M\#(`TQ<`]S/QG[.\J%CM;YP7!3T.D+U`0.SZ6,(%_(C@IDZ([^3I\ZF#0-4& MGG?Z7KZ7@>`.@;6[OO!RL%8KU[ZU"`>EEQZ(\G M#RV[!S&CO9[KJJSL'E!$'?N0#@U+%=CXL+QD7O1OIZX>D:!D^\ M^GOL2-F+2JATK[U#XCZ5;Y>-\`Z!N;N>\N5@5[/:V_SX7*:="P;[.F0/S3." M)KA5S7"^.#I?AEOMZYAOH_J]>+A@CB%YK6#T7 MC>B+-^?C]SJ'B+ZHV>.BQT7O*?JZY:>N+T/T]491?LX7_/7?&=4*3>A/W\DSC> M.5FQLS%4?:#U:4LPWU;Q.",[KY?^IA7:E7]#-P8"(^;QXJ^PC<5=F>Y\FU>R-;CY&!] MHA=9NB"O9X3:8DU7OY8$["XW7BZJ(I5/5Q2W*KT>R'N2WF_1)P'ACU59 MI;S!5-??T#J%BA5#.B M/`!B%+)(X)J?XF(R4PQMH.BJ9EY_,G8.\6`7)';P12Y_4!5OTVB$JP(7$Y$+ MMVE15LI?JQB856`'&'#`&K"?FLZP.8G+54'F]&6Y<-%&[8063*2-%?C[:@[? MPZ5#DI$RS>$K_(3CTKO*E)[1DL054>Y)04!@M\"JY%KQYSF?6YP@-]A#"S)! MBYQL30UG(Z:1;KZD0[F'QR9D4L#\X??QP_:;?I_E?O&0_SI@@%N03TA(OE]F#$&2ZF.1S@M\5>0S:O"KQE]4B'Y>D MN*-&.UTL5\`3!`!<]`>9(#YHG0NC.G:(3JPD:3G)5S#U`F0S4.YG*8PFBTA) M&O6IS]P!BG(0#AT"+IWDBS(%!PI7_TCN2*88XNDKT.GBH'[A&#B)+,?OE.DJ M3>+%A%PKR)M23(-=FX!+7N25,HOO@':E!`BEMV"R8$KI'/Q1I>0,_S`AP!(J M`4X-77F,U)<5_%>K=0YDQ*B7Y4`9QQD^52EG!!4)>"9Q"HQ*O'C@5..$J5K" MQ/("64;8?'!B!:F*O%P"KU-@PP/7:80&3`KH@&>D<2;-HR8SGJ,42LK./D;<82%Y;5RJ#F-"%@C3;)4T?FE-&W?I`^@T MJB$0"+*$IW%5VK*B.*WW*_!C8.G08DS(XR<%G,@G=`9C:B=A2`*RF[-)U4H$ M]U>4T]1J"\/+ACOL-,]=B\3+/JF;`1/R?TCW0>:EI3(E"U"-#$"-0"><#B"X7__[=M5^7H:Q\LW`2=QF,_'H()(85@;X`_`^`#T MX\^___=_*;3Q$T&8 MUW=@C_N_48.#A_K/[U,0'L#E@?HG.L#6Y3?49=$+##;D%483`(RL?'?UVKY2 MT@3F"&[FM6>XHU`;6<.1KINC4:C:OAVJIA6&:C0*7/<*'%_*:%J5R=7?(8)@ MF>1!*;3#T:."^ZW6^AO$%WA0C!=\JHD^#Z[\1?)C$^'Y+,#C1RJS*V$4DM)( M8UV&-QA4_VI&9&Q3&>V0WWOJMD#G@)K)FD!]Y@7?UY%],U>__.56&B,$H[0A M]T=KREZQ#ATGC'QMI*JAH;FNYX]&NNL,#=48.:;A!9MB-4S=>H1<6V?X%Q9Q M=,-@^C3Y"C$)M_4>O9;/?!%>TX3_KQZI<^CX7;1ZWN#2W'#*/0B2)G%*B^;8!T7=WUAUZH^SM0 MJU^D?*4?+D.RMN:YOJ$&MC$:NE%@F?`GE:RG>9%C:9N2-37U9F3=760-Q;8E6]QX1/ER#6SKE6W])M7]4#QW?\ MP`E]3[,BX5KU2!]NRO)B!+DWA^F:!%7-&&F&KVMAH`6.Y6DCQV<2=,R1;YM; MP='CDIDV&/OYI==EL^K[^LC41[Z/_A(RF2`,7696-2MTC"TH&JKF7JP@.QOS M!'YH^LX0$LZ1IP]M1&7(8A['L:U`W92B;KHGC7D^BQ1QW]N6[<8S5S^08AZ2 M<749LH5X5@T<+S0@D'4CS0YM2V>R]>V1:MM;"#UMHG*4Z]T6^!?TJ8YJCP"Z MON6XJN9Y5NBYKHB*K!U1T4L7<)?=;F!XNNX8GNWZKFN#[095%6XWL(Y8/\91M6*$=FB/:1V&Q=-@&#.]RN/I)"U:GDZSH.-KY6#S[9_W@'W'N M3[=Q:^NJZ6E!&`81)$BF:S@&^EK#LBU?-S6C_23XF6P^&Q%WV>\ZYM"P1Z;A MAE'@FZ9NAZXAHN>AH8=;BWJFUU9DU76Q=]:`ZUI@1;X;J:KKZY[G1T'@,0/N MV5JT7<]\"3+'PR8N0KAJX(9:,`JB(%(-U;1,W^3"-=WA_[/WI+V-&UG^%2*8 M!1)`[>%])-@`/#.=I..>N)-@/U(297.:(C4D95O_?MY[54461Q:+ MV8XEJECOU;NO,KV1=K:\YSE<0/#SG^)KELR8:=`-+4I\$,I1$+F.;[(`I6Z! MP>7]5QWDJ[.B@-=B*P@3UW5`D7J>BM*6O!_/"'UU='K/?6AAVES!D_A/W,_/ M\=LPK6ML5Z+2ZLDC..WP69[F&4'B)D9BA5KH&7%L@!@R;<\U36=4D6!JZJ@, M]T';F@42$`NG3>#$"`TW<4,]B@`8/3&MB$'B>*ZGC16D-@XI/A\DQAV0F';L M^FY@FU&8&#X(#MR6GJ(](75US0=]!\:TN)JQN4$[W2_QKF\N2^KLW_NL7!VFUY.>1`L% M/&8`>T*4N;*_;_NJI=FNI4>!DT2FJGJ^YIJ&ZDJ]FW)^G4CWK<[ M;@@RJ2'HM!,2>V$8NUJHZ5;@:Z&KJCKQLQ6'OC5NV@`$/`RLZ?W-"9EU-V1N M;(5![/B^I8>>%7N>Y<1"YH:ZIH\"G^XH//89D%7;;]$BXY+F)3;)O^^S(O__::M]]DWRM\_8R.DC'N! M`Y:NJ1F6&@=68.A:F$2N4+].'!_')#Y](Q/]:"$]MF%/NNJ&L$DU M\D*!)SM6W6]^/.JFO&N8QJD&R4^>T/!9?9;TYPU[U;(JUFPA"8/4]]WAL%4D M2_-5]Y:^+179;>**BY.PN*Q%T>L>N:M&T3PNER"[A_Z,2*1\54&>7^X(_39#0>[=IVV8U-IGG M-(&@VK=B\$.)#8P%M>+O5ZUHL!:@G2F*C\,:FE6=+[$5.2NJFP6L5Q[X`M38 M7*VR#`%C;>QIBT,_BGS+$-:T"`OMAG[79-E'^$O!LV63$[!SF776XZ(<^%?> M`__7%?9P*R!NJ"]9FKT`Z%K2Z`=V7FE3E?#G@7=WPQ=$3VRV!J[`6>X@*+'' M%)T4ABE%8W@W1V5?\`_P_6=]:S.UY.< M].C%L.%4J6E\`GQ,'V$O-79O+Y&TD"U6A*ZN#9Y-UN@Z;Y7T.LV+#J/X;<]; MV6:3,;+>[%LT'`$/W3P+T.<-<P5$3(W=W72/(5X!556Q MI]=S:"0DG2GOJCJK6#-YBRA#6K#N=EKQ&$*^)98%5 M^-`$/MN#3?V`#>"S17:-`S76:*Q6NUYTE:!J9.1L@=C9ZAG."Z#I`0!;D:7] MB!D@/MA"#RF-6AB3BB2Q\)CP;3=7&0D8!N4./J;>=UAM1-C(X_U!=X\R`E6. MV*7CD25(JK1?+.L76Z4E)Y)MN@:>D::3\!/IY1)?\AHX\-7/UNC!I$$:$F1X M&B4_"@G]_:D@47?\#K2]I`DUF$9=(Q\^Y.=#`20OEMTBLND!,1>([0Q9#$\8 M/[_.@3S3HI"X)6H?RBT2K=#Z=)Z$@.#:40 MT)<@KC-2@H#X?8,B*%T"ARYDUF.X."'J)L3<$2>1?L!9`;?L#,C>V+)KB4.[NDW"UCY#*HPDS!)GR(/=DM'X MC2M@1C;8JKKI5KAGM,9+Y^@+:3[20)R#OI\:GC8PMTHVM(;=IYX+2Y$-2^>F M9S>K1MGD=%\1MQS0#U/\LMP#NG^GQ9D1F[5D'Y*I!WS[1TDSV.D5-SF8>S0& M9]T9O;P,`W:X9^P%QSQUME,B!4^9C\0A[5IV.E`&\LC\A#U=7%7[8DWCGJHR M8\RUZL/G^+IM1;-;@(GIB2E;=8D6^VH%T`'++G"5AJU[D\EJOT*4M&1='"9? MQ5;FRISPPJ?!8'2(9J"AA00?@7\`R&,$WNSQ;)89,;GD."`>`)TUV==D)?]K MSU(<^.XEF7@KMB2?.D7CID`9$JMVH\'XC*1L8,Z+R6$K`I//Y\*#JG%+Z1H, M#X!D.*2KGW\$QY:+C8@12X,!74_.A\/QL#,R(OL3'_\^!W\J7_'[OCJ.6B@_ M=?X62+_EKLK*E/'?VX&/]JI%T7FIO`,ZU?G0Q040&U#`5;8&,MN`'$;;O$PO MV:2[=^EEF;4@^L-TATA#\4+SO$B7I:`V0+_`/Z#6HSJ]K,H-L/Y/V^4_%!K3 MA_]3PDKYY:?45[X5`ZUU]8?NX>XS[8?O%K#NS555%(RM=Y6@M' M%-;B@YEP$)SR$[`OL`_3:?!)`H+HXP;^6/"OX$$<-G;))I6E\B9!Y!9D*/-% MVO0C6?/H9N-:8+R4&>-)4KS2V[O!W,X/@^%4\M1%P!U(`WPO$U(@8%`(`'1K M]`;Z)P>+P4MI]"=9Q16>!4DWT+&[-%\+T=%<@4R^9Z6FK58?V5A`],7)3\,) MA;$89L_Z+8VVP:_0[K@D0ME5^Q1 M-(`^0W\:=#NR16M%&?*]=F] MG#D+["!-$PH,E.0Y:Q4FIZ-NBH$WAG#?X[Y;-"'XB M!@*I#3)_.X_DZK4ATX\\BO='F:.&N4!CNE&PDJ7&`%I(^DH8Q#$Q;ME_#0C" M7,+_5?5'&C;+(L)5O6!C!M$_8"[8,KM*BXU`Z/!E*/@?#-L]"0Q^N1=+:`WR M"2RPS.ASC0$!LH^^QVGH##/M30:F_CQ()I\$S%MA<"#YO10XD62S;)Y1Q$HE M6(]'1@GH@1E#H(-KCC%C,F(H%)8>1)PB+UB^06+6C_GJ(U[8UD@R_S"A!(.+@%#?M@,)8TQT`L%'6\(8":$^0$H:>:R$0N1SC^AP30("Z M3,AB)J]PC'E-V5*1"QZ$^+A*D\]1RNQ2-5$WQO\J`_EPM<*X')`84%R-;FZC M`&L6Q"W*<:=N1`<`7J4?F;+]K.R3_F]$Y%%P$9WV\."KTT+26\D M72EQ2N(OPY:\QJ0@@I5W:'O"2&%H6FF605J23QDQ&@R'_?7OR)8-5\5CYOD1G`S=R6YQ=?\0T M&/KO`JB<;WB"O^7TSFCM3)%J%NA,)V+#0VY'ZYD!U!\7RPD,KY8PNU"C=-J" M$8[LU`Q3`()\?T:11K%EQK3CYWVN?P?H.L?$<9^K_@VV?G5LY?Z%:>T_\QKL MFCP=I@8X2_5W%B"\X!5FP-J@88AN_.4><(=Z"W_$#S-DQX&&QUBW,)0MLR+/ MKD4"F"6:9:3D*"17>RD1_5BBNX\\$._HNOX*.V89Y'?@&17\_H5^G56&.K,+ MZ!95PPX9SE-_[*CQQY5,C,HQS0DR/WW67V!'G0$*CZMV?4.]Y74 MZ?*LEMAQ_<2%_W/<(`G]V#1YQ57H:%YT-,E#O.V;']4SW1Q"==_.YH!E7/@H MPX*#JJW`LGTKMG3'B=PH9%5V5A*&B>/<`8OZI6"AOH?N5[\#)XM?=ET1Y\5: M_GQ7P`'UD-Q`,[BPW&@.ZH> M!':4:)9JZD#526(S')B^E[CQ,]#T^[0^KTDPKZD.6/SPWF:)M[\EB[C2Q;?WI`:%O&W^/9B_=;_$X`"+']`,C"`S?C"-551-+M<1)A$!K$@`L MHOG-C^Y$M?CI_7S&QN\D(2<*0TNS7,_SM="+-37@0A$$O!KYYE-O_&W3[!^P MZ>$X9-^,5-.T53?Q#-T&6M$]P<"&'<<3>S9<[=X]LZU\XG[O:L^*`U5S#",Q M'*'"T*;,=Q8L\U/!R^)S:J!>%X M?/@=>YSJZ+EW=>ICHAF9%FNO&MHH=,)'MB\T9ECK#YGK3E6X,R7[+VO/- MA_3VT1T6OJ$EH%=-S_9P9F4(DCGT;3=1(\^RM'@\8-^9HLY3V_F,?=_3/Z$% ML6M:H1_I9N0`J0:VZ8A]Z_YX)(&E35'I9^\;7!4RKC$T\*%ZR#R`A_2&>*KM M!Y%FFI89)KZ?@,4'L,66'_BZZ8UNH'DS13^?L^,G!O\>DK1,'\1F$&B)8P-_ MNZ;KF@)\D/DC\+\`W&\I#`&_?%]1T.9)\&"X.NB"Q/9#(U1#3].#F$L1/=!4 MP$^<.*-F3TL=-X<]+7[$ MA7#P$J+?^B).8YYC`ONA0FF(#@1N.'=7.5[\1R(95J-:(Q_7PCO@CX M+^:[8.MT!YX/&B(*K,@+S"CT=%4'DP"-1QMG=8TGR!NC@6M/CX:7@O8[+L5( M[,"Q52\T8E4%*K55O%(L-@TCUBU_W!S[LI#X'OYK=7A,]UL0F*%NVD&D@@EI MXWS5B)OJKAOXAO_DW6]?.*UR(G$7I`UUPF",L<$>+$KZ*O/4*'U@[213=Z-. MWD8)VWBW^@5(J2J5L,(Z`!:ME`LRQ`,+.<>+`4SI&5%W(3^"=5?]$S>9_%V? MAA"5-[NZ*JM]V7S7A?=9W?'TIC'A.ET*DG<-8_^BPA_Q5M7[@3U9U7+X=$4; MIXP4]AE06D:TN[`+0P43+=C/@+(Q.3$ND%,:,61N0W(204Y;A0%D03(KQ MZWNYRNM^(R/]S[=Q,ZR"87=+\LK;\2H4I:^:K%].Y##+E-J7*+MUV_(`/'NV MV[O(D7'0NYP-5LT7AZ['@&=VL-!:^==^?OP]>];;V-76L]N#<:K(CBW8 ME4KU;5=7>=/",6&L^SB!PNI%\0V#"+EX[0(S[%B23H?`&PK.E$"\`\].@D;@ M3^H,847HK-T';V3&&'Z9;?*5*"BBM!8>!%5F2\S$OND0#5BL[K@`F%7Y=H7Y MHJ):_GU?>[VN^@N0.9DNJ)6)/J$D(>_IPV+YVZQ>46&]?%%RN2EPLD#&NL'Z M"V\1J7))-D@D5NF`Q,$NG^3WI+++IJF>'$P&>- M&]IB,Y;R6&'7+P/VWBYE5XP3Z#5=2L/-/OO]>9F>>,,?R^:VT69:-$X=%#5'[(AOWYXKB+,QV7N!XB)[C MXUM>W$^IF:8YEN87<3C8R/%MUYP`A1!FE2U#SMQ450O/9%+C7,.[@8O#*,V; MLFSNO<=S-J$"[TL^G;9/CBV9!@SZWS&G=QS&>8CE!E:;I2:>9GN1!6YV"`8, M,V0L+[+'X^%-3;LIJXOAV;2>0EAIV$D2O&8X11DH2C(1*& M:DSY0"=WAU<*A%1!CK3$_JO%:V.:MM[CRT)KOO%NPU:?K?!A\.NSZ(` M_R-Z@"3A'S?`NI&Q(S,,'\=N&*FQZ=B&';BVZB1Z&%B!$R6Q:FJ&[TR$-DT= M//`>4X]#Q[RH-/]I?DE4OK'D\*9K@X-M!D8@7WR\ M=OY9IG$\=^>5J+M'H%]U1=X?.UXH,MT,M&`=N:Q/\-A"74^V[ZR1#G(1TX+G MF<,GNH*HQ*UI>:/G+/ZH>::J_S-/_3+;XQHTY#G8^B":%,VE,D[[<>7:=V_7 MFG^[/IB1A:+;M%GG3/%;UAIAJ*(*%;;_#B>,*4;7/C=/(Y6EJ@H\50#ES`/5 M;)B&K3E])=6L>^3&\&N;D$ MY]^TA?YR#Q@V9YI/P[ZHR6H:8H%EC:BGV"0IC%0>R4A6YLKXBGZT*E)P>*G] M`EUY+)1D%;+=*"3RDAOZC>@%O$IYJ?].%`>#/LTR5D_,F18[96OEFHH`6(OF M:E7OR<=E`32,GU&\8YVQ:)=8+KO=41\_'\3#8IIU/Z^$%]):O<.?;5,V`8F] M6T($FY:RY>$\"EOT!;]Y+88P82DK/821FS5-N0`,BL<+5M9--;B2$AIBLX^4 M2"B%7Q7@/[Q!!X),B=?=\""BO?=:33P@U/`>"(I;LG@C8E\J!?_V*"B>=`\E MW4.#V`OO3&22@TV2:_D@&C;RB?W-XV#SR18#Z&U.GF6%Z5/@B@$_.VJRX,7> ML[SS`H-PZ*$2^\P$AA+=PZ:+OA6_JNOJAI\6AA/SV;2GY;Y4N>^8,ZLDC+)? M577+A`K#*?6N]#7Z4V2%`HU9T5)K^,BL-.8A4=XHS%]\M#>8VG:Q>Q>Y`9,E#:/8G]@MTXT'2RQHGYFU3['(B[?MH6?:/_YI*"5D=;[`@]6I?3=5RF6P4?$D69HC3/I@YMOOIB=KI^I MN*49[?078>!JEO=2+25C9DW7F38XF$(F*59RDE,';C^9FVQAJ6+IR"KN(B&/ M9]J&&?K"@/^]-^`O4BQ,X6;ZX54K@[]$ M65TYZ:HT!&FG,">B/`P%$Y&=)]$-0W/CM"7Q-^W,F" M%R(-5.^FUG''CF&/SS>EP;`TA?#U8D.J9YR@FE558J,]KZ?%LC5Q0P35P65` MWCFOY.-)7%$%]4'&EQP_F\'E>2BV?JNNN^":.9]TQYK+LLU7^8Y-PB^S&V&- M)+USA(5H-,F`X*:MO6YK4S*ZGNL`)XV[F1(T,UH2#P7G"3W(GO2&YO&7/*EY M6(Z*0I[0C)\[+/2P8+`XJ@<$@)6GLW[G(LA[+/YY8JH<9:]:A@ZT(M;XD<,N MJ\Z!)T5E_5E-A2P[,L<\/E%\U_`NK+I9X%NA>%T]],H:*OS8G]OESZ:Y3TGNJCT_]L<+\GF>,5> M^@-SEX\=5GFB8VC<5M3W'W4W7S_YM>'ZE[HVW-?4T+55W51#QS,=U];#6'-- MS0IB/_0CY[A_4%,G!JJ=P-HGHM;ZI_95H#8*?$WW7->/]"2P0T"S:VFND42> M:_AZ^!_VKJVW<1Q+OR^P_\$(9A:S0%4U[Q2[IQN02!%30$]U]U3U[.-`92N) MIQTKD.RJROSZ/:3D6^1FZ MJ."O>>FRT=G%)MH-CVW^6>SC5*&%B7#S9'^DT,SSYNQ.ZJ+H/)]^^EI\NBSF M%2CYQ_$W]\E#)SAY0CBRF!HL-5A-USJ=1D90I9A!:*/FUW3N;^6J+K*[\+P/ MJJ.!N(`XSD+D?`MK?_#HTU?XY`;`78?:%S=^!-@6Z$HD8MH5ZT2I-0BH"V`; M^,(5OKP#;/YB:+?,1\_9+!*"J::)1!PK5Q@'2^8.T$8:4?A4]HW->\=W;U1F M#*=8XGE=>#C*.!&@N6E0:K(3C>I]6`^7^9CYI"$;HY7;53 MT5;F*B>#T9,HC;@F&H$FUM4TA"+(MH,B3%JE+;>/XVECO:^&JZ$R5@PI`4&< MT$1&$6++$F91W*HNB`D5SQGKI^S;SZN3:D^"%U%K-8;@4J4LU4K(!"V+]S(3 MMPIG8L'O'/+6X3QKY/>!+9FVG,0:Q52;F*2(<+8HLR(@D&Z-G$?1\T;NF@@E MON;3[-=)-O5='IHN"55RDUY=3XJ;O-RY(@N,FQ,K>)Q&1DJMXD0(K'E*TQCF M4ZA53I=O>8O'#:VS-WJ@`HX4EDEDP7Z&IDM0 M>8]!Y8F2KN,'YAH<#*4L$M2!BAC&'!Q.;T'ME*FV*//QQ70=SYU0I"SF"BR8 M31()W#222>M0Y)&,%"*M2J6M0J4G0*RPJPQ=TUEONITD1):F@*<1FX M&(V'S:='@!FC,"4SA$%H`C$)TTSIJ,8L1E*TU?(1?F`[#EVAUV=5C71JJ=(& MP]R6,P1*:Y91,T%1>R*R93GEB-%\+A>1:^UC4@J1B%#>^AR9(&1CI*F,P%\H1A/,&:LC$XI-I%H+I]NR6"\`YMTS4FIAWIE&U&41 ME59<)$D$P82K[&GLEOS+B[/C@3P,4LA:893A0NHHDL8:+3"*(I3"U%NWV@/M M[X4^YN67\3`_`@N1I)K1E$>)Y@E!L=!&:V\AI-$QD/T)%F+MY9^%4Z^\NC0Q MH3IAG$F5BDC(.$D6D9```_L$Y>\*IS[[;]=`3E/$%)C-F(L4"R)K_ZU)C))V M=OI(Z=4Q;$(PDQ@9(\[=0@1*C4B]JZ$6O';2F@0_%;#K$I[O=W7!SY/A4D1*26`EB1VGD24XM;DBD1;5.7A<77Q)@^X M$S=TK9.81AS"3R$3BVG])CB!&7=[?BVV),9V?Y-R_,6WN/>)G@^%[[HPB>O3 MM?YOGLYV*8+5UA?7`M'>JO\M%#BL%2 M&1N(6A15C%$I.<,"V&8P3V/GMD`IQ"A[B6<+1)$I!%Y!2S`K7[I9XCR$QS'=,T@K2#?,HQDDDK,=EW*?34 M9I"*BB8V8 MM#X61<;@F*!6PJT7@NH[J`+BQ#B)XUBE/"6(6D6Y]PZIQ8JC=I)\RYINH/]> MXJC(T(@;3C02U*6&=**<9*S!UJ2BE8OH!=U/U&VG2IA(1W[7(%8R)E)&/J8E M*HDH:VWT#V[[X(:,:X9I:E-#W19/HW@2(:S+$,03A9A.C/<;[BBR1JUM&R_,_K[; M%$4XCZR.280C&F&DF/`AD;0\0DBU9@!TRYK[X5'M4ITMBU,N8T8YMD@K;J1? MGS+635YQ:]/J_F/"A1+>],&N'CY&9XF1A"C+TD188U,<^=F3X8S'EK6W9=$= M!;*$]T6$TM,P<1<)V\K9 M4YM9$L,Y@VDE(21A2G-LE/"*H[1.(W:T#OAX$UXL09A&6H+=UD1R1>OI*5B, ME'+&^J08QS3GCZ-(N?5R##[2<&6Q27Q>-T)I*I+VH>F>P'K"1.P*/2B+'XP&TTB+5")F4N$FN=1LU?>X!0LH8M<_L[9H+ MZX$?.+I\D,*ICE0"@6R:&I<`PE'ME1G!2:Q:/J!?X6R7"Z8)_J!UKO+W@GW]6G8TI.ARU8336??S\5D M5-^HP6VP`NZH6TR\K_M2UYV+0=[SLO+]=#XW11)]FZFLS%T#AL*U$9@5J\8" MKC/`H+8D=3.C\]J\#(;>3`UO!N>3^7`V]YI3U;UK7#O!^JZ^;5[37Z<<5W^X MGH&E[S_H1C2OQS%:TK<:5//AI6MIO/G\"GS*\NE?LW(UBKRQYUZ[F$YNW%C\70>7C?"OYZ5#P]WO_Y9=@]R( MUR]W%\!C?8%S^+&ZSH?SB?]N_?I3Z\1B;U/`"\G)]ZCUY-?2-2QIVD9EJ\JA MCJ--T="Z2>95]N^B=(X%OG#$*J[SNI1^59?K!RZ.YJ[.DVME\ON[P<=WP)_) M)"NK'P:7Q=?\2UZ^&0SSTK7``K+[6EB.W).5RW_CVJ6X M7)?%19E=^?:?SV^!X9$'Q^!*NCILQU?7\%8.V?L,38>]2@#5Y1LY:S"?@0C^ MT_0%=L1;^;5S-0+N&V61RXWU(S5'O#QRQ`>:%$UC:?$_VK`U*<>WU M%RYQ5AV$<^&:SLW6X`=K/BUJ3$=K/;U!1!HX.1IGTX7JOAFD\[*H'Y6X+GYP MB^MB/AU5W31L.XK.*`=H>](6+A#`&SN0(S@AIQ&U-C:ZM4/?F@>"T32F6,<>RMR&\Z](HK$#P?82O_&P/S,SL:YX_OTO62IK==9?M MF&8P,(*ZLO:Z"6/'=4"\,M#5BLU.'"O4'Y"3=QBEZZ0SJKTL?#6_FM?=/AN/ M6UQ=E_FE*R'QQ3OHXBIOVD4.)^#[Q^?CA5G+LW+J>T\UXZNR*]\#!9'][R"3YNO=#[[.L^E&)'N?K?1][CORS3"V[MPQ MX-)9R-"=^7XW^%!,%]UVV_KSH.).1\W4&WYS\=OP+K.P[1';U1XN72CVNQ!H M==I?;FM$5=TI_4X>_"?\AC'5;4S5&>(P.*1PIX-S7N0^7[6S7^K0<\C#SN_N M2">]W\CU'7T::>$:LTE5^\=MNZRKLLHPD4*S=P=U.B;:T#L+EC"U*34?/2P M143KT74UN,BG>>DR$O"7KHMQ#?DR^>P"GTF1S9HT[!8=K-'FX;C`!T(+3^Y=0CV#7+C-=8]W M4195=6"_)Z*^.CTE.O9XO75XM_R!6S#9]]K;N5MV\R:LS"\R3_TM9%]?5/*) MYYJA=<(9_F=N4CMQDZ;O]P7&T.=8'P_'VJ,V%J#0XK;-3=SOZV.IUR&7HYD5 MU^[&WU8WGGGS/LPGD^9O?CQ#9_[WZCH;+G[?/;T'CN%B/*T'F*#T@_+ M?_)U/)I=?J_$.Z9<#P8D$9:P@\-;L#_O'&'U:VWWFUU(:9/O?") MUT4'?EX89[?/(R?^?F&<73SO+G/5F.3ES:WF-B:Q=SZT-"V#[UYW!^N^- MJUK_J+;6[I,'A[GFH0H8B,LY?G\Y'H%7ZM3'KS(T][KF3;"70Z=G]V/5>)Z% MT[[^-JB*R7@T6"Q3=87E_?BUXX0NUVA?^%"G2-GA33'&KJ^7B;=#O;VB7<[87IO[R?+A9&JO]](L5[`/#] MM.Z7W?-G@P/4AX!Z>9BPJQ"E?^:BOR%,H&NP#+V%>F?+\+3H(AO^<5&Z#;YO MFX,7PV&>GY^?3EAQ*TA^\#A!9X:X/\@>L04^((@!N`!<`"[8N,"X`%P`[M4` MU\%"(SKV\-C>*N3RA%1WYV-:27*U$?PO]8'#V2YYP)XMZ.QM%NFO:ZJ^+LY5 MK!W:?$G$^D+S/W4-0O?O[$G5Z4N3KEZZ+U)TUWTN!\-)GI4_GDV+:7[VW?)U M`L-?'\.71^E(9QSHBSP#UP/7-ZX3G>W2[(L8^TCQ$TM%!!-P2B8@6(#`\--F M>`CH`M=?"]=#0-=)0O:1*>V0J3U4IA;D_K;K;&V/EAOWF\;U+2B:HM0[@+N6BGQ[VEAY)V9],1T=A!Z!8(>(50/3=F':R3")*K5W M1WE"##F62*%WV,TD;C*#BV!-&GURI MU:X3JZ\X>MK!)E.PR:-B[NIH=E;.YQ32\X]&Z1CR]WA/H>,66/I"A+U/WH(6 MO38MVGM\?-KJ].B3'Z_Q@$<(:H(Y#N9XMTDF#E8X!#5!BT)0$X*:?CKM4.SE M<<5>'M$2:>_IU!!@AJ/I`;@`W'$`UQNP@HU[)8P+P`7@^AXZAV,$+W.,(!1\ M"05?>I"7.J:T4RCX$AA^V@P/YX,#UU\+U[$,!X1['^/U:X(3;,")V8`0T06& MGS;#0T07N/Y:N$YX9S4)^B+'YW(\E'P)N=I>+S8>I-S+<%C.\]%@TC1^&N?[ MJ?UR,D@4<.1;'W;O,W"M4KN"G M@QE^I!FF@2"!(/>@%M$0R>TUJ7)BN9/W;JZ>5[-!FY5"-5&PS)";VL-W2F-YFGNTG85ZKX0\W`5BAYD[7T8[P'*'F]'?CJ61\&Y M?4^O@IH'-3^.33-!SQ\[@0B5'$*UFAX`%SQ+\"PA@'QISH4`,JCY$:LY[NSD M>M#S$$#NN138=[,,"+7M[P\FT368)N-I_O8R][!B@OY\&WSL,L5KE/SWO)J- MSV_JC\930!;$P>!ONL3W'_EY7@YFQ<".I]ET.,XF@P_%+!]@_&9P9K-Q.?AG M-IGG@[_G634O\RL81/7FS-?PH]7V6Q<3`?P?W:95_F@S-TN+'BU MP;F[PQ=_AZNU.[R[7YC-SW_];EZ]OCO^6C"WA, M/(2O_"8F,ZZ&D\(]YQ.@EDR*X1\__?=_#09_;=_IYV;KTPV\+XP^F\17KGBP MWTL&UP(P/Y[9]P1A]AO[5W/YOY)L`BCE'R_S?/9S,?3O'7\;5\L_\-NK=+T' M[>?5YJJ_YU>?\W+Y5ZM1)#G`M#D>#4;Y<'R53:H?S]Z*L\%X!*\(-WZK#"96RSY6PV*GX3\`PH]?L^O] M"8`G.E):"$&1Y-((:1D(0F"4<(*C)+XM`!$='O_#Z\'A\$\(M9$5EALFM28B M35+E%B7\T;\-8N&-ZL;K/SM0N`!F,KZ[AFD%Q[L(4?\Q^V+S"X'PR M'\[F'O!U9'9[Z7L@6Q?[UJ`%J&B6DHVKA@?K44UGV&ZGX#JH4:(T(['BD=1$ M,\X2`CS"2&%$4ZG/?JK;*GA,-S;=E^/JCT%6504$C*X%P]?Q['*@\PF\6?$_ M;O^8_*&"L*\U&MU>HV$WK]Z^L/V+YOB]/X;%!6C(YPBX=JTY7V'703SBZW=^ M"I_TQ$QH?4=(7DPM^#AA,1>TY&[)VC_$4R'O0M*>Q'Y`4+M=$PHK-X#O/$[] M`>Z%Y(DFQ$^2:=82)&:3*,:E1D4P*$(6S2#CE74',Y\AR5Z=1`GL3?C@1>,) M.'K<99EYHN0>!&+I\S'UL58O"DLZ@KE&42``F4\(;M:?4R#7\!F$9R-,\#3V MTV3^3>1^?PBN?V89P"A$S0^_1L%7SL1\7.&?/)J,"+KEB1!/!&SU)XNH`9&1 MM?#G:SYD&4_VY]1'6N7O@QKCP/`XF.N+,?/DD MA1]V<+GKIVL^LZ\,5I=\9E[T*);^CA`IF@9DX#U]WEG-\.__A>L59S`-XVA< MR$GCXNV`Q@W+9'#,0])+!D8`Z2!+@N&>*$%%F4!W8XBSW`0HL0 MS\.S$,8A$_$=CF04"*$#21F##@14H@BD+B8)B[_Z,`'"-R,`R@U\DPHOATMS MS(8!0THAPR,G^X-,8G'HT\CWA/K*X,2ZZ/SM"/'A/P;9:O#I7GP>A.QS<6'H M;&G$Z_A$?=`LXVF0^A,P6%8CC\N.=$9W"SX'7V<4`%M#J4<6`@ZHS^"!`HH! MMVI0(L,!#6!3`?B"`(D(FQJ,?:")GP"L*WD"=H]HI>8%O8/XB[F1)_@&DST7 MU.RZB5=IO-UTG+.5D9%63T+!,Y^G'0ZGP(,Q2^41Q`$P.4ZQ^!7!8 MUJ6X#51/GZX*81Y@BKZP9@N;VLRZ^@58][A?" M^K)[^FW9SK5^-[F=N\8[[UNM;J_G]LV6V>OJNFX8;=?HFK;5Z;4UO:^_],YO MEGUSN1CL09Z/X9:I/[#TX_`0JK1U2VMKX(3W^H;9-AJ:TV\B5=Q.RW;Z/6V) M*O9>5-D9\!V((0A7H/7R*[TIZO5/(YJPC]/T$^R1T6`KW^3^T1H*-9M.L]5K MF7;?MK2FZ;JM5EMX2[V>9NN=)0KINS&.''1.2#=K,]U:#;W;=YU&QS3=5KL) M@M=NY733'\;2_OFBL,UF4@FFR=8=8:Z0TBLX[3U M#F!GNPW@6Z/3ZN0K"^`=8\.BQD_84 M$,K\QVD">"<8*..^&+Y7&/HE"J;"U4K8XSRHQ6)TT%8.AE5(8_^!CUH>#OY` M.\G]IH%`*Z!)(KP,=`?`-0*OC\?Z7L2I"O$S[BS@Q88"!!L">.CPH#\^X?LF M1I!@;"C\^=V<"WP1%T+$)QE,@(%V1)&[_6,,;/XE?LB:A/&P!/I"<_>^MA$? M(5[.%]`H]NXS%.DB2/PH8L%4LZB2./L0%?52GAHO]K-`B\%,"W MY02Z<8V?1*`F1M\4(ROL)@4+DJ_^,,7+;_`$2EHF%O*1D`.8+16P*!<8) M=U^"+5MP=J\PNV19B,F&&/L*%O;(["=.B`'"PN7R#F_,94OJ:'*9+9>/-Y>! M[DP%?`\J/[SA:@WC6G[,]TQO1.-''G6%36_JB0-+2BGAX_$PFT]A#GQ3^;\D6D^"E: MG._/!+GT@85LZ*=+!^@<`P'&+2E(^JKH:X-+.B\/Q^T*M-'`.GB,F3@,S"TU M')]$P_0)@Z+SG1$^E]DB6SE`Q%3Q;"%@:68U@2O!\@5:GAWVX%^G0#S]>F[$ M`.JS<[U'-.:B6.Q?&(,%&\KS)TB(VQWO^]9(3Z]?/1[41Y]Q(-@K9MS,Q4%/ M4?Q?8&KO\#6[7Q`'?JB2"#MW/K>X,\/Y)9F9SD*6&/F0S_\/$';@SB_984X& MX;_`906P_PEH#J+Q=79*`UB%T1._+1)RG)Y\M&"CIS`S:9L`&MKD<_$0&]:B M5;Z,?OZ!$1V`_+"0S.]'"6E;;8P3&)TIP%7K@.=[278@E!V;SX>N->,!A=W7 MMV#%S71UOEUE*D>:"6=:9W;?3C6`9^EWHOCQ M4[,[62QAR*6]'_*M'>%&2B02[7SYD&:4!:;(6VE+L_Z=$VPJ;9),QV,TA(#Z MA<#%NCB$O\!09>VG6VK4%F9>R$;2\EDR:N%S\=.955U,6-+QG=G$/+>'>&#D M9._\?*5=\>=D0KW\>7_3'PC\Z(<"2#I-H_P'D0_%?WGR!^D(W@;B9+EHX"\$ M=)*PN_R/(H5X;MD<[F*!J5F*E[,RR6J'$E4-: M1_Z><9;X2:CG?9&5#F;@VMM2(Q>R3)?314LNWB>W@/?J@XC?,].SSR^R@.L5 M,F)JUP?D2^Y1^ZX$LE:R`EXA]%.\??CF79A;*\D^I>9W3^D]"H%WSZ0^/9NC MJ;X'I2M`W?/0L(I3#^#4G7O>[*=]`?TJ%4`JLWY"?F^Y')$ONRY*5:A8C](G ME:EN(K$3T<'TJ@KKX#C54/#B"[E5A1V5)MN+7(Z\SJ<7K\EJ&J3)8[B.Y#!T MN>[$:4I658I6BJ\47Y59%DTYFL5QF`@C[A.O.4<[I>16?F^59Y:=@]7U1B^_ MX?RR))5'(>GL(JTM:X644[V\1Z6%SE\+E=]Q_3*4T/XVTWF91B+9E]]9?I/= MH/H^O[U\B(V^M:?]:0_K*]Q7<1MEJL(Q90>-U>Y^P=+TYFCBI+:W-2&!!;H9 M2W3;T2IWZKXQ;HT97/,T*KPIZW+5`<3<2^O6 M@E'EA3WD*."+-)R4G6"NA6U1AH'Z1X1<]Y1GLP[R&1UPY86^0Y M9BN2)V^&47S#\\;G]4:S*C=8I0>3ZK&:K<>SNK(/9QGFA:H[HN0K+^I">?E+T=J\K2S7]WUEB;W%@GU] M&H+M45C85N.E:G95FMKM,R6HVFW78M)R^N:)EV;['N M8/ZIJ[?ZK=.<([82E(.@72Z36(16:P.\AN8V]4;+;)J:V6^;>0'!;D,SUD-K M-UX%;<\/IBO;?FRFKF.UG&;/T4VKV=8US3:LGBA&VNS8C7[?V4!=IY*DWM8-`,ER.VW7 M;+8;AM,T\N8J?;?GG%TER9Q8!*A%NM%XC*4,D6K2#$CC!`:D4`(LQPUT'R\I MB359$#=A)D;C">?DAV?".X"@$8.14U^$79["*;8RRAJT MS*8$PV>:\OKZ.$VA`M2\%8RHY8(%7#(1VA&^Q`=\*6^4^;`%+_;-8Y.LM8#_ MHK?!)$JQ70'O;2+J[>0M"*9@T4:>![:A/\S^$9L%8"/-S.B.LXI3Q88$6)P+ M6U',($A1Q+@1Q[ZQV./=&")N;Z(_F5>**KY]NZ)IQJYL=@J?1"Q)H=*F6`_1 MR&>7-2VA),8F/&M7_Z**Q2T:1R[^H&O'_N!Y(EB3S(DCA:9WG\Y1Q3$DV5:+ MQ3%4;8P7X=?6801O[589XSHWAG`CSG9@WO9)UIK.+6DFAG' M21BHQ5%9=I]WUI[P9J M%JRHU-<>ZFOYT%JIK_,MJU$F"3_,CSKR3A,\JIMB>_,P:Z[,>P3[O--#DNYC MHNV<*5*_3!!I(G@9F1[5DZK*&03G*RSY'33=D&8@544`3K(%5N_]DR7)BAM9,I(991)=5F"L!.-2MY5QJ7SCFFR%ER*4RN-3'E_%,XLP5$]X_5$T=$#7,T]F%'55)=-OK.HJV=I\@KK77Q1 M]1KIN,J9'TJ5*57VVI!&27;<):JRFH0UUM2F-S3)65IG7,>_&K12?*7XZL3] M(:IGI)6Y0?S[9?[QVJSCS2FEAV8+')'*]3=_J\.2E2.#&D7ELY%'I0EO9ZV?5[[$:\WK*AQHXQG M93Q7EW"*XTYD/->^6\3'R:Q:UV0:>R.:+!;L4H8$&A+*C%!FM3*KE30$G@PR:K"765O9,KI4(*Y!QU+ MNH-W@8*I#C9^S,I`ER^1LN[A539)SC#E577:>J/L$I+EJB>(Y[([7H`LEF2] M7JHLUOU(I[K7SFH<6*\4$2M#.,6)E\R)-7$I%KXX[XZ3M>*XX;_().2LP\^; M($J2[U*%L9UHXJU<*@* M8:0E@Y>'L_R@GWYK2RM35Y6%5#'T^OD>5>&="U4"CK3"#E59R-J\-GQ2K[5RP.PCW?YIRJLH.($)X[O*SUS>7K&.5XU MW*JP0I5#$76/1!Q<8TB=FZF36G526UG"U=7+DTDU=5*K#FD63"=51$YY8.JD M]L*5@+JN<43WJ/8VA#JI52>U5=3>ZJ16G=2>2G1/7Z3G,D3WL(UY@:;&EMZ7 MZB17(C'KQ88E';"L)U(]_`.[I((JRW2I"B.4'40H0XC.S-!02D@IH84@14G> MT?DJH8*M]`//YU_U_M$`$Q4%/!8$&9_]?*5=\6<@KY<_9Y"\8$5]9A%ET-W[ M8Y:0#^R)?([&-/R1K`-SE9'XY`_2T9UA[<+?BVRU^\O[V:D@@?LPW882"0X@ MOZ#\L!+'`5SHS)P;_?5N-99U>!5^ZZ7,.4S(9L.Z`"GU0ZR!,9FF(I!%QO29 MQ&P88(,([FKA<1D=_&>:I&,PT)/;5TO@)F17\7Z!``B%/WQ>\!@X+\M4/9^B M%.;U:1`\K^J/@!NKC@RC&`378S3.+HFS^F*0.HEI9@3S0SYSE3^9R8`^9%(I9YASI- M4,(@,$O@KVCP?@A=.9['`MV4"_ID"T\\L9@1]HTSQH`,XVA,8$$7)2MOMP(O MA"PE+*]&LU2&!MB#C_YS2N.4Q0EA(W?_T;(3[/7>(>>C\/^-V]$PT?V&03_8]BER:@=#O!__3^G_E<:H$8F M>"`!TWQFPY^OW!Z@W?A=__V^=T6`+*`R@N3GJYOF%?$'\,_42V],QVP;IMNV MN_"?=L-N::VVZ79KX7:;;K/]$J\;79.'F4O]^`\:3%D[25B:_,:^LD"_ MC_C_C?N8ALD01+D]ABTU7<3LG5BQ(EKO/K@%O&RC!V]TW*[;ZZAMTV]9W7;KM,&?)R>JD\=VB`N^^7$6/I+V#C3$`@9W*X7IKF\'=;IN:Z)HB+V;>U=L=MVHZM6O8*XCA`0%8O#LY MUM6GTR:+Y>GPN0A+B`0)%N(*^H+_L9EVP[*^RZ,!L*,&=)*PN_R/)6Y:[5/.S\/TE8=0._B$'#28 MH/'=GNYH-E`W#QUXX#CGR-]3<,K]GG'F^"DX97RO)A54*W=P,0-]Z^7\+4?] MLFBY)-R(+L_U//E%*O&(K]_Y*4SO9;=:WH7YX7BR MS_V6W1/O*\#6U=)[_+1*D?H8I/[-IP]^X*?/LDR4ZJF+ZIHPBEV59J@LJ??6 M#*I.U(8\Z,+)_H`E\`V*%]OPZMJ(#1X9H9Z'ES``>FF*N#J4K;$&5D61%.$4 MX2J;VZ5TG.(X13A%N!H33L)!HU9W\]B-8G`_0DP)X??(#PAURT^IG*TD7G&. MJ9D6%78_")K MQDDK=U.55<1Q5:L:617:7"2'BYW",71#&@]493T5KRM>7QC75)T:*V_B56 M&\;]R,MK45XT9`_BJ8+?2^/TDNKA[D&SJJ@."::'8K!CV*J*T_;AM+/A)+/5 M*GVC/",.J8NE4+EHH%+BRV>DMM+=RDI05L+Y'4*D.\7N])--Q!5FJP@BE.V]*BBY-BDJW MC\];G';._+C$!`]EU"AUK-3Q?DZFKK2P,FJ4%"FC1ADUU=RT5;&7W8J]A%&J M"KZF*<(IPM2!<98BE=-R%<)PBG")7.XLN@4 MKU\*KQL-:34)JK*.K^5Q5?)%Q6HK?=AXE'(OGA=/V8`$6>,GGY53^^5L4B'+ MN%]W[BF1E\DI1E,QB&*035&V:\.65RGJ`GBD+AMWY2)S%RA<:I]6:GA'-6PJ M!E$,LH%JCJDLN5*#*F<6.WF'OCI+4A+3E)'DB4Z(NEQ6S;A$[721.K-0ZZ[6 M_7+6O>FHY:[Z?EA?=[]VXJ#4X&6NN[32(&JU:[#:+6G^]KDL=XEW%52U476, M4-E:0VM7(_L:#EVN0ET5QCQ>A:*M7+N)QB60LL+7D0^G92UXKFSW2HFY$O-Z M7)I1N-W_??[WA7Q M!_`#]=(;JZ_9CMWI-O1>1[-Z35/O]TVWXUJ-?M=QVXVKMR_H7J3AO3]F"?G` MGLCG:$S7KT%A>."'[&;$^#+KAO;=CP5Q^,\T2?WALZREY(]/XE,/43#(DN"` M8(13C+QG%.DU9N&6YMB;X'_!S#I&WE?@Q'_R0^!48&\+WI')K^V4+,&_YSR9 M"&?ZC$,[8%X4T]2/PCO4).)3OTY#-A]<$;Q;&OH>% MI<4K8QK_EW%%0A+F36-^60Y>\Q@,@E]AS""FPU24:N2./+&0Q#8)G0B>3./KFCWE):W@?1`,@R9Z'*"E?45+^Q]Z5]CAN)-GO M"^Q_(!HS0"\@M_-F9N_80)),>GO@H^WNQ6(^-5@2JXJVCC(I=;GFUV\D=5:Q M#E$B)4J5QMA3.DAE1,9[<60RLO`NTGXR*U(K@Y6MN)[D4QCDU([L;O$N?'R9 MC8&XLF3H96.0:%9"ZYU7G=530M'#C(>"B M._!=C&R.(2LJ9AV>?GFRT]^F8UFPR).$,=F.J4H6&:3V2\"W`V]6V'?_ MG$WL+>>>Q[L!=P0WS<9>XH&[`:;JVW,0EA^O;SNY*-*\]$GPY9L9<-IE/AEY MR=3?%1JJ^?=7F?]ZSEC3L9%!HF5]3\3<#/>C^G7=.B1QS,ILD7X`(B8P<`2"!62 MJSR=IS,6&,V0,>VNGR#O5*-#V^0ET"K$;_-0;LVR[TK^7;]>1VF;4W>;%)OT M>G%WGV$7U&I/D,DL!=C2RL.IO\>VQ1:$B9?L"V:2YG,R6P]SM)'IEA,P6%4+ MO*M9-K#5AG?W(]25?)`H+'.)"HFLTX=BD3YL_.@`_H4ASM_/TV')V)!TE,G# MW$6-D]/GV[CJ@V%J;Y.\/"2H;+@S3\+Z=V`5ZP.%:GAAN&V1P4"2?#.O*NUD MW*1C?K=F-VL,Q>K*!X:W]-$[V]IQW+KG_99>V@%/O'B5J/X,^O8P.*4W_Y,. MKNP4:*O0,M_JO2E1"IE'J9KE=L[MYW_.$F!\N&!Q^`8L97 M&?"?+@IPK;K?GXUF0YM-Z7G%9@[Q>Y7S#W9J?F5?%O?[\LS]@KN?DM\G>3A, MBD+_E16K:T+`ZV24YC]FQ;3X*1U=I/D;((H^>,]A\=V;;\1&45[%G!G!,`^1 MU,PPXV-9%N5%Z&L6Q&^`>;/YV&;%X,WW4M#Y/&UHI[;(W5/9YSP9I-9+%7H\ M*%_\G(S2EY071T*0.`QUI'P_Y#$7))@KCRL?Q^JA\K@Z1]V53UP__/8+FA,: M%#$,`H)C$1D=BB#6$5/$GXL(HA/,*R)2BKLHX[[XVH70::R$$50J M1B56<41B39:Z(R%'#W4GQ#EJKD[D9<)(YHS:.Q'VERYX8]Y+&`B&4T7'@ MJS`,,.,45!92PV40QI*;BL;.BL9W4!CU?1[&V`"+2Q6P2%I2"FD4>&,BD,Q5I*$:0:4H2!]H2 M)Q4((OY%AA[XU."H*G*M%/WI8>XMJJV7UQ*5:A$31F(P:BZP41#!1DM1$97! M0U'9PEWL)RH,-$=/#T M#7$:LB!0$*,30#W#.B++H@B'M'^_&+,4]-AJJ9.;Q>#;%%&Q9`BX`$58A7*9 MS2JF*XQ`$:G#?DWIXVE&(U$0X5AS+'P!\1O7,5\F7CPT%?+F\)5#C_^0JQRQ M#UR.("[C.`XU$!\U:/GH`4)Q996#4ICY$]/'?DFFH-C'`0^T8C+@!J*:""\) M()*T&MKA.G[AJ`2P0SZD900HX0P"'RD-C2*I;1P4(9@FQDBE-H,1KY-"=H(/ M=\MV##*Q+WS"(LTA%=`:=+)2>`5+2"C[,H<"2A6@FL*^8A8P$@H MC67%1Y-:M86F[.9IEZ%]PRC6L8DH%F.[I*:B6*0H8&B$IAS+!DBD1HD0;Y\):IX)(@6<=-'UT7=1E< M\D@:S%7`XB@.M*"*!$D*61H."1]!C527Z.II0=\D#"E$9"1-3(4#*?Q38OM'D@,`HFLKI7 M$9$Z\?#1X;*;?=!8^E+$"G)C;;,:2&%6.V(LFU3L`Q\4-$?9"FQ8#$K@@HHP MHEI+N5P_1P'83K76AD_+3O9*BB-$(JPQC[15#58,X7"9%'.)*EDEJ[.M[FBZ MV8%.[**L32'!RU`I$)B+H"6=J)@H75V1`=S4*0\"G6D2UQSCKY4WFAV',M$^Y M[RO)0S]4RU@EY,B\^?XC^]=6RGA.P.YJZ=$X=UUYBV40,!QR#O&<3WT4JF@5 MR=$0@W;4.6OG!5>^#FE\C")C][T+9&B@[0Z*I:="0-*@)\S/45'/\?7:CS-- M)):Q'T/<)WU,P\`P$V`&H!,<`K[O/Q+_'+7S8@*U+K1P7Q`:B$C[X#RCR%>$ M+VF:^+ZV!B3.645;>KEUI=$81A0+(FE,&$DI9+#:QZ!5R=NT>7T5_60X_VB+ MKH;@32+*.3?&5R)D$5#$8FL@?&)\UGI7PXX\O.V%D]%-,KY;';'F_W?A79:Z M].[2)/.)1_,[S_G=<=@$J6PO<9D5J M']Q/![VR.T1NGZI/Q[93P73B)=Y-8ON%SFR[@O)'BFO[K5&:S)_&?V%,M9\# MWC"-^T;SPV0R*%L"U"I&(VHHP;&$8)X1$W.*>!`A\#&:1E$05DI*$.55*J_+ M7]YV/,\5]@6)C8^YB;6A"/ZC8HJ7X]$2/[)>PZI/0.TPH-+!!+8K!4R\[O\Y MRXILC<\(@I9LW+=OK+R1GC>U^RWM3Z[&MO^"+GZYW+@R2J8`?#VPUI\.YKRR M8J%'?FEUXS`%X\LF+^WY)ER:D(6AEESXTF!DL/1#221,6QA5GB%D"%42LQIZ M6MA1G%Z(G57U,4^_9I-9,;Q[5FF-JTH&D+'2*(R%[Q-P?#Q2$:B*0N0DHDII;@?%^V-/MIF*'HXG/1+/S&WHPV?WJ!^XLA$1.$(4Z7B"$4, M_FOU$U.?!;2ZU8C1?2RIDK9_FL*D6\F6DGQ*KTI!5V)87>79Q4<.8OM]Y"Y!-$U64#Y%>R]5TF?7NIUI'(MC)AI)AO(H95 M&`*BK)U,)]SP=1&5+E^=CQ98G M,$`D4)$.`@ZAIQ](%@JT-$L15_>=5'=8/"?4_N(_'6SX)J!A3`%6X!?@'[9L M`1'Z!JO*?I]##[Q5$T6&,@-YH#+&:`(2"Q8N82=53!X*OY_4XX?IT`<(B[/< M"E&5GOU*GYNV0$BNE`QA_(`K1>-0$Q(2+#CP!0R^2NU/3MLSP]I6D&+=D:=6 M*WJAB&"8AE$D".>"AVQ55@\)L-ZYM:)?D;'-N=8Z].9*[($TTYV[AQTZV0RO M8?3SAK&/-#^W+;BNEM*6[<02VP`18KG;XGVC'=*VF/=[YU.@96*^4(Q]O?E# M8]OT;7CO"`MLO[.Z\;Q)>S\=#A??^>X-^#+[NKA)^LO7]2WV-AM,K^%/D'-Q M]$@?])7<%.G[Y1^;DUP>);(>U.9YPNOC2,BCAVIL<21Q.9COW@CR]Q=/.KE_ MFLCB0KSK=>C0/^@$/$D!=SI+^_"']SU]]H_:C8#5TKF4WWZ?3>'F_?F-WGX8 M>Z-Y=]SBOYZOJ>UX`-"]LY2JAR(=YAR@#97V@<#3O%V?O9D-;.NX#CS$5;A; M8]*[-M&G=@BF`\US%KE.Q1QD'&0<9+:!S`1<^;;:K!?]@%K:/KROZXPA7[:ND:[,O;VNU>.%W?'K MCFDY)IAS3.*9Q3..8IE6F43U%?,5D72I'[Z^_]>+F8DE\E](` M>:$TL(O*:B3Z+7CKQI+(KLQSVQ[9.=XSAL-J#SAIS%X<+APN3AX7SDUTOL3= M%<5N;'*'4*MO=UN5^ZZ6YX"V@:=&57M4H#'&74;C:B?=<57G`ZT68CL',04EZ>H3VA0UNX7V M):V[[2C[:.\LMJO('F]P"^ZN&NN*[;1>F3H=&NQ<@.*8SC'=/MK"/8SC'=F3(=ZC':4L7U%5+=1K;[;=G'YK'O'VQ@=5O]M-K/2!>V9U%E MO$_=ZH5F/@OS6=C5_$-[DV5[HO%6*=T@[4_RTCN;M(W2M;5B7]_FPT&R;3=+#N596M>[(-)T4!XI;=JQKY MV;]1L6S0TLSD96-O,LN]=;<%;]77P"OF[?&>;ZZ\#P(I:1B!'\:7UBC*]+1.1>E8[U8$^_O=$>"GQ\;7#+#,9M>=C?^G"W M]SRT;VM[]G+:B?VZU_VM%7;<2.GO-1Z-;$J1E[V@=VE`>F*JO:^3@]KV_Y5O MO/!H?3>&JF$ZDZOT!$:Z.I3L!,:Z>6[:"0QW?A[""0STK3V([-1(J[&FB]T- M9TXCECZBX?Z03XKGF]AV8YSAXGR($QCJ_*BVTZ("A_97@7:]7K(Z#2!M%ZPX M.#DX'<-`:YRWY%RG,=1752>0E5>U_XQ$L[+-+]UI?-/J;A3%#:OHSU$ M2.L:ZAWI M(>G:U#JF.2>FZ?KYQMVAH38TU4921F5SO>E.VFH<@3D"ZX@I.@+;/M>3HKD. M8(WF>B=A:2X1/"MVZXI9=8+`.L-1I,=)<[V[NC[W^\91K_V\DD]I_C7KIUYR ME:=I>3+),:FFR\NV6)RN9CKGI-;]C<[N3-%>@ST6NL(2;6>K#A%GC(BW6#:V MY<6M@SFXG#E<)&EL&:!RYG"1 MS6T#[HKA'[[FV:'UEC85^_$ZR4=)_\X;9OUT7*3NV9;:BP^'VPKKV'J+HU:; M5.*QRZK!M[]5(^QO*NH(BY]4@U:NA]K.UKJ#H\*7N\ZIH?\Z303I*\C^* M\LS9J7WIC9-1HWMM+1%:YH.X-P>#AC/+P5C04E M+NQW:#ESM%#46&&J*X;OO(?#PQ[15&/5)(<'AX>3Q\-;[IZ8KC.1XZE7].*%L%N/_@R&/N816'+(>L5L)%MZG70=73BTO6*T8=3')Y>.Y[> M\L:V:[IHT*'-H>UY[X5=+:/]S=/W-$,JFNG0:L]#Q=\?`8.[-3D5GR?39-B. M_9V4EM>ZD;NI5.Y%?^>BUL[YE;T4NXO^.K^\U]QAK/N:Y2D47=;0 M6%=LI^VT\X28KE6K.[:>'?&]>N)[BWNLK;K:#BI[W06"$^)%%P$Z(CPK(F0] MJM#1-=85VSEV9.*8SC&=8[IVF$[T*&^I%NV8SC&=8SK'=!UA.DAN*6WN`6"7 MW#HB=$38#;-T1%AO>0,U=_SRJP_Y-O8E?#M-+H;I8]\_V,`VE#;,QNDWUVG) M>9B@OS^T22S`*#^M>-/=#9 MFUQZV7B:C*\R4)^7%$4Z+;S;I/`JHM;\R87%+4RQ%&R0]B=Y^?/OK4H7_($I M\N!&0WA[W]\L;UB>ZW&PT?NXV<%?3G)O>IUZ?\Z2?)KFA9>"-1Q.GG_.QNG: M,5+4\PC"U6<(.S\O,.IJ9KW+J-]YG@%LCI(IS$(R'L^2H9<\`228MV*%H:R` MOV`ZAQ"^%.\/9Y!4-B/XTJQ[AQLZ>^3(A%,9.JGV8-DO*#V"#+A:=M]'_8HU\R<9Z.$NN2RI4F_>L%YKUB9N,JZ]^].P@8"G@3HJZK M:_MM=5@MD!Y]I'GD7GJP3]>GR24X(^!"/1P^%B_`-T`+%[^G_:DWG=PG2&!! MT%,C8SH7[_13DO>O-P3!#0KR[OG@>?'W/[Z=%=]<)#SZL M)E:7\QIE17\X*69Y^AE$"8:3_A_?_^=_>-X_'E[[87239'DZT/W^;#0;6E\Y M?VL$@>R/DZ*`'&-LU?%;>OG=F_B#1=&O^,OB-E\^3>$*^]5@5D#@7!2?TBO[ MLM!_9<674?^/+^LFQ9\FPYG59O%3.KI(\_\G[UI[VTBRZU\AC/V0`)91[P<6 M&:">B8%9RV,I&>1CFVQ)G:782I.TK'^?6]ULDE+Q(5*TI7%F![.6V"3O/?== M=:K\;@``0W4>3__MW9EX-ZA&\/G%<';&,5;$BJB9\S$2+$S0QGI'@@T.:_5N M,)]4G3SSZ>C=;U1T5LN!V:OJN-()'0:"/CP0E% MT`_'Y/,<_+Z8EO`VF$IGD##-*(T^K6*/\?"=C_QQZ;>KPXPT3%(7E0M2>.P] M5HY2R5R@*O*GZC#&M^FS4[`3ZG*`>2'X9DWUM37L6": M)T2H!TL*YO_:B!R1!"(-,B)*N),&W)P[PA(>'`"AX#I/\3@-#I=-,9F.VYS_ M^BZAI7111`&^((5B3'+!VI@71CI/1.82>)M';%;K%!!L%5YY$2/&C$?EI10: M2ZX[X:T4&)E,^*WN_..$_Z$.C`0E(GBFB!)(4INBN`=`6T,R`%ZD?P.)^W-3 M7U6S7%FVVU(F!$,1]]H*Y^`/&/[;X/7 M[`'264$7!RLHB M@SP5O18QY-T7PQGHI]?"EC#2E=USE\7WA`2%$"H(Y-R1$)>72Z3QR^JGZ$-N'JW^T.J^(VQ[G M#]"U,VH"4=[%"(%(M>UQ,Q"[.6[D#>,&3XSG:57@'%3-.5S8"#K/J.4$8(;`(`93YCT"'5=A=!0Q^UC M%."KVF^!HOU!X4.`>"3DB37,PV)=0Z("=Y1@,)]DFEJ)G.SL[+U5R.W04/U, M#7T%?6`Y.DK'R%-/3Y!%C#K$HXS2]IU]%)+LT)$=J..ZF"?7O,BXC048* MBJ3D"MYAX3RM'J`SZ5L_,KJ"<'9W!ED,-2!HVA M-Q!>&(YB7_0LM*Q/<])9UN0?(MXI%=N3;*76G$G&B642.XH%8F8YO1F;+3>= MX5?2[$7)-$"?YSEW/%C(+I9C;TUOON!"W.:@9^@#$L=I^NRL\R*U=VL'K6MV`NJ]MR.OA4W@^^U+?%=F;B+E+0 M!@+0B?@^[8_WW5=]K<>C[H,ZO`;MT//79C*=9$OQ#7!BW@_NR\%-\1,WB/FI MM\G!$/-)`]]U/8$G1H,9=`I?RTEY5/$`BBOKLKAK/K6O0J"E>\'U=5@![JH,B(3Z=%3-(F6V0C*O;:K9NDTW(Z[?9&KJ"0M[JZ8E*,BL$7 MP#K!:*[+R?!A\"]=^E2$H+^[+V;Y$_[[O[8TFP+PGA7CD_%$_D;$B6F93=EN M/$7!Q\`O\=MC1%T[T;5$GOCN4(FJ[QZAL7+S?E==&,NFQ5M6[>._): M$KNJFNFLYZKV_*BVJ&W]VC9XMJG9PMQ^>-VKQM801.JQWWU803BXA,?GXXZI MN98C5[Q,@&]>]DD0'H"'(9T#5BFIIX\%*9O4^79_!@GR9/_AKQW%EPLD$[2= M#TW!A^LAX-D:K4FLMI;G.BBNF[+=S5P9K%VKG(`)^^B^*)MOR;CKX?WQR\6C M\`88I^5LEKAB8_#8^0R*TZ1UJX4]UDV^,6R02+PSR-F]T5J+IB2^$K$?Y@`"DYS7!@PWK99+25Z/GJ[AEB'M?K[L7T(5"J&Y@.'TT9 MBU_M*NKRM"D94B*$ZJQ<;U8&HU5NZK/2K(.G2=GHKBF_I:H-K<^V?F+U$8.YTT#WP&JEM_AC9.$2W*G__QP\0&R8'.WL-%ZF@,\Y\UDVA9E MB#RY'H8:?"Y]/!3P71_?9O(*,LC';1^+\7I1I/"Q'R?08!4-?%9*$O\#-IR. MJF';;'4EL:\^*5U5=6O3-DND`)C4@S&T:6#I-09J)U.KWR_0>C4E&"M5J\6V M5ZKO4(^*<=MN)HXNX#,"[QU6T&^EWT$[NZEZK=?N17PL$O\R%#9,.#]QUO[; M:>;J#33ZK^VV+T#WL![M[]<[NRWX+M(PS`:C!$>Z.WG2'K1KW[?*R0FG>KF" M!6`/S.S76*38C%T:[U,SNJQ6V[QS^VC9S6$=^C]ONA3Y2?0739<',JYW+5MN M6>`,JW36GT8ZO_J\6!S(R<0;V&G+CS*+0?5A24OK>N]%4]=-;&;58^]AJ&&D M*=+68,Z=IQ1KKX*2T+3%$(1@(>-7B8Q@^'PM]Z/S>U5\K<:@'7SC?#):<=W2 M4O-%VXBFG_Z$GO:R'=R7<.RFJ&^!;_5RUQHO0%PTQE"(]Q%4!4.>4*(5)A3# M_Y/(1?3:Q$3XB]D6&7D6>,>#L!_@SWU@=^<%VH@/BSIQZ`:A"]Y2@X4P(KE% MHG(O>`C$LD!S-L9SE-\AX%;MVE?MHH4\=/]6VA"H3PQ;P;PD$7.EE]L(PF8D M8RQWZ;$NRI'R[B/5*D*UQ8%&!B%J%$%&](PAQ4Q&F\=J"\EJO[SM).T7$_7' MR8)#/?U"0+R/E4"O.E'Z)!*=KL1=*P>T7(C08E@C#!,"?!TWKN] MTB0+7KHI=>V7ZR2J[/$K*@/#CF`O+?&2:XC;CF,BG!3:V9RH0#>%\,N5\>55 M"5/5:(V<>+`RS#N/$$BO,%6::Z&)O`0`NM@ M,([3T2NU=#(>8^9D9_H9`?\"7?J5KX-K!'B,X0ZIZ$#RR!'GRZ#'@[57JA%6&U8%NX)H\`P'S)&+@@F(ZR5Q-;B\ MR=#H&>GV`-G;OV-[0<^87+OBKIH5XT_EX=V29=RD`B$Y"M&BMJ+WN=89FMF` MHF=DIVW2G4ZK?4<1G2;*2$&8IQQ[K3DU/=^4:)UQ^,AS7.M8K;ZT>W2IWAP> M(M([+#&BU`=&A*#6<]&32J4167>"Z3.ZDS6!7B3['B.`>,A1"&6AP01!19BD M^B0+.N6G+O2+94]C5#%V]>UM/6D)2M/'9&]7C,?G=^UZ$(PC?Q9-4QQS#@X1 MXX0//HT:%E$EE%LP*;D&_UHGP4Y;*<##-JIVG+P_4/$][@BS%,134(Y%JY6$ MXAE#K[C$CPYPOA'%V]]9<)T1]'SI89,^ZKK<M`B>>(@?0Y'5P4H1*:C@@HTV&R,V31&[17JI`GMPUXXP$9PC-KC(A2<, MAKE6`6\5RTO;RR7/NJ#%BN@.$4/4GGJ,I9`V$N20ZV-41YTO*S%,-HP'JZ\_ M1##V!]NQ0LVD0LPZCPWX(TST""^3!X[9651,*=IN_TRP?K&U6W&\F-7#?][4 MXU'93,/_SK>M*V]'$0I<%`@,&YE/EH:LW_=?0=)L.9U#NL\FQ7TBO52!76BG M\]]>H<2?!C6@;G&\5,!BG"N0SO2?3`'7;4H?B#FB6)+@$>%:61P147+MBH1L MQ81HDE\TD`MQN)"[<$6.4VL#Y%FMA4'&JY60:8DD%Y+GE>(`(<^O?#6]JZ?% M^-^;>GZW/-.XD:Y_&-Y.,1>U:3>-0$9"C:!+O%U^9!6S+$\<*^B/4G>GY:B- M#@4=`SB75Q(;Y>"_C%.8#27-$B-A6?8YE;J3\OS*->6HFH%D[0Z1:3=@S]=H M63NWP9Z\N=]![)>?5\/210$#4_] M)!17BBKKH"NEBDI$9+_"B@$DG;5XKX[`&_(B[X)2R&N-@Z7"*(V4:KW(IU;? MY;O0?$.&^LMB^"R_6SZ5AI:/D^FLF;?C8?]M6][LYV4LOS;SHGFXO*\O;^KY M%/0*B6!6EI/<+!\_Q?7.-5)L:8#>!$N)O$PWV"DG84`4QD2977_T:V3&E^4! M:":PD-I@)'%`PBHII?(,.CMON*#Y`J;Z?^?+VRY$T;DB-DA$O34<:>>1@I3$4Y\" M4Y2BFDJ%WOV6CH&DFXBK-*$MQ6O/KR1>^7`A^G0W*+F&IT$%W/2_3X\*2@PB M$AQ1VGIB-/%I=S5&*'XP#7#]FJB$Y:E47\Q*O-=1?I'@71$FL(DP^A.DJ$4* M)A')%%8(FCH8PZ*E:9<"JS-$SHC:C?X3)$\/_8F\44=.$(,1+$"!"-Y3"-/E M-9"4FE9C=H;Q&>:OK/%KS%]K=14&=$F%)#;Q11F1`89680D+46BN6ISX&=)G M=$\*?PW/>&93L2*O6"QI3%1G3AU56(C%K6LPFZ?+$5MM1=*6T!-KVV\W?8'' M?3D=-M5=OH+W8[16U`68GJ5VAGIF`H%*!?6*IPMDJ$N9^6M9-*MC$U_3MN-@ M?I?^3I$J43_:4SJ_UY-1/>G.7GXM)O\%NPV`_B/XKOU>W\UM9-4]]W5!1X91]E_B3CB7JT^9C8OY1RZ#RQQU*(Q:5N M`EFE?+[#U%\QNR>$MJGW$X$Y:EHYD^O>AC#E5$0D,.YZ7 MK,\W!LXOT@-L6Z4,FF.,N!0!$^>(IM8JBF*0QE@MUW=QRGGS[C?^-CWX#:U= M2AA)I1):<1N5991#@5$4\\`=A,+3>\@2#7W#UMTO@NC+TJL@C!A"4@M"N60P M:7$)OAD23]:)#3=EHY,Z9SVYOBR;VQ2,IX8J??9L\=F7#W?E\O%8SYO/-53@ M6+6DB&&ZO1T*[A2"W$!9'5_>PV\>+JKO:Z%^D8C*SXAU%D*$'E@J"^X9=+JX M':MT5DYJX7"^>BM)OC>S!LI;@>LQ2N<0K?#>/OVMPU1]?PY(42>4K./,"!A: MH[0A@80E(5&3+'PW)<17`2D10KI#=4N(EI&Y.%M?)I`NRN&\NQ9H#Q*&,H\D%'!R.G]YNGV]GA:8%>E^1Z<,4<&$&)BS6#'D M%*=I%28GJ+&3VFBK8`8Q%X7`U%M,O$UWS6L(L!"(@&`C&P0CQPIV%&,#2Q#% M*Z=B`,&L4=@O"%%2*VIS^5C.A]H@Q!%2[B)C2$DA0T5H$;T),+I[TU^"R#6* M,>L;\PNQ3R/CRQ9Q7R?#:RMX!-$M`2\,`NJE%VV&YQ&S@/,,3[-K_M\^>*?- M]S8-P@YKS+VD#L"B5+?YGENK_09^6_XW([P%R$Z>_<$S%/7*&!.\QB0JXGB; M_8F)V.&,OH#)!E+4(<"D:^B/(LNQM/\5#8=_`Q541X=[\A;DNEQ0@#K?)=PH MR''"[DK!7AOA!:"8CH1HKUV@H:?/2\6S'3P%%?@X6:?3[E+Q]O8$7]P6U^7T M(EUQ,_NO8OS,LW;T$2W<4L>]DL@0Q+#F(#A$`N.&.*9(?#HH=M;)=8&"HN$_\7_8^]:F]LXENM?0:GBJINJ2)[WPRY_F.>-*K$D M6W;R,;4"EA1R(8#9!2WS_OK,[&*!!08@7@L2E-=5MD$26'3W]/1TS_2<0[$6 M/HQ`TIF$*>M0@?CCVVG=YGQ\2SY7S$DGG`$>A8&0&/IF220$)Z+OEKHMQAGR M[FD.#X6%8!!Q8IFT7EL6[-U<(8`.)3%U2P5\HMCO[F-0>W\3[W!.1X=>;5H_ MTA0@U.W":A_O=1AA*84D>+IT%'-H77N.KKXF*K%3_%2J=25^SN8Q*#^\O_&S M(A_?3NM@&9PL:/Q'%B%[/&E\TBE<$=3?6D7_/ M1[>Q>3,L,;-2O\6O6/OWS>!H+[_3(,%Y%1IA1 M!T-IJJ$.%88@2JO@-\'VLCE\P*]Q"[7[(*N]5$._B]A.C:WW&[;>T=ARWF0&Q!8@93"1$%>&1J"+ MT#">5H!#VYF<]EXR<90Q:S6BL8#`T.K(9BL$Q)!A9)-+Y)#+9*]D4X)CY7OT MA@,*^8X+R3'$7$,&-!6\E@\P;UEZ&,/%F?*=QH"`JJUS`YP.!:MD*N(U6$", M\I8*:NG%&1`N2G>PSK0U:$SUPJD/YH,(]3=H$/XJ^,;9UVE$[;V[*V9_5K!I MDX?K!('E](W\KAOPO0@:7=?F#=XPY#^6:PC#$8CPYC[BW(]J#I'8`/5E-AW4 MEX0;`-ZO604K^B4KPI<.9I_FV3B:L\$HC1B'S8E?9?)!MMHG:#"XP[_3M>]> M^Z9*DF%>Q"?':?E'>%G!^G^*VRHM56HLU&IC:C6Z5==67J$DAGRVPMF^R8OZ MH7?9^`CRB"?%^\6H6[S?:+JL_%Q!L,UV MJ,MQ[-/\.2O"6&)81_L%!'---1+'O$XAEQBUJU%>MA6%ORP<(T*QQC?E];7> M8U!]GS9P=&O'&-YK`/"X1I9K@/\AEOP\_(^\+,.7M5>1LG7EN/6'*MR^K@)1 M!<83AB->1U]`)F# M%Q'#=Q)-'`N\>T#2_'B676^);8($'0]'`8R7`#'%&-)*8)UI]8^ MC*!07R.HK!46&>8L.47D*1SF&5JM M""B/%AQ@01$A@CJ!C24V;IDUU<(@RX.5/:#)KMXN MN8_G6^]`MSUCHQT0*C;^:.&H@CZXOVITLR[=L4PN)9^MX==%KVWDI2]FT_!R M6,.:J6E$@HI5Q!)'NGI/R&K'=Z%P.&9#46NB$(G0$R$4RXB^W72A*VZQ8Q?? M4'SF+;I6(AWK@_&P?I*Y_W(_J?;!![_%.F!2P\BL@/G+'[:0U)R2,+^=[N%E MRT:SNUA+9%_B7M)H<'L_'E47`F.F?9?%WH:U2BA;>L0R%Q^NM)FWM,F6VM27 M6$+M5+-^-/MDS098>?^I'(_&606$&YYY&X%LXALBL]N\IE>,Q&SQ"^-IPB#2 M5<:"M=*D*M^:[IO!EO=MDL(EFA9YM7M45LH4H3;.:HZ;2&^R7[=0JLT&TU75 M-YM&,JF[V72Y3Q<%C3K.LX9F<_F7R?C_HA2-1;+!MB*P5FIII8?ZEL^!5FIK MKR;EK"(5W:EQI&2KKQ#-X@6B\&)6M+A6K:61RVS>$T6F78E7\G1MC.AK'+9[Y@DPM$C*&*9)-ECLEFQ0^6SG5 MCBPGNXBI&U$Z/*/)7^IH?RJLI`0.*6.\]XIJ&I;>D!8T/2',;;*4KYKY6]KM MDN5DD?<2(RB&*<."0XRPP*$Z%DW;#?8N.31+,\(#)5ZTAY@X*C$&O9W^=]PP M=97KU?GC1DJ[.(_T^2=V?-/@[M87@PU$5"A.`%=:.ZVP$1))(BD3GK03MLJ% MBH?8)=Q2^"!-UK5?YL<+VQR?9D*DL#:8&$2Y8QXXQTV#=6UPBN"-($B:ZA(I MCA9R'SL%"84MI:&N$(9J:S33 M(XB;IM$P61/,DY1CILLAN:BJ$7I38PH]4SA$6Z?#"#=7%#1.027#++D"79MW M+9_<_'6/MHYI$]P22C,+RR1ATG'-`E)668--HRP1, MJ3W@[C7I:0/4*=I:&_(%"@BRCC)"("9P@8?.)!`VN5K$4TC1_=I&"`*U/&Y> MT$\%!)/,,R.Q0A8;HJ6BS7:`)"*EQ4@VI+9+<9JDCW5L(2\,`Q%'23$3 M0:XL)$UL`$(D0?]U&@@/EK2JWTZ]?P&#W2R`W$>,%:_"8JS#V@P<%Y(3HY,@ M%FERMXNZ(<9)DCXV^"ID-"ADN"S&'X:4A=HO)74B<=*H^*F21E2B(O\O=&*6.V[9!6G<"C.6KLPJTV8=_G\_Z9=]8G?I:>43RKOJ>;OO[ROV?C:;6!6822:7I;LQ'7AY=!D../ M$8Q'6$,:*5L$0>-2J]8GV7,0S1X:OOLHWKT#.N0OFJ/7V53U?/^#`+JV<^']?4'@L> MR@^3(%00-#CXAT@7OJ!C->&]-31!X_G''U$$!PN)DL,BXG;04$D"T3"("633 MZ)%7\AH[&/%$T+!CB+-Q&1PSSF0:`I\F/S=\GRCM M?T@NY3Z_SH>/@:X(Z7_-AY.L+,.8A3$XTODUCAB^+7^ZS MR?CFH<)<*C_[R>QKO"FV%XO`B>"NH12C!B)KJ0>A,`ZF=EA;PXE-N_D.3JNO MPM*C?/P__YG?9I/ZF&3-KA^J`_#XA=ET'_)8\$-'#(KT1L%&DGA-:9,+,B12 M.,*45>I)[-2ZA+=RB/K28/Z(M?9U$?+(=H]#-"/6:8Z$I:;1'@IUWG)SD,@7 MM\"^EAZ`E?!.4$$5=A&1ND'"0%I+FG)3'S5-.C;!Z;L#QS<#>Z.-4-PK(`P@ M3'*S1'M5'*;A@QWE&Z=K\CS6VD>JC0BF$J&(IA*I=AUT:(F-2U,O2JD)G]M8 M)ZL.$8W`ER$CTIX)Z:24J)E`U*?%]'&J=ZG('H\7P%T=*K922@ MQJ6;Q_2H2K3[(;FF;$,K8)660&N"D0,ZO'"-\3A@R"M@`Z63JQ#>`7!'4+L M%81@#1AI(H>G*3_/<9'C#$V>R5S[#DN<]X!2ID)VSB-;3$A9&W,!QY*&@!U' MG,]EKM^G11X6F'_FHV8!>C]M)_N@\C#4IJH?X,=*A2]ND18QZZH&Z=LAJK9R3C"OO M%/5-_F$9-3*ET!1;>MMVRG*ZS(\=K1.DA$"8`H4MPQ:&X8#-N1ZF*@5ME7)[ MC76HS/&/(:D[K\&7"`F4CGT@G#`#J??2-]T@D;HS"4!X>\#>)LS),N\[KR<8 M"FDA19Q0*N).CUOYOMYRJW#[V<9^F3]D#U5C4"C9/A2S89Z/J@R[^G07USZ1 MP0Y!1:C23D:07R5MX">X/L!80&-ETNUEF M)$O2H-:6Y\,P[*4QE23*LALRJRL(:9WX0M2$4*69P4]X\+=)[P^W)D12J(+P6%XY;Q ML&S0YK(WT6F'#-TY[8\1_K>9JA%ZFJ['O/Q[L=DN:9>7*L"9MRK68.$%P5A@ MQDS(<"EP6C-KJ.4"0,>D3`'-R19*@7UZ'*QUE>+&[9#%7XX'=Z4A6FN,";4> M&B\1H=`T"Q`!)$E(>;+^'"->EXKMNZ%$!&(^I-@$ALP2`QJ\M+D"+H5,CT\N MJ5@(^'=Y,7^(%,25H0(:HS#241/>1&V@3+*KDP+_ M'2Y<=TKMN_Z!*G![!748,^:6$$BKF#3YW"G+R2+O"]Z26!49!9"BU"*(B0%+6!6< MWHC#.U>>?2(?4+R7IT%,4LTT"SZ##25`BLALHN*=!"V,!8:(B]\(WW+[^Z*H MDPM;#AJSO6BTR8AN=5?5W^/A(%_44,T]\%&];3FX6VC\J=9XW>9H;Q(N] M\`H#J\$ABXAG0C6<>"'6[_>"U\">-6HVJVAB+\HOK`,'I?44.G5="=XS;4 M9Y%7V^_QCXTO+WUXX=-+7]X`5XQ("DWF,UY@+LSNB_GG#=`%\OBE\B,#UT7G M>K3H=-=\C[?GUVS20IF3%(PN/OC/U8-K2,!A/IDL MWO/3*_"J^KF,7'B+GX]?`(,?WXZGM9#9_7S6_**HQ*I^\W4\FG_^0KE\761U2B_?2*R._6GM!Z]+:GK3X(3_S<4W\?^L;UP]^X?M_F M^.V:E8LH5$%4#[/)(A+4`?7'M;"(0HAKQ[SVSXL`W/Y5'93B;_:*V0K$LR#( M35@4?O@\'H7@V^F*MT*9>1SY9T1!NH=J'>@%@7#Z^.=J`]-O6?M\ZQ?%A6$JW#`&DJ,/DP]O3,M"HFFY+K[ M7D:0:7NP$S__9VVFPLE?]ZBM/B M9W#:U+R+;ZDV!)*ON#(?CYM5787/:[/NBXV]O1N?X,;X9;EQ[ZE_64_M`V[O MQM^`&Q\<<)^QL._,=W>GP>?[[@(4(TA0S@>OF\/(V""5]UX@.`H$T3'1\9"(>-V>$#_WJ1@,)V':_/0J,I>] M^GZIZ]7L%WV[ZVL??_KX$S\'^ZC31YT^ZO11YTFC3M=E]G6/?Q]U^JC31YWG MCSI]KG-,U#GMD#0;_B/RHDU'KQ>$UL-AGM_<7-7IZ/FV;:'-EQ67V5TQ^]]\ M.&_UJ\\^A:^N`'9.V?5$^W8]N[3S$?N7W4]*VMFDW&62:W&:2Z#]9 M^LG23Y;#)@OJ)\LQD^5;.W-:DP#&I[51:UY7O^G2T&U6P`CE M-1IDP_E]5HRSR6`R*\M_B[!+LV)0MCJ(&S2,_Q((XNS_*.M#ZW76U M?.O[%R]H2K_^X]Q.KGUC]Q/JV)E8'6"SH"G``-DW< MKO,Z+_/60*`W(%X[<[P+F/A%],UVUC=]J`5??%_UA4`34HN]"/^Y>*9Q=;'O MZA*./K#U@:V3+`[TD:V/;'UDNW;'["/;L1;K[!"_#VQ]8.L#6Q_8KB6P=7W' M]Z\=V%J;<]]7E#G;WO]D@K6,=I7<;)&O:741.#(!#H9%/@K_^Y+//\]&D5/I M?CZN6-8C^]*7/"MK`+GI(QMZ@QBK*XBY_,O=9/:0Y^42-(S_N.S?F(QO5D1P M:\10;P:#WW?W@>1E^*+(K1SE2,Q_6M7T72?/:0CK;HL\6U!3S=)'=YH,B_Y*- MI]$J-_?S^_#)QM+U0)6/\X@UKUO,CR=2.FX00T[RT6T^4I5"[V;SC_E=5@3S M3!Y^S>^"9OG(CZ?9=)C_F@_S\1]QSFYP=[^M22&7!+^F=C%I[5O"_E_'W[SK>IY:UE6``/(:`:(FVD]9A#HC1&'$JTR939 MIL@\0<5+&(G\0BYL)&^]4PX'.P$AK=7.41Z,1)V@TDFB+VND(K_)BZ!711O] M(2O>%Q_GD7WOO^*L^9`7'S\G%*D+W]FM$=1<:&8D\A1#S`!7D#74W$:*#;+= MYDN"9F\`;"EWD&C=J!-&>;>(_.@I, M41UOL&O$UT9"@4'X+^?!0SBQP(E:5BD$P@G?^$Y!J^\^0;@-%U@3 MSDD1PIJ13A"L/%3".=4L.E@0ZF77W(=/;I*W_S][3]?D MJ)'D^T7.``J\LSOVC#V]SQ>T1+>X0Z`%J6=Z?_UE M`5)+0M\"J235/$PW:D"56?F=69G;,$FQZ0I$.MPQ"`LLT];1%).6::#&.'IL MK)!DV];4`A";,`ZRC!*'DH!Z5H`LV_8=?89QM"`G*B"LYOSY_8&(L_QS:7N# M39.`21\_@MLNS'ZG+_P[84?SJ.CE\:CT!;:/0N?,"3S.`]=VL-@*%/C!=`(] MB#ZS\U'H,GBM7I2/P=&ICP-4SHWPDH1=JPW`&P(_*TK!'9KBO)K/#-@%;W-8 MS]C6>C49U<^/0!K!9;D[>SM*>V[T,IEDPILM@CP;\O@Y`@P*[^W3HSLI`/VE MP]N@#.-/4E+&.NF'7<1,W_+`^G"9Z5+=\;`'YBWV7!.TSC*Y4]JD]JVK6@^& MT*'"E/_T^#%+G^ZC?,BCA_%Z^EX#A6'9GND0%UP-6+^A>SK7S0!,$S.P`YN2 M92C,34"L7M/Q,!B;8?`!^90ZR/9]\"TX<3BP:04#)S;=Z#&ULOI*T?X+>#'_ MD(II#K"9(+S*C]VPB/I>-A02K237-W!YJ6(^C:IYZ/L"SEG`="XL M7Y?Y!CB-R+',@"#D@$^-:9,$5]B_'<)S5M1MH7O7M$S&P4HQ;$*)[GH4\4I9 MZ<#)MK.,.K)"X9X%=1^%9/CT6,4>UH&]*40Q_=-?T7.6/,/W+M[3#$\LX`U[ M%+P6W216H+N$@*4"RKWV70SL>3ORV@(4;0$[%9M.[]^3N#JH-@O*U//M*^B. M1L_L+B$A/J3%.)\(_3/[MC4/\TD41`_Y),Q?[K]F]X-L4H!A[@O5#]IT6V"( MVI;IZ^#LZI;N6C9XCI@PS^("9@ST1`?$<*M7A@4>YPZGH> M!0?0Q-1B!%'P!\%-\1I"T:)L$VO+BZ[C&-E@S/#]P`!EB8D;Z+KE@\O&#--S M+08TM8PF1%=8ZVVCR=@JO0X*L"XJ31[8Q'<8LA@-D$>H[6+&"?%=;F#.&Y)_ M9=2H8_IH"W!]7G*;+D$ZM4R3NQ:WP"7SJK`E]3T?Q,A)Q%I<4Q M,CV3Z-RDCN^[H*GXU(L+.&U96'X.7X3\+X(L+SW6*LP.BW9Z8```?Z_R+[98 M*)Z#+(0HIS9W?7`>`NKBJ84"]HJY#`'>:)KOL,*6P=MFNX*`=BT,@)G<$I$# M6B<%J,<-TZ(-V]7J#+PO@RP?'^Q!!;9#L>%Q'`0.]A'!F-?I``26Y')VX\VO M-MH(R<)B#E[S%N0CK@>!3@(6P')]V_6<@$[7C%C0%/Z;9>#F-3_&XX]9L3^% M&!RYAF,%KLL=9IHX<'1_*K!TRVPHZ%#?LBAQ=-T) M`J0C8A#"=9T[&/2[V=Q?C/55VGWM:HY9]Z80(L4.LX1-BTV#8<9T+]"GZ^:T MF?O$\._P=<]E0>%O!\4\#4P#@X"O34S.10+*<&=19L-I1IF1@6RRO.*5ZSAH MJ1MI@O``<]^S#8\$8.UXU`FF,6;=;Q(N,FS\BG5YLL2P[S`P\9\+]I,6S;=)J(]!#;E`5I$U67M`GWHI%,LA2\W89FCG3L!K9(,6'# MT`,&MGL=>``EMLF@NU4T\^@1S-=^7494!IMV1C=8!#H!0\5%'K9<4,4.%FEK MW30IAP\:7M*[AAR^<*SWH_A_/D9/8>*GXV6?Y',H7B2^(DRWAB-\$V$C`+U& M,2:$(4S-F7@P2",K=EI$CFJ[^=/CY<9[#,X,RW(]<.ML-S`)L4T1[V$,I(3I M^8UXC]%PE-;B02IT'1?O8>!D.;X9$"+RX=CUP6:A@47M0.#-;_A;9(7N[QA+ MW=3387`=D`^N@VU:.F+(QQXGIK#:N,<\M"GNT3[$IPAP(9,3\*8YMSS+!6D3 M>(R\UJ?934.OZ=P=`O@Q64APH%VL@[-GV-1U';%,5V3PN.U;GN,V[?XMU+DV M?[?[BK.!NV\'E!H>%DY+O6*'@]+:MZ6E'<]$@$DS<*P`)#8QF3_5FA3Y#:UI-:/3 M.Z]9%#I$?3_,15UWL60_]9:Y>*M':#FV$QCPS]9-SL"$\OBT@(OA)F$@9-`5 M'N&V11T/Q"9?T75LGU.?F[KC<]?CENGJ4R`PY8VJ`(38*J+9#XA2QH%RB])) MU(@<[$(S.#`1<7QJ!!11@UO$K^0>#3R'-;/A8!XT4S]+B]ASA5LX$72PR:V` M.]PP05APAS$Z#4HCNYES`;^&-.CZN!6N\RFF%LJ7Z&DX\RF$+N)Q,<[CAXFP M6;YD2?ESFTML$N8"1Z)`%Z+0U@VF>R;CA#%B(H\V8V0$VPWR.3&7J8%Z!M"6@RL`4Y8@@DSE<;["^9>J-4'`;]+<' MU/=1;Y!F2?;TLNO>VAXEG@,$RUUN@0?C^U@7>TN0X7K,:9SA@"V7DX+[XGC? METG^)'[.W^/LO.$Z<@/@4(MY%#%.P9USS6E(#?FHJ5E)L^3QQ,CX`Q3AP!F" M4]@+#P,:[&>+&X%N8)!8C(%,:D;EA^PTRM\Q.5$G'@CI`7H!MA"R?!0P'+O(-:RJHF8\;@AJ@ MUQO&BAQPML#.L-V4$!^;'@9/V>:BDK!B9\;`26ZXR(@TDY(G1L;Q[&QA3P]\ MVW>);KHVMBS+\TIV=G3F!%;3)M'U9@#EQ%"WH*L-P]5=[NH43!6F4ST(,)[J M:LMCFZ("FX'M#:+^)(D^/>X0HA-9B'OAWL_.=>Y2GQ[X!G5Q0)@1^*;I$(!@ MEF_VC>[KTT]=B_ZAK"FOCO+FT5.85\=J!F'Z!+#$J?9[[Y]`)5DZ=P*ZT,)7 M]&N9P#^@=FX#ZG;WXHRU.$(G4JN-`>LR3)OA;ONSJ"+BI$ MHWQW_,U]U4)_"WUIBH"XGE]+*C"8+'1T0.*>V8O+@_Q:+TJ2^IZR>$A<%Z.P M-[W>GZ*&(4CDM%ID.!EGTP^J#B7E)U_C_GCPWC9_-&R$,0.;&%G4,+Z?=E/H MP1Z$HR)Z/_UE'H%E=X17*.:;A;YV6#!7MGW=H=]HN;1?WA#K^ZW-&Q:[2-0/ MHD.?PR?^PE-_GP+PX@$D)_G"%CH!-SNQG+\3\*N4M`]3C^*QZDK<_3X>P\M[ M]7RA#ZD&3R7"+MYG(M4,`K*M(_?IT;L9I;46;/ M4JU*J_9>M+DB!NTUK0XVQ1^537$??NNF[9`,]"Q=JS!%O)N(5[3Z":L60Q^K M]CY`M*+*21-E3EI5YW37[/2SQLH]\>H50RF&DI>A!'66E<1B3%KIZ6NOI5F" M;NOZ*ZTLP%+J05&S=-1\GX'YJ,T%K.;H^#5B4L6LM+>"V&]V>&.G^^"&B3A% MK(5C[? M4_.[).S-K.3,UV-XU%B2(DA)8:4&#I` M#!$EA%H10@>%B\XO@*85/ZSETJ=N8YVGB65*C2M%5XJN%%TINKH47"FZ4G35 M.JZN+4>WL`*$ETJCWY6?M(GQ3RO*R^,Z62K*S'_0'J+'+(_FVJ57G3R*S14W M:\@9;TMAM[DS>V2J.\AEM3AK67:'6CRG)0J>>:K4\RRJJVQ:5==WE">).V*Z# M>N.K4W!;<"0+)76MYY0Z4WRE^$KQE>*K%M'57AQ$<9/B)L5-BINZ=\`D"GAT MB=NM>;5SL.05Q4E:S*X=BC192$V%**]`6[:*Y/K+RDYIF[7/J?FVQ=3=L0C= M*[6W.T95WD]Q_(TIX_/SM"P=V=A>PAB7H;G2NGC#_F*21 M1O1V6\)T@5X)D%D^U]XAQ1V1=`EG%;'57GG$%K3(0@>=FQ32B2CI+`LE@Y0, MFF_;T-Z!Z1W1S$Q2(DJ)*#GQ=Q$A>YGD5Q<( MZZ)"WCH5SBZ"@EJ,:_U4#E):>?^*W^>&BATW-VS=$+(5@^<+]V7N:I_)8YC: MADT\Q#"G/B.>[GFNX=O,]YGE!LSJ?/+8$L,M#],ZR32R^T%43P6#E6C5V*QB M,AR&.=Q7:+!C&FQ7$@_C-,Q?Q*F"K!I8)L:,B6?#.->>PV02%=./PJ*(QF)B M&>Q*'O7+`P=)'#Z(8>\QW`9_GPS%YZ]/O&Z@U@=*^7'GT0V'XG2'[5I0,-(. M)*NGC=D_&HABW3`M1DQ,K1:GC>$CIXT9[-2CG(QKGU6E`&SE"Z]^&-?Q^9OR M=C6.J\N1%?;V?\^@YSB9%\J+]!4;"4PIOZ+^ZA6'Q^GOV M>#%0S9F6K^OG8**LL['??LZS9WA"C/)MLD='JQ2O+B:C-7P%?/%SPTYZ_29K M-*Y#1-5ZX47[.`N7)R^EBX,HT;BI8N#W*"PF>3E!6_L,CV7]^?F$BDP5F4I! MIM-S]Z_*KW9PYU2()C2'-J\BQ#T5-4=]-82J!N"29Z+*$R5X+W3TFKT=R\L!F62M_PE`F_W.4S*:>$'A'G7 M=#QO$YAI8OJ0T,>V@V07=QX,WQGM%2_+0JY=.SC*A+ABCFC/0E>&N&*6*V<6 MH3Y:.U`L"^F?Q6"4R%_M$K>_95G_:YPD77#/]9S2)W?44K-B5"A((M5T/ M9P?=84M54:A(@D2*ZGJ8ZZW17DM052BI&$\QWNY:#:N!LRJ$MS,*O;HJ<*[% MB_+!2@UVI]LJ:*&"%BIHL2/#*&91S**896?M@O36H@^WP3`J`+@>B5\&63ZN M8G\/69Z7[0"+ZE1';=^-X`;1PR![G(L3]J.'L?*G-G=>OK/M[FOY;H.#+XA9 M+U<77@_O57AB&.'NP]2R\-*Q$0W%8HK%E'J[(`/UNNS0CYV;EI?'8J2]P_JW MP4?RL?3>Q7&$"FHJ MOE!\H32%BEL>FU\&Z^N]IOV1I6)`=)XE":Q3^R#F0T5%1R>>;\G)HGI[Q2#* MR5(!$A4@N5P+4\4P%8LJ%E7J]2+5:PO#X;$$4V27<5E>QRFP>`>35?Z8A3FU MZ9"5%N.=)\>\+#3;WO"J'9%T"3.LC#NC/<]_&V)DH83.#1+IY)=T=LG)\5>_ M4]S15-*R$*9,(JH+A%V@O]7$W450DA)QMR?B9*$]F:28-()*&5K'I6!^&HO,?&+C2XN/.[W[R?YKV! M1M"=AG5D_-@:[_SMITGQ[BD,1^^_]`91?Y)$GQ[=20%H*0I'Q!V*6'0J*=R7 MN:M[0)*;9+W_^_6__TO3_M9\@Y<-`=!!E!;Q<_0A[67#Z&-6%/=B!;.'-9$U MA(N_HL=?W@0_+JTGYLX=QWC[DD.\U&?DK/;E)4?4MC[85@VA\FCIS`7[*5EU:0" MT0BL:F\3P.L/XBJ9E/>FB]G8>)J-G8T8'H??[K2'E_)U((O%#.)<3`P!JDO` M;Z2M3U%))!<&2A*,B>C_]Y>=E);I:-6-97V_IU*I'T0'/F>? M^/M._=QIX+N0@E[I/*G9&KO/Q:";^'+.E7+_IS$H+E MD&M^:1MH_YBDD4;TNP.L@AU(<`@$D$2=H+6KVJ8C#+7J2MS]/A[#RWO+)/OV M0ZK!\XFPBO8Q6&>PD'7T>U)$[Q[`.C^Y"Y.W&Z]9!C*65](J2CV`4G<^;[RW MXRY3C4NGYWVR'/":UMTR>R_:.`_3(JF\HK`O'+'AH>=[UI+T&9#&.]:+PW:53YJ81X7(@C4G^3BQPC>F/5G M@:`Z@C0.OVG1MU&4%M7QRC@IBXN^PUICTPZ-_A>3T88=W!!CMD;CA=`PO&A& M*2W(+Y5?FT/")>3/;#7)]P0D?F6:6(F`:Q(!;TW4-MBJ^/J2+/O:4L!ZRU;5 M35GY4B%1&L0I2KQE2CS6][STL-N_TCR"5_\GZFM/89P6&GB3Y1$3L5W:(.H_ M'=:/ MM-9'^\;/V%ZP'2V/JKD=OFLMB'+UC2*R-DC!5Y4;G%GX2D:1TB%,4 M=XZ0[TU$2YRAF%;^GW`ZL3SLC2=A'H>))J(F=]HHC[-<*Z+\.>Y%`$LQ+D,? M95%27#WT`*LOG]\2-OD.5;5'ADRU1_C0VJ/K;17UV>334 MU7&#:II]*F_C)O3MKN6]9TY!W%"KT-8<&-4F5/E_YTYAW`S?JB[@T@5R(U$:Q"E*O&5*/"#:ME?? MX?,'WZ51+H+L#ND&L+Z9_LDD#A#S.(!S^N(# M$;5*2T.@/"50C.%'U7$/7E0_#C?\J&E"O$P/$\S7YWP-BQ5K65'(\_K-.WQ? M:T;`JJD@.\WT6#<0A,?%*`,4_Y9GDU'Q83JM`CX6TBA.)U'_TPR.ZN5?IE"Z M81*FO>C+((K&3MIW@/C%;6$BG@;9.P$!ML]0$>(9Q".>A;#K<,^)HQ60X#/,704&`OTE2$5-_;D/F*$N+BRXFA)1B M?_<.S7-O;HA`*8>&`(*?XK1:9#@99],/*O^C_$3&N2+F5<[=>'T.7R5\JC1' MS179'5_EY7GGBG2(5BG/FU:7XO:%R2+=S1,Y*8(O;$J#FB.2:=\E213DNPX=#%Z?GS)0CK'2K(+#=),8[B;1CK+YTZ1#M<<\&Z[+HYV3V99==@=;U%[9E=JJV$ M\AXEL1^4%+HL*=1>;?;_LW=MO8WCR/I]@/D/1'`&R`).MR3?Y/0%L)UXT;/; MZ>DD!_NL2'2L:5GRZ-*9[*]?4K(3.[Y*(B62JH<&8K=L3$CA6ABIP1\A*8P;2%)[OFS`I"N@JJ]LLXQ9(4M#)*[FJ@#`;7.G)7;8- M-IR`7(%<:R)7X%8!N/6D*OI=?^\JK*NL-FY?<=ZU%?KD!Z,_<'@WLT(\LB+7 M)D^[H:P\YDU)\,C+3`KGMU-9Y44&!7=37= M?5JA.5\D\;)<;AJ$Z(%*,2TH=3(Y(KR4,SU"EEX_#WP448&C]!_[^KI#[RE= M,9V(E7+=BBO)=*WJ'U3S!25)PZK(SCW]<2:;<"-4VKVIM(-"NS>VW*"8P`>G ME=FU$/[;QHLX78B7*W#:'P(*\*``3\%P!6AJ&4WE5(!73?:1%'[W,CD@W059 M^KSD+43/FY1"M$*D,\D16NL8_#,NI=`9>A^4ZPFXLP#T!?1U@+[8M0B76F?* MTI(KS!\:H9X:D-1(NX(\H=AG;.#(+-2!L3#U7"&03J@H7#^9RB`*"6 M)4@@L[K68,'6DO75_A>.HAT-M5ED1K,4NKA'%W9T=H<7-MJXE`C$\BZ%30$E M>'S@\0E>AM#D$J/*MSC!6805LJEH`[#56-`GGO%:4W2T@*N90QFA02-K\2G1 MI*.C<3I!L8D=&B7B..',#Z`RH+*R(0U.=EP3J4R2L,:>1I>&QKA*2^&FH&+( M"O0*]*KF9K/B&6D\%XC_I+.$'601,5B/>*.H-$)!$D>QY=/!'RXI+5HM4*&4 MY3=_Q5%)X00'&E<9,ZI%@&FG`A[Q<>GBWT:;64<[42:7=R0'B%=E/!C,$I94 MP0-8TOME>SV=8CO.3D#WDMC]B5&$[81<[N(C_5C`E`'C60@.!XVKUGB6OO7L MMT66+QT':)&$]LR*7B,(<6#_`$."&A)@1H!9#68UH*%ZHUKZ!>861W'HVC1" MG2XH*/%=/I6BQY+VF-H^:B"PL,A$T2[>"QDX'0#,''+DE(/70&#"QL:'9>ME M_HADE8](9@+4CE%AA*4LN8'&05[1QGWC0+`C'$01#+-B<'[OS#[HI[_K,VM3)\I$ M0@Q=/M]#%-UI*`F8S!H[B#*194D`4L<.>D@[NU`6L5\A165UW[GV3NLQ\YW* MBDWM!GK@>D)V&6/H,JOP!>@JZ<.O[Q6U>XRWBNZ#V/+X*""CO!=1]*RZEF]R M>0#]ZI)_1%$%B!/4'-\'GFD>SYC5=<,5115$#D7('HDHW&,(]LU@IQ9V:H45 MG*Q>'DNIP4XM;-)LF$[01`X\,-BI;3@)0+I&A>Z1]#8$[-3"3JV([`T[M;!3 M6Q=TZV_2TPSH%EN8-V1J'#G[$G9R&0I3+C7DM,&R7TAR^`=]3@U5MN4BBB+P M#B+P`)%BA@:0$)#01I""DW>D+@FMV4KOTWK^7==7-K"LHX"-/6^I9Y_.M+/T M,Q&OO?J\',D;5=1?+*+EZ.[=.8[0#7Y"M\'<\C^@?_C9=M>CX`X=WM"5'FHXP])UE"?D]?61#[=X^NELO>[ M_OW^Z@RY#OG"LN.+R>1JV.VVAYV^,>SUQ]WQH#=N3T:33F_4[USK^MGG-_-W M"*G[@'IH^G>QP8;#9#!VF+[XTR"SQB M.!TY-"3O^YT@IRVQYNL;W)"+GW/,<,:VND;><[GP$O![ MUB+"EZL_MO"]F[Y?0T^]G?&>$^@W'0QY0/^WG,R_O%'7BMY8\7V%7U"2^TQ) MQBG+_!F*OQ_HIXSS)TD3-W[F:;DM&OUH>N"1S89JL@37Q&<3TP6';`28?GK* MK)^'P'.RY_R>^/A5JFVMA8C)RZQ2'>)V:\/5:]`^H73MJQ7:LS5ET_,I&X.] MKDH@70<[9I_HU9=N3!YN+Z,55]2E"(EGYB-RMT?=>79I`<*)=E,FE>KVZB3Z M4YW>&H"+0/;3N9 M)YXEB0EXJK$"<`(XU:&@-_@PS8LQ2E@Z`>N`=3"4A1LJH!W0+BC:P5`&.`&< MP%`6=:CYEL[<>&\7,.NJ(*;PMI2POOH&"$A-NE6&> MNK)7V**@DETMU3&UDJ&(JMW2#':%ZJ+//;V/:PTG,`TP#3#-SOO.!^U^90)1 MN^,%T!#0$-!0,6D8+[EW./SIVAA9CR'&:<>G.JE&Y&U;G5E3/EBD3F^M7416M7;(UEL, M>RR(PA*\O55`A,*(.-=-9BDOL`\&<%$<+J;!;!M'%,6'Y0/P4%@<@P'@`?`` M>'@UI_K,8M!@3@%<%(>+R2X-6!3%KS[F*=!^"T_!_C&SPKEE/R//M;$?8:AM MR;WY4%TJ++#U"0<3*G/PH-[2NK"K!>`"4 MB8(B6-4`7)6"R]#YU]H#N`!<#037N<[?&P.3$8`'P-M>U33^WIHH**H^U*U6 M1/L^M!P\M\(?$;)\!\7T(_*M.;O0MFH1;)U9M@'PL\+;BNT^LYT.4;B"MP%`8#^<]9D8)F/V`%L71TM:8!:9$47Q8/0`/):PI9M$DP`/@07H\G'>A8@JL M*4#+B:N'#BF^I>.>`FTS<`V(8GOFD_=[?&:E,F(*CD-DM+K.1\#23=K1,G38 MSP)H`;3XU`I";W)(TP#D58Z\#A2K`+(`65S,14CJ!6@!M`1O+0'F(B`/D'>R MN3_6&F+:C%J9IU7@89ST#"'@[KKK;%@:`8=D8THK,+; MTP`\-1A/YSUVYLV)LFFV=P%H:S#:=(W=G@^L7H"GQN.IQ^Y<5<`3X*GI>#KO M,DO7!&L0T`9H.[QZZ1#+X)\\O2$98TLR`NWVO!7\Y@@ZY&DLI^(^B"V/C_Y) M)>57V9C%1&J6HC]5Q"K3=YE#8J+H M#F^W4R*FXZIU=NMSJ\XFH%1-;L`(%$O`@6(!"A4D38:;4'6NT2 M$T5WZK9,@.F`Z8#I^#!=K]7N/C; M=.+Z;HS_[?[$SA<_MOQ'ESQP&$4XCN[IL^^)($9>8/_X_.LO"'WZ:._=.8[0#7Y"M\'S?/*`\;.!*T3$H+2P7PZZQF_':6839Y;WJ@7O4^K M^@?A!:5\P7R9;"+4!+]9=`?%")C>EGVB5U^Z,7FXO?3-OOB(W.6Y@1_E\3%> MWJ!=0P;I$?$>%BG;,NOTXU.V"CP$GI,]Z,J-XM!]2&(BUE,7KHJ'>!=XZ?"8 MG7Q5PT3+YC\":`YIY(F]B`$R`!DQ9%F_1N;*)Q>N"?IRRE)O2<3JB=TR'UF> MY=NXA;Y:H3U[5>JVWD+$R:^UY8KP,1]V\4(5XH%F2^M#L^_*5*+!RR@P3;.9 M1F^9'>@3"TP#3`-,PY=I!JV!P?^0!5'FOBS3-+U[YVK7%%GV7XD;8J=(:$"Y M$]S8.9&BS#/O%1D67H7AD(G#-'2#F;X`+@`7TN,"E@GA0]RB"'9(S:O(I;M7 MQ-2R:;95FG?E.RC(V4#]]-Y1ZAQ'T&%7FJVZ1P.QDPJ6*G6@Q<&V`X@!Q`!B ML'I!/"Z__"9!B,F#D9V$(?;M9Q2'EA]Y5F8X.K1(8([]..)L.:K6=93A\:<- M:3H*@0V`$_]CK0!-@"9`$YSG`!VQZTZF_3WQ,6IK;%-HH22?I_242%FT5D>`?G.B*`]#;[=\GZ6M M-DG[^BG=X'B$?3QUXW$0O6W"=$)O);T_[%WI^K`_&!N#GJF;;6,X[+='1G\\ MZ(Z-MG*]E>YG&/DX1@MR1>"X-L)_+[`?830-0A0D(:*?Z#;.@KC<40L]S5Q[ MAES?]A*'O&QV:W;%^IUC[&'RY:IET]0-HQC]E5AAC$/:L(G*OH7D109I=ANZ=>R79/ MG4'%S8*J_KVJVUE5_7YMQ=]/S?F3I)>5<,[%RW#[]::#5]$>Y/_?W;U#?]#E MGI4Q#`K4*`6Z"?R+_$H$U`2:=4RSOB\]B&MBDCLONW]`4]4K4\WY#.(K6R$Z M$Z^U&W05S2W>TQN4U:_C_/(FZI>NM-P+:EQ`C3EM4HK`P:"I2FDJ$"ZHL0)J M?#+AUNC8B]XK-KWO#H<_71N3$40QND`/V?YEA+`5^L3Q<)*0O%2ZC?9,OJK3 MV95"G,RR'FH2B!S5TC)H`KU/_/H7===7X!_@'WH?ZZ0JL>(XR3TJ1-F11&.\Q3&G(PQZ:!TSLSZV]:`O.]>HY+DR506 M##OR+D@`%@`+@$59L#`["A+``F!1'2P&@"4/6%3;<]H8@4Z?MMZUYB+]AJ6@ MA_.`2.B_V>$.P10E?HCMX-$G5SG(LN/$"EW+0UX012VT"-T@1-%:AG-V"`3M M&Y0>$I$>+D8NAZVLJK-:5(]?2`1I>5=+=8`%$7<`%@`+(NX`+``6`$LM8#'H MQ6((T`?@K8C7_3SF;M[->E/8-RU>F2D>CZ[<,N3-5M:96YF\ZLI.]Y%"?[A; M&L)QGW`&!Q`;$!L3*TX#9@-F`V8373&!V?)*C-DF/A`;$!L0&Q";*,16W2%1 M,N@/P^!<^8.B#I[_M._0J#O\.,=^?(L7-+/!?_SB3^G9/C098?2\_,\\ATAU MS'9O..R.],G5\$KOF:.N9K0GHTFG9YJ=44=7[A"IB>M;ODVS/MQ7T:$0>Q85 M)XJ#]"2I,)5O>BA2L,!A]G]1)MXL*X0FDI#G>&[Z@(C>2-O>D2\=&G:D47X_ M!8%%D_+C(+:\Z,TA4NB@VAT2VALZ,@_(:.TQ&\N"L$=&9>=!Z9K&[@0HL^0! M4/UNQ0?LZ%K5/ZCF"TI?%V06HSNSE.T)!RO`P0IPL$*C&B1+UN=;:M<>-+6, MIG)JY4U>7Z2<)4Y.\&ZIWN*?V$]PH4KAHSI`E67QF2V)%XX=1LCBPAFR%:EX?TU_$F86K9W8M>5">V&,> M##11U<73:N'D`_K#W%<_;;$Q);89LPS;((QG:#@G%]@66LRL<&[9.$DE@IQU MQJ6Q\64-9:UG,@N?*,YN+_.8#K*OB&:_3]GNM-H:%(R")R&AE2"\M@'5;%"- MUM(Z/:":ZEQ(Z&( M0U5P`3[X`>%^Q4[Z\G=)^+BU\*QAC/Y%_W%=AX[M32I4NMYJ]]DU7"DJ-E&4 M$!Q7"9;$1H&SRZEVIX'@+._J=67.CDCONZ>9VFCW)J(HYBNKE!T.K0_:+6/` MNDI8[9H2\`4!3'L"E7JKHYV<[P9@XNQ`U@&]529)FW$55*-2L(02HC""`TUL MLB;FSXY6)@DZ,_.Q/?.)1CP^K^4(7M!S:YW$7I9XUAD_D\X3[_?,JOQP470( M+']Q+'_E\&2VV:4H-`1/'(W_GO2[1UE-L-`GN1M1L4P&;`9B6CLD;+:'-*"&@B MFTE2HK@GE&-HM8=RQ"_L$DI6H%>@5P*$4P4RTBIM-O'MI9W>(@RF;LQ#&P6+ M^M<.8V&$)9NW`!K'GPQK6WEY&L6E\\?XECRHX&W*Y#/V.\S"7Z+,(^\@%JP^ MP`%*<4!/9Q8T$F4>:PG]"&2O,MV?VY60LB7(HK-4OFF54;II%52MO%!!9:DR MRD>/)6(+X>P+0.9V/9D!U63UK.Y;*::*E)+QP*-TL#)U9LELHDPN^+_BK$_2 MX:'/KO^4*GB`';0]@AT'X2((K1BCZ^Q$^ZB%;G"A?;.C=IXR=MRYKK'SL8Y) MY55G)(K!Y3E;!3PL[AZ6.L@SNP`\)L!K>HE>VG011_%JW:LCLB$?_'2-TY&O M^X6C-@S!40.X[8=;M[+6<,U`6P$W\-C!U.+8IWQ72SN88S0-@SD:D_]W_80F M62[3+>EFX@A/@Q"CY87WUM^\R@"WYX!IW8P4C6PJ.ZF^3$V-'$?8,^P?75B8 M4N@<[Y"T1$PKG(D$]`GT61=]&K4+4PJ=8[B#\3ZV'CR\\_JUO].+D(T];ZE< MG\ZTL_0SD8"]^KSC+>[=.8[0#7Y"M\'<\C^@?:^SRX1^+<5GP>'3B0K4;/O=\@2UH95D`IS-=P2ODX`7522KW??J4WB^G\RVVK=B"( MH-/]B9W,?5CUO4(A7H0XPN2Q'HXB%,\LOTQ*XLO/&K^Q>`H*IF1(;D3&^S@G M@WPY5Z'_@8PU;7<2+M_O76D,`U;%QZJA-%9W)@@';ZHIB7:%!!08_95888Q# MA'V'P/KWQ,>HK;60H>D=Y/JVESA$*RUDSZSP$5,DL4#D_[4[B%SCT?,H6``\ MQ)X5D^''0?I.(8XM(F\'/07A#_*B-D8/242^(=STY!(J\%&0A&CSL*8UL:TN M+L\&J^L_OD^BBT?+6ES>V3/L)![^-KW+V.@6+X*0SLP7GPQUG@YG]+S\SWNB M)2,OL']\_O47A#Z^/.3-K5=N9'M!E(3XY0:BCS[5L5L\_70VN2+SV?VN?[^_ M.D.N0[ZP[/AB<'UU-1Q?FY/>E=8>C#NCX7#)_T*Y=@RX\S M>F9IB/Z'JCI5@52=@]<('E'P^"E8`_URY8LNT5?[7T2S`W]/Y_JTG^7+-;NH MY!U"]P1C4Z)!01BE/.)@`J2YZ]-?RO!'!Y4NA*L?7G&)DUY`%,8GG$.&^31S M[1G];#WB=&[P3\M+")BC]$+R`NE4^3;.5G&,QL&_Y0P9R@NCT?PB4 M"0)6UQ&ANS]=)R'0?@$_&3/Y+G8Q?0LBO=6/[?JM-9&N"1#1H]N0G\P?R/C) M57-L4=A%K>4+TFNWN/8A"ZBZJWU*G.U3IO?0$&M,0ZRIY,E_)Q[YE=2\<@BJ MLP`M>1=:HJ02KD-6W9(>],*D0.MNNY M2_5>TCSYTJ%RI/M*?NHJ+A!N1!'W#R&%F5+X9>68VZAIYS:7G3:P8SUI$^'+UQY:ALML. M?;%^S)W;;">8D>E8/IWUN[_EM&"7-^I%[].J_D$U7U#Z8OZR=G>Y'?&^V#OB M-J:+%U_S[/O2%;G><$4*V.`Y:D0Y2)67?@Z*"7RPDG=Z]:5+%D?77CK"7_R5 M&Q;E<8E/[W92B7A9'PW`1A/$/#.;G`MM!B9H5SR\9)*A&Z)_#*N`7/'F.NCL)W*&&7 M):C$P02=5EMC%X40??+I?=`Y2A$K07AM`ZK9H!JMI;%K82+\Y)>E&@8NI/3F MSV96%@?S1^%N02V&)5"BZ`/OY1M6:841\9+J;3#3%U5P`3[X`>%^Q4[Z\G=) M^+BU\*QAC/Y%_]5Z!+@Z/8'T5KM?69\$Y:U)<%PK6!(;!,@<88D&I77H,O"&#:$ZC46QWMY'PW`!-G![(.Z*TR M2=J,JZ`:E8(EE!"%$1QH8I,UL>G]>7K.Q=, M%!T"RU\=3DOK"1!.%>0=Q(+5!SA` M*0[HZM,DHWK8*JE1U?:V[B1M+\OL/^!,+)X)\!XTFS>,YD!FM>N=Y.QQ^-L/@8TU;*YH4B%AR?. MKW^KFY1$G=9!293<0#"Q)!Y5U?545U5W5TUTYH1R<+NW&Q41ED#>`N29F@!> M*\![[4?TKD:M*>MY[QB9C=.#GXSD0V4P7@<,1:`FX+8<;MK!2L.]#K1M$09. MR0WO-SG=Y=F2MVWF39J=E'=H9ILLKR<-N.VJXW-]X1WK[[P?W9T?@U;/S9Q$ M(9L]':K90KU;*7UTU(T3[=6/WEJ8)Z%S^TY)GY"E[9R+),RG,)_',I_XZ,(\ M"9UK<07CAR*XC^G"ZQM_\XNDD,9QK5P?+]`%_PP2"$>?%W!Q%PUH+GVFWZ3; M=!`D'Z1E["QRH;]%O>+Q/5;7L:C3NK'^Q1M[\9OHP(K=:JSO_92Q9"?#ME`* M%#Z.Z5U)&AQG-*3PVIGDN M%8]!LLN6Q/%K\3_:>(J4]H&D*`=Z'P9`Y+BO@O$!:.7E3K*:OW<[8UA@M?M8 MQ6>-U84;A-.9TY2@71F`@DI_E$%6T$RB20]@_>\RH9*"WDH8R:H4)6%<]D`K M`RE\#+('RI#4!B*_4U0)KHE9/XHV`)[1."B`_"+E/&6T"$#>/>E;FOT.C(94 MNB]S^`9LT[<(3$$BI64F33=K:HAM=/'NUF!T_8\_E/GE0Q`,WW^M;-`M':89 M&P\WRL,XS@&T.HT$0YQ\O+O4+*>K!;T%87%JJAG3B6;9EV;;MN9[CFT2W M%-?V3%GSS`NI3*+J667>N_BDJ'KE<#6(GJ=A"R*U+_)2(DU?H#B)/"@1GJ@5XEOR09#5/X^B_:NPO^M&E" M`1SY57Y+@QS4XCY^ODGS/((A)0/P5XOK?G4+N*F]^NK-&%4,V=,=8GBFJWI( M,64/:8IO^ZJ.;4_WY%E&+V7-G.-T/XS,2*L`500U+3/`?DYOLO0A"P:W=`#0 M`MF2L@!YL]=-KJF>/"T/MY+'ESMWN8+Z.C%=;!!#-6S?5)"CNUPDFN>XBH;G M%13-261;8A?P_)C&X.7DWA]E5#QO-KBVBA35,Y&N8^SK@"YP,JK!-2S;4.>@ M9EJ&M9"5*1HVIW&5.5!<65$L%:FR[\J.CQ3+]2L:B:$K6)^C4<-X=QJO^%0" M0W'#S%Z:D*(Z]LJ,Y5WZ.4T8#UD*4T+R,%[/W8@OW0>^'-E!6/>)1RQ%]16B MFZ:)3--7'3++EXP4>1Y9K1!^&&&L4D07.8ZF:HKI>$1&CF*8EE<)PS`5XJ)Y M81BZ=AQA?$X+NF`27&Y%QDQBARB:YR%;]IH^W/_*O(CZSVWE&?C'N9(83>$U@ABI$N1*9V45&S,9*UD'_WH!:_RK M"-S$I*@BC39S*EX0/DHY.)FTBM:HY*0#<*>?IX*UM"SR(D@8M:`?@T&:P'N8 MLD!P!P[N("J8%YB"#_L$6@5_,&]WF.8`$*F.4"LO,6](DI=PA@?`CU$1U[]S M2B@XQW'\#'XP7/,L@0PCX+['HN`PA@MZTOWS4EKM-,AZC!DW@GFV2.%%;]BU MHXLP^L`O&7^6/WS_3IIWKT]I%*\2B"!`8(!6Y>U2R=0A1SR1J/0MR*4LB/(Z ML[`B<[Z,K!?P7*<9ZTQB]2-[R/LDS)OCI\0>_P M?.^:W98(BO0$F)[ON[X;TX#9,8XYXEA4N@!F\#O\$/19H)J78"EZ;)MS#3Z. M(D#.W43=`*X0K$=#N(IGHPH)W/1O$'#R625*2LI`/@R>&[H8!OECX]V`>?;P M?EG`K/1N0K+TK_0;?:)9I=[P"!;-<1,25-XO(+ZZJ?&PC#NBH]B3W=B#&0_" M5%;UH[9WE;U@#^*$]NB0`:,>N%[&' MO@5VAE&5V8+)`=X/5%:6+H6G95(_X"9I=83;=7/#1KS*WP6U@Q]4$FU,$TRC MLK'3GZ^:7:9F%&:1=M7V:?RM@!9$-"TCJ\ZN2*#ZA^*"Y8XF!(R22*WP=;)J MVK"Y#(U16-,Q<[GHIH#9Y^9[ZFFUN4@L3^6O6ULOF*&\6A&0 M$;!9+ZH"CN-@F-/WHS_F M9QWX?8>^[S#\G4B5ML[MY!F3:W1[LW/(HN)LOYF++_4JD\=7F<;+3%NLKZRA M@@-0@)CN1:S[VM:[PYK?$A=CHK)O("JOW<$7'(M-:UH>5-!MM=\\A+HO='SW MO-U?6%JAJ5MIZMJ-8\7)^R5*ZZ<9R#61PC++:!(^2T46)'E<145!CP5B//_2 MJDJ+@L);V-+NZ&/G!"]A>'3`"K==Z,\!;=6: M9O]5)-#F+!W?147S[Q>9O)VR:/#_;53^%94M;:](QNNN6GK"?G1WIIK7@[OV MBI6*=BJ=]-^Z$U=UWY?KE*R$7@F].IUXX=23'E7!!WX^C9T?JTYV78X*H-S7 M)2F&<;!1%^E33<8='="=$=;)NK!"X\1VHW9G&S)@U2E&9T'[4A`699"Q\[$L M:_)6&F91FHV*UP$O>75^EV]*BJJ;[H'ZH#I(NS)M\IU<[3U2N[3W:/\=>$\N M>EQ[C[/8AM,5O[T[,]39H:&U,NGG@@:Q.K&+]-?=WGOD)8A7TYOZS<$:.XDE MC,Z$+F<[N[X>W(Z+T>#V,A"BM_Q)+H:<#CQ/#F6MK=^?"T0$&HZ+AK:.BWN72BPVZR?N M)YQ\:1S:=G_.X>3JNA(\^6Z"[9U\?[&9X"DHT+Z#M'T@\\R".&'9A&5K97E% M:VTWP;HRVV@9Y234;IMJ`,N;I1[,(HONCMWO[GC>G5A9SX-^E.7%N',CN/BL M.]*D6R/S^_NKUN19?-!:*T<9M]K*,6BTE&)-.I:5AS]PI]89.\O["`A\'P7? MY]V]]2:CEVQC3-U-)F,MTQY0_K?:K`GCS(*9U1Y=Q;]=Z-\VX>PWK M!\.^8%FKA#L"_)1`7L#_JHI[\*#Z=KB@;J(S[J;:V)_#&S3-T;)@(\_DS6N\ M;V<,KQJC19`]?NL/$H;EH*P$?.YM0,+)696?P__0/(6WY-5XU9_@ZV2ID$&0/45(1&91%.OJBBCKX-]4,9>GO5$O& MV$0&D@U-5=OK+2+K.S8740[=7$3&!W[AH=\G&#QY!I7N-HCI7EN#Y3Z=M=WT M:"WW`O;7D^-XXETMTD,T,QAM1'=&0>]=(^@ES8WHGRN?XFY?2V-=T.?.)>"% M\JY2WD:-IY]X<2=6V\EAM9U\5MOI7[RVT]NU^P,?F'H!*`&H[@**:2<#%4^7 M3*)N'D;RG(1=UTVX8743Q/0@M+ESVGS'^QRWESTZHXVK>UJG7#P.=@`F(J2L ML?+/018^2HJ\I-'Q`;?;=_X83WN[#%Y2NU-H"2#K[6V.ZOK(L_OVNO&I.W:H M_?SCR=2![H:LA%X)O1)Z)?3J5&0E]$KHU9%K)G0O'#QVC=(7 MRR5(]Y2=F6H<<@BK0PJK=]R(ODSR_I,[70F1V'UB+:OC)=C.!UJBU:!(FPK< MG4<=7C&U"8@)B$V\1B1V0)U9OGV?(B3\,/S,"?0BE4"B"5!<'X-G(=Y>8+>' M_<9G-\&](*.N:-*^YSDQG0E<"5P)7`E:UEO<17?3WCS^4^>5# M$`S??RW2\/?'-`9AY=X?950\?TX+ZD9Y&*=YF=$[8-^.X9I/?_^;)/TXNNTN M^+/1>^(K+8JX:H9&DMXO29F707R3I4]1SD\;LV:'\)Q;VO]XX;NLL>,7^W7W^F@WN: M74@]&D:#(,X_7ESJ%U+4@[<$87'IFP0[Q/-4%ZD8WJN[KJTC%SL&1KZ)G`NI M3***JC+O77RZE(U*02;BV8C/&1%E-``)/G,)?WT,,CHCB*M*$$O)MXCB`Z&& M89G$DHE.+$]1?-M7=84HV'4;Y.?\\1>?9$V>XV">C"WH5+^HR\6L$-/PB:^X MJH(T%UF>ZU=TZI9A^_)".M%N=/XWB$NZF3A-PS1=PR.R+MN.[()475*1:5@8 M6?JL-EBZO%J8G(;-:5PE2LNU?%7S-,^W/=M0'=TE-8VV@6'PYVC4T+S*OD`C M:R$0I@\)F*(>J'?=)6!#W=1T!SD6TK!L.H08KD547!&*;<=&P:FF:8RF&:H*1L%Q[!#)?0]8L(Z`] M:S*RBL:UF+Q[#(I?TS+N70V&0*K7[].PB)[8@VZ#8D/M)ZIC>::G6!96-!V` M8&)OQ*>FR.XLGRJ>4ZSMR)QA-:?7?2\O@,1BULY,)H8&W8YJVCJ8;$"`3N"# M[LHJIUMS7,_TG8M/,_-U<^Y]H4?@HNF^:QTW^7UWJ33,Z)#UABQXJ^0D2,(H MB*5&$](H8=)D'2MA^I2^1<6C]$]";MY*P'CPP"^2!D`L?/Z=2G0\!.R469#G MY6!8508I8#BE@`\B?QF\-\U8:X:@/J^6]MGUM*ANC:/@/HJC(F*/XC^RFUB+ MU/KO?`F][.9Z4R7[<]SEM5=F(.[&J]FG(8@F[;V3)!(6,.6.:1D$SU(O`F(S MJ9^E@_I](^;&-,.-5XF4EIF4#J,$V'S+GQ^$;(]GD#RS5Y1)4/:BHK(?BQK, M+I$Z[T\M!7$L5;TNV7F^,N,\!!//04IH2/,\R)Y9%VLID/I!E+%!S>'7JI<7 MZR(+%$Y>,TSSJ.#$PF5E/-MHEHLM9+V46*R8\^_9UY[11];)IV$ MUTO72[=AG;>%3=)BK$9P`PQTC]?S>1I!;2P=CF&&C7O*@15R_:V%!&,3P=.> M(>:H>B/G$YU9J./Y([/N[%G@6?1J0_._,@FYVG)+P]&4)!R:-8H6/>HMAQP@ MDF,:D!5&M06:7`U-XSI3'RRYJG;#7R`-^G*"US&/!^%-/>1.!?/8=)XF<89UFM7BF] M&1W7P^@#_V)*<.,?Y0_?OV0-YD/%Z;E[>E[_E=L*VB,0K<-L\[ED@=EUWXWB M$KZMW/GKL@!52)@=F9_XU7KB7^*^&+Y/3`^<2P_YFN)@V=%K]T6S%*RA!3$& M5N967*0Y M$$U4[#D&MC2R,B1AMATVO(AI;9B*B+3^B=J?SX0QL,-D3% MG5'$_2.Y]ID?8A:MEXY$&I':0KOF<8FJ6:*E9578:8Q7=U7[84>3:V MFBCU6O1,2%\P#L`?Z]0&JG+=_V_*)M91W%E=E=&>7\;QA_"9CSO1YI?'].L`,=C8*=9EG[C%>].&B$&DAT"&,&R9JNN MH4*0IU8(,50-');98=O#:"V0Z7$&[Y2]%]7!2+5E#V)WK"-L.P9R*N\%_O+\ MN952V;+V!K_.#.C)>B>*`_,5=E1B@%N"#.-IK.>*T1 M7O$3O/$.9KE?'U,(Q:Z_)7!S>9]'O2C(GF\@J$D*]F66/T;#4?CFP/4/-+]* M0K8!A%XE-T'4NTJ<8!@50;QY4HM%G2923.SXEFUXV#)E%VF:*Q//E9VY'1Y3 M\_V>F6E?:N!"5+LT2%%DT7W)=]/=I=5-?I8./J<)DV`&3VZ&S!N+U=:Q8IM@ M3%Q5E4&FX"LC$*NI69IJ$SSG+:M(WX=@M^6W?#*Q%801<4#AL:UXV,;RPEV,KT.L=29N'8DV,X*:96L^-DS/5+#G M>\1'!A@3759T["FFJ2[,""*D'4J<-5M-269#MFA.KZL=&\F#5VWV@4F2EUJK M+!&8I&5+BF.4?QUM)1C!_2M]J+;C-IW_\0M?\O0\P]&)9J@RP98MP[_8&&U< M=9`_YQN8VK1BKLM6.Z+0]BD*!2"*58@Z9!,'";B*61']Q54S[?\SB)+\IQ3<*@@%HC2KMWT[_]_>E36W<1SA MOX*BDU3R0''N0W%4-:?CLBW*IOR0IQ0$@A1B$*M:@";Y[].S!P$02RY6RX5$ M)WZ0"\OMG:^[9Z:[IZ=G,NB#X&'-4B+T?3Y>E)/]Z8?Y[++<#E1Z8JT"W&U_ MN=[VOFSXZY9@?UVD72Z%$I;OTAF!X`.GETXO?CT+X!2N[K:_T+:\8HS"RAN$ M,;$A8!U0,))%\%`QXG)W>^:F]`>6Y!]%93'+I[/+Q::V.NE(,%"+L8ABXF2$ MB)!YFW3$J(91LY6#JL;(_X2.V%<\K&#P8(T5AU'D&`-O6TF95$9HP#+0G349 M_7^5'7Q860BY9;*W-B*."0PER9*.N/*CF1OEB MPW(^&\]+$#?:?8K-FUZB-#!32FW*$5RNO9'6Z/.7M/"UY?K^-+Z=75U? M/4A:/;TRD\26\F3%JCN`/\OFQ?^7NT+RU`;CG"7*ZAJ.+YUW226R0XB9H*I@Q,.`$ MK0L+@E,(ILYC1(\I+@$\UM(:B\\FUU?WKY2YS0C/]BE8M8'A:`0+//+@@L*@ MH?LR#NWYT9N?*QR/MO(8D(1U7Q@5Y/(Z",,+Z!J`G+? MRBZ,$N/^BK'0(VQ:JG(T">7_W:9_V MN0+7'-&(I0U!*<*$T`*5,5ZR,2'BTX:HT& MG4N=(QJCI6<(:X4HKG7#S-;A&!OE*EQK@M46XB<@/82?@H+<@48OLWP?*3(J M")8A\B(7';&/1M92E%C`O/)C$A#1+],+]-O.3^R&%_-R4KZWRZ>VP*?#U5X9_=C#\] M,%/_G)Y?@HX\6,S+RHYN4K]-5=#EG^IM&8][/#"\/3(FC>K`P:0C283F3`8G M(]L]#4+?Y[1;^/],(6VZ+RU"JE:O("(J\EHIGLV!I6ZR\O>",LOJU>\7H.IB M0FF1'70C(:F1F!(-9BQ"((!`=@2D".)SNQL"!/UJA'>X'B9!2$(%2B"DYPK< M"X]CT<-\VF4<=I9?A!I62!V&X;/TL"ZR`K(XV_FBYU<&D9F*%<<(Q["N8EI"`%)VE)*C"1:*=X#S.F_UA]J\_LA:,/ MFEFL-(^$>TL5YP)#3S-@LKG8F?F[SE[SV>*WUQ=9MDK'`OP(/T:WQ:,\2T7T M'U>K3Z]/3FYN;E[=?LCGK[+\\H0@1$_2GT_2BT?5^ROPZB"\O%T5)P,<%1^O M/S_/)M5;'_,$])MR7L8V$JJEL:.;C#]-Y/9>WT/Q[ M_F&^C:C8F)R!?$_V@61B9`1%@5.!>"JG,:4[S;T'#YLT0FJAZ0D)@\F/(7BE M87+&&H)\':F$*"B/I@E2&TU?2$H9(;@QG#/C"?B)"-7[F4(PMA%2"TU/2(II);P" MV0N3]IH25A^3:"4/H7'$M='TE9)/)<2.!(UQH%YHK&W]><-DLY1::'I"8LPB MZRUX$`H&"TL)R$!@_#"C M(@I<8NO9_4%8V.!&1[>-IB\D&#.4>A>%E,0;R;WVM3OF\2/.20M-7T@1"T+3 MFG]Q<#=\VA3UM(B!9\V5;H340M,3DJ%.*0Q]0<'DES*P!*EZAXHBOG%-H(VF M+R1#`GC2QE@!Y@"B(>]5R3'F7M)&&]=&TQ.2I3H54H#9-$H)9B3"O/Z\%:[1 MQK71]#4HA%$.+4``1'DZJ0L'4D>N`=S]1H/20M,3D@/!1X,#0IYBI;0),,`K MJ\ZH;O2]VVCZ>I5$"L^YX\%"L&HY]M;D-RTA=E$-H#QPHZ MJRI,J(Z,@)_6#.EIFKZ0N'1&-1,UKZ/`@TU+GFUT/2%Q#E\D""+&'6(1QEE%28:"0:C,4)IH]D; M4KU@;/+)J+@'I*B@*PG'^:1E\;AZX^0B8:H_59.G8Z8_9[4W`Z+J4\>:<'"9 MI0!O0DL=L-*4UPL--H0&6PZ0]N`1XP&8[+)^O,FD)5(A8Q#TW M@WO0X/SNQ^0`BNRT(+W)HR+,.TVC!M?"&A$<"IX%;;35&'']^8I\?AX[K7`? M0H_B^7GLM&1^B`%)GI_'3FOPFSQ23@@%13,6$,SU7'LJ:C_4!-E@J+\8CYT6 M]0\Q'H?HJUVR!(<8CT/HL4O:89-'X:7G-OJT?)+\$QN<8\%QP0VU5C8D!_;C M43T_CYWR&(?HJWH`'KLD1EZH#]`ITW(('C$:0)%='8'*``=DI&?1"G8!. MV:5#Z)$_/X^=TE6'X%$.H,.R0H7NA`62GE-\F MC]R%Y#%`P!D80=8&A(2Q!F/H$TR)AG74+\9CIQSB(?KJ`'-.IZ3D(7@<(+CJ ME.5\H?-JI[3I(<8C&X#'+GG8%^H#=$KL'H+'`0+(3IGB@]C'`8*K3KGG%^H$ M=$IF'V)%9XB41Z?T^$$4.8#YZ)1P?Z&]M5,&_Q!KY0.8R$Y;`EYJ9^VTR>`0 M-G(`17;:M7`(OWR(-9TNVR`.T5D'X+'3OHJ7NBN@TTZ-P09D]5Z]A>1S9N]] MZ@@?RJ'$E4^7V74^24^OYH!ASHS?OB]N(\^7J_D+J[")=S\OK M:XW3=>"K='%Q*MX<38KS2"9WH]7ZI)_1/%L6MUS_"9/1U6P^3\_&&V>UCU;9 M:+%U1GMYB7,ZI/W5MR=;C27F\7Y(<9?>2RZ?SXG`($%IY3W8Z]2S=I9SEOT$#D^GH0W563W&]7A;,CN>C]]/)QT4VSR[O[E_N(^@N'O$@@GZ73X]7X]O1N"Q#SJ>3^7BY MG%W,BENW05*3#'HP"'(YGE>W=&?WRIE6)\FE^[F31">IXAH>%+=<50>,PX^- M6\2W;FQ_-2HO%[]9NA4EK[[9 M1S!=;-H@@JE.<82Q/8C M_(#GWYXDE+/7Z5_X^5]02P,$%`````@`,X+_1/^C.1A+%P``G5(!`!0`'`!M M8VLM,C`Q-#`V,S!?8V%L+GAM;%54"0`#8J3:4V*DVE-U>`L``00E#@``!#D! M``#M75ESXSB2?M^(_0]>S^NJS5MD1]5.^"CW*,+=]MK54_/&``'0YA9%NDG* MQ_SZ35"414L4#Q$`15>]^)!P9'Z92"02">#3WU_FX=$33=(@CCX?J[\HQT34[OSF>SX[__SW_^QZ?_FDS^=79[=701X\6<1MG1>4)11LG1 M4G)\1$P':4MVB]*_OK"/GA7_EG/2ZN.XYSDW[X5 M38.J@M"L>O*OWZ_NRM@3G^3M,T MCE1-_P7'\Q/V_WVDGX_38/X8`K\GG`BZ1$'R3Q0NZ+5_FJ8T2T_Q7XL@H>0T(EP4_[W.P;FE*DR<*!;^\/-(H;:D= M7/N0PG)']>_1(@]V(L)P8OVF<1@0-I^=H9"9YKL'"N:DD?JV#<@@]@8E@-P# MS0*,6@"_7W."&+G+X&>N!M?^.4H?+L/X>2\6:AN207P\?TSH`Y0!C9V!+S6G MO=G8W:0$AJX?:=+*R]BCI?[D7U`O`\-Q"7-2A,%TG&*P%&VFBN:*(HD[Q3A> M`"BW%%/PE6$>O4,PEUXBS(S>*U2ZI4]Q^`25P,TF0;;ZIJ-YE4B!2+AV?W-. M@>@@9@6X0=.K-PXP!"G.Y\$%):T'7WTE4415?]I5$!R:ELL@6\6110B+#G"Y M%F&67L*Z=T<#W"'8OW-1(+5:0+2IRH'`(CC!?&#H+'N=12P*D7>V^JZ)T`Y- M]"?X"THB%ABYH0ESA>/H[@'W6A=OK.KP-1 MS':T8=T:$45TJX'8IFI_`M\",[]3E"Z2I0O80%EM'4$D=91SIS;ZD_Q;')/G M(`QA4,RB#$7W`4AI&>CZ@S89LG:511-Y_@"?T'06G0-*K\R;FC._\]I?56L' M/-].1#-=_^V;OO"$H%^7H@$IS:&W]!XE;(-ALQ@/%/;H1S3K;]"+X+=MXZ*9 M;#7S=&FB/\'_H.2^2T!@9WD!I%S0!-;<3&YO$TK.?BL8]VQ-*!NS*,V2W#5> M;\FTT^]^C0I@JJ-'T+I^?U*7H;^OZ*5112I*65+_:.AFJ5A`$#F`U0F&FNH%!1E)&Q?R+JLB/ZDM&(4"*D*PZI MGV_TY=0!?6&,WP%RJ2H(<>`6//HKIG]\&X-"I/$WP4)V`^/A^KQT?/-+A_R/(_ERV@!+\;K-NI M\T6)$R!PZ;Q.@HS.5_79^8#QJ&1\J"($D`]UB%1R>;Y(V&RY++E..$OYCY=. MW;NJHFD&-K2?@Z>'1O(9):(%5S]DMAPI^&!?3E`E)RB%!1%A/MD3"O.D`9K% M>8+RJE[%8!B`"E=S-.01RY@03;,9M/K$4W1SHH&&*DBE-F"_WYC0?K@Q,0[Y MR9A-5O#66/Q5$=?$INHXBL7?*NL_G`9R`'=LSL8ZM4"6?U'JT54U2E7'%N"/ M&S^L\AZ.K,8V%O)(%EL*E1TI2:.BLF_PW`@QIACS'Q_FS_%Q0%(;VT@IEAH5 M!X7E+$Y+7[#5C6K;G@`'R%J/DD=X]Q$F6T61^%B=)_,Q.!$A8 M@5;TZJI$L-83)IDZ0072_J MDI09UAB0+>)O"J:J3O4#S*1:$E@$1!H9*?3;'7*OLD[:57?56U=4[3Q9N'TD&0L!R\9NE)*SV$7,C0: MA,KRKF,[BNFIAE#O$18:`;Q+ZB(*5TP@F*E]_MYW[6]1V'<6W'0<)V!>6DS?!3QW$H"5'2^)' MFF2O-R%:7I\&<]@C\_[KS4)=-=0VOY?DN2,D0Q]*$](Z.%^C!I7E75N? M$DMU>L4TALP$XR!]7L#($'HY*!Z1W>?7*^3?5-6UJ$J)2@XPO+5-["S"X8+D M=PDDN=YE61)XBRR_<"ON?"233P(+6(?+T9PAA-NH7WN@*FD9[U.89)8#K"EZ6U':M7WD3;$O8#DVE+9T$]7V M6IT#1%)"^1H!"F]00-C5R(]! MANJ6Y#MJN(I%G:DF8M#+6:%SEC\_F.3LRV0HB-:WZ9?N8[J@?H"#^DV:ILHN MTG4TU54TUD4\9^40@I@4<]'NGJ[5_4=U9J1;2S!N-)^H6$`*LYQ``&_S(AP^ M>3&B-TO9//E45W!MG?J,"Z%GH<:C'-Q0DJ$#7Y/\D8S75E[G=F'7TS1GZHM( M#)%T,(BS\+E`)$/POP=1G.0K\<;XUV91=XH,7U&H@$V!H18;TN,1'#"5'%%N MSB'8+LQ"@E/?L\1FJH\UYLD%+TE^9_X.Y0UZ90.B129I9057,2V=;86/-3+5 M5V#;7B0?E*3$L-DATZ]-9Y%K2KL(&U/BB]C_D&X+>$B?#T0R1']1!%!OZ1.- M%BV&?W4%5T..H_JJ@-UD.3$JS@K`#269.@"KV4X^06T]5_,L8I@B-$).8$J0 M1O`"2XJ'6#HFW<)%W"[M3BV5^BH:;6R)LQ+P@4B26Y@L*.ED#W;6<15+F2(A M06HY423^SB$WH&3;@5899]45F*K[4\L6L&*4[B0(6#'RPDQ:>+E\C+1U'F)E M)=VRA4,[CB)BO9H>+<T;<:<8:9XI0K?D!$JEZ9903"6=QL24DO02,'R+!S?<7;BSCNL`*[Z-1WO` M0)0XM\]J<@-03G;@(WHMW(ZV2K*SCHM4Q585$7MPDNX.DZ0E/!&4;4IF:;I@ M#C.C'+SE]$]P21.PO.Q>M?QFJ?SC,Y3[MW-VACT'GAU>3M\R(?(%R/5C?B]7 M2W/$O5\8D0::&B*F0CG1H`%,VB$(08K"%\/S,DY@K"X2<"]38+J4^5^GM8V5 M7=O1-:2*N&31^%"&4@B4,A7HVK\(&$(12;LI3W5%UT;$5G1?[*'I#Z0XW&"4 M/+QA@Q=@3P`&CFNRFNS3K&=6L M:`2@M:DZ[7<_[I!+N:&CFGPPE>E8?XV+B]MWWH[6PLEN;L2U/4WU#$ML6OD` M!JJWQ'T9)[0T9N^H`C[9!?33>5Q2&4IL>"`ZB):N7!NCR M0&[#@][[-`.+58S9(3^AD]M'U"6^H$J..Y:7!_D"LYOSU+$EP`,1HF$!B[9A M(Y*BE$PIA'6K>BB0*36D'1-A!!=C!_]QQW]/Z;-:'@4-\`%>`$CD?6XGX@#F, M(N6._AM$Q36D3:\_MFT$AM.4J$2$75*5#^X/<<14CF85;U]>S2ZOB]?)EV'U M\P>4W-=;I_JJKN50;ZIC$:'E#Q5;%@"DY#/\[P[/;U^7_9XV2UZBWNKJ M;UM%NJ/WVSR1S_UEG,#8B997#N'7KPF*4H2+('7^7S'@R/\MTJQXZ+(/7OMW MZ-J:,]6)B+OIY9@0_FI4%?$[!-RE!95W,'L!%O,)L6-PZ?\N4!CX[,'VT_0? ME-S3O@.^5=L@1NH[FHA-=CG;8X/JJBB(AU;+&_9!/N#R4C=QFB4T"Y)\NCRC M$?6#+#^>R>7\YBCGGABFEJ$:H[UZG9N^;-^+-C#.`X]1<7K:$B\%8Y..-PE_`,44!.R` M`8$B7%*Z:41J'&#U$-P-3?++,2Z"<)'5'@[84<-EUP?Y/CW`J:NTY`,=7EX` MN0`6UM`#+P4;.4OU8>)N;;F6XI@65D8[_7"1]W9@6#B*DG8>2GQLD+) MFI.5Z=I7QSJU"CCIB!!SM*\.B=E,HTBCH]7B0U"_SB-"IKBD!/17._RM?)"* MTJZM:#;QIP("Z8>BAI)DOAE^YX*U#!WZ+6$[`OF<5*,[I5*NB6WLJ?YX][K[ MRB;FB8T,&=^AD*9%#FI]\MU&21=-=5WS]-'*>F_9;#Z4V1L7.2'V%!;/S1G? M[\JYFFXB[.OC#7_S$G)?6*1.^<6!N583_JHLF#F%>&,6-6_;S0.B>K'/\7*JOV&R]7AK MF5@LQ65]LT41K(UJ7L7B_&C[[@Y7%PFM[R[+-Y4N$0["('N%2K?T*0Z?6"`R MH23(5M_\@9(D/W%X03,4"'MN?C?EN[\YI\!!$+,"LJBL5$2IG>T8"T/R7_WI M'7Z@9!%2MJ>5+L`F[Q[)]40?SDQP2$LY,6A4$MZ"MXM%PH(%^<.7BVP9J]Z( M2=6`)[!75T>^HA$L8+DS1(X13\7:O)#YH(0@PPFL9(>%H'R?XHP]REGQ?54+`[8]L3S,4UUH2/?C6SY`*3E]`FVXIW\L MYAY-F"JO#Q^E8%;3#$4L'%]C?3JVY'J.3K1IOY,,PERRY6T0*"Q):2-`MW[# MO7CLYA0\X.A^>9ZVWE'KV;AKF:8!2\S19L\+U92JN_]DPRWMMLDFQLY1&%X_ MYD8>C-`WMDCCH)W5K0).FJ>:WFB3:`Y.+;GA+$,?=Z"W!5O3WD"G=D`&*L'$ M$A`?E_.DK4R=$XVL.+>UVFV2%'.J[ERHSWR)@N2?*%S0WRE*%\E[GT)&7Y*@ M_2V.R7,0AF#=9F`*H_L`0#U-4YJEI8,:4CL]?V`3?SJ+S@&"_':[.8M;7_NK M:D,B4O_MF]`.@=32*N^6WB.6"':_66S(=<]E$(%EO@*TZE2O8GZJK^B:!G6P MWB_73SK'^1&2_7C.JP+7GJEB;;1!3IY"C85C)\.=JR'[%./%G$F*MGVWL'MC M#'+=U!VQ6](BHY+#J!0_.,5Y;KQ[R"='@3G0NU,FZZ'7(!<`!T1):4+IV&>6>Y>![CXE!W)KMOO;=F$ MJ_F*ZAGH`+=:MEFXH\E3@&EGUDOU7(T296KK`AZ*E+,<$2/8K0>P^4(H)6-B MB^:5+>^L+^6*P*T_U0P1"B-GZV(@A>F)X3`:PPYXX8R]2I@MDN@Z8I\M'?U. M^K.[&0:R[UB^@/-YDLY[#J1.7"'=XUZ*;8K*:^C8_PT%4C558CF:\BS)EAS3`:=/O$4W9QHH!H*4JFM M*MI^VFB,W[8=I@#$Q5[NZ#U;7Y>B\X+<[^V.)"TYMCM>)X)O?R>;%J%+GKO@ M/@K\`*,H*XY;Y`>HPP"+"RK5]IG_?A75G\]:XW$9)VQY6;G.ZRD3 MB12RV4^W+55`+K8ZO,V6IMP=W)'#%NX^E[3N8+;T(O5L_HAP=AT5W.4,U(P1 M#JVZ1%5]?VJ;$]/1E8F-/6UB4JPM+R3UB:;K-AFM+R);KX<1B$QO93\WX@8Q MM^P!H`=*!.<=;5/8'"+Z=,*^\E!*X9__!U!+`P04````"``S@O]$ISC6==<\ M``"NW`(`%``<`&UC:RTR,#$T,#8S,%]D968N>&UL550)``-BI-I38J3:4W5X M"P`!!"4.```$.0$``.Q=6W/;.)9^WZK]#][,Z[J-"P$279V=`@%BQE7I.!6G MI^>-Q4BPQ6V*])"4+_/K%Z0DRDYTX5U2>JM2CDT2!^=\^`@<`.>`O_SU>1Y= M/.HT"Y/X_3OX$WAWH>-),@WC^_?O?KN]Y+?B^OK=7__G/__CE_^ZO/RG^_G# MA4PFB[F.\PN1ZB#7TXNG,)]=_#[5V1\7=VDRO_@]2?\('X/_OKA+TKE.HY>+ MW_57%49&9G9YN1)UL?S-7/SC:Y#IB^97Q?TK=Y&% ML;DLDOG7,"Y1S4SMA1(_SU)]]_Z=*6;0@1:@&!38_&5?D?SE0;]_EX7SA\A` M<]630BH(TW\$T4+?W/$LTWG&)_]:A*F>\GCZ(0R^&N+DH<[,/4.[J=1Y$$9M MK.A4SS"F?PS2U/SVJ-M;M4O$,`I_";Y&NHV:;PMV5\[(GH=YT0UEIOE$$N>F M=S%_O6K(`UHVD#"*NA_,S_L2K,\ZT^FC-@]ZSP\ZSFJRH](BJ[Y=J9-=W)0^[H"QE#V4Y`:Y&8Z#R=!#>#;B1O( MD-O<_"QI<',G@FRFHN2IE0E[!8VA?#)_2/7,/&,8>VW1@M)W=67^FMN.@YEQJ1X8KH./C$]19VAXG#!(97CDTFR,*!\UA-MW&HS MCMX&9BQ5P:3H]%Y,H<_Z,8D>32'CD4_#?'VG8?:;, M%'F'@-XA:%_Y4"#5FD#4*=J#@JMUC,('-I7E+]=QL6!15K:^=TC1!B*Z*^P% M:5RLH7S2:>$*)_'MS+A=!U3<7V@HI=P@"R<&%1E&"S.R;W^H'M_[JV`H8QOV M8Q3M'N"E8+,[_J(%ND2Q?P@&9[RPRD4L-V;B2CN\I_2Y+I4QA% MYJ6XCO,@O@]-*RT7NC[J0QU9O<)#*REFYHK.KF-A4'HIO*EYX7?>W*V+U0.^ MWTJ&-GK_W8HO?4+0KN\*&- MK#7R-!'17>&_Z^E]DP6!G<\/H(K4J9ES%^U6#2BE^;5@;"EM4#.NXRQ/2]=X MLR53C]_=A`Y@5$./H';Y[JHNE_Z^!,\'*;+ER5ZK;XA1C9+=U?N8Q,4$T_P> M+3M]G>K,]"S;+Q_0N)VPL8UHV`S]".]NY*=B)3N)71WKNS#/OOGS@!'U"@^M M9$/DVPD;VHA:HTT3$>,HW`?D6R5U5_]6WQ?#U2LO]("6NPL,H4Q#UM87,(2R MFW7.[^^UU;^!S"%,JO7"'2K6@V+A?1S>A9,@SE>[0*;?_Y1$X>2PEURK[,`J MEO^_=%'TK80>U,V3R1^S))KJ-//^M0CS@]KM+#"$,M7RB$%B,5]$Q<;L33XK M%P"_W5G^D&29^U+<2&)#PYIOVH!5#@%(TXZPMH`AE-T'FYDWW]P9Q[JM'2UD M#V%B.\7>!JBTA6"`NH>`J-[8<:#85L6"=++6;?7K:_6JN-@PSJ^FX?QJ];L.IBT"=DFIY:N2?2ID?E\Z>9=3?1COE#*1L,@_"N+NN M;\3TJFHI^7*NYU]UVE;/;3+Z5')F9*63Q5=]64'24M4]DK8J;$@2QF'AIWTP MSZR>+'1J'\:]K$<_YSJ>ZND0-?40-UVI5RIGU(N2R3;$2[3O@NQK"?DBN[P/ M@@<#/<17.LJS]96B(\.7`*[B^?^RNNROM2\5S-;6Z^M MTD9C2I%U,D23)J,B90PS%\H>YN=)E&1Z^OY=GB[TYF(2Y^9-\J)R*]ET+LO9 MWQZR?3?HFPO;L/FDTS"9RC`S$Y])V3+/X;8WIDEQGT`EE"T4Q1Y2`F!$B5O! M[/"#;TY//-G31W_/F^&:.!D-: M=&T,4:[E;_6@!J/%3L]M0XIAVJHA$3JA=^:4&)\*;PP[3R9T9L`R'B;[E.K' M,%EDT?'OWXJI\6Z6069/I3&DXTCZ)5>B^?_N\B M6V9S[>104Q&^<>ML#]LRE[\\6RJF MIW6ZE$:B?,`\CJ'!#5,AJ''\N8?6!F).VM$"GQDM1D)OC"YE"TH[9BP'2O@0 M"H])!B24Q+P"TN*PZBZ9F0V.U&&Z:S6+NM+)#QJV8ZT M+2HX-?:RRJ/SS)AZ>E.7WEJP!B/ZP.K'Y\C)S&5.EQJ=W8Q5RN5>_^'-,SZ% M%K$4-P;:-D40$)M42X'8INHTYAH#0)ST@\B8[^VK/8F-_W(]-7YL>!<&57CX MWMT)L4B+O=CEDYMTYCJ>PY#5^S8L7&];.39V&2/$@[QRL8"0Y.1YV'UU_01Q M[K!\UM"*8*L5038S-XK-^<<@*K/'=)Z4)U6LRQU8@QM)"]]AEB6DI2SIFAF! M;?Z)JMLQU_%(7O0QZ'OZ<(_11Z_3=?;TH^M'?.Q0SQ80N68N`H!R)"65@^%Y M7CM/J??)^*!]74LLSFVTW61NC37`OJK1MS'U,'`)@8(!X&+/8A6VBGJ@%<^L ML^+9:4![;K0M8_J*3)?77L1(!-Y:MV\Y#I'`PYQA*12$D+I5A\\8;+>53OZT M5.X#Y',C]U`/WX(>L@%R!+2I0,HFA'J; M_5[IM**Y%^VV!\"?@<8] M8WLDWKY"\N;N@[GW91;$QI/ZI-.)L7S[L1Q5XDXSQG:KR\?%IJ%#DPQ!((XRNP*HA2&*]WI!"-#FF/=9NT:]IC,Z0&2'OL MAVS5X.N^5+_^/=2I47CV\D$_ZNA`S'$]`3YW/='M*^99P,!*F5U?,,38: MNUCE7$!W-.^HYJ1HH/;;Q9+.>(W!B6+#(E]M6'PQM1YP;K8]7FSP$26@HM*U M%;(E,5.U*B4-L';]Q*EE4[5U97I`[!@\.#B4;"_@4^)2SY&$.)YM612X1&[V MO(0#3M<5Z=90!UJ]$SH_4ON?G,]P"LW>.2[GRTP7UX)X:OYSW"2>[LZNW_N\ M;WD0$H MRB:7RFT7$](\*O\TA^Y^0#O_)%?A0DXGW"/*5A)`PP)CBP/C`"'%Q(W%E%G@3W1OM_)/GK[_GL22_N)M"W7&[;&",IF>48:%QW<[J$ M<)UV7#I2\$1_7.H?N2-QZF,P7[\+1N?E-Y&;D6B;!!^;EP8S;`9B\UIQXBE" M*[]=$KO=*4U'2AGNCS4]0#4&33X%+^7Z^I=DI>K:%)W]+4VR?9/50T5]"Q`( M",.6H,(1EH6*#)/U:240M'-;CI3CVY(8/6-TY%RP'7DR0U3C&_>.(\(M21T/ M>"YE$E3`"."U6_(X4E9M0_*<`)X=B-9LY%2+*'I9?2?^`+7:"_8=""T+".F: M5XK:CJ,\5J4_0,=MY]@<*:>U`YE&0_!(#H[4V20-'Y9AW%W\G#V"?"P9P(`1 M(HFPS>MD([R9>F+2[E2R(Z6A]N?N](?8&-SYN"A0N[D3Q8&K:5A\WNSW63B9 M+16^>="IF3;N\WWJ"?")0)`9(Q7`7#C$(ZY5Y=2ZDK0[0_U(N9PMN3((4F-P MI!@U11(_ZK18J%S^EA6W&6#W=MZ#33)`!&EE485=9"B,. MD5T>(;R*IS>]<"O.'"DILB5G!D6LS8IM$F=)%$Y+-VR='O3[+#'CX\U3K*>W MBZ]9.`V#]&7Y-;GB8IK-PH?UF+KZB.+ZS.^;N_4-=U7"N'GS)%Z:M6M)>%0E M?`LI"RH@$4#2XM)B$GN;B0EI-ZL_5E9C"Y_II.'NQSW_4N2_F*[Y3J?E*?3U M_>]O2_H`2RZ`4=M5%!(@F26KA0W+A2WC2Z^"CP7:DI/I/:?(8%I.4(+HN[)N75Z^+Y@JBS>?JR\]. M/T0ZUYOO^[0^?[6?.GT'<>HIQA4DB'N`"@RK7IMQMZ6#?QXK[*>&[IA9\=L^ M)-[7%XJ+*4VX_'H5CZ?&]2B@VGZPY>@5?S`_[U<;*9E.'[5YT'LN!JP#YP,, MKUK-@PHZ*V*D&&NG&Y=03]T@"N*)OIWI5\?HCEWOTH^3I:_:8_2?6LB(M\U&7WHH^DR7)1-ASL.^;%\IYY%93ID>*)>1EX M$:DU8.>PN[Y5?_[J*Q2W@>D<53`IWLP74^BS?DRBQ\*Y3?4TS-=W3N)HD6+\ M,[QYHU@U)N[Q*?:6\X&+A7&W/$=8#D">:P:OPOTR#KE-;:D.)HN.9^NA4T1V MEBD"4*'TB*22*4$MR[&`N[81>'BLH,F]QX7TU$K?IC[UA,G)'@S27]*-L&P. M/>Q1X@&OP$!@8`!A0GEF2N*,%2O?*.FFA^:MF5W3#)WSSYRPN*!2&LP\B3WA M4-NU26&O!`+;$)QA=DWM%FR<0M$.JQ^?(^-SHV5VS?&HT7VOMG%VC5288("P M`ZDD6'G$872I$J$>Y>V^WW'$[)K:$._,KFF&R+F>1!6R2)=11B71S3(A;Z9Y(D96[SP?I9K'7]Y M2K[,DD46Q-/;\+FXLG?$;B_05X1S2`A4F!&'/+'DV:XMEAP! ML[8$20Q&*GS4WRC)'](P^O)DKKP8K5[KJ!_-Q5I4Z2C:9X@:#XH)SWA!%$@! MBY-E).4(,F@1VQW)5S@2:<9%;Y1(IS<>U`'O\?N'?9L(FW#&&?.(`IQ)!,7: MVW*1:A>4._`!+/W[CIV!&;^I#_H-VQ[W75=AES!B7AF"+8"44')ME26`=;I> M8YT?Z6F5]@;G`-E*2FVZ.((\!#U8[ M);3EV5F#^7_=6B$9%IPQ7N,=&ZX'S[_=6\ZW7!L5NV488#.-LHCDGKVV4UJH MW8L]F#_7"PF&`&:4F?\6M^77X#F<+S9?JQ3!@[FS-ZNSB1C?+@T4@*,MW-=T]T?;&>X)L&/1QGM^")>1+,4Q0/MR]&J4]@F@%!%+2-=, M@VV7"\B]M5?O`:Y6"<-)EH/R',_QL_RVJY,SQ8"L`P?.@+G7&\T(?5R3TW=W5;?V<9'V*/ MN8R[EB<`8Y39A#IK^YC;\@NA@T7:#]/Z?:%SK/&"SXOIU,TBS_(@GAI?J.%( M\5UYWQ%0$>9(FTC%I<4Y]\3&]<;MUI@'.Y1FO#&B*U+'8HA('G4\!R/8\M28-,SDG8<&>RPF?$XTAFJ45R(2$_O]71Y M0M?')+\U76!QVDGT8CK#I#C18AF2KC=K-'O/VVLASD>U)E\D;T\V17GM(5%^(7X2+44"H12%6 MTN6V9;GE)K#G0LMK^8V)P0ZB&88Z@\$U5,;?[ER7W7=6P7_%`S]P7@OR.#=N M!)*,V8AP,^=PE\L2PG@3Y/!G\LXBKX4Y'!,;NIPS4!QN+8ANS,!WR M6FJW4OV\ED:8G&Q>2R\1L)YM(^FZT&"*',MQ;&*OH;!=-5:D6H5M#U0R%;(7.C]3^)Q?3<`K- M_D-%P$I.'>C8CH,MI9"+"29D;:QE62?V^=>N+=9/!&PSS'[`"%AH(8"@\<64 MQS"`R(&R`=N6-..B-\9PY)?#^[?=^P,S/A-+8)MS6WC MR/8OX?WXB.?N5&635)*Z^Q&EL9G$NXZ5E:S9R?WU%Y1,RK$MD0)!$,[]D!AAT6]AL$459W5^F1T?C4.5+?T MUZ#ZR=&$$TG^T67US>^;W6KSXY&SV@4_S@81)MPQ3IA$$*$Q5@QHZ9R#P/03 M)D2EMJ%&KOO3M;9>`K;74#8+G-%.*D40EJ+=V9,6=A)9#])BSY>GO2YL!TP& MYK643W+.`;!$&V(8$`AB1_NH%\*NXL#`%!6-J:-,0^97T7MU:_[2ZIZ\WC^O M[HQO$$&-"T]BZ>R)\7'2,]8(Y0RQC.P;!V#2;X3(5U$^.UH;9\MG\P#T>DMH M&=20,L0^FZS! MBQN=IF'UZW.D.ENP/FI,M@XO[X$KVR9ABFA&B%1(&PQ<;\1HE7I^XUR+>T:( M3_;`O0R17['^`_&V51PG"-@H/U0\VD@M`M`SK(6O+(KWTJK_9G):^6QPE8`]M.>?V'(ZTHU21Y4:5/`*2T6LUN,W#,Z@M7 M!T$8MT!JRZ3$2A/N6`\,-"HM(72A[A0YE)R&RU)UQG,W0R)<$:<@=5@X18!" M6/9)#AJ9M)KCA7I5Y"PGR@384K3)VPR).4S:M8XRYQV```'-^J@72CSZ=J&6 M%CE),@VG(E7I>1O;("20Y\##.'5&%ZG-5^K#YB)Q*5FHB44J#W*A4R8VG+.Q MC3*4:6^%9`09@JSBX*%*0CN@CB>EOX;V%*G:SX7.4NM"_L8VV&/-K)&Z[2[M MN8]?`.[D)I:DI7TNU',BY]HP%:G9>@;<;*_VQ]+NFNO9S_Y\\5DO_[:*9@1^ M=;/YG]7MKCFT#U%WUX\.[OU'L]KNHH[?W7UHDWK;W<%XP=OUW:;[4:^V-]N> M3F<^K:S/"0IQ$-<;;6%D$X5&0V*YA]HS9PS@@SOR]6(YU!PAVS,"$A+%+Y\[ M$:?Q:,8;)T6'H::L5/;ZV68*"[%F70?FU39K.!S?W)^I_*;EQO`F[)E1@?)] M7V8+E-0D(N,%\!TP1.A2YQA=M!&[`"V>U>+D0K1,5=:+;SNX*7=V7"!82FJD MX1`0XJ+SJ0'LY,1"J7HW;;-H;QPC)F'UZW*CNLW:^BBQ0,;F>GO_[O/^-(<1 M]7E/K@U>&@PA@=@R`0%U5FO9K_%65E>3ET4WS\KQIJ%20LL/;M#=%_?G]_AQ M-(.J?GE`H+;->B)&1*&8H`0X@7O)E*[LY(MY])T%FA)*/QA*1[OI^E^[0T7J M&;V?'!,<]=&>5U0[IQ'P`"O;6TT(J[2-G-D^]3I8GKJ\.I9UWURX^N#V$XO-Z\^UA M83G\VSQ/=JO-763D]GVS,>MOW]9W'[^N-DW)9[4?PU44W-[<[NZ;ZYQ>W2)9:BU^,9B8'?[U7+C,$/"[D`,G0GC#@X(7 MB@I./?3<*@9,7"=H)RGBN-39DJ,B>%DU-XH-"1`EF%BGGW\RD#)F6)#01P0( MMKX][)@PC/'QRP"$UA=CRZF-40J>A-0K4G4U(;-:-;Q4[/3->KNW> M"#?*:FX@T3T>EL-*^K_.3;:Y<:MC^ILTE05G"0=MYP2B+.,8V_BY=!+''RLY MZW+Y:>E"H,I3XT065G/_[D3T,>4VP2"A"30*4 MI4M6R(JO36/7G<"U(U@P!(2PSBLL!#"='`*#M"K3[$4#1=>4"S$IH=M_-ONV M9-?JCTC$+\W;70O3N\][Z;>/LE?5[]O[S>KJG-EQZ:V"H,S!H?Y]@!<#""XZ]UT(JXV&<'3N'%OK* MFA7-I^9$/J6`N!B9'K8TGJ/5[]:E3E#C[QR4I0A9#+P&D$K/E"6N-^FB4NKP MDNH@W&RP%K*4-_L]A=7MHYVS)RZA6=W>OML?:-_N6O^S+5^XNQ_PKE+O&K@U M&%)G&.=40B*C9]$;A<*]BKEN#D8\M[,+(5P-"[N-W^;Z_:$P3;7R?-F/FTS& MLS5I@:C:C>"YVY$%G.5LWU<+M\!1^_4 M2(B9YA[T.\Y2)":K%9LCYK9>IF!5C>VR%R*+Y7*\4W#0&""]X)YAH81B!OM^ M_86LLA/#,^DUQ6I)QJQ"FR6!21?<,VCJA=%"X^B$6NDI(;;?5E(0I[43+CP7 MY>74?.@MMF)=NE(%@3F5WGJ(,+88ZVCI]U^-C.M\W79*'E;D0&:N$L.7*\9& M=N::I:1MSE+!ON3SHT=;$`U!I8B2QTT><"#QA2)U&I8&?!CF>C63-;Q[/+,*^V MXUD/B/[Q:$+SF^8_N^;N:NCHT!&C`]/.&8884!HQ$M_"`_$`%#-2ELIW6*@# MVFB:G")J-F1+V)8O+8[].P_VO!HQ.G"!XK`#`,D^C6\ZY5$:R"`#MI7:) M3NW\C9=RZ'$$1R;"590D^D?_U[_?-)OX[*\_WC1_-+?C#9HS-PAQ.:?*,JC; M[O!&$XL5["3G3J?EG5P>$WN]-DT^;>YZ+D+14G;Q/,,AQ81#W@$N(]'Z' MJ_^\`*^X`6QN18^9G#+#^->E5&ICO%?2G3:5''FP+,$3L]I^ MC1BT?[C_[&[^6-W^-(>V.1"WZQ:T,\P9?8]@J964240A0-&Y-$ZU3;T?Y+1D!^N[M? MW7VY^?WVX?7?-C,UC#[_3/.U+0#=_G9G5IO-CU97AP,%/W?#ELP:Z=YA3.;' MLVNCZV.)T=`3+QR54#%!V]0IQ"7#V-C!#O7SR'3LF=Z]\5`NQHD1`3C/.90& M"(B!AM%'X*R33\G$Y,?,F143M+*>`X5J^+K]>'CP=F!3X.RX MX+"$<4HEW%#BL5700-V#`XKE7%^T%S!9T4^)DQ&A$N;'P^L-1E9_NBZ(Z+D[ M3QS75E,C,4+:=7(8R%F]`?E,^GFJ]0SHO%YM5QSX%%@NH^-5=? M[]:WZR\_QBGNY/4!*B'BJSH`@*+*"$UE9/DT^.SH1@)+J4U?_V=ULFFN[:Z,%[YO- MS?I9(%EF1CI^7_M:]U> M?_12&T,8D?=1]VZAVK-\T4LOJ%=`1SO10V\H)=J03C[@ M?:DSHR^,7H[6RLCHY64H_,6BEX9*(KWB;0VTITPH[&0/-BF6X9$E>CE:T1=% M+R]#J-YX%F04(`NP<1K+:(:0M*B4$9?L2*6:CL M\@_-E]7F^G#VW$^7+=H\I!6Y>1/=NF=O/\:W&C,\*$ZMM]0B+P@7.CK"ZJ$[ MJ"%178-5N'.[6UT<[[0P^L<_5O]:;\SM:CO8WF/2?0.)\ZP5- MAQ51H-3NX_F6'EF5?M*;FQ^^:GV^,P@_EGFHJ'7\78)5`$1%`6> M@2.N\FR66:GR-#5R-E2+).">?OOCN[]=?3M]ZG;BG8*-!H&,"[;CTGNM('6" M]A."`Q7[H;-H?#RK,J+YUV98=;[O:R16>4*9W?9^_:W9O+G9WI]VJ\]<'8BA M&`IMI"4Z>@A<,-]C!U0Y8HRL`)A+8T_K2"8C528,MOGCYJI17S;-H9QSD`$G M1@2%O9=.`(FY1PPI#S3O9&O/@ZHK7:$4"_*@E1`S>_]U%1WCJQ]OXM/OMLWY M@-G+%P?)@),>886-H5H##('M7U*SM!C)?.5C,ZLT&U`EONM/F]5U\VVU^7=; MXK3_H95\^.L^.RX0S"QC3#I+HZP<@;SXE9$6[T0>'] M@7K/L!GDR)CQ@7I*%6;4L>@$"D24(K"3N\W.2>)*]M/-BW-E!NQ*<.;=_==F M_F_N9_]_LYAX1? MF$:>?=JW%N9Z9,"EH+<^/1!OACGJ>QY<3-@N..<`V\ M!QXRZX'"LG?W$09I_%G"DYZ9/WGP6][T239Y`H&*0:NYH!(@"WF$M)]7M21I M.]1+N-@S,^5RK);)4.GS^B]+2YFU<\J<9P;]O;G^TIH,5U'F?5.=0H^QT2[Y M8P]TWUQG+V9168\O<>Q&]JAUU(*)2,O37/_IGV1J&S]XWA!>Z)A.U=] MBJ^J?SQHUC;;FR]W^VM''SN4_:&!"L`=3EC+Q MY%2?K*5!K3:5Z2BV_O%V=;_;-`-92R\/"-A!8P6G`'D?;74F#+$='(:+M-V[ M4L<)+QE=?4:ED\+QZ.41WDE%E'?UIAQ- M5=-)K4]&YU?1?77)0#6H?`$O=;UIXLSF_KS:-TOL)K_AGN7GQ@6GXI0H&`1, M6P$8YZ21S#H.Z`J!959X%D1*Z?F[,#-B"+P\(%`IF*($8`8<0 MBM8/P3V+"2S5>.:UVX)9T%V&-X,VP:DA01``I?*$8HB81``8I#KI/(&R7IMP MJKH&M3\)H5^-!]79A[6H?PEWX/".S;7:/KSV,7HY:"^,&!VPL5!#*@@B"!`I MN*6NDYE#6,Q9&&<\3%?=,U\A-T0E:/%V?7?=O_@@#5ZX.CA@(RK`"D8\TLY! MZF@OD\"5981G5_MT2$JH^24;:>Q]GS=XDUMBE=;VY M?)?[M1N.F?!=BCV#1L/I0<&3^)%I"+E"<0ZDC",A>@DIQO6:C].5-H(%DU#Z M%?E0G1E9$PW*J__]IOF^NKEV?W[?5\>HN^M]/K/9;3;1U!F9-#[^)D$828UB MV%'L@3&$:],OIX*84F7U(RV,'*I<%\*J6$W!)94$/\GC!)'6.^]WWWT^_G)/XE$[D*>'!VBUPYXCXBF(SE1[U&,? MWA=&5':HZCSY,C,`50$].H;_2*=(?XO`K/`FRFXX09P3Q_'QDY,8Z[J6C45H MD@I66:KLR?QVW6IB=3MXI.79<8$B[P3%"&NAN<<$:ME'WR"2E777GYL4TQ$J MRX2>KPEL.#$V8.JBC:SV-4U(,R0]DYV\UJ/*TO#G9D0>E.9*P'^6AMWGW->1 M01,:QM5`D`=')3,:V M1)`XSSD$SHY"H&")4(@Y5U2%340YAFJB@65GNY->([&X,^.J85#(L7UNYW;6 M#G]U5<$H$,03P0!!ED$.I)4U#8)Z/U[??`<^'.)D+QP^)D]'YU_/R\K\+/RO M`.?SYODL$W^YKI!(F;`G&8<,V7J.O-$8RY\0@?.Q!?UXKLU]]%8%6*6T]L4&+ M1`1)`5A-&06Z6PU?XIS:H=2@02#Y*(4Q$$`I'3,X9G(I$0A2C0@+J$:<`-N7 M36TJ9+JA\[OP?G3:U!A8GI_5:8JB"-:`$*.DT5B&?=!7/`988\J,`KZF#!!S]J#+$11%=67Y((A\I*(HI2$T M1DCAI4%`S;Y'> MFX>]2;++D9R^*MUYWYCN\%)PT:T*AB$%PAN"K=70!(O9FQT:'E"'NPE(!N-O MB"!W4JC:"\ZJG/[CL?H>,/D>[)*=V.Q^?RLPNT]?VT/G\H;.C"@PQE2%O94A MQ9#$AN,Z_A!H,K9;0G(&0[`[^X=%)$]$9KU9SM8O)Z1T=:K;>*OQ88D-%&I. M@$4ZF-/">`1KNKWM6.J<(9.P_T*0`I_LV\9KM\;!9IY!S$\J0:O+]YB*Z(:=Y@1?W6V4!'N[#D+R,*P+!V M4@9E+H"K%+`*XIHV:&@W%V:R4WK29.?U02153NNG1?BU_#KYD:IW\:L'C")= MMIE/C!Z$5S'N''^T2)P].:[P`$EMA,<240L)\$A!YB7A4@.D\952:`_-^5PR M[=$Q!4'"$+C:EVJYCL<)NM3I]WG+;H87SF`,/#=:2`68\-C]W3\-P MK@J+EBI\?SY42?')EG^RF,SW$]^?$?WI[DN[1)3C(PNL@PD4MD0AH,7A%3$: MZYI6ATFW+(5DCLC!9"$-/#E$X<_%LIQ6CXO9W^5]`$*7B\"!]2D5[\B(0E(N M@3:`"H>0`"0L0ZRF33B8ZY202UD_J$$P##97Y/O7I\GZG]5F?O_I^=MDNG8/ M#^5TE[_S([JR+A>+,S-JH[&8_H%(X?4#`M=#J'Z M,@M$/,RFD\7:;#,Q/RV.T/9I=5=.5M4BV%,OM]5JM3T>;!NYN7G8#0F-LMGIHLC))&+,>!;58[Q_V8/,]V*0MN MM9X]A]?LYJ&FZ(_39[BVOTE!G4$.:Q-T"P\%4HZCQH'@=,=BG&1!DL2^LZ'A MNI;`-#TJ[LJ'S>)>W?_/9K6.=H`/B'XIU^N=\^Z?L_53&!C[1=1*YX5"U?U! M!=1AO^!`!X993)WG`!'F'?7`2\9@-_4\6;0EG^!E@S2'<$9[IB%@]7/VL3OC MGXO-:C.9WRZK[[/H!3FUH%UTG\`.(IT7`7@JC4<`6>SW[(!`ZFXN7O:Q1"LE M8M=:UF[+8,_&,/3N*-=M5'O?[O/"=>O$G8J(JP3&,2($HP`K)6K#&#+7L7*- M?RSI28O9%8W*>N(WBU=!7S6=+C<[K=A2QJ M3K[Y\QK/'`/=*4_6;O/DZS9W"V0U)O7M?+*PLU5,'=@L6[9[:S&^H(8K[[6G M3"*E%=32*"&"DF(4-IB>C=DE\C)-G\K[S7S;,O0M%:N?9*S.9;1<=)^@YULM M+*$:<0^$=HP;L\<"&0MRM;@YTSQN4*Z^]0601$1"!VIDF*'9NA"U M3>GOS>%W]G<&V#+V*7I-PX42U/(.!9>,0"4.RIC,0/_HE9$BS:TBDKB,1 MM;?L8I%X/;!PE'DFA`SO%HIT&H@:_*@C(^M-FELF>D!U':&(48QIV"?ORO5F MN;C9+GJ[P\0N$I'CMRDX@@`"@;47W`CF)26U28FE)Z,[5"6OP`P&7(>,]/>S M4<_5QOSJA[^(P"VBJD?08%:SJKEJP7/+,O[V7JRN/^Z#)ODECLW?\UG MC]N1JZ,"E.&I!6$4(28-D]Q092@GFM>P>6*[Y<$G+'U.(6_CP_DZJ]OG//+ MSF?]:?%0+9^W(ITF>/7^.:.HL-Y/ZZ[\%E>#&$1MYM($M0Y!QQK5$ MGGM!)2%"(6Z#A!%LSAJ2J2-6)XC0+_LOV\>M6M^MD$I(KB02L9LRL-$'!O>X M2-4BDIC4L@X\&KU*!-MH0UF7G)4E)+':86:ZUUP)Y2F4-,&0FE^G=,=24 M@+E'SU2Z#*D<>LCEY^\(&@Q%'@BWSD-'@3+2US1PX=QX`T4=^'#B()YN.'Q, MGHXNI).7E?E9V/$L'N,E@-P2I:DE'HCHTMG380$?63UE)PZB#]ON3X`.A^7VZ/; MHL?`Y/YNY]EJO9S]M8FX?:GFVY^G^Y^<&%%83CA7&`*/$2$HT&U4/5TA4;;, MF7;[HJQ18=&#=OJ'&MF=B>;^KRMMZC5>W8=<*A$T>#[E,V@XM@+,4>L0A MIQ(Z:9FVCVLAN,AFOPR]\5IQ!BF'((48,26) ME]117-,1&[M]5)N]-7].FG/=T/FXW/Y@-GL>)OI)/0>#9#IY;8&J MQ7UMFIRTX%N/+PRC#*FPW$'N@UD7V-RC"'D8@TA9Y"AU2.\-E3XQA'?L0I[;N>K`Y&317=\`!+2&- MIVTX@V`P0BF#MIZN(AT/O$Z6W]N?D\-A,1SK[L/B,?^R63[&GUW6Y][W+:RS MEE%AN1.`.J80M(V.&L^1'\>Z/1@#SPM$,NPZB,W7++NZ_]L^%!(Y%.J;8(9.HB59:YAG4QV.C"B\ M]UN')(?<$$>BJ[)1-1SCW;B<++NY'Y>'Q2('GTVU_%:%N9[/1WIS9:$9]E13 M[HPR2#C@8Z%DK5I`V$VY3M8=K?#&M4L)9T4L1QO?%T-'#1^6_[5JE_KH0%% MF#SQA--X=`WGS+!`5@V#()2']_6Z%/,W=IU%-P&-O1P'.T*7 M`9?R51=0]V.]G`3NS!:3Y.;U=@\UU?.W9?D4`UK?RY^RK5_B M%]4BVF#7S-FI`VA_M,G0>7=Q(8&&3%+C@N7H,,$:4R<4A,+',^C566=&8JK. MIMK\EMW9CN_AE[?L#A\5?Y2/D_FNY=B1=)<#5Q4(.A+/L*!<(<)]L&`TE!<><6$&)-2Y8(`P2I4T]7PXL M'E\V2B_4JT%A&#_[1I->C;B?+L)Q$/62R>#GK[SYP=1'`4$AKX91$ M6"*+->/USF.\Z=9_:G`?:7=65$-#D+6&5/7L+@R#WE%$,,>%&<>5B8M2. M+HB1'-]F.S"_JG0H_3Y2,)H]>XS,S\_T5]Z';7^Y^=:]]+.HZ>PNW^X&A4#> M3^>SA9;9X-)/5DY]7__K/\O[Q1([;D+F]A010AM-%!&,]EHYK)C0[AD M4=YDHC0\5)F%YI0;/;PG-P]?)S_:24V;.Q4&,LHQ8!)C`[DT-MC[-194N['5 MR0_G#DX+5)8LH%,!EVW0\*ZKU38XM8TEMA"@'G@149Y#C817 MJL:(2SVV4HSAA"D?:#D$Z^U9:MCN@DRR)YEX/0LP7VP;3,]T\YE2EP9D1A./-$"AX,$PH-=)X! M8$E0'S3$#-JS.?(=IWPL#>#$U87RPCD99"7FO5HI)12BGJHEJ%O/PH%R`0:# MN1H:AP19`4=J];[/[H,XK^["JQ^6["]/D^6Q!M`GKR\<#K:5`EPC@#VEB@)/ M:OK">YXKA-4JKC$(GZKA4>E4;'G@T4=]U&=&%`Y1X[T'8:D'P&M&M&NFRPD; MX6&@`\%_CIF]\!D]6T<3?!@7-WMS\69^__JQ)\M9#UY;&"RMXPX"@R@D(I[> MYNLI*BI'4CPU&-#5L'AT:2)2_JLURPY>6]!`GZ%282X]BFU.C:3-!B)9MTC? MX*Z*%"P;`H\\M:G/S]5BJP`T$#3D1Z-W&3.;CUI^;887V`)K"!6$!8L)6&[1 MS[7*0CJB5@-#*L`)(;NL'I>3Y[LR8CA;/*K-^JE: MSOZ.)^'5UZCGF)9_,ANHXST+8P"R/KQL:GND'J'0PP:?T512IA*A7+A=T]6T M/\MWYS&;OFRCX)/IOO_&P9AX[3NYC05#X8OUKF-'M%R^5A=78EUU7@4`$#B/ MC$9&`"8%`\;4?-+APW$X5E/)]T?"/I_KK8W?\+17;O"*I&Z3W*6X/I7KV%EG ME7G*Y\O@_OW?XE=_A44S_/'_4$L#!!0````(`#."_T1!Q!R1'*,``#BD"``4 M`!P`;6-K+3(P,30P-C,P7VQA8BYX;6Q55`D``V*DVE-BI-I3=7@+``$$)0X` M``0Y`0``[)U=ZJVK+U=NST;&1 M@3-EFZDT>`"[[/GU*[[2:6>:E(1$TA,[%UTY=IKSZD%Z.3H2\..?'V_7Q@,M MRC3/?GH'/ICO#)HM\U6:7?_T[I>+$WP1GIV]^_.?_OW??OR/DY._!5_.#9(O M[V]I5AEA09.*KHSO:75C_+JBY3?CJLAOC5_SXEOZD+PWKO+BEA;K)^-7>AFG M:W;,\N2D.Y31?F(__/9#_9_+I*3&8YG^4"YOZ&URGB^3JM%T4U5W/YR>?O_^ M_58VL3F" M]%]_W/G^=]A\&R"$3IO?;KY:ION^R`X+3O_V\_E%T\Z3-"NK)%O2=XR&8;0\ MBGQ-O]`KH_[WER]G;\I#I_4W3C-Z79^'S[1(\]5%E135>7))UTQ'<[2;@E[M M/\2Z*%X+6:]7:.O$K6BCO'SB'? M%KVNOW;./G7?K`\_8,--],YBJ-<\7QS;2U4_OV*?%?7ERG21W MBPMZ75^UOM"[O*C8I0A?EE61+*N%[0((G-"WKLB#.%PT MQUO0[.27BSY\\R-%QW\G@F"7;D'+_+Y8ME9+ M=4!;/NLZD\B+OON]Z"2X6!IYL:(%2WWZOTJ*Y8$ST7WC=)FSZ_9==?+BI-09 MD.IVY(I[6@N&-6,OE-V1PS*5U?V:?KIZ'?DLJU.\)E$+GKI??DTNUW2!L(\\ MC"S?LBUDDLBW$>BE8.B$BVIS)3D\LC3$%QETU1L7O:&1UTDV\BMC=Q1NR7YO M7#YMOO%;HWU@:$YW>C@][\AG1M`.]9P4/7XI3G;(2C6>I[FXK,XFOC9@[3BY MO?D+Z^`4/Z;E`B&;P`BZQ`N"./"MV'%0%P`#-T0BCLM_5,T^V@AA60N3(FJ+ M`F3XS$X/%#$+X^.AQ9$VS1_P&7%$,W$/">'YV-XA,])_IK>7M%CX3NSZ'O,/ M$L4@/P(C7@$9JS!^DHF_4MP@. MC7M!4',:^:+2]XU]J>9SC_Z?D\?T]OZV"X+#&)G`(S8.'&+'IL]B]D&(Z0&1 M\2]V9,T.T(DQ?FOEB'J`("4^%]`'2,P'^-EH<8(7&`:\0`[73-Q`4GRNHL>( M5F6JI*+U_"*X+].,EF4WW2B;)"1V8N1#1#SBA9$=60BP*4<7-(PB2ZC^,BJ2 M9L?H-?7S]5)NMC"2)F>Y9#*04G7BP^CTE#J&J`P5-930G(GQ*&K,ZT*%0D3\ MQM3&://516#9V(($^]CQ/1?Y%B'>QOUP%`@9D="1=9=X^_J@W'1%D)+0&I0& M0+*&8!'G-Q3+DQ.]?3))"<-`2;I??%B0MJR*]O*]KHA?YNOFW M[%(CXMF>AR$P8VC9ML5,*,1].!]9)H\YC(VAV2:VI1D;;:(3G-$@A_UC2H9B M3C(3?*MNSUM3V9\%QA>*1N+\P&W/K(6UY]JF"\W&<0\T>8_WJH)T9!=6UHQ< M;=^12];V+6"=LXSQC*6/Y0(2UP*NYWH!LF(O]AUDVWUL&X:^1`XW+N!$J=W> MQ6'CMUJGT0B53/I&TA;*!:<#+94BCF(\R4ZE?=P$=BV-PCZO3%-1FP[L9E(` MC"LO_4(?:'9/"2W2![J*6:,O:/&0+FGYF;(NRZZLUW1A1L0!L>4!ST$@0L0- MR*::[T#`56A7%DSWZENKT>A$&K5*HY?YWG@6*I!TJ8%\.'F=G*_@$MYLT?(G MMI,CELMP%:#FR7EY:+R1_"H%.8,L6&U[U!@@NPH^T+.L MK(K[=@4G6_V5KJ[K[?]+]JNT2FE)TG*YSLO[@FYN"?`C%/@$8>@'*`ICF_@N M\AW@Q\PK@]AU.(>83@D:BX<;U<:6;"/)5D8GW'A6;CQ+/]YM,B,X#PSF*<[> M3(;[)$W-IQ\ MH>`:?6+09C>B!.6_.4ID,/!OE$RSK;U7R,*A@_TPLD(;@L"!<1QLAA>;*PAM ME!0ZLNZ-DJT8Z8V28I3XW$$?(#%OX&>C9Z/D-H:AC9)2N&;B"I+B7V^4'(%` MXEH8/'U,JOKJ6^]^L@'!."#LD@M\4-^4Y9MN'\TQ`Z$]U)(A=&\]V*AJ;FAL MAS&2#EXHD:CB9N\S7`BT^PQ MSUBX'$:"XNS\1:8-;[J+-!!N;XGS@J;76?2XO*GO.@OSK"DD="F4#0/3MD., MP@"BV+)([/:3*AR$OM"-H>,B:7:;3IS1JS-Z>;(SHI%<^?QG.J1B1C2&IA9' M&@0U8$UJ`,_$HQ0U)M?1!P5=ZRQC8YR6U9>DHA??D[LN&C`A\NI")S1A`!TW MQ&;<1S/M4.@N-I M`KU%1\A[!('.UGU$VW'0?Z3`"%2E"[5@AX)W!"&@1LXQ(QC MX(1]02I&V++%"M#CXVFO1_<2C:3<[/=Z5BD[#U."FK=KU:,":JMD' MJ0T6M]4QGXF[*6W23NE;-2YNS_N89ZM-]/XNV=CR8101R[9LSP'(<[Q-J#BT ML(C'R1Q?LZ=]S"M#EZ])X>3S,=TDQ7Q+$40MWK6'U(!7C>$Z$V\:U81<73>3 M7N$_W]RC:M6EH^0\]Q1+U,>_)WL.$:WU:G.!, MAL6H)KRY.BV+0V0:LBS2NWJ^\^FJ6V@*[XN"9LNG9QG/&^(7+@2.Z<>A#0D) M0&@A]KG5$9M.!(6NU\J#ZY^@]'KK-Q+T:["]9&-KZ#V+%I^L*#XAW#.7XYT+ MX6F,RM.@:THCA'-X?J/GS,S&.76U;W?FHQ/D0<]-LP=:5MM[C_):2[+&M_E] M5BT@A`X.?>1:V+40##W8[Z9FX4(">:QU;(PIMQQVRHQ6&J=/CH8X;(=3\I/- MZP30#7A;29ZQ+%<4C.Y2R9N1J.Y?PD^BK^R*M MG@9,KP3ULV5!''BV2:P`^[X?QA;H@\<$"&U$5!-1LQ?U(@_D$*()G"+:?%G; M]*#%3&L\8TU/QN?`-I"2J<4^DSQ,<:-VGK"O'IG<+'=[7]/>&\&9*P\6R2OTZ8E)L%Y%>#C9ML5?%:=*@^7+?B#.8.J.39[P8E&%^>UN_+Z-NA^@3_W6= M%#Z[F\/Y$'/#7G$]"=QUQO=&>ZJ2K5/5/O_-J,4;C?K)WQ@@!WG`4W6?MIE8 MKO9FOG[5P"18^7.=?]RS=&IS6;!1Z,+ZT;$1]@'"3E"_Z``1)PAC*[0P[]8+ MP:-JS&L:(4?,95Z`&,I@Y(C-9!#)JG^=K8R!(/#26C:>;O(U8U*V$3_F%7U^ M+NKSF`/$=V`4$Y_X'G8!"/%&@.,X-ED\T.(RYW^%K:JX(N-E6R+_!7!+ZA^- M5JSPRVR54>9,,XZ"5S"QV,.UKB#3%P]^/F(6PM*C[ MXCP>%*_VK`P61H_4`6;B/<=K_TXI]J@G0M;)6/"/E,DMTGR5+KN?ADS@PG(A M(H$#'9.XEN=8)""DCX],3W`A25%0S:4FILJXZV2Q#ZT!T" M:1"/='CVV_=&S;S7N?E5K?2XIOTF0'XS'G\.YFFR"MHU;)ZJP(TPQ>;)>]W; M?LO@*;J]6^=/M%BP1#*,`L=#D5TOI!%`X$:`Z_OA.%>4C:I]P7W?P'TAMGX2 M=R]WM%-*PY>URBFXJ_!*">03>>4;!(7,WU3L#RB^K5\4_,_FJ3KYU2]909?Y=9;^DZ[PLKI/BC19G^=E2W$T2$ZUE>O]O&'<7]-RTVVB9OO[W5:%M<[_7L M&FU\NC(VS=XO8\QOS+:U@N\=/=W>?(XWI_\NVS7U)?&'LE) MS<38AE+WI6TL>[INC6:W_Y;_WWL/]E[^5U3_+MLGTHOE7HG]K]&;>=[*/<<. ML"<_G:M4[KXZ@[>._[[YY?\BIB6\_,_DU`;VZ2I.LR1;,OF?\S)M'M#;5Z7- M.#")1XCK1Z[EN!@XP/+]F$#/BKT@Y+U)2DDLGH-$K/-[*$@^W MP25HA=AG,MU6VZ:=A6?EP+C'8SO:-U$\SXE]Z-CL?Z8?82N(0M!'L5V+ZY$A MDH?6/,'$%Q?1UPO!JJ$H'3Y?T@A&S(%:(<]@+73^.^^`6LHB(TZB)J-MYF+IFY]FR_D"? M=0J:D"*\?*8T/5DQD]I`;3YL27QO))71JVQ+3Q/;%A>Z`1M3BWXFMJ:X4;G. MWBIH>U_HDK*0EVM:?J15Y[4+!YH8F4%4/X':=$G$)G=V'\R!L="[Y^4B:+:U M+5'OC8SR/HYQ)#4^]](/3,RM7K!BBC;)U<36M)?+@!6-XS@3ZQG9B%QEUQ)^ MI^H#.WI>/+%0"\_W+6PAW_?"``)$3&B2-@8T8>0(O6E,Z,":C:37DLH9B1@C M/O_0AD?,-C8R&M.8_)VHSPP&+$(*U4R<04[[SEM/I0%P^\#G@MXEZ2IJ]Y"S M3.=3=4.+%Y.[1801#A!+;V*;V5#DVE:?W4#3![XG8@\JXFEVC4YBOZ^^O;L.?/6FKEIS<1`),4/U98%$0AD/OD=+:JG>M-,Q>RH M+N_O5@&#&<#U8<>7&,I.1+JIZ;XU5L-'<8_D\32[3=?."(9RM=A^/N=DP MC('O^-BT8K?>-&R&.(";%9\8FXY(TJ`LJ.8\XOP,!V?G9U_/H@L#?R3&Q==/ MX7_^]=,YB;Y<_-&(_NN7LZ__(^@3ZGCS.7M\/4=$S%P70"0%=BN8[E>[,$0;>K%``C5=T:$T6QY_:+T MED)YAQ-&*.QI.NE)N]@,[IMZ&Q&?:\ERG9]/2;?D;6<:!X=_FK5XWZ5/6#IG^EC&[I1:+%97.QZFT30)*'0NI)D",T>1(KDJFIS@:03:-RU M"D5G99((.6=I^ND)SMIZ6IVBH^V@V0MF:&(WCN1,7&=L*UY/_%1`X7]HRTU> M5%]I<1OD19%_KU^;M,"VBX'MVQ`'I'X50C/E[$)Y)A*ZW4#F^)I]II%TPO[P MUKCC;5TM68D33'_T0]2TH:8 M,.-%`>>(-V@/PN*PIG&09^90(QOSAE&I0,1?4LZSZSKYJK/F/A1T8PA]._*P M"1W'\4%(K#Z4"4@D5$N6./Y$1>2[^JFF[9.&UTQE.WM8#U"'DK"5KIB=8 M1-Y0JO4\UY%_3JK[XH"]ZZDC[^(9*B"/@#D3XQG5A-&J<8-M MWPK6](7C_7B&:\A0T9+>"K`3-B.7S!<;0\8/`@@$*/4*@;SE]H0GX M7FR*[!*4./PD.P9U+)H?!B>[6*Z4V?A%\J.OC`NMB'/#FXFIC&G!P15P01A2 M4Z:M[P[*DP"8D!"Z.R,:T8C9#DYTU"830O>&PSO^_'EYC44I-?**D M"=BXN5+TN%S?-Z\*F]6LB>N.AI%PY^(U(ULQ,'V2AB)VJ]26Q6U%)#@T8QQ& M7FAZV`^0Z[N;PI`9^TCX?BFY,)/,H9[UC,AFQK#D17U9NCZS:SLZD:S)0N^\`$. MG8``#R+LD#B,_X^\:^UQ',>N?T5`@J07J%F0E$1)R"=1)#>5]`O=M3,(YH/A M+JNZE'%)O99O#?OJR;W(/J+:CWU.0S+*94M5U7I>A-FV_5IG\#\Q#NO^_N-JF>,9Q!K)Q(6>)43:.>8\Y+F_YY M\O9$K-=4WL?E>2]:3+H>IH%N1Z1+AR=/7LK31(Y*:>7^7$!GNG\H(DH12GA, M<WF"Z\?P5_!=#[MMQX]RV^"P\"X-6W MHG>)!&';W%:;]C72"Z^LAK\MZKK=-:HV7K5MZD9D$6*$42^\K,Z\G*29)EU- MR_9\?^[Y_K5G^;(CT7XUY^TQX M-Y=Y)PB^]7S8_]6%Y\=^]_=^#!]IE\2/3YA0JH5,?A9I+%KJ4\'.#S=@!/[#X8>LKO)/7GQ3S-9 M*@>[!TO=!J3(W[YM\MN\K(O[_+*\KN[RMU7=UI#]<'.U_+$(.$^$T<"/(!+Z MBE@X'NQ$/D=*-VUUVS:==QWTR'XK_@%@KT?LO6DQJVX4:@^#9(IVQ@@HIFXJ MY'?WZ]I;00*S_1/F*HR>RO@,Q<81-37FWM,SZ@9I5*R4/6:K0YX:A@SRF*(X M)6D&,4MX/#QIA`@G2BMN$TW8./8UJ4BV.EERHF>!)S5MVY7)WD].SS,I?9Z7 MEXYS32?2$2&:Z\6SE;)GDB(M*U>;?%EO-S\/%MQ2&&(8A!`%`:4IIP".KZ0A M!G&R*/.OK1K*BD[RB$6Z?XR8/(^=ZOM%^TZ>U;5S84GD'1K[#`$ M!A;?IY`M)TFF6)XD1WMZ#Y;@+6O14T).Z-`,]AS1H#D>5-J:TNSS6`L*0Q13 M[E,<4!3&B&7IBZ>P_NU?8@2C_]!U%NME4N4T MQC"?:AJCNE`Y:27/JB/+,\>#%@U6*9$@KS[NBK#;B^R]+,2')ZV9! M@B#S4^(G$&1)!%/?Y\&X.!8E4&4:I?SEAB=0[3V`JFS$CZ_;RV<#+-65=G7. MY&3%*%T&1.4(G995YC%K)S1F,L&.*,QT_)6FEC8[K[DL=U<_/_8%AP[;U%7U ML$6-Z`#%+`C3%&`:P-"G+$;C@CW/2#@O%S("R4K^I"DM,A.3J:G4V<,Q7RDO MO-$);^>%H^*IAWZEM,YH?!T1:MM>OY@^6B!=VSM6BS!,D)\F"2.,12!,.4SX MN,`7<32Q#LTT8U:$_/EWE32_5_4RKW*2;952-3%6Y?$LCU*=4$MMU#JB@_K\ M47Q\2I$H:>UZ7BG'6T\DPF&8P@2D&>6$`S]+$QA%810%D#(H6PAJIA5S_>M( MTG*^.WVGF3K1TS11[$@_T^5-9:0=2O:QN^L_%F1;%V5>U^FUZ,9UM_'W,1=M ML6R67_,/-[]6S0&0_E.;?,6WZ_5/6JRW3;Y:)"0+HI@"B$*,*`U"DN(!%2"I M5`D82U`,+W<-'G@'+EQX>R>\#S=>[\9^*Y/$;=5=;UM"QUT.SVO*7X/@#L5QT?#JN"N'2L#@'W0C91ZR'QF)+4< MI3./M+:]K<[2%91OO99UM2Y67:]X*R!>W2[+WT0BOO[YX7N9KSYOO]3%JEAN M?O;[C^U?;NK;XMN`-A.?_YK7'T7_N5W6PIGA'\CN)Q8@"!$/`8T1B!!-$`:4 M#L@C2H':/=JSPS4\XC_P\,)K??0:`=KKO?0Z-[V]GQ=#48[1U5&)+KR=M^(S M.W_;8\!CRO_EYXN;RLZV&;E9F`-(S:48;K440W>.3 MW+1V!YK\7-D\ZMT-].YHZ"+P_93A,$`H25G(""`8#1[X-)(Z&.(@[#.,R%?Z M=/;#@!PAS0L=A(S/,=0VQIP'ZY'1UO1D,K>J$1_6G:D/R: M@V/(S:]/N-JF9-8T[`;KR/J'HRW&@;425YFIG._N3F6`NX6F11RG61S1,`1! MQFE[*H2,6SU)AE)WDC]9Q'_*O&_G_/Y+G!JWI1N3"VF?B7;D>,:W<_EUMAF7 MTCP3;>>59'@OMB$W7 M4'.:][\N((PQ\@$"B/(H\$/`(C):!UCI,1%-)L]S::M+=@1<;\#KO1D0JU8, MTD6]W+;2&5C7D\$@W#4\VY;>!/-,&<386!::6> M\%A-EM[G35_3\>%=T?Z'N(C<\[=#ZD6$_0P1#A)&8IAQSG`8C@E@3*7>_GX5 MCKS*=*LMY[JK\/K@2OK5^$!;>W'R:K,LZQOQ+5[;1[WWV>49AF!S+=!>XN9$ MXSMW9O=RF^-=*YM7GN=5A.T,Z:$33="5_-%84[298DZ-J.$:Y M,I#%6@JP])[)WZIJ];U8K]-2I-2-@%@(/&E=YTU-B_IZ7=7;33Y>5V8A)D&& M"4DBE!&`8A8&<>83G*0@3(#L^KU>H^:&\0%GE\_MD7H]5&^/]7RW]Y6H/+&< M;R8DCJSJ&W*NLM&J55]0N6NK$_VSDZEN`_8!C@5E"?19#(&?P@@$"0NS;+#* M6*#T'M1,4X:G?H?HO/S'M[SL[U05^VZ\[("JOHTRDV`YA;3(K9HD/J"UOZ+V M4!5MOW!RDJ@3@J>)84<43IP_Z M[`YJ]^1`J*A]I@,CIXT.Q41-.WO@OW3(GPKGQ9$XM0YXO0=>[X)EB9W']PD) MMA1(1R3:EK?567J+48G_GWRYN?I>+1A.6$HAAABDB(6T/24S@$%I)G6%PBR" M,PLZ-BKHTF$PH>,F(F!#OEO<0KXKIT5[1ZXVK58-UJN4:&4G9RGS-$I-"K)H MKODB`ICX!'"1\`,0HB0!"1G@I"22*A5H&L.913DR+\IRH3`FR]JC8$^86^CN M2W.+4J\X*X7L]LX`\2I(LB%/JXXR!!$,6[-%0;E:A MI2"<6:!CXP(M%PA3^JP]!M;DN47NO#JW(+6*LU*\7JTVJWDY6YHGD&I2F<5G M%SCJ7J1#$.,,T!11$([+YZD?*+T39PC"F94Y,:_,4H$PILRZ8V!/F<7/N*_, MXK-ZE5DE7J]7F96\G*_,ZJ0:4N;T1FC8""D@:;O@G:4`H_:ET"1-1TB4AP97 MF]5PG%.C.Z3FE5HQ,";DVEQ,;&CVLHO3ZU#N!TQKD^]I\7N5&C[1U5E"/H=> MA6+Y=W=%TYZ!;Y^LRJJR+=N?E]=%_MP)NY@!3A#R&<8\"0.0!C'P.>%!#)E` M(KL>JM>HR3LG(\[NO.H#I$Z<555B\D3'-Q,11[JZ(>>>E.LV1Z'>[GR5_VB( M(.B/10I]2CE*D9"4+(PCFF1L0)&R3*ENCV;3AE,P^:[=0O8ZS"W^6J[SC_ZZ'([\W/WC'DY,"8UY#+-`2#RC`:8XZ^!$G",&E-8F36$P MK+H#[/:8^PZ;-R+W#J!?M.^S#)_X_:J_##E9B(U%3$Z170B6FC2;CY.9=^.G M$7U"MDV'SA']-N[FXZ?@K=`JK>C]]=&KY8]G$G7L`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`7,P@7]_GF2R6K4U.MJ/2L0T#2'>P0F->(;O9E!TU1 MI2;3**=/-OA34Z8'Q+7Z1%XDSH@>'6'FA!+-Y=(1#9KM1J6WB>G1G:O;9?-; MM5VO+N^^+:\;=G.37S?%?:N*GY9-ON#"*/=%TL9B&&(`6!R/JY-ARH`669H+ MXGRJY34"NO>]Q>X5'7BOZ%.(]E-#A>SV;'MSFWOYX%CWKQOAFA[5FQW$6:)H M,WJ:-+,/6P?:ZU%[(^SN@Y].QL:FL+[`KKKNZ@J7V[*LS4LYU=9+JOQ%A$(@ MN2FNE^7N*93+\@C`R_I3OJRK.V]PK[M: M+AQLC]GO71Q^2O62P[E:@]SP\1H:@MKX%65?1:%NBCLQ^GZX&6"]%;\N0I8AYI.,Q"F',4I9A,9# MIHP0I5MX<:'J]:(5H>;!2+N.1M&8JIJ\,:>%9<*K9+\>1UXP.8%]X`M-7V M`:K78CW7*O*+),HL*>N+A"/B:\*S8XO-NLF;)9%OB^678ETT/S_E-]MRE:[^ M=UMWUZO;5Q,_YTVSSML__58TM^('B_+K>'IM`8F8ST2`D"RF?LAX!%"`.0LY MX`G&4/&0@%5H]O;A'HC!Z)'WIO?I+][>J_Y!Z[U?WG?AF-=[MC\)JD&M389\ MNJ([$FT]JF\TT-;&A^DA41Q#+,3>X7'&AO<28Y&U($B/5^U9Z1%%O8?05O[X M>[FMM\OUQTUU7]0"?;M=&R2,Q\1G89)Q!!#U^6[0A"`A2I>Y]%JVD-@?H+TX MD!;QAW;K80?9VV-6'$8T1T)NE#A?$-0&`;W\&U%W)2I/B+>9D#BBS8:(])M M^TRY_`AY>,:\`SW4AM60IL^*Q_0\W%8H]"3:4Z-@+8<^0:=BDJPC,(XHK3'W M)-)M*O1_ M),NZJ/N*4"&+B&@P`@Y-$(5,=/4!8,@2%"B]%V,-E>%)Z4'7W<'>K3:-T+MD MZ1#\Q-IS%@.I**9.Q7"R\NH+GUE-GLNVC(!;BZAK:F_/\6-#@V7JU<<1\O.@ MI_!-_H]M5S"AK>&%"6,91ABD!.%`M&,.XIUIG"6)TCD$'?8,:_\!+F\$-JVF MGQ9V%67;$K%J@CR-4[.*>YPH&2W50+-K*JG#I6/ZIXTN=65[SO"N,E@4(\A3 MB!(<4I``/XMC-)K.$JD*73KM6TQDVJWK' M:9-1/0VDNZ9Z.EPZIGK:Z)JE>O687NZ*Q`!`,0]3Z$=1DF8)%C#"T3;SE9XD MTV+P/+KW8#XXL0Z5'KZG2Y]1JK5HGR++UM3O,7.*\C>9>(?U;[I/$@(XD[`I M,]KQM_]9Y!OQ!;<_W^;W@M\VZR3MM6"*(0D033,24#^%@_6(J9UFU&32H@J. MZ&;/:V=QK#RUM47O=.639];T[/8$5W(37!UDNZ9VFKPZ/LW51]J\G.\ICEWB MF2$6Q1F*.(@2B`@-:!B-L@LBIBW;V],YZ*3Z)KPS*)^1_UEA>_+NBPK1 M]C*_8YRIIH"SN7=-'?4Z)Y,4:J)072LORV_;INZT&>X24ICY2.:==L>F8I%=J9#&@40A3X$J1Z6Y5?K_+-')UHLOXB?N_-:-(K*KL:0G#`;(T=- M5V5Y,:*$AQR<$+))5#FB0].P5QK:BJ(*M-]]6=;-IGL?7M<5UXS]Y14]2,R7S*R8<-*M649"Z+1A3F M"$TGQ&8NL8[HSFPW*KWM35&-LF5]*Y*A]A?VCVUQOUP_V!?9MZ<%#6D2X@2% M$*"(H(RE@(T`*%)ZVUR?5<.*U2+L9C;=;PZPZM$NC>S+J=EYB%?3-WV<&U$Z M:0I/:)_^,#BBA@8;99E?2-TIB^0O@`X"H((9RPC MQ(]9RMK;)4$(,$G"+`ZGG7768=CZ:N%^9[*IQJ7_$?7P1L*\E<"9L9BTT&9&P,8:W4DVY9?@]`3%$4TUX]OI!32=!*J7+=R+^%7^HR&"C#\6$(OT M%P,"@X!31B.>DL3GA`=Q=UR;3*I1.,608>4\+*XTMJ6GTOUNN^I*!H M=MT+.)U./H="9)Q!"(,PY`32U$\SX-,.1<1XDB141:DTFS:L70-:+^VK=>[P MCOG'^UPUP=--O9S(G9%U-=D;"5\^1[@C4JC&Y@EQ-!061^32E'>5E;8M*:EW MXBNSZNZN:/H"V:+=[A]G+_(#"&,),X0`"B/HARFD&*=AY&<\1F&(8>#CF/$7 M^K0!BP:7O@Z`]DM@AU`?]&>),G[&F5]5U]TJ=5=YU]4(/`!YID@\TE7!2"N6 MP?]Q=W7-C=M*]J_@(;4U4^5LD2#X5?L$$L2]4YL[]F:\^Y('%4?FV-R222\I M.>/\^@7X)?E#,@`"%)RJI)QX-.K3I\'3Z`8(.('G=%(I3]$;,FF0YS-+I$G/ M:N.#5&%]^`UK:93$":5>$OHIB2A$$<;]W!81E+FB9\(K?KOAU')B995SF2*7S#&KR7O=KTI;*-0HE)%=\QP.%-XSEFN./0'HM^J8'? MV$SKIBAOJW37-/P,O6XYE,UJ>_C=_VVZ[L+^YK>OQ?;RQW7^*],C!>H`.MGNT(-_?I0?RIFSY%/=F MU[U>]%`T97US`:IBRV]?+_L50'Y-4-'?]\1_6Y5];_P7"#ZYGR4SQKF&A%@^ M^0"C02[;]!GFF4?C54.?N%.?+\`X5D;'P(%G79P/?#NXM+-;>>+#@3FX<$HR M$Z43">O,P\*2='9N%FJKGE6-J9`PU7UD>!Z+]K]V^:;\\<3?IFO_6=S<%NT$ M+(I3GT`(4T*R`&783]-H`(8R2EU=64\/&L,)CE^'Q;#Q.]5N\[)JP2V)Z\`%L/,6>1)Y" MF1=73"F;;T7S6*Z+E'TV;8J;WK^,0^`1UUG$V14M#JK3)G;,FW&=#<\\$X)(-.!?=Y>)"W4W047(!?K"Q MS+-T1PL8>`&?.#.?0<^-I6E\P5&A.!FP<=Q^@"F%E;1)3$RLQ"^^D_&8:P=5 M^Y?[!Y85+ZO!EP[N!`FF61!'84J"V/.C`#N)-];OR(.I(S(E60*')1U@[57P M(C%\?WNJ3>'3EH@/.[$]>G!933EW2*D\6UZ^DRV7CYCXME:;(J>VSW6)"(KL M?IW)Y)'ML$O%QX+]L8NY6B\__#5V'(3G%&^TVQV7;_$-8N2$CD]01H(4C7`C M0N)55;!:MKBYKK?Y9GXCP214(6&)>V%YY97..DVV")-=U+-K@,PO\,\^*+3- M$S[U3GT&OW6](M,#8?&B>T:D%(OH)<;&!RB*%Z%!HLA=+BQ:,N1D.X'4\V$0 M0C?`%`81QC0<;0<1R70US(4-&BY#>]59/Q.IH=+L5FP_3_7G5FO&$2=\?OHP MPK7VYJV5>CY3G*69_P!**^^3A&PJ$B:L@=]8I=Q)\.6/WB@_5>PUE.D5)IP% M)'6)X[%JA7HA];(HBN+4P7Y$DR`0/2=>MUES#^J$E#^+;SZO9WM73Y+$$X^L MJ7!8\O0:9E3+OI#3U&PRQ=5CE89>E`5ADO"34IV44(K"T8(+$[E7;,2_ MUO`%>0O7Q%1=5[\ M]./7$C5..R:IBHGO9$E`/>IZH8N#*/*]T30.D"=U[K$&>XM40;.GY^;H%E.G MI9F6DRU!>B]>2==5WO`)V=DF7@*TGE`SG4&Q1.:TNO3RJ&/M=)U]"04Y61C[ M#HY\GP8^)33@[RD,\SY,G6D)14]KR214E244>3G^?8+[:U-L^)>`[T,C_*%O MA(MMF[2HD?*Q&N.BP\`2/3H[#0LUQN7"HK"BR(5I0B*:A92!&+-1G`0R;8(Y=@QW!]Z< MAKY4@7^M_[-HV[K2)]OOTSM;DK4RN^@"D3WJJJ:J."FEF-.<-8D[)S1P> M;5&:63Z\%)GYA"CK"ZGO\[):^1E&'K\W//.]B'@!C2`>K=&8TCD*(VCB+!K3 M8YNK,J(DJNF,`?YT*,V[U"VB-3T*";619--2O9'UXAW%42)%Z+P@R@;55<'& M5;5-ZNJF);OB;8NBNOZSOKZK=_SZL6_E3_Z;?Q7W[,]7!`>1 M&X51Y"%*8>+YGN^/:!!"0I?*&H9@6+,X+H`-=[%*: MQ9[CPL@EV8@KCA.A_5^+@5DDNW(G`/?B#4GH/`&]*UP!7DC"Z(ZRCAN/IF#2 MM2F0*NGW;QU#R:QL4RSGY.=E8BJBIM+Q4Q6Q+X8OZ^3.7+$BW-G,1!L4,]%`0$.5/S+TJ@3#M.X>L-)]X]HAF=?A76Q/IO MA@F32W"R7!EINKUFY$3#;09]EC3;YGA0:QM+LU0DS;?%;=T,YXP/^H61YT8X M3!!&"73\Q(?4F]I[,)!:1M1@;CF546SSZZ!417*,LZDJ0>VYNO[O\R,L2+/( MM5*@YGET4K`TD"6QK[1YJ!MFD,_+OA7K75-NRZ(=C:9LRI409I5"Z'@>C"`< MC>(@DSR29(XEP[(U@>OJ';"')UNA:N)53,"6HU1.N^:P:6C?Z`FB3NX_%8;Q[+ZO;Y7G>R*VCQ MO=GES=-!8WQ<_AZF5FF,(A0EGH<#)XFS+'.==-H*[T*A"8]I#(8U;(+^ZC40 MOEXUPG^^3C5M-%%8>C0:KO=7C6V)E)Q0_JV")+XL;$NPU%:##0=-9`%X!H%' MUGV7"(D%R[V+N%DO.])ENYK/D/0U1)8F68PQ@EX<91B[,7%'2X0Z4N]:*'R] MZ?[ER]<@5?H#*JP)-BK-$B;9G93DRDQ'\A4CI]J0ZO19,DN?X\'+AN-<,A15 M9*@"PC!T'(*2%*6!$T'7R_QI.PKT,JGE7"4#2RN)6D=`C3L5-3%`VTP].4\/ MX"U6A#5%DD0K5476AY.ZHD2(4,V/U^MZ5VW;WXMU43[RM]J9348CFT"-QJ?) M44K2B%\93P*4)JY+/#1M9X\3H3:D7HN&M6<$"O9(P03UX`&3+PHUDOY^G7X> MON5$ZT-0+5YMGX=RM=I:&_4B5;0P,4=J9OW$6E`A&W"J-CD6)>>M1PKRP6C@ M)JX?P""#,8(0D0SNCSC(,C^0F<#.LW2V[K#BGIZ9O(I-;I>C5%<;]TQ[>DX2 M=6+BJX=@2V;`FIRI38Q!2=5*=FU9%6V+U_^W*]NR.XN9%_=I0).8B2$*?>*F M,&`_IBU$6>!+'9ZO:L.P4HVPP`$NM1:>,HEBXK0$?W*RI$2=$3TZPLT))9K+ MIB4:--N-6N\@TZ`[_#^;8ESX3W%,?!0A1%R/9&R.YD=T6OA/4ZFMA?.MG4&+ M+L"(4;4=J(%D=84RQ^]\K9*B=C'=>L:8I(*IL6VQEBDZ)*!JE42;+S?N//'#&2 M*Q*+<2+>H3/'C5H73IPCD3;;,^^.M-+4&+"@7:8(O)X;?`V'BO/??=D6]^T* M\G5AZD,2QR'T,8R#9%K)27U?ZN7^>98,"^)OQT[&[OZ@@ZCCA'$)9L5F;LN1 M*B>F\_A<[+CQB:H3TS4]%%LR5=/DC,#1XZH4*;Z(,EXE\WN^+;YM^8U7P]$I M^6VQ@F$0$R=$T"%,.5T<9K![#=BE@9=$=,9K;K/,&M:T5R];C&`!1WL!>KQ@ M#WC6^ROS`B"F=F?B7D[Z--*^P&LOIT@\(8H&(F&)0IKP[.3+,AK)FS7K^U?^ ML[S?W2=UT]1_\F6,_(']R?9IA4*,,NSZF1=E&#D8>O%TB$("TV3N)%#9\,*; M^D9<&N:!ZERK3PL7H5G++/$"#%C!!%:`_,4FC<>(E)Q#SHZ')8)IQC>!&:8F M`F>)9O;SH6RZ'@IARNVN@LQ#7*W](*.9XSK028)I7<**=]74ZZ*X M:2ESF,-H1QPK"&$$:>A0-PA)Z!-^+,WT\DB$A2Z\F&_%L+J-P``/..B@[1]& M24F;0:68D"W#HIQ\*1)H1+..\G-"J>9S:HD^:7"DUCW M&\2I'R241'&`8(H@P:$S7&"09`YVI18IU*T8UJ(],/X$S=.B&52*:=$R+,II MD2*!AG;A'N'GA!;-Y]02+=+@R*N=MWJHF54)XGO^_L+E;MMN\^J&E:,KCWI) M0-(XB6D:T)`R4?1&XX@@J7-`]5@TO0MNK,1;<(!*0^VGP*UZ]6>65DWU7P]2 MC.;%2L!7S$D6@>K,6R)MFIT2*`3G4B:T(>YKW6SO\'W1E.N7IH$?0!R3R`TI]B,,<9!$R/,(\N,$9L+W(.JS:%CR.J!@0`H> M[O+F/E\7#.LZWX";`^2`'_;3#MA5]IAI#,)I;3P?_W+:^)SZ0Y0`=^-)@UGG&=(C680EVW-RCDZVQ9/.F5A7RSKZV!?).N+4'$D[!KBU(.^8\*HV.B`E,L^AP6_U MIOO)S-UPI`>NO M(]CGN>G?\ON'_YB5G18(U?M)RZXHR>6R9_HY@0<#>C#%36MEM4#4Q).?7=%3 MRXFS?9B7)&>;/Y([EPN-!2EU06?KV($:*TCL#`K?3WC+L">7R"P@3CSG+$.@ M6BYYD\@>W;_/2Q-'O3XB__-9LD#6-3A1ZQPXDHO:\.P%$^PP(A+]?0[91+%UJ^7X$].C)6H M,[)"?82;$VO2<]FT9!5ZMANUWD&F>KGN8"8)/.HG?IBE.(51YE`VV9S:/*XK MM=58]KL-Z\S^RM>Y%^:*)>BC#/W;% MK1(-PFKQ+=\4[>_%8U'MBJ_%=D4"SX-I1F@(:4(B:HN\ MNKG]]($SRR4]IHUP.PVQW1`!Q4[)]T29U^> MAW;%@S'UT2]TJ&'R(UF%^Q+T04 MA;Z7Q$$8!FG`3(WY+/*0.V84L?FJHA&%Y"&7-Z9SU`9$DI-65>[$YJTF25/? MJLK9XO+3G4GW+FU&)J]O$W-B_CJ324NFL'.]J+4.+VF9&:?*O*N4UA73NAV3 MNT'WZJI-BA]U4_2?N\Y_%FWV<]ODC-6RRING[MS/KXPH]C<9:9MN]MT[L/(" MC%%&:8*BA*38AS&.1LB!'V"9ROJ<.`U7Z$.]V1V\?FN*.)=KR<0!'&?#/_*RXB[BIFP90++C-U=>%4U9WS"/5BFD#HP()#CS2`S=Q(V2*"810A'$ MKB^W:69I<(97P0?<8#T`!]L]/KCI\(.'SH$+4/;JN,U_ M@F(HN>L?H"HWW=3W%RC;W%X\]H*=<9O#+ME6[[HASWQYWF"_`..@&-T"!WX! M[MB8/0?G0.\=N!H&!7-PZ2Z]YOB<:O&?:RA8DN7.Y__+Q87S!F)V/OOOJBGR M3?E7<3/BNJP(`_/(L#X6QT`R>`PF^Q<2AP012;"3C2!9*2IUL-&RR`QGLCUH ML&&(^0EC+*WE[1WXL:G_!'?%S6VAF,;83TUYS%#,YR6Q\X=;>P8[&`R'^8J? MV+MWS/[TI109A=QE=@18GK@,.R^8M98(P>R4U27/>[[Y[:\NH>*I0.#5);Y, MOUSQCW?OJW7?<56WVZ;8EDW!/Y045?&CW%ZQI[EE6?IKL;UBCC3#FVTI^VQ_ MP%;G&0XS&J/(1S1,$(48$31XYJ6>+W7QQ0=PQW!R//229[9\O=VQ5)AONEQY M`1XX\/&5<+"NAZ6+KACL;ZBNOV_*V^[O'\N6O[A]S8A;\)R&B[`0,3!NOUS+L!`!NC8N``_V+!EA(".D?'M>/")D_)Y.+G1 MIH2^W$A0F`58.$PMGSK8R)C@?,-&Z.([_HYY=5#L?[E_8%GNLAK6A(HM9V(1@,FLC=1G;TC>Q47"(<%>Q>7\+)>=(Q+ MY%*:E\W_Y)M=D3PE.;.S+K[=%<7V'TV]>RBK6_R=Y7V&917$<4I"WP_#S`O2 MC+@D30CR4C?Q7"<0VLVMRY0YR>4(00<1)$]@``DZE&"$"?X8@#94DZ?] M!_@V&0[JFME*GOY9W-SRUFO1LDES]]GK_/NF6/F1$V8PHQC%OA?[(<81'!%[ M4>3*="C/"--TL3$]V>WAVLO%BX=\].\"?'\Z^!P8?03<2?!'YY+L00WG'`-B MC<,/$G[55+I$Y(VT\5,D,^!8X_+-L5RAT,@>B M#-+$HQZEK@?1:"_QLD@F?RD;,9Q]WI8:-I-DV&33B#J18DE@$0[E)%R1/B-: M?(R>$TKZ_^1=77/;.I+]*WR\4^4["P(D2.X;"`*SJ?(FV=SL[L,\J!B)MCE7 M%K.2G'L]OW[Y(5*,+='X))%,U4Q-;(W5W:>!TXT&T-!&U!$>U+>C,CS4#'!0 M5CWFY6[%`^3#U/BZ,;&6>>NDZ=`L9'0NXZ2MUZFKVD31I`?$ MJ&TA\.6HSB3NEEYT%T5Q@@TMN,(1=K1AV:M'X"V!)W=*]#M!+`Z2C#/.6$W2 M48S2A/!>$`L9ECZT*?7MEKFPFWYZ=*<`F1BKV45+Y=C"LOST"H^WSL,I8><( MVV@8<.FTF`84DB?,.ZZZ+?,OS8/*Y?EU,8PP#N*$^1Q!T+RJS(=2&`QCA4M. MJI)FX90^I(_4TR(8=5PER&862%6(1PU-B\>`KP#UY@E=78!=8B=]8RZ>:S4# MD3!KC6K^PT;`;;DKVBX)J\"G?AAQGR84^RC%"`$Z%/"QV`/L9B199JWO=O-& M1S?^WFC8-461Y2U-9,5X:SY0Y7A+#T\KS#4)U01SF8'8$>8R9$QE8Q0J,]<@ M\\/=^9=MRK?RLY0A'L&`AP#Y$0NB(!K6B326VA$T(G`V'NM6*^/)=].<.SL< MN@^4R4P';%E.FPEG56I3AM@ROUV'38CF#*#N'-N9L.DJZ1D#S!3W]=GC\PIG M,:>U=!H%,(H"%J'S+D."D-2=8V-"Y^/`0:=+DW3XT"P72H!OA`_MX*[,B;J0 M+\&-@UKJ_"COA1^#(Q7LDN-)5>`4N+*EY/=5LPF;;\EC];0[KD+(61PBB-(X MC3@*_#1AO5`?)H$:0:I(FCTS[/7S.@6565`)5EGJLXVH;@XH#*9E?KN`DQ"I MZ>#K')-I&7.5OO0A4N"L@1Y?"$8AHS0@W(\3"E,,$XZ37G#&H=2^I+ZT13(Z M4_RE#+$LA\V!KHF\S14NNX*7$)_I8NT,GVY?FVTO5[A-5I[ MK=K*]\>T?2#&@8O`+T>%YI&W>W_K#20G2-*X,QSA2O-V7;LI918X\<>)UP_% MYFE;+Y_)^O^>RGVQX>6N/-8$_JW8O-L=Z^%:X7BI5W+[A-C8G<\)T?/,SC-SBO-.GA/D/@\?G2$V6%8AD#N]8U*N[1QZBA4.KVA! MY>*L42\(IM`+.4`RBS:*O9T,6AS(J23:@CL<85LKIKU,I:W!9X))SPJ\SQ^+ MTX6]+*4T84G"HH3SE/@AB\->C9@!N7*$8=F+,NK-=W.ZT5KU%K!QEVA3JW5O MF*17)4?,S;&7$%7C62W?N,^U>N:)\ZT!&(4YESX=CM5CL;\M#\-UG("&R(]3 MFF1!2K(XBC$?Z!T0.5Y5^7[+W-FKY&T;G20)40DO,=*S#94HL=;GE M`B83U*2#H"/THV5"96Y`R19"NY[LY'Y?M*W;>W$$<9ZP&"0HXA!#PD$:]>+\ M,.%2)4Y%&;:+EZ?W(/)!+]DJI"IV@O7%&6"3K!R>$#NKM!2]7,%FJLJGB:8C M-*-MQLO*G!%8A%I)?WS(]X_Y^OFVEM(($K#-`7(!]D@*<5" MUWDUOMXRR?1:>;U:$DVA50&;II>9L))CEE\-N* MXR?2#?NRP1=HU@`Z#O2ZUK6@,C94)-.XS_M\4SSF^]^;5B_M#\T*=,@=$4!4/9+\NDUH5ZDBRS[5FY_H6Z3>'M&OTD4SM-/,42O/F@E"/C M%RBV/[8UL,72O4FD)I(^,P@[DOH9,J:R,0AEZ:I8/^RJ;77_G.:'"W6T3GC( MPY`@'#*,TB2&`2&!WPO/4)Q(T981B;;I:U#RUU;+UW5I61HS@[,@GC$>&PNS.38JVM?Y0QE38`T050F MH'6$GHR8)3LDJ<^M1!,T%^GXKF\%KS!N=CM3^6_VRWHSX6 M^[+:^*L`PI`F@(9^S#$D2<3YL"S&84H-Y8-:.EA.$?^W*.\?CO4\)C6SYO>% M-RCKC;7U.G6]7YZ+?'_XBSG^U/./-J'.YAJS##OI)'<(=PI=-08VXB_W*=F, MF>(<;1!6$Z3==H9;)7$(XA3&E-:"(<&`9_R\9\.9L5Q53)SU++7KAT?S_?[Y M-+/E6]CH@ZI-J>;1-,N=K7[N<&2KCAH9RB'M/NM)VB-.;RI`F>`QLEX_/3YM M\SJ_&A/KBC5=7U/`.>`^SC@@*!D.)4($V&I7W#=_I,ULJ@H(S0 M0I>V7GK;/NA0MM+3Y]%/7:>@)$4\!G&(HI@%F&,`H[#7`R:95)L>X\(M5Z3' M;;V&.3E6N6W&./J%=N\U4TX1H[]%_2%'B19<8;FCFABD$_QIS3N.<*H]^ZZV M2K,"I-!-S0N2NZ)V5AZ.Y6[=_*+M)Q3ZG/*(=7#,XT[B;"2T6(-[\I_%AAQ./:@[I;+\6)PNV/`D3;(` M8TZI#U%*`0YHKT>:0B@:=:P(MQQ_3CI[9Z6]L]8>.7@?[KXCRT9S"5:TXX^W MH]'BKI"+2RI>4.F38\<=XN%J<;>H!2XE]W3:ZX4P%;RN!#.KT#L0UNS:5\TT MAB6W23[6`_8A/Q0?]TTGMVWK@&8EM_G'T^$X;NH&((@8B@A,DXC6:[L8H"'4 M,N)+W>,T)M1R:.OU]%I%O;.FWDA5R2T0:G+ZJ+X3>QO M&'>!(_L:YNVJ+(]=^77`)#630Z=*L>GU2!AI.NT&"%.*,X`)&_:R$0F%2-*: M\)G6`6_G-?6O>]7E,T_##A%>""SG"[6%@)0;-%8"AOTAO1)8SB]Z*X']V3_Y MH=GLST?^V33^J7^=O_3/7XVL!J0PFUX-V('?G=6`)?M>KP9L`BE]%'$D_G;H MHI#XM0`(:F%I%D("$`71L+%#L-"&O1%!2VRH:/1MT0-5+,N?#4\#NR4+=F>9 M@DG@@*<6NHXD[69LN7+`TP!`.L>FSQSZ;E,'YO*NS$=W)KK'(\ENT[^T7A:' M^K,ZAF_HTWY?_T%_,7==E-^:OSRL(K]9440\CE":)&'(?#+P+*!9J,)YBRIL MF3M'JBBRY++NE&/;'\:3BJP]LN]FO*`8F]CWW!I>`V[:/H_,]$YVWG@G2T<- M%03&RESG_(W[3^Z^P'+#Q[&PY`8F;]]?6-IA4N>F)/7.+^J='Q[J#UC]?_F6 M;YO:V_OB6-TUO^[_;A4G04"S@`=96J]"HOH_=#CZ5?]>^#D6U_2V'#2[]JSK M$SWF)WK<%<>F++"N%6TYM?U'<3:C*QCLI6IHK@$K<2K,%95_O+#;#Z"1V5V_ MN'ITM1^2GV`@R1]XP9$[AS>2P-X[RN39L'"B5.@O-A4.%SNFX M7-'C?,6]3CX19@BD8>C3!(`4L2`93I=PS(!-ZRJK(([# M##!$$I11[OL^3H?PFR2^TE[EVS>;6N5H?(3!D`=-.QO5:L[:?9-ZM\>JOVQ6<.DU7Y?_5'N[@\K MEL0H]@$(XR#R`4P"B(9H33(8]G'O\_Q[TRKJ*D2^SPH-`1O-NM7@ET&W;AOZ M1(!?F[[#U:[9ZSFO'#?%%]'7$US`.CUYKHM6/A;.2/-"*6 MV4>V/3+,[1O//4+FWB"^X(D9-H1U_/^3;0!K06%IPU??/8L4`].E,=09S8^LG+#L8!,=B%<*T"]T)Q>WN MPBH!`$(2(9`%D*8)0PE*>NUC=*Y/.!)^Q92V7I]_N6?M1IU>Q\V.!%Z#_OT1 M(FYK[L\6:%NCEHRP.*KO8:N!LIN)H%G\(&O0M[QD/A8:&Q<_=O`S!X.9 M:&?8+3KA;=0+Y& MJ_^GH>H5@CX(8PS3A&0`8I*$YV?Q"(XS,Z59RTK.5'ZM]?YW[WM=O5Y9`V', MMB>5`Y@+WC,8NL9-HNI,I3'(.]86>;5)WLFFFVM^OO':/*>U;/F@I><9N7`U MTRAP-U#-!<#;(6I65RRZ]FJ,NVS.*B`))0!G&8YCR`"/>!8,CPK6\7?I)9F& MZI97:N^'M=G0W.,'6*3I#(7EUFXSC0+7EG1M4+T20I6^VO*=TT$;U9?$)8$2"S06,9(+!!+PV'G=^SL@)KA3$3%'N$U5^Y?O;NN` M\"8W;(IR=5O2>9U8":9H4;.,CQPA2T$QPPJ%8__6^^O9OM74='=3_>,D"%RR_0`$Z M^"P\_[54K_2'A\3,[[Z]?^\214$6AT%&6>PS[`S)6'YNW);@T5N9DN#(B!63XV^E.1QDG]_+FT,8]9KE M:[Y[/KWM49,'@6D:,Y)`E,`,I3@ZB?(IIT)/F.M\O^7YWJGDG722?7E("SBQ M18!MS.380!HN.Z_@O<9D8E&@@Z`C*P,M$UX^8Z<-AWS]H&E.>7QN9%:[ID[< MIB<<^ED4IFG$(&4)H8!"W@N%02B4/IB19#NG:'7RSDK)+28,H2E9<[`.I&0: M(HVAW4K$)7A$"A-:L#K"1H:,N5:V,`"1,$.]D'5*KRCT(Q[B$/DHB"B)""-A M+\Q',)%A)C4),S.2['I'$SXQ*K*/G!X%Z:V)U#GH(BX3W*.'HR.81(D&4(LBS,8!3A7CK+*)8A'4,B M+;,0K_9%>;\[=;%:/WLC7<>/;0]M_#_G?TH2E"GLQ1AK`=CE*&RDX!6PEUK2 MB4$WP7*&L7>$]DQ;55D=L.K$6$_PO]44?%L=#KP&(2L.-3$T'WS8_]=3OBWO MGLO=??.D`=]6?_Q'L;DO^L?6$YP&E#(,?%#_3YRD23+H5B]I4T7:M*>095+] M[]V^J/5KCNIZH91K7H-&F^=<-?ZFS<^*,QP/NE,>$O M7D,%WMF*FFF\LQVO_.D`:RL[0(S3[?O7/<:?P>;K\6`NP%6B15;:_^?VBSK3GS3]'GJW,G`!,,58VZ17W.-GH]9= M9V+S(,IOX-R>WT\'J8_K;V0(8H8"E**0]9)X2H#2KHWXU\]W$+31R6N54MZH MD4!-?@<81\="Z[MMZB"H9*YM3E(DX+LBX=B M=RB_%>]VZ^JQ:)*4.OGX<%>G'BOJXS!"`"<(43]*:$9@T*L1ILQ??2WV9;6I M#=@?I1,X(QK(3*J7R@K/K[2X+W>[9KGW):\_6,]]D502-+&,P"C\CDQ*:^9= MSPDLP"@\G:=DI\5=M2\^%>MM?CB4=^6Z+2B>58HRRDCJH.\Y/.@(E<]B:C7_!)&D^)<"FPJ@ M0/0Y/='RL,?**_+];GCNI)KN#^F`+\5B@GO^4PH2+\WH=FW&Q;[K8>3\>%=G MSH)1PZ0W)L+((DYW)*XL8WOEP*RS7"N(8<88"'!(@S3,6)`E8%CCD"3N:P5L M)]BQVK1\^4I!KZKXN<3=YE^Q2""*O",,8,T\S2*!'(SB!ZM/:4O-&K\]Y/OB M<_'G,:WQ^'V58@(A(XQ&G`$<1PE-&.(I#Z(`X9A#JJY7W]T8OKU5L]N/6UQ":.G*MC:HCK&7` MD)='KPU!([Z'N7XH-D_;XL-=WUUG)!)R4"^9><(8#J(8PB@#G4C.2KU-S'&\YJIK`:FI7U`#"CM"5$5->[I,:@T>!LGBY*X_%;9VZ;=[M MCO4(+(>>8>U@.ZM"$00<9RSF``8UD4+&_5Z5*,52YZ!MR+=,<>]V=]7^L7\4 M]#[?;TZ]!$\ZG]H3*O.;04?(\MXR/E#GPT[?7UN%7WO`)9841E:(/8A#H:4Y=!F,Y!G4: M7O%WR.>'6>TU\;?A_JO>,^!"0%R(*^9!=.!);L,&5;;&FV2>?EONZD!%]\6F M//82^YZ\G_)CD16'];[\VDZ:D*<1XY`&`8QA%-$HC>F@0AQ(7>\V*==RU&A4 M;9+"3MEAQKKACQ61+X/&:4Q8R@(.!@D!Z$4@4.0R*7 MXLY>5>^LJP'65,%%\=?RN^YON:C+?/GXJOU?Y8;'BY:Q0X9[V'%8Q\#L/F+&B(,QA2 M$F#4ZP)1$DHU:K6A@&6V/.E\*C,V+[,=O;/>7J_XC7=2?;3RDRT+V_&/&)!=JXYRA(7MVOBR<:U]0'4.%;2/;?`XY`2D.$'B`<0"-'1MPX*S`6X_K:,+I M"&=IF_'V^0`%6(29IQ=R.]S:3BD-,&88U&CP,*4XHZ071%,F=:!2_MLML\UY MEMPJ]V-0@$R,8.RB)4$RPB3IVCO"(A@'_S]VY-;>-8WG\J_"Q MN\I=11(``>P;`!)3J9V-4YWT3&WU@TJQZ42SMN@2I6PRGWYX$2G*%QE7$NGJ MATYL13CG?\@?#FX'E:O'R)`=[QX>U^UU@Y.]XOV/NG(055VO)"HHI3(O\DPD M*$DA24<#:)YJY3'N6IV)-5?18.K5V6&ND[5=42U#"CD07X].\^IN1BUKR;WR M[$T%%3CG+@J!\<^A8Z]PT;5T!J.\X3[7R97J-?\Q^=MI-Q)@O)"2I+C("DE( M5A0\R2FA+$60,:%W2ZH/`SQ3M+U`/NIND&\WEC^Y%3IB+U\%;3QP=!D8W5'E M0C$Q'W*.%WI/+;Z*/O^8_B"D#9KJ"BN-6ST$+!`8^_7QU1&O-T%US@NW^W\V MVR\?JOO-37M;]N=ZOUO?[%=Q*I*,YA!C7!20428D1#F"A"+*I%"]AL2B!>^[ M!=L][H-5T9^#70M4#GU%H0MOI0-9`WGW7'CR_!"O&W&4WR/1O+E-4[?=+LJN MT1^G=S>G@@/*,04DSS/&DCQF0YL<%EJC0:N&/*;QZ:86"]8LV78@QPW"`Q9NUH+P9#*R2/M7;5:GZU9Q8UUK3CI]$>30SI MZJ0&'H\2Z:&F5:>:J!,0;*17`@NMS52N&_=,GF?5!G5W1SD76PU.B^JL MAZ^G]@6$+UT5+^V`\A600!#HS[^G.Y_\"JF,4;FI;];WO2$K5,`DCGF#:LX% MC!E/\`G5::R%2*TO]CU_W=ERK,JHB3X]@=2PYDT;/62=R1(0KZ;R7&"1D8J! M<,;,]LK!8Z3)A_?E_T]FKG;5MOGC37?'1,VVM\;Q_NR/@T< M"8,)1I*@1"`!!8ME0@;;,BZE#E=F,_\C8K?58[LF/IW[/7-)$U;S M1$L-+%DA3L7XE]`[ZRQ#039\_I<+?@R M:781DRSU^NZ"H>^K_?^6^R/R5BF7/,4T!Q(SEA<%HBD=%SUBJ76VR8\%'.-[LV/7-YNKNJO;]AN-2U,U5K)Y5?Y=4`O(3H>LAUI[?GG6L7!53: MK.8F!('0T[E;KVY)](;9[*;Y5;??-=_4 M-_=5?9C6O9:8$XF(P`(A'G-..)-=^4+"&$X+J)?<>C3$,TN/-D8G(Z.3E8KY MT@+14%%AH4@1&92L%3DL6$-;A>D8Z6;,'L/C*5\V4/ABHNPS8H%PVK.3 MSU)C_Y):<;MZ6&^V*T)BU.3;`&&94X`0XZ`8&LR;GL*6S6JM+,!?M?<[^K/W MP`5_%04W9ZQ[K>TYZDSFV3C:&:+)2CWE`^:AIB,*S#.11OUH47O?S.W'?7L0 MX4-[7VJU[5J]OOOC8['=;_8_SDT:[A9`A"12%K+)C%.:0IH4\6!-)A#5.H+D MQP3/1.RMCGJSHZ/=_:O8#$?_^!CUIE\]&YEJ7FCB.U!JL`P@1GHD]1@>/P>H MC`2^`%G/$0N$P+Z]?'IP:PY1U4\F5+MR\V4[->3%YC'-8,)(@7`&,>9`B#0_ M-@\`3+5F#URUZ?L\0V_FV8OO#,7.=%=C[Q*2Z\'6E=I^SDJHR7?I&(7C``3" M3N=N/3U\X44VBQ'[:?;@[V/1220PDY)+E-&4<99P*MC0N`!(V(W>35I<8B0_ M7*FP[??8OM8"BOK?-,8_87I-,:O]M('P@-'3OUYKC>7C(+$GXL M=]\V-V6[66S%BR1&;;'=..?-?Q@7F`Z--DS6&LK;M>1[O;XW);II;(E^BS[W M1M91N=ZU+^KM8=?N[-E_+:,?S8^LV:>EL2GS?,EKS[JK:-"[-6YQPDV$TB*; MB<#!$LW(F3=)9BZ1!<&&Z_JZ5@N4R8P0BK!,VS9%DH[<1`7,[1"FU91GAHW7 M6'80:X9:C[OJ7^5-.]5UY%E4?;[??#$IXF8KLBG#O.GK`F*CX$%0;"J5%L:, M-`Z68V;>O`DR"Y$L2%9\?^Q>X-_+_6&WO>X&RGT!Z15.DSB)">"28$$R21$< M]B`!*B%<;'3AVYNP=";@F^AL;[Q_WCY[ MJ';[S;^[1*>Z^]MZLZW;6Q'*NJL;-#R1+F6"6##,%.S^GGU)EV'?6PW94WU9?MYM\-+]8W^\-Z MMUG?1_>-@U=-:MHX&-6347>_)7!;[J/]Z&/S<>V,-02EW^@*0C!Q[I[CZ=/1 M^1?]TGOXZU74.7DV+1#]TCOZ:_=@G'R-)LY&O_3N_OHS/1RWU4UWE*?[5W^9 MA^3,JY_U87F2IS0Q:),/&&<@[E*/&8+R0J82TJ.P<&(3E!15>&^J]8CS?;GO M2^)M;OCIU/B*)RE-9,(900DO8"Q9D8PC7I2SU;[:K^]-QYJ&C6HE-*-]RFQJ MRRD\'LUJ_M!O7RB_MW\J%Q_JO"R9UC#'4O5@ASBV?KTYO'$BG,&)6U$]/.[* MK^V3V!X)OJD>RA8I3RLZ8(`%1#*%%",!I&P&7(3F2"(H!22&16?XHC9I9!!8"QW&1I#',XHQP*NA@%DX2K2N@?-LR(W:G=]7V!Y-\ M@-A3R'3!O'RT]$!M'*B0,&XDNA+6_88S.,Q[=O=5[,\AL_H(>%,WPNTWVT-C M33/:.XZZM[?-+QZK>GW_MUUU>#S=-LA8(9D`C(,8<2X;JW!CAH@9+$#S.^55 M0,?->IS.G5@:G4SMYMD&8Z/>VN4NW-24\](PV5-@`GG[O;GW=-#L54:=M_O4 M6H.6^\/M9OOE1>-^+[^5S0]6@J`T*V!&8I"F&*&,P'2PA%"L=8N+A^8]IW)' M,[0W4GC061FD2TJLS=()+]L-9$=[HYQ4=;9X?IYJB7B:JKPB%`U5O'C[G MJE\Q[1*G4_8F&Y5>_$C>;:7_\'5=E]>'XSPJ+^^JW3'U^[3^O@(2()B+E-$T M82D1DI'19(BIWNT&"]KI&=:M_5'[.$:W4WQ48W^K3_'E0FJ1-P<831?.R>&;&C=#R,S=!$PWBY_Y,0FG"I71 MP2+AL>ONFO:*N[OR9G]]]^+O5PSD7"``&R-B#@".!1N-$9*GPR;M3Y;]F;4A M!ENV/YF<4.DHM%]_CWXY+J3_.IQ-<=%7V:)P9.^Y?&Y*BWN2N3^^*G M0N@OWI)6MR=P%JJ0&>_.215Z.Y94F=S*].5"XZC9>-PS87TH09PB`&G\7TUX/N\KI>Z/_^U[_ MQN#IM-"'=@]AD]ZS_7ZW^7S8=XMP^RIZWW"A^9K&IOOV8\/AM)E9K1.&"XCV M$LU`R.S'MVJ&UT&3PZQI\79S?VAOJ_A8WC2)>GLQ1?&]?9++V]:N=IGOT&\/ MO[XKUKMM\^3630[_\>MZ5[*']C:W54)3S%"6Q3&C(J&Q3!'L+JW`$!0DUIKX MF<*A-'6H@,KK23`%'G3+>EOG%'D^TS!54-^N'%4Z\W MF"V47ECO1/T+G<"\T0VD=YC9Z6K)%TJS/_G0/+OE;M<6U*QN_N_#>G>]ZTIK MWOYC?7\H!QM6)!ESOHF^MA9IP=Z6P&KT7$%!;PZ MEC\0?KKVJO+ZS%H1L&NJ9H?]UVK7GJA>)1`EG+(8)R#-)$<1#2#:G>O:'A;)3J#=$DE*:L`=-)UQ,%,AF)8T6EZ\.^;H_?-V/;E00YC"E. M>4(2A"&,"\F&9CE,M.[KLFUK(3Y5)Q,=0$I+7'-2^=+5#:ZN522=C5D3:S3! M9:)RP/0R8R*7-,5`\/U?;RL%1DF&8LSCG("4J0E+*]:N;8='M228-E M+MKSS+/>1-M),2?"JG%L;DWU6':4,\"Y,`7=+G#-I>J!L,VI2Y6_A]2<<<\& MK2!/41I3F)$\SXN8\`RF0Y-%%C-#MFFW,RO3;*>]K`359II7+6U8MO1LUP6- MU+AEK&QXO#)WY75.615?+3&B](HX.A#3E#!5`NFZ\!1\C693!\VE7KNO#[L>D MP55"$2"<"0A%`F0*TB0><["$`:TY=9/O]PR,NM0N@PK@S5RKWCY83O+/OFWHE"4,$(YE(G+,L M%J)H_GYL,<5`:8'`03,+P[VUT0V-U$2U0;MS/=V2?6XI77#=N:1^L/Z&M'94 M;[]<&^I:P@7-=#U/E)!N((XET?/J8;W9KF@BF[X#@ESF(I$P`P#@H4T10Z4# M=$X:6ICJO95N8*0JK0W9/:CJENU+".J"[QZ$-2/\H&!TURZD+XG[WA!MX&LJ M&33R=7U1@KZ10);8__MF6[[;EP_U"LDT81F/*G_=" MF::35V=%FG[.PDRN0G1A^7;A9R*0%>"E5;A8%FJAH"CW7N_+_MWVIIQFQY>ZR<OB/>VE%8)LW(<`@&F2X^T$UE-L?Q4EQ8IX3`1+,%I M1K*8%43$@PV\Y:+HP*#=,33>$,1GA.-7,]>ELDNSB3 M1W4@IBQC(.@Q-/[2`$I3`F5X_+/[Z[EG%C].- MI@66K&!I0@"4%(`4Y.-^W@1SL&J^Z'.EF@\X;U[GA9I:JOQ>#19'Z][D9@35 M'QI]5F;HOS1QY#X4:L1:-`9Z4!O%/]H:]<:V.=CSFD174=Y6@6X^O=C]S;K2 M7@"BMR@%PDQ__E4S/>Z>R,O7]>9FE9,8$$DPD)(3RH1,:#INNDVDUB#,; M1V&=$9Y(JBBM6XRZ5]4K0]_0?U%L=K8Y8*9>2'XR8&HZ9TA+$PGM4'GLW)]S M^_9?AWK?[EL[$3Q':9J#6/(X051F+(?%.(O60-P:G@YM\8S3T[6(XYTM]7A' MAI.,U65<+,B[4$BT5P9V9;?%\CYZQN6AH-.387L^Q.T8RK"26W79=;GM(:`A MD]R'NRIL]R:SSN+$\%(<*]#TE:_.EI#%^O[^^K&;7V7;VW^N=[OU=E^O<"Y` M@@J188QH`FE,V3C%2@J]--FG'9XI?[2HQ<5C\Y'V8NEQGJ(MO:&_CNLO(LH+ MO$$$PYSO0X4L-:HW'73K331$LGD)H\&A^=>:3*6_O/3D/:"!\'T65Y\O3,TD MKUNN=S]K!A/E[8?UCZZW:8WZTOV[>E5PF5(IL_80&F8QA"#-QSV:"&O5()S! M',^4_[UL.N+-S7ZH=1\=MAOMK9!S1,4AXN<+R(RD[S[YV^?6J^CH5C3U*T3@ M7PR$+??=1/EGPK\CCTUZ`9=BV\Y^OS;Z6-$"@YBF!<`9+R3($X3HN#>T2*#. MM@;7;7O>^'"TR\T&/=HQ3-#0'!!.42Q2G@DL9Y\E(;YC25"=A=M6F[QGNX8CY M<=M3>])\FI&=)V2?C'>/.0N!&EB74%\/J"_=Z=Y9V4U>++X70U'`"PAU'8)` MT.GYBG`*<\`(J?9CA1IW2=EVU:H:(Q^.7KRJR4D MM<4W@Z-/W>VA&!P*S1%H*G2@Z#-VYPWDVM^!?>M>\:A>.GLH_,CCMJ2*\^6+JBV]N2H8B62EI(#'CNK@SO\ M^$35RS.=GB(4"#T].JA]4M).2B\')Y^:E(M"H@1E),GS#&!:0#[FMS'52S1] MVN&9NOG+ARFMN.LX$"8$7BX&UBP^B\CD.'H_;*\?JWI]WTZ+OO*YJ^A]?PRV M\3,T@FM%19GE?F(=)-4]N6IQC-9.7MMI@Q5/$DHR#E!1Y!3(E$O,Q@E=A!.= MA2C3-CPO.'UJ_XF;@?[;4X,8@C200G'.10Y%0B"//Q-"Y+@/`XX:AAQ5]QNE$G"%XF&SWI']Y48RB\ MUHB(NVE&@R@'R7`OCMI-,1I+:S?\7Q&`$96Y3%(`<@!X+/C8B=`,()OI1;46 M?H+)146I+(;J3E5R-$0/85RN.QY7UC$0+EDZH3+^UI1$F2Y.CZ3N.B2[?Z7R;@HM+;@3!H MU=7O&5U,?;,+1]U&0>6V41V!7NAUO&D

`BTO"NWMUT) M%2(YE0!F+&=M+]@8T'2)QX9S4FC5H;)O;?94^_0&GJRTR[1--#;*M#W+:YMI MZRD[1Z+]7##U1-M"[#`3;1N'+B?:UE)I+CAU0#TK]\<)Q!C00B:%0*G@+,UY M-V^!B`2"ZEW5I?_UWMY?][L]=_9'2^;N=)ZH M<.&-,-4KD#?!V/S*S6.C^>2+JMY?WQW;62&&0"$1@C@OBBR-,>7QT`AF.=&[ MNECONY6>>YMKB5MS_D/=F36WC:MI^*_P;I(J=P^X@"3F#@O1E9J<))7)7$R= M"Y5B,3:G9#&'E+/TKS\`-RFV)6&EF*M..P[Q?B^(AU@_=(-*Z:QF;U;3)K4O MJ0=_C+Z?HS&#DIG)\(L+9[A@YM9"J&`HOG;QPF@2X:]&=%P_B"%YM5]E(2\$ M=R+`8(&R+,F2*!J+@`P3G=5LG>=Z7L/NI`2]%DT0:+FCA@%?QNA!0,T3+P0X M,N!,^S>Q:2&MWTAZ;?^6:*S0#)MH=G?%CZ_EKBW;XL?M]E&F0*-ELU]7N_?[ M^[*A]^OFKFQ7C&'(Q)@UPH13,8`M1,=D%`!H@=7Z">[+]=Z'F.0&HUZ-]0#' M'E]>AKF"N4;L>>YJ,"D-!JE!IS48Q%[/=?5EF.NY;[8.\U>Y$X*WVY]!(V^4 M::3YMZ+'T0;KMJUO*]E:@N_5_C[8UOU^7]W>![?K7?"Y#&ZWY;KIRMMV#Y?7'33UYO&V^\=R3VFU MDY:5\@^=%OG$5O;?!;2#MFR^5;=E^Z>\*%7^6BM^M-UVZ3[O^F"ZAZPW#]6N MDC,(7=[F0_&FW-*7UTIQ8F_+SXBU@< MVG47G(Y-4E]J,K)V(?U_)Z&<7UZRL$>92\_@N"HB$L((IE&!PR3+,4`4CP51 MEJ.11I_4IPGT"S$`T2?#?>^!5?OZK&L?JEO*''%TH+@.,193#`A&<,1I=/4!@ECG94W\U(\K\'U M0]E>4GY_2@3_ISAC+VG"^&-@T!J MUZ^;T1:93^L?0SE$#/SEQ"J$."HHYDE*:4AR1AF8!G0TC:#>Z,JT%.\CJZ'U M"&7C!]KH.+6!?VKX\6J"5X.JN=ESPIR+>XS,[5P(=ZS#>'&/D:TM M#O/J]+.8XDE[M'=KNZDKY*9J;!P8(S+=C`IX6T M.A/EM?5+HCL=4>X/S5&MF7%2()9SQ'D!4E@D-)YV8^8%8]/$I\9LA7,1)A.C M^I,9AY;S[*K<7W4'H_"Y/[C:SIX;Q7NKI84T6(\!/AWU>[;2.)//=-J`\Y#% M(`IS0&((&"$QB%O#:& MQF@<,NCNKI9WW+/J6[4I=YM#DN[R=BO^LUDE!2\82J*")3F'25@@-'W;"<): M5YTZ*=!SPYN$!:.B9VU/^Y"""YO5INAF=UAOOFYT4>J3>?T'A3>_9/L?9,Y^ MWN&R@YM3XA0#.;4S/#DTX-TP9?"=NFWYVS?0$X"2C>4Y9'$:],B_56#PMIO?[B4[N[W961MJWZY!WR MG..49$4&15\*0`03D$^+F!&!6LE$7)?MO9-SC1MU-$W2;[O6=B^[Z=J'I]9R M'=FHW'#YNFJZ''>X;;M]7Z<[6M]E79_J-X2,7;QY,,T201:L,$@(R'A*<%93E1W6HSJR9_'6X91I\V\B;H M(^F.7AS%$HS!!.*;/H73_=9Q0%VNW/9Z*3QO$7B^@W=EE M\GDK*TXN!/ZHVA44>,QEQB",2$(BRG/`QR*3G&BE*+$IQW,'XEENGU&<((20 M=X8.[AW5V;SDWTRC#4P&/LZ1*.G8I(L;&>RL70@#G81R/FF2A3VVA&+UP[K: MK9(8(4@1S4*0)$6:,P+"L=`XQTJ9?-V4=#U*]0(=<4K55RM2>;#4&:LNNCDG MK7HQ^KS2-'C9Q-(-1HU91A9I)KWJ\D#]HY1#T15'-`[#)(Q9FH<`%HP0-!9$ M&=*:=]5_NFJ:XD^;1+=]E(SRF/";&.##F[&F1JWD*H M8A'`B\FQS*TP/@8[E`8913E.:"X*2G.8@"*/I](P27008EB$9XX\.]9IRA)3 M!]6`,H-Y>E0Q\6V68[$7\6)IY4(88QO%A5.R1J8H)>7JIZ8.,U6;_W]L][*; M]*[QY(\QNKQZ5E>JJ>8&M>;\V2:ME[K)(UZJ(3+S#>K8,+R`[E,)C: MQTNF?^3FMBPWPW6GW\IV7^T?F_+]%_+85KNRE>D9[B">1LA$=9&KV1IT8K=8UG=MCO>^!M;V^#DA=\NQ, M#]:EXPOISCH-Z?E9*\=V*?/NQ2N=_UI7NZ,[G[O[Q>6^D1=^E91?ZJ:<#G6O M"&4ITF'CW-J\[\IZZ7;VFT!&]/2Z]PM7NM\$G[O8 MQB-@ZMW%J]6[&JJ77.5Z6+]6;7OY&CBNEC-?CFN]``OYREPM_'H9[=#EU^O] M[H)(,99XWXTE,I106A0I`$D:Y2#'Q6$C4HW\]3UYGNUW>+= MYLUN+UI4]7G;;U]]\_!U735R5FJ5(IXQEM&$H1`6#*9I,5_2;TX*!3]YX?)UZK`7UVF_5P;>^PGUN#%%P[PU>GIB^$GFYC M>GH!D7O#E!9!QW+79\K%7_;R>H8?_3T!*X"*1&[W""GE:99F0L.D`N3DTFRM MIU*OWT)O@D[R'T+S<*6"QM*>CWI07^N[O'_M74CU^G-(,O]FE7.(5AQ'!81#B-&69QF$^S M_?(O=/J3/LJ?9]])/P3MAZ.=ZIM@TGUB<*K9X?12-VK]SVM7B]&N%:GKB@K,D1I3")&9A'L4H)M.I4ZJ' M9F\B///Y^("Y?TC[JRHU4B^BEO1P[:V"_%Q59FCP&7![K[.%T-M_G$]O0)O' M6*5)BBZ]V'V]%1ZWQ;\>J_W/3S)?Y@KSO"@0)Q@SE#*$D/ADB+)I2,*8)9'2 M!CV;YWNF[[&L_PAZ8<$_.VFJ9T*LW+L\CS.'<7I`O+9GZG,N,IGH942Q-O$S>>?S3W7FP`.O4`3R/A68( M/JG-CK\G'WN"P/86+8#!#H*H7;XUMAP>LC<4$:2<H83 MO4P5%L9=)K%_S_08?%6[U+GKWS8SXKZHRXZU+S[R!&7M;%D`7RT#J%V](1I, M?5=^?Z$@*'A-(<)QAGB4L8Q2!*=I#J1VXM#\Z9Z9*D0Y@(2A<9>9ZM\S/:9> MU2YUIOJWS8RI+^JR8^J+CSS!5#M;%L!4RP!J5V^(U1+:VVI7OMF7#^V*9BE/ M4)[1(H`C`6EX:,F2^CJ9=QE:4T*2_H]-FM#6E8:;*FYL=%%^MJ5S#0 M9H'-CY$N%]F4##5;:9N"5UYMT[=K`6QV$L;953=36Y2WK'5%?BR_BC?G?MV6 M'YKZKED_?"SE'(:\*^%Q?U\WU=_EYO`[^*%^W.U7E(*(\2Q),M>O;[J*" MW:;[OVU_;<%QIK7N7.V'NNG^0N6J:`!"4/"(DHCF($5Y"B@=@R+BAUK9>!<= MB>^Y5!E\\$OTP:L^_M>!/!9]$PP^!*,1P9$3W=&G(R].I#^\"09+5.^0U\TX MO.@J5$ULO.@@/,Y/_VZOH)_DS=>L_3/?]-_CK5Q(O^`W,>MIQNO?0[7&KI5A M0"QD%KN]&#&]V7VIFX=>['BI6X1B%*:4%SG.HRC-8`)YS`E/&I/+YHBK#9EM>H+^UC>5;(,P=#U0[D"#.9%00!`89@F!$"0P+&<$(50 M97QC_'#/0XZA=1Q$!5*5(H+,'3N/\UG,TL.WKD]GNJ5M>?OG7?WM/T64?8]4 M_.%I1_24`R]PQ=JL*W/$7G_MZ*W1Y@05A&K6VS>[3?GCO\N?*Y)E(,H*FO$X MR>((DX*"L2#&*=$#A>[3YR'%H"KH9`5"ES8KM%U3A85/PXQHH>&5,UX\,>$L M,$P-6PPQC`-XA@P[*Y28T0_=]KQJ;]?;_RO73;';L/6^7(6A'&^%#*<$AE&8 M$,+"L:P"%84J-HP+\$R.05?0"PND,M$KWP12FP8]S/V[#)!9K--CB)EK#CAR MRHL3*+&V;@$TL8^A=O@N:?=#>+4M&RJ*N*N;GRN:8"JOQJ%%&,KKIQF,DK&8 M/`%*AS)-GSU/'Z33%(RBM#L@FG:I=C_\.674^5`UR5G/XY?XS_8[S)Q:`">L MY#_K<]C8H$2'<1;ED_@GJU#T6](L!2%+`0]9%"60C,_/:*B4'D/[H9YY,$WT M23$:'-`SYC(`O'EB.,=\W@X'+?XXX!--W%:GX`\,%"<-TZESD---MWGI/GZN=]ZI,1@^&KJFW?7^&&4)`V2N' M//C%A`M@,#-L080P#.`%5-A8H<6,PZ"$BY^TJS0#G"."TQS'"*"$1QR/15$0 M*=UI;//\N;AQ/(CNE!F00]L[=7;XM,V0'AJ..>3'$R,N$,34M@4QQ#B$%RAB M9XXKAB%,1)LIA;HL06+$K:=*5MUW>K/$E0C`D7CTMY MED!$BFES1\%SI;N5])_JF2&3F$"JT:"&IC>72>'/%CTZJ#KB@`>_A'R"`6:V M+*#=&PJO;=\(_3T3]<-#O>M.T'2'G-OWC_MVO][)%,(KA$D(DJ*(0D:*`A(. M&3VLND*EK`Z.BIII-T4G,>@TWO2Y"]K@2*;^Y@HK>U67.F9SUFCEP]Q4=[LP MSAAT?DN&"V<7P".7T3S?K.'.)(UCN.M]*?'X_@M=M_=\6W]OIYVH`I,,ARFC M@$+,(A)'<98C"C#,`$[#2RD#G93AKUE-LN3I'2DLZ)0I;5GW=%SVM$\OM"ZG M]B[D<(N;6)Z=:W5FD'*[>E?N95D?FEIFZMN0G__;EILWN^$&@=T=OMU7W[J+ M!P[[OB.6H30&H$BB.$00Y20?E5"2:-W%XJ%XSSV'25IPT*9Y0M.'YVJ$N[+= M>MR3YQ4[W(UR@\\_@U=2<5#M7@JRFA?#39X3U;.^\[IV$ MT]G`]E/]L9165=M2Z.N/&,KCO9]J7:TYI@5C>9+B+$193AA+X*@5X$QIX?FJ M`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`*8TY!SC";UC:*-(J.K2Y2FQ M')[JEN9[\T>S_C(,0->#LN!K+\T:6]K&FJ++IZ=.\#4*##YT#1L.FEZ/LST=RF[:[N?P8:3;O1P?+UD[\S:.08_1%@Y=MQ<+,N.`E+=N MF%EEUSEK'L4`3&X6&2F:47P%28P#L?"TRBV[Z!IE^@9:!=V3/FT MTJ)+YM5%5]TR*;+?D;:DOME3ZW3[9\;6+Q9M5D&I]-,L+;-9)Y5+M4\7&-Z5 M^U7*4)PGB1C_YIBS#"5YFHP*2)00O0T<#@N>9T>'_7JGL;'&ZYU>'76ZWMGM M_3@Z2798B'Y[O!`MQ%\=B*=]>.AG\TGE@;ZD?+ANO!M$K M>:X'48-4#XO-[W"&FA[J8B'4]!&9<1X'3?-LJ2D75=J3F21XRJ,X2Y(0Q4F1 M)B"<.KD,QO'J6]E\KBVSY=@(T&G3QUJUUFE;+_ERK'RW@N=>JBVI:-E^=1*C&67=F*O/VP_KGD/8`RWVZ32DT"=KO?WX0[WUW-[7X MZ5?Y*ZN(PC`A*(MQ4D08`1RE4\8>B#/-H;S#@KT/Y4=IO^QEU@2L2Z/5P#JW MPT9`'47*=#&#S>1-T2F^Z$?TD=F:(JKMX!IX>JF(AT/016>W]/;:%Y/_4 M7_;?UTVY0BB5.2-)""**(:>(IM.!.`@+:LE$Y7*\(W"8+ZG^%CV==E`5E/(X MSJ;:/S;:_4T+2PWIY]9+9[`;95T;:Z,.'8II6[I4:.D';54)BR.`(DA0L4T5B<\X9:4LBG:.[CP49=M.I/6 M33O*7D7WAU+\QK?UMFN9ZT&X+=V(?N9M66Y:+MSH5H]>&)^O,L)XCD!*(4E! M6N0QR-$H@V.JF:'`=>F+7.5V;K$>+V?UU@Z97^HF>#6*#62K?#VL>NM-^7JE MIJ*?"N#\=WE7T]RXC43_"H[9*J>*!,"O(PD2*5=-XJGQ;/:0@TJ6:)N[,NDB MI4EF?_T"I$C1CD0#($`AVI;X3TRAP,CCT%86**=)CQ3WHR1)&^N8M*B7)>;\]M!D1OCC$(W0@C#S"%Q MFF4]$C<.I1H\&S!O^##Y`$W[AODY#0 MB>-T./,3A@Y1:#NC;DQA*5&I/U:/CV\*Z-"G&?2*Z9-A2I7TZ2V-U]6GB_Q, MZ--\3BW1)PV.5+H?MQD9TVW3'%C&EM\]?JK*I\%RX@:I#Q&*4R=,0^PR!,-* M8C0C=5(TMV@.51PQMB-MQV!V`VT[.=",$2V?4BW`\9S6$4ABYRG10%'B2DMQ9U,2R?=RU$[IS#?$IG3 M[=5$.J:-M)G5Y_WSFCW%_RRW_&3+A@ER\2V/RVW[<<+0;9E`\*M"VJLI^7LB M#?NQW6%;E$_W7#/N7ENU6#&UAE&8I%&6$B?$<1!FPX9NX"79_,)U*:2&!;=W M:,[NP!7"-Z<LE M.+II136N*632A?S2CXJ%$\\5R1!:/KA.B%2.G8_GV"[/;0&LW#A$*'2]*($1 M2B&%>&B\2UFQX2NL06BPNLQJ1!LF4`\8F0X5@PXUG9@UA[K.>7R97%`Q+20I+5V,=+1]'^?,R<>5%T4^RC*2I+X7D-"+'`)[&!0YJ>IBA`[; MAI<7E%XCU$VO_&+!TLS.6LP=IW+]:X1R!^F-5_("?`K6YCHC8XLVFG)OHG[6 M3Z.!EV)6?D*]T*%>@D*:A-0G..EOE6W3C'++_\I.C6Y6#D8^T^D0PL#'<9(%'AY4V\U8K2>1;&HU;#C3 M[+#R"C`_H@4U@PLVQZOM6?UWL3N0I)CJC8>8G%XM%'*">HI"#Q1PI)Q]TK/? M?I&)L&]$4668G-!4(P&Q1%7-^%8M\$1+*NMY:Y_SNJBV[V^:6,$$>8Y#G!2% M0>@FK@]1W_&-(H9,)AO5:GB!?/2'[>B"EN.E+84^1=4;!S%%O5H(Y!3UHFS> M@`XK.'.+SL*2*D/EA*0:B8@EDFK&MVJ!1UJ+I,8LAZ[K[RQ=_G6]XWL6D&WE*'4@@I(4F6$0=C$L`TQ=2'`<$1 M=*G8A`@2 M-XMH%"+?=7P2'3LD^(Z;R)VPF&/'\!HWAP9:;/RX/D=W`UI\`('?.H@3(U$_ MJV)"MQ2A18,JQ,#!CBRMECBV$`+3E:9 M9K(XK4G+$2BG1G9PMZTV!WXLJ)W:+>#P#9X%N'RGZLQ1+M78\9'3"O6DYVQ\]=NUT\,PJ\5;ZQ_6S+IR9M],]SI MA),X"!"":1KAD,%)$I?T:$@2SE54'1`,*^OYX7X"SH=Z!QT,V`6N35LT2,H* MO'1\="CQ[-`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`')[@W8``,3HAO^GL?.M"22JD[%F**><4PR"FGW@@845`Y+B>4 MU%!0+%%44]Y5BSS9"OL$HZSW:WN#PMWC8UY_KHM-OG)0&A,GQ5%"?==ST@BG MPS8K3ERA/G&Z;%WA[!WH0((6)6AA*BS:SB)8?+%]*6[G%^,6T"J_O+T4O3-7 MK%5IEEE]GJ#B@P5E'21:M$:LQ9TSR[[Z:!*:">*R/*QW7_+-H:Z+\FE\%]*^ M^H7I`Z!(:.EFSI%#H77= M18`8GD,Z_&!PX.T5:OL*,!]`ZP0X>0$&-]KSQ%V.**&'YJ/W\1QD5>#D)JB_ M:"KJ.O=+0?YTGYZ6[+Z>;V+-QN^=]6^2K=A\_HNW^?Q]M^' M9L]!W[)!4CX5#PSZ*H2QG]$HIJX'X\SQ"7*')=8H3I3>;%L>Y57./(]\`R/G M>,^LUCUP\@^<'+P!)Q?YCPY.SN_(N-0C(7=RRNZG07%=]SH/PE(-(_7$2>`` MU_6>#4OVW2P@XN-.EE<)C?#<^%-5;7\O=KM5YL8!]DGHQ:&;)1EQL1^PWP^# MR$<41YY\XWSA7RVC.,J]\9.A_7VR9M^0V-?0(Q0]&Q/C6IHP2X:A/.YJYI.B M^)#WAS+3`U^RZ:ZO6)$L=A$.G!B2A,(@2[PLZFT&&9)J(3/+D.$TK,<&UFK- M7^:1*);U+,:?7.+2P[HY'0'OD!UORKF2E)QC24!>9I%KF>3,\^6"#&D@2%J: M/K-'[WG=Y*>$X)0&-/SX>.(&A$"'("]%'DE3=#+N2!U3U&/1]*[HZ$C"^I3_ M\]?D*H6;OS6Q+"=BRQ&LJF8]PG&)-<)X)5F;Y$U`W_3P;IG0:7+J@N+II$Q: M^K[6Z[+9=2N#(ZM!Y$0)$UOH1MB-*.+=!GNKT!?;E=)DRK#8T:K.BZ<2\*W$ MO-Q\!_L33+`^X9PM?ZI,R^G>`B2K"MX(F@5"=YXH`86;R;!ETC;7FPN:IH4D M^744Y"44X<3!'LUPYM`D#(;?3S!%LM>9"?]B^544Z1O+V'_X:RR@B')EV4@0 MQWUI`47./G]FST>\1Q^7VGDU:Q6.Q69?[4^+PN=H5FR)O3M?V MA$'H4)Q05CQ!3((D)%&**/NW3[T@S;#DO6$FH%(?-WUH=`V\3K`]"=-7;R69P/;6?M$0(+9':97Q]ORNT','" MDOYS459UL?_>=PL^=^%:E#'C%"-$?!BF`7$"#Z8.)C%-_"`@F4P)IL.>X3KL M%_8(5>6>_??=N">W_-6$Y@@7T^2EN9:37FTT&]%8`>XFI%0G\Y8HIE:7*G,/ MJJ3^W>=/O"#\DK]6-1?>5I5QJ+]2%9#(QA MQ1L#!2>DLOV=GUP_H@<78G1C28XXE_0)"5XLGI:H M]'+^OF\@M2S1XK7XYCG?'G;YW:,4PO;(?'Z_7^_;!.ZX+7G_G.?[N-S&VVU[ M?FR].S]M.2&,@P33F$(W"Z'K>+AU)4AIP&8SJ=K>0ORFUPJ.+O,ME"]Y6H:Q^+FS9.*UFJ+WRT0V8WT_O8\'WB?V%?NP_XC]\;!N`L``00E#@``!#D!``#L75ESXSB2?M^( M_0_>FM=U%PX2!#JF=P(',>,(=]E1KIF>-P8MP1:W)-)#4J[R_OH%=-!V60=) MD;3LFHZ.LBT1B

_O;A M[U>G_$J>G7WXR__\YW_\^;].3_\I/I^?J&PTGYFT/)&YB4LS/OF6E).3/\:F M^'IRDV>SDS^R_&MR'__WR4V6STP^?3CYPUSK9&IE%J>G*U$GR]_LAU^OX\*< M?"^27XO1Q,SB\VP4EPMU)F5Y]^O'C]^^??OE^W4^_27+;S\B`/#'JM36)]Q? MI^O'3MU'IQ"=8OC+]V+\X<0:G18UY*^>_/6[^^#9\]_PXFG(&/NX^+9ZM$@V M/6C%PH___/W\:F'B:9(699R.S`>+P):7S+85M/IFEI749]J\G#;E'RP82!E'WW/Y[NP#KLRE,?F_L@^'W.Y,6 M-=G1:1V#F-R0_@=([,*<=.QPN)T.N2OOO@@87-S(N)GJ:?6MEPDY!0RB?S>YR,['/6,:> MV5AJ9@XV8[O(`0RZN#-YK2BCA:3#U5?FNK2.0]LQ*1U9U\%'UE/4&2KV%^Q3 M.3X:97,+RFF\+V3![G)3K;QJZUP$U MZ!.N[=](8Y5.,O=`9]`<5%L',"3%:#$.SLVX=N?;7:@OI39_VK0A.A`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`<(.1&:<-L*H4\`5S0`B#()N/W+ M`YJ_C@=X7()9*[]HE")9*"\>GORUB%UW6-]45,0$UA10'P^5!+'4A-<&B='<"(^*)"C/+P_1"GOS;.>L>])P*I;!8GZ0$46@J(`L%\ M(#4&7%.F.*#"(VMC?"V\MT^B?MJV(7%:H=V".LLC9L5E;NZ3;%Y,'SZ;47:; M)O]GPXO"!AR/*BH[S?K=S*Y-OH5$;41%F@FF/$)L\&4#(2$!\>3:0"$0^GGH MU+3%LT&1WTVM;H*JRWD^FL2%N'3Z2J%GH__=UXLDRNW\J^IB`@@$(0X MX$BP0-K.2P&N8`XY#%KR#OTTO.L9\?:N;"?W>;%4S(SKN+)&HB+`0HZAQ0T3 M*8D"A(=50(JYWY92^*>AU$#(#^'*-J"T)8+?4R*"4(9,,:"@\FWW41Z'E9MF MP-L[_SU^1S58T-XMU*]%H^7BC]D:S]D9Q8>UD5NX;O(O;J MK,5K,.@0;%N,=JLDWIW#V+-G(@(]W]/<&A@$!$'@!WY0>Q-RGKNF6#[Y>&5#'7;V67T40#NXT.6$1M:$6\T8JXF-@OW.&E^WBZR*XU M9;:XR6==;L]*[$!:1)1YGE2>]I2P4Z7`_B^K@=!^OG>#_>U,+SJE_O$WU1!C MPSH5J[#5)`0M.>H=\WF;HXT$VC?,6R/]XJ2VRU]\ M&OL,1/^-=4<>I;X"(>8,*ZDAA$140PUCL.VTS_])G/6Q-=!;ZQ"K2<"&^VZ' MF2$^^<)&7=2'`0HA]3U$M=MBT&NDN:_;QBVD=E?8D;#PTW6&@]OGE>>%5Y,L M+ZU3FXDLS[-O[@*K`>:!&VJ-0D8QA0#XU`L@0,Q#N'(@7*&V2QY!2UJ_3#/2(/AL@=+94P(!+IP/=)^'AN M0=&6/87^'#WE+;39N^@[BSCQ-3O-0H'(3L\0X@$&RD-2L!`SS-;(4]QZ7&'_ M#I=>LYV.N(<\N8YM`P"FAW%D7XT1P8HH3!#E(8$A1"1@54@*0R[;;B>!QM/G M%TF1[[D+=-PNK\3Y)TA>W)S;[[Y,XM2&@91KP=\2T M_DB1#8#\H)Q[^EZ(ER;L33UH)"="7%HD/*`A1IA`WV>0KW$@TG]':0A=$V,; M[WJ`?5#ZG:5W\[)8`(+WIGSN*!5YDF(D;;_5C%H;K5T,5C-^\9Z&T9[:?AO# M#L9Z"#ZY+8%RM27PQ=:Z9\#<]+C;A?.UA)HH$6@4*-_.":H<1L#:.JPI!6: M+8Y[?)D8]UF/B<^)KX'-0P4$Y1#5&7**RW:GC$XPL/Q@XTRW4#]]I.\I8!4 M48!]AC36UL[`JY90:"#;)O@=^C M3UN\7XE5X+P' M1@K:EH='N,HS%`^[1_V5^/@IGJW[D=4Y3,LG;SFJ1\!-$B)L.QQFV(:DMDMR M/]0^J086Y0=MK_4ZPAG?4(SK`.8A*'89/RS6YK]D*U77IICBKWE6[`KB]A6- M/.!#X#/L22*I]#SD4DC6=Q)!T#;X/\)`KA=2=8SO*^>:;4FBZ:.:R$Z2./*Y MIP@-02@(4Z`"1H*P[?K5F\L7;DB\(VB+`TC:;+37\^GT0273>;GW[IOV@B,* MH>L2FN`5+0-Y.IGZ[Y](@Z&_BL%=,H4HSRY6YZM/B2NVR$H MPHH!#)CO*U\&MBL&"#\N'&&_[5V+]=-KWR8/!T%["-Y]FKOUPXL;Z6XSSA/W M"M$_)LEHLE3XXL[D=GJ^*]:K)R#R)8+,&JD!YI+ZH2^\*DE8*+_MVQCJ)Z>^ M;9[U@O(0_'(COPN[!6+Y6^GNS"G*?.Z"V*N)1;4XLW&!&>]:L&LFR`*- M/**QT)[&B$,4+.[V7AW(M=Z_)=_JIW>^;;[UBG:;_:4L+;)I,E[F)ZSRC/Z8 M9'9,O_B6FO'5_+I(QDF.`U8O2%Z_!.#B9OV%6)6P8>TL M2Y=F;=O`&E2)R$/:@QHH!)#RN/*8PN'C),YON_+2(COS;7'XZ)NJFZG,%Y=$ M8X<$VY"+5UK4GZO\6#("6'$)K-I"$^@#Q3Q5+3YY`K8^^?7>MS?ZP7>(8;G_ M_K%C*.^_\LCS$!7N?"]S]XV%PH=A-2!AT'I:TR*=\6TQ^FB;J(7/Y&DZCZ>? MC;M9(DEOW1OF35HL+"JS3_+L[ZZ7JFRV3F6^S/,7$&!*B*RG=T=KD MKC5_4/$LOC7%53:_G93[KBS<6S;R"5$@X'X`2>`%?HBQA&N;-0C?08YMGT1X MD7+=+=PMEGE^4&&Y/Y_=7)5N'UXG4S.^2(69Q-.;BYLMO::)B,@3#&F$N"+" M4S[AD'AB;1#GX!V\77D`_O2,^C"7/6Q0_^)&V39,QW&Z\W4\>\M&5`NFL4>X MXJ[C6+MM+UK9JVCKX[%'M#+]>E[J8+C[#8ULZ&"#G/'CQH\9BW@:IR-S-3%/ M7O,TZ/1IT2M=.UW<:#O5M2T43R^S50[M_EE3G>*1#8*!;4]W"ID@U\=]B"C5 M"@=(!T+N/2G4C^6K0]3[;7S^8!0$OJ;8]^Q_@(8V7]#Y?''&?TT M;M8AJD.,`TL%UR^AK4N3'YZ/0BH\J0`36$`OQ#X30*[MXDKM74Y\.VQIVZ`; M>7$8C(.<[W#O8TT7;VM]\JI67DH[A7RP`]*^"4VM\I&`W!<:0P]+'?!`$JKU MVF[$T#NZM>[`=O]Q!:4'=(=@U9/77'\RY0J-'2S:^'SD8\`9$*&6R%UA'5H/ M[:WM\K%NF_QW1%.9?EC3!9I#L.0LO;>*9?G#[I>:/'TL"BA%'#%*`RDP=)E@ M0"VMP`"'K<]K'='$HQ].'`#B(#G$N;F+D_4*JG5YBW?Z/(-@!T-JE(Y"SKB; M1$'MV2X0$@^MG20&%-*@)7&.\*1+M\3I'MO!H]ZZT6ZD04@)@0%0/`R9(M?9`H;9[-D<;E!S,A9;(#='N.DF3TIPG]RZ);7UX;6GV;F^Q MNV`4,NQ#@H`.M>)<^Y"%X=I2KEC;%92CC3\.YDBG>`[!G">!T>-K*G<09N/S M4>"R'!A6BB&.`2,A\?G:+JU$VQ2K(SR^VA%/NH!QN)!T;RP:(:*5AU#(-/`9 M(0HA&TNO-/?LN-B2`,TO_!@H".UHJ;4A;H-LP3ZYSB8=7Y79Z.LDF]K6*%SL M4S[46(VO*R+BD/J4`Z2)"]^!Y`)74S#-P3NZ[Z_7[9R>\!Z8;?5W>[87BC2T MDSC(D/"(CTB@`RQ9%9)#^(ZV?+IO].VL.@SE0<:I94)'<1D_N"7D&FLH&PM$ MPGIA0+F'22B1'7*UNS^I"NWE.SC(UF7S_CBF=8'I$&RYFF1Y^<7D,Y'E>?8M M26]WA3@;GHZX9]VS1SW,A;*Q/%T,VRN;`L#:KN@?XAS1:&%!VHH?9<^LI[S02A%VS6W(UQGZ8$JG6`Z)%N^Q-]? MPE"#-!O+18P&%K@@#%&``^T)Y?'_)^_*NMO&L?1?PKX\8IW).=WE3,9]YA%' M)=..^CA26HL[Z5\_@&32CB-+)$2"M.HI50E!$=_]`-Q[<1=>S]/K[%3G"?I? M!N1.']"6"7Y=/MP^MV\Z3YPC3P?,/,:".*X`II0*:"RJYP2@=9ETF:`;9@"Z M7`YH(45WO:ON.NTQ[XX)@'/JB*+8*JBE%YY!7,_/RO/1H1^G3NLPZFXOL(YC M9W>RKX-2F`JM$=;2<&NQ0+16SZ#@/M?!V[V0ZN#^O2%VEDOQ+'WZM+H).#X@ M.,HUIW%SU,1:`YERMN&^CP?K55I&`WE@^D"XV"72ZU3.UC=)1P>%5$_.*^.X M`5P)+9E@C6X&O,B]39BVR30,AWI#N4S=OG=SKT]%<[\_*@BH#-46\,P;0-J&";U!W,1%U_.Q=4)U+QW2#!A09P4<@)X*&D]0Z5TKJ8\ M;=-J&"+UAG*A&-^#=/9??2ZQY,C3@2N$H@U@&?4V=:Q1%#5S2FVXK^=*H0_! M_A[(>R&@IC=5$'$49S@^:F-$Y07QZ`'A>B M6<1AWO^6?/7Z>+>X^+6UP/ M[`K2UP=D2C^@EDE#V\X6R^K.S=;+=#6FYO/=M]UC2EFWU?UBOCB=DW9N<$`" M2*`43R7="7;:`E#[-!$Q_(IB.@>@4>_X%O(9UQ^Y-P=37>%U];5:;A9/U;X` M9I6J.?Q1;6_N;V<_3GN2N[PI$.]EG#G!'**XR)"CC2,488]R[SXGJ#4/L64- M"G:YX.)FYSU_]!T?$"AU,"I\2"BM#&0N:G]U<@[27N?J2!.\IAB`1KU@6H(M MM^MJMMFM?[;2HW]_.-JCE$%"(2+$6N4M@$T*%W*0Y7H-V]]1R`-+EM5#6K,? MC2<7(SJ.6Z>3.R=82)&P'EM&;+0:D3.J=E0ASE2N\M.]4=O@]U@#,.1B/$LP MY.^+Y6H=/ZWNR'&"'V\?#9H0@Y7&$@(C.508>]*H;ESFIM).\)P9W,EW(;;C M["51J7K_+G;IFC6VU6Z.EDMMQ'EQURO5<0")3R-II%^UQ=&C4%"7"2DJGG>.` MJGA<^$93Y!Y=SYE9,J>B#ZQ?,6N$FHF'3E=?J^UB/NM"Q,6N``;::*S.E@'[&/>;@$6^:<6(0\8PS+P!O)ZEI#*[2>+T5)]^ MA=[^;K,;PN7O-N-ROEGOP;G;6W\GFG=U>T$0U@#J0105=!Z3:"007<_<^.SD MX$ERZW+QG[P![0GC\NPZM))5N^W7:!;\I[IKS:JW`T-R2&BI4@4.Q+RFFJ`& M2.[P7^/"M!\V78CM6"PZ].7NR*##H`"%XH(3ZA2&0FMB@`7U#*/N=46AA878 MDX7K6,RYV6TWV]DRV7L=Z?-J9/#8$B`YTE!`R@D!SJM&.2#9#:4_U@UJGQS* M![=P=$^&CM1B=#",2Z:`U=@*"JGWWM!FSLI=47#A`(3J'^#"I.J@&IT8%;!% M%`%)F+#6.B`T>S%9',ONH3)!Y_6P)+H0V%'(F=$X-'.E1QKI:3C3EB9 M"DX]STT)G$N:[K[EJR!-%JC%K]8/W]KV;OWP=("28J&5(<1`[!%&$#0[*%0X M5V_N[@3^B$2Y'-#BGM[&2[:YN4^5_/WCZM^C^WB;#^GFV_UM6/!JWY3(&F"H MLDACA/FAJS,'BIW7X(>9::I['S]UW[DZXJI__F.3RDC>?*]28\3E@YIO%T^' MRX/S\^_^LH"0C6H2!L`1A",_I="B1B7JWME=R*>XQOL@QZHPXF6LYM7]8IOB M"D\:R/5#`0&OI:$P[HA:::T-]Z">`5'ZBIJD#"G>WZM.Y^%;)J'AG[O-(0_P M=O6EFJ^6\\5C%=%Y"4F]7?6WCPWQ05A)[ M*;5F&CKPYZ=E7?KJ`.+M[,=)>Z_5 M^.`IAHP"Z9%1"@&7\KKK>2?GVN![YJ_AU;=_+6H.(:,RW'QNX?2W3_[FN>O\ MYVJ]6-V9:`<_G/*DTO5L+56Y-\$3O,N;&!5[E4NQ M1*04S!DA.D#VW!KJ!/W>'1,H$Q#1%+1L)?7*`(=9/3\D<6XB;OO[OX*))I-B M7E\B&>=0;A!Y3L%J8?RT?TDP%E*%(/56@0B$KZ"96=23?",'(5:E\$]KJ?DN6Q@`"-.!79& M.T\`U8SZ>KY8T-S[LPG&!8Y"K\O@'FWW2C6B]]Z9S!WL[?C`C;?,.X\83GH` M)13#>MX,X=Q=;(+1@F/M8A="/I)YF8SCM_B<:U+?]B6!V6A%$Q(5!:%\-*:( M8*1&0",R?-6H@CZ/<0W,?B10@H/M<>HE3B58R'5>80Y(5!BXA@!$+YXNLOEHCU5ZS]7 M5Q0SU1_F16*F9C^?'>1J_J_=8EV]VS7^5$Q5ZY<$9"@D6G*LB$-*`H58L]2I MRJ[@F.N"&V,G[(4@;Z.NAI+`*!S\W]7]]M]GTK??&Q.D9&E!:PB04=0;:5AS M@T>IRVV#F>N*NUJ&90(^"J'T;K-85IM-=:@XF3![_I>3J;@=7A-57"4$,898 MC(#&5$K7*!C:DUP%K[U_[B]"N_YD4)*)?K6.:,VKZF[C(YQ[0^D(7"W(V/)- M@6OKA03,4,T`[(W@A?-&I<15!I27'#C4 MA#CXF.`==E018I7BD'C'D&W\FRE9 M\GIBWH<4_N^91+W`78).7ZKOSXK!S7U;.KT[)F#.%>,>&Q*8@91&*T=`#('%G")C&KU"X]RTVES+\VIW MKPM`+[UYQ<_>K>=?9YNX$EI7?&WW@B`Q3XVO%*58@:C'6O6RF!SRN87O)QA2 M,M(FUAOVXQV9A[HE_UC>)2?-/$*]>*I2$>OTUWJV+Q_R+25C[$F0KDPV36WU M?=V3F^_I'\Z4%1CN=T-/[D-DF;KJ4R-#_[AKPD MR6[N[2*=3,N[33>"'1\8F/38&X<@%%8*1JD#MIXI(20W:[M]5<`K5B1[A;[T MP?YJE>PO7HX`U/*H;O&F0*5DV#FC+:/<""J!0346'H-<>V:"=09'4C#[%\*T M;C%ZN;T(3'LJ@*<:"Z^%9X;H.F7`"T6NJ)5-01H.AG\)!KK[^VJ^C;K'CZ@F M+!^J+_&4NEGN(R*6=^F/I)0\S1[3VCK!P2ZO"8!@%E>>0(@SHK3CE#3K$+KL M,WF">4*#W)T-B'4)QAW_T$,!C;?I`"<8U^4U(8)+`3#`8L$%U)`A7(>7>2RR M4VLG&#\P".,&Q'H\QJFX:Z_7/^,&?:[7;JOQ@1&L".<::V(0(5I[6)MKWD%6 MK$GS][U8(@_6VVMAVF507P_%;#2F)),*"P'B]JVQ<:)96@`6ZX1YH)A;#MWC M>32"=0/Z%<%&*$Z]^A9?_C4^LWBJ#D6!?OVZ\F6J#U^14/[]V[I5KF[SIJ!< MI`&T`-OD<8@"BK(Z""LJV8R=/=P'\S5T*B1L.!:.<:V1(QP8ZSWA]2P@TL,G MM8RA%/K"'<#M\B!\?N$]['HM[,?+99(B]%!6@J<9AY[B#E43`B*ZSFK M>((.[E:_.D+UCWJQVG]'/CTM#+]:5XN'I=E%:2[G/V_7L^4FSN)0]77_?X\' M^3=5\.H)GR#G,#\8@&.*>\L0U"H>QT08!FMD,5"Y`6T3W"![Y=FQ$H)C"V=L MVMNHOS[-T@WMYG]VL\?%?=+\U.:_J[N'YY2@?(:W>G=PZ0"R"'F%<:K8J&WM MEA'>67)%!=C'(O,0'GZZ65=1W]J$%O>W7 M%_QB(,!Q28$2E'I&O?5,TN:853[7S9N;S3C\U>M85"\GI+$7P(5L;F8-J?44 M4$64,EA+I21N-$"D9&X^6?>@Y9+^X$%UXP%@']D,:\*S/J?F!U'.V^UZ\>=N MFPIBW:Y2%>;5K=RG,1N%=1 M^T6O5`[`-1_4KE_"L1%!"\(YEBXN64-3)SUDFZ,(F_,AU@-=&J\US-=O3 MA3K?/!F@)T9P"*SD#@GF+0:-/]\:=$7]P2Z6Z*I/),OL[YNX4YRO1_W+7!E9$`_@)%X"&`9[X<:_"$V1U>+65T\)F.Q"0I.L M:-47-89&N<06DMQ04*0?LO]4][GM\\&AS2DB#+D%"1<*""-JN=CK)"# M&Y=O/!L?[D2Z%-*B%'EQ>K#LD&'9;=5JQ[@MC' MY4KX#Y[MC@F5.*PP5QUIIS:UJ*G5$S4S#7+9TS^/ZY\!?S4@ M+9EC"DMM$10D&A.TB2GS,INV*3?@VL_$Z8BE'/7C+)Y7YW/(RUG:_C8B4*J0 M,\H39@S4PAH+&L/5,)2;8`,GV5IB&-)="NHT]LJ>@S^&^<%@%578"2V%92B1.6>Z$.)U@4=%A>]HISH0H[G;+>J%+`0DDUP@0:"H$%C:%N"NL>QO;A=K!L%`L5MGEA\H6'9^=WA=1O65KAI?<.,.J(PD.`]M!A$`SCUB`)6:ZR;N$B-0'8UU0E6=.N;)CUA.@9C M[.)Q%_?S#.*\&1DT<23:Q9P#3JAC5E+P`AZFN0'/$XQ@NUS<9_AS&;33\#?$ MN3Q/8S^EBUP);]X5,'30<4^E!59P)ID$S<4&P_R*J9;-C,[.@LLPGYH?()>- MG=X:A'':4LJUXDA:CV"T9IO66\'!+]$0_;[H=LX))!Y)UBV&+! MJ%5`D\8683(W-VZ"X9]#,:L?9,=@C9YM%O,,!>V7<2&NAW3%Y9VQWB@CE?>- M1R75T;S>O:EW]>P28">CG.TGT8MJ]O*F@"TP'G@AF.#`2<\Q;FY2@7*YV]0' M4,PR.9&CEF7C/4&E+(.%'=X9G(QP0.,E81+%Q<^Q;8):2-SPKW?3&X*/PR$_ MVK':]3@-Q,:/]XCPE$3,(=1.-NH"P-E!\A]`$>N'47V@6B@GNV[[T;0":53' M:OX8_SBEQ[<9'HCSSDJ"G"7"4P*=E`V&6JK<&M[P+Q#T.@"^)5CU?]7BX6NR M9I[B[OE0_;'[]F>UKCMMW>RVF^ULF0(T6FC[75\5"#="&(NCM:,AB8L6R$97 M0,AD=V-N'S3[8=DV,-8C,N^U`^7U3+H3[[TW1:M+,/TZ/=<#1IQ\>>1#"EC?"/J\VNU37^\0'!""VU]UAS:FR4'!%* M8:\]$<02!\_F9I:8W6W$5#^>[H'XSH@`D1!406(1$PS&Z3D%ZOD9E1\?W'4% M1[;_N1IX#5\JXM40D(ZS)M5\OMHMMYLOU;Q:/*6HK7W5%S^;+QY3@]'EW9?J M:?7XE++WHP@7V_I?_IBMU_N2N;;:SA:/'WMQ8RB9%P`"1U(,)*5*>6$9`YHS MZ_A(;2&BB%,OUE]@OTTB.C'!=\<$HR&TCEIFI3>,1!("7<\1.)R=KS*](_I2 M(;^M0-`3I"6T/[W;Q*_=Q&7]K]UBL]C+ZL?B5$3C.R."(5Q!AQVC*1@O3L=@ M$.S(G%_&!J(,LS9BYBQV M1C`>3]8T7PL,YC"[4,$$.72QQ%LPZ!)L,PHNF2KJ`8O5WZMD=QRAP6_/!.LQ MQ0!A`9FEV#LJ)#M\$DU9H-EQKA]#W)GB6?6#9IG"2,N'B.VW=+[>QE\]<[(< M>SP(#F6:#;0\IA1Y+&IQX9L,?!^R45LY.*%JFK;2+*^"=2JYBL=KZQ??\12?5XWJQ M_/Q7^,W/T*OG?8Q52NO1K.6K,XE86.RE<6'!9L`:Z'GT+16"$A+*)[3_W37A MAD5^D`"'7Y;\"T;2ZX:"13\W!&&%"?/JC!/*'(2.%@.(2`RH4"`=A(L^@5V"-UQXC3F)(EJM&ATI5NPQH'+6O M$X8(@)QV@*EJDEB?6D%CA+>+];"ETR&RUV+0'[,?BV^[;[I8KXN_XF28/89/ MMC\;$NK4:S(=5>W^8!Y@1IGE\:*T(PH>)!>P'>'JUA$;:G"L(["O13GWXW%Q M2)*PLVT.&S+M1>N,`L80)<9JXQ77RD#ERC$;E5P":(2KWW`$:X?QM7A55BCZ M&/IL\\W]>O$8A]"07R?>DE&ON8O7.1(D$.>&:U&Y+5R0U%)W-^+8]\.S;K`> M@F\?UL5]GL_W^5YQ))MR*&?8=;)-AB1C-"AI@90*<\J$OY\\$Y)\M'XC1E=[ M+G6%[#`^W^/LY_&:P;K,.=DF@]A)+94FS@`IF>24B7)\,BCF1.;4KW=WX\SI M"MEKK7'J6]SXJ)>14JM])@ST5`K+J?7*$J64,T^.+DX]_&A>!>]&&=4'RM=B MERF^YZO9:AMO=5TN9JO[IL&JKU^0.06=)-`+9YQP"A/BP9-&3DXN&6'YO.'X MU1KF04RF93Y_R.=JL\FWF_?%]E-0O<&IR)<_@Q(NUMO\&-&>/^WBGJTEG/"Z M#''H$=7Q#V81-8HP7**"L$P-FQYA)G%/AE;_H`]!Q7C<_6ZUV:YW<>E_[G7L MDV'GQ^/KV<,Y?5?_)5D,$V2`,L(@]E8K3HC>1U0X#8D#J5;:"%.*^Z%=;U!? M)TWG]"?'H-'XP*12IM+N)FFZ&]P2CIB%!`$$%O7<2`X@$ MM*Y:_J5.#=,?X\%KQX0;%ODAUK]WJ^_!08O.6@TCZ?7#F68:&`$T(!)X3!BS M!%2*7^C4DF]CY%+G)E)K.(/7E2)%Y<`_);2$T%SF@GE2((2^&4@M+"`L)N0HY4&Y'624UMAF0GJ:FA!T$: M0=\EIJ>>:!]FC;%&*&>(962?+85)M=L!P(['N[>R5;C"]%E^Z*V)IE+0T&/+$0FQ=T*RQHGKI-1@S(<>IM<0;%[%L MAFV"@=.\B*6,)8P4T8P0J9`.SJ*KUE*M8.I-LSH:U\!-:@#IB0GHH>#.HAPH+_'P,'+D0#%@^EFG(C2)"`<\Q!S8NUI7:EE9, MO,9N>\*T`'-H2IC=.N)4DQG'IS-!&+=`:LNDQ$H3[E@%##0J-=#O1DX=NR5( M&J93K=5#N").0>JP<(H`A;"LSOTU,JFIFC=R0-`!L_H#>QJU>IC#)*[/E#GO M``0(:%9M=2*4NK;=R(Y./P1KA_$-UDY!2"#/@8=!97-J8^A0=48CDI>_&W'6 MVG.H*V1OKW:*,I1I;X5D!!F"K.+@&+&O'5`PU7(Z;6)(:-7ISY06Z7,_:HMQKBO=B:'9?=* MF=IO=D6MYN&#QV(S6_ZV+G:/FSHIW,W>E&DBK<+A/Q&6"2:8Q50?+L9D1BEP M,4*D-SR>=?;=ZGZYB^1Y>W`-+UUM^>HL\#86(J;44B41QX087R)F)W4JT1N7 M7NX*#BN2X77*V[\=18T(/UNL_S%;[O)#59@@W-\7LS^C[M['^L\BT/.[U<<8 M_Q_#7<(#[XO5NOPQWGA=1RUU^349=BP,QA,N#2%,+ MY*7Z%9U]1X:$1&&-YTX$8P\9;9P4)8::L@FER%R'>L4X!#=,-F!0?X<#G.A/ M_!ZY7X+E-0D#-(+X,LQ$J$G=-W<%7CQ*FVP*SEZ8MG M,R\-AI!`'"Q<"*BS6LMR/,;*"2V<'K;_GS;Z%.*` M4ZLMM(Q1:#0DML(1\-3LH!'2\_IFUC4E-\0,.`SK:93S_]T=ZA*<8?/)-IFC M/@Q04>V<1L`#K&R%,L(J-79AA(OLE7A1]".)E+RW4U_]/M\67S[/?IP(%;_8 M+J-4;\%3^+W8'(=R0.GNRYN/ZOQ+L5R*)B*KAT7P MC?,>EY,!0-":A39RD+4BA'+0!(K3`PPOCUH>C8`^P) M#E_9B]F97J@O`?7M[(?Y.EN_F;N7]J(,2$?B!C,TQC/.>!A:-3B07IF6WBHS M!H%QN.VGO2)]PN5\)-'%C:E&;\M4<)615=`AQ;!5%D-101\_F$XD^U#JJG\I M#!.[7.W$=$7/U%=FV'E+L#2&$FRAB$E*NHI>,#O![FRYA,8ORXR@B#G"!,`(<4J9(*A$1]VVP_Y>E',6VX)=O.M,;F%$FN0 MD@@J)(Q7HL*8\.0;2B>P/=B"Z".1UM5F1.BJ^_(EO]^>V"=JRO5+[\L4MMI0 M3`(>0&/,@5$5+L8G>\GU-P+E@<6K_"$6A?D\;3)W+([AHG#/SK]-C7WK)J_) M*,?&>8*P9\)+H264O$0!49.J6IMO!Q;;V7(2;.P1_N']E<^_W#C^-_$V*$#0 M>(854-*R(!QD#WEOW,8[NR_.B7[P>'(2&R7VO0@AU;-EO(K\T]<\C]\0F^R6!(XWKCCE4?0"01!\/*/_HW]G=J,+6Y-BKVJ MO.+^H(^+`ZSY;_RV=J%=2TL)2>8<>KQ#$*CD8%6,4TA@D1K"\MQ.)E\"\N(`FMZ M)4='N/:E-OQBF:^/-R^>5QJ_/)D9HDR,@S8.PIAN:2DB9>\%`:GA5B.*;QE` M9;2!M'M"E(.-=W&>8,+S1S(8U!CC#$#+@(<6(5(63%&*F^0:9B.JH-@K!5I@ MV9_L#UO-YU>*-Y_-@C5NF/?OGPF[<2* MSYX/J``BG>"$$0HD\,J::N4S7$V@=N&`!$D'MGN*J-"M^;YKR]E;)2Y?/9,) M0F+5;)O::IN4RQW-[?@BF=0]SG%K*;K5>A1YN@VXX] MCIV]RGG9LZ[L.U'C8.Q4D\P*;#B)T>A&*1VFJ+"'G4-.L"+Z2N5+7W:WSCG5 MR3:99@HAI^(^F`-,<&FD*\?(A)]0UFQ[,1?]@#K\S(PY^??[<[3E;IO/WW[H MFC&V7*"HX]=!S MJQ@PQH6?CYV.58EOGPN=BJX6'1*`[90-)RM+UFF62>@#`@1;;PWTA&&,>=GQ M6+!ZZHQH)KU:A$A"ME-*_'ZF4%O-EAGU""JF@:3QMGC/O*)/W1=T(N?%PZJ* M5'2'CY@UATBET/E?0I4.D4P?BO5>JMOM>O'G;AN!^ER\+U8QO"G@'KKV4%Z< M63NVMJLOS!AQDB$5L`3&,0Y9L,FKM5[BU%O<;T:A)7#L;-3ME00S!.7?Y]NG ML;9D<^-W9<93IX(<"#?*:FX@T14>EL-4HM97L+_F,-PD5?M&?1R*MY42S9PE M'$BE"`E^#\?8ALE6CCC\F+K;WCRVI[>TA.LKQ(8@3S4#QB"A"30*P8`@(89U76`A@RG$(#%+OJVH> M9'2S&JH-GD/PXI_YXN%K,#+4]T#BA_S]+E9)O_ORZCBJQA9MTU=ERG&OG$)0 M8.(EQBA6LSBB`?GENYBZ"EH*_?VSN%&UU#/H8Z+@_EBC`_[MWY-9`;#P@F/O MM9#*>"A1M;,$?>J*.")OM'^*)'(Q10!7(^+Q$.TU6E69ZE356/_-F;(4(8N! MUP!2Z9FRQ%5&;!#*[6_YC8.LO8ED(+]BO4]5G"V?G?.^<+[-;+F\>RPS+?\9 MKY%<;2_XL:EOS;@U&%)G&.=40B*#'U:9P<)-7L?VP:;77LE`TAD-@\L0AWS^ MX7`)N8KC>=BW:TWDLR_/G/9(>L_BR1%7@!",;+512GEJ#;Q;4<-CX7.70KJB M@7L*SN8F[JDW9=)Q#"1RF+,8?&HAI;+:4W5PN++`F2T]\#":BH2)%.C#T>6>M*G>]\/TM=@63J[7HZ5 M8:6XXQI9A#G2#%/Q9+>@Y+L&1FA5=B[]"^QJA_0XCN0^_&JGM#JA>_&NS&%@ MH`,66$\TP`P839YMZR=G/8R?>BFOJVU-CB/QE;; M#Z(32^WI39F#Q@#I!?<,"R44,]A7-@-D=KIV6B(G4JRT9+Q':*,EL+#!.S-- MO3!::!R1=[HTR8D](9JT6TAV.5\$,FM=7X M8FVB?D:H@G*91Z,M(/TI7G2^OZ/)_8BI%?G\L"1^>]P=Q'KW.G'M6[$[>X5E M)^_/H$1<4<8`4-)`"3PJ2PP3[`280'Y@=_1Y>3O<%00PO+:X8EG[+G6$01@8 MA;5"CA`2%G1"\*$."C/47=Z"Z&>$3T7%+[A]>RDT*S;?Z(T9@8)8Z"RUC,N` M#6'!P3SBHP#Y.Y3XJ$V1DY7A^X2\SYGO9XOU/V;+7?Y'/HLEZ'\)@AETRE<] M>58/O\:T/].L(L MPX`A9RL."^TFD!W;KK@E.*CY9U>Q'N4ROUM]C)9AO`DN//"^6*W+'^/:L#E5]Z?S[\AH M/'0`,"!F)0JKCN*NQ)`ZB284[M`-E4XIAH$%,<1>4C4V_?.9.O'K_-^[?'7_ M\T0UH@:M,Z:=,PPQH#1B)/3"`W$<,S-23BB"^PH\.<74SN0Q*`??ZO/)"D@- M6F=<(.@51))1"R3`1@A4C=G(U-KF8^9@%PPXQ:[.D+X6NS;5'/PCC\&W#>GU MLGD&P/^S=V7-;>1&^!\EN(]'G!M5:6V7[50J3R@N-9*82*3#0VOEUP=#:H:R M17*&X%P:YV'7UP!"?_VANP$T&I9YJB#F7"HC602`EE*[Y+WT(?.K"0[4X->% M4'?L0LO?_FV6+>//OG^^SIZRA_I>]$0'(7H#JBR#FB"KC"86*UA(SEWRN[@# M/`([2J M@.P$FXZT"%IA*R#WD%)-E4..<%(ZB/22]4-VQKT2JQD]=,$Q,UG=1PSR7]Q_ M-K.GR<,/T.<$ZVKW$2RUDC*)*`0HN@WC%'"E_!:E9E>/U,%>SL.V---# M"+E;0'U=[`+?K\O)?!45OJK,X#RGFP`8)X0SXXS66#CE\AU[0@'3DAI!4_>7 M!U1[=5C\;%$Y;6:&_+98W/PY>WB(H%S%]O.[68R$=R)\R-8_CJ.CE)`30]K/ M\AHY(F?U$ZB(JG8<6"XL8-89Q';).MQYC6FE/>\1BSII8.=U%*+U)!022KV& M5F%E`+8%&E+*$=UE:XDEBP[A[\\^F/N\`M;J:FXFR^5S;ENW]NWC;=&LS]2R M?NR(!LI["Y4C1*$8&VML\V++B$N&`9>5ZY.V$\<+::I2R8ZT",!YSJ$T0$`, M-$3<-C^ MNCIZ^E;1(B`JG8W++P^94\PRR00JAJN!'-'UA$0U+=K`,4'M7[/I_7SQL+A[ MKJ?TH]\'J(2(0W4``$65$Y:[A;[X- MT%AB-/0DKKZHA(H)B@MYL+&55[;?$2L:CA(NQ;)+;M2@1'!0<<*,H$I`IYV! MA/%B])[(SO)FOV7+V>(F^NSENI-52(+^CC#A3`B[)(":_F[R,_Q"2IZ>8#U`D]$\11H`M$O:?-HLI_>35::F MTWS[Z8?B\'7\S,GV`5NI(3<&`8.IQ=18B_=R@^[*F;]#(C6);)>,VA[8/.Q4 M=A:5#C<,7`*IX[Q!4!(H/09Q`A62(N92XYP?]U#TR$44(J MQK%EU@EBM<'>"H^MC_J%KJ>#U^8.3+R@7@$=%]T>>D,IT8:\R$>`3Y[I`]S# M:DGO-0],SL/Y_1Z8&"J)](KG10@]94)A)PLY#1E39NW%FC[KP.0\7(=[8`(9 M!<@";)S&,D;82B)3HL/5F/;,F]'GR0.3\]#L>>=<1T.*J7100FNX4ZH46%LU MHAOEB2JJN7-^#HK#WSG7QA#&'`,19T^U8=:HUB^;CM]7-V-UGF#PZ^B?=_N66L(KG"K(Y.PRN!''>. M[JIX&Z)Y=QQ9:^G\UGZ^QZ]I3]+)5^_GWRK\72/$Q6E87F+NHWD.BM M+<%:.B65PE6`2`( M!\XX9Z,%=HSN,2!NE%F(K7+EY]LQK>FB9S[NQ_YA\IA5U\@YKZ=@8]@A8UC@ MN/1>*TB=*"V"<&!$B_E6&%*?A0V@W\D=U\UJO7C,EM>SU?KX/L&)KP,Q%$.A MC;1$Q_"2"^9+[(#Z11AUF;9_OIEZ, M.@$DYAXQI#S0O)`-4CFB7+RN&-0,T@F;CY_N)W$E-WV^CC]]OLI.[SP>_CA( M!IST""ML#-4:8`AL.4C-4C<%!I@>TS8=&@.Y"WOR=3FYR1XGRW_G%ZZW?\@E MK[8J)]L%@IEEC$EG:9250VX<*3V[M:G>:8!Y,EW9EB;Q[H17Y5B>_/N\K%.K@V"MY`!C!_*%";"( M28H+R14GG;T/T[.12Z!"?9ZEX]TSTSYGN;'?E0-9KF?_W6IY=XL$IE'O5(^! M($2-!(9"X>,J67+ORZ""43VBDA1-DZ4^%QM40,_D_&UY.AVBJFF0@@*AD3`F MBHL4`][Z_9K)NZX\;\^FKV7"I6#=,[->I7:\GB5I7#O267#<$:Z!]\!#9O.W M"F6Y)X@P2&5?_>TVN6/?/+O+QS92]C6#?O\!7W*@%PA4#%K-!94`6<@CI*5- MUY*DYFB1LJR\W'N+^NKO*GT_U0O1YDFAFDM.3(:(.$H$09K)A6( M6JSZ`=4/,3M4Q/.+^,YLLO_ZY:(RO+_T%QZ13%C+(@$*.6L$0+G!! MRJ0^=#;`\_$ATC1-"P-E9_SQ)U__3NLQ<,`TCHN:Z&``H$CFA14*;)3FJ8>A M`SQT'RQ#$_0P3([ZQ>;D,VM)'0;HN92&"&4Q,PY(!AW9(Y-<_FV`Q_5#96B" M&@9*T/AMLP2-WP;&+:1((,B8`58A"V@9M2M,4O.6SC[S_X4)>KX:AD=0=1L5 MV#A+?^@UY`G),3HW"C!D5%Z#0Y4864]3XU'^?ZJVK8O^-O^VJ12_TA8?,SBN M$A1$PA-!&!92OSS`X3TROC(D;OLV9WG#O<;3+R=:!8T\$%YYZ1PC7"#$+2CD M5`*-Z-Y;2_JO+DZ4B'4G=T+*T9XP8MNY?Q[/:O<6(LS`Y_6?/$!$(825WOX=W.?_:TD&;3NAOVMJ^W]>)Q;+:"H, M-Y1JH+70RA=(<>0Z2TMLWYYTPJKO(5QYV-["_L'9X1(I9! M@4E4(^8`6.T8)Y9(["R(I$&56QPMK:\+A>EG/7F8S*?9E_LL6_^V7&R^S?(G ML:L-3MTN`M`PIRPU3-GH(KDS#A4("`9'='6Z$YX<>T"U637T9$A>X;9_HS@I M4^;@Q=T*L$Z8@C-:!R:EL9Q2SEV^X6NA-=H2;*#&$+#J.CTM3_E7<*]>RW&= M#R3J4C_O/S"+^5:FKW&H^OE%<39;S>[FVV^K"AZU]T,#%8"[&'0K(BF6E*M\ M,?B",A9B!&:E%`OW\8;+.S>_I6DB'&P3LH+&"4X"\]T(R M88@M)#-IN:??6&#H'9!GJMY!#A;K3]/UMF7/R??*EESN$$`-"XQ M+"=&0J.88\SG2X^=9,YA,)[=Y$;IT@B:7?#DK0>N"'L.-P@4"F8H@1@!AQ"* M+IO@<@80.**GX088]C2BDW[85AGZ'&L2!`%0*D\HAHC)J$B#5"&=)S`UQ7*` MCNQ2]5:R)0G1;L+DW1BS&[5Z&?9^%ZC2I=5H';"Q4$,J\G1Z0*3@EKI"9@[A MB(+HR]7^)HQN&MXN*/5A,;\I!UY)H0-?!P=L1`58P8A'VCE('2UE$GA$Q1H; MI\SE<'9!D4/.O"(J.M8DY"5U`2(.>8T]]CY:ZS+BT]BE/BTUP*LJ`XR+&M)* M7YRKC(V.-PJ>Q*FI(>0*1:M+&4="E!)2/*)E_N5*KL&:)%2[X,VG9?9M,KMY M287-#Q2W==W,9IEC5[/T7OU.@C"2QJ4K=A1[8`SAVI366A`SHNS&)FBPZ`CG MSJHZGE/+\0=YG"#2>N>=BX!%MZYC^%#N?%"76OMB@$%3"[RY%,[.Z/'"Y.O9 MY(_9P_;XOAY5CK4+D&'&B)`.^KC,C69<^]+S(YJ\6SW`\*DMVC0$;;>'8OL$ MC^L:Q3U/M@L$&DBYAT8:!K%F&`-3!H\L^1V:`5[%'6`$WJ1JNJ5@.=R/M_N_ MW-K@6DP\WCQ`JQWV'!%/05SB.L+W9PK"B!&]-MR0]H]RJC&0!T"MPD`_I].K M["(P*[R)LAM.$.?$<;SW&!+C$=T!Z85BJ4!W2[/M1/BPR'4X>5"/B\V\GNDZ MT"Y0Y)V@&&$M-,\?D]>RW,>%2*9>`AA@'-8VH2Y'MUL6E5Q/8-*1M@%3%Y>T M:EO1%FF&I&>RD-=ZU%TAQ'?/IF80[C2ANZQZV&>5P^'=!1%.:F&EPB).?N.) M%4R*O/HSC/_@64\5$/<2565S__1EB-PCF!'LF2'6:`2$*[7_PW=!(F6H$L8A0[9;D][KT@[:Y-(#0]7_N=I;-(==)QR8?*_'@=?? M!46HC2.&#AJ.**+"HW(^8$A3MUL'N/70"`[M_Y"E%DA/J(;*"`BH5I"_2>2CXB#8[+E5OW?M'YR$ZDOM'W.IHDXUF MFEK@/:2FL,I>*C2BZFJ7JSWE_M%9\+Z/^T?6(X&=L]&-$TZAY)27,GF#4JM- M#S".:9PRE\/9]>'[.=F/^X-EE`?MD+*XF)3:0LPX585,^?_2#]B''8AE.7R5FOBW9>MC%G-558!A2(+PAV%H-#8K>V^S0\(`Z MG&H\!NAO+N+"6U?3)LSU2;?*IG^Y6SS]=39_BDNR'>5VO_^9;+N_?;T4K,K? MJ6@1,,94Q7B/(<60Q(;CXH0BRF1L:B[^`/U.$]1I%LUNSGO6F^5L_7R"X:M3 M;\W7:A]==Y10)KNF0:^N+S=`;6#;N:M[O9-T,-TF3I&3 M0?WJ?)_8Y,\,G`H))1-.8@GBDIWH7LQ8VV4 MHU[X_D.+`!C63LJX.(G@*@6L@KB0#1J:NEL]P/?9FN5:$VBVF0][-8^_C5R\;:O0,X.E[>EAGP,CKE.Y_%2S M`)D5D`$-"?'66>Z5EH6D#M,1Y3<'TA'EY]'MU5)YT?;!(*$(Y)I0S2+H0%3@+B= MC!I8[U+K5KZSJ5I;T\>FZH6X=I,>\#)6M5G?+W*77W'L>[A!\`XS'U')7VN* M,8>#VMM",J9M:L`U9,:D:_<87RZ!M!^R5!X`'VL2K-7*6XFBB])"80RD485T MDG@S0L(DJK>2+4F(GN;+P3<^S&0^N9E\SIZR^2936^+G]S%7J^W*\NAI7-VF MP7G,@8<&:\D`,QX;!0L!#,,CN@!SN0X7K6+;66+:?/+P,O`OV?)I-LVN/G^I MEZ%VO&7`.BYZH_T5`EHR.DQ24Y`&N-7>&(_:@;93G_3*'=XAG2WM]ETEYGQ/=^T/Y]4%1T&'P'P.!KE[8XO`$Z( MTM)3E;Q4/]M2C8YSS0+?!26_S*(0M[/I9+XVV\L)5_,CLEVM/F>3U6(>[?SS MI\5JM7V*>7NR_O%VUR2RX.;EZQ.<;>DG!BLAC?^)_%58HBEV#*,R?/$V-<]F M@,?<[5!Z&'KI-/QSWR>/LUV:HUNM9X]QBGZ\+22ZCK_6B04K.PG4&>2P-C&J M]E`@Y3@J@R*GDZ]B#O`0NQUFM@9U7V0K:PA]SFXW\QMU\Z_-:IVOO'U$]$NV M7C]D^9_^,5O?QX9Y+91BJ78F(=-_4(`Z^BD.=%28Q=1Y#A!AWE$/O&0,IBZ( M!W@:WAUI.U-'%\3.=Q!*`5;[T>1SHL(/)7&(X`L]EMR0"!UKL^`_5G8LDNTAQ*GM\5\ M,DOA27$-=;33MN+[F?+RR$@AX2J!<8P(P2C`2HG:C`69R\Z8YW\6SNL6[P&O M[_7$;^9[@0QJ.ET\%7='^"]CM`!33PUGN$10,&&9@Q#L,%$\U\0H_O07]Q91 M[S)2YE,59S=?Q7_/UB&:FTDO#_QZD."9]^?2('[F^(M!N60P`8XX:P#V\5CB MV@)BI``0TM/-!SN*X"_G:_VLGNYYH6\-W@[2"2X\P=@P)"PW@%.4UJV\9IR; M*RJYT18#O"WZU3+(X]GAHPB7ZVK':\XH55`"9:S7'F"C).2<ZZ?BCO%/L]FS+6=/JW>/ M^'8&#O&`(UQ8`!%ER%I"M6(U`$!?4XVFMCBA&A#_/C30J`HMJUEYMY$K<75? M'R;S_WZ(L#W?_#XO[KX\_;8L[\K)XOEVC7OZY6+Y4'ZO%[JQ["YOGQ;3A\FR M>,D.T=LWCFS7[C\>`*'(4V`%`AQ9B1BPMD:<6WM%O<];YOC1TB@G9*SS-9CJ M\;&:?WF(_WG/,M7_)$)4/91CE"`DHY[C--`,U:!BRW-=!"-T7G4@ZD=-JU%N M@.U).!CO;[\?A%`F=:BF4=?VUA&J]([:,K^PR@@]8Q^2[?/(U$OF_*M+79QI M6=W],I\NBK@26VQ^GG'U?G^``*%@"(-D^?:<8`H4J?7,?YG?3LJX#C/Y7JXFLXXEZ8&O!B.P4\BEKJ36&,`5$Z2&+:X_-SUR MA-ZP$J->E+?:VF".TC>O7?06RM-GYZ MOHNMV\[H=C:9)P_JJS]6D0N*5;E8^_?7SYS96JO=3X7(@A;J>-`K(5*S!HM, M^B$51,8+?O*PZ@;1[<+JSO`_+Z6F]7ENG=PA`T&,*$,\P41J%6&R1FP0P@;D M'^P(L`PESZBVMD9``GY%>?K#,<^; MJDJ=T*:?@EROI[[N=Y%4P!13J)_=X_=9]7RBCG?#,0+5QCA-N70D596RT.+= M^ID0N24!1N@Q&C%OMD.JWGR[753_6TQ7N\_<_#8K[]># MWBS^<[+XOV*U;C)VH,$*W MT^"[YTIX8#A%=IU@_I?Z>BZ?$JBX(TI9[*$U)%Y8@*\O1H:Z@>(FOTP?BKNG M67'S+>HU>_K,ALI-+MD-1PB`,8P)!PH0KZE@#,2#:+M^)VUN'M.?07EMS#JO M,TD[(O^W,>%[FHZG&!,%<82B@=TP8(X9DW"D"F![H_O_#HVT-Y;Q7+ M4_40SQHG0&VU2(&$B'L@M&/@:F5&GLZO59DQW^.T(NZYC^#;@M!_%^DBS+>'?]LDI%Y/>/C9MO?__B MYJM4KNZGU9RL_)[TCHBNI/ML]NW6`\S/'Y<@K\ MVJ@388/W`S5<>:\]91(IK:"61M7K-IA>D8]D*.7MS6&NRM!`;\[%W]6]0W MEQMOZNVBK!9[HM9$FI6KR?SNZR(J#>O$\1<7ZO),'W^K7PV$4828-$QR0Y6A MG&A>P^:)S6UV,,)TN6YX=7PT&D:N=A_K%Y$$+CT8)40G(ED4`$R"!;8/1.D)!8[S"S7VFN!/*5R.W\%F;DB*U^GU*W: MP;!QX=9YZ"A01OIZ#5RX*RI5F4&W]RB?A5LOY54F?Y2/ M3X\GJ?_3Q&BO]SZ7>Z\HH%V#7!P^LW??K M+-AM)<6MQ#L58';TO>"IEP)+RRTWCKAX>8W2 MF\3`-'D]8,L09)QQ+9'G7E!)2+UJ@DUN>-4($QU[/7;:ASY#SFS[#MMB4?XH M[C:ME-8^F^5+DN0!@=/DU0"!3WUZ&U?TO)9?2L.L6Y M#\FT<>GY2;E8I\R^-$XZ(HX.OA.G03S.KTCU[8*/ MV@:X7[OZ&[&\][=K,;5+`KA!E$8B.&-(W,%."X*Q)50:S4X>LM=J:B>62BN\ M,AQJI3SDC)D:%V>NR2YV.6NT8&H_#^Z/:TIQWBGMJ4`,4A`EJ!4,U.OT"%P3 M6W7)!6>94L[#?+RF%(.40Y!"C)B2Q$OJ**[7H;%F5\0[[=#SJ"GE/#0SKCB? M(K<_J,>H/D\G^Y=[-;^K%>FCAI7&[P?#*$,J[AS(O:(BY17N!+5&[OI"/\XE M8=4]JAD,L@[MWO34G,SVYS)IR"'-!PA1E!*(M$6>0H?41LVNSW+FKRF=Z&(6 MZ0S6P>VQ0$M(&:?*&03C=8LR:.OI*B)RM8\Q6M0NYH+V<&R/['=1:,V^/"WN MT\^<,^7B<8-UUC(J+'<"4,<4@G:GHD&KX9+/>UF#[, MJUEU_]Q,SAQ\/D"B(,+66XBDT-Y!0G<`60)RO3XCS'BX7,JTA6(?MY:;[T4* M,YW?U]KXR5"3`V\$[_W:7,@A-\219$CWD[RQJLG@V;84TVY,\H@X8!/A05J50IFQZ^/L"U..SQQ&7Y7XR-6R`@! MK)7.,`0,I,[5JP8.Y6;7C?%>TZ<]K7WH>V&XR:Q8;MV6GXJC[I"?GPR688R, MLYXCKRV`@#._T^G`Z82#MK3:'\7BMVH4CKZFQ'W-.1L]5=X(Z'3B?>Y)U-H,R+77Y]8I^#J2$((S MV:53T/L0.+L.;ZF&ZF^K[TV$MD91))6H,6:475&I@8XY>"PDZC<@ M:\!V$FW&7'F`"%>$Q=5Z!),A%VQRR;F/>C(]Z8891T>SAHQ"*OCK55` M0^+I[2QAEID:'^2R%>P1^1C:8Y'+8J\R(>]TUY?W\_);.9W,5VHZK9Z2;+N_ MK6;EM!QHZ[^=1H/-?_BEX+F@S@M*C>=&I^Z7=$-;YJDT%`^S_?5D62Y3)Z*] MO3._.TJ-)C+@DF&#X`)XDK@P;@?#M3#2UDAQZW(KO8W2+-,&PU2#83^81%C_ M?+X*N0"0@4Q:PCEWCBBIC"?44B(DE?$J.U#EHI]ZBV_0;K+OC[T6K#0:2\TE M%M9&?1-:H.J5:N).2L"/<\"W0>XWCI_6D.WC$OOW951&W')5/J;*\D.0B+/O@BG69QDUMO,_%=#99+M<2 M?DVL77*0+9;31?E]ORS=.WQS[E!!,P<%B0TV.0;S._,0ZH;L_QEOO],.9^6WV?-;D!M#!^$(I#3>`>` MAAIB%/!0U*@Q[7.;_HXP8JH#_AN``GWP[9Z435T[#Z[Q4[7ZGV*E[JKOJ^*8 MP,L:+R#M->+I;LB5LLY1B>2.*,#3ZXG;ZH`S^X"\TZOY*FZ-AVH62;9T_WPJ M5\/?;G#[_OG!$-42AE/FN5,"2D5URFF7EFKCD4&G@]D[,L2_`362OSBS M8G#3,8*1F"&A35RTE40183474GN")-'<]E8DL@\;6R[YWZ2;=@-NOSMU_]Q[ M>GR:):?^.IC"5(_Q,P^I,]>/XL75J)_3'ZKY6K\?KOA![EZ'V@$:[QN8(VXH M<#(4@Z09W$EV]5(Q*^H MMVLN&0^EB.?@UUR;6Q;3?[NO?OS[75%NF"#^XS7MXZ_"K\7]9.;6;14/U!-X MYZF`H"-H;8!7J0"Y!,SA>M::N&NJ_YQ)KJHM\-HG^68J!W/^7S\2..;$"DJL M<0(Z!HG2IIXO!_8*C.074:EJ!;9>;)UK$-+A.9D_G\R+>>?I$,%02&OAE$18 M(HLUX]LU0>--;W[0;EDACXRO[9,7P]=K<9FM*E8K5HV+R[SW7O`(6DZUY@X9 M%^^@P"!?KQ.1TX$%'\=EK!_S[O/!(,@]911#3+A17+E4 MWF*S+HC1-;4%:(>^5?NH]E()\>5>MVY^-GOEI3EY%#4;(`CD/<>*6(N1L]0B MSEF]J]P2&2-DG+9U^5P,>Q9#QTSM4?+> M?/LZ^:.9'&HR4C"048X!DQ@;R*6Q"I$:"ZI=;SD5W]=1()%8BU4_7)7!#H=E M40=0]Y+S?LRML\X4>QW+U80%+Q@U<&N:](Q&VPU\[1(L&^BR1IP:9N?"?'"Y9U*YY"V4* M$:?TM\>]`Q)B:!E[H3#=K9H9;PV*5RHJ,(!QM0Z`W:JISTV?/C\*M?OTZ7ZD M9B:RUZTJ"F2=`X110S2UCE@)=OJ+DB)753P[UG2C*KIYQZ4FAE,4SP.ZW^B@ M4?04SXWUX9H;8SE*).0200NLMR1JXQIBI_#934W>+27T%K-#,3Q'G@[*"^=D MY*I4^,A**:$0]50M0;F]-4=K/#^?1E7;(&:4C;+EC_(N_3YX#"&6`&N$<">4D6!)_54XQET!:[\5@A5M8]E6V0_Z'4]\49PD=>] M]R`>*0!XS8AVN^ERPJZ@&V9+Y#I%_"P\,\A_,[O;_^S1HO(*`O=:(5+6+90:Y/Q6_-R;WN\\&&M=GJ%3Q0/,H=?HUDN[$ MFV2YD14CLFIU0>XVL,P@]]LSZIBKYL0;P7#FB130:/( MML_U]M#LXSH>[W*/U7P]YQW_[W@_6;861W/KFKP><-2!#:&"K+-2++?HY8"T MD%Y);XU6Z/ZF)D;K\/;C)(X3_EQ\?UI,'R;+XG91W2\FCY^+)$I3-;"GU4.U M*/]5W+T\HQY3@N!17W+FF,$8@*R/4EH9(3PC%'JXP^>BNL8?@XGZ0FY(:[2O M%D5Y/]\8U:?/Z[BS>!O?5(9Z-PJMME;=IC)R\0^K39.:)/:_5F<7%QUT7@$` M")Q'1B,C`)."`6-J.NGXRX\?5-'5WOA(=.O74-K$TOL1;:@64\&I,`I#*5,. MJ^122*LA!ZEHT,F*$_U[V?)Y,=,OE__!P)F$RG`9;[.2(499O-1NT(58QG]] M?%7O4K8ZPXO7&QV&]B/;8E'^6'MEEB\1N&JYB;V]D)D;C1V$--0BA(RUCA&G MJ(D:SP:O5#2ZO]X7U\"W74`^-(M&C3B>Z_]ZM=_6L1XWYI?;]/AZ6Z['N*TB MNL6J7&R:/>]%^,8M'0%8%QO;-D(T\5D3V:.\5&KW.,/@I>6*`H,-LHIZK[%D M->V4RT[<')'"V>-V&2_A9 M(36VPF97-6H>P_0J4+/S@+D>Y&]_]!B:U_^_NZOI31B&H3]I<3X<1]HEB>/K M3CLC-B%M$N(`VO]?6RC:!0&AA(YCI2J17UZ2^M4?4\5K)BW&:?0:,(I&BE'\ M:#42UU8-G6%MO`;TJT2UK1I4IP_MBU9\=9OI<[G>_4>U""1FU?G2RIH4"FG' ML=_?9*U/6?+9/JR/5\'W%_:8\!JWW[O.&>.?;5^+<0A$K3L/:J?J2TH6*@0^ MH>@0/0G&?>DX0NQ`?EJ%Z&(JW2!1WV$%'GEGO6^VJ^6Z_S4UFO2V^2,N3$;F MJGD60C89S*"(0P'%)7;']`%'X/($H1&-F-P"_D=_>C5P\F?ZJT=0;9K9KUDXPFEPK&K*EO`G`B#D[YN1R4-J,QD:I M[LLU?YGH6H(VQ;FMI_/`7IS5O[1]3(0V!!`M)7C%JA?.,$&I*_KMWG12`N*E(B4\T"Z!&\!<).( MPZ,%%R8K5I"O:N2%:&549F03.*J`+!E&K(RM3JV?OY=P.QE;`'[N`L``00E#@``!#D!``#M75MO&[<2?C_` M^0\\>CD.4$62[:1-$+?P)RD,WC=[R#"'.Y2-CGI?+GOGMZ? M7UUU?OGYW__Z\)]N][>SNVMTP1U_1IA"YX)@15ST2-44?76)_(;&@L_05RZ^ MT07^`8VYF!'A+=%7,KJD'O"4W6[("@573])]+YTIF6&$E1)TY"MR"6079(Q] M3YUT?/:GCSTZIL0%T3RB:UXID'JLL)@0=8-G1,ZQ0TXZ4Z7F[WN]F?.-2,G9 MX/#HM<-GOV9?`^2?8L+/SX^OGX:">\U%Q,HV3_JZ<6<]*#0ETH101U8KIRHE4"7]X&&Z*"W0 MES*I,'-B?9\R]GD\,J4'[]Z]ZYFG<5'IV@H"VT'OM\_7]P;I#@"/D(&>SN9< M*,0RD(VQ'!E27W8G&,^U88^Z_4'W:-!!@<-<(I&=WI)JQ> M@PP=U*LIC^`>D5L2R/#:6"+M$-N2R/!J)%&1)^7(DR71O[H175??Z@X.-Q0C M:<#UQ(CHMB+&NQX6CH8;D'-4ESS-/8)L<+E8\)$R_A.RSAX MNXF,AC4C$]VQ5Y6^S487_6C4J:UR]86`\,BP/:PE3IHP_M5- MV#04R"6TMFDB&GVQN4G(DS.M+4),9*XV%X*R!9&JMA@ILO!Z M@IMZ#'\?#>1W9(Q,O/H^'$6+H]K>7/`Y$8I"<)5*`@R#J2#CDPZ$_]THY/_= MP=YK"(.C$AG^JQ&&&:Z`Q/$]H\5U(F/$07??)QT)YO9(I/OW5LHEX[I*`0EE M=(=U\O"HKDY`0KP=566FR48(*VE<5U1;XDT_'P[Z\*^/NNB"2L?CTA<$?D1\4)K1A]XZ M]3IC7Q)WR'XVU^OV"*G#(D64:RVX.N%J*['3A7IM`EZS^@H1/^[#OZ-*B*,#73\R M`J#A&`4BH$@&!$*@E!0H%.,5.@@E>=7Z#),W6`BX6I#-W2'#JASIPXI(QZQ; M]%9,_H!''MD$LY!!(5)'??@WJ(A4P'#OP`$CS*C2D]42^IUSSA1E$_B5ZH`J MHE2%4_&@.7AG&313;!&&GC%AG.XD6]@RQKZ&_R=&TCO05BP(%/SX-"=,UNPR MMU-7<9\Z>&?I4ZM!CPZ2VE%8O2D>"K#'/6\%Y!H.HTTXEWM`IJ^NZ@'M,*O! M9J[V=XV&Y!YU]23W&?;T^L3]E$"(61G;4D9%4$(??M0W_?@]F-.L@QHD0Z8H MS16%;%'`MX5LW=*W6("*4Z(HR+P]`-?8EL'YQK3,VG"B@]5ZVB:IC12;40[' MYUA.+SW^N!&R=H8EF!Y7;J()>YVLZ@J0J:$%<]WV?`9:3J$,#$17#$`C6X/5 MPKH$X,,F`/,Q6JD*!76U4*_A,9P346L*L0['$F`'#5MN4L.^P7E!1@JBU$M( M]ID#X>.I`Z%BG=2V@$%)1GMLR6@U-Q/-QOQ0PK#%)K+$J6.6P^4=<0A=Z-F9 M>^P1>8D='?8O@>B.++BW`*)S05RJHB<-4YKO(4E)"G1L28(+O04=1+*A1#AD MI$.1$(8X%A`%$L9/7[7)4[$;YC\Y)V!FRG6!K;M[5XGSA;*8 M8JTC!8X$QC63%#YPJ!LEY!"7+#7^:!MC4ISV>>2W&M1^MVD;WJ2*DH6F'VWC M@1W9W/MMJZSI!WKOM^M[9#B^(]+WE+P4?);#X-D\I8$0Y;Z469ZN[4N16#I1 M#`4+7J7(H6A=;@VL6NN>A2Q*5CY_M*Q\YL*ZIVN?T0M">K$*S**65TR_"60$ MBYY5A:H*JR+(^O&,3?S:4NK2+&<9OBC%.'Z^;\!]Q(+IE[1NB=`K1)S=3[&H M.MF60UR2R`\L05;$"0$K%/!"AEF+A[;"&9;4@09Q03U?$==>J-X0NH6*2G*D M@668S,49'9BJ3?,,*T\*S]<*[_%8:$>D8)9W>3Y8)P!RLVBY/(_B)<_>1>AX$%U>@")M0Z%2"_=HWI&IN4,*DI'T= M6=I7Q-%L%4]XACO)?T#`MD4J;>3S*=PA\HJ=@U,O]7SZ3*^:#,<16;W&N*7* M2EKKT7'_N`'RZ"`4`)ZCARE!D1@HD$.O!4=LVJ:=@V'QT[AK?`[W:5AUN3-E MXMTJSE3)X6*A4DQ;U\I!,#6!-.J1TI-6L1#9 MTJW/E+7ZYW24TDK*O2,S=5*[^VA]HJI/U$J\*[$J2<"/+`EX)7SW-!7_'W$G M37:;9>E*4@3;!H"0R1[O+,N8\8((NC#]3)Q,&\^LU9#JRX)2\)99]M"F45WN7H9CI(*[KIMXHL!5K,4\:H M%;'DDA='*8>VK;96Y/8T+KFG$T;'U,%,A>_?0_Y[RSWJ5%_E*^91,CUC'=H2 MABCAB"*6+48I^YJ_RVT@%7(JQ$N?GF!I4,5XH8.`]?XU+L6=;U/NN43(CW_Z M5%7&*4M8$B'V;6_*.#30A#O:05/]6=:1N"MIN8UCO4O4UUS*<^6^@%G M8(>:D5M#;Y,,&7%$3O"%J.'[`3YMB6J>.WXV=JW5%O'2R"NEQ3GD9O*G'05GH6+\$@J@1UUTE'")QT#)0#T>_;K>OJ< M22X@&8H^4O>9S$9$=,Q!7B>=.@34\W2!J$[I@Q!4^5K"3X+[\Y...63V/55D MUD'!<4+!4;CO73[#E%W!`ZUX!P4%YT10[CZ8@JXOPAGLWB;JKGQ,L$Q5>^$= M5-.\:R9O!5E0[DMO"2IP2'C_(NZI'([-83?2^-X%A-!K6C>CW5DC%(I_*D_= M/WP):835"'5I7\X(L=+`#'L@MR]TD]0#'(QNAD[QF_.K+PQZRPL^"X]>.9T( M8AC<$A%^QB4TP.9\&AD#+#$/6139(CCZ5Q6;PKP%$>\2#L#2)6!@YSKNB'6M M4+"),L&=&:2="HOENCJCX&OM@"L94=48\.A`G91S`@:.'LPF9#C^E:OTCJ3H MF*M+W_.6X4=3(C-LA=,&H.N:FF*>UP?8=0*6$$B`.H[QW2] M=^DL6(>^RO@&"*UMNNV>KXH6%Z:_J:-W3/'RO9Q%W`>B>Z3A>$S$K:`.*=#, M4O2E^RK+(5O)V'/E0E$ZICA^:RQJ?-AV8IX^)``>Z'AX`?$*,R^9<7,X042W M;ISO5^U+]*/?&P#]0=[GL'#(]QE-Z)C/4V_<++>A[/V4"P5CS>R,"\$?]7>& MGL.F]FI>Q,1-QK=SS+"+[\B",`A<)OJX<*VTE.:EI=68MF+9W0ODPP]=KVFS M=G,'Q3;'9P7G9^'4,5UZ?3&9QS@-J6.]ZE(U]]4-HX]$S^C4"SV7`?[T`./` MURF'N'#XR*")@434I=`H@DDT?5/(*9U'L62\Q@1M`TMRQ6XQ=?4'7.9482\Q MS'-7L[,Q_K94-]^CT'./_W,W%2X3-FSQ6-*^8*WP/-T!G$A_GBR:H8O3"3SKH[RL:#8"\SR."6I2:F/3PXAKOP$X[G2"?VMX'\0 M1\75)!8:BL]8?"/*3/#Q<1DL.R';CDVEZ9D@,UA#_??<,W\A:W#U@NB]+R;Z M;[K,*7-#_UW+0[;!:/>B_1RM*BB^PRHM*&33KKP#%XXF]M.SI44%=GAZU"KV MZGQH<9$=A*K@!(3U#+-BV1?+*_-TC!=HSI;IXW2-,/IK(FMJ5B^^>YIR7X0C MR1D')[SPR=!1'/J)CWI4(H0]//*'*??U#,$]?=)W5KN:C3CLGGL;=3B%Y)`N MR)I>IW-!O8='N+,$1=)JZ9FN'--LSNOE%T&BK[_AS%?EKF9S<'[3QL<0?"C\ M!#F(F,1K(HTH=RZTS',6DUX%T\*K@03.BTAJ4;P\\#K<3.8%ES>^EHR/S8&S M\I)Z>@O1&9EB;SP<1RK6I&D.-C0L,H&T;]M=P`UY3(_%JP#F/=R]GNP&DHGI MZ0S8.+A2M%R'8/?4'7IN/FIY#U^^A:U/9DC(YCQ??S;W7'>*E`7;6DW7&$?# M=8EVKD.-M<_9LVNF'H*MCGJ<<-20A6_8ZYPYWLX;VV-C-KN[TME0M\VMLZ.[ MD?+:_RUX^PP[RVOHIW236.T`"U*A@NUNX"KF^>ZXQ]4OO M0PE7A\TW,(FKEV*B02:9V8J4K%CVI>:T\UPRY[1PB/XOR4CXT#92<7^4+:WZ M[68L=F^4CCX!P,>I(Z(RLSVEI79XRB=?]M5YGPKE_D[P75-FNH0*&*:+[MR$ M2+[8YFV/ZC9W_7)U^9O@-(#<::, M>WRRS)GD+RJP>UW'PY0<]@?',$S!GY_,--B:.@4%OJ,ZP0M.$MKW#,//_P-0 M2P$"'@,4````"``S@O]$0OL1/W(4`0!<@`\`$``8```````!````I($````` M;6-K+3(P,30P-C,P+GAM;%54!0`#8J3:4W5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`#."_T3_HSD82Q<``)U2`0`4`!@```````$```"D@;P4`0!M8VLM M,C`Q-#`V,S!?8V%L+GAM;%54!0`#8J3:4W5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`#."_T2G.-9UUSP``*[<`@`4`!@```````$```"D@54L`0!M8VLM M,C`Q-#`V,S!?9&5F+GAM;%54!0`#8J3:4W5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`#."_T1!Q!R1'*,``#BD"``4`!@```````$```"D@7II`0!M8VLM M,C`Q-#`V,S!?;&%B+GAM;%54!0`#8J3:4W5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`#."_T1A\[(AM6D``"@4!0`4`!@```````$```"D@>0,`@!M8VLM M,C`Q-#`V,S!?<')E+GAM;%54!0`#8J3:4W5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`#."_T283V'\"!```)&L```0`!@```````$```"D@>=V`@!M8VLM M,C`Q-#`V,S`N>'-D550%``-BI-I3=7@+``$$)0X```0Y`0``4$L%!@`````& -``8`%`(``#F'`@`````` ` end XML 22 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Narrative) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Stockholders' Equity [Line Items]    
Dividends Declared Per Common Share $ 0.24 $ 0.20
Stock Repurchase Program, Remaining Authorized Repurchase Amount $ 340  
Other Comprehensive (Income) Loss, Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest $ 12  
Old Rate Per Share [Member]
   
Stockholders' Equity [Line Items]    
Dividends Declared Per Common Share   $ 0.20
New Rate Per Share [Member]
   
Stockholders' Equity [Line Items]    
Dividends Declared Per Common Share $ 0.24  

XML 23 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt and Financing Activities Debt and Financing Activities (Celesio Debt) (Narrative) (Details)
3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended
Jun. 30, 2014
USD ($)
Mar. 31, 2014
USD ($)
Jun. 30, 2014
Accounts Receivable Factoring Facility [Member]
Celesio [Member]
USD ($)
Mar. 31, 2014
Accounts Receivable Factoring Facility [Member]
Celesio [Member]
USD ($)
Jun. 30, 2014
Revolving Credit Facility [Member]
USD ($)
Jun. 30, 2013
Revolving Credit Facility [Member]
USD ($)
Mar. 31, 2014
Revolving Credit Facility [Member]
USD ($)
Jun. 30, 2014
Revolving Credit Facility [Member]
Celesio [Member]
USD ($)
Mar. 31, 2014
Revolving Credit Facility [Member]
Celesio [Member]
USD ($)
Jun. 30, 2014
Revolving Credit Facility Due February Two Thousand Eighteen [Member]
Revolving Credit Facility [Member]
Celesio [Member]
USD ($)
Jun. 30, 2014
Revolving Credit Facility Due February Two Thousand Eighteen [Member]
Revolving Credit Facility [Member]
Celesio [Member]
EUR (€)
Mar. 31, 2014
Revolving Credit Facility Due February Two Thousand Eighteen [Member]
Revolving Credit Facility [Member]
Celesio [Member]
USD ($)
Jun. 30, 2014
Corporate Bond Securities [Member]
Celesio [Member]
USD ($)
Mar. 31, 2014
Corporate Bond Securities [Member]
Celesio [Member]
USD ($)
Jun. 30, 2014
Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member]
Celesio [Member]
USD ($)
Mar. 31, 2014
Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member]
Celesio [Member]
USD ($)
Feb. 06, 2014
Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member]
Celesio [Member]
Jun. 30, 2014
Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member]
Celesio [Member]
USD ($)
Mar. 31, 2014
Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member]
Celesio [Member]
USD ($)
Feb. 06, 2014
Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member]
Celesio [Member]
Line of Credit Facility [Line Items]                                        
Debt Instrument, Interest Rate, Stated Percentage                             4.00% 4.00% 4.00% 4.50% 4.50% 4.50%
Long-term Debt $ 10,200,000,000 $ 10,400,000,000                     $ 1,226,000,000   $ 500,000,000     $ 726,000,000    
Current portion of long-term debt 25,000,000 1,424,000,000                       1,244,000,000   507,000,000     737,000,000  
Credit Facility Capacity     315,000,000   1,300,000,000     2,000,000,000     500,000,000                  
Line of Credit Facility, Expiration Date     Sep. 30, 2015   Sep. 23, 2016         Feb. 28, 2018                    
Proceeds from Lines of Credit     758,000,000   0 0   159,000,000   0                    
Repayments of Lines of Credit     746,000,000         30,000,000                        
Borrowings Outstanding     $ 258,000,000 $ 246,000,000 $ 0   $ 0 $ 321,000,000 $ 188,000,000 $ 0   $ 0                
XML 24 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Common Share (Basic and Diluted Earnings per Common Share) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Schedule of Earnings Per Share [Line Items]    
Income from continuing operations $ 425 $ 428
Net income attributable to noncontrolling interests (8) 0
Income from continuing operations attributable to McKesson 417 428
Loss from discontinued operations, net of tax (14) (4)
Net income attributable to McKesson $ 403 $ 424
Weighted average common shares outstanding:    
Basic 231 227
Effect of dilutive securities:    
Options to purchase common stock 2 2
Restricted stock units 2 3
Diluted 235 232
Earnings (Loss) Per Common Share Attributable To McKesson (Diluted)    
Continuing operations $ 1.78 [1] $ 1.84 [1]
Discontinued operations $ (0.06) [1] $ (0.01) [1]
Total $ 1.72 [1] $ 1.83 [1]
Earnings (Loss) Per Common Share Attributable To McKesson (Basic)    
Continuing operations $ 1.81 [1] $ 1.88 [1]
Discontinued operations $ (0.06) [1] $ (0.02) [1]
Total $ 1.75 [1] $ 1.86 [1]
[1] Certain computations may reflect rounding adjustments.
XML 25 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Parentheticals) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Equity [Abstract]    
Foreign currency translation adjustments arising during period, income tax expense of nil and $2 $ 0 $ 2
Unrealized losses on cash flow hedges arising during period, income tax expense of nil and nil 0 0
Amortization of actuarial loss, prior service cost and transition obligation, income tax expense of $1 and $4 1 4
Foreign currency translation adjustments, income tax expense of nil and nil $ 0 $ 0
XML 26 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hedging Activities Derivative Instruments Fair Value (Details) (USD $)
In Millions, unless otherwise specified
Jun. 30, 2014
Mar. 31, 2014
Not Designated as Hedging Instrument [Member]
   
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset $ 2 $ 2
Derivative Liability, Fair Value, Gross Liability 26 14
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
   
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset 17 31
Derivative Liability, Fair Value, Gross Liability 0 0
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Prepaid Expenses and Other Current Assets [Member]
   
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset 2 4
Derivative Liability, Fair Value, Gross Liability 0 0
Derivative Asset, Notional Amount 64 64
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]
   
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset 15 27
Derivative Liability, Fair Value, Gross Liability 0 0
Derivative Asset, Notional Amount 399 399
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Prepaid Expenses and Other Current Assets [Member]
   
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset 2 2
Derivative Liability, Fair Value, Gross Liability 0 0
Derivative Asset, Notional Amount 174 255
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]
   
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset 0 0
Derivative Liability, Fair Value, Gross Liability 26 13
Derivative Liability, Notional Amount 1,275 836
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]
   
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset 0 0
Derivative Liability, Fair Value, Gross Liability 0 1
Derivative Liability, Notional Amount $ 68 $ 96
XML 27 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Noncontrolling Interests Noncontrolling Interests
3 Months Ended
Jun. 30, 2014
Noncontrolling Interest [Abstract]  
Noncontrolling Interest Disclosure [Text Block]
Noncontrolling Interests
At June 30, 2014, we owned approximately 75.9% of Celesio’s outstanding and fully diluted common shares, which was primarily obtained through our February 2014 acquisition of the then outstanding common shares and certain convertible bonds of Celesio. In April 2014, we completed tender offers and paid $32 million in cash to acquire approximately 1 million additional common shares of Celesio, which increased our ownership share by 0.5% and decreased noncontrolling interests by $35 million since March 31, 2014. The effect of changes in our ownership interest in Celesio on our equity of $3 million was recorded as an increase to McKesson’s stockholders’ paid-in capital. Net income attributable to McKesson and transfers from noncontrolling interests to McKesson equity amounted to $406 million for the first quarter of 2015.
EXCEL 28 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S M8S)E8S1F834B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?0F%L86YC M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K M#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K M#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YT7TQI83PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-T;V-K:&]L9&5R#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D)U#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DAE9&=I;F=?06-T:79I=&EE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D5A#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D5A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D=O;V1W:6QL7T%N9%]);G1A;F=I8FQE7T%S#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!E M;G-I;VY?0F5N969I='-?4&5N#I7;W)K#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?26YF;W)M871I;VY?4V-H961U;&5? M;SPO>#I.86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X- M"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V%A,38W,&9D7SAC9&%?-#(Q,U]B-64X M7SDV8C-C,F5C-&9A-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A M83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)RTM,#,M,S$\2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)TQA'0^ M)U$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]A83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO86$Q-C'0O:'1M;#L@8VAA'!E;G-E&5S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,#<\'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO2!R969L M96-T(')O=6YD:6YG(&%D:G5S=&UE;G1S+CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO86$Q-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPOF5D(&=A:6YS("AL;W-S97,I(&]N M(&-A"!E>'!E;G-E(&]F(&YI;"!A;F0@;FEL/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M/B@R*3QS<&%N/CPO"!E>'!E;G-E(&]F("0Q(&%N9"`D-#PO=&0^#0H@("`@("`@(#QT9"!C M;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2P@4&QA;G0@ M86YD($5Q=6EP;65N="P@3F5T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XR+#(P.3QS<&%N/CPO6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA"!L:6%B:6QI=&EE M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPOF5D+"!N;R!S:&%R97,@:7-S=65D(&]R(&]U='-T M86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]A83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO86$Q-C'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#`L M,#`P+#`P,#QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!M971H;V0\+W1D/@T*("`@("`@("`\=&0@8VQA6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'!E;F1I='5R97,\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`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`[4T5#)B,X,C(Q.RD@86YD+"!T:&5R969O#MT97AT+6%L M:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIU3II;FAE2!I;F1I8V%T:79E(&]F('1H92!R97-U;'1S('1H870@;6%Y M(&)E(&5X<&5C=&5D(&9O6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M'0M9&5C;W)A=&EO;CIN;VYE.SY-87)C:"8C,38P.S,Q M+"`R,#$T/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^('!R979I;W5S;'D@9FEL960@=VET:"!T:&4@ M4T5#(&]N($UA>2`Q-"P@,C`Q-"`H)B,X,C(P.S(P,30@06YN=6%L(%)E<&]R M="8C.#(R,3LI+B`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`[($5A6QE/3-$;&EN92UH96EG:'0Z M,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT M97AT+6EN9&5N=#HR-'!X.V9O;G0MFEN9R!R979E;G5E(&9R;VT@8V]N=')A8W1S('=I=&@@8W5S=&]M M97)S+B8C,38P.R!4:&4@86UE;F1E9"!G=6ED86YC92!E;&EM:6YA=&5D(&EN M9'5S=')Y('-P96-I9FEC(&=U:61A;F-E(&%N9"!A<'!L:65S('1O(&%L;"!C M;VUP86YI97,N)B,Q-C`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`H)B,X,C(P M.T-E;&5S:6\F(S@R,C$[*2!A;F0@8V5R=&%I;B!C;VYV97)T:6)L92!B;VYD M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#0N-2!B:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!N970@;V8@8V%S:"!A M8W%U:7)E9"`H=&AE("8C.#(R,#M!8W%U:7-I=&EO;B8C.#(R,3LI+B`@57!O M;B!T:&4@86-Q=6ES:71I;VXL(&%S(')E<75I6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#(N,R!B:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%S(&$@;&EA M8FEL:71Y(&]N(&]U3II;FAE2!U=&EL:7II;F<@82!S96YI;W(@8G)I9&=E(&QO86XL(&]U&ES=&EN M9R!A8V-O=6YT3II M;FAE2!A;F0@82!P6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+B`@5&AE(&%C<75I6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N M=#HR-'!X.V9O;G0M2!A;&P@;V8@=&AE(&-O M;G9E2!#96QE3I4:6UE3II;FAE3I4 M:6UE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,S8T.S(S+C4P/"]F;VYT/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('!E M3I4:6UE2`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&]F($-E;&5S M:6\F(S@R,3<[#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!$2!A;FYU86P@;&]S3II M;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,S8T.S(R M+CDY/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^('!E2`Q M-2P@,C`Q-"P@=&AE($%G65A2!T M:&4@96YD(&]F('1H92!C86QE;F1A'0M:6YD96YT.C(T<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1FEN86YC:6%L M(')E6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S M=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0M6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ M:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0M#MT97AT+6%L:6=N M.FIU'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[ M<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY!;6]U M;G1S(%)E8V]G;FEZ960@87,@;V8@06-Q=6ES:71I;VX@1&%T92`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`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.V)A M8VMG#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q/CQD:78@#LG(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1F%I6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`C,#`P,#`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`C,#`P,#`P.V)O6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`@("`\=&%B;&4@8VQA M'0@0FQO8VM= M/"]T9#X-"B`@("`@("`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`@("`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E#LG M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD M:78@6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`@("`\=&%B;&4@8VQA&5S/&)R/CPO"!$:7-C;&]S=7)E(%M!8G-T'0^)SQD M:78@'0M:6YD96YT.C(T<'@[9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^07,@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C M;W)A=&EO;CIN;VYE.SY*=6YE)B,Q-C`[,S`L(#(P,30\+V9O;G0^/&9O;G0@ M3II;FAE3II;FAE M3II;FAE3II;FAE3II;FAE"!E>'!E;G-E(&%N M9"!T:&4@969F96-T:79E('1A>"!R871E+"!I9B!R96-O9VYI>F5D+B`@1'5R M:6YG('1H92!N97AT('1W96QV92!M;VYT:',L(&ET(&ES(')E87-O;F%B;'D@ M<&]S65A6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ M-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0M M3II;FAE3II;FAE"!Y96%R+B`@1'5R:6YG('1H92!F:7)S="!Q=6%R=&5R(&]F(#(P,34L('=E M(&9I;&5D(&$@3F]T:6-E(&]F($%P<&5A;"!W:71H('1H92!487@@0V]U'0M:6YD96YT.C(T<'@[9F]N M="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^5&AR;W5G:"!T:&4@87!P96%L6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#(Q(&UI;&QI;VX\+V9O;G0^/&9O;G0@3II M;FAE2!B M965N(&%C8W)U960@:6X@;W5R(&9I;F%N8VEA;"!S=&%T96UE;G1S+B`@5V4@ M87)E(&%L'0M9&5C;W)A=&EO;CIN;VYE.R<^)#$W(&UI;&QI;VX\+V9O;G0^ M/&9O;G0@3II;FAEF5D('1A>"!B96YE M9FET+CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P M)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT M+6EN9&5N=#HR-'!X.V9O;G0M'0M:6YD96YT M.C(T<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5V4@"!E>'!E;G-E(&]F(#PO9F]N=#X\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P M,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#0\+V9O;G0^/&9O;G0@3II;FAE"!B96YE9FET+"!R96QA=&5D('1O M(&EN=&5R97-T(&%N9"!P96YA;'1I97,@:6X@;W5R(&-O;F1E;G-E9"!C;VYS M;VQI9&%T960@6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!B969O"!B M96YE9FET'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3I4:6UE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E M:6=H=#IB;VQD.SY%87)N:6YG'0M:6YD96YT.C(T<'@[ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^0F%S:6,@96%R;FEN9W,@<&5R(&-O;6UO M;B!S:&%R92!A2!T:&4@=V5I9VAT960@879E&-E<'0@=&AA="!I="!R969L96-T&5R8VES960@;W(@8V]N=F5R=&5D(&EN=&\@8V]M;6]N('-T;V-K+B`@/"]F M;VYT/CPO9&EV/CQD:78@'0M M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0M#MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A M9&1I;F#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ8V5N M=&5R.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K M9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F%C:V=R;W5N9"UC;VQO#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^-#(X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^26YC;VUE(&9R;VT@ M8V]N=&EN=6EN9R!O<&5R871I;VYS(&%T=')I8G5T86)L92!T;R!-8TME#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-#$W/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD M:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,C,U/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`N,#8\+V9O;G0^/"]D:78^/"]T M9#X\=&0@#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O M=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,2XW,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^0F%S:6,\+V9O;G0^/"]D:78^/"]T9#X\=&0@8V]L#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,2XX,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`N,#8\+V9O M;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E M>'0M:6YD96YT.C,V<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&]T86P\+V9O M;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;FF4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE3II M;FAE#MF;VYT+69A;6EL>3I4 M:6UE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@#L^/&9O;G0@3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY#97)T86EN(&-O M;7!U=&%T:6]N#MT97AT+6%L:6=N M.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE2!D:6QU=&EV92!S96-U2`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C M;W)A=&EO;CIN;VYE.SXS(&UI;&QI;VX\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY*=6YE)B,Q-C`[ M,S`L(#(P,30\+V9O;G0^/&9O;G0@3II;FAE M2!W97)E(&%N=&DM9&EL=71I=F4N/"]F;VYT/CPO9&EV/CPO9&EV M/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`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`E.V)O#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.7!T.V9O;G0M6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#LG M(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY"86QA M;F-E+"!*=6YE(#,P+"`R,#$T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,3`L-#,Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/"]T6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CQD:78@#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M9&5C;W)A=&EO;CIN;VYE.R<^2G5N928C,38P.S,P+"`R,#$T/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@'0M M9&5C;W)A=&EO;CIN;VYE.R<^36%R8V@F(S$V,#LS,2P@,C`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`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z.'!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF M;VYT+7=E:6=H=#IB;VQD.SY*=6YE)B,Q-C`[,S`L(#(P,30\+V9O;G0^/"]D M:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T M.V9O;G0M=V5I9VAT.F)O;&0[/DUA#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#MF;VYT+7-T>6QE.FET86QI8SL^*$1O;&QA6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@F4Z.'!T.W1E>'0M86QI9VXZ8V5N=&5R M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[/E=E:6=H=&5D M/"]F;VYT/CPO9&EV/CQD:78@F4Z.'!T.W1E>'0M M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O M;&0[/D%V97)A9V4\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&9O;G0M3II;FAEF4Z.'!T.W1E>'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.V9O;G0M=V5I9VAT.F)O;&0[/D%M;W)T:7IA=&EO;CPO9F]N M=#X\+V1I=CX\9&EV('-T>6QE/3-$9F]N="US:7IE.CAP=#MT97AT+6%L:6=N M.F-E;G1EF4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E:6=H=#IB;VQD.SY0 M97)I;V0\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&9O;G0M3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.#(U/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^.3DU/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#$Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,2PR,#@\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5')A9&5M87)K6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,34\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,36QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.'!T.SXF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`C M,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$;W9E#MP861D:6YG M+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG'0M86QI9VXZF4Z,3!P=#L^*#$L,S,Q/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`@17-T:6UA=&5D(&%N M;G5A;"!A;6]R=&EZ871I;VX@97AP96YS92!O9B!T:&5S92!A6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C M;W)A=&EO;CIN;VYE.SXD,S@S/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&UI;&QI;VXL(#PO9F]N M=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#0V M.#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/B!M:6QL:6]N+"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE3II M;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD M,S@R/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&UI;&QI;VX@9F]R('1H92!R96UA:6YD97(@;V8@ M,C`Q-2!A;F0@96%C:"!O9B!T:&4@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&UI;&QI;VX@=&AEF%T:6]N(&%S(&]F(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/DIU;F4F(S$V,#LS,"P@ M,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[/B!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY-87)C:"8C,38P.S,Q+"`R,#$T/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^+CPO9F]N=#X\+V1I=CX\+V1I=CX\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M,3!P=#LG/CQD:78@'0M86QI M9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^(&)O;F1S(&1U92!/8W1O8F5R(#$X+"`R,#$V(&%N9"`\+V9O;G0^ M/&9O;G0@3II;FAE3II;FAE3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&]F('1H92`\+V9O M;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@ M3II;FAE3II M;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&)O;F1S+"!F;W(@82!T;W1A;"!O9B`\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#$L,C0T)B,Q-C`[;6EL;&EO;CPO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BP@=V5R92!O=71S M=&%N9&EN9RX@($%S(&]F($UA2P@87,@;V8@2G5N92`S,"P@ M,C`Q-"P@=&AE'0M:6YD96YT.C(T<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5V4@ M86QS;R!C;VYS;VQI9&%T960@0V5L97-I;R8C.#(Q-SMS(&%C8V]U;G1S(')E M8V5I=F%B;&4@9F%C=&]R:6YG(&9A8VEL:71I97,@*'1H92`F(S@R,C`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`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`\+V9O;G0^/&9O;G0@3II M;FAE3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&)O3II;FAE3II;FAE3II;FAE2X@($%T($IU;F4F M(S$V,#LS,"P@,C`Q-"!A;F0@36%R8V@@,S$L(#(P,30L('1H97)E('=E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^;F\\+V9O;G0^/&9O;G0@3II;FAEF5D(&%C8V]U;G1S(')E M8V5I=F%B;&4@;W5T#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!W:71H M('1H97-E(&-O=F5N86YT2!M87D@8F4@6UE;G0@;V8@86YY(&]U M='-T86YD:6YG(&)A;&%N8V5S('5N9&5R('1H92!&86-I;&ET>2!M87D@8F4@ M3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO M;CIN;VYE.SY-87)C:"8C,38P.S,Q+"`R,#$T/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"`\+V9O M;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+B`\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI M;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,39P>#MT97AT+6%L:6=N M.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7-T>6QE.FET86QI8SL^4F5V;VQV:6YG($-R961I="!&86-I;&ET M>3PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP M861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN M9&5N=#HR-'!X.V9O;G0M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(@,C`Q-CPO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BX@ M("!";W)R;W=I;F=S('5N9&5R('1H:7,@9F%C:6QI='D@/"]F;VYT/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M8F5A6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^+B`@5&AE3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&)O2!D=7)I;F<@=&AE(&9I6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@ M3II;FAE3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SYN;SPO9F]N=#X\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P M<'0[/B!A;6]U;G1S(&]U='-T86YD:6YG('5N9&5R('1H:7,@9F%C:6QI='DN M/"]F;VYT/CPO9&EV/CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0W('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZ8V5N=&5R.V9O M;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#MF;VYT+7-T>6QE.FET M86QI8SL^*$EN(&UI;&QI;VYS*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!C;VQS M<&%N/3-$,R!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;FF4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+7=E:6=H=#IB;VQD.SXR,#$T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P M<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXR,#$S/"]F;VYT/CPO9&EV/CPO M=&0^/"]T6QE/3-$)W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^4V5R M=FEC92!C;W-T("T@8F5N969I=',@96%R;F5D(&1U65A#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZF4Z,3!P=#L^-3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`C,#`P,#`P M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HR<'@@6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)O6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HR<'@@6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)O6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E M>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0MF5D(&EN(&UE87-U'!E;G-E(&]V97(@=&AE(&5M<&QO>65E3II;FAE3II;FAE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O M='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X M.V9O;G0M2P@9&5R:79A=&EV97,@87)E(&]N;'D@ M=7-E9"!F;W(@:&5D9VEN9R!P=7)P;W-E#MT97AT+6%L:6=N.FIUF4Z,3!P=#MF;VYT+7-T>6QE.FET M86QI8SL^1F]R96EG;B!C=7)R96YC>2!R871E(')I#MT97AT+6%L:6=N.FIU#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'!O2!R871E(')I3II M;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B`@5&AE MF5D(&]N(&$@=')A;G-A8W1I;VYA;"!B M87-I6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ M-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-7!X.V9O;G0M M2!I;B!#86YA9&EA;B!D;VQL87)S+"!%=7)O3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+B`@0VAA;F=E#MT97AT+6%L:6=N.FIU#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^2G5N92`R,#$U/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B!.;VYE M(&]F('1H97-E(&-O;G1R86-T6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^36%R8V@F(S$V M,#LS,2P@,C`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY-87)C:"`S,2P@,C`Q-#PO9F]N=#X\ M+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0V('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZ8V5N M=&5R.V9O;G0M'0M86QI M9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY&86ER(%9A M;'5E(&]F(#PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY$ M97)I=F%T:79E/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S(')O M=W-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`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`C,#`P,#`P.V)A8VMG6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3<\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M:6YD96YT.C(T<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^070@ M/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SY*=6YE)B,Q-C`[,S`L(#(P,30\+V9O;G0^/&9O;G0@3II;FAE2!O9B!T M:&5S92!F:6YA;F-I86P@:6YS=')U;65N=',N("`\+V9O;G0^/"]D:78^/&1I M=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,39P M>#MT97AT+6%L:6=N.FIU#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6EN9R!A;6]U;G1S(&%N9"!E3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&%T(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT M+61E8V]R871I;VXZ;F]N93L^2G5N928C,38P.S,P+"`R,#$T/"]F;VYT/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%T M(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N M93L^36%R8V@F(S$V,#LS,2P@,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BX@(%1H92!EF5D(&]R('1H M870@=VEL;"!B92!R96%L:7IE9"!I;B!T:&4@9G5T=7)E+CPO9F]N=#X\+V1I M=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O M;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O M;G0M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M M9&5C;W)A=&EO;CIN;VYE.SY*=6YE)B,Q-C`[,S`L(#(P,30\+V9O;G0^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#(N M.2!B:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!W:&EC:"!A6EN9R!V86QU92!O9B!A;&P@;W1H97(@8V%S:"!E M<75I=F%L96YT2!S:&]R="UT97)M(&YA='5R92X\+V9O;G0^ M/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB M;W1T;VTZ,39P>#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAEF5D M(&]R('1H870@=VEL;"!B92!R96%L:7IE9"!I;B!T:&4@9G5T=7)E+B`@4F5F M97(@=&\@1FEN86YC:6%L($YO=&4@,3`L(")(961G:6YG($%C=&EV:71I97,L M(B!F;W(@;6]R92!I;F9O6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^;F\\+V9O;G0^/&9O;G0@ M3II;FAE2!D=7)I;F<@=&AE('%U87)T M97)S(&5N9&5D($IU;F4@,S`L(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT M97AT+61E8V]R871I;VXZ;F]N93L^,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!A;F0@/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXR M,#$S/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+CPO9F]N=#X\+V1I=CX\+V1I=CX\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`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`R,#$T+"!F;W5R(&AE9&=E(&9U;F1S(&UA M;F%G960@8GD@36%G;F5T87(@0V%P:71A;"!F:6QE9"!A(&-O;7!L86EN="!A M9V%I;G-T($1R86=O;F9L>2!';6)(("9A;7`[($-O($M'84$@*"8C.#(R,#M$ M2!O M9B!T:&4@0V]M<&%N>2P@:6X@82!'97)M86X@8V]U2!V:6]L871E9"!' M97)M86X@=&%K96]V97(@;&%W(&EN(&-O;FYE8W1I;VX@=VET:"!T:&4@0V]M M<&%N>28C.#(Q-SMS(&%C<75I&EM871E;'D@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#,U-BPP,#`\+V9O;G0^/&9O;G0@3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*2!I;B!D M86UA9V5S('!L=7,@86X@=6YS<&5C:69I960@86UO=6YT(&]F(&EN=&5R97-T M+"`\+V9O;G0^/&9O;G0@3II;FAE2!';6)( M("9A;7`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`H0U8@,#0M,SDX,R`H4THI M*2XF(S$V,#L@4')E=FEO=7-L>2P@=&AE(%5N:71E9"!3=&%T97,@86YD('1H M92!T=V5L=F4@#MT97AT+6%L:6=N M.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE2!I6QA;F0@9&ES=')I M8G5T:6]N(&-E;G1E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3QB2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78@#MT97AT+6%L:6=N.FIU#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE2!I;B!A;GD@9&EV:61E M;F1S(&1E8VQA#MT97AT+6%L:6=N.FIU#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE3I4:6UE M6QE.FYO6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[<&5R(&-O;6UO;B!S:&%R92!F;W(@ M9&EV:61E;F1S(&1E8VQA2!T M:&4@0F]A2!A;G1I8VEP871E2!C87-H(&1I=FED96YD6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP M861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN M9&5N=#HR-'!X.V9O;G0MF%T:6]N(&]U='-T86YD:6YG(&9O28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!W87,@/"]F;VYT/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,S0P/"]F;VYT M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[;6EL;&EO;B!A="`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`C M,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.3@\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M3II;FAE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z.'!T.W!A9&1I;F6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.SXH,2D\+V9O;G0^/"]D:78^/"]T9#X\=&0@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^5&AE(&9I2!T6QE/3-$=VED=&@Z,C1P>#L@6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MT97AT+6%L:6=N.FQE9G0[9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAE'!E;G-E"!E>'!E;G-E(&EN('1H92!C;VYS;VQI9&%T960@6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ M-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0M M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU M#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE"P@8GD@8V]M<&]N96YT(&%R92!A6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O M='1O;3HQ-G!X.W1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C(T<'@[ M9F]N="US:7IE.C$P<'0[/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT M;W`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=&5X="UA M;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB M;VQD.SY.970@;V8@5&%X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q/CQD:78@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M86QI9VXZF4Z,3!P=#L^,3$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#LG(')O=W-P86X],T0Q/CQD:78@'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#LG M(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HR<'@@'0M86QI9VXZF4Z,3!P=#L^,C6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;FF4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`@/&AE860^#0H@("`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`Z M,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`C,#`P M,#`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,S$L-#`S/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^.#,V/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^5&]T86P@4F5V96YU97,\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-#0L,#4X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`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`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`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`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`[8F]R9&5R+6)O='1O;3HR<'@@#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`@("`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`[4T5#)B,X,C(Q.RD@86YD+"!T:&5R969O3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN9&5N M=#HR-'!X.V9O;G0M65A65A3II;FAE3II;FAE2!F:6QE9"!W:71H('1H92!314,@;VX@ M36%Y(#$T+"`R,#$T("@F(S@R,C`[,C`Q-"!!;FYU86P@4F5P;W)T)B,X,C(Q M.RDN("`\+V9O;G0^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQD:78@#MT97AT+6%L:6=N.FIU#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z,3!P=#LG/CQD:78@'0M M:6YD96YT.C(T<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE($-O;7!A;GDF M(S@R,3<[65A65A2!!9&]P=&5D($%C8V]U;G1I;F<@4')O;F]U;F-E;65N M=',\+W1D/@T*("`@("`@("`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`[($5A6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ-G!X.W1E>'0M86QI M9VXZ:G5S=&EF>3MT97AT+6EN9&5N=#HR-'!X.V9O;G0M3II;FAEFEN9R!R979E;G5E(&9R;VT@8V]N=')A8W1S M('=I=&@@8W5S=&]M97)S+B8C,38P.R!4:&4@86UE;F1E9"!G=6ED86YC92!E M;&EM:6YA=&5D(&EN9'5S=')Y('-P96-I9FEC(&=U:61A;F-E(&%N9"!A<'!L M:65S('1O(&%L;"!C;VUP86YI97,N)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,BPT,3`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1V]O9'=I;&P\+V9O M;G0^/"]D:78^/"]T9#X\=&0@8V]L#L@'0M86QI9VXZF4Z,3!P=#L^,RPU-S`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`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`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`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`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`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-2PY.3<\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`P/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;FF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X M,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HR<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;FF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`E.V)O#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE M3II;FAE#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB M;VQD.SY1=6%R=&5R($5N9&5D($IU;F4@,S`L/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R M+71O<#HQ<'@@F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;FF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXR,#$S M/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#(U/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^3&]S6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O M=6YD+6-O;&]R.B-C8V5E9F8[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-#(T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`P,#`[<&%D9&EN9RUL969T M.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M:6YD96YT.BTQ,G!X.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^*#`N,#$\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MT97AT M+6EN9&5N=#HS-G!X.V9O;G0M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#LG(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`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`@ M("`\=&%B;&4@8VQA6EN M9R!!;6]U;G0@3V8@1V]O9'=I;&P\+W1D/@T*("`@("`@("`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`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`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`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`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`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`C,#`P,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$;W9E#MP861D:6YG M+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG'0M86QI9VXZF4Z,3!P=#L^,2PX-3,\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT M.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[,S`L(#(P,30\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M=V5I M9VAT.F)O;&0[/DUA#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT M+7-T>6QE.FET86QI8SL^*$1O;&QA6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PP M,30\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^.#(U/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^.3DU/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R<@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,38U/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$ M)W9E"!S;VQI9"`C M,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.W!A9&1I;F6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.'!T.SXF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.W!A M9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.V)A8VMG6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMG'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#$L,S,Q/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ8V5N=&5R.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`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`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`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`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE'!E;G-E/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.V)O6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M'1087)T7V%A M,38W,&9D7SAC9&%?-#(Q,U]B-64X7SDV8C-C,F5C-&9A-0T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B]A83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y M-F(S8S)E8S1F834O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+7=E:6=H=#IB;VQD.SY-87)C:"`S,2P@,C`Q-#PO9F]N=#X\+V1I=CX\ M+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`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`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`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`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3<\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`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`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`P,#`[8F%C:V=R;W5N9"UC;VQO M#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E'1087)T7V%A,38W,&9D7SAC9&%?-#(Q,U]B-64X7SDV8C-C,F5C-&9A M-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A83$V-S!F9%\X8V1A M7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$<&%D9&EN9RUL969T M.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I M;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`D-"`\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I M9VAT.C$R,"4[9F]N="US:7IE.C=P=#XH,BD\+W-U<#X\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@8V]L#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;FF4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#4S/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD M.SY.970@;V8@5&%X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q M/CQD:78@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@ M'0M86QI9VXZF4Z,3!P=#L^,3$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A M8VMG#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D M:6YG+7)I9VAT.C)P>#L@#LG M(')O=W-P86X],T0Q/CQD:78@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O M=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HR<'@@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,C6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;FF4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG M+6)O='1O;3HX<'@[9F]N="US:7IE.C$P<'0[/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C M96QL'0M86QI9VXZ;&5F=#LG/CQT6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PS-3<\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI9VXZF4Z,3!P=#L^,S$L-#`S/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X] M,T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R<@'0M86QI9VXZF4Z,3!P=#L^.#,V/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[)R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMGF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`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`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`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`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`C M,#`P,#`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`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`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO2!R97!O65A M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!/=VYE9"!3=6)S:61I87)Y+"!087)E M;G0@3W=N97)S:&EP($EN=&5R97-T+"!#:&%N9V5S+"!0=7)C:&%S92!O9B!) M;G1E2!087)E;G0\+W1D/@T*("`@("`@("`\=&0@8VQA2P@4&%R96YT($]W;F5R2!/=VYE9"!3=6)S:61I87)Y+"!087)E;G0@ M3W=N97)S:&EP($EN=&5R97-T+"!#:&%N9V5S+"!.970@26YC;VUE($%T=')I M8G5T86)L92!4;R!087)E;G0@86YD(%1R86YS9F5R'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO"!#:&%R9V4\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO#PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA#PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A M83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO86$Q-C'0O:'1M;#L@8VAA&5S("A. M87)R871I=F4I("A$971A:6QS*2`H55-$("0I/&)R/DEN($UI;&QI;VYS+"!U M;FQE"!;3&EN92!)=&5M MF5D M(%1A>"!"96YE9FET2!!'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!%>&%M:6YA=&EO;BP@ M3&EA8FEL:71Y("A2969U;F0I($%D:G5S=&UE;G0@9G)O;2!3971T;&5M96YT M('=I=&@@5&%X:6YG($%U=&AO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M"!!9&IU3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO86$Q-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A83$V M-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO86$Q-C'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO#PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'1087)T7V%A,38W,&9D7SAC9&%?-#(Q,U]B-64X7SDV8C-C,F5C-&9A-0T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A83$V-S!F9%\X8V1A7S0R M,3-?8C5E.%\Y-F(S8S)E8S1F834O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!3;VQU=&EO;G,@6TUE;6)E'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPOF%T:6]N(&5X M<&5N'!E;G-E+"`R,#$U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS M.#,\F%T:6]N($5X<&5N'0^)SQS<&%N/CPO'!E;G-E+"`R,#$X M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,3`\F%T:6]N($5X<&5N'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!T'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6EN9R!!;6]U M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA6EN9R!! M;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SD@>65A6EN9R!!;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPOF%T:6]N(%!E65A65A6EN9R!!;6]U;G0\+W1D/@T*("`@("`@("`\ M=&0@8VQA2!,:6-E;G-E'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R M."D\'0^)SQS<&%N M/CPO6EN9R!!;6]U;G0\+W1D M/@T*("`@("`@("`\=&0@8VQA2U"87-E9"!);G1A;F=I8FQE($%S'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^4V5P(#(S+`T*"0DR,#$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G1S(&]F($QI;F5S(&]F($-R961I M=#PO=&0^#0H@("`@("`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`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO65R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XD(#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&-E961I;F<@1W)E871E'1087)T7V%A,38W,&9D M7SAC9&%?-#(Q,U]B-64X7SDV8C-C,F5C-&9A-0T*0V]N=&5N="U,;V-A=&EO M;CH@9FEL93HO+R]#.B]A83$V-S!F9%\X8V1A7S0R,3-?8C5E.%\Y-F(S8S)E M8S1F834O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XD(#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO65A'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XD(#<\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!F M;'5C='5A=&EO;CQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^4V5P(#,P+`T*"0DR,#$T/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO2!O9B!&;W)E M:6=N($-U&-H86YG92!#;VYT'0^)SQS<&%N/CPO2!O9B!&;W)E:6=N($-U&-H86YG92!#;VYT'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO&EM=6T@6TUE;6)E'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO2P@1F%I M'0^)SQS<&%N/CPO M2P@1F%I&-H86YG92!#;VYT M'!E;G-E'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&-H86YG92!#;VYT'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@1F%I2P@3F]T:6]N86P@06UO=6YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XQ+#(W-3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@ M1F%I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA&-E<'0@4&5R(%-H M87)E(&1A=&$L('5N;&5S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO2!;3&EN M92!)=&5M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A83$V-S!F9%\X8V1A M7S0R,3-?8C5E.%\Y-F(S8S)E8S1F834-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO86$Q-C'0O M:'1M;#L@8VAA"D@*$1E M=&%I;',I("A54T0@)"D\8G(^26X@36EL;&EO;G,L('5N;&5S2!; M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M2!TF%T:6]N(&]F(&%C='5A#PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!T"!A;6]U;G0@7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!; M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!T2!T"!E>'!E;G-E(&]F(&YI;"!A;F0@;FEL M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2`H0VAA M;F=E'0^)SQS<&%N M/CPO#PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPOF5D($QO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO#PO=&0^#0H@("`@("`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` end XML 29 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt and Financing Activities (Accounts Receivable Sales Facility and Revolving Credit Facility) (Narrative) (Details) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended 3 Months Ended
Jun. 30, 2014
Accounts Receivable Sales Facility [Member]
Jun. 30, 2013
Accounts Receivable Sales Facility [Member]
Mar. 31, 2014
Accounts Receivable Sales Facility [Member]
Jun. 30, 2014
Revolving Credit Facility [Member]
Jun. 30, 2013
Revolving Credit Facility [Member]
Mar. 31, 2014
Revolving Credit Facility [Member]
Jun. 30, 2014
Celesio [Member]
Revolving Credit Facility [Member]
Mar. 31, 2014
Celesio [Member]
Revolving Credit Facility [Member]
Jun. 30, 2014
Celesio [Member]
Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member]
Mar. 31, 2014
Celesio [Member]
Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member]
Feb. 06, 2014
Celesio [Member]
Four Percent Bonds Due October Eighteen Two Thousand Sixteen [Member]
Jun. 30, 2014
Celesio [Member]
Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member]
Mar. 31, 2014
Celesio [Member]
Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member]
Feb. 06, 2014
Celesio [Member]
Four Point Five Percent Bonds Due April Twenty Six Two Thousand Seventeen [Member]
Line of Credit Facility [Line Items]                            
Credit Facility Capacity $ 1,350,000,000     $ 1,300,000,000     $ 2,000,000,000              
Line of Credit Facility, Expiration Date Nov. 15, 2014     Sep. 23, 2016                    
Line of Credit Facility, Interest Rate Description       bear interest based upon either the London Interbank Offered Rate or a prime rate                    
Proceeds from Lines of Credit 0 100,000,000   0 0   159,000,000              
Repayments of Lines of Credit 0 100,000,000         30,000,000              
Borrowings Outstanding 0   0 0   0 321,000,000 188,000,000            
Line of Credit Facility, Covenant Compliance we were in compliance with all covenants   we were in compliance with all covenants                      
Pledged Assets, Not Separately Reported, Finance Receivables $ 0   $ 0                      
Debt Instrument, Interest Rate, Stated Percentage                 4.00% 4.00% 4.00% 4.50% 4.50% 4.50%
XML 30 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Tables)
3 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
 
Quarter Ended June 30,
(In millions)
2014
 
2013
Revenues
 
 
 
Distribution Solutions (1)
 
 
 
North America pharmaceutical distribution and services
$
34,304

 
$
30,046

International pharmaceutical distribution and services
7,607

 

Medical-Surgical distribution & services
1,379

 
1,357

Total Distribution Solutions
43,290

 
31,403

 
 
 
 
Technology Solutions - products and services
768

 
836

Total Revenues
$
44,058

 
$
32,239

 
 
 
 
Operating profit
 
 
 
Distribution Solutions
$
748

 
$
619

Technology Solutions (2)
68

 
127

Total
816

 
746

Corporate Expenses, Net
(108
)
 
(85
)
Interest Expense
(101
)
 
(59
)
Income from Continuing Operations Before Income Taxes
$
607

 
$
602

(1)
Revenues derived from services represent less than 2% of this segment’s total revenues.
(2)
Technology Solutions operating profit for the quarter ended June 30, 2014 includes a charge of $34 million related to the retained workforce business within our International Technology business.
XML 31 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
3 Months Ended
Jun. 30, 2014
Equity [Abstract]  
Schedule of Comprehensive Income (Loss)
Information regarding other comprehensive income (loss) including noncontrolling interests, net of tax, by component are as follows:
 
Quarter Ended June 30,
 (In millions)
2014
 
2013
Foreign currency translation adjustments
 
 
 
Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 (1)
$
98

 
$
(61
)
 
 
 
 
Unrealized gains on cash flow hedges
 
 
 
Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil
(2
)
 
1

 
 
 
 
Changes in retirement-related benefit plans
 
 
 
Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1 and $4 (2)
3

 
7

Foreign currency translation adjustments, net of income tax expense of nil and nil
(1
)
 

 
2

 
7

 
 
 
 
Other comprehensive income (loss), net of tax
$
98

 
$
(53
)

(1)
The first quarter of 2015 includes net foreign currency translation loss of $12 million attributable to noncontrolling interests.
(2)
Pre-tax amount reclassified into cost of sales and operating expenses in the condensed consolidated statements of operations. The related tax expense was reclassified into income tax expense in the consolidated statements of operations.
Schedule of Accumulated Other Comprehensive Income (Loss)
Information regarding changes in McKesson’s accumulated other comprehensive loss, net of tax, by component are as follows:
(In millions)
Foreign Currency Translation Adjustments, Net of Tax
 
Unrealized Losses on Cash Flow Hedges,
Net of Tax
 
Unrealized Net Loss and Other Components of Benefit Plans, Net of Tax
 
Total Accumulated Other Comprehensive Income (Loss)
Balance at March 31, 2014
$
168

 
$
(11
)
 
$
(160
)
 
$
(3
)
 
 
 
 
 
 
 
 
Other comprehensive income (loss) before reclassifications
110

 
(2
)
 

 
108

Amounts reclassified to earnings and other

 

 
2

 
2

Other comprehensive income (loss)
110

 
(2
)
 
2

 
110

Balance at June 30, 2014
$
278

 
$
(13
)
 
$
(158
)
 
$
107

XML 32 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Pension Benefits Pension Benefits (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]    
Net periodic pension expense $ 11 $ 11
Defined Benefit Plan, Contributions by Employer $ 15 $ 5
Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets 10.00%  
XML 33 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations (Narrative) (Details)
3 Months Ended 0 Months Ended 3 Months Ended 3 Months Ended
Jun. 30, 2014
USD ($)
Feb. 06, 2014
Celesio [Member]
USD ($)
Jun. 30, 2014
Celesio [Member]
USD ($)
Jun. 30, 2014
Celesio [Member]
EUR (€)
Mar. 31, 2014
Celesio [Member]
Feb. 06, 2014
Celesio [Member]
country
Jun. 30, 2014
The 2014 and 2018 Bonds [Member]
Celesio [Member]
Mar. 31, 2014
The 2014 and 2018 Bonds [Member]
Celesio [Member]
Jun. 30, 2014
Fair Value, Inputs, Level 3 [Member]
Celesio [Member]
USD ($)
Business Acquisition [Line Items]                  
Effective Date of Acquisition   Feb. 06, 2014              
Business Acquisition, Percentage of Voting Interests Acquired           77.60%      
Name of Acquired Entity   Celesio AG              
Cash Paid for Acquisition   $ 4,500,000,000              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt   2,300,000,000              
Business Acquisition, Percentage Of Voting Interests Acquired Fully Diluted 75.90%     75.90% 75.40% 75.60%      
Description of Acquired Entity   Celesio is an international wholesale and retail company and a provider of logistics and services to the pharmaceutical and healthcare sectors. Celesio’s headquarters is in Stuttgart, Germany and it operates in 14 countries around the world              
Number of Countries in which Entity Operates           14      
Debt Conversion, Converted Instrument, Shares Issued             42,238 20,900,000  
Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase Of Interest By Parent, Common Shares 1,000,000   1,000,000            
Business Acquisition Tender Offer Price       € 23.50          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent 32,000,000   32,000,000            
Annual Recurring Compensation to NCI Under Domination Agreement, Per Share       € 0.83          
Put Option for NCI Under Domination Agreement, Celesio Per Share       € 22.99          
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles                 $ 536,000,000
XML 34 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations (Fair Value Of Assets Acquired And Liabilities Assumed) (Details) (USD $)
In Millions, unless otherwise specified
Jun. 30, 2014
Mar. 31, 2014
Feb. 06, 2014
Amounts Previously Recognized As Of Acquisition Date
Celesio [Member]
Jun. 30, 2014
Purchase Price Allocation Adjustments
Celesio [Member]
Jun. 30, 2014
Amounts Recognized As Of Acquisition Date As Adjusted
Celesio [Member]
Business Acquisition [Line Items]          
Receivables     $ 3,425 [1] $ (3) $ 3,422
Other current assets, net of cash and cash equivalents acquired     2,413 [1] (3) 2,410
Goodwill 10,431 9,927 3,570 [1] 436 4,006
Intangible assets     3,018 [1] (536) 2,482
Other long-term assets     1,272 [1] (44) 1,228
Current liabilities     (4,096) [1] (6) (4,102)
Short-term borrowings and current portion of long-term debt     (1,990) [1] 0 (1,990)
Long-term debt     (322) [1] 0 (322)
Other long-term liabilities     (1,293) [1] 156 (1,137)
Fair value of net assets, less cash and cash equivalents     5,997 [1] 0 5,997
Less: Noncontrolling Interests     (1,500) [1] 0 (1,500)
Net assets acquired, less cash and cash equivalents     $ 4,497 [1] $ 0 $ 4,497
[1] (1)As previously reported in our Form 10-K for the year ended March 31, 2014.
XML 35 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations
3 Months Ended
Jun. 30, 2014
Business Combinations [Abstract]  
Business Combinations
Business Combinations
On February 6, 2014, we completed the acquisition of 77.6% of the then outstanding common shares of Celesio AG (“Celesio”) and certain convertible bonds of Celesio for cash consideration of $4.5 billion, net of cash acquired (the “Acquisition”). Upon the acquisition, as required, we consolidated Celesio’s debt with a fair value of $2.3 billion as a liability on our consolidated balance sheet and our ownership of Celesio’s fully diluted common shares was 75.6%. The Acquisition was initially funded by utilizing a senior bridge loan, our existing accounts receivable sales facility and cash on hand. Celesio is an international wholesale and retail company and a provider of logistics and services to the pharmaceutical and healthcare sectors. Celesio’s headquarters is in Stuttgart, Germany and it operates in 14 countries around the world. The acquisition of Celesio expands our global geographic area; the combined company is one of the largest pharmaceutical wholesalers and providers of logistics and services in the healthcare sector worldwide.
From February 7 to March 31, 2014, substantially all of the convertible bonds issued by Celesio (held by both third parties and us) were converted to 20.9 million common shares of Celesio. During the first quarter of 2015, we completed tender offers and we acquired approximately 1 million common shares of Celesio at €23.50 per share for a total of $32 million in cash, and the remaining convertible bonds were fully converted into 42,238 common shares of Celesio. At June 30, 2014 and March 31, 2014, we owned approximately 75.9% and 75.4% of Celesio’s outstanding and fully diluted common shares.
On May 22, 2014, Celesio and McKesson, through its wholly-owned subsidiary Dragonfly GmbH & Co. KGaA, entered into a domination and profit and loss transfer agreement (the “Agreement”). Under the Agreement, Celesio will subordinate its management to McKesson and undertake to transfer all of its annual profits to McKesson, and McKesson will undertake to compensate any annual losses incurred by Celesio and to grant, subject to a potential court review, the noncontrolling shareholders of Celesio (i) an annual recurring compensation of €0.83 per Celesio share and (ii) a put right for their Celesio shares at €22.99 per Celesio share. On July 15, 2014, the Agreement was approved at the general shareholders’ meeting of Celesio. The Agreement becomes effective upon its registration in the commercial register of Celesio at the local court of Stuttgart, Germany. Celesio’s obligation to transfer its annual profits under the Agreement will apply for the first time for the entire profit generated in Celesio’s fiscal period beginning on January 1, 2015 or the subsequent fiscal year in which the Agreement becomes effective. McKesson’s obligation to compensate the annual losses of Celesio under the Agreement will apply for the first time for the full fiscal period of Celesio during which the Agreement becomes effective. We currently anticipate the Agreement to be effective by the end of the calendar year, at which time, we will obtain operational control of Celesio.
Financial results for Celesio are included within our International pharmaceutical distribution and services business, which is part of our Distribution Solutions segment, since the date of acquisition.

The following table summarizes the preliminary recording of the fair values of the assets acquired and liabilities assumed as of the acquisition date.
(In millions)
Amounts
Previously Recognized as of
Acquisition Date
(Provisional)
(1)
 
Measurement Period Adjustments
 
Amounts Recognized as of Acquisition Date (Provisional as Adjusted)
Receivables
$
3,425

 
$
(3
)
 
$
3,422

Other current assets, net of cash and cash equivalents
acquired
2,413

 
(3
)
 
2,410

Goodwill
3,570

 
436

 
4,006

Intangible assets
3,018

 
(536
)
 
2,482

Other long-term assets
1,272

 
(44
)
 
1,228

Current liabilities
(4,096
)
 
(6
)
 
(4,102
)
Short-term borrowings and current portion of long-term debt
(1,990
)
 

 
(1,990
)
Long-term debt
(322
)
 

 
(322
)
Other long-term liabilities
(1,293
)
 
156

 
(1,137
)
Fair value of net assets, less cash and cash equivalents
5,997

 

 
5,997

Less: Noncontrolling Interests
(1,500
)
 

 
(1,500
)
Net assets acquired, less cash and cash equivalents
$
4,497

 
$

 
$
4,497

(1)
As previously reported in our Form 10-K for the year ended March 31, 2014.
During the first quarter of 2015, the fair value measurements of assets acquired and liabilities assumed of Celesio as of the acquisition date were refined. Among the adjustments recorded, the fair value of acquired intangible assets was decreased by $536 million. The fair value was primarily determined by applying the income approach using unobservable inputs for projected cash flows and a discount rate, which were refined during the current period, and are considered Level 3 inputs under the fair value measurements and disclosure guidance. These refinements did not have a significant impact on our condensed consolidated statements of operations, balance sheets or cash flows in any period and, therefore, we have not retrospectively adjusted our financial statements. These amounts are subject to change within the measurement period as our fair value assessments are finalized.
During the last two years, we also completed a number of smaller acquisitions within both of our operating segments. Financial results for our business acquisitions have been included in our consolidated financial statements since their respective acquisition dates. Purchase prices for our business acquisitions have been allocated based on estimated fair values at the date of acquisition.
Goodwill recognized for our business acquisitions is generally not expected to be deductible for tax purposes. However, if we acquire the assets of a company, the goodwill may be deductible for tax purposes.
XML 36 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Noncontrolling Interests Noncontrolling Interests (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Noncontrolling Interest [Abstract]  
Business Acquisition, Percentage Of Voting Interests Acquired Fully Diluted 75.90%
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent $ 32
Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase Of Interest By Parent, Common Shares 1
Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase Of Interest By Parent, Percent Ownership 0.50%
Noncontrolling Interest, Period Increase (Decrease) 35
Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Paid In Capital 3
Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net Income Attributable To Parent and Transfers from NCI $ 406
XML 37 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Intangible Assets, Net (Changes In The Carrying Amount Of Goodwill) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Goodwill [Line Items]  
Beginning Balance $ 9,927
Goodwill acquired 14
Acquisition accounting and other 445
Foreign currency translation adjustments and other 45
Ending Balance 10,431
Distribution Solutions [Member]
 
Goodwill [Line Items]  
Beginning Balance 8,078
Goodwill acquired 14
Acquisition accounting and other 445
Foreign currency translation adjustments and other 41
Ending Balance 8,578
Technology Solutions [Member]
 
Goodwill [Line Items]  
Beginning Balance 1,849
Goodwill acquired 0
Acquisition accounting and other 0
Foreign currency translation adjustments and other 4
Ending Balance $ 1,853
XML 38 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Changes in Accumulated Other Comprehensive Income (Loss) by Component) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Beginning balance $ (3)  
Other Comprehensive Income (Loss), Net of Tax 98 (53)
Ending balance 107  
Foreign Currency Translation Adjustments, Net of Tax
   
Beginning balance 168  
Other comprehensive income (loss) before reclassifications 110  
Amounts reclassified to earnings and other 0  
Other Comprehensive Income (Loss), Net of Tax 110  
Ending balance 278  
Unrealized Losses on Cash Flow Hedges, Net of Tax
   
Beginning balance (11)  
Other comprehensive income (loss) before reclassifications (2)  
Amounts reclassified to earnings and other 0  
Other Comprehensive Income (Loss), Net of Tax (2)  
Ending balance (13)  
Unrealized Net Loss and Other Components of Benefit Plans, Net of Tax
   
Beginning balance (160)  
Other comprehensive income (loss) before reclassifications 0  
Amounts reclassified to earnings and other 2  
Other Comprehensive Income (Loss), Net of Tax 2  
Ending balance (158)  
Parent Company [Member]
   
Beginning balance (3)  
Other comprehensive income (loss) before reclassifications 108  
Amounts reclassified to earnings and other 2  
Other Comprehensive Income (Loss), Net of Tax 110  
Ending balance $ 107  
XML 39 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Operations (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Income Statement [Abstract]    
Revenues $ 44,058 $ 32,239
Cost of Sales (41,261) (30,309)
Gross Profit 2,797 1,930
Operating Expenses (2,109) (1,260)
Litigation Charges 0 (15)
Total Operating Expenses (2,109) (1,275)
Operating Income 688 655
Other Income, Net 20 6
Interest Expense (101) (59)
Income from Continuing Operations Before Income Taxes 607 602
Income Tax Expense (182) (174)
Income from Continuing Operations 425 428
Loss from discontinued operations, net of tax (14) (4)
Net Income 411 424
Net Income Attributable to Noncontrolling Interests (8) 0
Net income attributable to McKesson $ 403 $ 424
Earnings (Loss) Per Common Share Attributable To McKesson (Diluted)    
Continuing operations $ 1.78 [1] $ 1.84 [1]
Discontinued operations $ (0.06) [1] $ (0.01) [1]
Total $ 1.72 [1] $ 1.83 [1]
Earnings (Loss) Per Common Share Attributable To McKesson (Basic)    
Continuing operations $ 1.81 [1] $ 1.88 [1]
Discontinued operations $ (0.06) [1] $ (0.02) [1]
Total $ 1.75 [1] $ 1.86 [1]
Dividends Declared Per Common Share $ 0.24 $ 0.20
Weighted Average Common Shares    
Diluted 235 232
Basic 231 227
[1] Certain computations may reflect rounding adjustments.
XML 40 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Pension Benefits Pension Benefits Tables (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Defined Benefit Plan Disclosure [Line Items]    
Net periodic pension expense $ 11 $ 11
United States Pension Plan of US Entity, Defined Benefit [Member]
   
Defined Benefit Plan Disclosure [Line Items]    
Service cost - benefits earned during the year 0 1
Interest cost on projected benefit obligation 5 5
Expected return on assets (5) (5)
Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation 4 9
Net periodic pension expense 4 10
Foreign Pension Plan, Defined Benefit [Member]
   
Defined Benefit Plan Disclosure [Line Items]    
Service cost - benefits earned during the year 4 1
Interest cost on projected benefit obligation 9 1
Expected return on assets (7) (2)
Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation 1 1
Net periodic pension expense $ 7 $ 1
XML 41 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Operating Activities    
Net Income $ 411 $ 424
Adjustments to reconcile to net cash provided by (used in) operating activities:    
Depreciation and amortization 284 162
Deferred taxes 135 98
Charges associated with last-in-first-out inventory method 98 0
Other non-cash items 14 32
Changes in operating assets and liabilities, net of acquisitions:    
Receivables (699) (139)
Inventories (901) (60)
Drafts and accounts payable 1,368 589
Deferred revenue (134) (116)
Taxes (134) 31
Other (260) (305)
Net cash provided by operating activities 182 716
Investing Activities    
Property acquisitions (86) (69)
Capitalized software expenditures (33) (32)
Acquisitions, net of cash and cash equivalents acquired (14) (74)
Other 21 (9)
Net cash used in investing activities (112) (184)
Financing Activities    
Proceeds from short-term borrowings 917 100
Repayments of short-term borrowings (759) (100)
Proceeds from issuances of long-term debt 6 0
Repayments of long-term debt (230) 0
Common stock transactions:    
Issuances 34 50
Share repurchases, including shares surrendered for tax withholding (102) (127)
Dividends paid (59) (53)
Other 26 57
Net cash used in financing activities (167) (73)
Effect of exchange rate changes on cash and cash equivalents 9 (10)
Net (decrease) increase in cash and cash equivalents (88) 449
Cash and cash equivalents at beginning of period 4,193 2,456
Cash and cash equivalents at end of period $ 4,105 $ 2,905
XML 42 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Income Tax [Line Items]  
Unrecognized tax benefits $ 582
Unrecognized tax benefits that would impact income tax expense and the effective tax rate 427
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit (158)
Income Tax Examination, Penalties and Interest Expense 4
Accrued interest and penalties on unrecognized tax benefits 161
Canada Revenue Agency Assessments [Member]
 
Income Tax [Line Items]  
Tax assessments received 261
Internal Revenue Service (IRS) [Member]
 
Income Tax [Line Items]  
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority 21
Tax Adjustments, Settlements, and Unusual Provisions $ (17)
XML 43 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations (Tables)
3 Months Ended
Jun. 30, 2014
Business Combinations [Abstract]  
Fair Value Of Assets Acquired And Liabilities Assumed
The following table summarizes the preliminary recording of the fair values of the assets acquired and liabilities assumed as of the acquisition date.
(In millions)
Amounts
Previously Recognized as of
Acquisition Date
(Provisional)
(1)
 
Measurement Period Adjustments
 
Amounts Recognized as of Acquisition Date (Provisional as Adjusted)
Receivables
$
3,425

 
$
(3
)
 
$
3,422

Other current assets, net of cash and cash equivalents
acquired
2,413

 
(3
)
 
2,410

Goodwill
3,570

 
436

 
4,006

Intangible assets
3,018

 
(536
)
 
2,482

Other long-term assets
1,272

 
(44
)
 
1,228

Current liabilities
(4,096
)
 
(6
)
 
(4,102
)
Short-term borrowings and current portion of long-term debt
(1,990
)
 

 
(1,990
)
Long-term debt
(322
)
 

 
(322
)
Other long-term liabilities
(1,293
)
 
156

 
(1,137
)
Fair value of net assets, less cash and cash equivalents
5,997

 

 
5,997

Less: Noncontrolling Interests
(1,500
)
 

 
(1,500
)
Net assets acquired, less cash and cash equivalents
$
4,497

 
$

 
$
4,497

(1)
As previously reported in our Form 10-K for the year ended March 31, 2014.
XML 44 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Common Share (Narrative) (Details)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Earnings Per Share [Abstract]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2 3
XML 45 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Common Share (Tables)
3 Months Ended
Jun. 30, 2014
Earnings Per Share [Abstract]  
Basic And Diluted Earnings Per Common Share
The computations for basic and diluted earnings per common share are as follows:
  
Quarter Ended June 30,
(In millions, except per share amounts)
2014
 
2013
Income from continuing operations
$
425

 
$
428

Net income attributable to noncontrolling interests
(8
)
 

Income from continuing operations attributable to McKesson
417

 
428

Loss from discontinued operations, net of tax
(14
)
 
(4
)
Net income attributable to McKesson
$
403

 
$
424

 
 
 
 
Weighted average common shares outstanding:
 
 
 
Basic
231

 
227

Effect of dilutive securities:
 
 
 
Options to purchase common stock
2

 
2

Restricted stock units
2

 
3

Diluted
235

 
232

 
 
 
 
Earnings (loss) per common share attributable to McKesson: (1)
 
 
 
Diluted
 
 
 
Continuing operations
$
1.78

 
$
1.84

Discontinued operations
(0.06
)
 
(0.01
)
Total
$
1.72

 
$
1.83

Basic
 
 
 
Continuing operations
$
1.81

 
$
1.88

Discontinued operations
(0.06
)
 
(0.02
)
Total
$
1.75

 
$
1.86


(1)
Certain computations may reflect rounding adjustments.
XML 46 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 47 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies
3 Months Ended
Jun. 30, 2014
Accounting Policies [Abstract]  
Significant Accounting Policies
Significant Accounting Policies
Basis of Presentation: The condensed consolidated financial statements of McKesson Corporation (“McKesson,” the “Company,” or “we” and other similar pronouns) include the financial statements of all wholly-owned subsidiaries and majority‑owned or controlled companies. We also evaluate our ownership, contractual and other interests in entities to determine if they are variable interest entities (“VIEs”), if we have a variable interest in those entities and the nature and extent of those interests. These evaluations are highly complex and involve judgment and the use of estimates and assumptions based on available historical information and management’s judgment, among other factors. Based on our evaluations, if we determine we are the primary beneficiary of such VIEs, we consolidate such entities into our financial statements. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method and our proportionate share of income or loss is recorded in other income, net. Intercompany transactions and balances have been eliminated. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnote disclosures normally included in the annual consolidated financial statements.
To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. In our opinion, the accompanying unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods presented.
The results of operations for the quarter ended June 30, 2014 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies and financial notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2014 previously filed with the SEC on May 14, 2014 (“2014 Annual Report”).
Certain prior period amounts have been reclassified to conform to the current period presentation.
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year.
Recently Adopted Accounting Pronouncements
Cumulative Translation Adjustments: In the first quarter of 2015, we adopted amended guidance for parent’s accounting for the cumulative translation adjustment upon derecognition of certain subsidiaries or group of assets within a foreign entity or of an investment in a foreign entity.  The amended guidance requires the release of any cumulative translation adjustment into net income only upon complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.  Also, it requires the release of all or a pro rata portion of the cumulative translation adjustment to net income in case of sale of an equity method investment that is a foreign entity.  The adoption of this amended guidance did not have a material effect on our condensed financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
Discontinued Operations: In April 2014, amended guidance was issued for reporting of discontinued operations and disclosures of disposals of components.  The amended guidance raises the threshold for disposals to qualify as discontinued operations and permits significant continuing involvement and continuing cash flows with the discontinued operation.  In addition, the amended guidance requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation.  The amended guidance is effective for us prospectively commencing in the first quarter of 2016.  Early adoption is permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.
Revenue Recognition: In May 2014, amended guidance was issued for recognizing revenue from contracts with customers.  The amended guidance eliminated industry specific guidance and applies to all companies.  Revenues will be recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service. Revenue from a contract that contains multiple performance obligations is allocated to each performance obligation generally on a relative standalone selling price basis. The amended guidance also requires additional quantitative and qualitative disclosures. The amended guidance is effective for us commencing in the first quarter of 2018.  The amended guidance allows for either full retrospective adoption or modified retrospective adoption. Early adoption is not permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.
XML 48 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Comprehensive Income (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Statement of Comprehensive Income [Abstract]    
Net Income $ 411 $ 424
Other Comprehensive Income (Loss), Net of Tax    
Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 (1) 98 [1] (61) [1]
Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil (2) 1
Retirement-related benefit plans, net of income tax expense of $1 and $4 2 7
Other Comprehensive Income (Loss), Net of Tax 98 (53)
Comprehensive Income 509 371
Comprehensive Loss Attributable to Noncontrolling Interests 4 0
Comprehensive Income Attributable to McKesson $ 513 $ 371
[1] The first quarter of 2015 includes net foreign currency translation loss of $12 million attributable to noncontrolling interests.
XML 49 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements
3 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
At June 30, 2014 and March 31, 2014, the carrying amounts of cash, cash equivalents, restricted cash, marketable securities receivables, drafts and accounts payable and other current liabilities generally approximated their estimated fair values because of the short maturity of these financial instruments.
Our long-term debt and other financing are carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $10.2 billion and $10.7 billion at June 30, 2014 and $10.4 billion and $10.8 billion at March 31, 2014. The estimated fair values of our long-term debt and other financing were determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.
Included in cash and cash equivalents at June 30, 2014 and March 31, 2014 were investments in money market funds, time deposits and repurchase agreements of $3.4 billion and $2.9 billion, which are reported at fair value. The fair value of these investments was determined by using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.
Fair values of our forward foreign currency derivatives were determined using quoted market prices of similar instruments in an active market and other observable inputs from available market information.  These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, "Hedging Activities," for more information on our forward foreign currency derivatives.
There were no transfers between Level 1, Level 2 or Level 3 of the fair value hierarchy during the quarters ended June 30, 2014 and 2013.
XML 50 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information Document
3 Months Ended
Jun. 30, 2014
Document And Entity Information [Abstract]  
Entity Registrant Name MCKESSON CORP
Entity Central Index Key 0000927653
Current Fiscal Year End Date --03-31
Entity Filer Category Large Accelerated Filer
Document Type 10-Q
Document Period End Date Jun. 30, 2014
Document Fiscal Year Focus 2015
Document Fiscal Period Focus Q1
Amendment Flag false
Entity Common Stock, Shares Outstanding 231,599,218
XML 51 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingent Liabilities
3 Months Ended
Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingent Liabilities
In addition to commitments and obligations in the ordinary course of business, we are subject to various claims, other pending and potential legal actions for damages, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of our business. As described below, many of these proceedings are at preliminary stages and many seek an indeterminate amount of damages.
When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate a range of possible loss. When a loss is probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided.
Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. We review all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties. Such factors bear directly on whether it is possible to reasonably estimate a range of potential loss and boundaries of high and low estimates.
Significant developments in previously reported proceedings and in other litigation and claims, since the filing of our 2014 Annual Report are set out below. Unless otherwise stated, we are currently unable to estimate a range of reasonably possible losses for the unresolved proceedings described below. Should any one or a combination of more than one of these proceedings be successful, or should we determine to settle any or a combination of these matters, we may be required to pay substantial sums, become subject to the entry of an injunction or be forced to change the manner in which we operate our business, which could have a material adverse impact on our financial position or results of operations.
Litigation, Government Subpoenas and Investigations
On May 21, 2014, four hedge funds managed by Magnetar Capital filed a complaint against Dragonfly GmbH & Co KGaA (“Dragonfly”), a wholly-owned subsidiary of the Company, in a German court in Frankfurt, Germany, alleging that Dragonfly violated German takeover law in connection with the Company’s acquisition of Celesio by paying more to some holders of Celesio’s convertible bonds than it paid to the shareholders of Celesio’s stock, and seeking approximately $356,000 (or €261,000) in damages plus an unspecified amount of interest, Magnetar Capital Master Fund Ltd. et al. v. Dragonfly GmbH & Co KGaA, (No. 3-05 O 44/14).  Other minority shareholders may seek to file similar lawsuits alleging the same claim, seeking damages based on their shares of Celesio stock. Dragonfly has not yet responded to the complaint.
On June 17, 2014, U.S. Oncology Specialty, LP (“USOS”), an indirect wholly-owned subsidiary of the Company, was served with a fifth amended qui tam complaint filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States and twelve states, against USOS and fifteen oncology practices, alleging that USOS facilitated the payment of illegal “kickbacks” from Amgen to the oncology practices in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys’ fees and costs of suit, all in unspecified amounts, United States ex rel. Hanks v. U.S. Oncology Specialty, LP, et al., (CV 04-3983 (SJ)).  Previously, the United States and the twelve states named in the operative complaint declined to intervene in the case.  The Court set August 1, 2014 as the deadline for USOS and the other defendants to respond to the complaint.
From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests also can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the healthcare industry, as well as to settlements. Examples of such subpoenas and investigations are included in the Company’s 2014 Annual Report on Form 10-K, and include subpoenas from the U.S. Drug Enforcement Administration to certain of the Company’s pharmaceutical distribution facilities seeking information and records about the Company’s distribution of certain controlled substances. The Company is currently responding to these requests. In addition, as previously reported, the Company was informed in the third quarter of 2014 of an investigation by the United States Department of Justice through the United States Attorney’s Office for the Northern District of West Virginia of potential claims under the Comprehensive Drug Abuse Prevention and Control Act.  The Company believes that the investigation is focused on the Company’s pharmaceutical distribution of certain controlled substances by its Landover, Maryland distribution center, which closed in 2012.
XML 52 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Millions, unless otherwise specified
Jun. 30, 2014
Mar. 31, 2014
Current Assets    
Cash and cash equivalents $ 4,105 $ 4,193
Receivables, net 14,920 14,193
Inventories, net 14,124 13,308
Prepaid expenses and other 824 879
Total Current Assets 33,973 32,573
Property, Plant and Equipment, Net 2,209 2,222
Goodwill 10,431 9,927
Intangible Assets, Net 4,390 5,022
Other Assets 2,003 2,015
Total Assets 53,006 51,759
Current Liabilities    
Drafts and accounts payable 22,812 21,429
Short-term borrowings 507 346
Deferred revenue 1,124 1,236
Deferred tax liabilities 1,656 1,588
Current portion of long-term debt 25 1,424
Other accrued liabilities 3,121 3,478
Total Current Liabilities 29,245 29,501
Long-Term Debt 10,141 8,949
Other Noncurrent Liabilities 2,855 2,991
Commitments and Contingent Liabilities (Note 12)      
McKesson Corporation Stockholders' Equity    
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.01 par value, 800 shares authorized at June 30, 2014 and March 31, 2014, 383 and 381 shares issued at June 30, 2014 and March 31, 2014 4 4
Additional Paid-in Capital 6,686 6,552
Retained Earnings 11,800 11,453
Accumulated Other Comprehensive Income (Loss) 107 (3)
Other (7) 23
Treasury Shares, at Cost, 151 and 150 at June 30, 2014 and March 31, 2014 (9,611) (9,507)
Total McKesson Corporation Stockholders’ Equity 8,979 8,522
Noncontrolling Interests 1,786 1,796
Total Equity 10,765 10,318
Total Liabilities and Equity $ 53,006 $ 51,759
XML 53 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Common Share
3 Months Ended
Jun. 30, 2014
Earnings Per Share [Abstract]  
Earnings Per Common Share
Earnings Per Common Share
Basic earnings per common share are computed by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share are computed similar to basic earnings per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.
The computations for basic and diluted earnings per common share are as follows:
  
Quarter Ended June 30,
(In millions, except per share amounts)
2014
 
2013
Income from continuing operations
$
425

 
$
428

Net income attributable to noncontrolling interests
(8
)
 

Income from continuing operations attributable to McKesson
417

 
428

Loss from discontinued operations, net of tax
(14
)
 
(4
)
Net income attributable to McKesson
$
403

 
$
424

 
 
 
 
Weighted average common shares outstanding:
 
 
 
Basic
231

 
227

Effect of dilutive securities:
 
 
 
Options to purchase common stock
2

 
2

Restricted stock units
2

 
3

Diluted
235

 
232

 
 
 
 
Earnings (loss) per common share attributable to McKesson: (1)
 
 
 
Diluted
 
 
 
Continuing operations
$
1.78

 
$
1.84

Discontinued operations
(0.06
)
 
(0.01
)
Total
$
1.72

 
$
1.83

Basic
 
 
 
Continuing operations
$
1.81

 
$
1.88

Discontinued operations
(0.06
)
 
(0.02
)
Total
$
1.75

 
$
1.86


(1)
Certain computations may reflect rounding adjustments.
Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2 million and 3 million potentially dilutive securities were excluded from the computations of diluted net earnings per common share for the quarters ended June 30, 2014 and 2013, as they were anti-dilutive.
XML 54 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
3 Months Ended
Jun. 30, 2014
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
As of June 30, 2014, we had $582 million of unrecognized tax benefits, of which $427 million would reduce income tax expense and the effective tax rate, if recognized. During the next twelve months, it is reasonably possible that audit resolutions and the expiration of statutes of limitations could potentially reduce our unrecognized tax benefits by up to $158 million. However, this amount may change as we continue to have ongoing negotiations with various taxing authorities throughout the year.
We have received reassessments from the Canada Revenue Agency (“CRA”) for a total of $261 million related to a transfer pricing matter impacting years 2003 through 2010. On December 13, 2013, the Tax Court of Canada dismissed our appeal of the 2003 reassessment and we have filed a Notice of Appeal to the Federal Court of Appeal regarding this tax year. During the first quarter of 2015, we filed a Notice of Appeal with the Tax Court of Canada relating to the 2004 through 2008 reassessments.  The ultimate resolution of these issues could result in an increase or decrease to income tax expense.
Through the appeals process, we reached an agreement with the Internal Revenue Service (“IRS”) to settle all outstanding issues relating to years 2003 through 2006. As a result of this agreement we will pay additional taxes of $21 million, which have already been accrued in our financial statements. We are also recognizing a $17 million discrete tax benefit during the quarter to record a previously unrecognized tax benefit.
The IRS is currently examining our U.S. corporation income tax returns for 2007 through 2009. The CRA is currently examining our Canadian Income tax returns for 2011 through 2013. In nearly all jurisdictions, the tax years prior to 2003 are no longer subject to examination.
We report interest and penalties on tax deficiencies as income tax expense. During the quarter, we recognized income tax expense of $4 million, before any tax benefit, related to interest and penalties in our condensed consolidated statements of operations. At June 30, 2014, before any tax benefits, our accrued interest and penalties on unrecognized tax benefits amounted to $161 million.
XML 55 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Discontinued Operations (Tables)
3 Months Ended
Jun. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Results from Discontinued Operations
A summary of results of discontinued operations is as follows:
 
Quarter Ended June 30,
(In millions)
2014
 
2013
Revenues
$
36

 
$
85

 
 
 
 
Loss from discontinued operations
$
(15
)
 
$
(3
)
Income tax (expense) benefit
1

 
(1
)
Loss from discontinued operations, net of tax
$
(14
)
 
$
(4
)
XML 56 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
3 Months Ended
Jun. 30, 2014
Equity [Abstract]  
Stockholders' Equity
Stockholders’ Equity
Each share of the Company’s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company’s Board of Directors (the “Board”).
In July 2013, the Company’s quarterly dividend was raised from $0.20 to $0.24 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.  However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements and other factors.
The total authorization outstanding for repurchases of the Company’s common stock was $340 million at June 30, 2014.
Other Comprehensive Income (Loss)
Information regarding other comprehensive income (loss) including noncontrolling interests, net of tax, by component are as follows:
 
Quarter Ended June 30,
 (In millions)
2014
 
2013
Foreign currency translation adjustments
 
 
 
Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 (1)
$
98

 
$
(61
)
 
 
 
 
Unrealized gains on cash flow hedges
 
 
 
Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil
(2
)
 
1

 
 
 
 
Changes in retirement-related benefit plans
 
 
 
Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1 and $4 (2)
3

 
7

Foreign currency translation adjustments, net of income tax expense of nil and nil
(1
)
 

 
2

 
7

 
 
 
 
Other comprehensive income (loss), net of tax
$
98

 
$
(53
)

(1)
The first quarter of 2015 includes net foreign currency translation loss of $12 million attributable to noncontrolling interests.
(2)
Pre-tax amount reclassified into cost of sales and operating expenses in the condensed consolidated statements of operations. The related tax expense was reclassified into income tax expense in the consolidated statements of operations.
Accumulated Other Comprehensive Income (Loss)
Information regarding changes in McKesson’s accumulated other comprehensive loss, net of tax, by component are as follows:
(In millions)
Foreign Currency Translation Adjustments, Net of Tax
 
Unrealized Losses on Cash Flow Hedges,
Net of Tax
 
Unrealized Net Loss and Other Components of Benefit Plans, Net of Tax
 
Total Accumulated Other Comprehensive Income (Loss)
Balance at March 31, 2014
$
168

 
$
(11
)
 
$
(160
)
 
$
(3
)
 
 
 
 
 
 
 
 
Other comprehensive income (loss) before reclassifications
110

 
(2
)
 

 
108

Amounts reclassified to earnings and other

 

 
2

 
2

Other comprehensive income (loss)
110

 
(2
)
 
2

 
110

Balance at June 30, 2014
$
278

 
$
(13
)
 
$
(158
)
 
$
107

XML 57 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Pension Benefits Pension Benefits
3 Months Ended
Jun. 30, 2014
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]  
Pension and Other Postretirement Benefits Disclosure [Text Block]
Pension Benefits
Net periodic expense for the defined pension benefit plans of the Company and Celesio was $11 million for the first quarters of 2015 and 2014. Cash contributions to these plans were $15 million and $5 million for the first quarters of 2015 and 2014. The increase in contributions in 2015 compared to 2014 is primarily related to defined benefit pension plans of Celesio, which we acquired in the fourth quarter of 2014.
The net periodic expense for our pension plans, which includes net pension expense for Celesio in the first quarter of 2015, is as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
Quarter Ended June 30,
 
Quarter Ended June 30,
(In millions)
2014
 
2013
 
2014
 
2013
Service cost - benefits earned during the year
$

 
$
1

 
$
4

 
$
1

Interest cost on projected benefit obligation
5

 
5

 
9

 
1

Expected return on assets
(5
)
 
(5
)
 
(7
)
 
(2
)
Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation
4

 
9

 
1

 
1

Net periodic pension expense
$
4

 
$
10

 
$
7

 
$
1


The projected unit credit method is utilized in measuring net periodic pension expense over the employees’ service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.
XML 58 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Intangible Assets, Net
3 Months Ended
Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill And Intangible Assets, Net
Goodwill and Intangible Assets, Net
Changes in the carrying amount of goodwill were as follows:
(In millions)
Distribution
Solutions
 
Technology
Solutions
 
Total
Balance, March 31, 2014
$
8,078

 
$
1,849

 
$
9,927

Goodwill acquired
14

 

 
14

Acquisition accounting and other
445

 

 
445

Foreign currency translation adjustments and other
41

 
4

 
45

Balance, June 30, 2014
$
8,578

 
$
1,853

 
$
10,431


As of June 30, 2014 and March 31, 2014, the accumulated goodwill impairment losses were $36 million in our Technology Solutions segment.
Information regarding intangible assets is as follows:
 
June 30, 2014
 
March 31, 2014
(Dollars in millions)
Weighted
Average
Remaining
Amortization
Period
(years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer lists
9
 
$
3,022

 
$
(937
)
 
$
2,085

 
$
3,384

 
$
(863
)
 
$
2,521

Service agreements
16
 
1,014

 
(189
)
 
825

 
995

 
(173
)
 
822

Pharmacy licenses
27
 
1,051

 
(28
)
 
1,023

 
1,219

 
(11
)
 
1,208

Trademarks and trade names
15
 
377

 
(68
)
 
309

 
371

 
(59
)
 
312

Technology
3
 
218

 
(177
)
 
41

 
219

 
(173
)
 
46

Other
4
 
173

 
(66
)
 
107

 
165

 
(52
)
 
113

Total
 
 
$
5,855


$
(1,465
)
 
$
4,390

 
$
6,353

 
$
(1,331
)
 
$
5,022


Amortization expense of intangible assets was $130 million and $71 million for the quarters ended June 30, 2014 and 2013. Estimated annual amortization expense of these assets is as follows: $383 million, $468 million, $429 million, $410 million and $382 million for the remainder of 2015 and each of the succeeding years through 2019 and $2,318 million thereafter. All intangible assets were subject to amortization as of June 30, 2014 and March 31, 2014.
XML 59 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt and Financing Activities
3 Months Ended
Jun. 30, 2014
Debt Disclosure [Abstract]  
Debt and Financing Activities
Debt and Financing Activities
Celesio Debt
Upon the acquisition of Celesio, as required, we consolidated Celesio’s debt including corporate bonds consisting of 4.00% bonds due October 18, 2016 and 4.50% bonds due April 26, 2017. At June 30, 2014 and March 31, 2014, $500 million and $507 million of the 4.00% bonds and $726 million and $737 million of the 4.50% bonds, for a total of $1,226 million and $1,244 million, were outstanding. As of March 31, 2014, these bonds were classified within current liabilities as bondholders had the option to redeem the bonds at par value plus accrued interest. This redemption option expired during the first quarter of 2015 and the remaining bonds outstanding will mature according to their respective maturity dates. Accordingly, as of June 30, 2014, these bonds have been classified as long-term debt.
We also consolidated Celesio’s accounts receivable factoring facilities (the “Factoring Facilities”) with a total committed and uncommitted balance of $315 million. The Factoring Facilities will expire through September 2015. During the first quarter of 2015, Celesio borrowed and repaid $758 million and $746 million of short-term borrowings under the Factoring Facilities. At June 30, 2014 and March 31, 2014, there were $258 million and $246 million in secured borrowings and related securitized accounts receivable outstanding under the Factoring Facilities.
Celesio also maintains a syndicated €500 million five-year senior unsecured revolving credit facility, which expires in February 2018. Borrowings under this facility bear interest based upon the Euro Interbank Offered Rate plus an agreed margin. There were no borrowings under this facility during the first quarter of 2015 and there were no amounts outstanding under this facility as of June 30, 2014 and March 31, 2014.
Celesio also maintains bilateral credit lines with a total committed and uncommitted balance of $2.0 billion. During the first quarter of 2015, Celesio borrowed and repaid $159 million and $30 million under these credit lines primarily relating to short‑term borrowings. As of June 30, 2014 and March 31, 2014, there were $321 million and $188 million outstanding under these credit lines.
Accounts Receivable Sales Facility
We have an accounts receivable sales facility (the “Facility”) with a committed balance of $1.35 billion, although from time to time, the available amount of the Facility may be less than $1.35 billion based on accounts receivable concentration limits and other eligibility requirements. The Facility will expire in November 2014 and we anticipate renewing the Facility before its expiration.
During the first quarter of 2015, there were no borrowings under the Facility. During the first quarter of 2014, we borrowed and repaid $100 million of short-term borrowings under the Facility. At June 30, 2014 and March 31, 2014, there were no short‑term borrowings and related securitized accounts receivable outstanding under the Facility.
The Facility contains requirements relating to the performance of the accounts receivable and covenants relating to the Company. If we do not comply with these covenants, our ability to use the Facility may be suspended and repayment of any outstanding balances under the Facility may be required. At June 30, 2014 and March 31, 2014, we were in compliance with all covenants.
Revolving Credit Facility
We have a syndicated $1.3 billion five-year senior unsecured revolving credit facility, which expires in September 2016. Borrowings under this facility bear interest based upon either the London Interbank Offered Rate or a prime rate. There were no borrowings under this facility during the first quarters of 2015 and 2014. As of June 30, 2014 and March 31, 2014, there were no amounts outstanding under this facility.
XML 60 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hedging Activities
3 Months Ended
Jun. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Activities Disclosure [Text Block]
Hedging Activities
In the normal course of business, we are exposed to interest rate changes and foreign currency fluctuations. At times, we limit these risks through the use of derivatives such as interest rate swaps and forward foreign exchange contracts. In accordance with our policy, derivatives are only used for hedging purposes. We do not use derivatives for trading or speculative purposes.
Foreign currency rate risk
Prior to the acquisition of Celesio, the majority of our operations were conducted in U. S. dollars; however, certain assets and liabilities, revenues and expense and purchasing activities were incurred in and exposed to other currencies. We have established certain foreign currency rate risk programs that manage the impact of foreign currency fluctuation. These programs are utilized on a transactional basis when we consider there to be a risk in fair value or volatility in cash flows. These programs reduce but do not entirely eliminate foreign currency rate risk.
Historically, we have entered into forward contracts and a foreign currency option to hedge against cash flows denominated primarily in Canadian dollars, Euros and British pounds. At June 30, 2014 and March 31, 2014, forward contracts having a total notional value of $463 million were designated for hedge accounting. These contracts will mature between March 2015 and March 2020. Changes in the fair values for contracts designated for hedge accounting are recorded to accumulated other comprehensive income and reclassified into earnings in the same period in which the hedged transaction affects earnings; amounts recorded to earnings for these contracts were not material during the first quarters of 2015 and 2014. Changes in the fair values for contracts not designated for hedge accounting are recorded directly to earnings; amounts recorded to earnings for these contracts were not material during the first quarter of 2014. All forward contracts were designated for hedge accounting during the first quarter of 2015.
Celesio has a number of forward contracts to hedge against cash flows denominated primarily in British pounds and other European currencies. These contracts will mature from July 2014 to June 2015. None of these contracts were designated for hedge accounting and accordingly, changes in the fair value of these contracts are recorded directly in earnings. At June 30, 2014 and March 31, 2014, the total notional values of these contracts were $1,449 million and $1,091 million. Amounts recorded to earnings were not material during the first quarter of 2015.
Interest rate risk
Celesio also has interest rate swaps to hedge the interest rate risk associated with Celesio’s variable rate debt. Interest rate swaps are used to modify the market risk exposures in connection with the variable rate debt to achieve primarily Euro dollar fixed rate interest expense. The interest rate swap transactions generally involve the exchange of floating or fixed interest payments. The interest rate swaps will mature through September 2014. These contracts are not designated for hedge accounting and, accordingly, changes in the fair value of the swaps are recorded directly in earnings. At June 30, 2014 and March 31, 2014, the total gross notional values of these contracts were $68 million and $96 million. Amounts recorded to earnings were not material during the first quarter of 2015.
Information regarding the fair value of derivatives on a gross basis is as follows:
 
Balance Sheet
Caption
June 30, 2014
 
March 31, 2014
 
Fair Value of
Derivative
U.S. Dollar Notional
 
Fair Value of
Derivative
U.S Dollar Notional
(In millions)
Asset
Liability
 
Asset
Liability
Derivatives designated for hedge accounting
 
 
 
 
 
 
 
 
Foreign exchange
 contracts (current)
Prepaid expenses and other
$
2

$

$
64

 
$
4

$

$
64

Foreign exchange
 contracts (non-current)
Other assets
15


399

 
27


399

Total
 
$
17

$

 
 
$
31

$

 
Derivatives not designated for hedge accounting
 
 
 
 
 
 
 
 
Foreign exchange
 contracts (current)
Prepaid expenses and other
$
2

$

$
174

 
$
2

$

$
255

Foreign exchange
 contracts (current)
Other accrued liabilities

26

1,275

 

13

836

Interest rate swap contracts (current)
Other accrued liabilities


68

 

1

96

Total
 
$
2

$
26

 
 
$
2

$
14

 

Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.
XML 61 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Discontinued Operations Discontinued Operations (Schedule of Results from Discontinued Operations) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Discontinued Operations and Disposal Groups [Abstract]    
Revenues $ 36 $ 85
Loss from discontinued operations (15) (3)
Income tax (expense) benefit 1 (1)
Loss from discontinued operations, net of tax $ (14) $ (4)
XML 62 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Equity [Abstract]    
Foreign currency translation adjustments arising during period, net of income tax expense of nil and $2 (1) $ 98 [1] $ (61) [1]
Unrealized gains (losses) on cash flow hedges arising during period, net of income tax expense of nil and nil (2) 1
Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense of $1 and $4 (2) 3 [2] 7 [2]
Foreign currency translation adjustments, net of income tax expense of nil and nil (1) 0
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax 2 7
Other comprehensive income (loss), net of tax $ 98 $ (53)
[1] The first quarter of 2015 includes net foreign currency translation loss of $12 million attributable to noncontrolling interests.
[2] Pre-tax amount reclassified into cost of sales and operating expenses in the condensed consolidated statements of operations. The related tax expense was reclassified into income tax expense in the consolidated statements of operations.
XML 63 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Policy)
3 Months Ended
Jun. 30, 2014
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation: The condensed consolidated financial statements of McKesson Corporation (“McKesson,” the “Company,” or “we” and other similar pronouns) include the financial statements of all wholly-owned subsidiaries and majority‑owned or controlled companies. We also evaluate our ownership, contractual and other interests in entities to determine if they are variable interest entities (“VIEs”), if we have a variable interest in those entities and the nature and extent of those interests. These evaluations are highly complex and involve judgment and the use of estimates and assumptions based on available historical information and management’s judgment, among other factors. Based on our evaluations, if we determine we are the primary beneficiary of such VIEs, we consolidate such entities into our financial statements. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method and our proportionate share of income or loss is recorded in other income, net. Intercompany transactions and balances have been eliminated. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnote disclosures normally included in the annual consolidated financial statements.
Use Of Estimates
To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. In our opinion, the accompanying unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods presented.
The results of operations for the quarter ended June 30, 2014 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies and financial notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2014 previously filed with the SEC on May 14, 2014 (“2014 Annual Report”).
Reclassifications
Certain prior period amounts have been reclassified to conform to the current period presentation.
Fiscal Period
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year.
Recently Adopted Accounting Pronouncements
Cumulative Translation Adjustments: In the first quarter of 2015, we adopted amended guidance for parent’s accounting for the cumulative translation adjustment upon derecognition of certain subsidiaries or group of assets within a foreign entity or of an investment in a foreign entity.  The amended guidance requires the release of any cumulative translation adjustment into net income only upon complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.  Also, it requires the release of all or a pro rata portion of the cumulative translation adjustment to net income in case of sale of an equity method investment that is a foreign entity.  The adoption of this amended guidance did not have a material effect on our condensed financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
Discontinued Operations: In April 2014, amended guidance was issued for reporting of discontinued operations and disclosures of disposals of components.  The amended guidance raises the threshold for disposals to qualify as discontinued operations and permits significant continuing involvement and continuing cash flows with the discontinued operation.  In addition, the amended guidance requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation.  The amended guidance is effective for us prospectively commencing in the first quarter of 2016.  Early adoption is permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.
Revenue Recognition: In May 2014, amended guidance was issued for recognizing revenue from contracts with customers.  The amended guidance eliminated industry specific guidance and applies to all companies.  Revenues will be recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service. Revenue from a contract that contains multiple performance obligations is allocated to each performance obligation generally on a relative standalone selling price basis. The amended guidance also requires additional quantitative and qualitative disclosures. The amended guidance is effective for us commencing in the first quarter of 2018.  The amended guidance allows for either full retrospective adoption or modified retrospective adoption. Early adoption is not permitted. We are currently evaluating the impact of this amended guidance on our consolidated financial statements.
XML 64 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Pension Benefits Pension Benefits (Tables)
3 Months Ended
Jun. 30, 2014
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]  
Schedule of Net Benefit Costs [Table Text Block]
The net periodic expense for our pension plans, which includes net pension expense for Celesio in the first quarter of 2015, is as follows:
 
U.S. Plans
 
Non-U.S. Plans
 
Quarter Ended June 30,
 
Quarter Ended June 30,
(In millions)
2014
 
2013
 
2014
 
2013
Service cost - benefits earned during the year
$

 
$
1

 
$
4

 
$
1

Interest cost on projected benefit obligation
5

 
5

 
9

 
1

Expected return on assets
(5
)
 
(5
)
 
(7
)
 
(2
)
Amortization of unrecognized actuarial loss, prior service costs and net transitional obligation
4

 
9

 
1

 
1

Net periodic pension expense
$
4

 
$
10

 
$
7

 
$
1

XML 65 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingent Liabilities (Narrative) (Details)
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2014
USD ($)
States
Defendants
Jun. 30, 2014
EUR (€)
Committments and Contingencies Disclosure [Abstract]    
Loss Contingency, Damages Sought, Value $ 356 € 261
Loss Contingency Number of States Filed On Behalf Of 12 12
Loss Contingency, Number of Defendants 15 15
XML 66 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Intangible Assets, Net (Information Regarding Intangible Assets) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2014
Mar. 31, 2014
Intangible assets    
Gross Carrying Amount $ 5,855 $ 6,353
Accumulated Amortization (1,465) (1,331)
Net Carrying Amount 4,390 5,022
Customer lists
   
Intangible assets    
Weighted Average Remaining Amortization Period (years) 9 years  
Gross Carrying Amount 3,022 3,384
Accumulated Amortization (937) (863)
Net Carrying Amount 2,085 2,521
Service agreements
   
Intangible assets    
Weighted Average Remaining Amortization Period (years) 16 years  
Gross Carrying Amount 1,014 995
Accumulated Amortization (189) (173)
Net Carrying Amount 825 822
Pharmacy Licenses
   
Intangible assets    
Weighted Average Remaining Amortization Period (years) 27 years  
Gross Carrying Amount 1,051 1,219
Accumulated Amortization (28) (11)
Net Carrying Amount 1,023 1,208
Trademarks and trade names
   
Intangible assets    
Weighted Average Remaining Amortization Period (years) 15 years  
Gross Carrying Amount 377 371
Accumulated Amortization (68) (59)
Net Carrying Amount 309 312
Technology-Based Intangible Assets
   
Intangible assets    
Weighted Average Remaining Amortization Period (years) 3 years  
Gross Carrying Amount 218 219
Accumulated Amortization (177) (173)
Net Carrying Amount 41 46
Other
   
Intangible assets    
Weighted Average Remaining Amortization Period (years) 4 years  
Gross Carrying Amount 173 165
Accumulated Amortization (66) (52)
Net Carrying Amount $ 107 $ 113
XML 67 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (Parentheticals) (USD $)
Jun. 30, 2014
Mar. 31, 2014
McKesson Corporation Stockholders' Equity    
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 100,000,000 100,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 800,000,000 800,000,000
Common stock, shares issued 383,000,000 381,000,000
Treasury stock, shares 151,000,000 150,000,000
XML 68 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Discontinued Operations
3 Months Ended
Jun. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations
Discontinued Operations
In 2014, we committed to a plan to sell our International Technology and our Hospital Automation businesses from our Technology Solutions segment and certain businesses from our Distribution Solutions segment. As required, we classified the results of operations and cash flows of these businesses as discontinued operations for all periods presented in our consolidated financial statements in 2014 and depreciation and amortization expense was not recognized.
During the third quarter of 2014, our Hospital Automation business was sold for net cash proceeds of $55 million and we recorded a pre-tax and after-tax loss of $5 million and $7 million.
During the third quarter of 2014, we recorded an $80 million pre-tax ($80 million after-tax) non-cash impairment charge to reduce the carrying value of our International Technology business to its estimated net realizable value (fair value less costs to sell). The charge was primarily the result of the terms of the preliminary purchase offers received for this business during the third quarter of 2014. The impairment charge was primarily attributed to goodwill and other long-lived assets and as a result, there was no tax benefit associated with this charge. During the first quarter of 2015, we entered into an agreement to sell the software business within our International Technology business. We completed the sale of the software business on July 1, 2014 and no material gain or loss is anticipated. 
During the first quarter of 2015, we also decided to retain the workforce business within our International Technology business. This business consists of workforce management solutions for the National Health Service in the United Kingdom, which we now intend to wind down in 2016. As a result, we reclassified the workforce business, which had been designated as a discontinued operation since the first quarter of 2014, as a continuing operation for all periods presented. During the first quarter of 2015, we also recorded a non-cash pre-tax charge of $34 million ($27 million after-tax) primarily relating to depreciation and amortization expense for 2014 when the business was classified as held for sale. The non-cash charge was recorded in our condensed consolidated statement of operations as follows: $32 million in cost of sales and $2 million in operating expenses.
A summary of results of discontinued operations is as follows:
 
Quarter Ended June 30,
(In millions)
2014
 
2013
Revenues
$
36

 
$
85

 
 
 
 
Loss from discontinued operations
$
(15
)
 
$
(3
)
Income tax (expense) benefit
1

 
(1
)
Loss from discontinued operations, net of tax
$
(14
)
 
$
(4
)

The assets and liabilities of our discontinued operations are classified as held-for-sale effective in 2014. All applicable assets of the businesses to be sold are included under the caption “Prepaid expenses and other” and all applicable liabilities under the caption “Other accrued liabilities” within our condensed consolidated balance sheet at June 30, 2014 and March 31, 2014. The carrying values of the assets and liabilities classified as held-for-sale were $138 million and $144 million at June 30, 2014 and $267 million and $248 million at March 31, 2014.
XML 69 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Hedging Activities Derivative Fair Value Table (Tables)
3 Months Ended
Jun. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair Value, by Balance Sheet Grouping [Table Text Block]
Information regarding the fair value of derivatives on a gross basis is as follows:
 
Balance Sheet
Caption
June 30, 2014
 
March 31, 2014
 
Fair Value of
Derivative
U.S. Dollar Notional
 
Fair Value of
Derivative
U.S Dollar Notional
(In millions)
Asset
Liability
 
Asset
Liability
Derivatives designated for hedge accounting
 
 
 
 
 
 
 
 
Foreign exchange
 contracts (current)
Prepaid expenses and other
$
2

$

$
64

 
$
4

$

$
64

Foreign exchange
 contracts (non-current)
Other assets
15


399

 
27


399

Total
 
$
17

$

 
 
$
31

$

 
Derivatives not designated for hedge accounting
 
 
 
 
 
 
 
 
Foreign exchange
 contracts (current)
Prepaid expenses and other
$
2

$

$
174

 
$
2

$

$
255

Foreign exchange
 contracts (current)
Other accrued liabilities

26

1,275

 

13

836

Interest rate swap contracts (current)
Other accrued liabilities


68

 

1

96

Total
 
$
2

$
26

 
 
$
2

$
14

 
XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 133 250 1 true 50 0 false 9 false false R1.htm 0002000 - Document - Document and Entity Information Document Sheet http://mckesson123.com/role/DocumentAndEntityInformationDocument Document and Entity Information Document false false R2.htm 1001000 - Statement - Condensed Consolidated Statements Of Operations Sheet http://mckesson123.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements Of Operations false false R3.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://mckesson123.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income true false R4.htm 1003000 - Statement - Condensed Consolidated Balance Sheets Sheet http://mckesson123.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R5.htm 1003501 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://mckesson123.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) false false R6.htm 1004000 - Statement - Condensed Consolidated Statements Of Cash Flows Sheet http://mckesson123.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements Of Cash Flows false false R7.htm 2101100 - Disclosure - Significant Accounting Policies Sheet http://mckesson123.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R8.htm 2102100 - Disclosure - Business Combinations Sheet http://mckesson123.com/role/BusinessCombinations Business Combinations false false R9.htm 2106100 - Disclosure - Noncontrolling Interests Noncontrolling Interests Sheet http://mckesson123.com/role/NoncontrollingInterestsNoncontrollingInterests Noncontrolling Interests Noncontrolling Interests false false R10.htm 2107100 - Disclosure - Discontinued Operations Sheet http://mckesson123.com/role/DiscontinuedOperations Discontinued Operations false false R11.htm 2108100 - Disclosure - Income Taxes Sheet http://mckesson123.com/role/IncomeTaxes Income Taxes false false R12.htm 2111100 - Disclosure - Earnings Per Common Share Sheet http://mckesson123.com/role/EarningsPerCommonShare Earnings Per Common Share false false R13.htm 2113100 - Disclosure - Goodwill And Intangible Assets, Net Sheet http://mckesson123.com/role/GoodwillAndIntangibleAssetsNet Goodwill And Intangible Assets, Net false false R14.htm 2114100 - Disclosure - Debt and Financing Activities Sheet http://mckesson123.com/role/DebtAndFinancingActivities Debt and Financing Activities false false R15.htm 2115100 - Disclosure - Pension Benefits Pension Benefits Sheet http://mckesson123.com/role/PensionBenefitsPensionBenefits Pension Benefits Pension Benefits false false R16.htm 2117100 - Disclosure - Hedging Activities Sheet http://mckesson123.com/role/HedgingActivities Hedging Activities false false R17.htm 2118100 - Disclosure - Fair Value Measurements Sheet http://mckesson123.com/role/FairValueMeasurements Fair Value Measurements false false R18.htm 2119100 - Disclosure - Commitments and Contingent Liabilities Sheet http://mckesson123.com/role/CommitmentsAndContingentLiabilities Commitments and Contingent Liabilities false false R19.htm 2120100 - Disclosure - Stockholders' Equity Sheet http://mckesson123.com/role/StockholdersEquity Stockholders' Equity false false R20.htm 2121100 - Disclosure - Segment Information Sheet http://mckesson123.com/role/SegmentInformation Segment Information false false R21.htm 2201201 - Disclosure - Significant Accounting Policies (Policy) Sheet http://mckesson123.com/role/SignificantAccountingPoliciesPolicy Significant Accounting Policies (Policy) false false R22.htm 2302301 - Disclosure - Business Combinations (Tables) Sheet http://mckesson123.com/role/BusinessCombinationsTables Business Combinations (Tables) false false R23.htm 2307301 - Disclosure - Discontinued Operations (Tables) Sheet http://mckesson123.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) false false R24.htm 2311301 - Disclosure - Earnings Per Common Share (Tables) Sheet http://mckesson123.com/role/EarningsPerCommonShareTables Earnings Per Common Share (Tables) false false R25.htm 2313301 - Disclosure - Goodwill And Intangible Assets, Net (Tables) Sheet http://mckesson123.com/role/GoodwillAndIntangibleAssetsNetTables Goodwill And Intangible Assets, Net (Tables) false false R26.htm 2315301 - Disclosure - Pension Benefits Pension Benefits (Tables) Sheet http://mckesson123.com/role/PensionBenefitsPensionBenefitsTables Pension Benefits Pension Benefits (Tables) false false R27.htm 2317301 - Disclosure - Hedging Activities Derivative Fair Value Table (Tables) Sheet http://mckesson123.com/role/HedgingActivitiesDerivativeFairValueTableTables Hedging Activities Derivative Fair Value Table (Tables) false false R28.htm 2320301 - Disclosure - Stockholders' Equity (Tables) Sheet http://mckesson123.com/role/StockholdersEquityTables Stockholders' Equity (Tables) false false R29.htm 2321301 - Disclosure - Segment Information (Tables) Sheet http://mckesson123.com/role/SegmentInformationTables Segment Information (Tables) false false R30.htm 2402402 - Disclosure - Business Combinations (Narrative) (Details) Sheet http://mckesson123.com/role/BusinessCombinationsNarrativeDetails Business Combinations (Narrative) (Details) false false R31.htm 2402403 - Disclosure - Business Combinations (Fair Value Of Assets Acquired And Liabilities Assumed) (Details) Sheet http://mckesson123.com/role/BusinessCombinationsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails Business Combinations (Fair Value Of Assets Acquired And Liabilities Assumed) (Details) false false R32.htm 2406401 - Disclosure - Noncontrolling Interests Noncontrolling Interests (Narrative) (Details) Sheet http://mckesson123.com/role/NoncontrollingInterestsNoncontrollingInterestsNarrativeDetails Noncontrolling Interests Noncontrolling Interests (Narrative) (Details) false false R33.htm 2407402 - Disclosure - Discontinued Operations Discontinued Operations (Narrative) (Details) Sheet http://mckesson123.com/role/DiscontinuedOperationsDiscontinuedOperationsNarrativeDetails Discontinued Operations Discontinued Operations (Narrative) (Details) false false R34.htm 2407403 - Disclosure - Discontinued Operations Discontinued Operations (Schedule of Results from Discontinued Operations) (Details) Sheet http://mckesson123.com/role/DiscontinuedOperationsDiscontinuedOperationsScheduleOfResultsFromDiscontinuedOperationsDetails Discontinued Operations Discontinued Operations (Schedule of Results from Discontinued Operations) (Details) false false R35.htm 2408401 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://mckesson123.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) false false R36.htm 2411402 - Disclosure - Earnings Per Common Share (Narrative) (Details) Sheet http://mckesson123.com/role/EarningsPerCommonShareNarrativeDetails Earnings Per Common Share (Narrative) (Details) false false R37.htm 2411403 - Disclosure - Earnings Per Common Share (Basic and Diluted Earnings per Common Share) (Details) Sheet http://mckesson123.com/role/EarningsPerCommonShareBasicAndDilutedEarningsPerCommonShareDetails Earnings Per Common Share (Basic and Diluted Earnings per Common Share) (Details) false false R38.htm 2413402 - Disclosure - Goodwill And Intangible Assets, Net Goodwill And Intangible Assets, Net (Narrative - Goodwill) (Details) Sheet http://mckesson123.com/role/GoodwillAndIntangibleAssetsNetGoodwillAndIntangibleAssetsNetNarrativeGoodwillDetails Goodwill And Intangible Assets, Net Goodwill And Intangible Assets, Net (Narrative - Goodwill) (Details) false false R39.htm 2413403 - Disclosure - Goodwill And Intangible Assets, Net (Narrative - Intangible Assets) (Details) Sheet http://mckesson123.com/role/GoodwillAndIntangibleAssetsNetNarrativeIntangibleAssetsDetails Goodwill And Intangible Assets, Net (Narrative - Intangible Assets) (Details) false false R40.htm 2413404 - Disclosure - Goodwill And Intangible Assets, Net (Changes In The Carrying Amount Of Goodwill) (Details) Sheet http://mckesson123.com/role/GoodwillAndIntangibleAssetsNetChangesInCarryingAmountOfGoodwillDetails Goodwill And Intangible Assets, Net (Changes In The Carrying Amount Of Goodwill) (Details) false false R41.htm 2413405 - Disclosure - Goodwill And Intangible Assets, Net (Information Regarding Intangible Assets) (Details) Sheet http://mckesson123.com/role/GoodwillAndIntangibleAssetsNetInformationRegardingIntangibleAssetsDetails Goodwill And Intangible Assets, Net (Information Regarding Intangible Assets) (Details) false false R42.htm 2414401 - Disclosure - Debt and Financing Activities Debt and Financing Activities (Celesio Debt) (Narrative) (Details) Sheet http://mckesson123.com/role/DebtAndFinancingActivitiesDebtAndFinancingActivitiesCelesioDebtNarrativeDetails Debt and Financing Activities Debt and Financing Activities (Celesio Debt) (Narrative) (Details) false false R43.htm 2414402 - Disclosure - Debt and Financing Activities (Accounts Receivable Sales Facility and Revolving Credit Facility) (Narrative) (Details) Sheet http://mckesson123.com/role/DebtAndFinancingActivitiesAccountsReceivableSalesFacilityAndRevolvingCreditFacilityNarrativeDetails Debt and Financing Activities (Accounts Receivable Sales Facility and Revolving Credit Facility) (Narrative) (Details) false false R44.htm 2415402 - Disclosure - Pension Benefits Pension Benefits (Narrative) (Details) Sheet http://mckesson123.com/role/PensionBenefitsPensionBenefitsNarrativeDetails Pension Benefits Pension Benefits (Narrative) (Details) false false R45.htm 2415403 - Disclosure - Pension Benefits Pension Benefits Tables (Details) Sheet http://mckesson123.com/role/PensionBenefitsPensionBenefitsTablesDetails Pension Benefits Pension Benefits Tables (Details) false false R46.htm 2417402 - Disclosure - Hedging Activities (Narrative) (Details) Sheet http://mckesson123.com/role/HedgingActivitiesNarrativeDetails Hedging Activities (Narrative) (Details) false false R47.htm 2417403 - Disclosure - Hedging Activities Derivative Instruments Fair Value (Details) Sheet http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails Hedging Activities Derivative Instruments Fair Value (Details) false false R48.htm 2418401 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) false false R49.htm 2419401 - Disclosure - Commitments and Contingent Liabilities (Narrative) (Details) Sheet http://mckesson123.com/role/CommitmentsAndContingentLiabilitiesNarrativeDetails Commitments and Contingent Liabilities (Narrative) (Details) false false R50.htm 2420402 - Disclosure - Stockholders' Equity (Narrative) (Details) Sheet http://mckesson123.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity (Narrative) (Details) false false R51.htm 2420403 - Disclosure - Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Details) Sheet http://mckesson123.com/role/StockholdersEquityOtherComprehensiveIncomeLossNetOfTaxDetails Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Details) false false R52.htm 2420404 - Disclosure - Stockholders' Equity Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Parentheticals) (Details) Sheet http://mckesson123.com/role/StockholdersEquityStockholdersEquityOtherComprehensiveIncomeLossNetOfTaxParentheticalsDetails Stockholders' Equity Stockholders' Equity (Other Comprehensive Income (Loss), Net of Tax) (Parentheticals) (Details) false false R53.htm 2420405 - Disclosure - Stockholders' Equity (Changes in Accumulated Other Comprehensive Income (Loss) by Component) (Details) Sheet http://mckesson123.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossByComponentDetails Stockholders' Equity (Changes in Accumulated Other Comprehensive Income (Loss) by Component) (Details) false false R54.htm 2421402 - Disclosure - Segment Information (Narrative) (Details) Sheet http://mckesson123.com/role/SegmentInformationNarrativeDetails Segment Information (Narrative) (Details) false false R55.htm 2421403 - Disclosure - Segment Information (Schedule of Segment Information) (Details) Sheet http://mckesson123.com/role/SegmentInformationScheduleOfSegmentInformationDetails Segment Information (Schedule of Segment Information) (Details) false false All Reports Book All Reports Element us-gaap_DebtConversionConvertedInstrumentSharesIssued1 had a mix of decimals attribute values: -5 0. Element us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity had a mix of decimals attribute values: -7 -6. Element us-gaap_LongTermDebt had a mix of decimals attribute values: -8 -6. Element us-gaap_ProceedsFromLinesOfCredit had a mix of decimals attribute values: -6 0. Element us-gaap_RepaymentsOfLinesOfCredit had a mix of decimals attribute values: -6 0. 'Monetary' elements on report '2402402 - Disclosure - Business Combinations (Narrative) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2414401 - Disclosure - Debt and Financing Activities Debt and Financing Activities (Celesio Debt) (Narrative) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2414402 - Disclosure - Debt and Financing Activities (Accounts Receivable Sales Facility and Revolving Credit Facility) (Narrative) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2418401 - Disclosure - Fair Value Measurements (Narrative) (Details)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - Condensed Consolidated Statements Of Operations Process Flow-Through: 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income Process Flow-Through: 1003000 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: 1003501 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Process Flow-Through: 1004000 - Statement - Condensed Consolidated Statements Of Cash Flows mck-20140630.xml mck-20140630.xsd mck-20140630_cal.xml mck-20140630_def.xml mck-20140630_lab.xml mck-20140630_pre.xml true true XML 71 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill And Intangible Assets, Net Goodwill And Intangible Assets, Net (Narrative - Goodwill) (Details) (Technology Solutions [Member], USD $)
In Millions, unless otherwise specified
Jun. 30, 2014
Mar. 31, 2014
Technology Solutions [Member]
   
Goodwill [Line Items]    
Goodwill, Impaired, Accumulated Impairment Loss $ 36 $ 36
XML 72 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information
3 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Segment Information
We report our operations in two operating segments: McKesson Distribution Solutions and McKesson Technology Solutions. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. We evaluate the performance of our operating segments on a number of measures, including operating profit before interest expense, income taxes and results from discontinued operations.
Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
 
Quarter Ended June 30,
(In millions)
2014
 
2013
Revenues
 
 
 
Distribution Solutions (1)
 
 
 
North America pharmaceutical distribution and services
$
34,304

 
$
30,046

International pharmaceutical distribution and services
7,607

 

Medical-Surgical distribution & services
1,379

 
1,357

Total Distribution Solutions
43,290

 
31,403

 
 
 
 
Technology Solutions - products and services
768

 
836

Total Revenues
$
44,058

 
$
32,239

 
 
 
 
Operating profit
 
 
 
Distribution Solutions
$
748

 
$
619

Technology Solutions (2)
68

 
127

Total
816

 
746

Corporate Expenses, Net
(108
)
 
(85
)
Interest Expense
(101
)
 
(59
)
Income from Continuing Operations Before Income Taxes
$
607

 
$
602

(1)
Revenues derived from services represent less than 2% of this segment’s total revenues.
(2)
Technology Solutions operating profit for the quarter ended June 30, 2014 includes a charge of $34 million related to the retained workforce business within our International Technology business.